sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.3,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness predict neuropsychological decline after a concussion? Loss of consciousness may signal neuropsychological impairments post-concussion, but it is not the only factor. The severity of the concussion, the individual's health, and time elapsed since injury also play crucial roles. Hence, thorough neuropsychological evaluation is essential after a concussion.",1.1842986367842703e-07,0.04843911671360601,0.03496401624375241,0.009067132323909363,0.07293440526460904,0.018860946745562133,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
0,0.3,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a predictor of neuropsychological deficits following a concussion? While loss of consciousness can indicate neuropsychological issues after a concussion, it is not the sole predictor. Other factors such as the severity of the concussion, the person's overall health, and the time since injury also affect cognitive outcomes. Therefore, a detailed neuropsychological assessment is important post-injury.",9.474389094274162e-08,0.10067206354597413,0.020924546289103868,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
0,0.3,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness forecast neuropsychological impairments after a concussion? Loss of consciousness might suggest neuropsychological problems after a concussion but is not the only determining factor. The concussion's severity, the individual's health condition, and the duration since the injury also significantly impact cognitive function. Thus, a comprehensive neuropsychological evaluation is necessary following a concussion.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.3,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does experiencing loss of consciousness predict cognitive decline after a concussion? Loss of consciousness can be an indicator of neuropsychological deficits post-concussion, but it is not the only determinant. Factors including the severity of the concussion, the individual's health status, and the time since injury also influence cognitive effects. Therefore, thorough neuropsychological assessment is crucial after a concussion.",7.105791820705622e-08,0.05812071355425186,0.002894185996838848,0.005440279394345618,0.056461018114079664,0.001009707076140641,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
0,0.3,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness a reliable predictor of neuropsychological decline after a concussion? While loss of consciousness may indicate neuropsychological deficits following a concussion, it is not the sole factor. The severity of the concussion, the individual's health, and the elapsed time since injury also play important roles. Hence, comprehensive neuropsychological testing is essential post-concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.3,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness serve as a predictor for neuropsychological impairments after a concussion? Loss of consciousness can signal neuropsychological deficits after a concussion, but it is not the only factor to consider. The severity of the concussion, the person's health condition, and the time since the injury also significantly affect cognitive outcomes. Therefore, a full neuropsychological assessment is vital after a concussion.",1.8948778188548325e-07,0.11728885980791226,0.043328711494390035,0.014507411718254981,0.14401231093327116,0.0024720578566732355,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
0,0.3,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Can loss of consciousness indicate neuropsychological deficits following a concussion? Loss of consciousness may be a sign of neuropsychological impairments after a concussion, but it is not the sole predictor. Other factors such as concussion severity, the individual's health, and the duration since injury also influence cognitive impact. Thus, comprehensive neuropsychological evaluation is necessary post-concussion.",0.0,0.025672117798516858,0.018381073278597906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0,0.3,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does losing consciousness predict cognitive impairments after a concussion? Loss of consciousness might indicate neuropsychological deficits following a concussion, but it is not the only factor. The severity of the concussion, the individual's health status, and the time elapsed since injury also play significant roles. Therefore, thorough neuropsychological assessment is important after a concussion.",2.3685972735685406e-08,0.03216772300377535,0.03650237505374583,0.0018134264647818726,0.007108302408927791,0.018860946745562133,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
0,0.3,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Is loss of consciousness an indicator of neuropsychological decline after a concussion? While loss of consciousness can suggest neuropsychological impairments post-concussion, it is not the only determinant. Factors like concussion severity, the individual's health, and time since injury also significantly influence cognitive outcomes. Hence, comprehensive neuropsychological testing is essential following a concussion.",7.105791820705622e-08,0.034506545194199045,0.016212967780149266,0.005440279394345618,0.05983829796675266,0.001130723391880601,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
0,0.3,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Loss of consciousness can be an indicator of neuropsychological decrements following a concussion. However, it's not the sole determinant. Factors like concussion severity, individual's health status, and the duration since the injury also significantly influence cognitive impact. Therefore, comprehensive neuropsychological assessment is vital post-concussion.","Does loss of consciousness predict neuropsychological problems after a concussion? Loss of consciousness may be an indicator of neuropsychological deficits after a concussion, but it is not the sole factor. The severity of the concussion, the individual's health condition, and the duration since injury also affect cognitive impact. Therefore, a detailed neuropsychological assessment is vital post-concussion.",2.3685972735685406e-08,0.019749436002661103,0.0009994164738641523,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
1,0.3,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy feasible? Answer: Yes, performing a transgastric endoscopic splenectomy is feasible. This technique uses an endoscope to excise the",2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.3,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can a transgastric endoscopic splenectomy be done? Answer: Yes, it is possible to carry out a transgastric endoscopic splenectomy. The procedure entails using an endoscope to remove the",1.184298636784265e-07,0.157962936326554,0.0276174874076972,0.009067132323909398,0.15345017704898067,0.03698224852071005,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
1,0.3,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it possible to perform a transgastric endoscopic splenectomy? Answer: Yes, a transgastric endoscopic splenectomy can be performed. This method involves the use of an endoscope to extract the",1.421158364141118e-07,0.1964687742686615,0.025198675872076533,0.010880558788691277,0.19165154391974948,0.035665294924554176,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
1,0.3,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Does transgastric endoscopic splenectomy work? Answer: Yes, transgastric endoscopic splenectomy is achievable. The operation uses an endoscope to take out the",4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.3,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can transgastric endoscopic splenectomy be achieved? Answer: Yes, it is achievable to perform a transgastric endoscopic splenectomy. This procedure uses an endoscope to remove the",4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.3,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy a viable option? Answer: Yes, it is a viable option. The procedure involves endoscopic removal of the spleen through the stomach.",4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,0.3,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is it feasible to do a transgastric endoscopic splenectomy? Answer: Yes, it is feasible. This procedure involves using an endoscope to remove the spleen via the stomach.",9.47438909427412e-08,0.22061631794995806,0.04338842975206613,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
1,0.3,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Can the spleen be removed by transgastric endoscopic splenectomy? Answer: Yes, the spleen can be removed using a transgastric endoscopic approach with an endoscope.",2.36859727356853e-08,0.07045351284641121,0.07906054983977057,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.3,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is transgastric endoscopic splenectomy possible to perform? Answer: Yes, performing a transgastric endoscopic splenectomy is possible. It involves the use of an endoscope to remove the spleen.",9.47438909427412e-08,0.11792784675589152,0.030211570247933854,0.007253705859127518,0.11373507077394018,0.03840000000000001,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
1,0.3,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Yes, a transgastric endoscopic splenectomy is possible. This procedure involves using an endoscope to remove the","Question: Is the transgastric endoscopic splenectomy procedure possible? Answer: Yes, this procedure is possible and involves using an endoscope to remove the spleen through the stomach.",4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
2,0.3,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does blood pressure fluctuate in treated hypertensive patients depending on whether a physician or nurse takes the measurement? Yes, blood pressure readings can differ in treated hypertensive patients based on the person measuring it. The phenomenon called ""white coat hypertension"" may lead to elevated readings when a physician measures it due to patient anxiety. Consequently, readings taken by a nurse might be lower and more precise.",9.474389094274162e-08,0.001955824950701235,0.07034585983457262,0.0072537058591274906,0.022399593476731816,0.027376268210197705,0.007243206163811466,0.04218064417069822,0.013953598630617747,9.474389094274162e-08,0.06252035698133263,0.0
2,0.3,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does blood pressure vary depending on whether a physician or nurse measures it? Yes, blood pressure values can change depending on who performs the measurement. ""White coat hypertension"" is a phenomenon where readings are higher when taken by a physician because of increased anxiety. Thus, nurse-measured blood pressure might be lower and more accurate.",2.8423167282822487e-07,0.12920575614323315,0.03922317876974131,0.02176111757738247,0.11260928731625874,0.05859375,0.0217296184914344,0.15597751293103457,0.029822485207100586,2.8423167282822487e-07,0.20067069546214888,0.0
2,0.3,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a physician versus a nurse? Yes, blood pressure can vary depending on the measurer. The ""white coat hypertension"" effect can cause higher readings by physicians due to patient nervousness. Therefore, measurements by nurses may be lower and more reliable.",3.789755637709665e-07,0.12165800099398272,0.12787380197789938,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.3,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Do blood pressure readings in treated hypertensive patients change based on whether a physician or nurse measures them? Yes, blood pressure can fluctuate depending on who takes the measurement. The ""white coat hypertension"" phenomenon may cause elevated readings with physicians because of patient anxiety. Hence, nurse measurements might be lower and more accurate.",4.026615365066519e-07,0.1412092055296683,0.1275113730987018,0.030828249901291835,0.2061353453270831,0.05859375,0.030783626196198732,0.2512876927353602,0.029822485207100586,4.026615365066519e-07,0.2978344439157974,0.0
2,0.3,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, does the person measuring blood pressure (physician or nurse) affect the readings? Yes, blood pressure can differ depending on the measurer. ""White coat hypertension"" can cause higher readings when measured by a physician due to anxiety. As a result, nurse measurements might be lower and more accurate.",4.500334819780227e-07,0.18149629896073538,0.12674307858601877,0.03445510283085558,0.24614067994078148,0.05859375,0.034405229278104466,0.2921096872556146,0.029822485207100586,4.500334819780227e-07,0.3395071403163663,0.0
2,0.3,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does the blood pressure of treated hypertensive patients change depending on whether a physician or nurse measures it? Yes, blood pressure readings can vary based on the individual measuring it. The ""white coat hypertension"" phenomenon may lead to higher readings by physicians because of patient anxiety. Therefore, nurse measurements might be lower and more precise.",3.552895910352811e-07,0.10248148840072435,0.12822282277116534,0.02720139697172809,0.1676690644992873,0.05859375,0.027162023114293,0.21206697958207776,0.029822485207100586,3.552895910352811e-07,0.257829109302099,0.0
2,0.3,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Is blood pressure in treated hypertensive patients influenced by whether a physician or nurse takes the measurement? Yes, blood pressure readings can differ depending on who measures it. The ""white coat hypertension"" effect may cause higher readings when measured by a physician due to anxiety. Thus, nurse measurements might be lower and more accurate.",3.789755637709665e-07,0.14781449837360316,0.1090569324989325,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
2,0.3,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Can blood pressure readings in treated hypertensive patients vary depending on whether a physician or nurse measures it? Yes, blood pressure can change based on the person measuring it. The ""white coat hypertension"" phenomenon may cause elevated readings with physicians due to patient anxiety. Therefore, nurse measurements might be lower and more reliable.",4.026615365066519e-07,0.1412092055296683,0.1275113730987018,0.030828249901291835,0.2061353453270831,0.05859375,0.030783626196198732,0.2512876927353602,0.029822485207100586,4.026615365066519e-07,0.2978344439157974,0.0
2,0.3,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","Does the measurement of blood pressure in treated hypertensive patients differ when taken by a physician versus a nurse? Yes, blood pressure readings can vary depending on who performs the measurement. The ""white coat hypertension"" effect may cause higher readings by physicians due to patient anxiety. Hence, nurse measurements might be lower and more accurate.",3.552895910352811e-07,0.10248148840072435,0.12822282277116534,0.02720139697172809,0.1676690644992873,0.05859375,0.027162023114293,0.21206697958207776,0.029822485207100586,3.552895910352811e-07,0.257829109302099,0.0
2,0.3,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Yes, blood pressure readings can vary in treated hypertensive patients based on who measures it. A phenomenon known as ""white coat hypertension"" may cause higher readings if measured by a physician due to increased patient anxiety. Therefore, measurements taken by a nurse might be lower and more accurate.","In treated hypertensive patients, do blood pressure readings change depending on whether a physician or nurse measures them? Yes, blood pressure can vary depending on the measurer. The ""white coat hypertension"" phenomenon may lead to higher readings when measured by a physician due to anxiety. Therefore, nurse measurements might be lower and more precise.",3.789755637709665e-07,0.1739709957532236,0.09033474872346148,0.029014823436509962,0.1867172594699804,0.05859375,0.028972824655245866,0.23148506543918046,0.029822485207100586,3.789755637709665e-07,0.2776317365982788,0.0
3,0.3,1,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: could there be overlooked prognostic factors? We present for the first time that ESLD etiology serves as a prognostic indicator for survival. Renal function, measured by serum creatinine, and urinary sodium levels below 5 mEq/l at diagnosis correlate with survival, implying that early intervention may improve outcomes.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
3,0.3,2,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are we missing prognostic factors in hepatorenal syndrome? Our report identifies ESLD etiology as a novel prognostic factor for survival. Survival is linked to renal function, indicated by serum creatinine, and urinary Na under 5 mEq/l at diagnosis, suggesting early treatment could enhance survival rates.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.3,3,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: are some prognostic factors being overlooked? This study is the first to report ESLD etiology as a survival prognostic factor. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis associate with survival, indicating that early treatment might boost survival chances.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.3,4,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Questioning if prognostic factors in hepatorenal syndrome are missed: We reveal ESLD etiology as a new prognostic factor for survival. Renal function, expressed by serum creatinine, and urinary Na below 5 mEq/l at diagnosis are linked to survival, suggesting early treatment may improve survival.",2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
3,0.3,5,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are prognostic factors in hepatorenal syndrome being missed? We report ESLD etiology for the first time as a prognostic factor for survival. Renal function (serum creatinine) and urinary sodium under 5 mEq/l at diagnosis are associated with survival, indicating early treatment could increase survival.",2.6054570009253947e-07,0.22778393087071303,0.0,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
3,0.3,6,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: might some prognostic factors be overlooked? For the first time, we identify ESLD etiology as a prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary Na less than 5 mEq/l at diagnosis correlate with survival, suggesting early intervention may enhance survival.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.3,7,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Could we be missing prognostic factors in hepatorenal syndrome? We report ESLD etiology as a novel prognostic factor for survival. Renal function (serum creatinine) and urinary sodium below 5 mEq/l at diagnosis are associated with survival, implying early treatment might improve survival outcomes.",2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
3,0.3,8,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Hepatorenal syndrome: are there unrecognized prognostic factors? We demonstrate for the first time that ESLD etiology is a prognostic factor for survival. Renal function, measured by serum creatinine, and urinary Na under 5 mEq/l at diagnosis relate to survival, suggesting early treatment may increase survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
3,0.3,9,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Is hepatorenal syndrome missing some prognostic factors? We report ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis are linked to survival, indicating that early treatment might improve survival chances.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
3,0.3,10,human,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.","Are we overlooking prognostic factors in hepatorenal syndrome? We identify ESLD etiology as a prognostic factor for survival for the first time. Renal function, expressed as serum creatinine, and urinary Na below 5 mEq/l at diagnosis associate with survival, suggesting early treatment could enhance survival.",2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
4,0.3,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be a novel risk factor for pathological gambling? Answer: Recent research indicates a potential association between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. Nonetheless, more studies are required to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.3,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is Aripiprazole a new risk factor for pathological gambling? Answer: Recent findings suggest a possible connection between Aripiprazole, an antipsychotic medication, and increased pathological gambling risk. However, additional research is necessary to",2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
4,0.3,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Does Aripiprazole represent a new risk factor for pathological gambling? Answer: Current studies point to a potential link between Aripiprazole, an antipsychotic agent, and a greater risk of pathological gambling. Further investigation is needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.3,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: could it be a new risk factor for pathological gambling? Answer: Recent studies have suggested a possible relationship between Aripiprazole, an antipsychotic drug, and an elevated risk of pathological gambling. More research is required to",7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
4,0.3,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is there a new risk factor for pathological gambling in Aripiprazole? Answer: Recent research suggests a potential association between Aripiprazole, an antipsychotic medication, and increased risk of pathological gambling. However, further studies are needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.3,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole as a novel risk factor for pathological gambling? Answer: Studies recently indicate a possible link between Aripiprazole, an antipsychotic drug, and a higher risk of pathological gambling. Additional research is necessary to",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.3,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be linked to pathological gambling as a new risk factor? Answer: Recent evidence suggests a potential connection between Aripiprazole, an antipsychotic medication, and increased risk of pathological gambling. Further research is needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
4,0.3,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Is Aripiprazole associated with a new risk factor for pathological gambling? Answer: Recent studies point to a possible link between Aripiprazole, an antipsychotic drug, and a heightened risk of pathological gambling. More investigation is required to",7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
4,0.3,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Aripiprazole: a potential new risk factor for pathological gambling? Answer: Current research suggests a possible association between Aripiprazole, an antipsychotic medication, and increased pathological gambling risk. However, further research is necessary to",2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
4,0.3,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Recent studies suggest a possible link between Aripiprazole, an antipsychotic medication, and an increased risk of pathological gambling. However, further research is needed to","Question: Could Aripiprazole be considered a new risk factor for pathological gambling? Answer: Recent studies indicate a possible link between Aripiprazole, an antipsychotic drug, and an increased risk of pathological gambling. Additional studies are needed to",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
5,0.3,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there varying degrees of risk for transitioning to psychosis within Ultra High Risk (UHR) criteria? Yes, the risk levels differ based on factors like age, symptom frequency and intensity, and family history. However, UHR criteria are not absolute predictors, and not everyone identified as UHR will develop psychosis.",5.684633456564497e-07,0.23217831296817826,0.12244897959183675,0.043522235154764985,0.27585536648845155,0.097412109375,0.04345923698286881,0.32083281976598643,0.07100591715976333,5.684633456564497e-07,0.367170346952161,0.04338842975206613
5,0.3,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does Ultra High Risk (UHR) criteria indicate different risk levels for psychosis transition? Indeed, risk varies according to age, symptom severity and frequency, and family history. Yet, UHR criteria do not guarantee psychosis development for all classified individuals.",8.290090457489889e-07,0.4924614112318437,0.12244897959183675,0.06346992626736558,0.5424840297423992,0.097412109375,0.06337805393335035,0.5941261547656675,0.07100591715976333,8.290090457489892e-07,0.6474723121063186,0.04338842975206613
5,0.3,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is the risk of transitioning to psychosis categorized into different levels under Ultra High Risk (UHR) criteria? Yes, risk levels depend on age, symptom intensity and frequency, and family history. Nonetheless, UHR criteria are not definitive, and not all labeled UHR will progress to psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.3,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there distinct risk levels for psychosis transition in Ultra High Risk (UHR) criteria? Yes, risk is influenced by factors such as age, how often and severe symptoms are, and family history. Still, UHR criteria are not conclusive predictors, so not all UHR individuals develop psychosis.",6.39521263863506e-07,0.2967168341057498,0.12244897959183675,0.0489625145491106,0.3418133342802476,0.097412109375,0.04889164160572741,0.3882741005615187,0.07100591715976333,6.39521263863506e-07,0.43616321843911265,0.04338842975206613
5,0.3,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Do Ultra High Risk (UHR) criteria reflect varying levels of risk for psychosis transition? Yes, risk varies with age, symptom frequency and intensity, and family history. However, these criteria are not definitive, and not all classified as UHR will develop psychosis.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.3,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Within Ultra High Risk (UHR) criteria, are there different risk levels for psychosis transition? Yes, risk depends on age, symptom frequency and severity, and family history. But UHR criteria are not absolute predictors, and not everyone labeled UHR will develop psychosis.",7.57951127541933e-07,0.41449986976213316,0.12244897959183675,0.058029646873019966,0.462441322068865,0.097412109375,0.057945649310491745,0.5118880565286945,0.07100591715976333,7.57951127541933e-07,0.5629149240782549,0.04338842975206613
5,0.3,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are different levels of risk for psychosis transition recognized in Ultra High Risk (UHR) criteria? Yes, factors like age, symptom intensity and frequency, and family history determine risk. However, UHR criteria do not definitively predict psychosis development for all individuals.",7.816371002776183e-07,0.4398176777464249,0.12244897959183675,0.05984307333780184,0.488416808472123,0.097412109375,0.05975645085144461,0.5385563036108554,0.07100591715976333,7.816371002776184e-07,0.5903138982663703,0.04338842975206613
5,0.3,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Does the Ultra High Risk (UHR) criteria identify varying risk levels for transitioning to psychosis? Yes, risk is assessed based on age, symptom frequency and severity, and family history. Yet, UHR criteria are not definitive, and not all UHR individuals will develop psychosis.",7.105791820705622e-07,0.36570970559270144,0.12244897959183675,0.05440279394345622,0.4124309014942016,0.097412109375,0.05432404622858601,0.4605947621411448,0.07100591715976333,7.105791820705622e-07,0.5102711905928361,0.04338842975206613
5,0.3,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Is there a differentiation in risk levels for psychosis transition within Ultra High Risk (UHR) criteria? Yes, risk is influenced by age, symptom frequency and intensity, and family history. However, UHR criteria are not absolute predictors, so not all classified as UHR will develop psychosis.",6.632072365991914e-07,0.3191896899578075,0.12244897959183675,0.050775941013892475,0.36480285250494715,0.097412109375,0.05070244314668028,0.4118045979717131,0.07100591715976333,6.632072365991914e-07,0.46026077001817267,0.04338842975206613
5,0.3,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis in Ultra High Risk (UHR) criteria. It's determined by factors such as age, frequency and intensity of symptoms, and family history. However, it's important to note that UHR criteria are not definitive predictors, and not all individuals classified as UHR will develop psychosis.","Are there multiple risk levels for psychosis transition in Ultra High Risk (UHR) criteria? Yes, risk varies by age, symptom severity and frequency, and family history. Nonetheless, UHR criteria are not definitive, and not all individuals identified as UHR will develop psychosis.",7.342651548062476e-07,0.38980725717176146,0.12244897959183675,0.05621622040823809,0.4371235140845733,0.097412109375,0.05613484776953888,0.48591257012543654,0.07100591715976333,7.342651548062476e-07,0.5362466769960941,0.04338842975206613
6,0.3,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","A model for healing Los Angeles grades C and D reflux oesophagitis: is there an ideal duration for acid suppression to maximize healing? Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis is possible with timely and sufficient acid suppression, though the ideal timing differs among individuals and depends on factors such as severity.",1.4211583641411244e-07,0.07143754124395274,0.020600274348422445,0.010880558788691236,0.07048447956987314,0.02282578875171476,0.0108648092457172,0.06941955073990291,0.025165432098765497,1.4211583641411244e-07,0.068232449516199,0.027619204389574666
6,0.3,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there an optimal acid suppression period for maximal healing in a model of Los Angeles grades C and D reflux oesophagitis? Yes, effective healing can be attained through prompt and adequate acid suppression, but the best timing varies per individual and is influenced by severity and other factors.",3.316036182995957e-07,0.07705668237979424,0.1262002743484225,0.025387970506946217,0.10164330299047775,0.11282578875171474,0.025351221573340132,0.1270737296210167,0.09876543209876548,3.316036182995957e-07,0.15339238115913867,0.08401920438957469
6,0.3,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Regarding a healing model for Los Angeles grades C and D reflux oesophagitis, is there a best time for acid suppression to achieve maximal healing? Yes, optimal healing requires timely and proper acid suppression, with timing dependent on individual factors like disease severity.",4.737194547137081e-07,0.21058807500431742,0.1262002743484225,0.03626852929563745,0.23821883799622778,0.11282578875171474,0.03621603081905733,0.2668356719961751,0.09876543209876548,4.737194547137081e-07,0.29649322479981377,0.08401920438957469
6,0.3,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Does a model of healing for Los Angeles grades C and D reflux oesophagitis indicate an optimal acid suppression duration for maximum healing? Yes, maximal healing is achievable with timely and adequate acid suppression, though the exact timing varies with individual severity and other factors.",4.263475092423373e-07,0.16406805936942348,0.1262002743484225,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
6,0.3,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","In a healing model of Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression timeframe for best healing outcomes? Yes, healing is optimized by timely and sufficient acid suppression, but the perfect timing depends on individual severity and other variables.",4.263475092423373e-07,0.16406805936942348,0.1262002743484225,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
6,0.3,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there an ideal acid suppression period for maximal healing in Los Angeles grades C and D reflux oesophagitis according to a healing model? Yes, optimal healing can be achieved with timely and adequate acid suppression, though timing varies based on individual severity and related factors.",4.026615365066519e-07,0.14159520351736576,0.1262002743484225,0.030828249901291835,0.16760127078227383,0.11282578875171474,0.030783626196198732,0.19451501041654895,0.09876543209876548,4.026615365066519e-07,0.22238525264609033,0.08401920438957469
6,0.3,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","A healing model for Los Angeles grades C and D reflux oesophagitis: is there a best timing for acid suppression to maximize healing? Yes, timely and sufficient acid suppression leads to optimal healing, but the ideal timing depends on individual severity and other considerations.",4.500334819780227e-07,0.2192969813410972,0.10295764396293497,0.03445510283085558,0.21412128641716777,0.11282578875171474,0.034405229278104466,0.24214305940580338,0.09876543209876548,4.500334819780227e-07,0.27117541681552204,0.08401920438957469
6,0.3,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","For Los Angeles grades C and D reflux oesophagitis, does a healing model suggest an optimal acid suppression duration for maximal healing? Yes, optimal healing is possible with timely and adequate acid suppression, though the timing varies among individuals depending on severity.",4.974054274493935e-07,0.23468562658337744,0.1262002743484225,0.038081955760419325,0.2629114505865995,0.11282578875171474,0.0380268323600102,0.2921534799804668,0.09876543209876548,4.974054274493935e-07,0.32246871120307175,0.08401920438957469
6,0.3,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","Is there a perfect timing for acid suppression to maximize healing in a model of Los Angeles grades C and D reflux oesophagitis? Yes, optimal healing requires timely and sufficient acid suppression, with timing influenced by individual severity and other factors.",5.210914001850789e-07,0.25937823917374914,0.1262002743484225,0.0398953822252012,0.2882292585708912,0.11282578875171474,0.039837633900963065,0.3181289663837248,0.09876543209876548,5.210914001850789e-07,0.3491369582852326,0.08401920438957469
6,0.3,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: Yes, optimal healing of Los Angeles grades C and D reflux oesophagitis can be achieved via timely and adequate acid suppression. However, the perfect timing varies across individuals and is dependent on factors like severity of the","In a model of healing for Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression period for maximal healing? Yes, timely and adequate acid suppression can achieve optimal healing, but the exact timing depends on individual severity and other factors.",4.263475092423373e-07,0.19557474939487607,0.10348529327757337,0.03264167636607371,0.19059078900697335,0.11282578875171474,0.0325944277371516,0.21804550782674337,0.09876543209876548,4.263475092423373e-07,0.24648280422515034,0.08401920438957469
7,0.3,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to predict discordance between TEOAE and AABR results in newborns? Considering current screening methods, some degree of discordance between TEOAE and AABR outcomes may be unavoidable in certain types of hearing loss among apparently healthy newborns whose mothers had prenatal care. The limitations of using perinatal morbidities as criteria for targeted screening in these cases should be acknowledged.",1.8948778188548325e-07,0.1040002334552419,0.027926530612244864,0.014507411718254981,0.10240450977053595,0.03110153061224491,0.014486412327622933,0.10061675128655345,0.03443877551020409,1.8948778188548325e-07,0.1269100160200658,0.017538265306122455
7,0.3,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordant results between TEOAE and AABR in newborns be anticipated? With the screening technologies available, discordance between TEOAE and AABR might be inevitable for some hearing loss categories in apparently healthy newborns whose mothers received prenatal care. There are potential drawbacks to relying on perinatal morbidities for targeted screening in such instances.",0.0,0.026659506944613387,0.019076051645147855,0.0,0.027182242374899968,0.0195503540191587,0.0,0.027725887222397994,0.019991670137442734,0.0,0.0,0.0
7,0.3,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is discordance in TEOAE and AABR outcomes among newborns predictable? Given current screening tools, some discordance between TEOAE and AABR is likely unavoidable in certain hearing loss types among apparently healthy newborns whose mothers underwent prenatal care. The use of perinatal morbidities as a basis for targeted screening may have limitations in these cases.",2.3685972735685406e-08,0.020054214100678536,0.0007221837754709942,0.0018134264647818726,0.019940821287388832,0.0003766243752402823,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
7,0.3,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we foresee discordance between TEOAE and AABR results in newborns? Based on available screening technologies, some discordance between TEOAE and AABR outcomes may be inevitable for specific hearing loss categories in apparently healthy newborns whose mothers had prenatal care. The potential shortcomings of using perinatal morbidities for targeted screening should be considered.",0.0,0.053319013889226774,0.03798888888888887,0.0,0.05436448474979949,0.03899375000000001,0.0,0.05545177444479554,0.039930555555555566,0.0,0.028291721655508084,0.020399305555555556
7,0.3,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it feasible to predict discordance in TEOAE and AABR outcomes in newborns? Given current screening methods, discordance between TEOAE and AABR may be unavoidable for certain hearing loss types among apparently healthy newborns with mothers who received prenatal care. The limitations of targeting screening based on perinatal morbidities need to be recognized.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.3,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Are discordant TEOAE and AABR results in newborns predictable? With the screening technologies at hand, discordance may be inevitable for some hearing loss categories in apparently healthy newborns whose mothers had prenatal care. The potential constraints of using perinatal morbidities as a screening basis should be noted.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
7,0.3,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is predicting discordance between TEOAE and AABR outcomes in newborns possible? Considering current screening technologies, some discordance between TEOAE and AABR may be unavoidable in certain hearing loss categories among apparently healthy newborns whose mothers received prenatal care. The limitations of perinatal morbidity-based targeted screening should be acknowledged.",1.1842986367842703e-07,0.16575960180085714,0.045969929691725246,0.009067132323909363,0.16641249567249794,0.045299945916711756,0.009054007704764333,0.1669735983742653,0.04434829637641968,1.1842986367842703e-07,0.1391373542178176,0.02271498107084911
7,0.3,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can discordance in TEOAE and AABR outcomes be predicted in newborns? Given the available screening tools, discordance may be inevitable for some types of hearing loss in apparently healthy newborns whose mothers had prenatal care. There are potential limitations in using perinatal morbidities as criteria for targeted screening in these cases.",4.737194547137081e-08,0.014098300735944314,0.03840000000000001,0.0036268529295637453,0.01282309223879885,0.019599999999999992,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
7,0.3,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Is it possible to anticipate discordance in TEOAE and AABR results among newborns? Based on current screening technologies, some discordance between TEOAE and AABR outcomes may be unavoidable for certain hearing loss categories in apparently healthy newborns whose mothers received prenatal care. The potential limitations of targeted screening based on perinatal morbidities should be considered.",4.737194547137081e-08,0.014042988476523632,0.01696332179930795,0.0036268529295637453,0.03949202582307443,0.0007390532544378596,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
7,0.3,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases","Can we predict discordance between TEOAE and AABR outcomes in newborns? With the screening methods available, discordance might be inevitable for some hearing loss types among apparently healthy newborns whose mothers had prenatal care. The limitations of using perinatal morbidities as a basis for targeted screening should be recognized.",9.474389094274162e-08,0.026723693784310054,0.03840000000000001,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
8,0.3,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This article examines the suitability of the RAQ within Australian cultural contexts and highlights the necessity for developing comprehensive and inclusive recovery outcome metrics.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.3,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper explores whether the RAQ is culturally appropriate in Australia and stresses the importance of creating robust, inclusive measures for recovery outcomes.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.3,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This study addresses the cultural relevance of the RAQ in Australian environments and points out the need for rigorous and inclusive recovery outcome assessments.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.3,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The discussion focuses on the cultural fit of the RAQ in Australian settings and underscores the requirement for developing thorough and inclusive recovery outcome tools.,2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
8,0.3,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research evaluates the appropriateness of the RAQ in the context of Australian culture and emphasizes the need to establish rigorous, inclusive recovery outcome measures.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
8,0.3,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper considers the cultural suitability of the RAQ in Australia and identifies a gap for creating comprehensive, inclusive recovery outcome evaluations.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
8,0.3,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This work discusses the cultural compatibility of the RAQ in Australian settings and highlights the necessity for inclusive and rigorous recovery outcome measures.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.3,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The article investigates the cultural appropriateness of the RAQ within Australia and points to the need for developing inclusive and robust recovery outcome metrics.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.3,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper analyzes the cultural relevance of the RAQ in Australian contexts and stresses the importance of formulating rigorous, inclusive recovery outcome measures.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.3,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The study explores the cultural fit of the RAQ in Australia and identifies the need for comprehensive and inclusive recovery outcome measurement tools.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
9,0.3,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging enable prediction of various histologic subtypes in primary parotid gland tumors? Yes, it does. By evaluating apparent diffusion coefficient values, this imaging technique can differentiate benign from malignant tumors, facilitating precise diagnosis and treatment planning.",4.500334819780226e-07,0.15786509525817305,0.16493055555555555,0.03445510283085558,0.2352184321811599,0.1204,0.034405229278104466,0.31541275229664567,0.07100591715976332,4.500334819780227e-07,0.3986088947559989,0.0181755829903978
9,0.3,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Yes, it can. The method uses apparent diffusion coefficient measurements to distinguish between benign and malignant tumors, supporting accurate diagnosis and treatment decisions.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.3,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it possible to predict histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Yes, diffusion-weighted echo-planar MR imaging enables this by analyzing apparent diffusion coefficient values to differentiate benign from malignant tumors, aiding diagnosis and treatment.",4.500334819780226e-07,0.22895711377714134,0.1137983422611801,0.03445510283085558,0.27169986273694624,0.09410343316289262,0.034405229278104466,0.31541275229664567,0.07100591715976332,4.500334819780227e-07,0.3986088947559989,0.0181755829903978
9,0.3,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging allow prediction of various histologic subtypes in primary parotid gland tumors? Yes, by assessing apparent diffusion coefficient values, it can distinguish benign from malignant tumors, which helps in accurate diagnosis and treatment planning.",4.974054274493932e-07,0.2105088287435919,0.16493055555555555,0.038081955760419325,0.2892856534514361,0.1204,0.0380268323600102,0.37098260345145784,0.07100591715976332,4.974054274493935e-07,0.4557673085959473,0.0181755829903978
9,0.3,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can different histologic subtypes of primary parotid gland tumors be predicted through diffusion-weighted echo-planar MR imaging? Yes, this imaging technique uses apparent diffusion coefficient values to differentiate benign and malignant tumors, assisting in diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.3,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is diffusion-weighted echo-planar MR imaging effective in predicting histologic subtypes of primary parotid gland tumors? Yes, it is. By measuring apparent diffusion coefficient values, it can differentiate benign from malignant tumors, aiding accurate diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.3,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging facilitate prediction of different histologic subtypes in primary parotid gland tumors? Yes, it does. The technique evaluates apparent diffusion coefficient values to distinguish benign and malignant tumors, supporting diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.3,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Can diffusion-weighted echo-planar MR imaging be used to predict different histologic subtypes of primary parotid gland tumors? Yes, by analyzing apparent diffusion coefficient values, it helps differentiate benign from malignant tumors, aiding in diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
9,0.3,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Is it feasible to predict different histologic subtypes of primary parotid gland tumors with diffusion-weighted echo-planar MR imaging? Yes, this imaging method assesses apparent diffusion coefficient values to distinguish benign and malignant tumors, facilitating accurate diagnosis and treatment planning.",4.737194547137079e-07,0.18384058166143102,0.16493055555555555,0.03626852929563745,0.26188667926332077,0.1204,0.03621603081905733,0.342811726484761,0.07100591715976332,4.737194547137081e-07,0.42677977172269577,0.0181755829903978
9,0.3,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Yes, diffusion-weighted echo-planar MR imaging allows the prediction of different histologic subtypes of primary parotid gland tumors. By assessing the apparent diffusion coefficient values, distinctions can be made between benign and malignant tumors, aiding in accurate diagnosis and treatment planning.","Does diffusion-weighted echo-planar MR imaging provide prediction of various histologic subtypes in primary parotid gland tumors? Yes, by evaluating apparent diffusion coefficient values, it can differentiate benign from malignant tumors, aiding in precise diagnosis and treatment planning.",5.210914001850785e-07,0.2379078029317072,0.16493055555555555,0.0398953822252012,0.31745653041813293,0.1204,0.03983763390096307,0.39997014032470934,0.07100591715976332,5.210914001850789e-07,0.48562027174562905,0.0181755829903978
10,0.3,1,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, it can correlate, but the strength of this correlation may vary depending on factors like disease severity and ventilation mode.",6.158352911278206e-07,0.13634790661809282,0.33439143655489806,0.04714908808432869,0.233566751542015,0.1875,0.04708084006477453,0.30468842970830323,0.15089163237311393,6.158352911278206e-07,0.3781841069562075,0.109375
10,0.3,2,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants within the first week of life? Yes, end-tidal CO2 can correlate with arterial CO2, though the accuracy may be influenced by disease severity and ventilation settings.",5.684633456564497e-07,0.05290038342066472,0.359375,0.04352223515476494,0.18355633096735158,0.1875,0.0434592369828688,0.25339513532075353,0.15089163237311393,5.684633456564497e-07,0.3255403734707887,0.109375
10,0.3,3,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal carbon dioxide measurements reflect arterial carbon dioxide in extremely low birth weight infants in their first week? Yes, a correlation exists, but it may fluctuate due to factors such as the infants illness severity and ventilation method.",6.632072365991912e-07,0.18946527253343248,0.33307843316289265,0.050775941013892434,0.28621048502743385,0.1875,0.050702443146680265,0.3587556509785794,0.15089163237311393,6.632072365991914e-07,0.4337539581110197,0.109375
10,0.3,4,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does measuring end-tidal CO2 correspond with arterial CO2 levels in extremely low birth weight infants during the initial week? Yes, there is a correlation, but it can be affected by disease severity and the type of ventilation used.",6.868932093348765e-07,0.179652089059807,0.359375,0.052589367478674306,0.31360945921554917,0.1875,0.05251324468763313,0.38692652794527627,0.15089163237311393,6.868932093348768e-07,0.4627414949842712,0.109375
10,0.3,5,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is end-tidal carbon dioxide measurement a reliable indicator of arterial carbon dioxide in extremely low birth weight infants in the first week of life? Yes, it correlates, although the correlation strength can vary based on disease severity and ventilation mode.",6.395212638635059e-07,0.1625543648338721,0.333751731301939,0.04896251454911056,0.259542237945273,0.1875,0.0488916416057274,0.3313566767904641,0.15089163237311393,6.39521263863506e-07,0.40558308114432284,0.109375
10,0.3,6,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal CO2 levels be used to estimate arterial CO2 in extremely low birth weight infants during their first week? Yes, there is a correlation, but factors like disease severity and ventilation mode may influence its accuracy.",7.105791820705618e-07,0.20705106324792233,0.359375,0.05440279394345618,0.341780336182246,0.1875,0.054324046228586005,0.4159140648185278,0.15089163237311393,7.105791820705622e-07,0.492594458133953,0.109375
10,0.3,7,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement align with arterial carbon dioxide in extremely low birth weight infants within the first week? Yes, it can, but the correlation may be impacted by disease severity and ventilation techniques.",7.579511275419324e-07,0.3049828406502204,0.3299902433425161,0.05802964687301994,0.4006208362051793,0.1875,0.05794564931049175,0.47653868663496324,0.15089163237311393,7.57951127541933e-07,0.5551148151152865,0.109375
10,0.3,8,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Is there a relationship between end-tidal and arterial carbon dioxide in extremely low birth weight infants during the first week of life? Yes, a correlation exists, though it may vary due to disease severity and ventilation mode.",7.105791820705618e-07,0.20705106324792233,0.359375,0.05440279394345618,0.341780336182246,0.1875,0.054324046228586005,0.4159140648185278,0.15089163237311393,7.105791820705622e-07,0.492594458133953,0.109375
10,0.3,9,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Can end-tidal CO2 monitoring correlate with arterial CO2 levels in extremely low birth weight infants in their first week? Yes, it can, but the correlation may be affected by the severity of illness and ventilation method.",7.342651548062471e-07,0.23522194021461917,0.359375,0.05621622040823806,0.3707678730554975,0.1875,0.05613484776953888,0.44576702796820955,0.15089163237311393,7.342651548062476e-07,0.5233661168007067,0.109375
10,0.3,10,ai,"Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Yes, end-tidal carbon dioxide measurement can correlate with arterial carbon dioxide in extremely low birth weight infants during the first week of life. However, the correlation can vary, and factors such as disease severity and ventilation mode may affect the correlation accuracy. Therefore,","Does end-tidal carbon dioxide measurement correspond with arterial carbon dioxide in extremely low birth weight infants during their first week? Yes, it does, but the correlation can vary depending on disease severity and ventilation mode.",7.579511275419324e-07,0.3049828406502204,0.3299902433425161,0.05802964687301994,0.4006208362051793,0.1875,0.05794564931049175,0.47653868663496324,0.15089163237311393,7.57951127541933e-07,0.5551148151152865,0.109375
11,0.3,1,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? The analyses indicate that the slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are due to greater exposure to adverse childhood experiences within this group. Adolescent MD/AUD comorbidity probably serves as a risk indicator rather than a direct cause.,1.4211583641411244e-07,0.07552222043422674,0.015380859375,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
11,0.3,2,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is comorbidity of major depression and alcohol use disorder in adolescence associated with poorer depression outcomes? Findings suggest that the marginally increased depression rates by age 35 in those with both MD and AUD are explained by higher exposure to negative childhood environments. Thus, adolescent MD/AUD comorbidity is more likely a risk marker than a causal factor.",2.1317375462116866e-07,0.1277079736047959,0.015380859375,0.016320838183036854,0.15154989812720032,0.0,0.0162972138685758,0.15415067982725983,0.0,2.1317375462116866e-07,0.1568424714929706,0.0
11,0.3,3,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the coexistence of major depression and alcohol use disorder in adolescence lead to worse depression outcomes? The data show that the slightly higher depression rates through age 35 in the comorbid group are attributable to greater adverse childhood experiences. Therefore, adolescent MD/AUD comorbidity likely acts as a risk marker instead of a direct cause.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.3,4,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes poorer in adolescents with both major depression and alcohol use disorder? The results reveal that the marginally elevated depression rates up to age 35 in the comorbid MD/AUD group stem from increased exposure to adverse childhood conditions. Hence, adolescent MD/AUD comorbidity is probably a risk marker rather than a cause.",3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.3,5,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does adolescent comorbidity of major depression and alcohol use disorder predict worse depression outcomes? The analyses suggest that the slightly higher depression rates by age 35 among the comorbid group are explained by more frequent adverse childhood experiences. Adolescent MD/AUD comorbidity is thus likely a risk marker, not a direct cause.",3.552895910352811e-07,0.24103665891180004,0.015380859375,0.02720139697172809,0.2670627852490446,0.0,0.027162023114293,0.2719337154836441,0.0,3.552895910352811e-07,0.2769867833350337,0.0
11,0.3,6,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is the combination of major depression and alcohol use disorder in adolescence linked to poorer depression outcomes? Findings indicate that the marginally increased depression rates through age 35 in the comorbid group result from greater exposure to adverse childhood circumstances. Therefore, adolescent MD/AUD comorbidity is more of a risk marker than a causal factor.",2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
11,0.3,7,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a",Does having both major depression and alcohol use disorder during adolescence lead to worse depression outcomes? The results suggest that the slightly higher depression rates up to age 35 in the comorbid group are due to increased adverse childhood experiences. Adolescent MD/AUD comorbidity is likely a risk indicator rather than a direct cause.,3.079176455639103e-07,0.20181594575851758,0.015380859375,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
11,0.3,8,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Are depression outcomes negatively impacted by adolescent comorbidity of major depression and alcohol use disorder? The analyses show that the marginally elevated depression rates by age 35 among the comorbid group are explained by greater exposure to adverse childhood environments. Thus, adolescent MD/AUD comorbidity probably serves as a risk marker instead of a cause.",2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
11,0.3,9,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Does the presence of both major depression and alcohol use disorder in adolescence result in poorer depression outcomes? The data suggest that the slightly higher depression rates through age 35 in the comorbid group are attributable to increased adverse childhood experiences. Hence, adolescent MD/AUD comorbidity is likely a risk marker rather than a direct cause.",2.6054570009253947e-07,0.16407561777567015,0.015380859375,0.0199476911126006,0.18859116980755042,0.0,0.019918816950481533,0.19189100781010726,0.0,2.6054570009253947e-07,0.1953087523207664,0.0
11,0.3,10,human,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a","Is adolescent comorbidity of major depression and alcohol use disorder associated with worse depression outcomes? Findings indicate that the marginally increased depression rates up to age 35 among the comorbid group are explained by greater exposure to adverse childhood circumstances. Therefore, adolescent MD/AUD comorbidity is more likely a risk marker than a causal factor.",2.8423167282822487e-07,0.18276775078782448,0.015380859375,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
12,0.3,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does having an optimistic perspective lead to improved survival rates in older age? Answer: Yes, maintaining an optimistic outlook is associated with better survival outcomes in advanced age. Studies suggest optimism contributes to longevity, possibly because it affects how people manage stress and challenges.",0.0,0.1575334501272594,0.11024900784881851,0.0,0.12895761498789637,0.09204470742932283,0.0,0.06601401719618405,0.047500000000000014,0.0,0.03381205758828987,0.024375
12,0.3,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism forecast enhanced survival in elderly individuals? Answer: Yes, optimism is a predictor of increased survival among the elderly. Research shows that optimism may promote longer life spans by influencing coping mechanisms.",2.605457000925387e-07,0.0986419322990697,0.13296398891966763,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
12,0.3,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is an optimistic attitude linked to greater survival chances in later life? Answer: Yes, an optimistic attitude is correlated with better survival at older ages. Evidence points to optimism aiding longevity through its impact on coping strategies.",1.6580180914979753e-07,0.059166411452129974,0.07908643789925945,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
12,0.3,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does optimism improve survival prospects for seniors? Answer: Yes, optimism can enhance survival prospects in advanced age. Studies indicate that optimism supports longevity, likely due to its role in how individuals handle adversity.",2.605457000925387e-07,0.14065085233300545,0.10269055141966763,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
12,0.3,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can a positive outlook predict longer survival in the elderly? Answer: Yes, a positive outlook is predictive of better survival among older adults. Research suggests this may be because optimism shapes effective coping behaviors.",2.3685972735685343e-07,0.15033569627408783,0.07437023891966763,0.01813426464781874,0.17774385927312153,0.06177126992932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
12,0.3,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is there a connection between optimism and survival at advanced ages? Answer: Yes, optimism is connected to improved survival rates in older populations. This relationship may stem from optimism's influence on coping approaches.",2.605457000925387e-07,0.0986419322990697,0.13296398891966763,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.27856262745386307,0.024375
12,0.3,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does an optimistic mindset contribute to longer life expectancy in old age? Answer: Yes, having an optimistic mindset is linked to increased survival in advanced age. Studies attribute this to optimism's effect on how people cope with difficulties.",1.4211583641411222e-07,0.030526195150736513,0.08049485311719848,0.010880558788691236,0.05879200322684275,0.06503853458981666,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
12,0.3,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Can optimism be used to predict survival outcomes in elderly individuals? Answer: Yes, optimism serves as a predictor for better survival outcomes in the elderly. Research highlights the role of optimism in promoting longevity through coping strategies.",1.6580180914979753e-07,0.059166411452129974,0.07908643789925945,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.15339948449985608,0.024375
12,0.3,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Is better survival at advanced ages associated with optimism? Answer: Yes, better survival in later life is associated with an optimistic outlook. This is thought to be due to optimism's positive influence on coping mechanisms.",2.1317375462116813e-07,0.11901825291155843,0.07603102289579253,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
12,0.3,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Yes, an optimistic outlook can predict better survival at advanced ages. Research indicates that optimism is linked to longevity, potentially due to the way it influences individuals' coping strategies during","Question: Does maintaining optimism affect survival rates in older adults? Answer: Yes, maintaining an optimistic attitude positively affects survival rates in older adults. Studies indicate this may be because optimism helps individuals manage stress effectively.",2.3685972735685343e-07,0.19110905983643622,0.04555503990822121,0.01813426464781874,0.21975277930705817,0.03169090930237175,0.018108015409528687,0.24924139707245496,0.01628251821019771,2.3685972735685406e-07,0.24577280463087137,0.024375
13,0.3,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR independently predicts maternal and neonatal adverse outcomes in suspected preeclampsia and could help improve risk prediction models.,2.8423167282822456e-07,0.1577951642086508,0.0850113378684807,0.02176111757738247,0.18178458653290042,0.0750031456606439,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.3,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia serve as a prognostic indicator for negative maternal and neonatal outcomes? ACR is an independent prognostic marker for adverse outcomes in both mother and newborn in cases of suspected preeclampsia and may aid in risk assessment models.,0.0,0.16975032993304806,0.11848958333333331,0.0,0.14440566261665522,0.10275824770146022,0.0,0.11798249881871392,0.08436992969172526,0.0,0.09041050181216681,0.06489994591671175
13,0.3,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict maternal and neonatal adverse outcomes? ACR independently forecasts adverse maternal and neonatal outcomes in suspected preeclampsia and might be valuable for risk prediction within prognostic frameworks.,2.3685972735685396e-07,0.10130861891139453,0.08775667559451342,0.018134264647818726,0.12569061912063573,0.07646168086435284,0.018108015409528666,0.12124719024711839,0.08436992969172526,2.3685972735685406e-07,0.15471195622081746,0.06489994591671175
13,0.3,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic factor for poor maternal and neonatal outcomes? ACR independently predicts adverse outcomes in mothers and newborns in suspected preeclampsia and may be useful in risk prediction models.,1.8948778188548325e-07,0.01401823740605268,0.11451388888888886,0.014507411718254981,0.03791589417729968,0.10275824770146022,0.014486412327622933,0.06860345676169954,0.08436992969172526,1.8948778188548325e-07,0.10064473495054127,0.06489994591671175
13,0.3,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict adverse maternal and neonatal outcomes? ACR acts as an independent prognostic factor for negative outcomes in both mother and child and could inform risk prediction in prognostic models.,2.1317375462116866e-07,0.004898792408134511,0.13888888888888887,0.016320838183036854,0.06323370216159141,0.10275824770146022,0.0162972138685758,0.09457894316495752,0.08436992969172526,2.1317375462116866e-07,0.12731298203270214,0.06489994591671175
13,0.3,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia an independent prognostic factor for maternal and neonatal adverse outcomes? ACR independently predicts adverse outcomes in suspected preeclampsia and may be helpful for risk prediction within prognostic models.,2.1317375462116866e-07,0.03955615143613089,0.11390532544378695,0.016320838183036854,0.06323370216159141,0.10275824770146022,0.0162972138685758,0.09457894316495752,0.08436992969172526,2.1317375462116866e-07,0.12731298203270214,0.06489994591671175
13,0.3,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for adverse maternal and neonatal outcomes? ACR is an independent predictor of negative outcomes in mothers and newborns and might be useful for risk prediction models.,1.6580180914979784e-07,0.043891371761297204,0.13888888888888887,0.012693985253473108,0.013223281586927982,0.10275824770146022,0.012675610786670066,0.043285648777407815,0.08436992969172526,1.6580180914979784e-07,0.0746692485472833,0.06489994591671175
13,0.3,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic marker for adverse maternal and neonatal outcomes? ACR independently forecasts maternal and neonatal adverse outcomes and may aid in risk prediction within prognostic models.,2.8423167282822456e-07,0.1577951642086508,0.0850113378684807,0.02176111757738247,0.18178458653290042,0.0750031456606439,0.0217296184914344,0.17681704140193055,0.08436992969172526,2.8423167282822487e-07,0.2118703700607658,0.06489994591671175
13,0.3,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia function as an independent prognostic factor for maternal and neonatal adverse outcomes? ACR independently predicts adverse outcomes and could be useful for risk prediction in prognostic models.,2.6054570009253926e-07,0.056192086795684215,0.13888888888888887,0.0199476911126006,0.11587743564701025,0.10275824770146022,0.019918816950481533,0.1486461644352337,0.08436992969172526,2.6054570009253947e-07,0.1828828331875143,0.06489994591671175
13,0.3,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic factor for maternal and neonatal adverse outcomes? ACR independently predicts negative outcomes and may help inform risk prediction models.,3.7897556377096576e-07,0.19727068505559053,0.13888888888888887,0.029014823436509983,0.2610594454915094,0.10275824770146022,0.028972824655245893,0.29817789840619735,0.08436992969172526,3.789755637709665e-07,0.3370335130147728,0.06489994591671175
14,0.3,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening might not reliably identify glandular cell abnormalities in Pap smears. Manual slide examination by a cytotechnologist or pathologist is generally more dependable for detecting these abnormalities.,2.1317375462116844e-07,0.3289915395021401,0.08253968773098032,0.016320838183036854,0.33012572934107753,0.08044982698961935,0.0162972138685758,0.30015990470975895,0.055363321799307974,2.1317375462116866e-07,0.2684499827465596,0.02854671280276816
14,0.3,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Rapid prescreening may fail to effectively detect glandular cell abnormalities in Pap smears. More traditional approaches, like manual review by a cytotechnologist or pathologist, are usually more accurate.",2.1317375462116844e-07,0.40195440061371324,0.1310772093572779,0.016320838183036854,0.36759314450647995,0.10651974288337923,0.0162972138685758,0.3386680814075338,0.08264462809917354,2.1317375462116866e-07,0.3080583930642704,0.056932966023875105
14,0.3,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can rapid prescreening identify glandular cell abnormalities in Pap smears? Rapid prescreening often does not effectively detect glandular cell abnormalities in Pap smears. Manual slide review by trained professionals remains the more reliable method.,3.3160361829959494e-07,0.5341890157085798,0.1254171328266656,0.025387970506946238,0.4928705900443586,0.09274673008323425,0.02535122157334016,0.4621136311638754,0.06420927467300831,3.316036182995957e-07,0.42920206429343644,0.033293697978596916
14,0.3,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Rapid prescreening may not be effective for identifying glandular cell abnormalities in Pap smears. Conventional manual examination by a cytotechnologist or pathologist is typically more reliable.,2.3685972735685374e-07,0.39707114018816725,0.1105693968572779,0.018134264647818726,0.3606469881263088,0.08264462809917354,0.018108015409528666,0.3305312489163281,0.056932966023875105,2.3685972735685406e-07,0.29860247286444963,0.029384756657483937
14,0.3,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities in Pap smears caught by rapid prescreening? Rapid prescreening might not successfully detect glandular cell abnormalities in Pap smears. Traditional manual slide review by experts is generally more trustworthy.,3.5528959103528024e-07,0.5282028693456402,0.10118243894911463,0.027201396971728117,0.5288117108220018,0.09566326530612247,0.027162023114293034,0.4978847321828237,0.06632653061224487,3.552895910352811e-07,0.4646970577635088,0.03443877551020409
14,0.3,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening detect glandular cell abnormalities in Pap smears? Rapid prescreening may not adequately identify glandular cell abnormalities in Pap smears. Manual review by cytotechnologists or pathologists is usually more effective.,3.7897556377096555e-07,0.6102606372169892,0.13405890314426014,0.029014823436509997,0.5660734509389287,0.09876543209876545,0.028972824655245907,0.5349731674472866,0.06858710562414266,3.789755637709665e-07,0.5014956366401968,0.035665294924554176
14,0.3,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Is rapid prescreening capable of detecting glandular cell abnormalities in Pap smears? Rapid prescreening may not reliably detect glandular cell abnormalities in Pap smears. Manual examination by a cytotechnologist or pathologist is often more dependable.,3.0791764556390964e-07,0.4981582702009657,0.12142073640840748,0.023574544042164358,0.45816059512442253,0.09000000000000004,0.023540420032387287,0.42756998454058737,0.06222222222222223,3.079176455639103e-07,0.3949216023724662,0.0322222222222222
14,0.3,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Can glandular cell abnormalities in Pap smears be detected through rapid prescreening? Rapid prescreening might not be sufficient to detect glandular cell abnormalities in Pap smears. Manual slide review by specialists is typically more accurate.,3.0791764556390964e-07,0.457384906638616,0.0942890149128335,0.023574544042164358,0.45816059512442253,0.09000000000000004,0.023540420032387287,0.42756998454058737,0.06222222222222223,3.079176455639103e-07,0.3949216023724662,0.0322222222222222
14,0.3,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Are glandular cell abnormalities detected by rapid prescreening in Pap smears? Rapid prescreening may not effectively identify glandular cell abnormalities in Pap smears. Traditional manual review by cytotechnologists or pathologists is generally more reliable.,3.3160361829959494e-07,0.4921800956746436,0.0976395235665526,0.025387970506946238,0.4062271924743657,0.031217481789802305,0.02535122157334016,0.3726752852851729,0.0,3.316036182995957e-07,0.3829922522561069,0.0
14,0.3,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening may not effectively detect glandular cell abnormalities in Pap smears. Traditional methods, such as manual slide review by a cytotechnologist or pathologist, are typically more reliable for identifying these kinds of abnormalities.",Does rapid prescreening effectively detect glandular cell abnormalities in Pap smears? Rapid prescreening may not be effective in identifying glandular cell abnormalities in Pap smears. Manual slide examination by trained professionals is usually more reliable.,3.0791764556390964e-07,0.4981582702009657,0.12142073640840748,0.023574544042164358,0.45816059512442253,0.09000000000000004,0.023540420032387287,0.42756998454058737,0.06222222222222223,3.079176455639103e-07,0.3949216023724662,0.0322222222222222
15,0.3,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program may achieve lower expenditures than HMOs and primary care case management, though the actual savings vary based on factors like PSN efficiency.",2.1317375462116866e-07,0.07106505155473064,0.06420741505968786,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.3,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? In Florida's Medicaid program, Provider Service Networks (PSNs) can potentially lower costs compared to HMOs and primary care case management, but the degree of savings depends on multiple factors including how efficient the PSN is.",1.1842986367842703e-07,0.008073812113420509,0.0535679480408431,0.009067132323909363,0.02586034786381619,0.04633017672855455,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
15,0.3,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Does Florida's Medicaid program see reduced spending through provider service networks versus HMOs or primary care case management? Provider Service Networks (PSNs) might reduce expenditures relative to HMOs and primary care case management in Florida's Medicaid program, although the exact amount saved depends on several factors such as PSN operational efficiency.",1.8948778188548325e-07,0.048033172071661134,0.06616512345679013,0.014507411718254981,0.061888690811792824,0.06306381099027097,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
15,0.3,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do provider service networks result in lower costs compared to HMOs or primary care case management? Provider Service Networks (PSNs) have the potential to lower expenditures compared to HMOs and primary care case management, but the precise savings are influenced by factors like the PSN's efficiency.",2.1317375462116866e-07,0.09935677321023872,0.044865655609638885,0.016320838183036854,0.11256793227350581,0.04158400615148021,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.3,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Within Florida's Medicaid program, do provider service networks reduce expenses more than HMOs or primary care case management? Provider Service Networks (PSNs) could lead to lower expenditures than HMOs and primary care case management, though the actual savings depend on various factors including the efficiency of the PSN.",2.6054570009253947e-07,0.11875726320115199,0.06005527210884355,0.0199476911126006,0.1287578169970871,0.06041779862163629,0.019918816950481533,0.16917868806769043,0.03566529492455417,2.6054570009253947e-07,0.19793819929384737,0.0181755829903978
15,0.3,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Are costs lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program may result in reduced expenditures compared to HMOs and primary care case management, but the exact savings depend on factors such as PSN efficiency.",1.8948778188548325e-07,0.07575905929405868,0.047161960514233284,0.014507411718254981,0.09018041246730091,0.04284214519789904,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
15,0.3,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks in Florida's Medicaid program achieve lower expenditures compared to HMOs or primary care case management? Provider Service Networks (PSNs) can potentially reduce costs relative to HMOs and primary care case management, though the specific savings depend on factors like the efficiency of the PSN.",2.6054570009253947e-07,0.11875726320115199,0.06005527210884355,0.0199476911126006,0.1287578169970871,0.06041779862163629,0.019918816950481533,0.16917868806769043,0.03566529492455417,2.6054570009253947e-07,0.19793819929384737,0.0181755829903978
15,0.3,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Is there a cost advantage for provider service networks over HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) might lower expenditures compared to HMOs and primary care case management, but the actual savings depend on several factors including the PSN's efficiency.",2.8423167282822487e-07,0.1133326806482784,0.07876275510204082,0.02176111757738247,0.15207613855752378,0.059457931997282734,0.0217296184914344,0.19165154391974815,0.03566529492455417,2.8423167282822487e-07,0.2209277175185469,0.0181755829903978
15,0.3,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","In Florida's Medicaid program, do provider service networks offer lower expenditures than HMOs or primary care case management? Provider Service Networks (PSNs) have the potential to reduce costs compared to HMOs and primary care case management, although the exact savings depend on factors such as the efficiency of the PSN.",2.1317375462116866e-07,0.042773329899222556,0.08394290123456792,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
15,0.3,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider Service Networks (PSNs) in Florida's Medicaid program can potentially result in lower expenditures compared to HMOs and primary care case management. However, the exact savings depend on various factors such as the efficiency of the PSN,","Do provider service networks lead to cost savings compared with HMOs or primary care case management in Florida's Medicaid program? Provider Service Networks (PSNs) in Florida's Medicaid program can potentially lower expenditures relative to HMOs and primary care case management, but the precise savings depend on various factors including the efficiency of the PSN.",1.1842986367842703e-07,0.008073812113420509,0.0535679480408431,0.009067132323909363,0.02586034786381619,0.04633017672855455,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
16,0.3,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective treatment for postoperative cerebrospinal fluid fistula following spine surgery? Yes, lumbar drainage is typically an effective approach for managing cerebrospinal fluid (CSF) fistulas after spine surgery, providing a dependable solution for CSF leaks.",7.10579182070559e-08,0.086895085258059,0.10705017301038065,0.005440279394345618,0.13323334788337027,0.14876033057851237,0.0054324046228586,0.06368762398617411,0.10380622837370242,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
16,0.3,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is generally effective and considered a reliable method to control CSF leaks post spine surgery.",2.842316728282236e-07,0.07941607171475384,0.1875,0.021761117577382527,0.15444872456841052,0.14876033057851237,0.02172961849143446,0.23356389948175682,0.10380622837370242,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
16,0.3,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a successful method for postoperative cerebrospinal fluid fistula management after spine surgery? Yes, lumbar drainage is usually effective and serves as a trusted technique to handle CSF leaks following spine surgery.",1.658018091497971e-07,0.04287805954258639,0.1572265625,0.01269398525347313,0.015450312226986451,0.14876033057851237,0.012675610786670094,0.057673233018092684,0.10380622837370242,1.6580180914979784e-07,0.13478570065126494,0.05387755102040818
16,0.3,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Can lumbar drainage effectively manage postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is commonly effective and is a reliable way to treat CSF leaks after spine surgery.",2.605457000925383e-07,0.1399312595669251,0.11891289437585734,0.019947691112600648,0.11808108039753584,0.14876033057851237,0.019918816950481588,0.19582357149890983,0.10380622837370242,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
16,0.3,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective in treating postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is generally effective and widely used to manage CSF leaks postoperatively.",3.552895910352795e-07,0.19274475702175797,0.1875,0.027201396971728166,0.2722317602247948,0.14876033057851237,0.027162023114293082,0.3561662215740897,0.10380622837370242,3.552895910352811e-07,0.44494062895510433,0.05387755102040818
16,0.3,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Does lumbar drainage provide effective treatment for postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is typically a dependable and effective method to address CSF leaks after spine surgery.",2.36859727356853e-07,0.10284282430246217,0.12117346938775513,0.018134264647818768,0.08298976058626684,0.14876033057851237,0.018108015409528715,0.15945592732803515,0.10380622837370242,2.3685972735685406e-07,0.2401462163090904,0.05387755102040818
16,0.3,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage a reliable treatment for postoperative cerebrospinal fluid fistula following spine surgery? Yes, it is generally effective and serves as a trusted approach to manage CSF leaks.",2.842316728282236e-07,0.07941607171475384,0.1875,0.021761117577382527,0.15444872456841052,0.14876033057851237,0.02172961849143446,0.23356389948175682,0.10380622837370242,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
16,0.3,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is commonly effective and considered a reliable treatment for CSF leaks.",3.789755637709648e-07,0.23356675154201278,0.1875,0.029014823436510045,0.3147913746435904,0.14876033057851237,0.028972824655245956,0.4006179841449238,0.10380622837370242,3.789755637709665e-07,0.4914606445899983,0.05387755102040818
16,0.3,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage an effective intervention for postoperative cerebrospinal fluid fistula after spine surgery? Yes, it is generally effective and a dependable method to control CSF leaks.",3.316036182995942e-07,0.1535240438684755,0.1875,0.025387970506946286,0.23140976570453997,0.14876033057851237,0.02535122157334021,0.3136066071552941,0.10380622837370242,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
16,0.3,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Yes, lumbar drainage of postoperative cerebrospinal fluid (CSF) fistula after spine surgery is generally effective. It serves as a reliable method to manage CSF leaks, which can","Is lumbar drainage effective in managing postoperative cerebrospinal fluid fistula after spine surgery? Yes, lumbar drainage is usually effective and regarded as a reliable technique to treat CSF leaks.",2.842316728282236e-07,0.128926584611893,0.15183470507544583,0.021761117577382527,0.15444872456841052,0.14876033057851237,0.02172961849143446,0.23356389948175682,0.10380622837370242,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
17,0.3,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are increased depression rates in women explained by differences in symptom reporting? Differential symptom reporting does play a role, as women may be more inclined to report symptoms or seek assistance. However, it",1.894877818854824e-07,0.04985675617422425,0.12244897959183673,0.014507411718255009,0.12293641386604559,0.0763888888888889,0.014486412327622968,0.1634259169526584,0.05246913580246914,1.8948778188548325e-07,0.20615466749235,0.027006172839506164
17,0.3,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do higher depression rates among women result from varied symptom reporting? Differential symptom reporting contributes, since women might be more prone to report symptoms or seek help. However, it",2.842316728282236e-07,0.18338814879874654,0.12244897959183673,0.021761117577382527,0.26108675234686274,0.0763888888888889,0.02172961849143446,0.30652676059333084,0.05246913580246914,2.8423167282822487e-07,0.35457467261062314,0.027006172839506164
17,0.3,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the higher prevalence of depression in women due to differences in how symptoms are reported? Differential symptom reporting partially explains this, as women may be more likely to disclose symptoms or seek care. However, it",1.184298636784265e-07,0.03975540251546272,0.12244897959183673,0.00906713232390937,0.0305630937350303,0.0763888888888889,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
17,0.3,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Can the elevated depression rates in women be attributed to differential symptom reporting? Yes, differential symptom reporting contributes because women might report symptoms or seek help more often. However, it",2.605457000925383e-07,0.19610008281919766,0.08801020408163264,0.019947691112600648,0.22471910817598806,0.0763888888888889,0.019918816950481588,0.26878643261048385,0.05246913580246914,2.6054570009253947e-07,0.3153539594573407,0.027006172839506164
17,0.3,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are women's higher depression rates a consequence of differential symptom reporting? Differential symptom reporting does contribute, with women potentially more likely to report symptoms or seek help. However, it",2.842316728282236e-07,0.2328986616958857,0.08678368466728256,0.021761117577382527,0.26108675234686274,0.0763888888888889,0.02172961849143446,0.30652676059333084,0.05246913580246914,2.8423167282822487e-07,0.35457467261062314,0.027006172839506164
17,0.3,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Does differential symptom reporting account for the greater depression rates in women? It does contribute, as women may be more inclined to report symptoms or seek assistance. However, it",2.842316728282236e-07,0.18338814879874654,0.12244897959183673,0.021761117577382527,0.26108675234686274,0.0763888888888889,0.02172961849143446,0.30652676059333084,0.05246913580246914,2.8423167282822487e-07,0.35457467261062314,0.027006172839506164
17,0.3,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Is the increased incidence of depression in women explained by differences in symptom reporting? Differential symptom reporting plays a role since women might report symptoms or seek help more frequently. However, it",2.131737546211677e-07,0.08160545448880407,0.12244897959183673,0.01632083818303689,0.1557262366890373,0.0763888888888889,0.01629721386857584,0.19732746862834016,0.05246913580246914,2.1317375462116866e-07,0.24124598730361901,0.027006172839506164
17,0.3,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Are higher depression rates in women due to differences in symptom reporting? Differential symptom reporting contributes because women may be more likely to report symptoms or seek help. However, it",2.605457000925383e-07,0.14829682898747754,0.12244897959183673,0.019947691112600648,0.22471910817598806,0.0763888888888889,0.019918816950481588,0.26878643261048385,0.05246913580246914,2.6054570009253947e-07,0.3153539594573407,0.027006172839506164
17,0.3,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Do women have higher depression rates because of differential symptom reporting? Differential symptom reporting partially accounts for this, as women might be more prone to report symptoms or seek help. However, it",2.131737546211677e-07,0.1263246274281551,0.09022675736961452,0.01632083818303689,0.1557262366890373,0.0763888888888889,0.01629721386857584,0.19732746862834016,0.05246913580246914,2.1317375462116866e-07,0.24124598730361901,0.027006172839506164
17,0.3,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Differential symptom reporting does contribute to higher rates of depression in women, as women might be more likely to report symptoms or seek help. However, it","Could differential symptom reporting explain why depression rates are higher in women? It does contribute, as women may be more likely to report symptoms or seek help. However, it",2.842316728282236e-07,0.18338814879874654,0.12244897959183673,0.021761117577382527,0.26108675234686274,0.0763888888888889,0.02172961849143446,0.30652676059333084,0.05246913580246914,2.8423167282822487e-07,0.35457467261062314,0.027006172839506164
18,0.3,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows that OTC pharmacy syringe sales did not lead to higher reported crime rates in Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.07309743965520443,0.030969041469467145,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.3,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does crime correlate with over-the-counter pharmacy syringe sales? Findings indicate no association between OTC syringe sales and increased crime reports in Los Angeles neighborhoods between 2006 and 2008.,1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,0.3,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales connected to crime? The data reveal that OTC syringe sales were not linked to a rise in reported crime in local Los Angeles areas during 2006-2008.,7.10579182070559e-08,0.05750215177378237,0.027060100148354166,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
18,0.3,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime related to the sale of syringes over the counter in pharmacies? Our study found no evidence that OTC pharmacy syringe sales caused an increase in reported crime in Los Angeles communities from 2006 through 2008.,7.10579182070559e-08,0.17102921705750251,0.06035379812695108,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
18,0.3,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Do over-the-counter pharmacy syringe sales influence crime rates? Results demonstrate that OTC syringe sales did not correspond with an increase in reported crime in Los Angeles localities during 2006-2008.,1.184298636784265e-07,0.12979572412054274,0.024688503202396905,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
18,0.3,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? Our findings indicate that OTC syringe sales were not tied to higher crime reports in Los Angeles neighborhoods from 2006 to 2008.,2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.3,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are crime rates affected by over-the-counter pharmacy syringe sales? The investigation showed no link between OTC syringe sales and increased crime in Los Angeles communities during 2006-2008.,1.658018091497971e-07,0.15439318337712526,0.06035379812695108,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
18,0.3,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a connection between crime and the sale of syringes at pharmacies without a prescription? Evidence suggests OTC pharmacy syringe sales did not cause a rise in reported crime in Los Angeles local areas between 2006 and 2008.,1.184298636784265e-07,0.2250964383277787,0.06035379812695108,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
18,0.3,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies impact crime? Our findings confirm that OTC pharmacy syringe sales were not associated with increased crime reports in Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.3,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime associated with OTC pharmacy syringe sales? The study results show no increase in reported crime in local Los Angeles communities linked to OTC syringe sales during 2006-2008.,1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
19,0.3,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology evaluation required for the treatment of ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation is crucial for the treatment of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.09676491279688726,0.07680498163452701,0.003626852929563759,0.10594427408294083,0.10612022684310021,0.003621603081905747,0.11621306957942412,0.1279483070348455,4.737194547137081e-08,0.07442356653769577,0.10560000000000003
19,0.3,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is specialized breast pathology analysis important for managing ductal carcinoma in situ? Answer: Yes, specialized breast pathology analysis is vital for managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.19185234400277373,0.06256944444444454,0.003626852929563759,0.1921715029084372,0.07580589569160992,0.003621603081905747,0.19197212887348414,0.08078634652061223,4.737194547137081e-08,0.13780497272019776,0.04158790170132326
19,0.3,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Does managing ductal carcinoma in situ necessitate expert breast pathology review? Answer: Yes, expert breast pathology review is necessary for managing ductal carcinoma in situ (DCIS).",7.10579182070559e-08,0.19009710614174846,0.04506944444444441,0.005440279394345639,0.18660424439477064,0.04859501133786848,0.005432404622858621,0.18196333015267374,0.045662379578463495,7.105791820705622e-08,0.18287598996711107,0.04338842975206613
19,0.3,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is it necessary to have expert breast pathology assessment for ductal carcinoma in situ management? Answer: Yes, expert breast pathology assessment is indispensable for managing ductal carcinoma in situ (DCIS).",2.36859727356853e-08,0.004341051389695316,0.022569444444444448,0.0018134264647818796,0.007590156824194949,0.028799999999999937,0.0018108015409528735,0.011309146026370787,0.03402366863905328,2.3685972735685406e-08,0.03774032798284699,0.0
19,0.3,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert evaluation by a breast pathologist required for ductal carcinoma in situ management? Answer: Yes, expert evaluation by a breast pathologist is essential for managing ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.0520457398575358,0.06191254463348045,0.003626852929563759,0.05973446204561084,0.08189999999999997,0.003621603081905747,0.068409815747704,0.09741775147928994,4.737194547137081e-08,0.02491305364055707,0.07100591715976333
19,0.3,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is professional breast pathology assessment needed for the management of ductal carcinoma in situ? Answer: Yes, professional breast pathology assessment is critical for managing ductal carcinoma in situ (DCIS).",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.3,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is the involvement of an expert breast pathologist necessary in managing ductal carcinoma in situ? Answer: Yes, the involvement of an expert breast pathologist is necessary for managing ductal carcinoma in situ (DCIS).",9.47438909427412e-08,0.009852279666816344,0.06944444444444445,0.007253705859127518,0.021188960179037153,0.096,0.007243206163811494,0.03410129061890643,0.11834319526627218,9.474389094274162e-08,0.004471407528683802,0.09876543209876545
19,0.3,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology examination mandatory for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology examination is mandatory for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,0.3,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology consultation required for effective management of ductal carcinoma in situ? Answer: Yes, expert breast pathology consultation is required for effective management of ductal carcinoma in situ (DCIS).",4.73719454713706e-08,0.14148408573623872,0.08450255102040813,0.003626852929563759,0.15215408612027037,0.12580495867768585,0.003621603081905747,0.16401632341114514,0.15583438663997037,4.737194547137081e-08,0.12393407943483492,0.13888888888888887
19,0.3,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is essential for managing ductal carcinoma in situ (DCIS).","Question: Is expert breast pathology input essential for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology input is essential for managing ductal carcinoma in situ (DCIS).",0.0,0.047803253831721015,0.027886079605124875,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20,0.3,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an initial night impact on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording might suffice for patients with moderate to high frequency SB. Nevertheless, low RMMA frequency on the first night should be verified.",2.3685972735685406e-08,0.10449845089304066,0.09487176711851247,0.0018134264647818726,0.0953654920637459,0.05536332179930796,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.3,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night influence sleep bruxism? Results showed no significant first night effect on RMMA frequency severity in young, healthy patients with SB. In practice, one night of sleep recording may be adequate for those with moderate to high frequency SB. However, low RMMA frequency during the first night could be confirmed.",7.105791820705622e-08,0.012044243996589987,0.030215997963811303,0.005440279394345618,0.007324302819299522,0.03576332179930797,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.3,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night effect on sleep bruxism? The study found no overall first night impact on RMMA frequency severity in young, healthy SB patients. For clinical purposes, a single night sleep recording may be enough for moderate to high frequency SB cases. Still, low RMMA frequency on the first night should be confirmed.",2.3685972735685406e-08,0.055690442232240844,0.05369254544554915,0.0018134264647818726,0.0583242203833958,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
20,0.3,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does sleep bruxism show a first night effect? The results demonstrated no overall first night effect on RMMA frequency severity in young, healthy individuals with SB. Clinically, one night of sleep recording might be sufficient for patients with moderate to high SB frequency. However, low RMMA frequency on the first night requires confirmation.",7.105791820705622e-08,0.0146152629480234,0.04997917534360677,0.005440279394345618,0.0198579395556,0.05536332179930796,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.3,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there an effect of the first night on sleep bruxism? Findings revealed no overall first night effect on RMMA frequency severity in young, healthy patients with SB. In clinical settings, one night of sleep recording may be adequate for moderate to high frequency SB patients. Yet, low RMMA frequency on the first night should be verified.",2.3685972735685406e-08,0.07039947759153264,0.038804097898065104,0.0018134264647818726,0.070160140043384,0.03718773880891016,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
20,0.3,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the initial night affect sleep bruxism? The results showed no significant first night effect on RMMA frequency severity in young, healthy SB patients. One night of sleep recording may be sufficient in clinical practice for moderate to high frequency SB. However, low RMMA frequency on the first night needs confirmation.",1.1842986367842703e-07,0.009983760486949933,0.10834099796381133,0.009067132323909363,0.020147395058098372,0.05536332179930796,0.009054007704764333,0.07293440526460904,0.018860946745562133,1.1842986367842703e-07,0.10109611687136999,0.0
20,0.3,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night influence on sleep bruxism? The findings indicated no overall first night effect on RMMA frequency severity in young, healthy individuals with SB. Clinically, a single night of sleep recording may suffice for moderate to high frequency SB patients. Low RMMA frequency on the first night, however, should be confirmed.",4.737194547137081e-08,0.0713914482964797,0.11059373729483787,0.0036268529295637453,0.0392760254127027,0.05536332179930796,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
20,0.3,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is the first night effect present in sleep bruxism? Results showed no general first night effect on RMMA frequency severity in young, healthy SB patients. One night of sleep recording may be enough in clinical practice for moderate to high frequency SB. Nonetheless, low RMMA frequency on the first night could be confirmed.",7.105791820705622e-08,0.038703750941202486,0.010652721468665166,0.005440279394345618,0.03450654519419949,0.016212967780149266,0.0054324046228586,0.03211241074435467,0.018860946745562133,7.105791820705622e-08,0.05942342047080107,0.0
20,0.3,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Is there a first night impact on sleep bruxism? The study found no overall first night effect on RMMA frequency severity in young, healthy patients with SB. Clinically, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night should be verified.",4.737194547137081e-08,0.03536234443073605,0.0518715535193669,0.0036268529295637453,0.0392760254127027,0.05536332179930796,0.003621603081905733,0.012309783448174905,0.018860946745562133,4.737194547137081e-08,0.03922071315328246,0.0
20,0.3,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed","Does the first night affect sleep bruxism? Findings showed no overall first night effect on RMMA frequency severity in young, healthy SB patients. In clinical practice, one night of sleep recording may suffice for moderate to high frequency SB. Still, low RMMA frequency on the first night could be confirmed.",1.4211583641411244e-07,0.0786125925540202,0.022839454753934757,0.010880558788691236,0.06964781478416482,0.034539419581109676,0.0108648092457172,0.0939878144624422,0.018860946745562133,1.4211583641411244e-07,0.12260232209233335,0.0
21,0.3,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns cause less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not result in lower cumulative opioid use.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.3,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? Minimal access surgery for repairing esophageal atresia or congenital diaphragmatic hernia does not lead to decreased total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.3,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less pain? The repair of esophageal atresia or congenital diaphragmatic hernia via minimal access surgery is not linked to reduced cumulative opioid consumption.,4.73719454713706e-08,0.11363644642723303,0.03510904882244257,0.003626852929563759,0.11449462833039359,0.03443877551020409,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.3,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia repairs do not correspond with lower overall opioid doses.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery cause less pain in newborns? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not associate with decreased total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.3,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain relief better with minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not correlate with less cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery reduce pain in newborns undergoing major surgery? Repair of esophageal atresia or congenital diaphragmatic hernia by minimal access surgery is not connected to lower cumulative opioid doses.,4.73719454713706e-08,0.11363644642723303,0.03510904882244257,0.003626852929563759,0.11449462833039359,0.03443877551020409,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.3,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less opioid use after minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not show reduced total opioid consumption.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair is not associated with diminished cumulative opioid doses.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is minimal access major surgery less painful for newborns? The use of minimal access surgery to repair esophageal atresia or congenital diaphragmatic hernia does not lead to lower cumulative opioid doses.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
22,0.3,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites representative of community practice? Answer: Yes, family practice at residency teaching sites typically mirrors community practice. Residency programs aim to ready physicians for community work by familiarizing them with prevalent health concerns.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.3,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice during residency training reflect the nature of community practice? Answer: Yes, family practice at residency teaching sites usually reflects community practice. These programs are structured to prepare physicians for community settings by exposing them to common health problems.",2.3685972735685406e-08,0.1641673501420673,0.09807397959183672,0.0018134264647818726,0.16750184502222787,0.1012244897959184,0.0018108015409528666,0.13541977807061834,0.0783673469387755,2.3685972735685406e-08,0.10160307741296659,0.05387755102040818
22,0.3,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is the family practice experienced at residency teaching sites similar to community practice? Answer: Yes, family practice at residency teaching sites often parallels community practice. Residency programs are designed to equip physicians for community practice by introducing them to typical health issues.",4.737194547137081e-08,0.09004892491704597,0.028266154107072214,0.0036268529295637453,0.12457034243601983,0.05257228729756206,0.003621603081905733,0.12608022702691368,0.053383783493673585,4.737194547137081e-08,0.12757856381622457,0.05387755102040818
22,0.3,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites align with community practice? Answer: Yes, family practice at residency teaching sites generally aligns with community practice. Residency training prepares physicians for community practice by exposing them to frequently encountered health conditions.",2.36859727356853e-08,0.0653070684012107,0.02631135098667564,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.3,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice in residency teaching sites reflective of community practice? Answer: Yes, family practice at residency teaching sites commonly reflects community practice. Residency programs prepare physicians for community practice by providing experience with common health challenges.",7.10579182070559e-08,0.017076991825933696,0.041999152602217385,0.005440279394345618,0.023633152666627133,0.07346938775510208,0.0054324046228586,0.027206193430387327,0.0783673469387755,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
22,0.3,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does the family practice at residency teaching sites correspond to community practice? Answer: Yes, family practice at residency teaching sites often corresponds with community practice. Residency programs are designed to train physicians for community practice by exposing them to prevalent health issues.",4.737194547137081e-08,0.0570419163189535,0.005575349204692853,0.0036268529295637453,0.056946227259440096,0.0048037447265246586,0.003621603081905733,0.05676550897091914,0.0038604075669712717,4.737194547137081e-08,0.056486545297256274,0.0027453377260327275
22,0.3,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites indicative of community practice? Answer: Yes, family practice at residency teaching sites is often indicative of community practice. Residency programs aim to prepare physicians for community practice by familiarizing them with common health concerns.",2.3685972735685406e-08,0.0387049953876728,0.04104583009674459,0.0018134264647818726,0.005784950117757592,0.02122448979591833,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
22,0.3,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice at residency teaching sites represent community practice? Answer: Yes, family practice at residency teaching sites frequently represents community practice. Residency programs are structured to ready physicians for community practice by exposing them to typical health problems.",2.36859727356853e-08,0.029761059141726776,0.0029835463597203127,0.0018134264647818726,0.029717171588468982,0.002581738577784029,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,0.3,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Is family practice at residency teaching sites consistent with community practice? Answer: Yes, family practice at residency teaching sites is consistent with community practice. Residency programs prepare physicians for community practice by providing exposure to common health issues.",4.73719454713706e-08,0.13337651313807042,0.05236891843105612,0.0036268529295637453,0.09779677227449612,0.0306114477040816,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,0.3,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community practice by exposing them to the common health issues,","Question: Does family practice during residency at teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites often reflects community practice. Residency programs are designed to prepare physicians for community settings by exposing them to common health concerns.",0.0,0.10397207708399137,0.07258748374696139,0.0,0.14218403703793614,0.1012244897959184,0.0,0.10944429166736036,0.0783673469387755,0.0,0.07493483033080572,0.05387755102040818
23,0.3,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression associated with the likelihood of returning to treatment? Yes, the duration of psychological treatment for depression can be linked to returning for further treatment. Extended treatment periods may reflect more severe or chronic cases that require repeated therapy sessions. Nonetheless, this relationship can vary based on individual patient responses and other factors.",4.737194547137081e-08,0.11074679361716422,0.05296198347107435,0.0036268529295637453,0.062407464857966666,0.019435669225879006,0.003621603081905733,0.06269223125544832,0.019322583011394202,4.737194547137081e-08,0.06295662331933816,0.019131008851288562
23,0.3,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the duration of psychological treatment for depression influence the chances of returning to treatment? Indeed, the length of psychological treatment for depression may correlate with a return to treatment. Longer treatments often suggest more severe or persistent conditions that necessitate ongoing therapy. However, individual patient differences and other variables also play a role.",9.474389094274162e-08,0.0071386678739076,0.04543123698458974,0.0072537058591274906,0.055065467193283535,0.01352986551461545,0.007243206163811466,0.05425598119686015,0.015213551306285114,9.474389094274162e-08,0.05334269276149417,0.01699057838326732
23,0.3,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a connection between how long psychological treatment for depression lasts and the likelihood of returning to treatment? Yes, the duration of treatment can be related to returning for additional therapy. Longer treatment durations might indicate chronic or severe depression requiring repeated sessions, though this depends on patient-specific factors and other influences.",1.1842986367842703e-07,0.07843912667388153,0.12039999999999998,0.009067132323909363,0.00549496778345393,0.07100591715976332,0.009054007704764333,0.01969412374324042,0.05436390532544381,1.1842986367842703e-07,0.045819512856614786,0.036982248520710054
23,0.3,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Can the duration of psychological treatment for depression affect the probability of returning to treatment? Yes, longer psychological treatments for depression may be associated with a higher chance of returning to treatment due to the severity or chronic nature of the condition, but individual patient responses and other factors also impact this.",1.4211583641411244e-07,0.02252568630792018,0.06180624999999998,0.010880558788691236,0.04203354673512383,0.05101424702232058,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
23,0.3,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the time spent in psychological treatment for depression related to the chance of returning to treatment? Yes, the length of treatment can relate to returning for further therapy. Extended durations may reflect more severe or ongoing depression, necessitating repeated treatments, though this varies with individual patient factors.",2.3685972735685406e-07,0.022656990197488458,0.12039999999999998,0.018134264647818726,0.09768926845177672,0.07100591715976332,0.018108015409528666,0.12505463940106631,0.05436390532544381,2.3685972735685406e-07,0.15345017704897979,0.036982248520710054
23,0.3,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the length of psychological treatment for depression have a relationship with returning to treatment? Yes, longer treatment durations can be linked to a return to therapy, often indicating more severe or chronic depression, but this also depends on individual patient responses and other factors.",3.079176455639103e-07,0.08861495798928454,0.12039999999999998,0.023574544042164344,0.16513054924730897,0.07100591715976332,0.023540420032387266,0.19404751088801797,0.05436390532544381,3.079176455639103e-07,0.22406774426293374,0.036982248520710054
23,0.3,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the duration of psychological treatment for depression connected to the likelihood of returning to treatment? Yes, longer treatments may suggest severe or chronic depression that requires repeated therapy sessions, though individual patient differences and other factors influence this relationship.",4.263475092423372e-07,0.20924294577790192,0.12039999999999998,0.03264167636607371,0.2887445052144848,0.07100591715976332,0.0325944277371516,0.32079921652716026,0.05436390532544381,4.263475092423373e-07,0.35412087251113133,0.036982248520710054
23,0.3,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is there a relationship between the length of psychological treatment for depression and the chance of returning to treatment? Yes, longer durations can be associated with a return to treatment, possibly due to the severity or chronic nature of the condition, but this also depends on individual patient responses and other variables.",1.4211583641411244e-07,0.059021040816778836,0.12039999999999998,0.010880558788691236,0.014307659512725834,0.07100591715976332,0.0108648092457172,0.03989683106075903,0.05436390532544381,1.4211583641411244e-07,0.06643880005935054,0.036982248520710054
23,0.3,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Does the duration of psychological treatment for depression relate to the likelihood of returning to treatment? Yes, prolonged treatment may indicate severe or chronic depression requiring repeated therapy, although individual patient factors and other influences also matter.",4.974054274493931e-07,0.2892856534514361,0.12039999999999998,0.038081955760419325,0.37098260345145784,0.07100591715976332,0.038026832360010206,0.40535660455522393,0.05436390532544381,4.974054274493935e-07,0.44113224950076146,0.036982248520710054
23,0.3,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: Yes, the duration of psychological treatment for depression can be related to a return into treatment. Longer treatment durations may indicate severe or chronic conditions, which might need recurrent therapy sessions. However, this could also depend on individual patient responses and other influencing factors.","Is the length of psychological treatment for depression linked to the probability of returning to treatment? Yes, longer treatment durations might be related to returning for further therapy due to more severe or chronic conditions, but this can vary depending on individual patient responses and other factors.",2.6054570009253947e-07,0.04416319541845182,0.12039999999999998,0.0199476911126006,0.11966817517055173,0.07100591715976332,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.1764396952736793,0.036982248520710054
24,0.3,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical method targeting the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It can be regarded as the preferred approach for typical TMJ surgeries.",4.737194547137081e-08,0.12862063739118046,0.06265295796173082,0.0036268529295637453,0.0711683211052474,0.021266540642722105,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
24,0.3,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical technique for the temporomandibular joint improve surgical access and lower complication rates? Answer: The VMPA allows direct access and clear visibility of the TMJ region, producing good aesthetic and functional results. It is considered the method of choice for standard TMJ procedures.",4.737194547137081e-08,0.04282808173713892,0.06091623303744516,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.3,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,Question: Does a novel surgical approach to the temporomandibular joint enhance access and decrease complications? Answer: The VMPA provides direct access with optimal visibility to the TMJ area and achieves satisfactory aesthetic and functional outcomes. It is regarded as the preferred approach for common TMJ surgeries.,7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical technique for the temporomandibular joint improve accessibility and reduce the risk of complications? Answer: The VMPA grants direct access and favorable visualization of the TMJ region, leading to positive aesthetic and functional results. It is considered the approach of choice for routine TMJ surgeries.",0.0,0.11552453009332408,0.08264462809917356,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.3,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel surgical approach to the TMJ capable of improving access and minimizing complications? Answer: The VMPA ensures direct access and good visibility to the TMJ area, yielding excellent aesthetic and functional outcomes. It is viewed as the preferred method for typical TMJ operations.",7.105791820705622e-08,0.04143361511890653,0.016318097486928668,0.005440279394345618,0.06796903311257019,0.0014484404281270048,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a fresh surgical approach to the temporomandibular joint enhance access and lower complication risks? Answer: The VMPA provides direct access and clear visibility to the TMJ region, resulting in favorable aesthetic and functional results. It is considered the best approach for common TMJ surgeries.",7.105791820705622e-08,0.010627073760686834,0.038296331722753874,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a new surgical method for the temporomandibular joint improve access and reduce complications? Answer: The VMPA offers direct access and optimal visualization of the TMJ area, producing good aesthetic and functional outcomes. It is regarded as the approach of choice for standard TMJ surgeries.",7.105791820705622e-08,0.020179467597532863,0.06043388429752067,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical approach to the TMJ improve access and decrease the likelihood of complications? Answer: The VMPA allows direct access and favorable visibility to the TMJ region, yielding satisfactory aesthetic and functional results. It is considered the preferred approach for routine TMJ surgeries.",7.105791820705622e-08,0.04143361511890653,0.016318097486928668,0.005440279394345618,0.06796903311257019,0.0014484404281270048,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it feasible for a novel surgical technique targeting the temporomandibular joint to improve access and reduce complications? Answer: The VMPA provides direct access and excellent visibility to the TMJ area, resulting in positive aesthetic and functional outcomes. It is viewed as the method of choice for common TMJ surgeries.",4.737194547137081e-08,0.12862063739118046,0.06265295796173082,0.0036268529295637453,0.0711683211052474,0.021266540642722105,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
24,0.3,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical approach to the temporomandibular joint enhance access and minimize complications? Answer: The VMPA grants direct access and clear visualization of the TMJ region, leading to good aesthetic and functional results. It is considered the preferred approach for typical TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
25,0.3,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection? Most individuals in France are swayed by the context when determining if a doctor should violate confidentiality to protect the spouse of a patient with an STD.,7.105791820705622e-08,0.007959027215065362,0.037769847781801716,0.005440279394345618,0.006423629273291986,0.039930555555555566,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
25,0.3,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Is it acceptable for French non-experts and medical professionals to breach confidentiality to protect a patient's wife from an STD? In France, most people base their decision on situational factors when deciding if a physician should disclose confidential information to protect the patient's spouse.",1.8948778188548325e-07,0.12131819365303764,0.035351119614512476,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.3,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French health workers and laypersons find it acceptable to breach confidentiality to shield a patient's wife from a sexually transmitted disease? In France, the majority are influenced by the circumstances when deciding whether a doctor should break confidentiality to protect the spouse of an STD-infected patient.",1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.3,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French laypeople and medical professionals agreeable to breaching confidentiality to protect a patient's wife from sexually transmitted diseases? Most French people consider situational factors when deciding if a physician should breach confidentiality to protect the patient's spouse infected with an STD.,2.3685972735685406e-07,0.2043309540718976,0.00994154750164366,0.018134264647818726,0.2023491358974101,0.014946992110453645,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
25,0.3,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople accept breaching confidentiality to protect a patient's wife from an STD? Most people in France are influenced by the situation when deciding if a doctor should break confidentiality to safeguard the spouse of a patient with a sexually transmitted disease.,1.4211583641411244e-07,0.0744229571875259,0.03638300619834711,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.3,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from an STD acceptable to French laypeople and health professionals? Most individuals in France take situational factors into account when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with an STD.,1.4211583641411244e-07,0.10522949854574559,0.014245453623580318,0.010880558788691236,0.10388828709054065,0.017215574484706456,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.3,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French laypersons and healthcare providers find it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted infection? In France, most people are influenced by the specific circumstances when deciding if a doctor should breach confidentiality to protect the patient's spouse.",1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.3,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health professionals and laypeople willing to breach confidentiality to protect a patient's wife from sexually transmitted diseases? Most French people consider the context when deciding if a physician should disclose confidential information to protect the spouse of a patient with an STD.,1.8948778188548325e-07,0.12131819365303764,0.035351119614512476,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,0.3,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French laypeople and medical professionals deem it acceptable to breach confidentiality to protect a patient's wife from an STD? In France, the majority are influenced by situational factors when deciding if a doctor should breach confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.",4.737194547137081e-08,0.04333377245552272,0.002370333175803374,0.0036268529295637453,0.043132485122120645,0.0016573461457676936,0.003621603081905733,0.04287659944973932,0.0008672350871665457,4.737194547137081e-08,0.04255961441879652,0.0
25,0.3,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable among French health professionals and laypersons to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most people in France are guided by situational factors when deciding if a physician should break confidentiality to protect the spouse of a patient with an STD.,7.105791820705622e-08,0.036840159738396494,0.01700584829867674,0.005440279394345618,0.03591925397797047,0.018664014912833465,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
26,0.3,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance, as research indicates a link between the I allele and higher risk.",4.974054274493924e-07,0.2674683032176941,0.1875,0.038081955760419374,0.3615737363468665,0.1388888888888889,0.038026832360010254,0.4598396148102375,0.08264462809917357,4.974054274493935e-07,0.5330598142792184,0.04246913580246913
26,0.3,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Research suggests that the insertion allele (I) of the ACE gene I/D polymorphism may serve as a candidate gene for insulin resistance due to its association with increased risk.,5.210914001850777e-07,0.3025596230289631,0.1875,0.039895382225201254,0.3979413805177412,0.1388888888888889,0.03983763390096313,0.4975799427930845,0.08264462809917357,5.210914001850789e-07,0.5722805274325009,0.04246913580246913
26,0.3,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The ACE gene I/D polymorphism's insertion allele (I) is potentially a candidate gene for insulin resistance, supported by studies showing its correlation with elevated risk.",6.158352911278189e-07,0.45671030285622205,0.1875,0.04714908808432877,0.5582840305929211,0.1388888888888889,0.04708084006477462,0.6646340274562514,0.08264462809917357,6.158352911278206e-07,0.7466339145772793,0.04246913580246913
26,0.3,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Evidence points to the insertion allele (I) of the ACE gene I/D polymorphism as a possible candidate gene for insulin resistance, given its association with greater risk.",5.684633456564483e-07,0.3766675951826848,0.1875,0.04352223515476501,0.47490242165387064,0.1388888888888889,0.043459236982868875,0.5776226504666218,0.08264462809917357,5.684633456564497e-07,0.6556621363715514,0.04246913580246913
26,0.3,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The insertion allele (I) in the ACE gene I/D polymorphism might be considered a candidate gene for insulin resistance, based on findings linking it to increased risk.",5.684633456564483e-07,0.3766675951826848,0.1875,0.04352223515476501,0.47490242165387064,0.1388888888888889,0.043459236982868875,0.5776226504666218,0.08264462809917357,5.684633456564497e-07,0.6556621363715514,0.04246913580246913
26,0.3,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Studies have found that the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance due to its connection with higher risk.,5.210914001850777e-07,0.3025596230289631,0.1875,0.039895382225201254,0.3979413805177412,0.1388888888888889,0.03983763390096313,0.4975799427930845,0.08264462809917357,5.210914001850789e-07,0.5722805274325009,0.04246913580246913
26,0.3,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The I allele of the ACE gene I/D polymorphism is a potential candidate gene for insulin resistance, as research shows an association with increased risk.",6.158352911278189e-07,0.45671030285622205,0.1875,0.04714908808432877,0.5582840305929211,0.1388888888888889,0.04708084006477462,0.6646340274562514,0.08264462809917357,6.158352911278206e-07,0.7466339145772793,0.04246913580246913
26,0.3,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk",Research findings indicate that the insertion allele (I) of the ACE gene I/D polymorphism could be a candidate gene for insulin resistance because of its link to elevated risk.,5.210914001850777e-07,0.3025596230289631,0.1875,0.039895382225201254,0.3979413805177412,0.1388888888888889,0.03983763390096313,0.4975799427930845,0.08264462809917357,5.210914001850789e-07,0.5722805274325009,0.04246913580246913
26,0.3,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","The ACE gene I/D polymorphism's insertion allele (I) may qualify as a candidate gene for insulin resistance, supported by evidence of its association with increased risk.",5.921493183921336e-07,0.41588830833596724,0.1875,0.04533566161954689,0.5157244161741255,0.1388888888888889,0.04527003852382175,0.6201822648854174,0.08264462809917357,5.921493183921352e-07,0.7001138989423854,0.04246913580246913
26,0.3,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: Yes, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance. This is based on research showing an association between the I allele and increased risk","Based on research demonstrating a relationship with increased risk, the insertion allele (I) of the ACE gene I/D polymorphism may be a candidate gene for insulin resistance.",5.684633456564483e-07,0.3766675951826848,0.1875,0.04352223515476501,0.47490242165387064,0.1388888888888889,0.043459236982868875,0.5776226504666218,0.08264462809917357,5.684633456564497e-07,0.6556621363715514,0.04246913580246913
27,0.3,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a link between androgens and sexual desire in women? Yes, androgens like testosterone significantly influence female sexual desire and responsiveness. Lower androgen levels can result in reduced sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.3,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Do androgens affect sexual desire in women? Indeed, androgens such as testosterone are crucial for female sexual desire and responsiveness. A decrease in these hormones may cause diminished sexual desire, showing a positive relationship.",5.447773729207636e-07,0.26117036095658674,0.33219569830246926,0.04170880868998309,0.3209272610420495,0.22634676324128575,0.04164843544191596,0.39127435484794404,0.15104166666666666,5.447773729207643e-07,0.46446854237148383,0.07496876301541024
27,0.3,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is sexual desire in women related to androgen levels? Yes, androgens including testosterone play an important role in female sexual desire and responsiveness. Reduced androgen levels can lead to lower sexual desire, suggesting a positive correlation.",4.97405427449393e-07,0.19992935121742894,0.3339224229997011,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.3,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens connected to sexual desire in women? Yes, hormones like testosterone are key in female sexual desire and responsiveness. Low androgen levels may cause decreased sexual desire, indicating a positive link.",5.921493183921342e-07,0.3264009708433355,0.33024691358024705,0.04533566161954685,0.385465782179621,0.22634676324128575,0.04527003852382171,0.4579657293466175,0.15104166666666666,5.921493183921352e-07,0.5334614138584346,0.07496876301541024
27,0.3,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does a correlation exist between androgens and female sexual desire? Yes, androgens such as testosterone significantly impact sexual desire and responsiveness in women. Lower levels might reduce sexual desire, showing a positive correlation.",5.684633456564489e-07,0.24993309958940468,0.36246913580246926,0.04352223515476497,0.3526759593566293,0.22634676324128575,0.04345923698286883,0.42406417767093574,0.15104166666666666,5.684633456564497e-07,0.4983700940471656,0.07496876301541024
27,0.3,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there an association between androgens and sexual desire in women? Yes, androgens including testosterone are important for female sexual desire and responsiveness. Decreased hormone levels can lead to reduced sexual desire, suggesting a positive connection.",4.97405427449393e-07,0.19992935121742894,0.3339224229997011,0.03808195576041933,0.26030263922561403,0.22634676324128575,0.03802683236001021,0.3287539978666105,0.15104166666666666,4.974054274493935e-07,0.3999300212339123,0.07496876301541024
27,0.3,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Are androgens related to sexual desire in women? Yes, androgens like testosterone play a vital role in female sexual desire and responsiveness. Low levels of these hormones may diminish sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.3,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is female sexual desire linked to androgen levels? Yes, androgens such as testosterone are essential for sexual desire and responsiveness in women. Reduced androgen levels may result in decreased sexual desire, showing a positive relationship.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.3,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Does androgen level influence sexual desire in women? Yes, androgens including testosterone have a significant role in female sexual desire and responsiveness. Lower androgen levels may lead to decreased sexual desire, suggesting a positive association.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
27,0.3,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: Yes, there is a correlation between androgens and sexual desire in women. Androgens, such as testosterone, play a significant role in female sexual desire and responsiveness. Low levels of these hormones may lead to decreased sexual desire, suggesting a positive correlation between androgens and","Is there a relationship between androgens and sexual desire in women? Yes, hormones like testosterone are crucial for female sexual desire and responsiveness. Low androgen levels might cause reduced sexual desire, indicating a positive correlation.",5.210914001850783e-07,0.23008184133531895,0.33308437914498534,0.03989538222520121,0.2901556023752958,0.22634676324128575,0.039837633900963086,0.3595256565333642,0.15104166666666666,5.210914001850789e-07,0.43167871954849213,0.07496876301541024
28,0.3,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do sports medicine journals hold significance and practical value for practitioners and athletes? Answer: Absolutely, sports medicine journals are extremely pertinent to both practitioners and athletes. They deliver the latest research findings, treatment innovations, and injury prevention strategies related to sports. They also provide important knowledge on improving athletic performance and nutrition.",1.8948778188548325e-07,0.21310232393113493,0.032523948354852145,0.014507411718254981,0.20792208214981178,0.026800951814396214,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
28,0.3,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals useful and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are very useful for practitioners and athletes. They offer current research, new treatments, and preventive approaches for sports injuries. Additionally, they give valuable information on enhancing athletic performance and nutrition.",4.737194547137081e-08,0.08006802086047538,0.025100054083288248,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.3,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do practitioners and athletes find sports medicine journals relevant and applicable? Answer: Indeed, sports medicine journals are highly relevant to practitioners and athletes. They present up-to-date studies, treatment progress, and preventive techniques for sports injuries. They also provide important insights into athletic performance improvement and nutrition.",4.737194547137081e-08,0.08006802086047493,0.025100054083288248,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.3,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals important and practical for practitioners and athletes? Answer: Yes, sports medicine journals are crucial for practitioners and athletes. They provide the latest research, advancements in treatment, and preventive measures for sports-related injuries. They also offer valuable guidance on athletic performance and nutrition.",4.737194547137081e-08,0.04993118692308629,0.0038321995464852404,0.0036268529295637453,0.048328098854266255,0.0020526554379765236,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.3,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Is the content of sports medicine journals relevant and useful to practitioners and athletes? Answer: Certainly, sports medicine journals are very relevant to practitioners and athletes. They supply current research, treatment developments, and injury prevention methods in sports. They also deliver key insights into enhancing athletic performance and nutrition.",1.1842986367842703e-07,0.12049053767214213,0.009012345679012337,0.009067132323909363,0.11671743766161535,0.004813050113072946,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
28,0.3,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do sports medicine journals offer relevant and applicable information to practitioners and athletes? Answer: Yes, sports medicine journals provide highly relevant information for practitioners and athletes. They include updated research, treatment innovations, and preventive strategies for sports injuries. They also offer valuable advice on athletic performance and nutrition.",9.474389094274162e-08,0.1263947395214453,0.02777777777777779,0.0072537058591274906,0.12393066880576553,0.025134411171674104,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
28,0.3,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals applicable and significant to practitioners and athletes? Answer: Absolutely, sports medicine journals are significant to both practitioners and athletes. They contain the latest research, treatment advancements, and preventive care for sports injuries. They also provide important insights into athletic performance enhancement and nutrition.",7.105791820705622e-08,0.07400222907489118,0.00563007030827474,0.005440279394345618,0.10178325435209201,0.02467255675266781,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
28,0.3,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals relevant and beneficial to practitioners and athletes? Answer: Yes, sports medicine journals are beneficial for practitioners and athletes. They present up-to-date research, new treatment methods, and prevention techniques for sports injuries. They also offer valuable information on improving athletic performance and nutrition.",4.737194547137081e-08,0.08006802086047538,0.025100054083288248,0.0036268529295637453,0.07913464021248595,0.024190208012743315,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
28,0.3,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Do sports medicine journals provide relevant and practical knowledge to practitioners and athletes? Answer: Indeed, sports medicine journals provide relevant knowledge to practitioners and athletes. They feature current research, treatment progress, and injury prevention in sports. They also give important insights into athletic performance and nutrition.",4.737194547137081e-08,0.04047931488908141,0.0572715318869165,0.0036268529295637453,0.044091525220392835,0.06297404818560379,0.003621603081905733,0.048000054441462936,0.06781677572873293,4.737194547137081e-08,0.01538864524228023,0.023242630385487524
28,0.3,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are highly relevant to practitioners and athletes. They provide up-to-date research, treatment advancements, and preventive measures in sports-related injuries. They offer valuable insights into athletic performance enhancement, nutrition,","Question: Are sports medicine journals useful and relevant for practitioners and athletes? Answer: Yes, sports medicine journals are useful and relevant for practitioners and athletes. They offer the latest research, treatment advancements, and preventive measures for sports-related injuries. They also provide valuable insights into enhancing athletic performance and nutrition.",9.474389094274162e-08,0.01087020942812078,0.051582391433670466,0.0072537058591274906,0.00594816998705161,0.05847433163231582,0.007243206163811466,0.0005612763935602949,0.06489994591671175,9.474389094274162e-08,0.03147734034957228,0.04434829637641968
29,0.3,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the quantity of needles affect acupuncture treatment for neck pain? Yes, it can. The number of needles depends on how severe and where the pain is located. More needles may be applied for more intense or extensive pain.",1.8948778188548304e-07,0.07685249763154944,0.08078255273457616,0.014507411718254981,0.10332495305143485,0.06632653061224489,0.014486412327622933,0.16916400543669896,0.02271498107084911,1.8948778188548325e-07,0.20585205420414887,0.0
29,0.3,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the number of needles important in acupuncture for treating neck pain? Yes, it matters. The amount used varies based on the pain's severity and location, with more needles possibly needed for severe or widespread pain.",2.6054570009253894e-07,0.12260916531273613,0.10707911957168353,0.019947691112600606,0.18788234107949853,0.06632653061224489,0.019918816950481547,0.2561753824263291,0.02271498107084911,2.6054570009253947e-07,0.29546421289383584,0.0
29,0.3,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","When treating neck pain with acupuncture, does the needle count matter? Yes, it does. The number of needles depends on the pains intensity and area, with more needles used for more severe or broad pain.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.3,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the number of acupuncture needles impact neck pain treatment? Yes, it can influence the outcome. The needle count is determined by the severity and location of the pain, with more needles used for intense or extensive pain.",2.1317375462116834e-07,0.06703931415792397,0.10707911957168353,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.1973348824033958,0.02271498107084911,2.1317375462116866e-07,0.23483959107740038,0.0
29,0.3,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","In acupuncture for neck pain, is the number of needles significant? Yes, it is. The quantity depends on how severe and where the pain is, with more needles potentially used for widespread or intense pain.",2.8423167282822424e-07,0.15159670218598764,0.10707911957168353,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.3,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the amount of needles used in acupuncture important for neck pain relief? Yes, it depends on the pains severity and location. More needles might be applied for more intense or widespread pain.",3.3160361829959484e-07,0.2122213240024231,0.10707911957168353,0.025387970506946245,0.2802556612105138,0.06632653061224489,0.025351221573340167,0.3514855622306543,0.02271498107084911,3.316036182995957e-07,0.39390428570708913,0.0
29,0.3,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Does the number of needles used in acupuncture affect neck pain treatment? Yes, it can. The number depends on the severity and location of the pain, with more needles used for severe or widespread pain.",2.8423167282822424e-07,0.23314342931068754,0.048485369571683534,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.2869470410930828,0.02271498107084911,2.8423167282822487e-07,0.32721291120841567,0.0
29,0.3,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","For neck pain acupuncture, does needle quantity matter? Yes, it does. The number of needles varies based on pain severity and location, with more needles used for intense or broad pain.",3.7897556377096544e-07,0.27675984513999463,0.10707911957168353,0.029014823436510004,0.3469470357091873,0.06632653061224489,0.028972824655245914,0.42047843371760507,0.02271498107084911,3.789755637709665e-07,0.4653632496892328,0.0
29,0.3,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","Is the needle count relevant in acupuncture for neck pain? Yes, it is. The number depends on the intensity and location of the pain, with more needles used for severe or extensive pain.",3.3160361829959484e-07,0.2122213240024231,0.10707911957168353,0.025387970506946245,0.2802556612105138,0.06632653061224489,0.025351221573340167,0.3514855622306543,0.02271498107084911,3.316036182995957e-07,0.39390428570708913,0.0
29,0.3,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: Yes, the number of needles used in acupuncture for neck pain treatment can matter. It depends on the severity and location of the pain. More needles might be used for intense or widespread pain.","When using acupuncture to treat neck pain, does the number of needles matter? Yes, it can. The needle quantity depends on the severity and location of the pain, with more needles used for more intense or widespread pain.",2.1317375462116834e-07,0.06703931415792397,0.10707911957168353,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.1973348824033958,0.02271498107084911,2.1317375462116866e-07,0.23483959107740038,0.0
30,0.3,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are we adhering to guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence shows minimal systematic falls risk assessment for high-risk individuals during rehabilitation. When risks were identified, strategies were usually applied. However, overlooking some risk factors may have restricted the fall prevention measures provided. Failure to adequately",2.8423167282822487e-07,0.10128573167356691,0.07877526753864447,0.02176111757738247,0.14803262020791852,0.048261993679977015,0.0217296184914344,0.17360129192760532,0.03274920999712727,2.8423167282822487e-07,0.20003864529554383,0.016661878770468257
30,0.3,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we comply with guidelines in preparing patients at high risk of falls for discharge post-rehabilitation? Answer: There is scant evidence that systematic falls risk assessments are conducted for high-risk patients during rehabilitation. When risks are detected, strategies tend to be implemented. Nonetheless, missing some risk factors could have limited the fall prevention options offered. Failure to adequately",1.1842986367842703e-07,0.0273316461485269,0.07877526753864447,0.009067132323909363,0.01700435780151377,0.048261993679977015,0.009054007704764333,0.04006989930308258,0.03274920999712727,1.1842986367842703e-07,0.0639064709709638,0.016661878770468257
30,0.3,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines met in preparing high fall-risk patients for discharge after rehabilitation? Answer: Little evidence exists that systematic falls risk assessments occur for high-risk patients during rehabilitation. When risks are found, strategies are generally put in place. However, not assessing certain risk factors might have constrained fall prevention efforts. Failure to adequately",2.6054570009253947e-07,0.08186764581646422,0.07877526753864447,0.0199476911126006,0.12822999291173875,0.048261993679977015,0.019918816950481533,0.1533985846100867,0.03274920999712727,2.6054570009253947e-07,0.17941935809280807,0.016661878770468257
30,0.3,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is preparation of high fall-risk patients for discharge after rehabilitation aligned with guidelines? Answer: There is limited evidence that systematic falls risk assessments are performed during rehabilitation for those at high risk. When risks are identified, strategies are typically implemented. Yet, failure to assess some risk factors may have restricted fall prevention strategies. Failure to adequately",1.6580180914979784e-07,0.032514930111312346,0.060924027869222984,0.012693985253473108,0.05272244040359286,0.048261993679977015,0.012675610786670066,0.07643754347395681,0.03274920999712727,1.6580180914979784e-07,0.1009477426513139,0.016661878770468257
30,0.3,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we follow guidelines when preparing patients at high risk of falls for discharge after rehabilitation? Answer: Evidence indicates that systematic falls risk assessments are rarely done for high-risk individuals during rehabilitation. When risks are recognized, strategies are usually applied. However, neglecting some risk factors might have limited the fall prevention strategies offered. Failure to adequately",1.6580180914979784e-07,0.00775967366274255,0.07877526753864447,0.012693985253473108,0.05272244040359286,0.048261993679977015,0.012675610786670066,0.07643754347395681,0.03274920999712727,1.6580180914979784e-07,0.1009477426513139,0.016661878770468257
30,0.3,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are patients at high risk of falls properly prepared for discharge after rehabilitation according to guidelines? Answer: There is little proof that systematic falls risk assessments are conducted during rehabilitation for high-risk patients. When risks are identified, strategies are generally implemented. However, failure to assess certain risk factors may have limited fall prevention measures. Failure to adequately",1.4211583641411244e-07,0.014381050267199491,0.06123700223252202,0.010880558788691236,0.03470393490091439,0.048261993679977015,0.0108648092457172,0.05808840480576105,0.03274920999712727,1.4211583641411244e-07,0.08225560963915957,0.016661878770468257
30,0.3,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Is the discharge preparation of patients at high risk of falls after rehabilitation guideline-compliant? Answer: Minimal evidence suggests systematic falls risk assessments are performed during rehabilitation for high-risk patients. When risks are detected, strategies tend to be applied. However, missing some risk factors may have restricted fall prevention strategies. Failure to adequately",2.6054570009253947e-07,0.08186764581646422,0.07877526753864447,0.0199476911126006,0.12822999291173875,0.048261993679977015,0.019918816950481533,0.1533985846100867,0.03274920999712727,2.6054570009253947e-07,0.17941935809280807,0.016661878770468257
30,0.3,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are guidelines followed in preparing high fall-risk patients for discharge post-rehabilitation? Answer: There is little evidence that systematic falls risk assessments occur for high-risk patients during rehabilitation. When risks are identified, strategies are usually implemented. However, failure to assess some risk factors might have limited fall prevention efforts. Failure to adequately",2.8423167282822487e-07,0.12846797404846644,0.05917526753864448,0.02176111757738247,0.14803262020791852,0.048261993679977015,0.0217296184914344,0.17360129192760532,0.03274920999712727,2.8423167282822487e-07,0.20003864529554383,0.016661878770468257
30,0.3,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Do we meet the guidelines for preparing patients at high risk of falls for discharge after rehabilitation? Answer: Evidence shows limited systematic falls risk assessments for high-risk individuals during rehabilitation. When risks are found, strategies are generally put in place. However, neglecting some risk factors could have constrained fall prevention measures. Failure to adequately",2.1317375462116866e-07,0.044127317833616786,0.07877526753864447,0.016320838183036854,0.08976371208394296,0.048261993679977015,0.0162972138685758,0.11417787145680425,0.03274920999712727,2.1317375462116866e-07,0.1394140234791097,0.016661878770468257
30,0.3,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately","Question: Are high fall-risk patients adequately prepared for discharge after rehabilitation in line with guidelines? Answer: There is scant evidence that systematic falls risk assessments are conducted during rehabilitation for high-risk patients. When risks are identified, strategies are typically implemented. Yet, failure to assess certain risk factors may have limited fall prevention strategies. Failure to adequately",1.8948778188548325e-07,0.050983531185782915,0.06059968454824667,0.014507411718254981,0.07107157907178863,0.048261993679977015,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
31,0.3,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms play a role in selecting patients for phase I clinical trials? Yes, symptoms are important when choosing patients for Phase I clinical trials.",4.73719454713706e-08,0.06214132936440109,0.07268698060941828,0.003626852929563759,0.06850803410538919,0.0885664819944598,0.003621603081905747,0.07577318814187173,0.10390581717451527,4.737194547137081e-08,0.08410887609719842,0.1187049861495845
31,0.3,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms significant when evaluating patients for phase I clinical trials? Indeed, symptoms are crucial in the assessment of patients for Phase I clinical trials.",4.73719454713706e-08,0.06214132936440109,0.07268698060941828,0.003626852929563759,0.06850803410538919,0.0885664819944598,0.003621603081905747,0.07577318814187173,0.10390581717451527,4.737194547137081e-08,0.08410887609719842,0.1187049861495845
31,0.3,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Should symptoms be considered when selecting patients for phase I clinical trials? Yes, symptoms are a key factor in patient selection for Phase I clinical trials.",2.36859727356853e-08,0.16765706073691522,0.11491838556809604,0.0018134264647818796,0.1763641220551957,0.13342185389528627,0.0018108015409528735,0.18597804293973574,0.15051738742244913,2.3685972735685406e-08,0.1966429089282773,0.1662049861495845
31,0.3,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms influence the consideration of patients for phase I clinical trials? Yes, symptoms are relevant when considering patients for Phase I clinical trials.",7.10579182070559e-08,0.00953610363314139,0.0664819944598338,0.005440279394345639,0.015837135006176783,0.08310249307479223,0.005432404622858621,0.023251898216416045,0.09972299168975071,7.105791820705617e-08,0.03201801106795754,0.11634349030470917
31,0.3,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is the presence of symptoms important when deciding on patients for phase I clinical trials? Yes, symptoms do matter in the decision process for Phase I clinical trials.",2.36859727356853e-08,0.2569407184163328,0.12331198060941831,0.0018134264647818796,0.26529333204360217,0.13967759310557093,0.0018108015409528735,0.27418154530876926,0.15397526161895972,2.3685972735685406e-08,0.283654285917907,0.1662049861495845
31,0.3,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","When considering patients for phase I clinical trials, do symptoms matter? Yes, symptoms are important in this consideration.",2.1317375462116791e-07,0.05165009674068077,0.2326869806094183,0.01632083818303691,0.11357645595964572,0.2160664819944598,0.01629721386857586,0.18119230401242525,0.19390581717451527,2.1317375462116828e-07,0.2553422148147799,0.1662049861495845
31,0.3,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Are symptoms a factor in patient selection for phase I clinical trials? Yes, symptoms matter when selecting patients for Phase I clinical trials.",9.47438909427412e-08,0.017138872408706707,0.09972299168975074,0.007253705859127518,0.026329225131624945,0.12188365650969524,0.007243206163811494,0.03717505038336011,0.14404432132963993,9.474389094274152e-08,0.05003943473640193,0.1662049861495845
31,0.3,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms affect the evaluation of patients for phase I clinical trials? Yes, symptoms are significant in evaluating patients for Phase I clinical trials.",7.10579182070559e-08,0.00953610363314139,0.0664819944598338,0.005440279394345639,0.015837135006176783,0.08310249307479223,0.005432404622858621,0.023251898216416045,0.09972299168975071,7.105791820705617e-08,0.03201801106795754,0.11634349030470917
31,0.3,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Is symptom assessment important in phase I clinical trial patient selection? Yes, symptoms are important when assessing patients for Phase I clinical trials.",9.47438909427412e-08,0.08015225245961055,0.1426869806094183,0.007253705859127518,0.09234324232780988,0.16856648199445978,0.007243206163811494,0.10648976843935465,0.19390581717451527,9.474389094274152e-08,0.05003943473640193,0.1662049861495845
31,0.3,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for Phase I clinical trials. The nature","Do symptoms have an impact on choosing patients for phase I clinical trials? Yes, symptoms do impact the choice of patients for Phase I clinical trials.",2.36859727356853e-08,0.11220528629212012,0.0784919692715498,0.0018134264647818796,0.11860185700853343,0.09361750240262309,0.0018108015409528735,0.12570437506495802,0.10773801672100054,2.3685972735685406e-08,0.133629528877373,0.120853512226682
32,0.3,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might improve blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly providing significant metabolic and cardiovascular benefits. Future prospective studies should investigate this metabolic impact of airway surgery in OSA.",1.4211583641411244e-07,0.019441621306655943,0.0733372454996116,0.010880558788691236,0.07079865820420617,0.039150354019158694,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.3,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Airway surgery may enhance lipid levels in the blood of OSA patients, especially those with dyslipidemia before surgery, potentially offering important metabolic and cardiovascular advantages. Prospective research is needed to explore this metabolic effect further.",1.4211583641411244e-07,0.07971528918143411,0.030165694644628246,0.010880558788691236,0.10160519956242586,0.016939610217505802,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
32,0.3,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is serum lipid reduction achieved through airway surgery in obstructive sleep apnea patients? Surgery could improve blood lipid levels in OSA patients, notably in those with preexisting dyslipidemia, potentially resulting in major metabolic and cardiovascular benefits. This potential effect warrants investigation in prospective studies.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.13979152969115782,0.039150354019158694,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
32,0.3,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does performing airway surgery lower serum lipid concentrations in patients with obstructive sleep apnea? Airway surgery may lead to improved blood lipid levels in OSA patients, particularly those with dyslipidemia prior to surgery, which might confer significant metabolic and cardiovascular benefits. Prospective studies should assess this potential metabolic outcome.",9.474389094274162e-08,0.02437369452619853,0.07424173834314171,0.0072537058591274906,0.027313546264467803,0.039150354019158694,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.3,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery lead to a decrease in serum lipid levels among obstructive sleep apnea patients? Surgery might improve lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially providing substantial metabolic and cardiovascular benefits. This metabolic effect should be evaluated in future prospective studies.",1.6580180914979784e-07,0.011283694088042306,0.09506564056134,0.012693985253473108,0.09327151405626388,0.039150354019158694,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
32,0.3,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Airway surgery may improve blood lipid levels in patients with OSA, particularly those with dyslipidemia before surgery, possibly offering major metabolic and cardiovascular advantages. Prospective studies are recommended to examine this effect.",1.1842986367842703e-07,0.026789831557660904,0.052596504758870864,0.009067132323909363,0.04881975148543116,0.039150354019158694,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
32,0.3,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery have an effect on lowering serum lipid levels in obstructive sleep apnea patients? Surgery may enhance blood lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially yielding significant metabolic and cardiovascular benefits. Further prospective studies should explore this potential effect.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.3,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Can airway surgery improve serum lipid levels in patients suffering from obstructive sleep apnea? Surgery might improve blood lipid concentrations in OSA patients, particularly those with dyslipidemia prior to surgery, potentially resulting in important metabolic and cardiovascular benefits. This potential effect should be studied prospectively.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.1162610322809634,0.039150354019158694,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.3,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Is airway surgery effective in reducing serum lipid levels in obstructive sleep apnea patients? Surgery may improve blood lipid levels in OSA patients, especially those with preoperative dyslipidemia, potentially providing major benefits in metabolism and cardiovascular health. Prospective studies should investigate this potential metabolic effect.",1.8948778188548325e-07,0.09676992999100476,0.0497141666384375,0.014507411718254981,0.1485004360279376,0.01590772363367117,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
32,0.3,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this potential metabolic effect of airway surgery for OSA.","Does airway surgery contribute to lowering serum lipid levels in patients with obstructive sleep apnea? Airway surgery may improve lipid levels in the blood of OSA patients, particularly those with dyslipidemia before surgery, possibly offering significant metabolic and cardiovascular benefits. This potential effect warrants further prospective study.",1.4211583641411244e-07,0.07971528918143411,0.030165694644628246,0.010880558788691236,0.10160519956242586,0.016939610217505802,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
33,0.3,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible for computerized tomography to substitute bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.3,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our study suggests that routine bone scintigraphy is not needed when CT imaging of the thorax, abdomen, and pelvis is performed in patients with metastatic breast cancer.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.3,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases from breast cancer? Answer: Findings imply that routine bone scintigraphy is not required for metastatic breast cancer patients if CT of the thorax, abdomen, and pelvis is done.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.3,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be replaced by computerized tomography in the detection of bone metastases in breast cancer? Answer: Our data suggest that routine bone scintigraphy is unnecessary if CT scans of the thorax, abdomen, and pelvis are performed in patients with metastatic breast cancer.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.3,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography have the potential to replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings indicate that routine bone scintigraphy is not essential for metastatic breast cancer patients when CT imaging of the thorax, abdomen, and pelvis is available.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.3,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging substitute bone scintigraphy in detecting bone metastases in breast cancer cases? Answer: The evidence suggests that routine bone scintigraphy is not required if CT scans of the thorax, abdomen, and pelvis are carried out in patients with metastatic breast cancer.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.3,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it feasible to replace bone scintigraphy with computerized tomography for detecting bone metastases from breast cancer? Answer: Our findings recommend that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT of the thorax, abdomen, and pelvis is performed.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.3,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography serve as a replacement for bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Our results suggest that routine bone scintigraphy is not needed in metastatic breast cancer patients when CT scans of the thorax, abdomen, and pelvis are done.",2.6054570009253894e-07,0.24315650106229247,0.021728395061728398,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
33,0.3,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Could computerized tomography replace bone scintigraphy in the detection of bone metastases in breast cancer patients? Answer: Our findings show that routine bone scintigraphy is not required if CT imaging of the thorax, abdomen, and pelvis is conducted for patients with metastatic breast cancer.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.3,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography an effective substitute for bone scintigraphy in detecting bone metastases from breast cancer? Answer: According to our findings, routine bone scintigraphy is unnecessary for metastatic breast cancer patients if CT scans of the thorax, abdomen, and pelvis are performed.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
34,0.3,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is indeed a clinically important concern in general adult psychiatry. Chronic pain frequently coexists with psychiatric conditions such as depression and anxiety, making its evaluation and treatment essential in psychiatric practice.",4.737194547137081e-08,0.11589948207617917,0.15414581811541275,0.0036268529295637453,0.07800642589427342,0.0879732134022163,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.3,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Does pain represent a clinically relevant challenge in general adult psychiatry? Yes, pain is a clinically relevant issue in this field. Chronic pain is commonly linked with psychiatric disorders including depression and anxiety, so addressing and managing pain is vital in psychiatric care.",7.105791820705622e-08,0.044600872377285494,0.0767064136832798,0.005440279394345618,0.05310382532501512,0.08739357330703484,0.0054324046228586,0.05663695340827024,0.09204470742932283,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
34,0.3,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a significant clinical problem in general adult psychiatry? Yes, pain is recognized as a clinically important problem in general adult psychiatry. Chronic pain often overlaps with psychiatric illnesses like depression and anxiety, thus its assessment and management are key components of psychiatric treatment.",2.3685972735685406e-08,0.14108714146544488,0.15570404238667981,0.0018134264647818726,0.07006512440861101,0.06536762149263864,0.0018108015409528666,0.07242010897961038,0.06824934752450428,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
34,0.3,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain an important clinical concern in general adult psychiatry? Yes, pain is a clinically relevant problem within general adult psychiatry. Chronic pain is frequently associated with psychiatric disorders such as depression and anxiety, which makes its evaluation and management critical in psychiatric care.",4.737194547137081e-08,0.14813888582315382,0.17711986630101653,0.0036268529295637453,0.111013434492365,0.11176857330703485,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
34,0.3,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically relevant issue in the context of general adult psychiatry? Yes, pain is a clinically significant problem in this area. Chronic pain is often intertwined with psychiatric conditions like depression and anxiety, so assessing and managing pain is essential in psychiatric treatment.",2.3685972735685406e-08,0.12919513819806872,0.1069235545818018,0.0018134264647818726,0.13454393190255942,0.11176857330703485,0.0018108015409528666,0.10542711757770196,0.09204470742932283,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
34,0.3,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a relevant clinical problem in general adult psychiatry? Yes, pain is a clinically pertinent issue in this specialty. Chronic pain commonly co-occurs with psychiatric disorders like depression and anxiety, necessitating careful assessment and management within psychiatric care.",1.6580180914979763e-07,0.08900373734992639,0.22352081811541274,0.012693985253473108,0.015738271146777283,0.11176857330703485,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
34,0.3,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically meaningful problem in general adult psychiatry? Yes, pain is a clinically relevant concern in this field. Chronic pain is often linked to psychiatric disorders such as depression and anxiety, making its assessment and treatment crucial in psychiatric practice.",9.474389094274162e-08,0.09736552915126806,0.1748686156170564,0.0072537058591274906,0.06222327032293329,0.11176857330703485,0.007243206163811466,0.03131914542397851,0.09204470742932283,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
34,0.3,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically important problem in general adult psychiatry? Yes, pain is a significant clinical issue in general adult psychiatry. Chronic pain frequently coincides with psychiatric disorders like depression and anxiety, so pain assessment and management are vital in psychiatric care.",9.474389094274162e-08,0.09736552915126806,0.1748686156170564,0.0072537058591274906,0.027565911294936907,0.08678500986193294,0.007243206163811466,0.03131914542397851,0.09204470742932283,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
34,0.3,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically relevant matter in general adult psychiatry? Yes, pain is an important clinical problem in this domain. Chronic pain is often connected with psychiatric illnesses such as depression and anxiety, thus its evaluation and management are essential in psychiatric care.",7.105791820705622e-08,0.15608018730881623,0.19972545821059418,0.005440279394345618,0.08691588291330499,0.11176857330703485,0.0054324046228586,0.05663695340827024,0.09204470742932283,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
34,0.3,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry. Chronic pain is often interconnected with psychiatric disorders like depression and anxiety. Therefore, assessment and management of pain is crucial within psychiatric care.","Is pain a clinically significant problem in general adult psychiatry? Yes, pain is a clinically relevant issue in this field. Chronic pain is commonly associated with psychiatric disorders like depression and anxiety, making its assessment and management critical in psychiatric treatment.",1.1842986367842703e-07,0.070982313681482,0.1736593222705374,0.009067132323909363,0.03690546233864156,0.11176857330703485,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
35,0.3,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that administering statins before surgery may decrease the occurrence of AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.3,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin use prevent atrial fibrillation after coronary artery bypass grafting? Answer: Findings from our study indicate that preoperative statin treatment appears to reduce AF development post-CABG.,4.73719454713706e-08,0.02459745925658252,0.035665294924554176,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.3,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after CABG with preoperative statin use? Answer: Our study showed that preoperative statin therapy seems to lessen the risk of AF following CABG.,9.47438909427412e-08,0.09689103160334289,0.033293697978596916,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.3,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins given before surgery reduce atrial fibrillation after coronary artery bypass grafting? Answer: The results of our study suggest that preoperative statin therapy may help in reducing AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.3,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does taking statins before coronary artery bypass grafting decrease atrial fibrillation incidence? Answer: Our study indicates that preoperative statin use appears to reduce the development of AF post-CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.3,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Are preoperative statins effective in lowering atrial fibrillation after CABG? Answer: According to our study, preoperative statin therapy seems to diminish AF occurrence following CABG.",2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.3,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin therapy reduce the risk of atrial fibrillation after coronary artery bypass grafting? Answer: Our research indicates that statins administered before surgery may reduce AF development after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.3,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can administering statins before CABG surgery reduce atrial fibrillation? Answer: Our findings suggest that preoperative statin treatment appears to lower the incidence of AF after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.3,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is atrial fibrillation less common after CABG in patients treated with preoperative statins? Answer: Our study suggests that preoperative statin therapy may reduce AF occurrence following CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.3,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin use have an effect on atrial fibrillation rates after coronary artery bypass grafting? Answer: Our study found that preoperative statin therapy seems to reduce the development of AF after CABG.,1.658018091497971e-07,0.1964021034110619,0.0302734375,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
36,0.3,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.3,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and practical value for practitioners and athletes? Few studies address diagnostic and treatment interventions in the sports medicine field. The body of evidence in sports medicine must expand in volume and improve in quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.3,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and meaningful to practitioners and athletes? The sports medicine literature shows a shortage of studies on diagnostic and treatment approaches. Increasing both the amount and quality of evidence in sports medicine is necessary.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.3,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals relevant and useful to practitioners and athletes? There is a scarcity of research on diagnostic and therapeutic interventions within sports medicine literature. The evidence base for sports medicine should grow in both size and quality.,7.105791820705622e-08,0.0760984489201686,0.006963732238457573,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,0.3,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information for practitioners and athletes? Studies on diagnostic and treatment interventions are limited in sports medicine literature. The evidence supporting sports medicine must be enhanced in volume and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.3,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals valuable and applicable to practitioners and athletes? The literature reveals a deficiency in studies concerning diagnostic and treatment interventions. The evidence base in sports medicine needs to increase in both quantity and quality.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.3,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and relevant to practitioners and athletes? There is a notable lack of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence base must continue to grow in terms of both volume and quality.,9.474389094274162e-08,0.055062155514041144,0.06798695809684818,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.3,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals important and applicable for practitioners and athletes? The sports medicine literature lacks sufficient studies on diagnostic and treatment interventions. The evidence base must expand in both quantity and quality.,2.84231672828224e-07,0.28687004658525206,0.06175303975214779,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
36,0.3,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and practical for practitioners and athletes? There is a shortage of research on diagnostic and treatment interventions in the sports medicine field. The evidence supporting sports medicine must increase in volume and quality.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.3,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and relevant to practitioners and athletes? The sports medicine literature has a limited number of studies on diagnostic and treatment interventions. The evidence base needs to grow in both quality and quantity.,1.8948778188548283e-07,0.1642734888416455,0.06521541950113377,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
37,0.3,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study demonstrated for the first time that RALP causes less tissue damage compared to RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.3,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? Answer: This research revealed for the first time that RALP leads to reduced tissue trauma relative to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.3,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is RALP less invasive than RRP? Answer: This study was the first to show that robotically assisted laparoscopic radical prostatectomy results in lower tissue injury than retropubic radical prostatectomy.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.3,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma than retropubic radical prostatectomy? Answer: This study found for the first time that RALP induces less tissue trauma than RRP.,4.73719454713706e-08,0.06963656462503831,0.09876543209876545,0.003626852929563759,0.024147543681296568,0.06858710562414266,0.003621603081905747,0.02459745925658252,0.035665294924554176,4.737194547137081e-08,0.07696104113612945,0.0
37,0.3,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Answer: This study showed for the first time that RALP produces less tissue trauma than RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.3,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy associated with less tissue damage than retropubic radical prostatectomy? Answer: This study demonstrated for the first time that RALP causes less tissue trauma than RRP.,7.10579182070559e-08,0.05706352137059145,0.0322222222222222,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.3,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy result in lower tissue trauma compared to retropubic radical prostatectomy? Answer: This study revealed for the first time that RALP induces less tissue trauma than RRP.,9.47438909427412e-08,0.09020969383952471,0.031217481789802305,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.3,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Answer: This study was the first to demonstrate that RALP leads to reduced tissue trauma compared to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.3,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is RALP associated with less invasiveness than RRP? Answer: This study found for the first time that robotically assisted laparoscopic radical prostatectomy results in lower tissue trauma than retropubic radical prostatectomy.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.3,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy cause less tissue injury than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
38,0.3,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A model for healing Los Angeles grades C and D reflux oesophagitis suggests that after 4 weeks of acid suppression therapy, healing plateaus, and further increases in intragastric pH>4 duration do not significantly improve outcomes.",6.632072365991907e-07,0.6007738604289297,0.0,0.05077594101389245,0.6143663027068302,0.0,0.050702443146680286,0.628608659422373,0.0,6.632072365991914e-07,0.6435502394205721,0.0
38,0.3,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In treating LA grade C or D reflux oesophagitis, 4 weeks of acid-suppressive therapy seems to achieve maximal healing, beyond which additional acid suppression hours yield minimal benefit.",8.290090457489878e-07,0.8312975190407621,0.0,0.06346992626736561,0.8527773261518279,0.0,0.0633780539333504,0.8754687373538994,0.0,8.290090457489892e-07,0.8994836135577735,0.0
38,0.3,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Healing of Los Angeles grade C and D reflux oesophagitis reaches an optimal point after 4 weeks of acid suppression, with no substantial gains despite longer periods of intragastric pH above 4.",7.342651548062466e-07,0.693147180559945,0.0,0.056216220408238086,0.7096764825111554,0.0,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
38,0.3,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","For LA grade C or D oesophagitis, 4 weeks of acid-suppressive treatment appears sufficient for maximal healing, as extending acid suppression time does not enhance recovery.",8.763809912203584e-07,0.9082585601768915,0.0,0.06709677919692936,0.9328200338253652,0.0,0.06699965701525615,0.9588503462929499,0.0,8.7638099122036e-07,0.9864949905474032,0.0
38,0.3,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","A healing model for LA grades C and D reflux oesophagitis indicates that after 4 weeks of acid suppression, further increases in intragastric pH>4 duration do not significantly improve healing.",7.816371002776172e-07,0.7598385550586184,0.0,0.059843073337801846,0.7786693539981062,0.0,0.059756450851444654,0.79850769621777,0.0,7.816371002776184e-07,0.8194409058842362,0.0
38,0.3,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","In LA grade C and D reflux oesophagitis, successful healing plateaus after 4 weeks of acid-suppressive therapy, with no additional benefit from longer acid suppression periods.",8.763809912203584e-07,0.9082585601768915,0.0,0.06709677919692936,0.9328200338253652,0.0,0.06699965701525615,0.9588503462929499,0.0,8.7638099122036e-07,0.9864949905474032,0.0
38,0.3,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Maximal healing in LA grade C or D reflux oesophagitis is typically achieved after 4 weeks of acid suppression, beyond which increasing intragastric pH>4 hours offers little improvement.",8.290090457489878e-07,0.8312975190407621,0.0,0.06346992626736561,0.8527773261518279,0.0,0.0633780539333504,0.8754687373538994,0.0,8.290090457489892e-07,0.8994836135577735,0.0
38,0.3,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing reaches a threshold where further increases in acid suppression duration do not enhance outcomes.",8.290090457489878e-07,0.8312975190407621,0.0,0.06346992626736561,0.8527773261518279,0.0,0.0633780539333504,0.8754687373538994,0.0,8.290090457489892e-07,0.8994836135577735,0.0
38,0.3,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","The model shows that for LA grade C and D reflux oesophagitis, 4 weeks of acid suppression is optimal, as extending the time with intragastric pH>4 does not significantly boost healing.",7.579511275419319e-07,0.7259370033829367,0.0,0.058029646873019966,0.7435780341868372,0.0,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
38,0.3,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Successful healing of LA grade C or D reflux oesophagitis seems to plateau after 4 weeks of acid-suppressive therapy, with no notable improvement from longer acid suppression times.",8.290090457489878e-07,0.8312975190407621,0.0,0.06346992626736561,0.8527773261518279,0.0,0.0633780539333504,0.8754687373538994,0.0,8.290090457489892e-07,0.8994836135577735,0.0
39,0.3,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Are viral infections implicated in benign paroxysmal positional vertigo? Answer: BPPV is linked to positive viral serology, especially during specific seasons like spring and autumn. Viral infections may trigger BPPV episodes by causing vestibulopathy or lead to secondary BPPV through neurolabyrinthitis related to viral infection.",1.4211583641411244e-07,0.15596968431222535,0.02221074380165289,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
39,0.3,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Do viral infections contribute to benign paroxysmal positional vertigo? Answer: There is an association between BPPV and positive viral serology, particularly in spring and autumn. Viral infections might cause BPPV attacks by inducing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Is there a role of viral infections in benign paroxysmal positional vertigo? Answer: BPPV correlates with positive viral serology, mainly during spring and autumn months. Viral infections could facilitate BPPV attacks through vestibulopathy development or cause secondary BPPV by viral neurolabyrinthitis.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.3,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Can viral infections influence benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, especially in the spring and autumn seasons. Viral infections may provoke BPPV attacks by leading to vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Are viral infections involved in benign paroxysmal positional vertigo? Answer: Positive viral serology is linked with BPPV, particularly during spring and autumn. Viral infections might trigger BPPV episodes due to vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.3,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Do viral infections play a part in benign paroxysmal positional vertigo? Answer: BPPV shows an association with positive viral serology, mainly in spring and autumn. Viral infections may promote BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,0.3,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Is benign paroxysmal positional vertigo related to viral infections? Answer: BPPV is connected with positive viral serology, particularly during spring and autumn months. Viral infections might contribute to BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Do viral infections have an impact on benign paroxysmal positional vertigo? Answer: There is a link between BPPV and positive viral serology, especially in spring and autumn. Viral infections could trigger BPPV attacks by inducing vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",1.6580180914979784e-07,0.17914268883151596,0.02271498107084911,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
39,0.3,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Are viral infections a factor in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, mainly during the spring and autumn seasons. Viral infections might cause BPPV attacks through vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Question: Could viral infections be involved in benign paroxysmal positional vertigo? Answer: Positive viral serology is linked to BPPV, especially in spring and autumn. Viral infections may promote BPPV attacks by causing vestibulopathy or lead to secondary BPPV through viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
40,0.3,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In this 'at-risk' group with skin microvascular dysfunction, maximal oxygen uptake was similar to healthy controls. However, within the 'at-risk' group, those with higher aerobic fitness showed improved microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.3,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function influenced by aerobic fitness in healthy adults at risk of Type 2 diabetes? Among the 'at-risk' individuals with skin microvascular dysfunction, maximal oxygen uptake did not differ from healthy controls. Yet, within this group, higher aerobic fitness correlated with better microvascular and endothelial function.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.3,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults at risk for developing Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction had maximal oxygen uptake comparable to healthy controls. Still, those with greater aerobic fitness within this group exhibited enhanced microvascular and endothelial responsiveness.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.3,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk of Type 2 diabetes? In the 'at-risk' group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Nevertheless, individuals with higher aerobic fitness in this group had superior microvascular and endothelial responses.",1.4211583641411244e-07,0.12168562639213665,0.004430562630850447,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.3,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? Maximal oxygen uptake in the 'at-risk' group with skin microvascular dysfunction was not reduced compared to healthy controls. However, higher aerobic fitness in this group was associated with better microvascular and endothelial responsiveness.",9.474389094274162e-08,0.052279090842322073,0.016711854752580996,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
40,0.3,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function among healthy adults at risk for Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction showed no reduction in maximal oxygen uptake relative to healthy controls. Yet, within this group, those with higher aerobic fitness had improved microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.3,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness affect microvascular function in healthy adults at risk of developing Type 2 diabetes? In the 'at-risk' group with skin microvascular dysfunction, maximal oxygen uptake matched that of healthy controls. However, individuals with greater aerobic fitness within this group demonstrated enhanced microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.3,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness play a role in microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not decreased in the 'at-risk' group with skin microvascular dysfunction compared to healthy controls. Still, higher aerobic fitness in this group was linked to better microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.3,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function in healthy adults at risk of Type 2 diabetes affected by aerobic fitness? Among those 'at-risk' with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. However, higher aerobic fitness within this group corresponded with improved microvascular and endothelial responsiveness.",2.6054570009253947e-07,0.17273284727348592,0.03631185475258099,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
40,0.3,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults at risk of Type 2 diabetes? The 'at-risk' group with skin microvascular dysfunction did not show reduced maximal oxygen uptake compared to healthy controls. Nonetheless, individuals with higher aerobic fitness in this group had better microvascular and endothelial responses.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
41,0.3,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Does the ultra high risk (UHR) criteria for psychosis indicate varying levels of risk for transitioning to psychosis? Our findings show that UHR intake criteria predict 6-month transition risk in the sequence Trait alone < APS < BLIPS. The highest short-term transition risk in BLIPS patients aligns with the 'early' versus 'late' prodrome model and suggests the need for focused clinical attention.,2.6054570009253947e-07,0.19199044062893833,0.018863076293497046,0.01994769111260064,0.19144022083788137,0.016661878770468257,0.019918816950481547,0.17095779814363965,0.0,2.6054570009253947e-07,0.17366349405084325,0.0
41,0.3,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Are there distinct risk levels for psychosis transition within the ultra high risk (UHR) criteria? Data indicate that UHR intake criteria forecast transition over six months as Trait alone < APS < BLIPS. BLIPS patients' elevated short-term risk supports the 'early' versus 'late' prodrome framework and highlights the importance of targeted clinical care.,4.737194547137081e-07,0.3061683120857426,0.013886133703630227,0.036268529295637494,0.33085424431699106,0.0,0.036216030819057346,0.33647223662121295,0.0,4.737194547137081e-07,0.34228620648663544,0.0
41,0.3,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Do different levels of risk for psychosis transition exist within ultra high risk (UHR) criteria? Our data suggest a 6-month transition risk order of Trait alone < APS < BLIPS. The highest risk in BLIPS patients corresponds with the 'early' versus 'late' prodrome model, implying a need for specialized clinical focus.",5.210914001850789e-07,0.34538902523902504,0.013886133703630227,0.03989538222520124,0.37085957893068944,0.0,0.03983763390096308,0.3772942311414673,0.0,5.210914001850789e-07,0.38395890288720436,0.0
41,0.3,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Within ultra high risk (UHR) criteria for psychosis, are there varying transition risk levels? Evidence shows UHR intake criteria predict 6-month transition risk in the order Trait alone < APS < BLIPS. The elevated risk in BLIPS patients aligns with the 'early' versus 'late' prodrome concept and calls for particular clinical attention.",4.974054274493935e-07,0.37995088269264476,0.02526422031552847,0.03808195576041937,0.35065687161317083,0.0,0.03802683236001021,0.35667494393873156,0.0,4.974054274493935e-07,0.3629054936893712,0.0
41,0.3,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Is there a gradient of risk for psychosis transition in ultra high risk (UHR) criteria? Our results indicate that the 6-month transition risk follows Trait alone < APS < BLIPS. The highest short-term risk in BLIPS patients fits the 'early' versus 'late' prodrome model and suggests focused clinical monitoring.,5.684633456564497e-07,0.3862110197592794,0.013886133703630227,0.043522235154764985,0.41253227533125836,0.0,0.04345923698286881,0.41985384556026384,0.0,5.684633456564497e-07,0.4274440148269427,0.0
41,0.3,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Do ultra high risk (UHR) criteria for psychosis reflect different levels of transition risk? Findings reveal a 6-month transition risk ranking of Trait alone < APS < BLIPS. The pronounced risk in BLIPS patients supports the 'early' versus 'late' prodrome theory and underscores the need for dedicated clinical care.,5.684633456564497e-07,0.3862110197592794,0.013886133703630227,0.043522235154764985,0.41253227533125836,0.0,0.04345923698286881,0.41985384556026384,0.0,5.684633456564497e-07,0.4274440148269427,0.0
41,0.3,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are there varying transition risks within ultra high risk (UHR) psychosis criteria? Data demonstrate that UHR intake criteria predict transition over six months as Trait alone < APS < BLIPS. BLIPS patients' highest risk aligns with the 'early' versus 'late' prodrome model, indicating a requirement for special clinical attention.",5.684633456564497e-07,0.3862110197592794,0.013886133703630227,0.043522235154764985,0.41253227533125836,0.0,0.04345923698286881,0.41985384556026384,0.0,5.684633456564497e-07,0.4274440148269427,0.0
41,0.3,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be",Does the ultra high risk (UHR) psychosis criteria show different transition risk levels? Our data suggest a 6-month transition risk order of Trait alone < APS < BLIPS. The highest risk in BLIPS patients matches the 'early' versus 'late' prodrome framework and points to the need for focused clinical care.,5.447773729207643e-07,0.39388345421205173,0.006513171851925329,0.04170880868998311,0.3914788661334252,0.0,0.041648435441915946,0.3983476403393005,0.0,5.447773729207643e-07,0.4054651081081677,0.0
41,0.3,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Are different risk levels for psychosis transition identified in ultra high risk (UHR) criteria? Evidence indicates that UHR intake criteria predict transition over six months in the sequence Trait alone < APS < BLIPS. The elevated short-term risk in BLIPS patients corresponds with the 'early' versus 'late' prodrome model, necessitating particular clinical attention.",4.737194547137081e-07,0.3061683120857426,0.013886133703630227,0.036268529295637494,0.33085424431699106,0.0,0.036216030819057346,0.33647223662121295,0.0,4.737194547137081e-07,0.34228620648663544,0.0
41,0.3,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates that particular clinical attention may need to be","Within ultra high risk (UHR) criteria for psychosis, do risk levels for transition vary? Our findings show a 6-month transition risk ranking of Trait alone < APS < BLIPS. The highest risk observed in BLIPS patients aligns with the 'early' versus 'late' prodrome model and suggests the importance of specialized clinical focus.",4.974054274493935e-07,0.3255863979428453,0.013886133703630227,0.03808195576041937,0.35065687161317083,0.0,0.03802683236001021,0.35667494393873156,0.0,4.974054274493935e-07,0.3629054936893712,0.0
42,0.3,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Answer: Yes, the preoperative platelet count in esophageal squamous cell carcinoma may serve as a prognostic factor. Higher platelet counts prior to surgery have been linked to worse outcomes and greater tumor aggressiveness. Nonetheless, more studies are required for conclusive evidence.",9.474389094274162e-08,0.09133742710330006,0.009535699009974752,0.0072537058591274906,0.11530423420055236,0.025754377480457474,0.007243206163811466,0.14224822387763414,0.044244628099173545,9.474389094274162e-08,0.17016490512830273,0.06353305785123965
42,0.3,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can be a prognostic marker in esophageal squamous cell carcinoma. Elevated platelet levels before surgery correlate with poorer prognosis and increased tumor aggressiveness, though further research is necessary for definitive conclusions.",7.105791820705622e-08,0.015272316684695753,0.03141460297838265,0.005440279394345618,0.012130795156159113,0.035823194579155976,0.0054324046228586,0.020179467597532863,0.06043388429752067,7.105791820705622e-08,0.02252890632223936,0.06353305785123965
42,0.3,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? Answer: Yes, it can. Increased platelet counts before surgery in esophageal squamous cell carcinoma patients have been associated with a worse prognosis and more aggressive tumors. Additional research is needed to confirm these findings.",9.474389094274162e-08,0.020289099805566924,0.07138994050838293,0.0072537058591274906,0.005312282779206701,0.05637484411944804,0.007243206163811466,0.0029935369217577446,0.05992964702832444,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,0.3,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is there a prognostic significance of preoperative platelet count in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count may serve as a prognostic factor in esophageal squamous cell carcinoma. Elevated platelet counts prior to surgery are linked with poorer prognosis and higher tumor aggressiveness, but more research is required for definitive proof.",7.105791820705622e-08,0.09541113440303572,0.024927278910382197,0.005440279394345618,0.12090350791450089,0.04324708885071986,0.0054324046228586,0.1489669095348587,0.06304462809917356,7.105791820705622e-08,0.15036227783212297,0.06353305785123965
42,0.3,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can indicate prognosis in esophageal squamous cell carcinoma. Higher platelet counts before surgery have been associated with worse outcomes and increased tumor aggressiveness, although further studies are needed for confirmation.",0.0,0.0554517744447951,0.037524454326329226,0.0,0.05658344331101617,0.03975905732006435,0.0,0.0866433975699934,0.06182072588097527,0.0,0.08848687411403544,0.06353305785123965
42,0.3,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count a reliable prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, it is considered a potential prognostic factor. Elevated platelet counts before surgery in esophageal squamous cell carcinoma patients have been linked to poorer prognosis and greater tumor aggressiveness, but additional research is necessary.",4.737194547137081e-08,0.06661581846653686,0.07406766420287246,0.0036268529295637453,0.040794662467614096,0.058254004693398594,0.003621603081905733,0.04282808173713892,0.06091623303744516,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
42,0.3,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Does the preoperative platelet count affect prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count can influence prognosis. Higher platelet counts before surgery are associated with worse prognosis and increased tumor aggressiveness in esophageal squamous cell carcinoma, though more research is needed to establish this definitively.",4.737194547137081e-08,0.008853553419874594,0.03353163872363446,0.0036268529295637453,0.011299037762935615,0.03719008264462807,0.003621603081905733,0.04282808173713892,0.06091623303744516,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
42,0.3,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is preoperative platelet count prognostically significant in esophageal squamous cell carcinoma? Answer: Yes, it may be. Elevated platelet counts before surgery have been correlated with poorer prognosis and more aggressive tumors in esophageal squamous cell carcinoma, but further investigation is required.",2.1317375462116866e-07,0.10580590093192344,0.06357520498465145,0.016320838183036854,0.13079695377514478,0.05086164465099239,0.0162972138685758,0.12766084394440647,0.0570213594011126,2.1317375462116866e-07,0.124074567869636,0.06353305785123965
42,0.3,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Can the preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? Answer: Yes, it can. Increased platelet counts prior to surgery have been linked to worse prognosis and higher tumor aggressiveness in esophageal squamous cell carcinoma, though more research is necessary for definitive conclusions.",4.737194547137081e-08,0.06661581846653686,0.07406766420287246,0.0036268529295637453,0.040794662467614096,0.058254004693398594,0.003621603081905733,0.04282808173713892,0.06091623303744516,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
42,0.3,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Yes, preoperative platelet count in esophageal squamous cell carcinoma can be a prognostic factor. Elevated platelet counts before surgery have been associated with poorer prognosis and increased tumor aggressiveness. However, further research is needed for definitive","Question: Is the preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Answer: Yes, preoperative platelet count is a potential prognostic indicator. Elevated platelet levels before surgery have been associated with poorer outcomes and increased tumor aggressiveness, but further studies are needed for confirmation.",9.474389094274162e-08,0.050425933742955564,0.09290145667302856,0.0072537058591274906,0.025494258579012996,0.07851239669421484,0.007243206163811466,0.028513153103694844,0.08264462809917356,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
43,0.3,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions might offer an additional personalized intraoperative evaluation metric. Further studies linking these skills to operative performance outcomes are needed.,7.105791820705622e-08,0.05441355041844975,0.000939510352663115,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
43,0.3,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a relationship between residents' leadership skills and their technical skill ratings? Studies on general surgery research residents revealed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty in bowel repair. Evaluating residents' directional instructions could provide a new individualized intraoperative assessment tool. More research on how this relates to operative performance outcomes is necessary.,1.1842986367842703e-07,0.06600691697266114,0.015118114988199115,0.009067132323909363,0.06505688274619104,0.01694411414982164,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
43,0.3,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Do residents' leadership skills have a connection to their technical skill ratings? In general surgery research residents, intraoperative leadership skills were significantly correlated with their views on skill decay and task difficulty during bowel repair. Analyzing residents' directional instructions may serve as an additional personalized intraoperative assessment measure. Further investigation into operative performance outcomes is justified.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.3,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are residents' leadership skills linked to their technical skill ratings? Research involving general surgery residents showed that intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair. Reviewing residents' directional instructions might add a personalized intraoperative assessment metric. Additional evaluation related to operative performance outcomes is warranted.,7.105791820705622e-08,0.05754362157529469,0.001047792634361909,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
43,0.3,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Does a resident's leadership ability relate to their technical skill ratings? In general surgery research residents, intraoperative leadership skills were significantly associated with their perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions given by residents may offer an extra individualized intraoperative assessment metric. Further research on operative performance outcomes is needed.",0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.3,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there an association between residents' leadership skills and technical skill ratings? General surgery research residents' intraoperative leadership skills showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could provide an additional individualized intraoperative assessment metric. More evaluation regarding operative performance outcomes is warranted.,4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.3,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,"Do leadership skills of residents correlate with their technical skill ratings? In general surgery research residents, intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may provide an extra individualized intraoperative assessment metric. Further research on operative performance outcomes is justified.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
43,0.3,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Are the leadership skills of residents related to their technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating directional instructions from residents might offer an additional individualized intraoperative assessment metric. Further evaluation concerning operative performance outcomes is warranted.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.3,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Is there a link between residents' leadership skills and their technical skill ratings? General surgery research residents' intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may provide a supplementary individualized intraoperative assessment metric. Further studies on operative performance outcomes are needed.,4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
43,0.3,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.,Do residents' leadership skills relate to their technical skill ratings? Research with general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could serve as an additional individualized intraoperative assessment metric. Further evaluation related to operative performance outcomes is warranted.,2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
44,0.3,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is identified as a potential risk factor for causing and progressing chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.3,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in hypertensive individuals? Answer: Findings suggest that the ACE-DD genotype may increase the risk of developing chronic kidney failure among those with hypertension.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.3,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in patients with high blood pressure? Answer: It has been concluded that the ACE-DD genotype might be a risk factor for the onset and progression of chronic kidney failure in hypertensive patients.,9.474389094274141e-08,0.14003931107046297,0.028673775897650584,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
44,0.3,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients influenced by polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene? Answer: The ACE-DD genotype appears to be a risk factor for the development and causation of chronic kidney failure in patients with hypertension.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.3,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism impact the likelihood of chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is concluded to potentially increase the risk of chronic kidney failure among those with hypertension.,9.47438909427412e-08,0.11980950112335131,0.00612461419753086,0.007253705859127504,0.1564192712116812,0.0302734375,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.3,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in individuals with hypertension? Answer: It is concluded that the ACE-DD genotype may contribute to the causation and progression of chronic kidney failure in hypertensive patients.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.3,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene lead to chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may be a risk factor for causing and developing chronic kidney failure among patients with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.3,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can the ACE-1 gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Answer: It is concluded that the ACE-DD genotype could be a risk factor for the development and causation of chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.3,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism responsible for chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may increase the risk of chronic kidney failure development in patients with hypertension.,1.894877818854824e-07,0.20963572898998795,0.019175437823872224,0.014507411718255023,0.24362208265775243,0.0,0.014486412327622981,0.2513144282809061,0.0,1.8948778188548325e-07,0.25951119548508395,0.0
44,0.3,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of ACE-1 gene polymorphism contribute to chronic kidney disease among hypertensive patients? Answer: It is concluded that the ACE-DD genotype might be a risk factor for the causation and progression of chronic kidney failure in hypertensive patients.,4.73719454713706e-08,0.08959879647112645,0.02748557235736722,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
45,0.3,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories accurately reporting serum quantitative hCG results? Numerous factors lead to incorrect reporting of hCG results, such as (a) the complexity of the hCG molecule and confusion over the nomenclature of its various forms; (b) laboratory staff's unawareness of the differences among hCG forms and failure to understand assay specificity; (c) lack of...",2.6054570009253947e-07,0.09826766797835962,0.09260127675343245,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
45,0.3,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories report serum quantitative hCG results correctly? Several issues cause errors in hCG reporting, including (a) the complicated nature of the hCG molecule and confusion about the naming of its different forms; (b) laboratory personnel not recognizing the distinctions between hCG forms and the specificity of assays used; (c) lack of...",3.079176455639103e-07,0.11057745142653452,0.11146222349899458,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
45,0.3,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Is the reporting of serum quantitative hCG results by laboratories accurate? Errors in hCG result reporting arise from multiple factors: (a) the complexity of the hCG molecule and ambiguous nomenclature of its forms; (b) laboratory staff's insufficient knowledge of hCG form differences and assay specificity; (c) lack of...,4.026615365066519e-07,0.19225548244080182,0.11146222349899458,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
45,0.3,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are serum quantitative hCG results being reported correctly by laboratories? The erroneous reporting of hCG results is due to several factors, including (a) the complex structure of the hCG molecule and confusion about the various forms' names; (b) laboratory personnel's lack of understanding of the different hCG forms and assay specificity; (c) lack of...",2.6054570009253947e-07,0.12442416535798007,0.07378440727446556,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
45,0.3,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Do laboratories provide accurate serum quantitative hCG results? Many factors contribute to inaccurate hCG reporting, such as (a) the complexity and confusing nomenclature of the hCG molecule's various forms; (b) laboratory staff's unawareness of the distinctions among hCG forms and assay specificity; (c) lack of...",4.737194547137081e-07,0.2897201402580505,0.08874724242814547,0.03626852929563745,0.38193461069797285,0.0,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
45,0.3,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories correctly reporting serum quantitative hCG results? Several factors cause errors in hCG result reporting, including (a) the complex nature of the hCG molecule and confusion regarding the nomenclature of its forms; (b) laboratory personnel's lack of awareness about the differences between hCG forms and assay specificity; (c) lack of...",3.316036182995957e-07,0.1303800787227143,0.11146222349899458,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
45,0.3,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Is the serum quantitative hCG reporting by laboratories accurate? Errors in hCG results occur due to (a) the complexity of the hCG molecule and confusion over the nomenclature of its forms; (b) laboratory staff's failure to recognize distinctions among hCG forms and assay specificity; (c) lack of...,4.263475092423373e-07,0.21376168766176518,0.11146222349899458,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
45,0.3,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Are serum quantitative hCG results reported correctly by laboratories? The incorrect reporting of hCG results stems from factors like (a) the complex hCG molecule and confusing nomenclature of its forms; (b) laboratory personnel's lack of knowledge about the differences between hCG forms and assay specificity; (c) lack of...,4.026615365066519e-07,0.2217511071454803,0.09019568285627248,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
45,0.3,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of",Do laboratories report serum quantitative hCG results accurately? Errors in reporting hCG results are caused by (a) the complexity of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory staff's lack of awareness of the distinctions among hCG forms and assay specificity; (c) lack of...,3.552895910352811e-07,0.20716622935124862,0.07071980611556314,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
45,0.3,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of","Are laboratories providing correct serum quantitative hCG results? Many factors lead to erroneous hCG reporting, including (a) the complexity of the hCG molecule and confusion in the nomenclature of its forms; (b) laboratory personnel's failure to understand the differences between hCG forms and assay specificity; (c) lack of...",4.026615365066519e-07,0.19225548244080182,0.11146222349899458,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
46,0.3,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex found in cervical disk disease? Current studies show that this complex is present in cervical disk disease and is linked to intervertebral disc degeneration, a major factor in the condition. Nonetheless, further research is required to clarify its exact role.",1.8948778188548325e-07,0.007386618000717604,0.15154388323157456,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.3,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does cervical disk disease involve the fibronectin-aggrecan complex? Research suggests that the fibronectin-aggrecan complex exists in cervical disk disease and is connected to the degeneration of intervertebral discs, which is central to the disease. More investigation is necessary to fully understand its function.",2.1317375462116866e-07,0.09846634230933482,0.10376200956120626,0.016320838183036854,0.12135944742253635,0.05502008506616258,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.3,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cases of cervical disk disease? Evidence from current research confirms its presence and association with intervertebral disc degeneration, a significant contributor to the disease. Additional studies are needed to better comprehend its role.",3.0791764556391007e-07,0.06652176647394503,0.19794483504597077,0.023574544042164344,0.19020154389432875,0.07939508506616258,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
46,0.3,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Present research indicates that this complex is indeed present and linked to intervertebral disc degeneration, which plays a key role in the disease. However, more research is essential to fully grasp its impact.",2.3685972735685406e-07,0.00946414050397637,0.19794483504597077,0.018134264647818726,0.11224000242461818,0.07939508506616258,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.3,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Can the fibronectin-aggrecan complex be found in cervical disk disease? Current findings reveal that it is present and related to intervertebral disc degeneration, a primary factor in cervical disk disease. Further research is necessary to understand its full role.",3.0791764556391007e-07,0.13948462758551816,0.14547569924350162,0.023574544042164344,0.22766895905973117,0.05238891222665641,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
46,0.3,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Research to date shows that this complex exists in cervical disk disease and is connected to the degeneration of intervertebral discs, a crucial element of the disease. More studies are needed to elucidate its role.",1.8948778188548325e-07,0.007386618000717604,0.15154388323157456,0.014507411718254981,0.09645684685327804,0.055599725161344024,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.3,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Does the fibronectin-aggrecan complex play a role in cervical disk disease? Existing research confirms its presence and association with intervertebral disc degeneration, which significantly contributes to the disease. Additional research is required to fully understand its role.",3.5528959103528067e-07,0.12058898774422122,0.19794483504597077,0.02720139697172809,0.24577139504914092,0.07939508506616258,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
46,0.3,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex present in patients with cervical disk disease? Current research supports that this complex is found in cervical disk disease and is linked to intervertebral disc degeneration, a key factor in the condition. Further investigation is needed to clarify its role.",1.8948778188548325e-07,0.0248527857462566,0.17470220466048325,0.014507411718254981,0.06344983825518646,0.07939508506616258,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
46,0.3,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex a component of cervical disk disease? Studies indicate that this complex is present and associated with intervertebral disc degeneration, an important contributor to the disease. However, more research is needed to fully understand its function.",3.0791764556391007e-07,0.06652176647394503,0.19794483504597077,0.023574544042164344,0.19020154389432875,0.07939508506616258,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
46,0.3,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Current research indicates that the fibronectin-aggrecan complex is indeed present in cervical disk disease. This complex is associated with intervertebral disc degeneration, a key contributor to cervical disk disease. However, more research is needed to fully understand the role it plays.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Research shows that it is indeed present and related to intervertebral disc degeneration, which is a major contributor to cervical disk disease. More research is necessary to comprehend its complete role.",2.8423167282822477e-07,0.07609228933017098,0.17232156634790982,0.02176111757738247,0.16353329681216788,0.07939508506616258,0.0217296184914344,0.25261066381089314,0.020399305555555556,2.8423167282822487e-07,0.2876820724517808,0.0
47,0.3,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the criteria used for residency selection predict how well someone will perform in Orthopaedic Surgery Residency? The selection criteria for residency can give some insight into a candidate's likely success in Orthopaedic Surgery Residency. Elements such as medical school grades, board exam scores, recommendation letters, and interview results can partially forecast a resident's potential to excel. Nonetheless, personal commitment and flexibility are also vital factors.",1.8948778188548325e-07,0.18895795391330505,0.04086249838371031,0.014507411718254981,0.18613631257773422,0.037778723160743544,0.014486412327622933,0.16100689317942596,0.0181755829903978,1.8948778188548325e-07,0.13815033848081626,0.0
47,0.3,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can residency selection criteria forecast performance in Orthopaedic Surgery Residency? The criteria used to select residents can indicate a candidate's potential success in Orthopaedic Surgery Residency. Medical school grades, board scores, letters of recommendation, and interview outcomes can somewhat predict a resident's performance. Yet, individual dedication and adaptability remain essential.",1.8948778188548325e-07,0.0862096445156495,0.04616586664023726,0.014507411718254981,0.10876604300488024,0.03257588418265612,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
47,0.3,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Is it possible to predict performance in Orthopaedic Surgery Residency based on residency selection criteria? Residency selection criteria offer some predictive value regarding a candidate's performance in Orthopaedic Surgery Residency. Factors like academic grades, board exam results, recommendation letters, and interview evaluations can provide some indication of success. However, personal dedication and adaptability are also important.",4.737194547137081e-08,0.014934722164236636,0.014628391674572208,0.0036268529295637453,0.013446110422199009,0.01641753788014435,0.003621603081905733,0.037992417039609094,0.0006853637551643317,4.737194547137081e-08,0.03774032798284743,0.0
47,0.3,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Do residency selection criteria serve as predictors for performance in Orthopaedic Surgery Residency? The criteria applied during residency selection can help anticipate a candidate's potential in Orthopaedic Surgery Residency. Medical school grades, board scores, letters of recommendation, and interview performance can partly forecast a resident's ability to succeed. Still, individual commitment and adaptability play key roles.",4.737194547137081e-08,0.010270629856125257,0.03254437869822491,0.0036268529295637453,0.012226007376317849,0.034887860448558225,0.003621603081905733,0.011835919659988203,0.0181755829903978,4.737194547137081e-08,0.03774032798284743,0.0
47,0.3,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can the criteria for selecting residents predict how well they will perform in Orthopaedic Surgery Residency? Residency selection criteria can somewhat predict a candidate's performance in Orthopaedic Surgery Residency. Academic grades, board exam scores, recommendation letters, and interview results contribute to this prediction. However, the resident's personal dedication and adaptability are also crucial.",1.1842986367842703e-07,0.023521794623059478,0.048508284023668684,0.009067132323909363,0.046442531040014945,0.03379978640085441,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
47,0.3,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Does the selection process for residency predict success in Orthopaedic Surgery Residency? The residency selection criteria can indicate a candidate's potential performance in Orthopaedic Surgery Residency. Factors such as medical school grades, board scores, letters of recommendation, and interview performance offer some predictive value. Nonetheless, individual dedication and adaptability are significant.",1.6580180914979784e-07,0.06487526833191071,0.04697772846811313,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.11092682230421813,0.0181755829903978,1.6580180914979784e-07,0.13883644485421742,0.0
47,0.3,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Are residency selection criteria reliable predictors of performance in Orthopaedic Surgery Residency? Selection criteria for residency provide some indication of a candidate's potential success in Orthopaedic Surgery Residency. Medical school grades, board exam results, recommendation letters, and interview performance can partially predict outcomes. However, personal dedication and adaptability are also important.",1.6580180914979784e-07,0.09260115555430826,0.02715273852796926,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.11092682230421813,0.0181755829903978,1.6580180914979784e-07,0.13883644485421742,0.0
47,0.3,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","To what extent do residency selection criteria predict performance in Orthopaedic Surgery Residency? The criteria used in residency selection can offer some insight into a candidate's likely success in Orthopaedic Surgery Residency. Grades, board scores, letters of recommendation, and interview outcomes can somewhat forecast performance. Still, individual dedication and adaptability are crucial factors.",1.1842986367842703e-07,0.050181301567672865,0.02943223237852083,0.009067132323909363,0.046442531040014945,0.03379978640085441,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
47,0.3,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","How well do residency selection criteria predict success in Orthopaedic Surgery Residency? Residency selection criteria can provide an indication of a candidate's potential to perform well in Orthopaedic Surgery Residency. Medical school grades, board exam scores, letters of recommendation, and interview performance can somewhat predict success. However, personal dedication and adaptability also play important roles.",7.105791820705622e-08,0.03515092394505226,0.01330828402366871,0.005440279394345618,0.033107002596560964,0.015721970176325387,0.0054324046228586,0.030884114630681303,0.0181755829903978,7.105791820705622e-08,0.05715841383995013,0.0
47,0.3,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Residency selection criteria can provide an indication of a candidate's potential performance in Orthopaedic Surgery Residency. Factors like medical school grades, board scores, letters of recommendation, and interview performance can somewhat predict a resident's ability to succeed. However, individual dedication and adaptability also play crucial roles.","Can performance in Orthopaedic Surgery Residency be predicted by residency selection criteria? The criteria used to select residents can partially predict a candidate's success in Orthopaedic Surgery Residency. Factors such as medical school grades, board scores, letters of recommendation, and interview performance contribute to this prediction. Nonetheless, individual dedication and adaptability remain key.",1.1842986367842703e-07,0.023521794623059478,0.048508284023668684,0.009067132323909363,0.046442531040014945,0.03379978640085441,0.009054007704764333,0.07010482778396376,0.0181755829903978,1.1842986367842703e-07,0.0971637484536485,0.0
48,0.3,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Amblyopia: Is the vision loss permanent? Older individuals with a history of amblyopia who suffer visual loss in their previously normal eye may regain visual function in the amblyopic eye over time. This improvement follows the visual loss.,2.8423167282822456e-07,0.08979498844092282,0.2130881557598702,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
48,0.3,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is visual loss in amblyopia permanent? Answer: In older adults with amblyopia, if the previously normal eye loses vision, the amblyopic eye can gradually recover visual function. This recovery happens after the loss of vision.",3.3160361829959516e-07,0.14536483959573498,0.2130881557598702,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
48,0.3,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Does amblyopia cause permanent vision loss? Older people who have amblyopia and then lose vision in their good eye can experience a restoration of sight in the amblyopic eye over time. This recovery occurs following the visual loss.,2.8423167282822456e-07,0.08979498844092282,0.2130881557598702,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
48,0.3,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is visual impairment from amblyopia irreversible? In elderly patients with amblyopia, visual loss in the formerly normal eye may lead to gradual improvement of vision in the amblyopic eye. This recovery takes place after the loss of vision.",2.8423167282822456e-07,0.12726240360632524,0.18608198292036404,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
48,0.3,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is the vision loss in amblyopia permanent? Answer: Visual function can return in the amblyopic eye of older adults who lose vision in their previously normal eye, with recovery occurring over time after the visual loss.",3.0791764556390986e-07,0.11719396262903814,0.2130881557598702,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
48,0.3,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is vision loss due to amblyopia permanent? Older individuals with amblyopia who develop vision loss in their previously unaffected eye may see their amblyopic eye's vision improve gradually. This improvement follows the loss of vision.,3.5528959103528046e-07,0.21512574003133622,0.18370339910238626,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
48,0.3,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Does amblyopia cause permanent visual loss? In older patients with amblyopia, if the previously normal eye experiences vision loss, the amblyopic eye may recover function over time. This recovery happens subsequent to the vision loss.",3.5528959103528046e-07,0.1743523764689865,0.2130881557598702,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
48,0.3,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Is the visual loss from amblyopia permanent? Among older adults with amblyopia, those who lose vision in their previously normal eye can experience a gradual restoration of vision in the amblyopic eye. This recovery occurs after the visual loss.",2.6054570009253926e-07,0.13608960247033508,0.16061901995740105,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
48,0.3,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,"Question: Is vision loss in amblyopia permanent? Answer: In older people with a history of amblyopia, visual function in the amblyopic eye can improve over time if the previously normal eye loses vision. This recovery follows the visual loss.",2.6054570009253926e-07,0.06312674135876195,0.2130881557598702,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
48,0.3,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss,Is vision loss caused by amblyopia permanent? Older individuals with amblyopia who develop vision loss in their previously normal eye may regain visual function in the amblyopic eye over time. This recovery occurs after the loss of vision.,2.8423167282822456e-07,0.12726240360632524,0.18608198292036404,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
49,0.3,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? No, they are not.",2.842316728282239e-07,0.1770327801258551,0.24376731301939059,0.02176111757738254,0.2991251250708653,0.20999999999999996,0.02172961849143448,0.4321193696274799,0.1541950113378685,2.842316728282244e-07,0.5776226504666218,0.08264462809917354
49,0.3,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? No, they do not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.3,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is the noise level of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? No, it is not.",1.421158364141118e-07,0.15943945649535607,0.24376731301939059,0.010880558788691277,0.0575498188678667,0.20999999999999996,0.010864809245717241,0.0526297479225768,0.1541950113378685,1.4211583641411228e-07,0.1721575423584576,0.08264462809917354
49,0.3,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? No, they are not.",2.6054570009253857e-07,0.11249425898828447,0.24376731301939059,0.019947691112600665,0.2301322535839132,0.20999999999999996,0.019918816950481606,0.35801139747375865,0.1541950113378685,2.6054570009253904e-07,0.4975799427930854,0.08264462809917354
49,0.3,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? No, they do not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.3,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? No, there is not.",1.894877818854825e-07,0.05935599793837465,0.24376731301939059,0.014507411718255037,0.04781069678995875,0.20999999999999996,0.014486412327622985,0.1638553830328009,0.1541950113378685,1.8948778188548298e-07,0.2899405780148414,0.08264462809917354
49,0.3,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP when used with preterm infants? No, they are not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.3,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Do high flow nasal cannulae cause more noise than bubble CPAP in preterm infants? No, they do not.",2.3685972735685321e-07,0.05186963717184945,0.24376731301939059,0.01813426464781879,0.16559373244634257,0.20999999999999996,0.018108015409528732,0.28901852598680655,0.1541950113378685,2.368597273568537e-07,0.42347197063936415,0.08264462809917354
49,0.3,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Is the sound produced by high flow nasal cannulae greater than that of bubble CPAP for preterm infants? No, it is not.",1.421158364141118e-07,0.15943945649535607,0.24376731301939059,0.010880558788691277,0.0575498188678667,0.20999999999999996,0.010864809245717241,0.0526297479225768,0.1541950113378685,1.4211583641411228e-07,0.1721575423584576,0.08264462809917354
49,0.3,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No, high flow nasal cannulae are not noisier than bubble CPAP for preterm infants.","Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? No, they are not.",2.842316728282239e-07,0.1770327801258551,0.24376731301939059,0.02176111757738254,0.2991251250708653,0.20999999999999996,0.02172961849143448,0.4321193696274799,0.1541950113378685,2.842316728282244e-07,0.5776226504666218,0.08264462809917354
50,0.3,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is practical and effective in such cases, enabling prompt diagnosis and treatment, which lowers complication risks and enhances patient recovery.",4.500334819780227e-07,0.059706785458251144,0.21432098765432098,0.03445510283085558,0.15786509525817305,0.16493055555555558,0.034405229278104466,0.2108974784773019,0.13660974593919203,4.500334819780227e-07,0.26590223939950697,0.10560000000000004
50,0.3,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy be used effectively in acute overt-obscure gastrointestinal bleeding? Indeed, this approach is feasible, offering immediate diagnostic and therapeutic benefits that improve patient outcomes and reduce complications.",5.921493183921345e-07,0.2222257149560254,0.21432098765432098,0.04533566161954683,0.32491917992133734,0.16493055555555558,0.045270038523821686,0.3827477354039619,0.13660974593919203,5.921493183921352e-07,0.44283294755858593,0.10560000000000004
50,0.3,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it feasible to use emergency double-balloon enteroscopy along with real-time capsule endoscopy for acute overt-obscure gastrointestinal bleeding? Yes, combining these methods allows for quick diagnosis and intervention, minimizing complications and improving recovery.",6.395212638635051e-07,0.28285033677246085,0.21432098765432098,0.04896251454911059,0.38743953690267086,0.16493055555555558,0.04889164160572743,0.4472862565415334,0.13660974593919203,6.39521263863506e-07,0.5095243220572594,0.10560000000000004
50,0.3,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing work in acute overt-obscure gastrointestinal bleeding? Yes, this combined approach is practical and facilitates immediate diagnosis and treatment, which helps prevent further complications and enhances patient outcomes.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.3,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy with real-time capsule endoscopy a practical approach for acute overt-obscure gastrointestinal bleeding? Yes, this method is feasible and enables prompt diagnosis and therapy, reducing risks and improving patient prognosis.",6.395212638635051e-07,0.28285033677246085,0.21432098765432098,0.04896251454911059,0.38743953690267086,0.16493055555555558,0.04889164160572743,0.4472862565415334,0.13660974593919203,6.39521263863506e-07,0.5095243220572594,0.10560000000000004
50,0.3,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Can emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing be effectively used in acute overt-obscure gastrointestinal bleeding? Yes, this combined approach is viable, allowing for immediate diagnosis and treatment that lowers complication rates and improves outcomes.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.3,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy feasible in cases of acute overt-obscure gastrointestinal bleeding? Yes, it is a practical method that supports rapid diagnosis and treatment, reducing complications and enhancing patient care.",5.447773729207639e-07,0.16506730111607704,0.21432098765432098,0.04170880868998307,0.26607867989840406,0.16493055555555558,0.04164843544191594,0.32212311358752643,0.13660974593919203,5.447773729207643e-07,0.3803125905772524,0.10560000000000004
50,0.3,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is it possible to use emergency double-balloon enteroscopy with real-time capsule endoscopy in acute overt-obscure gastrointestinal bleeding? Yes, this combined technique is feasible and allows for immediate diagnosis and intervention, improving patient outcomes and minimizing risks.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
50,0.3,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy provide a feasible solution for acute overt-obscure gastrointestinal bleeding? Yes, this approach is effective, enabling prompt diagnosis and treatment to reduce complications and improve recovery.",6.158352911278198e-07,0.25207867810570717,0.21432098765432098,0.04714908808432871,0.35569083858809103,0.16493055555555558,0.04708084006477456,0.4144964337185417,0.13660974593919203,6.158352911278206e-07,0.47562277038157763,0.10560000000000004
50,0.3,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible approach in acute overt-obscure gastrointestinal bleeding. This combined approach allows for immediate diagnosis and treatment, reducing the risk of further complications and improving patient outcomes.","Is emergency double-balloon enteroscopy along with real-time capsule endoscopy a feasible combined approach for acute overt-obscure gastrointestinal bleeding? Yes, this method allows for immediate diagnosis and treatment, decreasing the risk of complications and enhancing patient outcomes.",5.684633456564492e-07,0.19323817808277388,0.21432098765432098,0.04352223515476495,0.29506621677165557,0.16493055555555558,0.04345923698286881,0.3519760767372082,0.13660974593919203,5.684633456564497e-07,0.4110842492440061,0.10560000000000004
51,0.3,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: It is unlikely that gestational age misclassification accounts for the observed difference in average birthweights between Aborigines and whites. These findings may assist in understanding other comparisons between populations.,2.3685972735685406e-08,0.006233239504464194,0.020226055919095737,0.0018134264647818726,0.05522892197167373,0.023242630385487524,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.3,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification probably does not explain the reported differences in average birthweights between Aborigines and whites. The results could aid in interpreting other population comparisons.,9.474389094274162e-08,0.13941954583995742,0.030948656370032523,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.3,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassifying gestational age account for birthweight differences in Australian Aborigines versus whites? Answer: Misclassification of gestational age is an improbable cause for the observed disparity in average birthweights between Aborigines and whites. These findings may be useful for analyzing other between-population differences.,2.3685972735685406e-08,0.03929114810468315,0.04457414534324541,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.3,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the variation in birthweights between Australian Aborigines and whites explained by gestational age misclassification? Answer: Gestational age misclassification is unlikely to explain the reported differences in average birthweights for Aborigines and whites. The results might help interpret other population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age misclassification be the reason for birthweight differences between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification explains the observed divergence in average birthweights between Aborigines and whites. These findings may assist in the interpretation of other between-population comparisons.,2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.3,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does the misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? Answer: The misclassification of gestational age is an unlikely reason for the reported difference in average birthweights between Aborigines and whites. The results may help interpret other comparisons between populations.,0.0,0.06301338005090251,0.04395179757830192,0.0,0.06447880749394885,0.04613236961451247,0.0,0.06601401719618405,0.047500000000000014,0.0,0.03381205758828987,0.024375
51,0.3,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites caused by gestational age misclassification? Answer: Gestational age misclassification is an improbable explanation for the reported divergence in average birthweights between Aborigines and whites. The findings could aid in interpreting other population comparisons.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.3,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can the difference in birthweights between Australian Aborigines and whites be attributed to gestational age misclassification? Answer: It is unlikely that gestational age misclassification accounts for the reported differences in average birthweights between Aborigines and whites. These results may help in understanding other between-population comparisons.,2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.05522892197167373,0.023242630385487524,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.3,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification account for the birthweight differences observed between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to be the cause of the reported difference in average birthweights for Aborigines and whites. The results may assist with interpreting other population comparisons.,2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.3,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed divergence in average birthweights between Aborigines and whites. These findings might help interpret other between-population comparisons.,7.105791820705622e-08,0.11134572749075655,0.028603969340660812,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
52,0.3,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it feasible to sustain a zero central line-associated bloodstream infection rate? Maintaining a zero rate of central line-associated bloodstream infections is an aspirational target in healthcare, but consistently achieving it is difficult. It demands strict infection control protocols, ongoing staff education, and thorough surveillance. Even with these measures, sporadic cases might still arise due to",7.105791820705622e-08,0.11377094531302401,0.04070173523589619,0.005440279394345618,0.14021526554103314,0.0593513606027061,0.0054324046228586,0.14144656979116865,0.05975554549569943,7.105791820705622e-08,0.1160068637818168,0.040742417383431435
52,0.3,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can a zero central line-associated bloodstream infection rate be maintained over time? Striving for zero central line-associated bloodstream infections is a commendable objective in medical facilities, yet sustaining it indefinitely poses challenges. This necessitates rigorous infection prevention strategies, continuous training of personnel, and vigilant monitoring. Despite these precautions, occasional infections may still occur because of",4.737194547137081e-08,0.0940215093103629,0.039702318762032035,0.0036268529295637453,0.09488225556815433,0.04018547033047327,0.003621603081905733,0.09573886787586217,0.04053216987093972,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
52,0.3,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is a zero rate of central line-associated bloodstream infections sustainable? Attaining zero central line-associated bloodstream infections is an ideal aim in healthcare environments, but keeping this rate at zero continuously is challenging. It involves implementing strict infection control practices, ongoing staff training, and consistent monitoring. Nonetheless, occasional cases may happen due to",2.3685972735685406e-08,0.03233272174126389,0.036471890561339995,0.0018134264647818726,0.03347456775862456,0.03793273099944672,0.0018108015409528666,0.0346832326941664,0.03935623994014388,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.3,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it possible to maintain a zero central line-associated bloodstream infection rate? Achieving zero infections related to central lines is a desirable goal in healthcare, but sustaining it over time is difficult. It requires robust infection control measures, regular staff education, and diligent surveillance. Despite these efforts, occasional infections may still occur due to",2.3685972735685406e-08,0.15234572969375915,0.09506564056134,0.0018134264647818726,0.12814705535670257,0.07786328655500228,0.0018108015409528666,0.10298028896337286,0.05975554549569943,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,0.3,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can zero central line-associated bloodstream infections be sustained? Reaching a zero infection rate for central line-associated bloodstream infections is an ideal target in healthcare settings, but maintaining it indefinitely is challenging. This requires stringent infection control, continuous staff training, and rigorous monitoring. Even with these efforts, occasional cases may arise due to",2.3685972735685406e-08,0.032332721741264336,0.036471890561339995,0.0018134264647818726,0.03347456775862456,0.03793273099944672,0.0018108015409528666,0.0346832326941664,0.03935623994014388,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.3,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is sustaining a zero central line-associated bloodstream infection rate achievable? Achieving a zero rate of central line-associated bloodstream infections is an ideal goal in healthcare, but maintaining it consistently is challenging. It demands strict infection control protocols, ongoing staff training, and thorough monitoring. Despite these measures, occasional infections may still occur due to",0.0,0.053319013889225886,0.03758958891619213,0.0,0.08154672712470035,0.05826328655500229,0.0,0.08317766166719309,0.05975554549569943,0.0,0.056583443311015724,0.040742417383431435
52,0.3,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is it sustainable to have zero central line-associated bloodstream infections? Aiming for zero central line-associated bloodstream infections is a perfect goal in healthcare, but sustaining it perpetually is difficult. It requires rigorous infection control, continuous education for staff, and vigilant monitoring. Even with these precautions, occasional cases may happen due to",4.737194547137081e-08,0.010899159902590494,0.03531009506564056,0.0036268529295637453,0.012140191574885772,0.03712086917157085,0.003621603081905733,0.013474534623608037,0.03893164327750115,4.737194547137081e-08,0.014910746910446804,0.040742417383431435
52,0.3,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is maintaining a zero central line-associated bloodstream infection rate possible? Achieving zero infections associated with central lines is an ideal objective in healthcare, but sustaining it over time is challenging. It necessitates strict infection control measures, ongoing staff training, and consistent monitoring. Despite these efforts, occasional infections may still occur due to",2.3685972735685406e-08,0.11387944886596335,0.09506564056134,0.0018134264647818726,0.0889263422034201,0.07786328655500228,0.0018108015409528666,0.06297495434967448,0.05975554549569943,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,0.3,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Is a zero central line-associated bloodstream infection rate maintainable? Achieving zero central line-associated bloodstream infections is an ideal target in healthcare settings, but keeping it at zero continuously is challenging. It involves stringent infection control, continuous staff education, and rigorous monitoring. Nonetheless, occasional cases may occur due to",1.1842986367842703e-07,0.056285456262339384,0.03153258271010034,0.009067132323909363,0.05472893461040851,0.03447485680293616,0.009054007704764333,0.0529893953488525,0.037544801694046545,1.1842986367842703e-07,0.051047220881349276,0.040742417383431435
52,0.3,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is an ideal goal in healthcare settings but maintaining it perpetually can be challenging. It requires stringent infection control measures, continuous staff training, and rigorous monitoring. Despite these efforts, occasional instances may occur due to","Can zero central line-associated bloodstream infection rates be maintained? Striving for zero central line-associated bloodstream infections is an ideal goal in healthcare, but sustaining it indefinitely is challenging. This requires strict infection control protocols, ongoing staff training, and vigilant monitoring. Despite these efforts, occasional infections may still arise due to",7.105791820705622e-08,0.011001050714258831,0.03410155738553662,0.005440279394345618,0.009657917363496082,0.036275384853679024,0.0054324046228586,0.008193366755572917,0.038489004852977335,7.105791820705622e-08,0.006595458310516555,0.040742417383431435
53,0.3,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormonal differences play a role? Answer: Female gender independently offers protection against multiple organ failure and nosocomial infections, a benefit observed in both premenopausal and postmenopausal women compared to men of the same age. This finding contrasts with earlier experimental studies and the expected physiological changes in sex hormones after injury.",4.737194547137081e-08,0.03226086221822477,0.0,0.0036268529295637453,0.03278982282299214,0.0,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
53,0.3,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes gender differences after injury and hemorrhagic shock, and are hormones the cause? Answer: The protective effect of being female on reducing multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women relative to age-matched men, opposing previous experimental data and known hormonal changes post-injury.",2.6054570009253947e-07,0.19885085874516495,0.0,0.0199476911126006,0.20252426411147262,0.0,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
53,0.3,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormonal variations responsible? Answer: Female gender independently protects against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to men of similar age, which contradicts earlier experimental findings and known physiological sex hormone alterations after trauma.",1.8948778188548325e-07,0.1405819506211894,0.0,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
53,0.3,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the nature of gender dimorphism following injury and hemorrhagic shock, and do hormonal differences explain it? Answer: The female gender shows an independent protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women when compared to similarly aged men, a result that differs from previous experimental studies and established sex hormone changes after injury.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,0.3,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism defined after injury and hemorrhagic shock, and are hormones the underlying cause? Answer: Female gender independently reduces the risk of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared with men of the same age, which is contrary to earlier experimental research and known physiological sex hormone shifts post-injury.",9.474389094274162e-08,0.0678225963387602,0.0,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
53,0.3,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What characterizes the gender differences after injury and hemorrhagic shock, and are hormonal factors responsible? Answer: The protective effect of female gender on multiple organ failure and infection rates remains significant in both premenopausal and postmenopausal women versus age-matched men, opposing previous experimental studies and known sex hormone changes following injury.",2.3685972735685406e-07,0.17904823144898518,0.0,0.018134264647818726,0.182321556793954,0.0,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
53,0.3,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How does gender dimorphism present after injury and hemorrhagic shock, and do hormonal differences cause it? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of similar age, which contradicts earlier experimental findings and known physiological sex hormone changes after trauma.",1.6580180914979784e-07,0.12188981760903506,0.0,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
53,0.3,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: The independent protective effect of female gender on multiple organ failure and hospital-acquired infection rates is significant in both premenopausal and postmenopausal women compared to similarly aged men, differing from previous experimental studies and known sex hormone changes post-injury.",1.8948778188548325e-07,0.1405819506211894,0.0,0.014507411718254981,0.14310084364067155,0.0,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
53,0.3,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to men of the same age, which is contrary to prior experimental data and known physiological sex hormone alterations after injury.",1.4211583641411244e-07,0.10354067894083929,0.0,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
53,0.3,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and are hormones the reason? Answer: The female gender independently reduces the incidence of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared with age-matched men, a finding that contradicts previous experimental studies and known sex hormone changes following trauma.",1.1842986367842703e-07,0.08552217343816082,0.0,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
54,0.3,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to keep their weight stable? Answer: The number of calories needed to maintain weight depends on personal factors such as age, height, weight, and activity level, not race or ethnicity.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.3,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is the calorie requirement for weight maintenance lower for African American women? Answer: Caloric needs for maintaining weight are influenced by individual characteristics like age, height, weight, and physical activity, rather than racial or ethnic identity.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.3,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women require fewer calories to sustain their weight? Answer: Weight maintenance calorie needs are based on factors like age, height, weight, and activity level, not on race or ethnicity.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.3,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are fewer calories needed by African American women to maintain their weight? Answer: Caloric intake for weight maintenance is determined by personal attributes such as age, height, weight, and physical activity, not by racial or ethnic background.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.3,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women have lower calorie requirements for weight maintenance? Answer: The calories needed to maintain weight depend on individual factors including age, height, weight, and physical activity, not on race or ethnicity.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.3,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is the caloric intake to maintain weight less for African American women? Answer: Calorie requirements for weight maintenance are influenced by individual factors like age, height, weight, and physical activity level, rather than race or ethnicity.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,0.3,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women need fewer calories to keep their weight? Answer: The amount of calories required to maintain weight is based on personal factors such as age, height, weight, and physical activity, not racial or ethnic background.",7.10579182070559e-08,0.08223809823697303,0.0,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
54,0.3,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Are African American women required to consume fewer calories to maintain weight? Answer: Caloric needs for weight maintenance depend on individual characteristics like age, height, weight, and activity level, not on race or ethnicity.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.3,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Do African American women require less caloric intake to maintain weight? Answer: The calorie intake necessary to maintain weight is determined by factors such as age, height, weight, and physical activity, rather than racial or ethnic background.",4.73719454713706e-08,0.01810243598940975,0.027006172839506164,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
54,0.3,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: Caloric intake for weight maintenance is not determined by racial or ethnic background, but individual factors like age, height, weight, and physical activity level.","Question: Is the calorie requirement for weight maintenance different for African American women? Answer: Caloric intake for maintaining weight is influenced by individual factors like age, height, weight, and physical activity level, not by race or ethnicity.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
55,0.3,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Yes, elevated neutrophil migration after significant trauma may play a role in causing ARDS by promoting lung inflammation and releasing damaging agents.",5.684633456564495e-07,0.16807452855349503,0.24826388888888892,0.04352223515476494,0.24996844378615402,0.17159999999999997,0.0434592369828688,0.30288146959800644,0.14532871972318342,5.684633456564497e-07,0.3577137802495387,0.11649408284023667
55,0.3,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is heightened neutrophil migration after major trauma a factor in the onset of acute respiratory distress syndrome? Indeed, increased neutrophil activity post-trauma can lead to lung inflammation and harmful substance release, potentially resulting in ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.3,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can increased neutrophil migratory activity after severe trauma be involved in the etiology of acute respiratory distress syndrome? Yes, because enhanced neutrophil movement can cause lung inflammation and the discharge of injurious substances, contributing to ARDS.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.3,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does major trauma-induced neutrophil migratory activity increase contribute to acute respiratory distress syndrome? Yes, since elevated neutrophil activity can trigger lung inflammation and release harmful compounds, which may cause ARDS.",7.816371002776172e-07,0.4383648582934083,0.24826388888888892,0.059843073337801846,0.5286818462551754,0.17159999999999997,0.059756450851444654,0.5905635420497872,0.14532871972318342,7.816371002776184e-07,0.6549653037174696,0.11649408284023667
55,0.3,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is the rise in neutrophil migratory activity after major trauma a contributing factor to acute respiratory distress syndrome? Yes, as this increase can promote lung inflammation and the secretion of damaging substances, potentially leading to ARDS.",6.395212638635054e-07,0.25031262679046806,0.24826388888888892,0.04896251454911057,0.3345258318142177,0.17159999999999997,0.04889164160572741,0.38989284658763657,0.14532871972318342,6.39521263863506e-07,0.4473259389392257,0.11649408284023667
55,0.3,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can the increased migration of neutrophils following major trauma be a cause of acute respiratory distress syndrome? Yes, because greater neutrophil activity can induce lung inflammation and release harmful agents that may result in ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.3,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after significant trauma a factor in acute respiratory distress syndrome development? Yes, since it can cause lung inflammation and the release of harmful substances, thereby contributing to ARDS.",7.105791820705613e-07,0.33992478548015503,0.24826388888888892,0.05440279394345621,0.426899151945233,0.17159999999999997,0.05432404622858603,0.4852030263919618,0.14532871972318342,7.105791820705622e-07,0.545766011752479,0.11649408284023667
55,0.3,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Does the enhanced neutrophil migration post-major trauma play a role in the etiology of acute respiratory distress syndrome? Yes, as it can lead to lung inflammation and the discharge of damaging substances, potentially causing ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.3,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Is increased neutrophil migratory activity after major trauma linked to the development of acute respiratory distress syndrome? Yes, because the heightened activity can cause lung inflammation and release harmful substances, which may lead to ARDS.",6.632072365991907e-07,0.27930016366371957,0.24826388888888892,0.05077594101389245,0.36437879496389947,0.17159999999999997,0.050702443146680286,0.42066450525439025,0.14532871972318342,6.632072365991914e-07,0.4790746372538055,0.11649408284023667
55,0.3,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Yes, increased neutrophil migratory activity after major trauma can be a factor in the etiology of Acute Respiratory Distress Syndrome (ARDS). This is because heightened neutrophil activity can contribute to inflammation in the lungs and the release of harmful substances, potentially leading to ARDS.","Can heightened neutrophil migration after major trauma contribute to acute respiratory distress syndrome? Yes, since increased neutrophil activity can result in lung inflammation and the release of harmful compounds, potentially causing ARDS.",7.342651548062466e-07,0.37167348379473486,0.24826388888888892,0.056216220408238086,0.4596889747682247,0.17159999999999997,0.056134847769538906,0.5191045780676435,0.14532871972318342,7.342651548062476e-07,0.580857331563748,0.11649408284023667
56,0.3,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment are necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression was not apparent. Prompt diagnosis of sarcoidosis from other organs and steroid therapy is essential.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in treating spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early identification of sarcoidosis in other organs and steroid treatment is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery help spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not clear. Early diagnosis of sarcoidosis in other organs and steroid therapy should be implemented.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.3,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a successful treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was inconclusive. Early detection of sarcoidosis in other organs and steroid therapy is necessary.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show effectiveness for spinal cord sarcoidosis with compressive cervical myelopathy? The results of decompression were not evident. Early diagnosis of sarcoidosis from other organs and steroid treatment is important.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression was not demonstrated. Early diagnosis of sarcoidosis in other organs and steroid therapy should be pursued.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression was not obvious. Early diagnosis of sarcoidosis in other organs and steroid treatment is needed.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefit in spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was unclear. Early diagnosis of sarcoidosis from other organs and steroid therapy is required.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.3,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for treating spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy should be considered.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
57,0.3,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective option for treating GERD in elderly patients, showing low morbidity and mortality rates and symptom improvement similar to that in younger individuals.",2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
57,0.3,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in elderly patients, with low rates of morbidity and mortality and symptom relief comparable to younger patients.",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.3,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication for laparoscopic surgery in GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older patients, with low morbidity and mortality and symptom improvement similar to younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.3,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a limiting factor for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, associated with low morbidity and mortality and significant symptom improvement comparable to younger patients.",7.105791820705611e-08,0.10965398141320737,0.025623268698060954,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
57,0.3,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does being elderly contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, showing low morbidity and mortality and symptom improvement on par with younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.3,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in advanced age? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement comparable to younger patients.",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.3,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is old age a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD in elderly patients, with low morbidity and mortality and symptom relief similar to that in younger patients.",1.42115836414112e-07,0.19265885652503245,0.02775510204081633,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.3,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger individuals.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.3,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication to laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, yielding low morbidity and mortality and symptom improvement similar to younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.3,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic antireflux surgery in GERD patients? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger patients.",7.105791820705611e-08,0.14519999067269174,0.05113221329437545,0.005440279394345618,0.11246733753370775,0.026296566837107373,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
58,0.3,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and healthcare professionals consider it acceptable to break confidentiality to safeguard a patient's wife from a sexually transmitted infection? Research indicates that both groups agree it is acceptable to breach confidentiality in order to protect a patient's wife from an STI.,1.8948778188548325e-07,0.24406171547933786,0.1368834923625607,0.014507411718254981,0.2864244528845967,0.18975286160249744,0.014486412327622933,0.29719070080453447,0.2191213579604579,1.8948778188548325e-07,0.308657696102673,0.24765868886576478
58,0.3,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it acceptable for French laypeople and health professionals to violate confidentiality to protect a wife from a sexually transmitted disease? Studies show that both French laypeople and health professionals find breaching confidentiality acceptable to protect a patient's wife from an STD.,2.3685972735685406e-07,0.08870687835994984,0.06543339010330221,0.018134264647818726,0.16501886979936087,0.138487429503732,0.018108015409528666,0.20990031929919262,0.19236414466608245,2.3685972735685406e-07,0.22088297115933697,0.2213621220286574
58,0.3,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French non-professionals and medical professionals find it permissible to disclose confidential information to protect a patient's wife from a sexually transmitted disease? Evidence suggests that both groups accept breaching confidentiality for this purpose.,4.2634750924233657e-07,0.10832677624015208,0.22892819979188353,0.03264167636607373,0.08050475459713935,0.23725286160249745,0.03259442773715163,0.0514178961736631,0.2434963579604579,4.263475092423373e-07,0.020975623650891784,0.24765868886576478
58,0.3,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypeople and health care workers in favor of breaking confidentiality to shield a patient's wife from a sexually transmitted infection? Research reveals that both French laypeople and health professionals consider it acceptable to breach confidentiality to protect the patient's wife.,2.3685972735685406e-07,0.19014305112482033,0.1325074547224898,0.018134264647818726,0.23433358785535496,0.1873913657576221,0.018108015409528666,0.24544632855867698,0.21787308926239696,2.3685972735685406e-07,0.2573644017151233,0.24765868886576478
58,0.3,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and health professionals approve of breaching confidentiality to protect a patient's wife from an STI? Research indicates that both groups find it acceptable to disclose confidential information in order to protect the patient's wife.,3.5528959103528067e-07,0.15682997653200736,0.2011730977510672,0.02720139697172809,0.17011691328682632,0.23725286160249745,0.027162023114293006,0.1437912163046784,0.2434963579604579,3.552895910352811e-07,0.116285803455217,0.24765868886576478
58,0.3,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French laypeople and health professionals? Studies suggest that both groups agree it is acceptable to breach confidentiality for this reason.,4.0266153650665127e-07,0.09740637582748413,0.1995434431343996,0.03082824990129185,0.11127641326389304,0.23725286160249745,0.030783626196198753,0.08316659448824293,0.2434963579604579,4.026615365066519e-07,0.05376544647388348,0.24765868886576478
58,0.3,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and health professionals find it justifiable to violate confidentiality to protect a patient's wife from a sexually transmitted infection? Research shows that both groups consider breaching confidentiality acceptable to protect the patient's wife.,3.7897556377096597e-07,0.12755886594537413,0.20038148698911537,0.02901482343650997,0.14112937641357481,0.23725286160249745,0.02897282465524588,0.11393825315499662,0.2434963579604579,3.789755637709665e-07,0.08551414478846331,0.24765868886576478
58,0.3,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Are French laypeople and health professionals willing to breach confidentiality to protect a patient's wife from an STD? Research suggests that both groups find this breach acceptable to safeguard the patient's wife.,4.7371945471370717e-07,0.045806419258818565,0.22892819979188353,0.03626852929563749,0.015966233459567825,0.23725286160249745,0.036216030819057374,0.015273478325010359,0.2434963579604579,4.737194547137081e-07,0.048017247836058985,0.24765868886576478
58,0.3,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Do French laypeople and health professionals accept breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Research indicates that both groups find it acceptable to disclose confidential information to protect the patient's wife.,3.7897556377096597e-07,0.12755886594537413,0.20038148698911537,0.02901482343650997,0.14112937641357481,0.23725286160249745,0.02897282465524588,0.11393825315499662,0.2434963579604579,3.789755637709665e-07,0.08551414478846331,0.24765868886576478
58,0.3,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Research suggests that both French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease. This,Is it considered acceptable by French laypeople and health professionals to breach confidentiality to protect a patient's wife from a sexually transmitted infection? Studies show that both groups agree on breaching confidentiality for the protection of the patient's wife.,3.0791764556391007e-07,0.2494053745000584,0.22892819979188353,0.023574544042164344,0.2256867644416385,0.23725286160249745,0.023540420032387266,0.20094963014462675,0.2434963579604579,3.079176455639103e-07,0.17512630347815028,0.24765868886576478
59,0.3,1,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI can potentially distinguish pleomorphic adenoma and myoepithelial adenomas from other tumor types studied. However, because of overlap within benign and malignant groups and between them, definitive diagnoses should not be made solely on this basis.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
59,0.3,2,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it possible to predict various histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI shows promise in differentiating pleomorphic adenoma and myoepithelial adenomas from other examined tumors. Nevertheless, due to overlaps within and between benign and malignant lesions, diagnosis should not rely exclusively on this method.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
59,0.3,3,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging of primary parotid gland tumors predict different histologic subtypes? Answer: epiDWI may help distinguish pleomorphic adenoma and myoepithelial adenomas from other entities studied. Still, because of overlapping features within and between benign and malignant groups, diagnoses should not be based solely on this imaging.",2.1317375462116866e-07,0.1686227124357922,0.0,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
59,0.3,4,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Does diffusion-weighted echo-planar MR imaging allow prediction of histologic subtypes in primary parotid gland tumors? Answer: epiDWI has the capability to differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor types analyzed. However, due to overlap among benign and malignant lesions, diagnosis should not be made solely on this imaging.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
59,0.3,5,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is predicting different histologic subtypes of primary parotid gland tumors possible with diffusion-weighted echo-planar MR imaging? Answer: epiDWI can potentially separate pleomorphic adenoma and myoepithelial adenomas from other entities studied. Yet, because of overlaps within benign and malignant groups and between them, diagnosis should not be based only on this technique.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
59,0.3,6,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging differentiate histologic subtypes of primary parotid gland tumors? Answer: epiDWI may distinguish pleomorphic adenoma and myoepithelial adenomas from other examined tumors. However, due to overlapping characteristics within and between benign and malignant lesions, diagnoses should not be made solely on this imaging.",2.6054570009253947e-07,0.2102954088363611,0.0,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
59,0.3,7,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is it feasible to predict histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI has potential to differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor entities studied. Nonetheless, because of overlap within benign and malignant groups, diagnosis should not rely solely on this method.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
59,0.3,8,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Can diffusion-weighted echo-planar MR imaging predict various histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows potential in distinguishing pleomorphic adenoma and myoepithelial adenomas from other tumors analyzed. Still, due to overlapping features within and between benign and malignant lesions, diagnosis should not be made solely on this imaging.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
59,0.3,9,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Is diffusion-weighted echo-planar MR imaging capable of predicting histologic subtypes in primary parotid gland tumors? Answer: epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other entities studied. However, because of overlap within benign and malignant groups, diagnoses should not be based only on this technique.",2.8423167282822487e-07,0.23180161405732447,0.0,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
59,0.3,10,human,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on","Question: Does diffusion-weighted echo-planar MR imaging help in predicting different histologic subtypes of primary parotid gland tumors? Answer: epiDWI may differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor types examined. Yet, due to overlapping characteristics within and between benign and malignant lesions, diagnosis should not rely solely on this imaging.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
60,0.3,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible to get correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Yes, with careful design and execution, homebrew assays can match the precision and sensitivity of commercial kits, provided consistent procedures and quality control are maintained.",5.684633456564497e-07,0.3799698322563083,0.05145322918413599,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
60,0.3,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew assays yield correlated results for BCRABL transcript detection via quantitative real-time PCR? Yes, when properly designed and performed, these assays can offer comparable accuracy and sensitivity to commercial alternatives, assuming strict adherence to protocols and quality checks.",6.632072365991912e-07,0.44704628221519815,0.07524858908895454,0.050775941013892434,0.5421417516957199,0.015380859375,0.050702443146680265,0.5753641449035611,0.0,6.632072365991914e-07,0.5877866649021217,0.0
60,0.3,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results achievable from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? Yes, if the assays are well-designed and carefully conducted, they can deliver precision and sensitivity similar to commercial kits, with consistent methods and quality controls being crucial.",6.158352911278206e-07,0.39575298782764845,0.07524858908895454,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
60,0.3,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it feasible to obtain correlated BCRABL transcript detection results from homebrew quantitative real-time PCR assays? Yes, with meticulous assay design and execution, homebrew methods can rival commercial kits in accuracy and sensitivity, provided that procedures and quality assurance are consistently applied.",5.921493183921352e-07,0.37106037523727675,0.07524858908895454,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
60,0.3,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can quantitative real-time PCR homebrew assays produce correlated BCRABL transcript detection results? Yes, these assays can achieve comparable precision and sensitivity to commercial kits if they are accurately designed, carefully executed, and supported by consistent quality control.",7.105791820705618e-07,0.5011135034854743,0.07524858908895454,0.05440279394345618,0.597711602850532,0.015380859375,0.054324046228586005,0.6325225587435095,0.0,7.105791820705622e-07,0.646627164925055,0.0
60,0.3,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are homebrew assays capable of providing correlated results for BCRABL transcript detection using quantitative real-time PCR? Yes, with precise design and thorough execution, homebrew assays can match the performance of commercial kits, given that consistent procedures and quality control are upheld.",6.158352911278206e-07,0.43041034685564483,0.05026502564385262,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
60,0.3,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it possible for homebrew assays to yield correlated quantitative real-time PCR results for BCRABL transcript detection? Yes, when designed and performed with care, these assays can offer similar precision and sensitivity as commercial kits, provided that quality control and consistent protocols are maintained.",5.447773729207643e-07,0.3234323262480223,0.07524858908895454,0.04170880868998307,0.4153900460565776,0.015380859375,0.04164843544191593,0.44531101665536355,0.0,5.447773729207643e-07,0.454255272277599,0.0
60,0.3,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Can homebrew quantitative real-time PCR assays detect BCRABL transcripts with correlated results? Yes, if the assays are carefully designed and executed with strict quality control, they can provide results comparable to those from commercial kits.",7.579511275419324e-07,0.5582719173254227,0.07524858908895454,0.05802964687301994,0.6565521028734653,0.015380859375,0.05794564931049175,0.693147180559945,0.0,7.57951127541933e-07,0.7091475219063885,0.0
60,0.3,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Are correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR attainable? Yes, with accurate design and meticulous execution, homebrew assays can achieve precision and sensitivity on par with commercial kits, assuming consistent procedures and quality control.",6.395212638635059e-07,0.4566168050714241,0.04962532039089359,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
60,0.3,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Yes, it is possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR. These assays, when accurately designed and meticulously executed, can provide comparable precision and sensitivity to commercial kits. However, consistency in procedure and quality control measures are vital to ensure reliable results.","Is it achievable to get correlated BCRABL transcript detection results from homebrew quantitative real-time PCR assays? Yes, these assays can provide comparable accuracy and sensitivity to commercial kits if they are carefully designed, executed, and quality controlled consistently.",6.868932093348765e-07,0.473714529297359,0.07524858908895454,0.052589367478674306,0.5695407258838352,0.015380859375,0.05251324468763313,0.603535021870258,0.0,6.868932093348768e-07,0.6167742017753732,0.0
61,0.3,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosis. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary surgeries. Ultrasonography is the preferred imaging technique in uncertain cases.",1.4211583641411233e-07,0.08148776092423571,0.04434829637641969,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
61,0.3,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we require imaging to diagnose appendicitis in pediatric patients? Diagnosis mainly relies on clinical examination. Still, in girls older than 10, targeted imaging should be used to avoid needless appendectomies. Ultrasound is the imaging modality of choice when the diagnosis is unclear.",7.105791820705622e-08,0.007379788770512263,0.04434829637641969,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
61,0.3,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging needed for diagnosing appendicitis in children? The diagnosis is primarily based on clinical assessment. Yet, in girls above 10 years, selective imaging is advised to reduce unnecessary appendectomies. Ultrasonography should be used in ambiguous cases.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.3,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be used to diagnose appendicitis in children? Clinical assessment is crucial for diagnosis. Nevertheless, in girls older than 10, selective imaging helps prevent unnecessary appendectomies. Ultrasonography is the preferred method in doubtful cases.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641969,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
61,0.3,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do children with suspected appendicitis require imaging for diagnosis? Diagnosis depends mainly on clinical evaluation. However, in girls over 10 years old, selective imaging is recommended to avoid unnecessary surgery. Ultrasound is the imaging choice in equivocal situations.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641969,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.3,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging essential to diagnose appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Still, for girls older than 10, selective imaging should be employed to prevent unnecessary appendectomies. Ultrasonography is the preferred imaging in uncertain cases.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913525,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
61,0.3,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Do we need to use imaging to diagnose appendicitis in children? The key to diagnosis is clinical assessment. However, in girls older than 10 years, selective imaging should be considered to avoid unnecessary appendectomies. Ultrasonography is the imaging method of choice in ambiguous cases.",4.737194547137081e-08,0.016150708639682154,0.04434829637641969,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
61,0.3,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging required to diagnose appendicitis in children? Diagnosis primarily relies on clinical assessment. Yet, in girls above 10, selective imaging is recommended to prevent unnecessary appendectomies. Ultrasound is the preferred imaging technique when diagnosis is unclear.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641969,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
61,0.3,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Should imaging be performed to diagnose appendicitis in children? Clinical evaluation is fundamental for diagnosis. Nevertheless, in girls older than 10 years, selective imaging should be applied to avoid unnecessary appendectomies. Ultrasonography is the imaging modality of choice in equivocal cases.",1.1842986367842703e-07,0.05616995293994398,0.04434829637641969,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
61,0.3,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.","Is imaging necessary for diagnosing appendicitis in children? Clinical assessment is the main diagnostic tool. However, in girls over 10, selective imaging is advised to prevent unnecessary appendectomies. Ultrasound is the preferred imaging option in uncertain cases.",2.1317375462116823e-07,0.20003864529554471,0.01659319433560336,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
62,0.3,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries necessary during thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring MEP and SSEP shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low rates of immediate and delayed paraplegia. This suggests routine reimplantation of segmental vessels is unnecessary.",2.6054570009253947e-07,0.21855051475472065,0.01922337562475971,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
62,0.3,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should spinal cord arteries be reimplanted during thoracic and thoracoabdominal aneurysm repair? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe and results in low rates of paraplegia. This indicates routine reimplantation is not required.",3.552895910352811e-07,0.2719337154836441,0.0,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
62,0.3,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is it worthwhile to reimplant spinal cord arteries in thoracic and thoracoabdominal aneurysm repair? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to low immediate and delayed paraplegia rates, suggesting routine reimplantation is unnecessary.",3.316036182995957e-07,0.25131442828090833,0.0,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
62,0.3,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplantation of spinal cord arteries benefit thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring MEP and SSEP reveals that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low paraplegia rates, implying routine reimplantation is not indicated.",4.263475092423373e-07,0.3364722366212156,0.0,0.03264167636607371,0.34294475112682976,0.0,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
62,0.3,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during TAA/A repair a futile effort? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation is safe and results in low paraplegia rates, suggesting routine reimplantation is unnecessary.",4.974054274493935e-07,0.43847211670625885,0.023795359904818555,0.038081955760419325,0.4135623183407837,0.0,0.0380268323600102,0.4219944100593742,0.0,4.974054274493935e-07,0.430782916092455,0.0
62,0.3,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Should surgeons reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair? Answer: Evidence from MEP and SSEP monitoring shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation is safe and results in low paraplegia rates, indicating routine reimplantation is not needed.",4.263475092423373e-07,0.3672787779794353,0.02221074380165289,0.03264167636607371,0.34294475112682976,0.0,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
62,0.3,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is it necessary to reimplant spinal cord arteries in thoracic and thoracoabdominal aneurysm repair? Answer: Monitoring with MEP and SSEP demonstrates that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates, suggesting routine reimplantation is not warranted.",2.8423167282822487e-07,0.21130909366720996,0.0,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
62,0.3,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Does reimplantation of spinal cord arteries improve outcomes in thoracic and thoracoabdominal aneurysm repair? Answer: MEP and SSEP monitoring shows that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low paraplegia rates, indicating routine reimplantation is unnecessary.",3.789755637709665e-07,0.29298712468147725,0.0,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
62,0.3,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair justified? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation is safe and leads to acceptably low rates of paraplegia, suggesting routine reimplantation is not justified.",4.026615365066519e-07,0.34463016383982925,0.021728395061728398,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
62,0.3,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with","Question: Is reimplanting spinal cord arteries during TAA/A repair beneficial? Answer: Monitoring MEP and SSEP indicates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates, implying routine reimplantation is unnecessary.",4.737194547137081e-07,0.44641341819192126,0.046400951814396206,0.03626852929563745,0.4224717753598153,0.023795359904818555,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
63,0.3,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, such a connection exists.",2.8423167282822376e-07,0.17195366882557162,0.18953463738436552,0.02176111757738255,0.1516564552764943,0.23582766439909295,0.02172961849143448,0.21304219765545085,0.2222222222222221,2.8423167282822456e-07,0.2797212513199212,0.20408163265306126
63,0.3,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques related to discopathy in patients with multiple sclerosis? Yes, there is a relationship.",3.3160361829959447e-07,0.2127203510864062,0.2448979591836735,0.025387970506946304,0.27681959823049995,0.23582766439909295,0.025351221573340226,0.3465735902799736,0.2222222222222221,3.3160361829959526e-07,0.42282209496059453,0.20408163265306126
63,0.3,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, there is one.",3.079176455639091e-07,0.15209572926997117,0.2448979591836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
63,0.3,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there an association between cervical cord plaques and discopathy in patients suffering from multiple sclerosis? Yes, an association is present.",2.3685972735685306e-07,0.058891517828191464,0.19503646333879815,0.018134264647818796,0.0404308201662702,0.23582766439909295,0.018108015409528735,0.09525916199906703,0.2222222222222221,2.3685972735685385e-07,0.15455810836591555,0.20408163265306126
63,0.3,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques linked to discopathy in patients with multiple sclerosis? Yes, they are linked.",3.552895910352798e-07,0.2772588722239768,0.2448979591836735,0.02720139697172818,0.34581246971745205,0.23582766439909295,0.0271620231142931,0.4206815624336948,0.2222222222222221,3.552895910352806e-07,0.5028648026341309,0.20408163265306126
63,0.3,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there any correlation between cervical cord plaques and discopathy in multiple sclerosis patients? Yes, a correlation exists.",3.079176455639091e-07,0.15209572926997117,0.2448979591836735,0.023574544042164428,0.21228107709292932,0.23582766439909295,0.023540420032387353,0.2775807187930215,0.2222222222222221,3.079176455639099e-07,0.3487141228068733,0.20408163265306126
63,0.3,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Do cervical cord plaques relate to discopathy in patients with multiple sclerosis? Yes, they do.",3.789755637709652e-07,0.3462517437109289,0.2448979591836735,0.029014823436510056,0.4199204418711733,0.23582766439909295,0.028972824655245973,0.5007242701072312,0.2222222222222221,3.7897556377096597e-07,0.589876179623761,0.20408163265306126
63,0.3,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a connection between cervical cord plaques and discopathy among patients with multiple sclerosis? Yes, there is a connection.",2.605457000925384e-07,0.04087009415974707,0.2448979591836735,0.019947691112600675,0.0944980414365455,0.23582766439909295,0.019918816950481606,0.15241757583901583,0.2222222222222221,2.605457000925392e-07,0.21518273018235057,0.20408163265306126
63,0.3,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Are cervical cord plaques connected to discopathy in patients with multiple sclerosis? Yes, they are connected.",3.552895910352798e-07,0.2772588722239768,0.2448979591836735,0.02720139697172818,0.34581246971745205,0.23582766439909295,0.0271620231142931,0.4206815624336948,0.2222222222222221,3.552895910352806e-07,0.5028648026341309,0.20408163265306126
63,0.3,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a relation between cervical cord plaques and discopathy in patients with","Is there a relationship between cervical cord plaques and discopathy in patients diagnosed with multiple sclerosis? Yes, such a relationship exists.",2.3685972735685306e-07,0.058891517828191464,0.19503646333879815,0.018134264647818796,0.0404308201662702,0.23582766439909295,0.018108015409528735,0.09525916199906703,0.2222222222222221,2.3685972735685385e-07,0.15455810836591555,0.20408163265306126
64,0.3,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality rates following emergency general surgery laparotomies a significant concern requiring improvement? Answer: Mortality rates at 30 days and 1 year after emergency general surgery laparotomies continue to be problematic. The high mortality rates highlight the necessity for advancements in perioperative care. Improvements in surgical methods, patient selection, and postoperative management may help lower these rates.",2.3685972735685406e-08,0.04987008617045374,0.0537574180485286,0.0018134264647818726,0.0406952414882209,0.01719469248222487,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
64,0.3,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a need to address 30-day and 1-year mortality in emergency general surgery laparotomies? Answer: Mortality within 30 days and 1 year after emergency general surgery laparotomies remains a critical issue. The elevated mortality rates suggest that perioperative care needs enhancement. Optimizing surgical techniques, patient selection, and postoperative care could reduce these mortality figures.",1.4211583641411244e-07,0.06304683471140615,0.028938991661700317,0.010880558788691236,0.10792772743767642,0.0018500471818279247,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
64,0.3,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Should 30-day and 1-year mortality rates in emergency general surgery laparotomies be a focus for improvement? Answer: Mortality rates following emergency general surgery laparotomies at 30 days and 1 year are still concerning. These high rates indicate a pressing need to improve perioperative care. Advancements in surgical approaches, better patient selection, and enhanced postoperative care might decrease mortality.",7.105791820705622e-08,0.05513281302017603,0.0033362592098613447,0.005440279394345618,0.07683029577660072,0.01837944354358135,0.0054324046228586,0.07694100961913897,0.017851239669421492,7.105791820705622e-08,0.05310982531394792,0.0
64,0.3,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are the 30-day and 1-year mortality rates after emergency general surgery laparotomies an area needing improvement? Answer: Mortality rates at 30 days and 1 year post-emergency general surgery laparotomies remain high. This raises concerns and highlights the need for better perioperative management. Enhanced surgical techniques, improved patient selection, and superior postoperative care could help reduce these mortality rates.",7.105791820705622e-08,0.031231186104315967,0.013680598480396995,0.005440279394345618,0.05250934207274227,0.0008763865356541979,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
64,0.3,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a concern about 30-day and 1-year mortality in emergency general surgery laparotomies that requires action? Answer: Mortality rates at 30 days and 1 year following emergency general surgery laparotomies continue to be a concern. The elevated mortality points to the need for improved perioperative care. Refining surgical techniques, selecting patients more effectively, and enhancing postoperative care may lower these rates.",2.3685972735685406e-08,0.04008630973291005,0.01698885273430429,0.0018134264647818726,0.005818066165202751,0.016087331226659014,0.0018108015409528666,0.006297787702283841,0.016661878770468257,2.3685972735685406e-08,0.01709443335929972,0.0
64,0.3,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Do 30-day and 1-year mortality rates in emergency general surgery laparotomies indicate a need for improvement? Answer: Mortality rates within 30 days and 1 year after emergency general surgery laparotomies remain problematic. These high rates emphasize the need for better perioperative care. Improvements in surgical procedures, patient selection, and postoperative management could reduce mortality.",1.6580180914979784e-07,0.15934585833146198,0.026377641715664604,0.012693985253473108,0.15326073741055524,0.02101593745406076,0.012675610786670066,0.15295323226890423,0.01922337562475971,1.6580180914979784e-07,0.12861737782209381,0.0
64,0.3,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is improvement needed in 30-day and 1-year mortality outcomes for emergency general surgery laparotomies? Answer: Mortality rates at 30 days and 1 year post-emergency general surgery laparotomies are still concerning. The high mortality rates suggest a need to enhance perioperative care. Advancing surgical techniques, improving patient selection, and optimizing postoperative care might help reduce these rates.",1.1842986367842703e-07,0.04412813806514393,0.029585551489727135,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
64,0.3,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Are 30-day and 1-year mortality rates after emergency general surgery laparotomies an issue that requires improvement? Answer: Mortality rates at 30 days and 1 year following emergency general surgery laparotomies remain a significant concern. The elevated mortality highlights the need for better perioperative care. Enhancing surgical methods, selecting patients carefully, and improving postoperative care could potentially reduce mortality.",7.105791820705622e-08,0.05513281302017603,0.0033362592098613447,0.005440279394345618,0.07683029577660072,0.01837944354358135,0.0054324046228586,0.07694100961913897,0.017851239669421492,7.105791820705622e-08,0.05310982531394792,0.0
64,0.3,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Should the high 30-day and 1-year mortality rates in emergency general surgery laparotomies be addressed? Answer: Mortality rates at 30 days and 1 year after emergency general surgery laparotomies remain high, raising concerns. This indicates a need for improvement in perioperative care. Better surgical techniques, improved patient selection, and enhanced postoperative care may help lower these rates.",9.474389094274162e-08,0.0742018628840353,0.004524874482835103,0.0072537058591274906,0.09539847836542492,0.019003416154085913,0.007243206163811466,0.09540961069360954,0.0181755829903978,9.474389094274162e-08,0.07145896398214369,0.0
64,0.3,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates for 30-day and 1-year post-emergency general surgery laparotomies remain an issue. Concerns arise due to high mortality rates, indicating a need for improvement in perioperative care. Enhanced surgical techniques, better patient selection, and improved post-operative care could potentially reduce these rates.","Question: Is there a need to improve 30-day and 1-year mortality rates in emergency general surgery laparotomies? Answer: Mortality rates within 30 days and 1 year post-emergency general surgery laparotomies continue to be an issue. The high mortality rates call for improvements in perioperative care. Advancements in surgical technique, patient selection, and postoperative management could reduce these mortality rates.",7.105791820705622e-08,0.04025270582439466,0.022683037883239304,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
65,0.3,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency double-balloon enteroscopy (DBE) is a practical, safe, and effective method for managing acute overt-obscure gastrointestinal bleeding (OGIB), potentially preventing the need for major surgery by diagnosing and treating most cases successfully. Using DBE alongside real-time capsule endoscopy (CE) viewing is particularly helpful in detecting recurrent bleeding from vascular lesions.",2.3685972735685406e-07,0.13872411660458717,0.033856571252693125,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
65,0.3,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In cases of acute overt-obscure gastrointestinal bleeding, emergency DBE proves to be a feasible, safe, and effective technique that can avoid major surgical interventions by diagnosing and treating the majority of patients. The combined use of DBE with real-time capsule endoscopy viewing is especially beneficial for identifying recurrent bleeding vascular lesions.",2.1317375462116866e-07,0.11852140928706856,0.033856571252693125,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
65,0.3,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency double-balloon enteroscopy is an effective and safe approach for acute OGIB, capable of diagnosing and treating most patients while potentially eliminating the need for major surgery. When combined with real-time capsule endoscopy viewing, it is particularly useful for detecting recurrent bleeding from vascular lesions.",3.552895910352811e-07,0.24635478079695217,0.033856571252693125,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
65,0.3,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","The use of emergency DBE in acute overt-obscure gastrointestinal bleeding is both feasible and safe, effectively diagnosing and treating most patients and possibly preventing major surgery. This method, combined with real-time capsule endoscopy viewing, is especially advantageous for identifying recurrent bleeding vascular lesions.",4.026615365066519e-07,0.2928747964318461,0.033856571252693125,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
65,0.3,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE is a safe, feasible, and effective procedure for acute OGIB that can diagnose and treat most cases, potentially avoiding major surgery. Combining this with real-time viewing from capsule endoscopy is particularly useful for spotting recurrent bleeding vascular lesions.",4.73719454713708e-07,0.36698276858556955,0.033856571252693125,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
65,0.3,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In acute overt-obscure gastrointestinal bleeding, emergency double-balloon enteroscopy is a feasible and safe method that effectively diagnoses and treats most patients, potentially circumventing the need for major surgery. The combined approach with real-time capsule endoscopy viewing aids significantly in identifying recurrent bleeding vascular lesions.",3.789755637709665e-07,0.2693442990216517,0.033856571252693125,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
65,0.3,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE offers a feasible, safe, and effective solution for acute OGIB, diagnosing and treating most patients while possibly avoiding major surgery. The combined use with real-time capsule endoscopy viewing is especially helpful in detecting recurrent bleeding from vascular lesions.",4.73719454713708e-07,0.36698276858556955,0.033856571252693125,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
65,0.3,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","For acute overt-obscure gastrointestinal bleeding, emergency double-balloon enteroscopy is a safe, feasible, and effective technique that can diagnose and treat most patients and may prevent major surgery. When paired with real-time capsule endoscopy viewing, it is particularly useful for identifying recurrent bleeding vascular lesions.",3.789755637709665e-07,0.2693442990216517,0.033856571252693125,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
65,0.3,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","Emergency DBE is an effective, safe, and feasible approach in acute OGIB, capable of diagnosing and treating most patients and potentially avoiding major surgery. The combined use with real-time viewing via capsule endoscopy is especially valuable for detecting recurrent bleeding vascular lesions.",4.263475092423373e-07,0.3169723480109061,0.033856571252693125,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
65,0.3,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as","In acute overt-obscure gastrointestinal bleeding, emergency double-balloon enteroscopy is a feasible, safe, and effective method that diagnoses and treats most patients, potentially avoiding major surgery. This combined approach with real-time capsule endoscopy viewing is particularly useful for identifying recurrent bleeding vascular lesions.",4.263475092423373e-07,0.3169723480109061,0.033856571252693125,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
66,0.3,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during ischemic stroke, potentially offering a greater treatment advantage for women.",2.3685972735685406e-07,0.19422150524599857,0.003587829580463598,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
66,0.3,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis could change the usual survival and recovery benefits men experience in ischemic stroke, with women possibly gaining a larger positive effect.",2.3685972735685406e-07,0.2231026377693297,0.024351829063588574,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
66,0.3,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the expected survival and recovery benefits typically seen in men, potentially providing a greater therapeutic benefit for women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.3,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the outcome of intravenous thrombolysis in ischemic stroke affected by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis might alter the natural survival and recovery advantage observed in men, with women possibly experiencing a larger beneficial effect.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.3,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex influence the therapeutic response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis may change the survival and recovery benefits usually expected in men, potentially resulting in a greater benefit for women.",2.8423167282822487e-07,0.23803682107885304,0.004492322423993712,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
66,0.3,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is intravenous thrombolysis response in ischemic stroke dependent on sex? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis could modify the survival and recovery advantage typically seen in men, with a possibly larger benefit for women.",3.789755637709665e-07,0.33187877394528265,0.006559287267083869,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
66,0.3,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does biological sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may alter the natural survival and recovery advantage for men, potentially yielding a greater beneficial effect in women.",3.079176455639103e-07,0.2606854352184591,0.004974671163918205,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
66,0.3,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is there a sex difference in response to intravenous thrombolysis for ischemic stroke? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might modify the expected survival and recovery benefits in men, with women potentially experiencing a larger positive treatment effect.",3.079176455639103e-07,0.2606854352184591,0.004974671163918205,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
66,0.3,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may influence the survival and recovery advantage typically observed in men, possibly providing a greater benefit to women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
66,0.3,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with","Is the effect of intravenous thrombolysis on ischemic stroke outcomes influenced by sex? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the survival and recovery benefits usually seen in men, with a potentially larger beneficial effect in women.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987416,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
67,0.3,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers release GABA? No, mossy fibers in the cerebellar neuronal circuit do not release GABA; they mainly release glutamate, an excitatory neurotransmitter, whereas GABA is inhibitory and not linked to mossy fibers.",2.8423167282822413e-07,0.32135730697955545,0.008062693698347109,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
67,0.3,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are GABA neurotransmitters released by mossy fibers? No, mossy fibers, which are components of the cerebellum's neuronal network, release glutamate, an excitatory neurotransmitter, not GABA, which is inhibitory and not usually connected to mossy fibers.",2.6054570009253883e-07,0.24949542379593792,0.02221074380165289,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
67,0.3,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by mossy fibers? No, mossy fibers in the cerebellum release glutamate, an excitatory neurotransmitter, rather than GABA, which is inhibitory and not commonly associated with these fibers.",3.7897556377096533e-07,0.4085601184256267,0.02221074380165289,0.02901482343651001,0.45198512374305766,0.0,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
67,0.3,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers secrete GABA? No, mossy fibers, part of the cerebellar neuronal circuit, primarily release glutamate, an excitatory neurotransmitter, and do not release GABA, which is an inhibitory neurotransmitter.",3.7897556377096533e-07,0.4085601184256267,0.02221074380165289,0.02901482343651001,0.45198512374305766,0.0,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
67,0.3,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers responsible for releasing GABA? No, mossy fibers in the cerebellum release glutamate, an excitatory neurotransmitter, not GABA, which is inhibitory and not typically released by them.",4.0266153650665063e-07,0.4931619511340348,0.013454551122901285,0.03082824990129189,0.48835276791393234,0.0,0.030783626196198795,0.5031035776720798,0.0,4.026615365066519e-07,0.5187937934151678,0.0
67,0.3,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers emit GABA? No, in the cerebellar neuronal circuit, mossy fibers release glutamate, an excitatory neurotransmitter, and do not release GABA, which is inhibitory and not usually associated with mossy fibers.",3.0791764556390943e-07,0.35344174439737097,0.009006737988149414,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
67,0.3,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Is GABA released by mossy fibers in the cerebellum? No, mossy fibers release glutamate, an excitatory neurotransmitter, and not GABA, which is an inhibitory neurotransmitter not typically linked to mossy fibers.",3.5528959103528003e-07,0.42086837878727446,0.011082954176944024,0.02720139697172813,0.41689380393178865,0.0,0.027162023114293048,0.42899560551835814,0.0,3.552895910352811e-07,0.4418327522790384,0.0
67,0.3,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers discharge GABA? No, mossy fibers, which are part of the cerebellar neuronal circuit, release glutamate, an excitatory neurotransmitter, rather than GABA, which is inhibitory and not commonly linked to mossy fibers.",2.8423167282822413e-07,0.2793483869456197,0.02221074380165289,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
67,0.3,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Are mossy fibers GABAergic? No, mossy fibers in the cerebellum release glutamate, an excitatory neurotransmitter, and do not release GABA, which is inhibitory and not typically associated with these fibers.",3.7897556377096533e-07,0.4563633722573468,0.0122280317085512,0.02901482343651001,0.45198512374305766,0.0,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
67,0.3,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers, which are part of the neuronal circuit in the cerebellum, do not release GABA. They primarily release glutamate, which is an excitatory neurotransmitter. GABA is an inhibitory neurotransmitter that is not typically associated with mossy fibers.","Do mossy fibers produce GABA? No, mossy fibers, components of the cerebellar neuronal circuit, do not produce GABA; they primarily release glutamate, an excitatory neurotransmitter, while GABA is inhibitory and not typically linked to mossy fibers.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
68,0.3,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential to understand and clarify gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.3,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is key to identifying and explaining how mortality risks linked to marital status differ by gender. The influence of living alone compared to living with a partner seems to vary between males and females.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
68,0.3,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is vital for uncovering and explaining gender-specific differences in mortality risks associated with marital status. The impact of living alone and cohabiting with a partner appears to differ for men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.3,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements plays a crucial role in recognizing and explaining gender differences in mortality risks by marital status. The effects of living alone versus living with a partner seem to be distinct in men and women.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
68,0.3,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is important for identifying and explaining how mortality risks related to marital status vary between genders. The impact of living alone and living with a partner appears to differ between men and women.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.3,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is essential to understanding and explaining gender disparities in mortality risks by marital status. The influence of living alone and living with a partner seems to differ between men and women.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
68,0.3,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is critical for identifying and explaining gender differences in mortality risks associated with marital status. The effects of living alone compared to living with a partner appear to be different for men and women.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
68,0.3,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is fundamental for recognizing and explaining gender-specific mortality risk differences by marital status. The impact of living alone and living with a partner seems to vary between men and women.",2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.3,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Reviewing living arrangements is key to identifying and explaining gender differences in mortality risks linked to marital status. The effects of living alone versus living with a partner appear to differ between men and women.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
68,0.3,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Studying living arrangements is crucial for understanding and explaining gender disparities in mortality risks related to marital status. The influence of living alone and living with a partner seems to be different in men and women.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
69,0.3,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Are aromatase inhibitor-related musculoskeletal symptoms primarily addressed by preventing osteoporosis? While osteoporosis prevention can reduce some symptoms, other factors like lifestyle, health, and treatments are also important.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.3,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the key to eliminating musculoskeletal symptoms from aromatase inhibitors through osteoporosis prevention? Preventing osteoporosis helps but managing symptoms also depends on lifestyle, health, and other treatments.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.3,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis fully resolve aromatase inhibitor-related musculoskeletal symptoms? It helps, but patient lifestyle, health status, and concurrent therapies are also critical.",9.474389094274142e-07,0.9981730152472714,0.049048751486325794,0.07253705859127502,1.0755073826494446,0.016661878770468257,0.07243206163811478,1.1330984647392786,0.0,9.47438909427416e-07,1.1700712526502541,0.0
69,0.3,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can osteoporosis prevention alone eliminate musculoskeletal symptoms caused by aromatase inhibitors? It contributes, but other factors including overall health and treatments matter too.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
69,0.3,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is stopping osteoporosis the main way to get rid of musculoskeletal symptoms linked to aromatase inhibitors? It aids symptom relief, yet lifestyle and medical factors also influence outcomes.",8.053230730133024e-07,0.7468585869663635,0.049048751486325794,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
69,0.3,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.",Are musculoskeletal symptoms from aromatase inhibitors best managed by preventing osteoporosis? Prevention helps but comprehensive management includes lifestyle and health considerations.,9.711248821630995e-07,1.0469631794167027,0.049048751486325794,0.07435048505605689,1.1268006770369947,0.016661878770468257,0.07424286317906764,1.1871656860095539,0.0,9.711248821631014e-07,1.227229666490203,0.0
69,0.3,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is osteoporosis prevention sufficient to eliminate aromatase inhibitor-related musculoskeletal symptoms? It is beneficial, but other elements like patient health and treatments are essential.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
69,0.3,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Does preventing osteoporosis solve all musculoskeletal symptoms related to aromatase inhibitors? It alleviates some symptoms, but lifestyle and concurrent treatments also play roles.",9.237529366917289e-07,0.9516529996123775,0.049048751486325794,0.07072363212649313,1.0267172184800133,0.016661878770468257,0.07062126009716191,1.0818051703517284,0.0,9.237529366917307e-07,1.1160040313799788,0.0
69,0.3,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Is the prevention of osteoporosis the key factor in addressing musculoskeletal symptoms from aromatase inhibitors? It is important, though other health and lifestyle factors are also involved.",8.290090457489877e-07,0.7845989149492105,0.049048751486325794,0.06346992626736561,0.8523638313352349,0.016661878770468257,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
69,0.3,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Aromatase inhibitor-related musculoskeletal symptoms are a significant issue for some patients. While preventing osteoporosis can help alleviate some of these symptoms, it's not the only solution. Other factors such as patient lifestyle, overall health, and concurrent medical treatments also play a crucial role in managing these symptoms.","Can musculoskeletal symptoms caused by aromatase inhibitors be eliminated solely by preventing osteoporosis? Prevention helps, but overall health and treatment factors are equally important.",9.000669639560436e-07,0.9072012370415434,0.049048751486325794,0.06891020566171124,0.9801972028451194,0.016661878770468257,0.06881045855620903,1.0330150061822971,0.0,9.000669639560454e-07,1.0647107369924287,0.0
70,0.3,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in younger individuals might represent a distinct clinical entity. Additional studies are required to confirm our results and determine the best treatment strategy for this group.,0.0,0.03554600925948437,0.025256675594513445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
70,0.3,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer among young patients could be considered a distinct clinical entity. More research is necessary to validate our observations and establish the optimal management for this population.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.3,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in the young a different clinical entity? Answer: Colorectal cancer in young patients may be a distinct clinical entity. Further investigation is needed to confirm these findings and to identify the best approach for this demographic.,0.0,0.03554600925948437,0.025256675594513445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
70,0.3,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a unique clinical entity? Answer: Colorectal cancer in young individuals might constitute a distinct clinical entity. Additional research is essential to verify our findings and to define the ideal treatment approach for this group.,4.7371945471370706e-08,0.05521227558824604,0.0036742074484456683,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
70,0.3,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a distinct clinical condition? Answer: Colorectal cancer in younger patients may represent a unique clinical entity. Further studies are required to validate our findings and to determine the most effective management for this population.,2.36859727356853e-08,0.09729847673474801,0.051405325443786974,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.3,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients form a separate clinical entity? Answer: Colorectal cancer in young patients could be a distinct clinical entity. More research is needed to confirm our findings and to establish optimal care strategies for this group.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.0441811108194079,0.05009232205178152,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,0.3,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Colorectal cancer among young patients might be a distinct clinical entity. Further research is necessary to validate these findings and to define the best treatment approach for this population.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.3,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young individuals be a distinct clinical entity? Answer: Colorectal cancer in young patients may constitute a unique clinical entity. Additional studies are needed to confirm our results and to identify the optimal management approach for this group.,4.7371945471370706e-08,0.05521227558824604,0.0036742074484456683,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
70,0.3,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young people a distinct clinical entity? Answer: Colorectal cancer in young patients might represent a distinct clinical entity. Further investigation is required to validate our findings and to determine the best approach for this population.,0.0,0.07109201851896785,0.04904363706266815,0.0,0.07296286111157402,0.05207078010166813,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.3,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a unique clinical entity? Answer: Colorectal cancer among young patients may be considered a distinct clinical entity. More research is necessary to confirm these findings and to define the optimal treatment strategy for this group.,7.105791820705611e-08,0.11473198273599206,0.02888888888888888,0.005440279394345618,0.11246733753370775,0.026296566837107373,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
71,0.3,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.3,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the dimension of compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The current study results suggest that septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after a year.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
71,0.3,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the compensatory hypertrophy size of the middle turbinate? Answer: According to the present study, compensatory hypertrophy of the middle turbinate remains unchanged by septoplasty, even one year post-operation.",7.10579182070559e-08,0.06343738469967075,0.01989229024943312,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.3,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the dimensions of compensatory hypertrophy in the middle turbinate? Answer: The studys findings show that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.3,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty affect the size of compensatory hypertrophy of the middle turbinate? Answer: This study suggests that septoplasty does not change the compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.07081796270702423,0.00689342403628114,0.003626852929563759,0.07065111569757931,0.005663265306122434,0.003621603081905747,0.07031474764223633,0.004104308390022647,4.737194547137081e-08,0.06977545539104257,0.0022165532879818914
71,0.3,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The present research indicates that septoplasty has no effect on compensatory hypertrophy of the middle turbinate, even after one year.",7.10579182070559e-08,0.10815655763902221,0.010644718792866922,0.005440279394345639,0.10791285581450571,0.008765432098765416,0.005432404622858621,0.10740318290669926,0.006364883401920436,7.105791820705622e-08,0.1065740342677306,0.0034430727023319757
71,0.3,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study suggest that compensatory hypertrophy of the middle turbinate is unaffected by septoplasty, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.3,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does the size of compensatory hypertrophy of the middle turbinate change following septoplasty? Answer: The study findings indicate no change in compensatory hypertrophy of the middle turbinate after septoplasty, even one year later.",2.36859727356853e-08,0.07680410906996382,0.031128117913832118,0.0018134264647818796,0.07803169370493279,0.032448979591836694,0.0018108015409528735,0.07926281956263947,0.033441043083900245,2.3685972735685406e-08,0.08049027395829977,0.034104308390022674
71,0.3,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty cause changes in the compensatory hypertrophy dimensions of the middle turbinate? Answer: According to the current study, septoplasty does not alter compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.007213730997908563,0.025555555555555554,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.3,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in compensatory hypertrophy of the middle turbinate after septoplasty? Answer: The present study findings suggest no effect of septoplasty on compensatory hypertrophy of the middle turbinate, even after one year.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
72,0.3,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the nature of general practice affect the adoption of IT innovations in primary care? Yes, characteristics like practice size, staff tech skills, leadership, openness to change, and infrastructure play a key role in adopting IT innovations in primary care.",4.500334819780226e-07,0.3601096307000655,0.02568211702827085,0.03445510283085558,0.4054651081081633,2.7755575615628914e-17,0.034405229278104466,0.4519011932563264,0.027006172839506164,4.500334819780227e-07,0.4238142467763608,0.0
72,0.3,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do features of general practice impact the uptake of IT innovations in primary care? Indeed, factors such as the size of the practice, technological proficiency of staff, leadership approach, readiness for change, and available infrastructure influence IT adoption in primary care.",4.263475092423373e-07,0.26281115396531796,0.07708744247205782,0.03264167636607371,0.30652676059333217,0.05246913580246911,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
72,0.3,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are general practice attributes influential in the adoption of IT innovations in primary care? Yes, elements like practice scale, staff technology literacy, leadership style, change willingness, and infrastructure affect how IT innovations are embraced in primary care.",5.210914001850785e-07,0.41053066399069715,0.04670768411785177,0.0398953822252012,0.4147403452335632,0.05246913580246911,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
72,0.3,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does general practice profile affect IT innovation uptake in primary care? Yes, aspects including practice size, staff's tech knowledge, leadership methods, willingness to adapt, and infrastructure significantly impact IT adoption in primary care.",6.158352911278197e-07,0.49461904503652887,0.07085352412735743,0.047149088084328716,0.53610120223783,0.05246913580246911,0.047080840064774566,0.6241543090729946,0.0,6.158352911278206e-07,0.6400373552459979,0.0
72,0.3,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Can characteristics of general practice determine the uptake of IT innovations in primary care? Yes, factors such as the size of the practice, staff technological skills, leadership style, openness to change, and infrastructure influence the adoption of IT systems in primary care.",4.026615365066519e-07,0.2710852975235296,0.0534188034188034,0.030828249901291835,0.28120895260904044,0.05246913580246911,0.030783626196198732,0.3617900446055051,0.0,4.026615365066519e-07,0.3697470255060846,0.0
72,0.3,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice traits influence the acceptance of IT innovations in primary care? Yes, practice size, staff tech literacy, leadership approach, readiness for change, and infrastructure all affect IT innovation uptake in primary care.",5.921493183921344e-07,0.46253460761871334,0.07179756841715974,0.04533566161954684,0.5043525039232502,0.05246913580246911,0.04527003852382169,0.5913644862500029,0.0,5.921493183921352e-07,0.6061358035703162,0.0
72,0.3,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Is the uptake of IT innovation in primary care affected by general practice characteristics? Yes, variables like practice size, staff technology literacy, leadership style, willingness to change, and infrastructure impact IT adoption in primary care.",5.684633456564491e-07,0.43144608799744555,0.0726862492596758,0.04352223515476496,0.47358084525649646,0.05246913580246911,0.04345923698286882,0.5596157879354231,0.0,5.684633456564497e-07,0.5733459807473245,0.0
72,0.3,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Do general practice factors affect the adoption of IT innovations in primary care? Yes, characteristics such as practice size, staff's technological skills, leadership style, openness to change, and infrastructure influence IT innovation uptake in primary care.",5.447773729207638e-07,0.40129359787955554,0.07352429311439158,0.04170880868998308,0.4437278821068147,0.05246913580246911,0.041648435441915946,0.5288441292686694,0.0,5.447773729207643e-07,0.5415972824327446,0.0
72,0.3,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Are the characteristics of general practice important for the uptake of IT innovations in primary care? Yes, factors including practice size, staff tech literacy, leadership style, willingness to change, and infrastructure play a significant role in IT adoption in primary care.",4.263475092423373e-07,0.26281115396531796,0.07708744247205782,0.03264167636607371,0.30652676059333217,0.05246913580246911,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
72,0.3,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics significantly influence the uptake of an IT innovation in primary care. Factors such as practice size, staff's technological literacy, leadership style, willingness to change, and infrastructure can impact the adoption rate and integration of a new IT system.","Does the uptake of IT innovations in primary care depend on general practice characteristics? Yes, aspects like practice size, staff technological literacy, leadership style, readiness to change, and infrastructure affect how IT innovations are adopted in primary care.",4.974054274493932e-07,0.38105016673783787,0.048193454896751566,0.038081955760419325,0.38656946826686633,0.05246913580246911,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
73,0.3,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa serves as a pathognomonic endoscopic sign for primary eosinophilic esophagitis, characterized by a delicate esophageal lining prone to tearing or a crepe-paper appearance during endoscopy, reflecting a high eosinophil count.",1.8948778188548325e-07,0.03901165235158244,0.10783179012345678,0.014507411718254981,0.06585945876344335,0.05943591682419662,0.014486412327622933,0.08813666263107267,0.04683962617257141,1.8948778188548325e-07,0.11106515216600643,0.0330973646827217
73,0.3,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does fragility of the esophageal mucosa represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Indeed, the fragile nature of the esophageal mucosa is a hallmark endoscopic feature of primary eosinophilic esophagitis, showing reduced mucosal resilience that may cause tearing or a crepe-paper-like esophagus during endoscopy due to eosinophil infiltration.",2.1317375462116866e-07,0.062043531834651944,0.10587408172635451,0.016320838183036854,0.08824697856964825,0.05817777777777779,0.0162972138685758,0.08092343148692249,0.06716098723117257,2.1317375462116866e-07,0.10307573268229131,0.05436390532544381
73,0.3,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is esophageal mucosa fragility an endoscopic hallmark of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, indicating a weakened esophageal lining that can tear or appear crepe-paper-like during endoscopy, associated with elevated eosinophils.",3.789755637709665e-07,0.17375662917864965,0.13559130506245892,0.029014823436509962,0.19304458279152836,0.096025,0.028972824655245866,0.21269595437836575,0.08842752787389467,3.789755637709665e-07,0.2681554830417414,0.05436390532544381
73,0.3,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Yes, the esophageal mucosa's fragility is a distinctive endoscopic sign of primary eosinophilic esophagitis, manifesting as a delicate lining prone to tearing or crepe-paper texture during endoscopy, linked to high eosinophil levels.",2.6054570009253947e-07,0.10973574348107329,0.10172193877551021,0.0199476911126006,0.13457369723061863,0.055500054083288244,0.019918816950481533,0.15652600143842177,0.04407923149747499,2.6054570009253947e-07,0.17903418527857662,0.0316489242545947
73,0.3,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the fragile nature of the esophageal mucosa a diagnostic endoscopic sign of primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic feature of primary eosinophilic esophagitis, where the mucosa lacks resilience, leading to tearing or a crepe-paper appearance during endoscopy, indicative of eosinophil accumulation.",2.3685972735685406e-07,0.08560987337650294,0.10383897452076199,0.018134264647818726,0.1111438643115239,0.05686694214876034,0.018108015409528666,0.10307084594059601,0.06669913281216627,2.3685972735685406e-07,0.12505463940106631,0.05436390532544381
73,0.3,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the fragility of the esophageal mucosa indicate primary eosinophilic esophagitis in endoscopy? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, characterized by a fragile lining that may tear or resemble crepe paper during endoscopy due to a high concentration of eosinophils.",2.3685972735685406e-07,0.08560987337650294,0.10383897452076202,0.018134264647818726,0.1111438643115239,0.05686694214876034,0.018108015409528666,0.1332076798779851,0.04503909812182855,2.3685972735685406e-07,0.155861180759286,0.03215316152379091
73,0.3,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is the esophageal mucosa's fragility a specific endoscopic sign of primary eosinophilic esophagitis? Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, showing a delicate mucosal lining prone to tearing or a crepe-paper-like appearance during endoscopy, reflecting eosinophilic infiltration.",3.079176455639103e-07,0.15977543868851773,0.09722222222222224,0.023574544042164344,0.18313502806564141,0.05258322427126706,0.023540420032387266,0.20485410029268802,0.042026576059498465,3.079176455639103e-07,0.22705451948610955,0.030568545420625252
73,0.3,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Can the fragility of the esophageal mucosa be used as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, presenting as a fragile esophageal lining that tears easily or appears crepe-paper-like during endoscopy due to eosinophil presence.",1.8948778188548325e-07,0.14991520124117352,0.03527063090752858,0.014507411718254981,0.12244290207445951,0.01967685950413227,0.014486412327622933,0.1170177951544038,0.026205305651672464,1.8948778188548325e-07,0.11106515216600643,0.0330973646827217
73,0.3,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Is fragility of the esophageal mucosa a definitive endoscopic marker for primary eosinophilic esophagitis? Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, characterized by a delicate mucosa prone to tearing or crepe-paper appearance during endoscopy, indicating eosinophilic infiltration.",3.079176455639103e-07,0.15977543868851773,0.09722222222222224,0.023574544042164344,0.18313502806564141,0.05258322427126706,0.023540420032387266,0.20485410029268802,0.042026576059498465,3.079176455639103e-07,0.22705451948610955,0.030568545420625252
73,0.3,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Yes, the fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis. This condition manifests as a lack of resilience in the esophageal lining, which can lead to tearing or crepe-paper esophagus during endoscopy, indicating a high concentration of eosinophils.","Does the presence of esophageal mucosa fragility confirm primary eosinophilic esophagitis in endoscopy? Yes, fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis, marked by a fragile esophageal lining that can tear or show a crepe-paper texture during endoscopy, due to high eosinophil concentration.",2.3685972735685406e-07,0.0010335241934904538,0.16500932052089898,0.018134264647818726,0.022656990197488458,0.1204,0.018108015409528666,0.07293401200320737,0.08842752787389467,2.3685972735685406e-07,0.12505463940106631,0.05436390532544381
74,0.3,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering required before scoliosis surgery in patients with myelomeningocele? The study indicates that untethering might not be needed for MM patients undergoing scoliosis correction if they lack clinical signs of tethered cord, despite radiographic evidence of tethering.",2.6054570009253936e-07,0.248461359298501,0.0,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
74,0.3,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele, is untethering necessary prior to scoliosis correction? Research suggests that spinal cord untethering may be unnecessary in MM patients having scoliosis surgery who show no clinical symptoms of tethered cord, even if imaging shows tethering.",2.6054570009253936e-07,0.248461359298501,0.0,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
74,0.3,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need spinal cord untethering before scoliosis correction? The findings imply that untethering may not be required in MM patients undergoing scoliosis correction without clinical tethered cord symptoms, despite radiographic tethering.",3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
74,0.3,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is untethering essential before scoliosis correction? The study results suggest that spinal cord untethering might be unnecessary if the patient has no clinical signs of tethered cord, even when tethering is visible on imaging.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.3,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to perform spinal cord untethering prior to scoliosis correction in myelomeningocele patients? According to the study, untethering may not be needed for MM patients undergoing scoliosis surgery who do not exhibit clinical symptoms of tethered cord, despite radiographic evidence.",2.1317375462116866e-07,0.19845093872383757,0.0,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.3,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should spinal cord untethering be done before scoliosis correction in patients with myelomeningocele? The research suggests that untethering may be unnecessary if the patient lacks clinical symptoms of tethered cord, even if imaging shows tethering.",3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
74,0.3,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For myelomeningocele patients, is untethering required before scoliosis correction? The study indicates that spinal cord untethering may not be necessary in patients undergoing scoliosis surgery who do not have clinical signs of tethered cord, despite radiographic tethering.",3.3160361829959526e-07,0.32850406697203516,0.0,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
74,0.3,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering mandatory prior to scoliosis correction in patients with myelomeningocele? Study findings suggest that untethering might be unnecessary in MM patients without clinical tethered cord symptoms, even if tethering is seen on radiographs.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.3,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does scoliosis correction in myelomeningocele patients require prior untethering? The study suggests that spinal cord untethering may not be necessary if there are no clinical symptoms of tethered cord, despite radiographic evidence.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.3,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering needed before scoliosis surgery in patients with myelomeningocele? According to the study, untethering may be unnecessary for MM patients without clinical signs of tethered cord, even when tethering is present on imaging.",3.5528959103528056e-07,0.356674943938732,0.0,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
75,0.3,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: Although bile duct sludge and stones are alike, their clinical implications differ. Bile duct sludge, which is thickened bile fluid, typically leads to temporary blockage and usually clears on its own. However, bile duct",1.4211583641411244e-07,0.12524404565620362,0.02628660189849008,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.3,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does the clinical relevance of bile duct sludge differ from that of bile duct stones? Answer: Bile duct sludge and stones share similarities but differ in clinical impact. Bile duct sludge, a concentrated bile fluid, often results in transient obstruction and tends to resolve spontaneously. However, bile duct",1.4211583641411244e-07,0.09695232400069598,0.00060234773385337,0.010880558788691236,0.07576912757786136,0.04158790170132326,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.3,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Is the clinical significance of bile duct sludge distinct from bile duct stones? Answer: While bile duct sludge and stones are similar, their clinical significance varies. Bile duct sludge, characterized by thickened bile fluid, frequently causes temporary blockage and resolves without intervention. However, bile duct",4.737194547137081e-08,0.007833200048292355,0.03813280736357649,0.0036268529295637453,0.015013325609441353,0.02271498107084911,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
75,0.3,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What distinguishes the clinical significance of bile duct sludge from bile duct stones? Answer: Bile duct sludge and stones are comparable but have different clinical roles. Bile duct sludge, a viscous bile fluid, often leads to short-term obstruction and typically resolves on its own. However, bile duct",9.474389094274162e-08,0.07537900542299036,0.009147445960632938,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
75,0.3,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Can the clinical importance of bile duct sludge be considered different from bile duct stones? Answer: Although bile duct sludge and stones resemble each other, their clinical significance is not the same. Bile duct sludge, which is thickened bile, often causes temporary blockage and usually clears spontaneously. However, bile duct",1.6580180914979784e-07,0.14929715457506543,0.034304916356198756,0.012693985253473108,0.12585895817175086,0.020399305555555556,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
75,0.3,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: Bile duct sludge and stones, despite their similarities, have distinct clinical significance. Bile duct sludge, a thick bile fluid, commonly causes transient obstruction and resolves on its own. However, bile duct",2.3685972735685406e-08,0.004263900361972439,0.019723865877711633,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,0.3,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones are similar but differ clinically. Bile duct sludge, a thickened bile fluid, often results in temporary obstruction and tends to resolve spontaneously. However, bile duct",7.105791820705622e-08,0.019372652701599602,0.027762984878369423,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.03911087718850137,0.02271498107084911,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: While bile duct sludge and stones share similarities, their clinical significance differs. Bile duct sludge, a thick bile fluid, frequently causes temporary blockage and usually resolves on its own. However, bile duct",7.105791820705622e-08,0.019372652701599602,0.027762984878369423,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: How does bile duct sludge's clinical significance compare to that of bile duct stones? Answer: Bile duct sludge and stones are alike but have different clinical implications. Bile duct sludge, characterized by thickened bile fluid, often leads to transient obstruction and resolves spontaneously. However, bile duct",7.105791820705622e-08,0.07964632057637688,0.027854928953830294,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge and stones, though similar, have different clinical significance. Bile duct sludge, a thickened bile fluid, often causes temporary obstruction and resolves spontaneously. However, bile duct","Question: Is there a clinical difference between bile duct sludge and bile duct stones? Answer: Bile duct sludge and stones, although similar, differ in clinical significance. Bile duct sludge, a thickened bile fluid, commonly causes temporary obstruction and typically resolves on its own. However, bile duct",4.737194547137081e-08,0.007833200048292355,0.03813280736357649,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
76,0.3,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Do quantitative real-time PCR assays for BCRABL detection yield comparable results across different labs despite methodological differences? Yes, if the same positive control cell line and quality control gene are used, results can be correlated, highlighting the need for assay standardization between labs.",5.684633456564497e-07,0.409976203709121,0.0302734375,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
76,0.3,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection produce correlated results? The findings indicate that despite methodological variations, comparable results are achievable if labs use the same positive control cell line and quality control gene, emphasizing assay standardization.",6.395212638635059e-07,0.48408417586284447,0.0302734375,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
76,0.3,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are correlated results possible from homebrew quantitative real-time PCR assays for BCRABL detection? The data suggest that with consistent use of a positive control cell line and quality control gene, different labs can achieve comparable outcomes, underscoring the importance of assay standardization.",5.921493183921352e-07,0.43407375528818104,0.0302734375,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
76,0.3,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it feasible to get comparable quantitative real-time PCR results for BCRABL detection from different homebrew assays? Yes, provided the same positive control cell line and quality control gene are employed, which stresses the necessity for assay standardization among laboratories.",6.395212638635059e-07,0.48408417586284447,0.0302734375,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
76,0.3,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can quantitative real-time PCR assays for detecting BCRABL transcripts be comparable across labs using homebrew methods? The evidence shows that despite methodological differences, results can be correlated if the same positive control cell line and quality control gene are used, making assay standardization essential.",5.447773729207643e-07,0.3864457062989266,0.0302734375,0.04170880868998307,0.4153900460565776,0.015380859375,0.04164843544191593,0.44531101665536355,0.0,5.447773729207643e-07,0.454255272277599,0.0
76,0.3,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Do different laboratories achieve comparable BCRABL detection results using quantitative real-time PCR with homebrew assays? Results suggest yes, if they use the same positive control cell line and quality control gene, highlighting the need for assay standardization.",7.105791820705618e-07,0.5641268835363786,0.0302734375,0.05440279394345618,0.597711602850532,0.015380859375,0.054324046228586005,0.6325225587435095,0.0,7.105791820705622e-07,0.646627164925055,0.0
76,0.3,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are the results of quantitative real-time PCR for BCRABL detection consistent across labs with varying homebrew assays? They can be, as long as the same positive control cell line and quality control gene are utilized, which points to the importance of standardizing assays.",5.684633456564497e-07,0.409976203709121,0.0302734375,0.04352223515476494,0.4394875976356376,0.015380859375,0.0434592369828688,0.47000362924573524,0.0,5.684633456564497e-07,0.4795730802618907,0.0
76,0.3,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Is it possible to obtain correlated BCRABL transcript detection results from different quantitative real-time PCR homebrew assays? The findings imply that comparable results are possible if the same positive control cell line and quality control gene are applied, necessitating assay standardization.",6.158352911278206e-07,0.45876636787855274,0.0302734375,0.04714908808432869,0.48949801821030103,0.015380859375,0.04708084006477453,0.521296923633285,0.0,6.158352911278206e-07,0.5322168137473096,0.0
76,0.3,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Can homebrew quantitative real-time PCR assays for BCRABL detection produce consistent results across laboratories? The data suggest that with the use of the same positive control cell line and quality control gene, results can be comparable, underscoring the imperative of assay standardization.",5.921493183921352e-07,0.43407375528818104,0.0302734375,0.045335661619546816,0.4641802102260093,0.015380859375,0.045270038523821665,0.495321437230027,0.0,5.921493183921352e-07,0.5055485666651487,0.0
76,0.3,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not only for","Are comparable results achievable from quantitative real-time PCR assays for BCRABL detection across labs despite methodological differences? Yes, if the same positive control cell line and quality control gene are used, indicating the critical need for assay standardization among laboratories.",6.395212638635059e-07,0.48408417586284447,0.0302734375,0.04896251454911056,0.515473504613559,0.015380859375,0.0488916416057274,0.5479651707154458,0.0,6.39521263863506e-07,0.5596157879354249,0.0
77,0.3,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex appear in cervical disk disease? Answer: Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a link to pH levels. Further investigation of FAC as a diagnostic biomarker or treatment option is warranted.",4.737194547137081e-08,0.01282309223879885,0.019599999999999996,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
77,0.3,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex found in cervical disk disease? Answer: Analysis of injured cervical intervertebral disks biochemically identifies inflammatory markers including MCP, structural matrix protein fragments like FAC, and a correlation with pH. FAC is being further assessed as a diagnostic marker or therapeutic target.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.3,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex detected in cervical disk disease? Answer: Biochemical examination of injured cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and an association with pH. FAC is under further evaluation as a potential diagnostic biomarker or therapy.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
77,0.3,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does cervical disk disease involve the fibronectin-aggrecan complex? Answer: Biochemical analysis of injured cervical intervertebral disks shows inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is being further studied as a diagnostic biomarker or therapeutic agent.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.3,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Answer: Injured cervical intervertebral disks biochemically exhibit inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a pH correlation. FAC is further evaluated as a diagnostic or therapeutic biomarker.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.3,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex involved in cervical disk disease? Answer: Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a link to pH. FAC is being further explored as a diagnostic biomarker or treatment option.",9.474389094274162e-08,0.05449578863936777,0.019599999999999996,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
77,0.3,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex associated with cervical disk disease? Answer: Biochemical studies of injured cervical intervertebral disks detect inflammatory markers including MCP, fragments of structural matrix proteins like FAC, and a correlation with pH. FAC is under further evaluation as a diagnostic or therapeutic biomarker.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999996,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
77,0.3,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Does the fibronectin-aggrecan complex exist in cervical disk disease? Answer: Analysis of injured cervical intervertebral disks biochemically reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a pH association. FAC is further studied as a diagnostic biomarker or therapy.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999996,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
77,0.3,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex identified in cervical disk disease? Answer: Biochemical examination of injured cervical intervertebral disks shows inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is being further evaluated as a diagnostic or therapeutic biomarker.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
77,0.3,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic","Question: Is the fibronectin-aggrecan complex detectable in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is further assessed as a potential diagnostic biomarker or treatment.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999996,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
78,0.3,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis a precursor to bronchiectasis? A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. However, it is still unclear if this mechanism drives the progression from PBB to bronchiectasis.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.3,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis lead to bronchiectasis? A weakened phagocytic activity of alveolar macrophages against apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis alike. Whether this process promotes the transition from PBB to bronchiectasis is yet to be determined.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis act as an early indicator for bronchiectasis? Reduced phagocytic host responses by alveolar macrophages to apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in both conditions. The role of this mechanism in the progression from PBB to bronchiectasis remains unknown.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the dysfunction of alveolar macrophage phagocytosis in children with protracted bacterial bronchitis a potential forerunner to bronchiectasis? A compromised alveolar macrophage response to apoptotic cells or NTHi may underlie neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It is still uncertain if this dysfunction facilitates the advancement of PBB into bronchiectasis.,7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.3,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could impaired alveolar macrophage phagocytic function in children with protracted bacterial bronchitis be a precursor to bronchiectasis? A reduced phagocytic response to apoptotic cells or NTHi by alveolar macrophages might contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this contributes to PBB progressing into bronchiectasis is not yet known.,4.737194547137081e-08,0.013369432360373246,0.03631185475258099,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.3,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early step towards bronchiectasis? A diminished host phagocytic response to apoptotic cells or NTHi by alveolar macrophages may lead to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The involvement of this mechanism in PBB's progression to bronchiectasis remains unclear.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.3,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis precede bronchiectasis? A reduced phagocytic response to apoptotic cells or NTHi by alveolar macrophages could contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It is unknown if this mechanism also drives the progression from PBB to bronchiectasis.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.3,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis a potential precursor to bronchiectasis? Reduced alveolar macrophage phagocytosis of apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism influences the progression from PBB to bronchiectasis remains to be established.,4.737194547137081e-08,0.013369432360373246,0.03631185475258099,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.3,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis serve as an early marker for bronchiectasis? A decreased phagocytic response to apoptotic cells or NTHi by alveolar macrophages might promote neutrophilic inflammation and NTHi colonization in both conditions. The role of this dysfunction in the progression from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.00638944757401072,0.017799928800284807,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis linked to the onset of bronchiectasis? A weakened alveolar macrophage response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism also plays a part in PBB progressing to bronchiectasis remains uncertain.,7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
79,0.3,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,1.011714496651741,0.136444776777417,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.3,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women?,7.342651548062452e-07,0.9868014430111844,0.20745069393718035,0.05621622040823819,1.1473358509176652,0.09204470742932283,0.05613484776953903,1.2737603282888132,0.047500000000000014,7.34265154806247e-07,1.3771749161219726,0.024375
79,0.3,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Can biochemical markers of bone turnover serve as true representatives of bone histomorphometry in 370 postmenopausal women?,6.63207236599189e-07,0.8658054758029334,0.14522847171495812,0.05077594101389256,0.9241922996034555,0.09204470742932283,0.050702443146680404,1.0325982714719255,0.047500000000000014,6.63207236599191e-07,1.114810651654481,0.024375
79,0.3,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women?,6.63207236599189e-07,0.7791620782329405,0.20745069393718035,0.05077594101389256,0.9241922996034555,0.09204470742932283,0.050702443146680404,1.0325982714719255,0.047500000000000014,6.63207236599191e-07,1.114810651654481,0.024375
79,0.3,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover valid proxies for bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.3,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Do biochemical markers of bone turnover correspond well with bone histomorphometry findings in 370 postmenopausal women?,6.868932093348744e-07,0.8437005993705111,0.20745069393718035,0.05258936747867444,0.9931851710904076,0.09204470742932283,0.052513244687633284,1.1067062436256467,0.047500000000000014,6.868932093348764e-07,1.1948533593280173,0.024375
79,0.3,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",How well do biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.3,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover indicative of bone histomorphometry status in 370 postmenopausal women?,7.105791820705599e-07,1.011714496651741,0.136444776777417,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
79,0.3,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",To what extent do biochemical markers of bone turnover mirror bone histomorphometry in 370 postmenopausal women?,6.868932093348744e-07,0.8437005993705111,0.20745069393718035,0.05258936747867444,0.9931851710904076,0.09204470742932283,0.052513244687633284,1.1067062436256467,0.047500000000000014,6.868932093348764e-07,1.1948533593280173,0.024375
79,0.3,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Biochemical markers of bone turnover may not always accurately represent bone histomorphometry in postmenopausal women. Variations can occur due to factors such as age, hormonal levels, and lifestyle. Therefore,",Are biochemical markers of bone turnover consistent with bone histomorphometry results in 370 postmenopausal women?,7.105791820705599e-07,0.9126934708574632,0.20745069393718035,0.05440279394345632,1.0672931432441288,0.09204470742932283,0.05432404622858615,1.1867489512991831,0.047500000000000014,7.105791820705617e-07,1.2818647363176474,0.024375
80,0.3,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, opioid dependence and MMT are usually documented in the medical record, including diagnosis, treatment plans, medication details, and patient monitoring, offering essential information for healthcare providers.",4.500334819780226e-07,0.29102761257603094,0.10537273242630386,0.03445510283085558,0.308181293292733,0.06793086419753083,0.034405229278104466,0.2906574958480763,0.08842752787389466,4.500334819780227e-07,0.3481981907152756,0.05436390532544381
80,0.3,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence along with methadone maintenance treatment (MMT) noted in the medical record? Indeed, both conditions are commonly documented, covering diagnosis, treatment strategies, medication specifics, and patient response monitoring, which aids healthcare professionals.",5.921493183921344e-07,0.3158976602012591,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
80,0.3,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record include documentation of opioid dependence and methadone maintenance treatment (MMT)? Yes, these are generally recorded, detailing diagnosis, treatment plans, medication information, and monitoring of the patient's progress, crucial for ongoing care.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.3,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? Yes, documentation typically includes diagnosis, treatment plans, medication details, and patient response monitoring, providing vital information for healthcare providers.",6.39521263863505e-07,0.3784180171825926,0.20659722222222224,0.048962514549110596,0.47160721024539143,0.12039999999999998,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5995126189961817,0.05436390532544381
80,0.3,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, both are usually recorded, including diagnosis, treatment plans, medication details, and monitoring of patient response, essential for current and future care.",5.210914001850785e-07,0.22888628321162896,0.20659722222222224,0.0398953822252012,0.31745653041813293,0.12039999999999998,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4352095677049057,0.05436390532544381
80,0.3,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? Yes, they are typically documented with diagnosis, treatment plans, medication details, and patient response monitoring, supplying important information for healthcare professionals.",6.158352911278197e-07,0.3466693188680128,0.20659722222222224,0.047149088084328716,0.43881738742239973,0.12039999999999998,0.047080840064774566,0.500378026830147,0.08842752787389466,6.158352911278206e-07,0.5644212991849127,0.05436390532544381
80,0.3,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Is opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical record? Yes, both are commonly noted, including diagnosis, treatment plans, medication details, and monitoring of the patient's response, which is critical for healthcare providers.",5.210914001850785e-07,0.2673944599094038,0.1788421201814059,0.0398953822252012,0.31745653041813293,0.12039999999999998,0.03983763390096307,0.37521488387614,0.08842752787389466,5.210914001850789e-07,0.4352095677049057,0.05436390532544381
80,0.3,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record documentation? Yes, these conditions are usually documented with diagnosis, treatment plans, medication details, and patient monitoring, providing key information for medical care.",5.684633456564491e-07,0.2860446970515773,0.20659722222222224,0.04352223515476496,0.3762970304410662,0.12039999999999998,0.04345923698286882,0.43583950569257546,0.08842752787389466,5.684633456564497e-07,0.4977299246862392,0.05436390532544381
80,0.3,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Yes, both are typically recorded, including diagnosis, treatment plans, medication details, and monitoring of patient response, essential for healthcare management.",6.39521263863505e-07,0.3784180171825926,0.20659722222222224,0.048962514549110596,0.47160721024539143,0.12039999999999998,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5995126189961817,0.05436390532544381
80,0.3,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, both opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. This documentation includes diagnosis, treatment plans, medication details, and monitoring of patient's response, providing crucial information for both current and future healthcare professionals involved in the patient's care.","Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Yes, documentation generally includes diagnosis, treatment plans, medication details, and monitoring of the patient's response, which is vital for healthcare providers.",5.921493183921344e-07,0.3158976602012591,0.20659722222222224,0.04533566161954684,0.4070686891078199,0.12039999999999998,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.5305197475092309,0.05436390532544381
81,0.3,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimating basal metabolic rate in Chinese individuals: do existing prediction formulas apply? Answer: Existing equations for predicting basal metabolic rate (BMR) might not fully suit the Chinese population because of unique genetic, environmental, and lifestyle influences. Hence, developing a",1.4211583641411233e-07,0.06016015536854491,0.05824278670562455,0.010880558788691236,0.08856483467130483,0.041520208891625554,0.0108648092457172,0.1180427993023625,0.023242630385487524,1.4211583641411244e-07,0.1541506798272576,0.0
81,0.3,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can current basal metabolic rate prediction equations be used for the Chinese population? Answer: The current BMR prediction models may not be completely accurate for Chinese people due to specific genetic, environmental, and lifestyle differences. Therefore, it is necessary to create a",7.105791820705622e-08,0.08503983530414683,0.109375,0.005440279394345618,0.02390250286240292,0.06781677572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
81,0.3,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the existing basal metabolic rate estimation formulas valid for Chinese individuals? Answer: Due to particular genetic, environmental, and lifestyle factors, the current BMR prediction equations may not be fully applicable to the Chinese population. Thus, there is a need to develop a",4.737194547137081e-08,0.10857033271434124,0.109375,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.3,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Basal metabolic rate estimation in Chinese: are current prediction equations suitable? Answer: The prediction equations currently used to estimate BMR might not be entirely appropriate for the Chinese population because of distinct genetic, environmental, and lifestyle characteristics. Therefore, formulating a",1.1842986367842703e-07,0.0015923121067187296,0.08439143655489809,0.009067132323909363,0.02610791771226051,0.06781677572873293,0.009054007704764333,0.09137455222020163,0.023242630385487524,1.1842986367842703e-07,0.1267517056391423,0.0
81,0.3,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Is the estimation of basal metabolic rate using current equations accurate for Chinese people? Answer: Current BMR prediction equations may not be wholly applicable to the Chinese population owing to certain genetic, environmental, and lifestyle factors. Consequently, it is important to establish a",4.737194547137081e-08,0.10857033271434124,0.109375,0.0036268529295637453,0.048000054441462936,0.06781677572873293,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
81,0.3,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are current basal metabolic rate prediction equations applicable to the Chinese population? Answer: The existing BMR estimation formulas might not be fully relevant for Chinese individuals due to unique genetic, environmental, and lifestyle factors. Hence, creating a",1.8948778188548293e-07,0.04171187033499546,0.109375,0.014507411718254981,0.10615062538579467,0.06781677572873293,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
81,0.3,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Can the current basal metabolic rate prediction models be applied to Chinese individuals? Answer: Due to specific genetic, environmental, and lifestyle influences, the current BMR prediction equations may not be entirely suitable for the Chinese population. Therefore, developing a",1.4211583641411233e-07,0.024614146109060542,0.08375173130193905,0.010880558788691236,0.052083404115518483,0.06781677572873293,0.0108648092457172,0.1180427993023625,0.023242630385487524,1.4211583641411244e-07,0.1541506798272576,0.0
81,0.3,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Estimation of basal metabolic rate in Chinese: do current prediction equations fit? Answer: The current equations used to estimate BMR may not be completely applicable to the Chinese population because of particular genetic, environmental, and lifestyle factors. Thus, there is a need to create a",0.0,0.15403270679109848,0.109375,0.0,0.09452007007635688,0.06781677572873293,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
81,0.3,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Are the existing basal metabolic rate prediction equations effective for the Chinese population? Answer: Given certain genetic, environmental, and lifestyle differences, the current BMR prediction formulas might not be fully applicable to Chinese individuals. Therefore, it is necessary to develop a",9.474389094274162e-08,0.06094228372508681,0.109375,0.0072537058591274906,0.0007901097279687797,0.06781677572873293,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
81,0.3,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current prediction equations for estimating the basal metabolic rate (BMR) may not be entirely applicable to the Chinese population due to certain genetic, environmental, and lifestyle factors. Therefore, creating a","Question: Basal metabolic rate estimation in Chinese population: are current prediction equations valid? Answer: The present BMR prediction equations may not be entirely suitable for the Chinese population due to specific genetic, environmental, and lifestyle factors. Hence, formulating a",1.6580180914979763e-07,0.051525053808620935,0.08307843316289262,0.012693985253473108,0.07875165119767935,0.06781677572873293,0.012675610786670066,0.14544177349047782,0.023242630385487524,1.6580180914979784e-07,0.18232155679395445,0.0
82,0.3,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Our findings from coronary artery disease patients support the hypothesis that bezafibrate may help prevent colon cancer.",1.8948778188548272e-07,0.18835066359864783,0.01244203397612488,0.014507411718254988,0.1452950764710219,0.047500000000000014,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.3,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients suggest a potential preventive effect of bezafibrate on colon cancer development.",2.3685972735685332e-07,0.20998326302009485,0.03910156249999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.3,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in individuals with coronary artery disease? Our study data from such patients indicate a possible protective role of bezafibrate against colon cancer.,2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.3,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, which targets peroxisome proliferator-activated receptors and lowers lipids, prevent colon cancer in coronary artery disease patients? Evidence from these patients supports the idea that bezafibrate might prevent colon cancer.",3.079176455639092e-07,0.30949433482781386,0.036081302021403076,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.3,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is there a preventive effect of the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate on colon cancer in patients with coronary artery disease? Our data from these patients back the hypothesis of bezafibrate's protective role.,2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.3,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, reduce the risk of colon cancer in coronary artery disease patients? Patient data supports the possibility that bezafibrate prevents colon cancer.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.3,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevent colon cancer in patients with coronary artery disease? Our findings from these patients support this preventive hypothesis.",4.026615365066504e-07,0.40638536643115675,0.06937499999999999,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
82,0.3,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is the lipid-lowering drug bezafibrate, a peroxisome proliferator-activated receptor ligand, effective in colon cancer prevention among coronary artery disease patients? Data from such patients suggest a potential preventive effect.",3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,0.3,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a peroxisome proliferator-activated receptor ligand with lipid-lowering properties, prevent colon cancer in coronary artery disease patients? Our patient-derived data support the hypothesis of its preventive effect.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
82,0.3,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, capable of preventing colon cancer in patients with coronary artery disease? Data from these patients support the hypothesis of a possible preventive effect.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
83,0.3,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK radiologists content with the training and support provided for suspected child abuse cases? The survey reveals considerable dissatisfaction among consultant radiologists regarding the current service, highlights a small number of paediatric radiologists involved in this area, and indicates that enhancing training could boost the number of child abuse radiology experts by 27%.",7.105791820705622e-08,0.08261751549370011,0.019826576555107524,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.3,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists feel satisfied with the training and support they receive for suspected child abuse? The survey indicates notable dissatisfaction among consultant radiologists with the existing service, shows few paediatric radiologists handling such cases, and suggests that better training could increase the number of child abuse radiology specialists by 27%.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
83,0.3,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are consultant radiologists in the UK satisfied with the training and support for suspected child abuse? Survey results point to significant dissatisfaction, a low count of paediatric radiologists working in this field, and the possibility of raising the number of child abuse radiology experts by 27% through improved training.",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
83,0.3,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Is the training and support for suspected child abuse adequate for UK radiologists? The survey demonstrates considerable dissatisfaction among consultant radiologists, confirms a limited number of paediatric radiologists engaged in this work, and proposes that enhanced training could increase child abuse radiology experts by 27%.",2.8423167282822487e-07,0.24791349039377053,0.004863741401427618,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
83,0.3,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How satisfied are UK radiologists with the training and support for suspected child abuse? The survey shows marked dissatisfaction among consultant radiologists with current services, a low number of paediatric radiologists involved, and suggests a 27% potential increase in child abuse radiology experts if training is improved.",2.3685972735685406e-07,0.20209187173487386,0.003877155392306906,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
83,0.3,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? The survey reveals significant dissatisfaction among consultant radiologists, a small number of paediatric radiologists participating, and indicates that better training could raise the number of child abuse radiology experts by 27%.",2.1317375462116866e-07,0.17994445728120034,0.0034153009733006133,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.3,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Are UK consultant radiologists happy with the training and support they receive for suspected child abuse? Survey findings highlight notable dissatisfaction, few paediatric radiologists working in this area, and the potential to increase child abuse radiology experts by 27% with improved training.",3.552895910352811e-07,0.2870243675822719,0.017851239669421492,0.02720139697172809,0.3184537311185349,0.0,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
83,0.3,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Do UK radiologists feel adequately trained and supported in suspected child abuse cases? The survey uncovers significant dissatisfaction among consultant radiologists, a low number of paediatric radiologists involved, and suggests that enhanced training could boost the number of child abuse radiology specialists by 27%.",3.079176455639103e-07,0.3038751260869659,0.028549712144974714,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.3,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Is the current training and support for suspected child abuse satisfactory to UK radiologists? Survey results show considerable dissatisfaction among consultant radiologists, confirm a limited number of paediatric radiologists in this field, and propose that improving training could increase child abuse radiology experts by 27%.",2.8423167282822487e-07,0.24791349039377053,0.004863741401427618,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
83,0.3,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","How do UK radiologists rate their training and support for suspected child abuse? The survey indicates significant dissatisfaction among consultant radiologists, a small number of paediatric radiologists engaged, and the potential for a 27% increase in child abuse radiology experts with better training.",3.316036182995957e-07,0.2629268160032119,0.017851239669421492,0.025387970506946217,0.2937611185281632,0.0,0.025351221573340132,0.30010459245033916,0.0,3.316036182995957e-07,0.30673026742247655,0.0
84,0.3,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Forecast Success in Orthopaedic Surgery Residency? Answer: Our study revealed that USMLE Step 2 scores, the count of honors received during medical school clerkships, and AOA membership showed the most significant correlations with resident performance. The purpose of analyzing this data was to help residency programs broadly identify which criteria might be most predictive.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
84,0.3,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 scores, the number of honors earned in medical school clerkships, and AOA membership had the strongest links to resident performance. Our aim in reviewing these data was to guide residency programs in understanding which criteria could be considered 'high yield.'",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.3,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Indicators of Performance in Orthopaedic Surgery Residency? Answer: Findings indicated that USMLE Step 2 results, honors count in medical school clerkships, and AOA membership correlated most strongly with resident performance. Our objective in analyzing these results was to offer residency programs insight into which criteria may be most valuable.",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.3,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does the Residency Selection Process Predict Orthopaedic Surgery Resident Performance? Answer: We found that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership were the strongest predictors of resident performance. The goal of this analysis was to inform residency programs about which criteria might be 'high yield.'",9.474389094274162e-08,0.07275935428242919,0.0,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
84,0.3,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Selection Criteria for Residency Predict Performance in Orthopaedic Surgery? Answer: Our analysis showed that USMLE Step 2, honors in medical school clerkships, and AOA membership had the highest correlation with resident performance. We aimed to provide residency programs a clearer understanding of which criteria are most effective.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
84,0.3,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Do Orthopaedic Surgery Residency Selection Criteria Predict Resident Performance? Answer: The strongest correlations with resident performance were found with USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership. Our goal was to help residency programs identify which criteria may yield the best predictive value.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.3,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Is Resident Performance in Orthopaedic Surgery Predicted by Selection Criteria? Answer: We observed that USMLE Step 2, honors earned in medical school clerkships, and AOA membership correlated most strongly with performance. Our analysis aimed to give residency programs insight into which criteria are most predictive.",2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
84,0.3,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Are Residency Selection Criteria Effective Predictors of Orthopaedic Surgery Resident Performance? Answer: The data showed that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership had the strongest association with resident performance. Our goal was to assist residency programs in recognizing high-yield selection criteria.",2.3685972735685406e-07,0.19290366612449228,0.0,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
84,0.3,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Does Performance in Orthopaedic Surgery Residency Correlate with Selection Criteria? Answer: We identified USMLE Step 2, number of honors in medical school clerkships, and AOA membership as the criteria most strongly linked to resident performance. Our intent was to inform residency programs about which criteria might be most predictive.",1.8948778188548325e-07,0.15123096972392336,0.0,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
84,0.3,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high yield"" in","Question: Can Residency Selection Criteria Serve as Predictors of Success in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our purpose was to provide residency programs with guidance on which criteria may be most valuable.",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
85,0.3,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, but more research is needed to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to provide a safe and effective palliative approach for gallbladder carcinoma, though additional studies are required to define its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative option for gallbladder carcinoma, but further investigation is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.25318184550457135,0.03729315417627105,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative management of gallbladder carcinoma, yet more studies are needed to determine its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.3,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, but further research is essential to understand its role in palliative or adjuvant treatment.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
85,0.3,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy appears to be both safe and effective for palliative care in gallbladder carcinoma, although additional studies are necessary to define its role in palliative or adjuvant treatment.",9.474389094274162e-08,0.13626887683741185,0.02915546544890174,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
85,0.3,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative management strategy for gallbladder carcinoma, but more research is needed to clarify its role in palliative or adjuvant therapy.",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
85,0.3,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma; however, further studies are required to determine its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.22266058671934008,0.03509835306671685,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.3,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a reliable treatment for gallbladder carcinoma? External radiotherapy seems to offer a safe and effective palliative option for gallbladder carcinoma, but additional research is necessary to establish its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1477257563885339,0.01834530108339633,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.3,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How safe and effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, though further studies are needed to confirm its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.22266058671934008,0.03509835306671685,0.012693985253473108,0.18394995018825266,0.004512471655328806,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
86,0.3,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Evidence does not support the common use of central venous pressure for guiding fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.3,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure indicate fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure to direct fluid therapy. This practice should be stopped.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.3,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Current evidence does not justify using central venous pressure to guide fluid management. This technique should be abandoned.,1.658018091497971e-07,0.242947756473066,0.014072951135888224,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.3,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure an effective tool for predicting fluid responsiveness? Answer: No data supports the widespread use of central venous pressure in fluid therapy guidance. This approach should be discontinued.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.3,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: There is a lack of evidence supporting the use of central venous pressure for fluid therapy decisions. This practice should be ceased.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.3,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure predict how patients respond to fluids? Answer: Data does not support using central venous pressure to guide fluid resuscitation. This method should be abandoned.,1.658018091497971e-07,0.242947756473066,0.014072951135888224,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.3,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid predictor of fluid responsiveness? Answer: The widespread use of central venous pressure to guide fluid therapy is not supported by data and should be stopped.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.3,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure measurement predict fluid responsiveness? Answer: No evidence supports using central venous pressure for guiding fluid therapy; this practice should be discontinued.,2.36859727356853e-07,0.36815896487538335,0.02246211904228749,0.018134264647818796,0.36529559575252746,0.012203145043839323,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
86,0.3,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure reliably predict fluid responsiveness? Answer: There are no data to endorse the common practice of using central venous pressure for fluid therapy guidance. This approach should be abandoned.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.3,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is central venous pressure useful in predicting fluid responsiveness? Answer: The data do not support the routine use of central venous pressure to guide fluid resuscitation, and this practice should be stopped.",7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
87,0.3,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in either normal or low oxygen environments. Measurement of tumor hypoxia should rely solely on specialized hypoxia tracers.,4.737194547137081e-08,0.05234601051320098,0.0033396814404432346,0.0036268529295637453,0.05044051459933652,0.0011882035402833654,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
87,0.3,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? The study found that FDG is ineffective as a surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Only dedicated hypoxia tracers are appropriate for measuring tumor hypoxia.,0.0,0.0,0.0,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
87,0.3,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? Findings indicate that FDG is not suitable as a surrogate tracer for tumor hypoxia in normal or hypoxic states. Tumor hypoxia measurement requires the use of specific hypoxia tracers.,7.1057918207056e-08,0.19343831754777208,0.07962906855955677,0.005440279394345618,0.1931738431033252,0.08153617943827732,0.0054324046228586,0.1955672377668587,0.08264462809917354,7.105791820705622e-08,0.16145491887239505,0.056932966023875105
87,0.3,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG a reliable surrogate tracer for detecting tumor hypoxia? The study revealed that FDG fails to be a good surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Specific hypoxia tracers should be employed to assess tumor hypoxia.,4.7371945471370706e-08,0.019666266328762116,0.021582468146067776,0.0036268529295637453,0.053117365915339665,0.0013130033920054525,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
87,0.3,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG act as a surrogate tracer to measure tumor hypoxia? Results show that FDG is not an effective surrogate tracer for tumor hypoxia in either ambient or hypoxic environments. Measurement should be done using only specific hypoxia tracers.,7.1057918207056e-08,0.011031164768838142,0.04641811460333585,0.005440279394345618,0.04330418244171419,0.02498356344510192,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
87,0.3,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia measurement? This investigation demonstrated that FDG is inadequate as a surrogate tracer for tumor hypoxia under both normal and low oxygen conditions. Only specialized hypoxia tracers are recommended for this purpose.,2.3685972735685406e-08,0.13120059399348527,0.0726140382827402,0.0018134264647818726,0.16839049525371586,0.10044896250645516,0.0018108015409528666,0.17190120862640512,0.10380622837370242,2.3685972735685406e-08,0.13907049257836945,0.08044982698961935
87,0.3,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Does (18)F-FDG serve as a surrogate tracer for tumor hypoxia? The study concluded that FDG is not a good surrogate tracer for tumor hypoxia in ambient or hypoxic conditions. Tumor hypoxia should be measured exclusively with specific hypoxia tracers.,7.1057918207056e-08,0.12047545643619895,0.03109154693325919,0.005440279394345618,0.11823901277251991,0.028893987575306257,0.0054324046228586,0.118550884371309,0.02775510204081633,7.105791820705622e-08,0.08223809823697303,0.0
87,0.3,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? Research indicates that FDG does not perform well as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Specific hypoxia tracers must be used for accurate measurement.,4.7371945471370706e-08,0.12630429410721433,0.052717844511113846,0.0036268529295637453,0.16256165758270047,0.07882266492860049,0.003621603081905733,0.16504597898162743,0.08044982698961935,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
87,0.3,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? The study showed that FDG is not suitable as a surrogate tracer for tumor hypoxia in both ambient and hypoxic conditions. Only specific hypoxia tracers should be utilized for measuring tumor hypoxia.,0.0,0.03381205758828987,0.023706063628950516,0.0,0.06931471805599454,0.049523375926702314,0.0,0.07109201851896829,0.05113221329437545,0.0,0.03648143055578634,0.026296566837107373
87,0.3,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.,Is (18)F-FDG an appropriate surrogate tracer for tumor hypoxia? Findings reveal that FDG is not effective as a surrogate tracer for tumor hypoxia under normal or hypoxic conditions. Measurement of tumor hypoxia should rely on specific hypoxia tracers only.,7.1057918207056e-08,0.12047545643619895,0.03109154693325919,0.005440279394345618,0.11823901277251991,0.028893987575306257,0.0054324046228586,0.118550884371309,0.02775510204081633,7.105791820705622e-08,0.08223809823697303,0.0
88,0.3,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial in DCIS management.,2.1317375462116776e-07,0.24966525916159688,0.08453850415512462,0.016320838183036916,0.28874450521448525,0.07100591715976333,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,0.3,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does the management of ductal carcinoma in situ require expert breast pathology assessment? Expert assessments in breast pathology are still vital for DCIS management.,1.421158364141118e-07,0.10086226660522124,0.09101157024793383,0.010880558788691277,0.1421410310226099,0.07100591715976333,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.3,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert assessment in breast pathology needed for the treatment of ductal carcinoma in situ? Such expert evaluations continue to be important in managing DCIS.,1.184298636784265e-07,0.001971015688352562,0.13439999999999996,0.009067132323909398,0.09768926845177583,0.07100591715976333,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.3,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is it necessary to have expert breast pathology evaluation for managing ductal carcinoma in situ? Expert breast pathology assessments remain necessary for DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.3,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology review required for the management of ductal carcinoma in situ? Expert pathology assessments are still essential in managing DCIS.,1.658018091497971e-07,0.08504036130127712,0.13439999999999996,0.012693985253473157,0.18866104665750383,0.07100591715976333,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,0.3,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert pathology assessment of the breast indispensable for managing ductal carcinoma in situ? Expert breast pathology evaluations continue to be necessary in DCIS care.,1.184298636784265e-07,0.001971015688352562,0.13439999999999996,0.009067132323909398,0.09768926845177583,0.07100591715976333,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.3,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does managing ductal carcinoma in situ necessitate expert breast pathology assessment? Expert breast pathology assessments remain critical in DCIS management.,2.368597273568531e-07,0.37756955771629874,0.030593771626297547,0.018134264647818796,0.4198280798803098,0.015642595360455362,0.018108015409528732,0.4626235219481134,0.0,2.368597273568538e-07,0.48550781578170144,0.0
88,0.3,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology evaluation a must for the management of ductal carcinoma in situ? Expert assessments in breast pathology continue to be necessary for DCIS management.,7.10579182070559e-08,0.02869470947266306,0.09599999999999995,0.005440279394345639,0.01430765951272539,0.07100591715976333,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.3,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology analysis required for managing ductal carcinoma in situ? Expert breast pathology assessments are still needed in DCIS management.,1.894877818854824e-07,0.26358841132854094,0.040217174515235404,0.014507411718255037,0.30676592888292964,0.021144421314887994,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,0.3,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology consultation necessary for the management of ductal carcinoma in situ? Expert breast pathology assessments continue to be essential in DCIS management.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
89,0.3,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our study indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might provide protective effects for the kidneys against damage from glomerular hyperfiltration.,1.8948778188548325e-07,0.14865823925215604,0.027771203155818505,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.3,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women with multiple births? According to our research, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys of women with more parities. Pregnancy could offer protective mechanisms for the kidneys against the harmful effects of glomerular hyperfiltration.",1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.3,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy lead to kidney damage in women who have had several pregnancies? Our findings suggest that glomerular hyperfiltration during pregnancy does not harm the kidneys in women with increased parity. Pregnancy may have protective roles that shield the kidneys from the negative effects of glomerular hyperfiltration.,4.737194547137081e-08,0.03821295466917718,0.05459147237975217,0.0036268529295637453,0.042355667146938725,0.05975554549569943,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
89,0.3,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney injury in women with multiple pregnancies? Our study suggests that pregnancy-related glomerular hyperfiltration does not cause kidney damage in women with higher numbers of parities. There may be protective mechanisms during pregnancy that guard the kidneys against glomerular hyperfiltration's adverse effects.,9.474389094274162e-08,0.06606270028826033,0.010680272108843536,0.0072537058591274906,0.030340781209246437,0.038027150433971035,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.3,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-induced glomerular hyperfiltration damage the kidneys in women with many pregnancies? Our research suggests no harmful impact on kidneys from glomerular hyperfiltration in women with more parities. Pregnancy might have protective factors that defend the kidneys from the adverse effects of glomerular hyperfiltration.,1.8948778188548325e-07,0.16872908151623411,0.0012896275777163069,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.3,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women with multiple childbirths? Our study proposes that glomerular hyperfiltration caused by pregnancy does not adversely affect the kidneys of women with higher parity. Pregnancy may provide protective mechanisms that prevent kidney damage from glomerular hyperfiltration.,1.6580180914979784e-07,0.1420759946839234,0.003786982248520712,0.012693985253473108,0.13212403556133845,0.013354593681303227,0.012675610786670066,0.1305742451143348,0.01694705747861288,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.3,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy cause kidney harm in women with numerous pregnancies? Our investigation suggests that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with increased parity. Pregnancy might have protective effects that shield the kidneys from glomerular hyperfiltration's harmful consequences.,1.6580180914979784e-07,0.11056930465847348,0.025555555555555567,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.3,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does kidney damage occur from glomerular hyperfiltration in pregnant women who have had many children? Our findings indicate that glomerular hyperfiltration due to pregnancy does not adversely affect kidney function in women with more parities. Pregnancy may offer protective mechanisms for the kidneys against the detrimental effects of glomerular hyperfiltration.,4.737194547137081e-08,0.0947963979801929,0.09515625000000001,0.0036268529295637453,0.042355667146938725,0.05975554549569943,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
89,0.3,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is glomerular hyperfiltration in pregnancy harmful to the kidneys of women with multiple pregnancies? Our study suggests that glomerular hyperfiltration caused by pregnancy does not damage the kidneys in women with higher parity. Pregnancy might have protective roles that help prevent kidney damage from glomerular hyperfiltration.,1.4211583641411244e-07,0.054489312779265386,0.049229024943310676,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.3,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Does glomerular hyperfiltration during pregnancy negatively affect the kidneys in women with several pregnancies? According to our research, pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with more parities. Pregnancy may provide protective mechanisms that guard the kidneys against the adverse effects of glomerular hyperfiltration.",1.1842986367842703e-07,0.13228674525721962,0.06194444444444443,0.009067132323909363,0.11460247806529189,0.006570985116545455,0.009054007704764333,0.11406060093225401,0.004609056539471058,1.1842986367842703e-07,0.11335916643797228,0.00241872816728924
90,0.3,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are the home blood pressure readings reported by stroke patients dependable? Stroke patients' home blood pressure readings can be trustworthy when measured properly, but factors like wrong cuff size, poor technique, or cognitive issues might affect accuracy. Hence, it is important to educate patients on correct measurement and reporting methods.",2.1317375462116866e-07,0.08618648899129466,0.05745191067271642,0.016320838183036854,0.08368679975017468,0.06221832667237916,0.0162972138685758,0.08092343148692249,0.06716098723117256,2.1317375462116866e-07,0.07787038066192942,0.07227989234909649
90,0.3,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients reliably report their home blood pressure readings? When done correctly, stroke patients' home blood pressure reports can be accurate. Nonetheless, errors may arise from incorrect cuff sizing, improper measurement technique, or cognitive impairments. Thus, ensuring patients know how to measure and report accurately is essential.",2.6054570009253947e-07,0.10197526983469674,0.07594685804605067,0.0199476911126006,0.09862098305969802,0.08207783331197402,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.3,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is it reliable to trust stroke patients' self-reported home blood pressure readings? Stroke patients can provide reliable home blood pressure readings if they follow proper procedures. However, accuracy can be compromised by factors such as using the wrong cuff size, incorrect technique, or cognitive difficulties. Therefore, patient education on correct measurement and reporting is vital.",9.474389094274162e-08,0.04450818883184393,0.08143374532780974,0.0072537058591274906,0.04700987056109618,0.08494528162814029,0.007243206163811466,0.04966831008912598,0.08842752787389466,9.474389094274162e-08,0.025313855573301236,0.07227989234909649
90,0.3,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Do stroke patients provide reliable home blood pressure readings? When stroke patients measure their blood pressure at home correctly, their reports can be reliable. Accuracy may be affected by issues like improper cuff size, technique errors, or cognitive impairment, making it important to ensure patients understand proper measurement and reporting.",2.1317375462116866e-07,0.05789476733578658,0.07767357646508835,0.016320838183036854,0.025924534703512858,0.10380622837370242,0.0162972138685758,0.05142780678224401,0.08842752787389466,2.1317375462116866e-07,0.07787038066192942,0.07227989234909649
90,0.3,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are home blood pressure readings reported by stroke patients trustworthy? Stroke patients' reports can be reliable if the measurements are taken correctly. Accuracy might be influenced by factors such as wrong cuff size, incorrect technique, or cognitive problems. Thus, it is crucial to educate patients on how to measure and report blood pressure accurately.",1.1842986367842703e-07,0.05100379403710242,0.09955504710295766,0.009067132323909363,0.05411817297002397,0.10380622837370242,0.009054007704764333,0.03025022423202328,0.08842752787389466,1.1842986367842703e-07,0.0055112282771214716,0.07227989234909649
90,0.3,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients' home blood pressure readings be considered reliable? If stroke patients take their blood pressure correctly at home, their reports can be dependable. However, factors like incorrect cuff size, poor technique, or cognitive impairment may affect accuracy, so proper patient instruction is necessary.",3.316036182995957e-07,0.14044867824258844,0.09570101277767068,0.025387970506946217,0.13592542991784162,0.10380622837370242,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
90,0.3,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Is the reliability of stroke patients' home blood pressure readings assured? Stroke patients can reliably report their home blood pressure if they measure it properly. Yet, accuracy may be impacted by incorrect cuff size, improper technique, or cognitive issues, making patient education on accurate measurement essential.",3.079176455639103e-07,0.14808221508151753,0.07406769747210011,0.023574544042164344,0.1444426017185947,0.0810912473028533,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
90,0.3,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Are the home blood pressure readings from stroke patients accurate? Stroke patients' home blood pressure readings can be accurate if taken correctly, but factors such as wrong cuff size, improper technique, or cognitive impairment can affect reliability. Therefore, ensuring patients know how to measure and report accurately is important.",2.3685972735685406e-07,0.10857400879749957,0.05619377162629757,0.018134264647818726,0.10596919331070298,0.061337092571233286,0.018108015409528666,0.10307084594059601,0.06669913281216626,2.3685972735685406e-07,0.09984928738070442,0.07227989234909649
90,0.3,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","How reliable are home blood pressure readings reported by stroke patients? When stroke patients measure their blood pressure correctly at home, their readings can be reliable. However, accuracy may be influenced by incorrect cuff size, poor technique, or cognitive impairment, so patient education on proper measurement is key.",2.6054570009253947e-07,0.07247964513001826,0.0971494532057977,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
90,0.3,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Stroke patients' reports of home blood pressure readings can be reliable if taken correctly. However, accuracy may be influenced by factors such as incorrect cuff size, improper technique, or cognitive impairment. Therefore, it's crucial to ensure patients understand how to accurately measure and report their blood pressure.","Can stroke patients be trusted to report accurate home blood pressure readings? Stroke patients' reports can be accurate if the measurements are done correctly. Factors like incorrect cuff size, improper technique, or cognitive impairment may affect accuracy, so it's important to ensure patients understand how to measure and report their blood pressure properly.",1.4211583641411244e-07,0.03145258950141683,0.09919261822376008,0.010880558788691236,0.034700087112921274,0.10380622837370242,0.0108648092457172,0.010447596935843517,0.08842752787389466,1.4211583641411244e-07,0.014691479040397137,0.07227989234909649
91,0.3,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals, independent of other cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese men? The study shows that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, regardless of cardiovascular risk factors. Changes in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.3,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is a rise in carotid artery pulsatility and resistance indexes an early marker of vascular abnormalities among young obese males? Results suggest that young, obese, normotensive individuals have impaired vessel compliance and elevated vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes could...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are higher carotid artery pulsatility and resistance indexes early signs of vascular issues in young obese males? Our data reveal that young, obese, normotensive subjects experience reduced vessel compliance and increased vascular resistance beyond traditional cardiovascular risk factors. Modifications in arterial wall characteristics may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.3,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Could increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Findings suggest that depressed vessel compliance and elevated vascular resistance are present in young, obese, normotensive individuals, independent of cardiovascular risk factors. Changes in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.3,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do young obese males show early vascular abnormalities through increased carotid artery pulsatility and resistance indexes? The evidence points to reduced vessel compliance and increased vascular resistance in young, obese, normotensive subjects, regardless of cardiovascular risk factors. Alterations in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.3,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance indexes a sign of early vascular abnormalities in young obese males? Our results imply that young, obese, normotensive individuals have diminished vessel compliance and heightened vascular resistance, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased carotid artery pulsatility and resistance indexes early indicators of vascular dysfunction in young obese males? The study suggests that reduced vessel compliance and increased vascular resistance are characteristic of young, obese, normotensive subjects, independent of cardiovascular risk factors. Arterial wall changes may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.3,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Might increased carotid artery pulsatility and resistance indexes be early markers of vascular abnormalities in young obese males? Our findings indicate that young, obese, normotensive individuals exhibit decreased vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes represent early signs of vascular abnormalities in young obese males? Results suggest that depressed vessel compliance and heightened vascular resistance are features of young, obese, normotensive subjects, independent of cardiovascular risk factors. Alterations in arterial wall properties might...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
92,0.3,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic perspective predict improved survival rates in advanced age? Optimism seems to be a strong indicator of survival in the oldest-old women and possibly in men, though the male sample is limited.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.3,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic attitude linked to better survival among the very elderly? Evidence suggests optimism is a key predictor of survival for the oldest-old women and potentially for men, but the male data set is small.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.3,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism forecast greater longevity in advanced years? An optimistic outlook is a notable predictor of survival in the oldest-old women and may also predict survival in men, though the male sample size is small.",2.3685972735685343e-07,0.14106902273719024,0.08238381664955091,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.3,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does maintaining optimism correlate with higher survival chances at advanced ages? Optimism appears to significantly predict survival in the oldest-old women and might do so for men, but the male sample is limited.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.3,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is a positive outlook associated with improved survival among the oldest-old? Optimism is a significant survival predictor for oldest-old women and possibly for men, although the male sample is small.",3.5528959103527993e-07,0.3071636076362494,0.07732979779683076,0.027201396971728138,0.3322773942774351,0.06937499999999999,0.027162023114293055,0.4088257436809468,0.023795359904818555,3.552895910352811e-07,0.45547552868282537,0.0
92,0.3,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does an optimistic mindset enhance survival prospects in very old age? Optimism seems to be an important survival predictor for oldest-old women and may be for men as well, but the sample size for men is small.",1.8948778188548283e-07,0.081645422032667,0.08401347126621853,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.3,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is optimism a reliable predictor of survival in advanced age? It appears to significantly predict survival in oldest-old women and potentially in men, though the male sample size is limited.",3.5528959103527993e-07,0.3071636076362494,0.07732979779683076,0.027201396971728138,0.3322773942774351,0.06937499999999999,0.027162023114293055,0.4088257436809468,0.023795359904818555,3.552895910352811e-07,0.45547552868282537,0.0
92,0.3,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does a hopeful outlook predict better survival rates among the oldest-old? Optimism is a significant survival predictor for oldest-old women and possibly for men, but the male sample is small.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.3322773942774351,0.06937499999999999,0.027162023114293055,0.4088257436809468,0.023795359904818555,3.552895910352811e-07,0.45547552868282537,0.0
92,0.3,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can an optimistic outlook serve as a predictor of longevity in advanced age? Optimism is a key survival predictor among oldest-old women and may also be for men, but the male sample size is small.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.3,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is having an optimistic perspective linked to better survival outcomes in very old age? Optimism appears to be a significant predictor of survival in oldest-old women and possibly in men, though the male sample is limited.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
93,0.3,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a correlation between the radiographic transition zone and the level of aganglionosis observed in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone generally corresponds to the level of aganglionosis in Hirschsprung's disease specimens, though it is not always precise or definitive.",0.0,0.12602676010180902,0.0615354938271605,0.0,0.16119701873487147,0.09693701049782648,0.0,0.19804205158855703,0.1324307958477509,0.0,0.20287234552973965,0.14204081632653065
93,0.3,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone match the extent of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, typically the radiographic transition zone aligns with the aganglionosis level in Hirschsprung's disease specimens, but it is not consistently accurate or conclusive.",1.4211583641411222e-07,0.04906965333461688,0.10581668962350782,0.010880558788691236,0.059709588924196755,0.13075311148604635,0.0108648092457172,0.07139721225970863,0.15217569380693458,1.4211583641411244e-07,0.044648340314845214,0.14204081632653065
93,0.3,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone often reflects the aganglionosis level in Hirschsprung's disease specimens, although it may not always be exact or definitive.",1.4211583641411222e-07,0.06037463833274259,0.03881944444444449,0.010880558788691236,0.05269265657200917,0.05511552952665422,0.0108648092457172,0.04412731783361634,0.0705557958477509,1.4211583641411244e-07,0.0345684803205768,0.08510785030265555
93,0.3,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, it often correlates with the aganglionosis level in Hirschsprung's disease specimens, but it is not invariably accurate or conclusive.",2.1317375462116813e-07,0.04880334371197792,0.09548611111111113,0.01632083818303686,0.0755390078570568,0.09564738292011014,0.016297213868575813,0.10313274813395479,0.08993079584775086,2.1317375462116866e-07,0.13160721594483604,0.07981859410430842
93,0.3,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is there a relationship between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone frequently correlates with the aganglionosis level in Hirschsprung's disease specimens, though it is not always perfectly accurate or definitive.",4.737194547137081e-08,0.06750419588579071,0.0544442041522491,0.0036268529295637453,0.07189364295074796,0.06916212214913509,0.003621603081905733,0.07663646850332118,0.08116536374898543,4.737194547137081e-08,0.08176990643610793,0.0909086030321552
93,0.3,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone align with the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, the radiographic transition zone usually aligns with the aganglionosis level in Hirschsprung's disease specimens, but it is not always definitive or fully accurate.",9.474389094274162e-08,0.0748259463331169,0.08904628027681658,0.0072537058591274906,0.11811754012737197,0.13481404958677684,0.007243206163811466,0.12749117967197332,0.15363422901064352,9.474389094274162e-08,0.10021819146965738,0.14204081632653065
93,0.3,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone a reliable indicator of the aganglionosis level in Hirschsprung's disease specimens? Answer: Yes, it often indicates the aganglionosis level in Hirschsprung's disease specimens, yet it is not always fully reliable or definitive.",1.6580180914979753e-07,0.01747148320437608,0.1025390625,0.012693985253473108,0.009319846558809353,0.10182793847566574,0.012675610786670066,0.037090718962346614,0.0949698583477509,1.6580180914979784e-07,0.0658859236831062,0.08344706632653065
93,0.3,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone reflect the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, it commonly reflects the aganglionosis level in Hirschsprung's disease specimens, but it is not always exact or definitive.",2.3685972735685343e-07,0.03870444387862593,0.17578125,0.01813426464781874,0.015692563208724142,0.18092950097566574,0.018108015409528687,0.007877646698900342,0.1799307958477509,2.3685972735685406e-07,0.07671251668942158,0.14204081632653065
93,0.3,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Is the radiographic transition zone consistent with the aganglionosis level found in Hirschsprung's disease specimens? Answer: Yes, it is often consistent with the aganglionosis level in Hirschsprung's disease specimens, although it is not always completely accurate or definitive.",1.4211583641411222e-07,0.023893207776955805,0.059557101977107146,0.010880558788691236,0.022242173758794337,0.1046831955922865,0.0108648092457172,0.03288903556193379,0.12456747404844293,1.4211583641411244e-07,0.005039929997133985,0.11349410352376249
93,0.3,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone often correlates with the level of aganglionosis on the specimen in Hirschsprung's disease. However, it's not always accurate and definitive, hence,","Question: Does the radiographic transition zone correspond with the level of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, it frequently corresponds with the aganglionosis level in Hirschsprung's disease specimens, but it is not always perfectly accurate or conclusive.",1.6580180914979753e-07,0.09240631353518092,0.15392517301038067,0.012693985253473108,0.10620468353451518,0.1834478364348494,0.012675610786670066,0.08173451199078663,0.1799307958477509,1.6580180914979784e-07,0.015660803441593707,0.14204081632653065
94,0.3,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be used as a new diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be regarded as a diagnostic criterion for acute appendicitis.,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.3,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: High D-dimer levels should not be used as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.3,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a novel diagnostic indicator for acute appendicitis? Answer: Increased D-dimer levels are not reliable as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.13652035442868815,0.04241283654545255,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.3,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer become a diagnostic marker for acute appendicitis? Answer: Raised D-dimer levels should not be considered diagnostic for acute appendicitis.,1.421158364141118e-07,0.26598420988005955,0.010517751479289968,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.3,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to be a new diagnostic parameter in acute appendicitis? Answer: Elevated D-dimer should not be used as a diagnostic marker for acute appendicitis.,2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
94,0.3,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new diagnostic parameter for acute appendicitis? Answer: Higher D-dimer levels should not be taken as a diagnostic sign for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.3,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be introduced as a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer values should not be considered diagnostic for acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.3,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels serve as a new diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer levels should not be relied upon for diagnosing acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.3,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be used as a diagnostic tool in acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.3,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be established as a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be accepted as a diagnostic parameter for acute appendicitis.,0.0,0.15403270679109848,0.10668504826567932,0.0,0.10663802777845355,0.07638888888888888,0.0,0.0554517744447951,0.03993055555555556,0.0,0.0,0.0
95,0.3,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Increased expression of TGF-1 and VEGF was observed in polyps relative to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Additionally, there was a",1.4211583641411244e-07,0.0159642943138798,0.07638888888888888,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
95,0.3,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does endometrial polyp formation correlate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? The study found increased TGF-1 and VEGF expression in polyps compared to adjacent normal endometrium, suggesting these cytokines could be involved in polyp formation. Furthermore, there was a",1.8948778188548325e-07,0.06041605688471252,0.07638888888888888,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
95,0.3,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there an association between endometrial polyp formation and increased expression of VEGF and TGF-beta1? Findings showed elevated TGF-1 and VEGF levels in polyps versus normal endometrial tissue nearby, implying these cytokines might influence polyp development. Moreover, there was a",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.3,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are elevated levels of vascular endothelial growth factor and transforming growth factor-beta1 linked to the formation of endometrial polyps? The data revealed higher expression of TGF-1 and VEGF in polyps than in adjacent normal endometrial tissue, suggesting a role for these cytokines in polyp formation. In addition, there was a",7.105791820705622e-08,0.04721460730765248,0.07638888888888888,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
95,0.3,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is increased expression of VEGF and TGF-beta1 associated with the development of endometrial polyps? Polyps showed greater TGF-1 and VEGF expression compared to surrounding normal endometrial tissue, indicating these cytokines might contribute to polyp formation. Also, there was a",3.316036182995955e-07,0.20701953107658788,0.07638888888888888,0.025387970506946217,0.2937254777052001,0.019599999999999992,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
95,0.3,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the formation of endometrial polyps involve elevated expression of vascular endothelial growth factor and transforming growth factor-beta1? The research indicated increased TGF-1 and VEGF in polyps relative to adjacent normal tissue, suggesting these cytokines play a role in polyp formation. Additionally, there was a",1.8948778188548325e-07,0.06041605688471252,0.07638888888888888,0.014507411718254981,0.14344327465586337,0.019599999999999992,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
95,0.3,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is there a connection between endometrial polyp formation and increased levels of VEGF and TGF-beta1? Results demonstrated higher expression of TGF-1 and VEGF in polyps compared to normal endometrial tissue nearby, implying these cytokines may be involved in polyp development. Furthermore, there was a",2.1317375462116866e-07,0.08340557510941204,0.07638888888888888,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
95,0.3,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Are vascular endothelial growth factor and transforming growth factor-beta1 expression levels elevated in endometrial polyps? Increased TGF-1 and VEGF expression was found in polyps versus adjacent normal endometrium, suggesting these cytokines could contribute to polyp formation. Moreover, there was a",3.079176455639102e-07,0.1810440446733299,0.07638888888888888,0.023574544042164344,0.2670572306230392,0.019599999999999992,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
95,0.3,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Is the presence of endometrial polyps associated with increased expression of VEGF and TGF-beta1? The study observed elevated TGF-1 and VEGF in polyps compared to nearby normal endometrial tissue, indicating these cytokines might play a role in polyp formation. In addition, there was a",2.1317375462116866e-07,0.08340557510941204,0.07638888888888888,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
95,0.3,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a","Does the expression of vascular endothelial growth factor and transforming growth factor-beta1 increase in endometrial polyps? Findings showed higher levels of TGF-1 and VEGF in polyps than in adjacent normal endometrial tissue, suggesting these cytokines may be involved in the formation of polyps. Also, there was a",1.4211583641411244e-07,0.0159642943138798,0.07638888888888888,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
96,0.3,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture in growing children a rare and frequently missed injury? Answer: Yes, sternal fractures are uncommon and often go unnoticed in growing children. They may result from direct chest trauma but are frequently overlooked during initial assessments because they are rare and other injuries may be more apparent.",2.3685972735685406e-08,0.10406757865836935,0.05961507807960676,0.0018134264647818726,0.07678615062853433,0.040742417383431435,0.0018108015409528666,0.04950041972606645,0.020823902218198284,2.3685972735685406e-08,0.02105340919783316,0.0
96,0.3,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in children rare and commonly overlooked? Answer: Indeed, sternal fractures are infrequent and often missed in children who are still growing. These fractures can happen from direct chest trauma but are usually not detected initially due to their rarity and the focus on more obvious injuries.",2.3685972735685406e-08,0.061843285483454746,0.05802301471533402,0.0018134264647818726,0.035964156108279965,0.040742417383431435,0.0018108015409528666,0.007827723325497526,0.020823902218198284,2.3685972735685406e-08,0.02150620522096336,0.0
96,0.3,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture a rare and often ignored injury in growing children? Answer: Yes, sternal fractures are uncommon and frequently overlooked in children. They typically occur from direct trauma to the chest but are often missed during early evaluations because they are rare and other injuries may take precedence.",0.0,0.11090354888959109,0.07877376196132271,0.0,0.056583443311015724,0.040742417383431435,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0
96,0.3,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children rare and often missed? Answer: Yes, sternal fractures are rare and commonly overlooked in children. They can be caused by direct chest trauma but are often not identified in initial exams due to their rarity and the presence of more obvious injuries.",4.737194547137081e-08,0.04004517654507289,0.057177530397442194,0.0036268529295637453,0.014910746910446804,0.040742417383431435,0.003621603081905733,0.013678481895465833,0.020823902218198284,4.737194547137081e-08,0.04348511193973836,0.0
96,0.3,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is it true that sternal fractures are rare and often overlooked in growing children? Answer: Yes, sternal fractures are uncommon and frequently missed in children. They occur from direct trauma to the chest but are often overlooked during initial assessments because they are rare and other injuries may be more evident.",2.3685972735685406e-08,0.02252085153366945,0.0018845247263646892,0.0018134264647818726,0.02133437618373879,0.0008118618278758691,0.0018108015409528666,0.04950041972606645,0.020823902218198284,2.3685972735685406e-08,0.02105340919783316,0.0
96,0.3,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Do sternal fractures in growing children occur rarely and get overlooked? Answer: Yes, sternal fractures are rare and often go unnoticed in children. They result from direct chest trauma but are often missed in early evaluations due to their infrequency and the presence of more apparent injuries.",7.105791820705622e-08,0.04725840768922307,0.07749889145604336,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.03565738861424084,0.020823902218198284,7.105791820705622e-08,0.06595796779179608,0.0
96,0.3,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in children rare and often undetected? Answer: Yes, sternal fractures are uncommon and frequently overlooked in growing children. They can happen due to direct trauma to the chest but are often missed during initial evaluations because they are rare and other injuries may be more obvious.",2.3685972735685406e-08,0.061843285483454746,0.05802301471533402,0.0018134264647818726,0.035964156108279965,0.040742417383431435,0.0018108015409528666,0.007827723325497526,0.020823902218198284,2.3685972735685406e-08,0.02150620522096336,0.0
96,0.3,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is a sternal fracture a rare and often missed injury in children who are growing? Answer: Yes, sternal fractures are rare and commonly overlooked in growing children. They occur from direct chest trauma but are often not detected in initial assessments due to their rarity and the presence of more obvious injuries.",4.737194547137081e-08,0.15119064232065815,0.07954205647400575,0.0036268529295637453,0.0965887779247141,0.040742417383431435,0.003621603081905733,0.06970312704358506,0.020823902218198284,4.737194547137081e-08,0.04167269640056892,0.0
96,0.3,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Are sternal fractures in growing children infrequent and often overlooked? Answer: Yes, sternal fractures are rare and frequently missed in children. They can result from direct trauma to the chest but are often overlooked during initial evaluations because they are rare and other injuries may be more apparent.",4.737194547137081e-08,0.01116404402174176,0.036543209876543234,0.0036268529295637453,0.014584877794231677,0.019475876740709334,0.003621603081905733,0.013678481895465833,0.020823902218198284,4.737194547137081e-08,0.04348511193973836,0.0
96,0.3,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Yes, sternal fractures are rare and often overlooked in growing children. They can occur due to direct trauma to the chest but are often missed in initial evaluations due to their infrequency and the presence of more","Question: Is it common for sternal fractures in growing children to be rare and overlooked? Answer: Yes, sternal fractures are rare and often missed in children. They occur due to direct chest trauma but are frequently overlooked during initial examinations because they are uncommon and other injuries may be more noticeable.",0.0,0.08317766166719354,0.05883487654320989,0.0,0.056583443311015724,0.040742417383431435,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0
97,0.3,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women are more prone to obesity due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.3,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to maintain their weight? Answer: The results do not support the notion that African American women have a higher obesity risk because they need fewer calories to maintain weight.,9.47438909427412e-08,0.05337117035417105,0.03637739613522416,0.0072537058591274975,0.0876200035741257,0.016397279362256018,0.00724320616381148,0.12349336091481211,0.006476247106542904,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.3,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie requirements to maintain their weight? Answer: These findings do not confirm that African American women are at increased obesity risk because of lower calorie needs for weight maintenance.,0.0,0.03960841031771123,0.027421996943288215,0.0,0.08154672712469857,0.05802419235396247,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.3,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories necessary for African American women to maintain their weight? Answer: The data do not support the claim that African American women are more susceptible to obesity due to requiring fewer calories to maintain weight.,4.73719454713706e-08,0.06413383176404563,0.005863191559908984,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.3,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less caloric intake to keep their weight steady? Answer: The evidence does not support the belief that African American women face greater obesity risk because they need fewer calories to maintain weight.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.3,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: The results do not endorse the view that African American women are at higher risk of obesity because they require fewer calories to maintain weight.,7.10579182070559e-08,0.20419030895203116,0.08608636760618084,0.005440279394345625,0.20687747871511197,0.08740894901144641,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.3,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to sustain their weight? Answer: These results do not back the perspective that African American women are more likely to become obese due to lower calorie requirements for weight maintenance.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.3,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women at risk of obesity because they require fewer calories to maintain weight? Answer: The findings do not support this hypothesis.,2.605457000925383e-07,0.21886058987062373,0.11238293444328822,0.019947691112600675,0.26854621799996403,0.08740894901144641,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
97,0.3,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have reduced calorie needs to maintain weight? Answer: The data do not uphold the idea that African American women are at greater obesity risk because of lower calorie requirements.,4.73719454713706e-08,0.015575301180038803,0.052029136316337134,0.003626852929563759,0.01837377008561525,0.05619146722164411,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
97,0.3,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it accurate that African American women require fewer calories to maintain their weight? Answer: The results do not support the assertion that African American women are more prone to obesity due to needing fewer calories for weight maintenance.,9.47438909427412e-08,0.12446318887313934,0.011158444647369814,0.0072537058591274975,0.1605828646856997,0.03493981320897727,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
98,0.3,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists content with the training and support they receive for suspected child abuse cases? Research shows mixed satisfaction among UK radiologists about their training and support in suspected child abuse. Some feel well-prepared, while others see a need for enhanced training and support, suggesting improvements are necessary.",1.8948778188548325e-07,0.0525610641003742,0.06434071040290518,0.014507411718254981,0.035449096104921196,0.08618868634603256,0.014486412327622933,0.05765417888111379,0.07359999999999998,1.8948778188548325e-07,0.08515993164293967,0.056400000000000027
98,0.3,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Do UK radiologists feel satisfied with the training and support provided for suspected child abuse? Studies reveal varied satisfaction levels among UK radiologists concerning their training and support in suspected child abuse cases. While some believe they are adequately trained, others call for more comprehensive support and training, indicating room for improvement.",1.1842986367842703e-07,0.05464125382821017,0.13574729945633984,0.009067132323909363,0.02819604509544682,0.08746355685131194,0.009054007704764333,0.005524722740418486,0.07359999999999998,1.1842986367842703e-07,0.020621410505368143,0.056400000000000027
98,0.3,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Is the training and support for suspected child abuse satisfactory to UK radiologists? Research highlights differing satisfaction levels among UK radiologists about the training and support they receive in suspected child abuse cases. Some feel sufficiently prepared, but others express the need for better training and support, pointing to areas needing enhancement.",1.1842986367842703e-07,0.009982998446384617,0.05361058601134211,0.009067132323909363,0.02725572934934828,0.04769968149305523,0.009054007704764333,0.022766998915089598,0.05320069444444443,1.1842986367842703e-07,0.020621410505368143,0.056400000000000027
98,0.3,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","How satisfied are UK radiologists with the training and support for suspected child abuse? Evidence suggests UK radiologists have mixed feelings about the training and support they get for suspected child abuse. Some feel prepared, whereas others see a need for more thorough training and support, emphasizing the need for improvements.",1.4211583641411244e-07,0.0887044646228432,0.011796527054425993,0.010880558788691236,0.049155939966197604,0.04649114381295129,0.0108648092457172,0.04397569698564796,0.0527760977818017,1.4211583641411244e-07,0.041674819703201305,0.056400000000000027
98,0.3,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? Research indicates that satisfaction among UK radiologists varies when it comes to training and support for suspected child abuse. Some report feeling adequately prepared, while others highlight the necessity for more comprehensive training and support, signaling a need for improvement.",0.0,0.07426576934570894,0.050345279888893174,0.0,0.07561605606108524,0.053091321663310855,0.0,0.07701635339555013,0.0550880740477038,0.0,0.07846949213886178,0.056400000000000027
98,0.3,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Do UK radiologists feel adequately supported and trained in suspected child abuse cases? Findings show varied satisfaction among UK radiologists about their training and support in suspected child abuse. Some feel well-equipped, but others suggest that more extensive training and support are needed, underscoring the need for enhancements.",2.1317375462116866e-07,0.06578593120984966,0.10873530256463011,0.016320838183036854,0.0877333444959838,0.06406679723668854,0.0162972138685758,0.0796330855998888,0.07359999999999998,2.1317375462116866e-07,0.10763278749499738,0.056400000000000027
98,0.3,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists happy with the training and support they receive for suspected child abuse? Research reveals mixed satisfaction levels among UK radiologists regarding their training and support in suspected child abuse cases. While some feel prepared, others indicate a requirement for more detailed training and support, pointing to the need for improvements.",9.474389094274162e-08,0.03942831015868231,0.07599175396064042,0.0072537058591274906,0.048542317239125055,0.08785522698875467,0.007243206163811466,0.025727430057937095,0.07359999999999998,9.474389094274162e-08,2.1233026323841386e-06,0.056400000000000027
98,0.3,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Is the current training and support for suspected child abuse sufficient for UK radiologists? Studies demonstrate varied satisfaction among UK radiologists with the training and support they receive in suspected child abuse. Some feel adequately prepared, but many call for more comprehensive training and support, highlighting the need for advancement.",1.6580180914979784e-07,0.0004805314541354022,0.08817848724591001,0.012693985253473108,0.013781194725740242,0.08663132477055638,0.012675610786670066,0.036147973660150434,0.07359999999999998,1.6580180914979784e-07,0.06318102492416466,0.056400000000000027
98,0.3,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","How do UK radiologists view the training and support provided for suspected child abuse? Research shows differing satisfaction levels among UK radiologists about their training and support in suspected child abuse cases. Some feel sufficiently trained, while others emphasize the need for enhanced training and support, indicating a need for improvement.",1.4211583641411244e-07,0.03325269017804722,0.050387445515474416,0.010880558788691236,0.0074275033448181205,0.08705592143319911,0.0108648092457172,0.015094564462317273,0.07359999999999998,1.4211583641411244e-07,0.041674819703201305,0.056400000000000027
98,0.3,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Research indicates varied satisfaction levels among UK radiologists regarding training and support received in suspected child abuse cases. While some feel adequately prepared, others indicate a need for more comprehensive training and support, highlighting a need for improvements in this area.","Are UK radiologists satisfied with the education and assistance they receive in suspected child abuse cases? Evidence points to mixed satisfaction among UK radiologists regarding training and support in suspected child abuse. Some feel adequately prepared, while others stress the importance of more comprehensive training and support, highlighting areas for improvement.",1.4211583641411244e-07,0.03266404714203919,0.13421550094517956,0.010880558788691236,0.0074275033448181205,0.08705592143319911,0.0108648092457172,0.015094564462317273,0.07359999999999998,1.4211583641411244e-07,0.041674819703201305,0.056400000000000027
99,0.3,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing the length of stay does not seem to lead to higher readmission rates or more physician visits within 30 days post-discharge. Further research is necessary to determine the ideal length of stay and anticipated readmission rates.,4.737194547137081e-08,0.06180783293894487,0.018773589446458537,0.0036268529295637453,0.062039761969391094,0.018511925952296185,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
99,0.3,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals detrimental to care quality? Answer: Shortening hospital stays to improve efficiency does not appear to increase readmission rates or physician visits within 30 days after discharge. Additional studies are needed to establish optimal stay durations and expected readmission figures.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.3,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from hospitals in Winnipeg compromise care quality? Answer: Reducing length of hospital stay to boost efficiency does not seem to cause more readmissions or physician visits within 30 days post-discharge. Research is required to find the best length of stay and typical readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.0037282753365996506,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.3,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals affect care quality negatively? Answer: Improving hospital efficiency by shortening stays does not appear to raise readmission rates or physician visits within 30 days after discharge. Further investigation is needed to identify optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.3,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care harmed by earlier patient discharge from Winnipeg hospitals? Answer: Decreasing hospital length of stay to enhance efficiency does not seem to increase readmission or physician visit rates within 30 days post-discharge. Research is needed to determine ideal stay durations and readmission expectations.,2.3685972735685406e-07,0.16858271242063472,0.01753826530612245,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.3,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early discharge from Winnipeg hospitals adversely impact the quality of care? Answer: Shortening hospital stays to improve efficiency does not appear to increase the frequency of readmissions or physician visits within 30 days after discharge. More research is necessary to establish optimal lengths of stay and expected readmission rates.,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
99,0.3,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier in Winnipeg hospitals reduce care quality? Answer: Enhancing hospital efficiency by reducing length of stay does not seem to lead to higher rates of readmission or physician visits within 30 days post-discharge. Further studies are needed to identify optimal stay lengths and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.3,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals negatively affect patient care quality? Answer: Improving hospital efficiency by shortening length of stay does not appear to cause increased readmission rates or physician visits within 30 days after discharge. Research is required to determine optimal lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.3,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is patient care quality compromised by earlier discharge from Winnipeg hospitals? Answer: Reducing hospital stay length to improve efficiency does not seem to result in more readmissions or physician visits within 30 days post-discharge. Additional research is needed to find optimal stay durations and expected readmission rates.,2.3685972735685406e-07,0.16858271242063472,0.01753826530612245,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.3,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals impact the quality of care? Answer: Shortening hospital stays to enhance efficiency does not appear to increase readmission or physician visit rates within 30 days after discharge. Further research is necessary to identify the best lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
100,0.3,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on sleep bruxism? Yes, the first night effect does influence sleep bruxism, causing an increase in teeth grinding or clenching during the first night in a new setting due to heightened arousal and anxiety.",3.789755637709664e-07,0.4489614911709259,0.12205549218619456,0.029014823436509962,0.424360747949462,0.05246913580246914,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
100,0.3,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism exhibit a first night effect? Indeed, sleep bruxism shows a first night effect, characterized by more frequent bruxism events on the initial night in an unfamiliar environment, often triggered by increased anxiety and arousal.",4.500334819780223e-07,0.488928072828962,0.046332773346592554,0.03445510283085558,0.4732443953925731,0.02854671280276816,0.03440522927810447,0.44393138893595907,0.0,4.500334819780227e-07,0.45473615711494775,0.0
100,0.3,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism affected by the first night effect? Yes, sleep bruxism is impacted by the first night effect, which leads to a rise in bruxism episodes on the first night of sleeping somewhere new, typically because of elevated arousal and anxiety.",3.316036182995957e-07,0.47174705971301156,0.22001467585966394,0.025387970506946217,0.41715787312844377,0.12856099342585828,0.025351221573340132,0.3422762766819605,0.025623268698060954,3.316036182995957e-07,0.31365755885504143,0.0
100,0.3,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect influence sleep bruxism? Yes, the first night effect causes an increase in sleep bruxism events during the first night in a novel environment, usually due to heightened anxiety and arousal.",4.974054274493929e-07,0.6652080769617195,0.2443064567813074,0.03808195576041934,0.634359249556105,0.15666666666666665,0.03802683236001022,0.5478777095373921,0.031217481789802305,4.974054274493935e-07,0.5172565140962813,0.0
100,0.3,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there an increase in sleep bruxism due to the first night effect? Yes, sleep bruxism increases on the first night in a new environment, a phenomenon known as the first night effect, driven by increased anxiety and arousal.",4.026615365066517e-07,0.5292828502319025,0.21345857683603248,0.030828249901291835,0.467142805974222,0.11102040816326532,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
100,0.3,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism subject to a first night effect? Yes, the first night effect results in more bruxism occurrences on the initial night in a new place, often caused by elevated arousal and anxiety levels.",4.974054274493929e-07,0.47133532013793555,0.006927098095097051,0.03808195576041934,0.4924764850977952,0.0,0.03802683236001022,0.5045560107523945,0.0,4.974054274493935e-07,0.5172565140962813,0.0
100,0.3,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does sleep bruxism show a first night effect? Yes, sleep bruxism exhibits a first night effect, meaning there is an increase in teeth grinding or clenching during the first night in an unfamiliar setting due to heightened anxiety and arousal.",3.789755637709664e-07,0.4489614911709259,0.12205549218619456,0.029014823436509962,0.3878793173936752,0.026296566837107373,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
100,0.3,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is there a first night effect on bruxism during sleep? Yes, the first night effect leads to more frequent bruxism events on the first night in a new environment, typically because of increased arousal and anxiety.",4.737194547137076e-07,0.5749580079378802,0.14058720872296526,0.03626852929563746,0.5441702490728133,0.05859375,0.036216030819057346,0.47378435208564085,0.0,4.737194547137081e-07,0.48550781578170144,0.0
100,0.3,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Does the first night effect impact sleep bruxism? Yes, the first night effect impacts sleep bruxism by causing an increase in bruxism events during the first night in a novel environment, usually linked to heightened anxiety and arousal.",4.26347509242337e-07,0.5616253278212682,0.22052408274741903,0.03264167636607371,0.5355243088616155,0.14325068870523416,0.0325944277371516,0.4545522623804188,0.02854671280276816,4.263475092423373e-07,0.42488319396526597,0.0
100,0.3,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: Yes, there is a ""first night effect"" on sleep bruxism. This effect refers to the increase in bruxism events during the first night of sleep in a new environment, usually due to heightened arousal and anxiety. This may result in more teeth grinding or clenching.","Is sleep bruxism influenced by the first night effect? Yes, sleep bruxism is influenced by the first night effect, which causes more teeth grinding or clenching on the first night in a new setting due to increased arousal and anxiety.",3.789755637709664e-07,0.5690161380202636,0.259586582747419,0.029014823436509962,0.5110932970548396,0.16262975778546715,0.028972824655245866,0.4343088312387011,0.05387755102040818,3.789755637709665e-07,0.40623295682309246,0.02775510204081633
101,0.3,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Grandmultiparous women experienced higher maternal and neonatal morbidity and neonatal mortality, even after adjusting for confounders, indicating the necessity for more careful monitoring compared to regular multiparous patients during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.3,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women who are grandmultiparous showed elevated maternal and neonatal morbidity as well as neonatal mortality after controlling for confounding factors, highlighting the importance of closer surveillance than that given to typical multiparous women during labor and delivery.",1.1842986367842703e-07,0.14888138737307655,0.024375,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
101,0.3,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for negative perinatal outcomes? Grandmultiparous women had greater maternal and neonatal complications and neonatal death rates even when accounting for confounders, suggesting they require more intensive monitoring than standard multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.3,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with adverse perinatal outcomes? Women with grandmultiparity exhibited increased maternal and neonatal morbidity and neonatal mortality after adjusting for confounders, implying the need for heightened observation compared to regular multiparous women during labor and delivery.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
101,0.3,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does being grandmultiparous independently raise the risk of adverse perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality despite controlling for confounding variables, indicating a need for closer monitoring than usual multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.3,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Even after adjusting for confounders, grandmultiparous women had higher maternal and neonatal morbidity and neonatal mortality, suggesting they should be observed more closely than regular multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for adverse perinatal outcomes? Grandmultiparous women experienced increased maternal and neonatal morbidity and neonatal mortality after controlling for confounders, pointing to the need for more vigilant monitoring than that provided to regular multiparous patients during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.3,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to adverse perinatal outcomes? After accounting for confounders, grandmultiparous women had elevated maternal and neonatal morbidity and neonatal mortality, indicating the necessity for closer observation than that given to typical multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for poor perinatal outcomes? Grandmultiparous women had increased maternal and neonatal morbidity and neonatal mortality even after adjusting for confounders, suggesting a requirement for more attentive monitoring than regular multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.3,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently linked to adverse perinatal outcomes? Women with grandmultiparity showed higher maternal and neonatal morbidity and neonatal mortality after controlling for confounders, implying the need for closer observation than standard multiparous women during labor and delivery.",9.474389094274131e-08,0.10630951163719482,0.0026311728395061636,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
102,0.3,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses explain this dissatisfaction: physicians might lack interest in assisting caregivers; even if willing, they may receive insufficient compensation for typical counseling sessions; and providing professional support to family caregivers is inherently challenging.",3.789755637709665e-07,0.3062702360237095,0.005603697399809551,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
102,0.3,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians fulfill the requirements of family caregivers for frail elderly patients? Possible reasons for dissatisfaction include physicians' disinterest in aiding caregivers, inadequate payment for usual counseling sessions, and the demanding nature of being a professional caregiver to family caregivers.",5.447773729207642e-07,0.441213152445771,0.016124697661918846,0.04170880868998307,0.4732877044469239,0.0,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
102,0.3,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are family caregivers of frail elderly individuals receiving sufficient support from physicians? The dissatisfaction may stem from physicians' lack of interest in helping caregivers, poor remuneration for counseling, and the inherent difficulty of professionally supporting family caregivers.",6.158352911278201e-07,0.5212558601193051,0.016124697661918846,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
102,0.3,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Is the medical community meeting the needs of family caregivers for the frail elderly? Hypotheses for dissatisfaction include physicians' possible disinterest, low compensation for counseling caregivers, and the demanding role of being a professional caregiver to family caregivers.",5.921493183921348e-07,0.4938568859311898,0.016124697661918846,0.045335661619546816,0.5273549257172001,0.0,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
102,0.3,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians adequately support family caregivers of frail elderly patients? The dissatisfaction might be due to physicians' lack of interest, insufficient payment for counseling sessions, and the challenging nature of providing professional care to family caregivers.",6.395212638635054e-07,0.549426737086002,0.016124697661918846,0.04896251454911057,0.5845133395571485,0.0,0.04889164160572741,0.5978370007556193,0.0,6.39521263863506e-07,0.6118015411059923,0.0
102,0.3,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are the needs of family caregivers of frail elderly individuals being met by physicians? Potential reasons for discontent include physicians' indifference, poor remuneration for counseling, and the demanding responsibility of professionally supporting family caregivers.",6.86893209334876e-07,0.6082672371089353,0.016124697661918846,0.05258936747867433,0.6451379613735839,0.0,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
102,0.3,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians effectively addressing the needs of family caregivers for the frail elderly? Hypotheses for dissatisfaction suggest physicians may be uninterested, poorly compensated for counseling, and that being a professional caregiver to family caregivers is itself demanding.",6.158352911278201e-07,0.55976403681708,0.011630404378897483,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
102,0.3,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Do physicians meet the needs of family caregivers caring for frail elderly patients? The dissatisfaction could be due to physicians' disinterest, inadequate payment for counseling, and the demanding nature of professional caregiving to family caregivers.",6.632072365991907e-07,0.5784142739592535,0.016124697661918846,0.05077594101389245,0.6143663027068302,0.0,0.050702443146680286,0.628608659422373,0.0,6.632072365991914e-07,0.6435502394205721,0.0
102,0.3,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are family caregivers of frail elderly patients receiving adequate support from physicians? Possible explanations for dissatisfaction include physicians' lack of interest, low remuneration for counseling sessions, and the demanding role of professional caregiving to family caregivers.",6.395212638635054e-07,0.549426737086002,0.016124697661918846,0.04896251454911057,0.5845133395571485,0.0,0.04889164160572741,0.5978370007556193,0.0,6.39521263863506e-07,0.6118015411059923,0.0
102,0.3,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.","Are physicians fulfilling the needs of family caregivers for frail elderly individuals? Hypotheses for dissatisfaction include physicians' possible lack of interest, poor compensation for counseling, and the challenging nature of being a professional caregiver to family caregivers.",6.158352911278201e-07,0.5212558601193051,0.016124697661918846,0.04714908808432869,0.555525802683897,0.0,0.04708084006477454,0.5679840376059375,0.0,6.158352911278206e-07,0.5810298824392386,0.0
103,0.3,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Studies suggest that airway surgery may improve serum lipid profiles in obstructive sleep apnea patients, but more research is needed due to influencing factors like lifestyle and postoperative conditions.",2.6054570009253947e-07,0.2591293038081499,0.015238629795295361,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
103,0.3,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Evidence shows airway surgery might enhance serum lipid levels in these patients, though definitive conclusions require further study considering lifestyle and postoperative variables.",4.263475092423367e-07,0.5079981273808243,0.058079503910407726,0.03264167636607372,0.5193359113257174,0.06035379812695108,0.03259442773715162,0.48960880141341656,0.031217481789802305,4.263475092423373e-07,0.4578330936254802,0.0
103,0.3,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Research suggests potential improvement in lipid profiles post-surgery, but more investigation is necessary due to factors such as patient lifestyle and recovery.",3.552895910352808e-07,0.26034728510336214,0.057476051645147866,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
103,0.3,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery have an effect on serum lipid levels among obstructive sleep apnea patients? Studies indicate possible improvement in serum lipid profiles following surgery, but conclusive evidence is lacking because of various influencing factors including lifestyle and postoperative care.",3.079176455639102e-07,0.24324956087742722,0.03185278294708691,0.023574544042164344,0.29423947299793873,0.0,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
103,0.3,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can serum lipid levels be lowered by airway surgery in obstructive sleep apnea patients? Research points to a potential benefit of airway surgery on lipid profiles, though further research is required given the impact of lifestyle and postoperative factors.",3.316036182995955e-07,0.2701604685769876,0.031179484808040493,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
103,0.3,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is airway surgery effective in lowering serum lipid levels in patients with obstructive sleep apnea? Findings suggest airway surgery may improve lipid profiles, but definitive conclusions await more studies considering lifestyle and postoperative influences.",4.50033481978022e-07,0.41676655631504333,0.027202614145147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.3,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does airway surgery improve serum lipid profiles in obstructive sleep apnea patients? Research indicates a possible positive effect, but more investigation is needed due to the influence of lifestyle and postoperative factors.",4.974054274493926e-07,0.4372779932624411,0.057476051645147866,0.03808195576041936,0.5306282510621703,0.0,0.03802683236001024,0.5447271754416723,0.0,4.974054274493935e-07,0.5596157879354227,0.0
103,0.3,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Can airway surgery impact serum lipid levels in obstructive sleep apnea patients? Evidence suggests it might improve lipid profiles, yet further research is necessary because of various factors like patient lifestyle and postoperative recovery.",4.50033481978022e-07,0.3747576362811076,0.057476051645147866,0.0344551028308556,0.46608972992459874,0.0,0.03440522927810449,0.4780358009429988,0.0,4.500334819780227e-07,0.4906229164484719,0.0
103,0.3,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Studies show potential improvement, but a firm conclusion requires more research due to lifestyle and postoperative variables.",4.974054274493926e-07,0.4372779932624411,0.057476051645147866,0.03808195576041936,0.5306282510621703,0.0,0.03802683236001024,0.5447271754416723,0.0,4.974054274493935e-07,0.5596157879354227,0.0
103,0.3,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Research indicates that airway surgery can potentially improve serum lipid profiles in patients with obstructive sleep apnea. However, a definite conclusion requires further investigation as the correlation can be influenced by various factors, including the patients' lifestyle and postoperative","Does undergoing airway surgery reduce serum lipid levels in obstructive sleep apnea patients? Research indicates potential benefits on lipid profiles, but further studies are needed as the correlation is affected by lifestyle and postoperative factors.",4.263475092423367e-07,0.3449046731314258,0.057476051645147866,0.03264167636607372,0.43531807125784505,0.0,0.03259442773715162,0.446287102628419,0.0,4.263475092423373e-07,0.4578330936254802,0.0
104,0.3,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the use of audits to identify maternal mortality merely a distinction between wealthy and impoverished areas? No, audits reveal that maternal mortality is influenced by more than just economic status. Besides resources and healthcare access, audits uncover factors such as care quality, medical protocols, cultural beliefs, and education that impact maternal mortality in various environments.",3.789755637709665e-07,0.17122439745496587,0.054614405565815274,0.02901482343650999,0.20009858000851644,0.042771218534194695,0.028972824655245866,0.223632145795285,0.028959679215860994,3.789755637709665e-07,0.2478773048135059,0.014702606371129419
104,0.3,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Does auditing maternal mortality only differentiate between rich and poor settings? No, audits show that maternal mortality is affected by multiple factors beyond wealth. While access to healthcare and resources matter, audits also expose the roles of care standards, medical procedures, cultural norms, and education in different contexts.",5.684633456564497e-07,0.2979812990274331,0.1073955687322779,0.04352223515476497,0.3604412300836972,0.042771218534194695,0.0434592369828688,0.38726156957708646,0.028959679215860994,5.684633456564497e-07,0.41493138947667196,0.014702606371129419
104,0.3,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is maternal mortality auditing simply a difference between affluent and poor regions? No, audits demonstrate that maternal mortality rates are shaped by more than economic disparities. They reveal influences like healthcare quality, medical practices, cultural perspectives, and educational attainment across diverse settings.",7.105791820705622e-07,0.4388732669167945,0.10428710937499999,0.05440279394345621,0.5002031724588556,0.042771218534194695,0.054324046228586,0.5303624132177616,0.028959679215860994,7.105791820705622e-07,0.5615348636685473,0.014702606371129419
104,0.3,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the identification of maternal mortality through audits just a contrast between rich and poor areas? No, audits indicate that maternal mortality is influenced by various factors besides wealth. These include the quality of healthcare, medical approaches, cultural attitudes, and education levels in different environments.",6.39521263863506e-07,0.3659503321400033,0.10594712830415089,0.04896251454911059,0.42788251087922946,0.042771218534194695,0.0488916416057274,0.4562544410640381,0.028959679215860994,6.39521263863506e-07,0.4855489566906259,0.014702606371129419
104,0.3,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is auditing maternal mortality solely a matter of economic status differences? No, audits show that maternal mortality is affected by more than just wealth. Factors such as healthcare quality, medical practices, cultural beliefs, and education also play significant roles across different settings.",7.105791820705622e-07,0.4388732669167945,0.10428710937499999,0.05440279394345621,0.5002031724588556,0.042771218534194695,0.054324046228586,0.5303624132177616,0.028959679215860994,7.105791820705622e-07,0.5615348636685473,0.014702606371129419
104,0.3,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the use of audits to detect maternal mortality only a distinction between rich and poor settings? No, audits reveal that maternal mortality is influenced by more than economic conditions. They highlight the importance of care quality, medical protocols, cultural attitudes, and education in various contexts.",6.158352911278206e-07,0.34277732762071267,0.10645136557334711,0.047149088084328716,0.40489299265452994,0.042771218534194695,0.04708084006477453,0.4327239436538437,0.028959679215860994,6.158352911278206e-07,0.4614514051115659,0.014702606371129419
104,0.3,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is maternal mortality identification through audits just about the divide between rich and poor? No, audits uncover that maternal mortality rates depend on more than financial resources. They emphasize the impact of healthcare quality, medical practices, cultural values, and education across diverse settings.",6.868932093348768e-07,0.4139706663475362,0.10486674947018144,0.052589367478674334,0.4755105598684839,0.042771218534194695,0.05251324468763313,0.5050446052334698,0.028959679215860994,6.868932093348768e-07,0.5355593772652893,0.014702606371129419
104,0.3,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is auditing maternal mortality merely a difference between wealthy and impoverished settings? No, audits reveal that maternal mortality is shaped by multiple factors beyond wealth, including healthcare quality, medical procedures, cultural attitudes, and education levels in different environments.",8.053230730133035e-07,0.5451827785539893,0.10165593653549383,0.0616564998025837,0.6055636881166815,0.042771218534194695,0.061567252392397465,0.6385759978579926,0.028959679215860994,8.053230730133038e-07,0.6727604987787719,0.014702606371129419
104,0.3,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is the use of audits to identify maternal mortality simply a contrast between rich and poor areas? No, audits demonstrate that maternal mortality is influenced by more than economic status, highlighting factors like quality of care, medical practices, cultural norms, and education across various settings.",6.39521263863506e-07,0.3659503321400033,0.10594712830415089,0.04896251454911059,0.42788251087922946,0.042771218534194695,0.0488916416057274,0.4562544410640381,0.028959679215860994,6.39521263863506e-07,0.4855489566906259,0.014702606371129419
104,0.3,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: No, audit to identify maternal mortality isn't just a matter of rich and poor settings. While resources and healthcare access can influence maternal mortality rates, audits also highlight other factors like quality of care, medical practices, cultural attitudes, and education levels, which affect these rates across diverse settings.","Is auditing maternal mortality just about distinguishing between rich and poor settings? No, audits show that maternal mortality rates are affected by more than wealth, including healthcare quality, medical protocols, cultural attitudes, and education in diverse contexts.",8.290090457489888e-07,0.5736225142744771,0.10090700733418367,0.06346992626736557,0.6337345650833783,0.042771218534194695,0.06337805393335033,0.6675635347312441,0.028959679215860994,8.290090457489892e-07,0.7026134619284536,0.014702606371129419
105,0.3,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","What role do hormonal differences play in gender dimorphism after injury and hemorrhagic shock? Evidence indicates that hormonal variations might affect gender-specific responses, with estrogen potentially enhancing female resilience. Nonetheless, further detailed studies are required to clarify this connection.",5.447773729207641e-07,0.38238315617676744,0.0652508464142813,0.04170880868998307,0.4603217435592093,0.016661878770468257,0.04164843544191593,0.49401850544960846,0.0,5.447773729207643e-07,0.5050949490570056,0.0
105,0.3,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal factors responsible for gender dimorphism observed after injury and hemorrhagic shock? Research points to hormonal influences, particularly estrogen, which may provide females with greater protection. However, more extensive investigation is necessary to fully comprehend these effects.",5.684633456564494e-07,0.4090514032589283,0.0652508464142813,0.04352223515476494,0.4877207177473246,0.016661878770468257,0.0434592369828688,0.5221893824163053,0.0,5.684633456564497e-07,0.5340824859302571,0.0
105,0.3,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormones the cause? Hormonal differences, especially the protective role of estrogen in females, might contribute to this dimorphism, though additional research is essential for a complete understanding.",5.447773729207641e-07,0.38238315617676744,0.0652508464142813,0.04170880868998307,0.4603217435592093,0.016661878770468257,0.04164843544191593,0.49401850544960846,0.0,5.447773729207643e-07,0.5050949490570056,0.0
105,0.3,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Is the gender dimorphism seen after injury and hemorrhagic shock due to hormonal differences? Studies suggest that estrogen may confer increased resilience in females, indicating hormonal influence, but further research is needed to confirm this relationship.",6.1583529112782e-07,0.46462125441374047,0.0652508464142813,0.047149088084328696,0.544879131587273,0.016661878770468257,0.047080840064774546,0.5810298824392386,0.0,6.158352911278206e-07,0.5947071077466926,0.0
105,0.3,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Does hormonal variation explain gender dimorphism following injury and hemorrhagic shock? Evidence suggests females may benefit from estrogen's protective effects, contributing to gender differences, yet more comprehensive studies are required.",7.579511275419318e-07,0.6526734859166807,0.0652508464142813,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
105,0.3,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal differences the reason for gender dimorphism after injury and hemorrhagic shock? The protective impact of estrogen in females could explain increased resilience, but a deeper investigation is needed to fully understand this phenomenon.",6.395212638635053e-07,0.493608791286992,0.0652508464142813,0.048962514549110575,0.5747320947369547,0.016661878770468257,0.04889164160572742,0.6118015411059923,0.0,6.39521263863506e-07,0.6264558060612724,0.0
105,0.3,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","What is the connection between hormonal differences and gender dimorphism after injury and hemorrhagic shock? Hormones, particularly estrogen, might influence female resilience, though further research is necessary to elucidate this link.",7.342651548062465e-07,0.618771934240999,0.0652508464142813,0.05621622040823809,0.7039438262169617,0.016661878770468257,0.05613484776953891,0.7453329337305146,0.0,7.342651548062476e-07,0.7646061445420895,0.0
105,0.3,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Could hormonal differences be responsible for gender dimorphism following injury and hemorrhagic shock? Research indicates estrogen may enhance female protection, but more thorough studies are required for confirmation.",8.053230730133024e-07,0.7241324498988244,0.0652508464142813,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
105,0.3,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","To what extent do hormonal differences account for gender dimorphism after injury and hemorrhagic shock? Estrogen's protective role in females is suggested, yet additional research is essential to fully grasp this association.",7.105791820705612e-07,0.5859821114180073,0.0652508464142813,0.054402793943456214,0.67004227454128,0.016661878770468257,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
105,0.3,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism following injury and hemorrhagic shock may be influenced by hormonal differences. Studies suggest that females could have increased resilience due to estrogen's protective effects. However, more comprehensive research is needed to fully understand the relationship between hormonal differences and physiological responses to such conditions.","Are hormonal factors behind the gender dimorphism observed after injury and hemorrhagic shock? Evidence points to estrogen providing females with increased resilience, but further detailed research is needed to understand this relationship completely.",6.868932093348759e-07,0.5542334131034274,0.0652508464142813,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
106,0.3,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The programs had a significant effect across various levels; graduates were seen as valuable contributors to their workplaces and frequently influenced national health policies. The impact aligned closely with the goals of public health education. The qualitative study provided deeper insights into the graduates' influence and career trajectories.,1.8948778188548325e-07,0.14154982304850883,0.01586888657648284,0.014507411718255009,0.1213608570042668,0.0,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
106,0.3,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"How do MPH programs contribute to health system strengthening in low- and middle-income countries? Graduates made notable contributions at multiple levels, often affecting their workplaces and national health sectors. The observed impact matched the objectives of public health education. Qualitative research offered a more detailed understanding of graduates' effects and career development.",4.737194547137081e-07,0.33085424431699106,0.0,0.03626852929563748,0.33647223662121295,0.0,0.03621603081905733,0.34228620648663544,0.0,4.737194547137081e-07,0.3483066942682176,0.0
106,0.3,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,What role do MPH programs play in enhancing health systems in low- and middle-income countries? There was a substantial impact at various levels; graduates were recognized for their significant workplace contributions and national influence. The impact corresponded with public health education goals. The qualitative study gave a deeper comprehension of graduates' impact and career paths.,4.026615365066519e-07,0.27369583047704094,0.0,0.030828249901291863,0.2782033284972374,0.0,0.030783626196198732,0.28286278601583437,0.0,4.026615365066519e-07,0.28768207245178345,0.0
106,0.3,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"What is the effect of MPH programs on health system strengthening in low- and middle-income countries? Graduates were perceived to have considerable influence at multiple levels, contributing meaningfully to their workplaces and often at the national level. The impact reflected the aims of public health education. The qualitative method revealed a deeper understanding of graduates' impact and career progression.",3.079176455639103e-07,0.20223686649489725,0.0,0.023574544042164372,0.2054439742148082,0.0,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
106,0.3,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How have MPH programs impacted health system strengthening in low- and middle-income countries? There was a notable effect across many levels; graduates were seen as key contributors to their workplaces and sometimes influenced national health policies. The impact was consistent with public health educational goals. The qualitative study provided more in-depth insights into graduates' impact and career development.,3.316036182995957e-07,0.21962860920676608,0.0,0.025387970506946245,0.22314355131420882,0.0,0.025351221573340132,0.22677331936479117,0.0,3.316036182995957e-07,0.23052365861183333,0.0
106,0.3,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"In what ways do MPH programs strengthen health systems in low- and middle-income countries? Graduates contributed significantly at various levels, influencing both their workplaces and national health sectors. The impact aligned with the objectives of public health education. The qualitative research uncovered a deeper understanding of graduates' impact and career progression.",4.974054274493935e-07,0.35065687161317083,0.0,0.03808195576041935,0.35667494393873156,0.0,0.0380268323600102,0.3629054936893712,0.0,4.974054274493935e-07,0.36936010346605075,0.0
106,0.3,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"What impact do MPH programs have on health system strengthening in low- and middle-income countries? Graduates were perceived as making significant contributions at multiple levels, including workplace and national influence. The impact was in line with public health education goals. The qualitative study revealed deeper insights into graduates' impact and career paths.",4.737194547137081e-07,0.33085424431699106,0.0,0.03626852929563748,0.33647223662121295,0.0,0.03621603081905733,0.34228620648663544,0.0,4.737194547137081e-07,0.3483066942682176,0.0
106,0.3,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? There was considerable influence at many levels; graduates were recognized for their contributions to workplaces and national health sectors. The impact matched public health educational aims. The qualitative method study provided a deeper understanding of graduates' impact and career trajectories.,3.552895910352811e-07,0.2620834427547365,0.017851239669421492,0.027201396971728117,0.2411620568168873,0.0,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
106,0.3,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"What contributions do MPH programs make to health system strengthening in low- and middle-income countries? Graduates had a substantial impact at various levels, often influencing their workplaces and national health policies. The impact was consistent with public health education goals. The qualitative study offered more detailed insights into graduates' impact and career development.",4.500334819780227e-07,0.31143615845988837,0.0,0.03445510283085561,0.3166696093250332,0.0,0.034405229278104466,0.3220834991691168,0.0,4.500334819780227e-07,0.32768740706548183,0.0
106,0.3,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career,"How do MPH programs affect health system strengthening in low- and middle-income countries? Graduates were seen as significant contributors at multiple levels, including workplace and national influence. The impact aligned with public health educational aims. The qualitative research provided a deeper understanding of graduates' impact and career progression.",5.684633456564497e-07,0.41253227533125836,0.0,0.04352223515476497,0.41985384556026384,0.0,0.0434592369828688,0.4274440148269427,0.0,5.684633456564497e-07,0.43531807125784683,0.0
107,0.3,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by neoadjuvant chemotherapy, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a comprehensive lymphadenectomy is recommended for patients undergoing neoadjuvant chemotherapy followed by surgery, irrespective of their response to the chemotherapy.",4.737194547137081e-08,0.03872771712894396,0.0007114496724635287,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.3,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it possible to adjust the extent of lymphadenectomy based on neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not change the frequency or distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Hence, an extensive lymphadenectomy should be conducted in patients treated with neoadjuvant chemotherapy plus surgery regardless of treatment response.",1.1842986367842703e-07,0.05836387334327675,0.05043236459864256,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
107,0.3,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? The rate and anatomical distribution of lymph node metastases are unaffected by neoadjuvant chemotherapy, and clinical non-responders present with more involved lymph nodes. Consequently, a thorough lymphadenectomy is advised for patients receiving neoadjuvant chemotherapy and surgery, no matter their response.",9.474389094274162e-08,0.07901481056001103,0.0014797441851465525,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.3,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can the scope of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not modify the frequency or topographic distribution of lymph node metastases, and patients who do not respond clinically have a higher number of involved lymph nodes. Therefore, systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery regardless of response.",1.4211583641411244e-07,0.07610201902293667,0.04926453064699038,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
107,0.3,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is the extent of lymphadenectomy in cervical cancer affected by neoadjuvant chemotherapy? The frequency and location of lymph node metastases remain the same after neoadjuvant chemotherapy, with clinical non-responders showing more involved lymph nodes. Thus, a comprehensive lymphadenectomy is necessary for patients undergoing neoadjuvant chemotherapy and surgery, irrespective of their response.",9.474389094274162e-08,0.051288923337613035,0.01851192595229618,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
107,0.3,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Could neoadjuvant chemotherapy modify the extent of lymphadenectomy in cervical cancer? The distribution and frequency of lymph node metastases are not altered by neoadjuvant chemotherapy, and clinical non-responders have more involved lymph nodes. Hence, a systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery regardless of response.",4.737194547137081e-08,0.03872771712894396,0.0007114496724635287,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
107,0.3,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is it feasible to change the extent of lymphadenectomy due to neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not affect the frequency or distribution of lymph node metastases, and clinical non-responders exhibit more involved lymph nodes. Therefore, an extensive lymphadenectomy is recommended for patients treated with neoadjuvant chemotherapy followed by surgery, regardless of their response.",2.3685972735685406e-08,0.015903050187911827,0.05553577785688854,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
107,0.3,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Can neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? The frequency and topographic distribution of lymph node metastases remain unaltered by neoadjuvant chemotherapy, with clinical non-responders showing more involved lymph nodes. As a result, systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery regardless of response.",2.3685972735685406e-08,0.019176512593258366,0.0003490207932659514,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
107,0.3,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Does neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The rate and location of lymph node metastases are not modified by neoadjuvant chemotherapy, and clinical non-responders have more involved lymph nodes. Thus, a comprehensive lymphadenectomy is advised for patients undergoing neoadjuvant chemotherapy and surgery, irrespective of their response.",1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
107,0.3,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.","Is modification of lymphadenectomy extent by neoadjuvant chemotherapy possible in cervical cancer? The frequency and distribution of lymph node metastases are unaffected by neoadjuvant chemotherapy, and clinical non-responders show more involved lymph nodes. Therefore, systemic and extensive lymphadenectomy should be performed in patients treated with neoadjuvant chemotherapy plus surgery regardless of response.",7.105791820705622e-08,0.08585078079123276,0.020638428066862512,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
108,0.3,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are doctors effectively supporting family caregivers of frail elderly patients? Although some physicians do meet these needs, support is inconsistent. Time constraints, limited resources, and knowledge gaps often hinder their ability to fully assist caregivers. Improvements in training and policy are necessary.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.3,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians adequately address the needs of family caregivers for the frail elderly? While some do, this is not uniform. Barriers such as limited appointment time, insufficient resources, and knowledge deficiencies can prevent full support. Enhanced training and policy reforms are needed.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.3,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly patients receiving sufficient support from physicians? Some physicians provide adequate care, but this is not consistent. Challenges like time limitations, lack of resources, and knowledge gaps restrict their support. Training and policy updates are essential.",5.210914001850789e-07,0.3264569985827763,0.08002462296091106,0.0398953822252012,0.3791338068410486,0.049048751486325794,0.039837633900963065,0.4105485904583839,0.033293697978596916,5.210914001850789e-07,0.44312301666624077,0.01694411414982164
108,0.3,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","To what extent are physicians meeting the needs of family caregivers for the frail elderly? Although some physicians do so well, it is not consistent. Constraints such as brief appointments, resource shortages, and knowledge gaps limit their support. Policy changes and better training are required.",4.263475092423373e-07,0.23114681877845067,0.08002462296091106,0.03264167636607371,0.2814953372771307,0.049048751486325794,0.0325944277371516,0.31046513190140246,0.033293697978596916,4.263475092423373e-07,0.3404688626061585,0.01694411414982164
108,0.3,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians fulfilling the needs of family caregivers of frail elderly individuals? Some physicians meet these needs adequately, but this is not consistent. Factors like limited time, inadequate resources, and knowledge gaps hinder full support. Training improvements and policy changes are necessary.",4.974054274493935e-07,0.3017643859924046,0.08002462296091106,0.038081955760419325,0.35381599885675685,0.049048751486325794,0.0380268323600102,0.3845731040551259,0.033293697978596916,4.974054274493935e-07,0.4164547695840799,0.01694411414982164
108,0.3,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians consistently meet the needs of family caregivers for the frail elderly? While some do, many face challenges such as time constraints, resource limitations, and knowledge gaps that impede full support. Enhanced training and policy reforms are needed.",5.684633456564495e-07,0.37775029297032603,0.08002462296091106,0.04352223515476494,0.4317775403264674,0.049048751486325794,0.0434592369828688,0.46461581172866007,0.033293697978596916,5.684633456564497e-07,0.49869286782105293,0.01694411414982164
108,0.3,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are the needs of family caregivers for frail elderly patients being met by physicians? Some physicians address these needs well, but it is inconsistent. Issues such as limited appointment time, insufficient resources, and knowledge gaps restrict support. Training and policy improvements are required.",4.737194547137081e-07,0.2776668344133446,0.08002462296091106,0.03626852929563745,0.32912338626638515,0.049048751486325794,0.03621603081905733,0.3592552960708342,0.033293697978596916,4.737194547137081e-07,0.3904792831808219,0.01694411414982164
108,0.3,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are physicians adequately supporting family caregivers of frail elderly patients? Some do, but support is inconsistent due to challenges like lack of time, inadequate resources, and knowledge gaps. Policy changes and better training are needed.",6.632072365991907e-07,0.48897592808055057,0.08002462296091106,0.05077594101389245,0.5461878915042129,0.049048751486325794,0.050702443146680286,0.5823988473850439,0.033293697978596916,6.632072365991914e-07,0.6200537248253197,0.01694411414982164
108,0.3,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Are family caregivers of frail elderly individuals receiving adequate support from physicians? While some physicians do meet their needs, this is not consistent. Constraints including limited time, resource shortages, and knowledge gaps hinder full support. Training and policy reforms are necessary.",5.210914001850789e-07,0.3264569985827763,0.08002462296091106,0.0398953822252012,0.3791338068410486,0.049048751486325794,0.039837633900963065,0.4105485904583839,0.033293697978596916,5.210914001850789e-07,0.44312301666624077,0.01694411414982164
108,0.3,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: While some physicians adequately address the needs of family caregivers for the frail elderly, it is not consistent across the board. Challenges like lack of time during appointments, inadequate resources, and gaps in knowledge can restrict their ability to fully support caregivers' needs. Training and policy changes are required","Do physicians meet the needs of family caregivers for the frail elderly consistently? Some physicians do, but challenges such as time limitations, lack of resources, and knowledge gaps often prevent comprehensive support. Improvements in training and policy are required.",5.684633456564495e-07,0.37775029297032603,0.08002462296091106,0.04352223515476494,0.4317775403264674,0.049048751486325794,0.0434592369828688,0.46461581172866007,0.033293697978596916,5.684633456564497e-07,0.49869286782105293,0.01694411414982164
109,0.3,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Question: Does neck pain correlate with a decline in health-related quality of life after six months? Answer: Our findings indicate that neck pain is linked to poorer physical health-related quality of life, but it does not affect mental health-related quality of life. This suggests that neck pain could be a factor leading to reduced physical HRQoL in the future. Increasing awareness about the potential long-term effects of neck pain is important.",3.552895910352811e-07,0.1385050689589793,0.17821148936886874,0.027201396971728103,0.1828463789004271,0.07000878410687539,0.027162023114293,0.24921579162398766,0.0,3.552895910352811e-07,0.25344890080953686,0.0
109,0.3,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Question: Is there a connection between neck pain and diminished health-related quality of life six months later? Answer: We observed that neck pain negatively impacts physical health-related quality of life, while mental health-related quality of life remains unaffected. Our study implies that neck pain might contribute to future declines in physical HRQoL within the population. It is crucial to raise awareness about the possible future consequences of neck pain.",3.079176455639103e-07,0.1363315994587957,0.10405997693194924,0.023574544042164344,0.15080717438275748,0.07269492715931879,0.023540420032387266,0.198358368457336,0.01514792899408284,3.079176455639103e-07,0.22314355131420882,0.0
109,0.3,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Does experiencing neck pain affect health-related quality of life after six months? Answer: The results show that neck pain is associated with worse physical health-related quality of life but does not influence mental health-related quality of life. This analysis indicates that neck pain may lead to poorer physical HRQoL in the future. Promoting awareness about the potential long-term impact of neck pain is advised.,2.1317375462116866e-07,0.007264061012426382,0.2245812389346926,0.016320838183036854,0.06149390954063261,0.09474610020703796,0.0162972138685758,0.13448288502329442,0.016124697661918846,2.1317375462116866e-07,0.1596301455918825,0.0
109,0.3,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Is neck pain linked to poorer health-related quality of life six months later? Answer: We found that neck pain correlates negatively with physical health-related quality of life but not with mental health-related quality of life. Our findings suggest that neck pain could be a contributing factor to future declines in physical HRQoL in the general population. Raising awareness about the possible future effects of neck pain is important.,3.079176455639103e-07,0.10325306154004288,0.18726914415720383,0.023574544042164344,0.15080717438275837,0.0726949271593188,0.023540420032387266,0.198358368457336,0.01514792899408284,3.079176455639103e-07,0.22314355131420882,0.0
109,0.3,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Does neck pain have an association with health-related quality of life six months afterward? Answer: Our study found that neck pain is negatively associated with physical HRQoL but does not affect mental HRQoL. This suggests that neck pain may contribute to future poor physical health-related quality of life. Increasing public awareness of the potential future impact of neck pain is essential.,1.4211583641411244e-07,0.03206659309587323,0.11244132123921935,0.010880558788691236,0.06171791540034732,0.03134956989257915,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
109,0.3,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Is there an association between neck pain and health-related quality of life six months later? Answer: We discovered that neck pain adversely affects physical health-related quality of life but not mental health-related quality of life. Our analysis indicates that neck pain might be a factor in future physical HRQoL decline in the population. It is important to raise awareness about the potential long-term impact of neck pain.,2.8423167282822487e-07,0.11873773858141323,0.10740703556771808,0.02176111757738247,0.13439697101454318,0.07409993669078394,0.0217296184914344,0.18276775078782448,0.015380859375,2.8423167282822487e-07,0.20763936477824352,0.0
109,0.3,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Does neck pain influence health-related quality of life six months later? Answer: Findings reveal that neck pain is linked to poorer physical health-related quality of life but has no significant effect on mental health-related quality of life. This suggests neck pain could contribute to future physical HRQoL deterioration. Awareness about the possible future consequences of neck pain should be increased.,1.1842986367842703e-07,0.028039371275157876,0.21098962847698546,0.009067132323909363,0.03486735874802438,0.0679038903742344,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
109,0.3,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,"Question: Is neck pain associated with a decline in health-related quality of life after six months? Answer: Our research found a negative association between neck pain and physical health-related quality of life, with no impact on mental health-related quality of life. This implies that neck pain may lead to future poor physical HRQoL. Raising awareness about the potential future effects of neck pain is necessary.",2.1317375462116866e-07,0.0722466091899201,0.17166847185346365,0.016320838183036854,0.12750792673681843,0.0459868646953792,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
109,0.3,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Does having neck pain relate to worse health-related quality of life six months later? Answer: We found that neck pain negatively affects physical health-related quality of life but not mental health-related quality of life. Our analysis suggests neck pain may contribute to future poor physical HRQoL in the population. It is important to raise awareness of the possible future impact of neck pain.,1.8948778188548325e-07,0.0671872667888076,0.10502227851925086,0.014507411718254981,0.08830421068055472,0.06364837281242658,0.014486412327622933,0.11785581355365027,0.016388888888888897,1.8948778188548325e-07,0.14310084364067155,0.0
109,0.3,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck,Question: Is neck pain connected to poorer health-related quality of life six months later? Answer: Our findings show that neck pain is negatively associated with physical health-related quality of life but not with mental health-related quality of life. This suggests that neck pain might be a factor contributing to future declines in physical HRQoL. Raising awareness about the potential future impact of neck pain is crucial.,2.3685972735685406e-07,0.026685491360853852,0.21908293377308777,0.018134264647818726,0.07909115538510125,0.09295029754669834,0.018108015409528666,0.15083814044068644,0.01586888657648284,2.3685972735685406e-07,0.1758906664636637,0.0
110,0.3,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical importance of bile duct sludge compared to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge has a clinical significance comparable to that of common bile duct stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.,7.105791820705622e-08,0.005780670033979085,0.3106024930747925,0.005440279394345618,0.061766069438595306,0.043359924283396425,0.0054324046228586,0.10442962480224383,0.024375,7.105791820705622e-08,0.07232066157962613,0.0
110,0.3,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical relevance of bile duct sludge differ from bile duct stones? Answer: Findings show that symptomatic bile duct sludge shares similar clinical significance with common bile duct stones. Bile duct sludge may be an early form of choledocholithiasis.,4.737194547137081e-08,0.15092164994648272,0.3751433094013229,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.3,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical impact of bile duct sludge distinct from that of bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge has a clinical significance akin to that of common bile duct stones. Bile duct sludge likely represents an early stage in the development of choledocholithiasis.,1.4211583641411244e-07,0.015911984054941986,0.3316152830807412,0.010880558788691236,0.10200100925561939,0.059166666666666604,0.0108648092457172,0.1703875925940399,0.024375,1.4211583641411244e-07,0.13976194237515838,0.0
110,0.3,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical significance of bile duct sludge in comparison to bile duct stones? Answer: The data reveal that symptomatic bile duct sludge holds clinical importance similar to that of common bile duct stones. It seems that bile duct sludge is an initial phase of choledocholithiasis.,9.474389094274162e-08,0.020972078400755656,0.2994915472092361,0.0072537058591274906,0.08533716788007739,0.04134297520661155,0.007243206163811466,0.12690248065430154,0.024375,9.474389094274162e-08,0.09531017980432566,0.0
110,0.3,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to be an early stage of choledocholithiasis.,2.3685972735685406e-08,0.15324398360420677,0.3931024930747923,0.0018134264647818726,0.0384697994073715,0.052434253780407655,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.3,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The results indicate that symptomatic bile duct sludge has a clinical significance similar to that of common bile duct stones. Bile duct sludge seems to represent an early phase of choledocholithiasis.,2.3685972735685406e-08,0.06144095674332384,0.33448753462603864,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.3,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What distinguishes the clinical significance of bile duct sludge from bile duct stones? Answer: The findings suggest that symptomatic bile duct sludge is clinically similar to common bile duct stones. Bile duct sludge may be an early stage in choledocholithiasis development.,4.737194547137081e-08,0.15092164994648272,0.3751433094013229,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.3,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical relevance of bile duct sludge different from that of bile duct stones? Answer: Evidence shows that symptomatic bile duct sludge has clinical significance comparable to common bile duct stones. Bile duct sludge appears to be an early form of choledocholithiasis.,0.0,0.12266513581234229,0.37862718443281707,0.0,0.0454652977353458,0.07478796844181461,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.3,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does bile duct sludge compare clinically to bile duct stones? Answer: The findings indicate that symptomatic bile duct sludge shares similar clinical significance with common bile duct stones. Bile duct sludge seems to be an initial stage of choledocholithiasis.,7.105791820705622e-08,0.18253074206622966,0.39019591868032855,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.3,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: The evidence suggests that symptomatic bile duct sludge has clinical significance similar to that of common bile duct stones. Bile duct sludge is likely an early phase of choledocholithiasis.,4.737194547137081e-08,0.06404584102313615,0.3518005540166206,0.0036268529295637453,0.0376286495127971,0.04547052154195008,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
111,0.3,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy forecast the results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy does not directly determine the outcome for patients treated with radical perineal prostatectomy, although it offers useful insights about the patient.",2.3685972735685406e-08,0.1409864695922498,0.10338300540123455,0.0018134264647818726,0.18173769595220524,0.14150253479137892,0.0018108015409528666,0.15175455989416253,0.12543252595155707,2.3685972735685406e-08,0.08277604458519949,0.0783673469387755
111,0.3,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can a history of benign prostate biopsy predict outcomes in patients treated with radical perineal prostatectomy? Having had a benign prostate biopsy before does not directly predict the treatment outcome for patients undergoing radical perineal prostatectomy, but it can provide important patient information.",2.3685972735685406e-08,0.22938504407939098,0.1311425203402367,0.0018134264647818726,0.23348206819806272,0.14275080348943986,0.0018108015409528666,0.20304785428171224,0.12543252595155707,2.3685972735685406e-08,0.13541977807061834,0.0783673469387755
111,0.3,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is the outcome for patients treated with radical perineal prostatectomy influenced by a prior benign prostate biopsy? A previous benign prostate biopsy does not directly predict the outcome for these patients, though it may give valuable information about the patient.",4.7371945471370706e-08,0.14766006994149405,0.1257595486111111,0.0036268529295637453,0.15482678825264484,0.1408292366523325,0.003621603081905733,0.12508631281200167,0.12543252595155707,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.3,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a prior benign prostate biopsy serve as a predictor for outcomes in patients receiving radical perineal prostatectomy? Prior benign prostate biopsy does not directly forecast the outcome for patients treated with this procedure, yet it can supply useful patient data.",2.3685972735685406e-08,0.17564382862024708,0.12764149812819575,0.0018134264647818726,0.14619168669272087,0.11599359019506442,0.0018108015409528666,0.11527312933837619,0.0991359591144497,2.3685972735685406e-08,0.08277604458519949,0.0783673469387755
111,0.3,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can prior benign prostate biopsy results predict the prognosis for patients treated with radical perineal prostatectomy? The presence of a prior benign prostate biopsy does not directly predict patient outcomes after radical perineal prostatectomy, but it provides valuable patient information.",4.7371945471370706e-08,0.11211406068201013,0.1009239477040816,0.0036268529295637453,0.11834535769685806,0.11465666768697072,0.003621603081905733,0.08761889764659925,0.0984263531120509,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.3,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does having a benign prostate biopsy before affect the outcome prediction for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy does not directly determine the outcome for these patients, although it can offer important information about the patient.",7.1057918207056e-08,0.11887831964932793,0.1237810905612245,0.005440279394345618,0.1271725565608679,0.1401196306499337,0.0054324046228586,0.09768733862388634,0.12543252595155707,7.105791820705622e-08,0.027206193430387327,0.0783673469387755
111,0.3,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is there a predictive value of prior benign prostate biopsy on outcomes for patients treated with radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict outcomes for these patients, but it can provide valuable insights about the patient.",4.7371945471370706e-08,0.11211406068201013,0.1009239477040816,0.0036268529295637453,0.11834535769685806,0.11465666768697072,0.003621603081905733,0.08761889764659925,0.0984263531120509,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
111,0.3,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Does a previous benign prostate biopsy impact the outcome prediction for patients treated with radical perineal prostatectomy? A prior benign prostate biopsy does not directly influence the outcome prediction, though it can provide useful patient information.",1.421158364141119e-07,0.02725928212658202,0.1171875,0.010880558788691243,0.039309220135856915,0.13774104683195593,0.010864809245717214,0.010675961634256215,0.12543252595155707,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
111,0.3,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Can the outcome for patients undergoing radical perineal prostatectomy be predicted by a prior benign prostate biopsy? Prior benign prostate biopsy does not directly predict the outcome, but it may offer valuable information about the patient.",1.421158364141119e-07,0.06686769244429325,0.1452154714761249,0.010880558788691243,0.039309220135856915,0.13774104683195593,0.010864809245717214,0.010675961634256215,0.12543252595155707,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
111,0.3,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy does not directly predict the outcome for patients treated with radical perineal prostatectomy. While it can provide valuable information about the patient's,"Is prior benign prostate biopsy a direct predictor of outcomes in patients treated with radical perineal prostatectomy? Prior benign prostate biopsy does not directly predict outcomes, although it can provide important information about the patient.",1.658018091497972e-07,0.005223114480584545,0.11473948848855359,0.012693985253473122,0.03378821951934752,0.10677200536248879,0.012675610786670087,0.06341739581749506,0.09421504416175477,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
112,0.3,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be offered? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade remains the sole independent prognostic factor for patient survival.,1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.3,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still advisable? Answer: Second-look laparotomy shows no benefit in overall or disease-free survival. Tumor grade is the only independent prognostic indicator for survival.",1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.3,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy continue to be performed in Thai women with advanced epithelial ovarian carcinoma? Answer: Second-look laparotomy does not positively affect overall or disease-free survival. Tumor grade is the only independent predictor of patient survival.,1.1842986367842661e-07,0.16856130494597243,0.02775510204081633,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,0.3,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, is it necessary to offer second-look laparotomy? Answer: Second-look laparotomy has no beneficial effect on overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.",9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.3,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still warranted? Answer: The procedure does not improve overall or disease-free survival. Tumor grade is the sole independent prognostic variable for survival.,2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be continued? Answer: Second-look laparotomy does not favorably impact overall or disease-free survival. Tumor grade is the only independent prognostic factor for patient survival.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.3,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be offered to Thai women with advanced epithelial ovarian carcinoma? Answer: It does not improve overall or disease-free survival. Tumor grade is the only independent prognostic variable for survival.,2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Is it advisable to continue second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy lacks a positive effect on overall and disease-free survival. Tumor grade is the only independent prognostic factor for survival.,9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,0.3,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In the case of advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy remain a treatment option? Answer: Second-look laparotomy does not enhance overall or disease-free survival. Tumor grade is the only independent prognostic variable for patient survival.",4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
112,0.3,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be maintained as a practice for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not improve overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
113,0.3,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment alone reliably rule out aspiration after an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.3,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is it possible to depend solely on bedside assessment to exclude aspiration following an acute stroke?,9.000669639560431e-07,1.1576157229314283,0.07496876301541024,0.0689102056617113,1.2588673750769428,0.03840000000000001,0.06881045855620908,1.3396940328878886,0.019599999999999992,9.00066963956045e-07,1.4271163556401447,0.0
113,0.3,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment by itself provide a reliable exclusion of aspiration post-acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.3,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can aspiration be reliably excluded after an acute stroke using only bedside assessment?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.3,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment sufficient to confidently exclude aspiration after an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
113,0.3,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment alone be trusted to rule out aspiration following an acute stroke?,9.474389094274138e-07,1.3007165665721017,0.07496876301541024,0.07253705859127504,1.4130180549042004,0.03840000000000001,0.07243206163811483,1.506748117551055,0.019599999999999992,9.474389094274156e-07,1.6094379124341,0.0
113,0.3,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is bedside assessment a dependable method to exclude aspiration after an acute stroke on its own?,9.000669639560431e-07,1.1576157229314283,0.07496876301541024,0.0689102056617113,1.2588673750769428,0.03840000000000001,0.06881045855620908,1.3396940328878886,0.019599999999999992,9.00066963956045e-07,1.4271163556401447,0.0
113,0.3,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Can bedside assessment reliably identify the absence of aspiration after an acute stroke?,9.711248821630991e-07,1.380759274245638,0.07496876301541024,0.07435048505605692,1.5000294318938305,0.03840000000000001,0.0742428631790677,1.6020582973553803,0.019599999999999992,9.71124882163101e-07,1.714798428091926,0.0
113,0.3,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Is it accurate to rely solely on bedside assessment to exclude aspiration after an acute stroke?,9.000669639560431e-07,1.1576157229314283,0.07496876301541024,0.0689102056617113,1.2588673750769428,0.03840000000000001,0.06881045855620908,1.3396940328878886,0.019599999999999992,9.00066963956045e-07,1.4271163556401447,0.0
113,0.3,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone cannot reliably exclude aspiration following an acute stroke. While useful, it only serves as an initial screening tool. It needs to be combined with other diagnostic methods like instrumental swallowing evaluations for a comprehensive and accurate identification of aspiration risk.",Does bedside assessment alone suffice to exclude aspiration following an acute stroke?,9.948108548987845e-07,1.4677706512352682,0.07496876301541024,0.07616391152083879,1.5953396116981557,0.03840000000000001,0.07605366472002058,1.7074188130132062,0.019599999999999992,9.948108548987864e-07,1.8325814637483098,0.0
114,0.3,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the boycott urged by Catholic bishops impact polio vaccination rates in Kenya in 2015? Yes, the boycott call by Catholic bishops notably reduced polio vaccination coverage in Kenya in 2015, causing lower immunization rates and increased vaccine hesitancy, which led to a public health crisis.",2.6054570009253947e-07,0.10646537173131465,0.06816959264511702,0.0199476911126006,0.08451411520222063,0.09588890633965973,0.019918816950481533,0.07375122407961276,0.109375,2.6054570009253947e-07,0.12799630575027088,0.07496876301541025
114,0.3,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was the polio vaccination coverage in Kenya in 2015 influenced by the Catholic bishops' boycott call? Indeed, the boycott call from Catholic bishops significantly lowered polio vaccination coverage in Kenya in 2015, resulting in decreased immunization and greater vaccine skepticism, contributing to a health crisis.",2.8423167282822487e-07,0.10163242956131269,0.08657853413098163,0.02176111757738247,0.1734478683639118,0.04919567283323939,0.0217296184914344,0.19630274728408592,0.0383690828402367,2.8423167282822487e-07,0.21971797250591063,0.02631656051705391
114,0.3,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call affect Kenya's polio vaccination coverage in 2015? Yes, the boycott advocated by Catholic bishops had a major negative impact on polio vaccination coverage in Kenya in 2015, causing a drop in immunization rates and rising doubts about vaccines, which triggered a public health emergency.",1.6580180914979784e-07,0.0786565197917879,0.1373830242622131,0.012693985253473108,0.007748376791651523,0.09965247856123896,0.012675610786670066,0.014299362767795643,0.0881084593572779,1.6580180914979784e-07,0.03702452754454422,0.07496876301541025
114,0.3,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' call for a boycott influence polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops in 2015 substantially affected polio vaccination coverage in Kenya, leading to reduced immunization rates and increased vaccine skepticism, which contributed to a public health crisis.",2.1317375462116866e-07,0.03337211424370734,0.13481404958677684,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.3,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Was there an effect on polio vaccination coverage in Kenya in 2015 due to the Catholic bishops' boycott call? Yes, the boycott urged by Catholic bishops significantly impacted polio vaccination coverage in Kenya in 2015, causing a decline in immunization and heightened vaccine hesitancy, resulting in a public health crisis.",1.6580180914979784e-07,0.022073076480771725,0.09762396694214875,0.012693985253473108,0.05001388825501074,0.058595752163388665,0.012675610786670066,0.0732906121771526,0.04584194214876035,1.6580180914979784e-07,0.09729819541932194,0.031580333263344126
114,0.3,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the call for boycott by Catholic bishops in 2015 affect polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops in 2015 notably decreased polio vaccination coverage in Kenya, leading to lower immunization rates and increased skepticism about vaccines, which contributed to a public health crisis.",1.8948778188548325e-07,0.05925553010774154,0.056764716004346016,0.014507411718254981,0.10302089088291222,0.03636509681585019,0.014486412327622933,0.09672044509624733,0.04447505408328825,1.8948778188548325e-07,0.08980997562153892,0.05275801921375736
114,0.3,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the Catholic bishops' boycott call in 2015 influence polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops in 2015 had a significant effect on polio vaccination coverage in Kenya, causing a drop in immunization rates and greater vaccine hesitancy, which led to a public health crisis.",1.6580180914979784e-07,0.022073076480771725,0.09762396694214875,0.012693985253473108,0.007748376791651523,0.09965247856123896,0.012675610786670066,0.014299362767795643,0.0881084593572779,1.6580180914979784e-07,0.03702452754454422,0.07496876301541025
114,0.3,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the polio vaccination coverage in Kenya in 2015 suffer due to the Catholic bishops' boycott call? Yes, the boycott call by Catholic bishops in 2015 greatly affected polio vaccination coverage in Kenya, resulting in decreased immunization rates and increased vaccine skepticism, contributing to a public health crisis.",2.1317375462116866e-07,0.00387648953902886,0.11397717774629122,0.016320838183036854,0.0373226404552609,0.0978519505104961,0.0162972138685758,0.05909539136107522,0.08716425619834711,2.1317375462116866e-07,0.08147629011537694,0.07496876301541025
114,0.3,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","In 2015, did the Catholic bishops' boycott call impact polio vaccination coverage in Kenya? Yes, the boycott call from Catholic bishops in 2015 significantly reduced polio vaccination coverage in Kenya, leading to lower immunization rates and heightened skepticism around vaccines, which caused a public health crisis.",2.6054570009253947e-07,0.04485228901487437,0.11030427579018783,0.0199476911126006,0.08451411520222063,0.09588890633965973,0.019918816950481533,0.10599062782658697,0.08613236961451248,2.6054570009253947e-07,0.12799630575027088,0.07496876301541025
114,0.3,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by Catholic bishops significantly affected the polio vaccination coverage in Kenya in 2015. This led to a decrease in immunization rates and heightened skepticism around vaccines, contributing to a public health crisis.","Did the boycott call by Catholic bishops in 2015 have an effect on polio vaccination coverage in Kenya? Yes, the boycott call by Catholic bishops in 2015 substantially affected polio vaccination coverage in Kenya, causing a decline in immunization rates and increased vaccine hesitancy, resulting in a public health crisis.",1.6580180914979784e-07,0.11938553179676781,0.007683070620133459,0.012693985253473108,0.16553841834833527,0.01875961973743781,0.012675610786670066,0.16177748629118716,0.015550639500297461,1.6580180914979784e-07,0.15757186329409967,0.011199037438104506
115,0.3,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy feasible? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.3,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model is technically achievable. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.3,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: The procedure appears technically feasible in a pig model. More long-term survival trials are intended.,2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.3,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Transgastric endoscopic splenectomy: feasibility? Answer: This technique seems technically viable in a porcine model, with further long-term survival tests planned.",7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
115,0.3,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be performed? Answer: It appears technically feasible in a pig model, and additional long-term survival experiments are forthcoming.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.3,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy achievable? Answer: In a porcine model, the procedure seems technically feasible. Further long-term survival studies will be conducted.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.3,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to carry out transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy is technically feasible in a pig model, with more long-term survival experiments planned.",7.10579182070559e-08,0.1295569760778843,0.00498842975206612,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
115,0.3,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Feasibility of transgastric endoscopic splenectomy? Answer: The technique appears technically possible in a porcine model, and additional long-term survival research is planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.3,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be technically done? Answer: It seems feasible in a pig model, with further long-term survival experiments planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.3,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy technically possible? Answer: The procedure is feasible in a porcine model, and more long-term survival studies are planned.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
116,0.3,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used in perioperative bridging? Answer: The use of fondaparinux for perioperative bridging has not been clearly defined, and there are significant limitations preventing its routine use as a bridging agent.",9.47438909427412e-08,0.04076668226083413,0.055363321799307974,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.3,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: Fondaparinux's role in perioperative bridging therapy remains unestablished, with notable constraints limiting its standard application.",2.842316728282236e-07,0.4439732848059381,0.027281306299865568,0.021761117577382555,0.4405191031173308,0.014841716949297971,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.3,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be used for perioperative bridging? Answer: The application of fondaparinux in perioperative bridging is not well established, and there are key limitations to its routine use as a bridging therapy.",9.47438909427412e-08,0.04076668226083413,0.055363321799307974,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.3,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux is not currently established as a standard agent for perioperative bridging due to important limitations.,3.079176455639089e-07,0.43128203700618917,0.011974892047241843,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
116,0.3,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: What is the role of fondaparinux in perioperative bridging? Answer: Fondaparinux has not been established as a perioperative bridging agent, and its routine use is limited by several important factors.",1.421158364141118e-07,0.10530520339840566,0.055363321799307974,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.3,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux effective for perioperative bridging therapy? Answer: The effectiveness of fondaparinux in perioperative bridging therapy is not established, with significant restrictions on its routine use.",2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.3,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux serve as a perioperative bridging agent? Answer: The role of fondaparinux in perioperative bridging therapy is unclear, and there are important limitations to its routine use.",1.894877818854824e-07,0.22380858778249557,0.019698026874753798,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.3,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux part of perioperative bridging protocols? Answer: Fondaparinux's role in perioperative bridging protocols has not been established, and there are notable limitations to its routine application.",2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.3,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Should fondaparinux be used for perioperative bridging? Answer: Fondaparinux is not established for use in perioperative bridging and has important limitations that restrict its routine use.,2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.3,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there an established role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy remains unestablished, with significant limitations to its routine use.",1.894877818854824e-07,0.27331910067963516,0.015642595360455355,0.014507411718255037,0.271247020764406,0.008435535717941887,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
117,0.3,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do individuals with episodic migraines tend to focus selectively on visual stimuli related to headaches? Studies suggest that those with episodic migraines may indeed pay more attention to headache-related visual cues. This selective attention is thought to arise from a cognitive bias toward headache-associated signals, which might influence the occurrence and severity of migraine attacks. Nevertheless, personal experiences differ widely.",2.3685972735685406e-07,0.28018272488212714,0.0668665692431746,0.018134264647818726,0.25198377029266084,0.04498614958448753,0.018108015409528666,0.25189491553384924,0.04246913580246913,2.3685972735685406e-07,0.22684712818344366,0.021728395061728398
117,0.3,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraine sufferers more likely to concentrate on headache-related visual stimuli? Research shows that episodic migraineurs often exhibit selective attention to visual cues linked to headaches. This phenomenon is attributed to a cognitive bias favoring headache-related information, potentially affecting how often and how intensely migraines occur. However, there is considerable variability among individuals.",9.474389094274162e-08,0.21993022371903415,0.10072314049586772,0.0072537058591274906,0.16668610524352978,0.06222222222222222,0.007243206163811466,0.14066928042362425,0.04246913580246913,9.474389094274162e-08,0.11351844287643953,0.021728395061728398
117,0.3,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people experiencing episodic migraines selectively focus on headache-related visual stimuli? Evidence points to episodic migraineurs having a tendency to attend more to visual stimuli associated with headaches. This selective attention stems from a cognitive bias toward headache cues, which may play a role in the frequency and intensity of migraine episodes. Individual responses, however, can vary greatly.",1.8948778188548325e-07,0.29268957800146334,0.10072314049586772,0.014507411718254981,0.24079407739725145,0.06222222222222222,0.014486412327622933,0.21617683293177015,0.04246913580246913,1.8948778188548325e-07,0.19047948401256942,0.021728395061728398
117,0.3,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is there selective attention to headache-related visual stimuli among episodic migraine patients? Research indicates that episodic migraine sufferers may selectively attend to visual stimuli linked to headaches due to a cognitive bias. This bias might contribute to the frequency and severity of migraine episodes, although individual experiences show significant variation.",0.0,0.08487516496652425,0.05998072311243629,0.0,0.08664339756999295,0.06222222222222222,0.0,0.05899124940935696,0.04246913580246913,0.0,0.03013683393738864,0.021728395061728398
117,0.3,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraineurs show selective attention to visual stimuli related to headaches? Studies suggest that individuals with episodic migraines might focus more on headache-related visual cues because of a cognitive bias. This bias could influence how often and how severe migraine attacks become, but experiences differ widely among patients.",2.3685972735685406e-08,0.12083932107480422,0.10072314049586772,0.0018134264647818726,0.06558998837215979,0.06222222222222222,0.0018108015409528666,0.0374850441883936,0.04246913580246913,2.3685972735685406e-08,0.008157927218613636,0.021728395061728398
117,0.3,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are headache-related visual stimuli selectively attended to by those with episodic migraines? Research suggests that episodic migraineurs may have a cognitive bias that leads them to focus on headache-related visual cues, potentially affecting migraine frequency and intensity. However, personal experiences vary considerably.",1.8948778188548325e-07,0.07060168071706885,0.07634814049586772,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
117,0.3,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do people with episodic migraines selectively attend to headache-related visual stimuli? Evidence suggests that episodic migraineurs may have a cognitive bias that causes them to focus on visual cues associated with headaches, which could impact the frequency and severity of migraine episodes. Nonetheless, individual experiences can vary.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.022104876432421428,0.06222222222222222,0.0054324046228586,0.006966718382439119,0.04246913580246913,7.105791820705622e-08,0.0373044468581436,0.021728395061728398
117,0.3,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Is selective attention to headache-related visual stimuli present in episodic migraineurs? Research indicates that individuals with episodic migraines may selectively attend to headache-related visual cues due to a cognitive bias, which might contribute to migraine frequency and intensity. However, there is significant individual variability.",1.4211583641411244e-07,0.053640381633472956,0.05432218868147152,0.010880558788691236,0.07989500365262181,0.038426862317403665,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
117,0.3,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Do episodic migraine sufferers selectively focus on visual stimuli related to headaches? Studies indicate that episodic migraineurs may exhibit selective attention to headache-related visual cues because of a cognitive bias, potentially influencing migraine frequency and severity. Individual experiences, however, can differ greatly.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
117,0.3,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Research indicates that episodic migraineurs may selectively attend to headache-related visual stimuli. This is due to a cognitive bias towards headache-related cues, which potentially contributes to the frequency and intensity of migraine episodes. However, individual experiences can vary significantly.","Are episodic migraineurs inclined to selectively attend to headache-related visual stimuli? Research suggests that a cognitive bias toward headache-related cues may cause episodic migraine sufferers to focus more on such visual stimuli, possibly affecting the frequency and intensity of migraine episodes. Nonetheless, individual experiences vary significantly.",9.474389094274162e-08,0.05630079993723269,0.10072314049586772,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
118,0.3,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? Yes, a surgeon's previous experience significantly impacts their skill in performing transurethral resection of the prostate. With increased practice, proficiency improves, resulting in fewer complications and better patient outcomes. Hence, prior experience is essential for successful surgeries.",1.4211583641411244e-07,0.07008665527094715,0.11516251810726973,0.010880558788691236,0.07649796330438363,0.12653055555555554,0.0108648092457172,0.05615975214573732,0.11700974593919201,1.4211583641411244e-07,0.03520285338441287,0.10560000000000003
118,0.3,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does a surgeon's previous experience affect their capability to perform transurethral resection of the prostate? Indeed, the surgeon's past experience plays a crucial role in their ability to carry out transurethral resection of the prostate. Greater experience leads to enhanced proficiency, reduced complications, and improved outcomes for patients. Thus, prior experience is vital for successful procedures.",9.474389094274162e-08,0.13613786040869424,0.13576737579723616,0.0072537058591274906,0.11621306957942412,0.1279483070348455,0.007243206163811466,0.09565177796881175,0.11774879919362988,9.474389094274162e-08,0.07442356653769533,0.10560000000000003
118,0.3,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the skill to perform transurethral resection of the prostate dependent on the surgeon's past experience? Yes, the surgeon's previous experience influences their competence in performing transurethral resection of the prostate. As experience grows, so does proficiency, which decreases complications and improves patient results. Therefore, prior experience is important for successful operations.",1.8948778188548325e-07,0.027517394462033717,0.11226799456767768,0.014507411718254981,0.0351444895955324,0.12499999999999999,0.014486412327622933,0.015044938251430384,0.11621044038363645,1.8948778188548325e-07,0.005619141135841499,0.10560000000000003
118,0.3,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does previous experience impact a surgeon's ability to perform transurethral resection of the prostate? Yes, a surgeon's ability to perform transurethral resection of the prostate is affected by their previous experience. Increased practice enhances skill, leading to fewer complications and better patient outcomes. Consequently, prior experience is critical for successful surgeries.",2.1317375462116866e-07,0.10536336111372835,0.035936269784811514,0.016320838183036854,0.1276484948657468,0.026041666666666685,0.0162972138685758,0.15056942243578364,0.014160766347355247,2.1317375462116866e-07,0.17415067385706706,0.000724716553287999
118,0.3,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the ability to conduct transurethral resection of the prostate influenced by the surgeon's experience? Yes, the surgeon's prior experience significantly affects their ability to perform transurethral resection of the prostate. Proficiency improves with practice, resulting in fewer complications and improved patient outcomes. Thus, previous experience is essential for successful procedures.",2.1317375462116866e-07,0.022185699446535256,0.09136584902391451,0.016320838183036854,0.013810113411793612,0.12418813817212412,0.0162972138685758,0.0061637598191279785,0.11578584372099372,2.1317375462116866e-07,0.02667255033367466,0.10560000000000003
118,0.3,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's experience determine their skill in performing transurethral resection of the prostate? Yes, the surgeon's previous experience plays a key role in their ability to perform transurethral resection of the prostate. With more experience, proficiency increases, complications decrease, and patient outcomes improve. Therefore, prior experience is crucial for successful operations.",1.8948778188548325e-07,0.027517394462033717,0.11226799456767768,0.014507411718254981,0.0351444895955324,0.12499999999999999,0.014486412327622933,0.015044938251430384,0.11621044038363645,1.8948778188548325e-07,0.005619141135841499,0.10560000000000003
118,0.3,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the surgeon's prior experience a determinant in performing transurethral resection of the prostate? Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Practice enhances proficiency, reduces complications, and leads to better patient outcomes. Hence, prior experience is vital for successful surgeries.",2.3685972735685406e-07,0.04521757892960476,0.08940814062681222,0.018134264647818726,0.007987995526588243,0.12334265385423229,0.018108015409528666,0.027831661198308932,0.11534320529646991,2.3685972735685406e-07,0.04817875555463802,0.10560000000000003
118,0.3,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's previous experience influence their ability to perform transurethral resection of the prostate? Yes, the surgeon's past experience impacts their skill in performing transurethral resection of the prostate. Increased practice results in greater proficiency, fewer complications, and improved patient outcomes. Therefore, prior experience is essential for successful procedures.",2.3685972735685406e-07,0.01692585727409668,0.1091436268016923,0.018134264647818726,0.007987995526588243,0.12334265385423229,0.018108015409528666,0.027831661198308932,0.11534320529646991,2.3685972735685406e-07,0.04817875555463802,0.10560000000000003
118,0.3,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Is the capability to perform transurethral resection of the prostate affected by the surgeon's experience? Yes, the surgeon's previous experience affects their capability to perform transurethral resection of the prostate. With more experience, proficiency improves, complications lessen, and patient outcomes are better. Thus, prior experience is critical for successful operations.",2.3685972735685406e-07,0.10180102224062049,0.051242392233791095,0.018134264647818726,0.09463139309658164,0.06217230785409533,0.018108015409528666,0.11631853531234437,0.05223981624746675,2.3685972735685406e-07,0.13858925736680483,0.04070005408328828
118,0.3,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Proficiency in this procedure enhances with practice, leading to fewer complications and improved patient outcomes. Therefore, a surgeon's prior experience is critical for successful operations.","Does the surgeon's experience influence their proficiency in transurethral resection of the prostate? Yes, the surgeon's prior experience influences their proficiency in performing transurethral resection of the prostate. Practice leads to improved skill, fewer complications, and enhanced patient outcomes. Therefore, prior experience is important for successful surgeries.",3.079176455639103e-07,0.17789570983532021,0.04285974923576347,0.023574544042164344,0.10718387569215704,0.09860402494331066,0.023540420032387266,0.09580069431087912,0.1138947648683429,3.079176455639103e-07,0.11562003635017026,0.10560000000000003
119,0.3,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the link between marital status, living arrangements, and mortality differ by gender? Answer: Yes, gender influences the relationship between marital status, living arrangements, and mortality. Research indicates men generally face higher mortality when unmarried or living alone, whereas women often exhibit higher rates in different contexts.",4.737194547137081e-08,0.07598393330192943,0.02388762912572437,0.0036268529295637453,0.13422581764502128,0.06534389823531647,0.003621603081905733,0.13590473601439745,0.06632653061224489,4.737194547137081e-08,0.10746514262173745,0.045351473922902494
119,0.3,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the association between marital status, living arrangement, and mortality influenced by gender? Answer: Indeed, the connection between marital status, living arrangement, and mortality varies according to gender. Studies reveal men usually experience increased mortality when single or living alone, while women tend to show elevated rates in other scenarios.",2.3685972735685406e-08,0.03298572939483613,0.03678094072033461,0.0018134264647818726,0.09195818855147353,0.07989923827766944,0.0018108015409528666,0.09447112089549092,0.08264462809917357,2.3685972735685406e-08,0.06698066889307208,0.06353305785123965
119,0.3,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender affect the relationship between marital status, living arrangement, and mortality? Answer: Yes, gender plays a role in how marital status and living arrangements relate to mortality. Evidence suggests men have higher death rates when unmarried or living alone, whereas women often have higher mortality under different conditions.",0.0,0.08487516496652381,0.06058834876543211,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0
119,0.3,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is there a gender difference in how marital status and living arrangement relate to mortality? Answer: Yes, the association between marital status, living arrangement, and mortality differs by gender. Research shows men are more likely to have higher mortality when living alone or unmarried, while women often have increased mortality in other circumstances.",9.474389094274162e-08,0.19163850206352606,0.08098765432098766,0.0072537058591274906,0.10892384019686752,0.020823902218198284,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
119,0.3,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the connection between marital status, living arrangement, and mortality change based on gender? Answer: Yes, gender modifies the association between marital status, living arrangement, and mortality. Studies find men tend to have greater mortality risks when single or living alone, while women frequently show higher mortality in other contexts.",2.3685972735685406e-08,0.005259842172438578,0.017777777777777795,0.0018134264647818726,0.06366646689596545,0.060163752102789375,0.0018108015409528666,0.06558998837215979,0.06222222222222222,2.3685972735685406e-08,0.0374850441883936,0.04246913580246913
119,0.3,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: How does gender influence the association between marital status, living arrangement, and mortality? Answer: Gender influences this association, with men showing higher mortality rates when unmarried or living alone, and women often displaying higher mortality in different living situations.",2.3685972735685396e-07,0.15063777461843442,0.05536438562292671,0.018134264647818726,0.2047337186581739,0.020823902218198284,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
119,0.3,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Are the effects of marital status and living arrangement on mortality different for men and women? Answer: Yes, the effects vary by gender. Men typically have higher mortality when living alone or unmarried, while women often experience higher mortality rates in other scenarios.",1.4211583641411244e-07,0.08193210328898104,0.03458670250659146,0.010880558788691236,0.1046502601011925,0.020823902218198284,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
119,0.3,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does the relationship between marital status, living arrangement, and mortality vary between genders? Answer: Yes, it does. Men generally have increased mortality risks when unmarried or living alone, whereas women often exhibit higher mortality under different conditions.",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
119,0.3,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Is the link between marital status, living arrangement, and mortality gender-specific? Answer: Yes, the association varies by gender, with men facing higher mortality when single or living alone, and women showing higher mortality rates in other contexts.",2.8423167282822456e-07,0.20520291400977175,0.05398148148148149,0.02176111757738247,0.2588009399284501,0.020823902218198284,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
119,0.3,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Yes, the association between marital status, living arrangement, and mortality does vary by gender. Studies have found that men tend to have higher mortality rates when living alone or being unmarried, while women often show higher","Question: Does gender impact how marital status and living arrangement relate to mortality? Answer: Yes, gender impacts this relationship. Men tend to have higher mortality rates when unmarried or living alone, while women often have higher mortality in other living arrangements.",2.1317375462116866e-07,0.15908867543065286,0.031126158476112324,0.016320838183036854,0.21430424151439986,0.004799366479862666,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
120,0.3,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of living in an urban environment affect the risk of non-communicable diseases in Thailand? Answer: Urban living was linked to higher behavioral and physiological risk factors, but these links might not directly cause increases in biological risk factors. These biological risks likely result from a complex interplay involving long-term accumulation.",1.4211583641411244e-07,0.036755986567840626,0.0507015306122449,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
120,0.3,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does living in an urban area impact non-communicable disease risk in Thailand over time? Answer: Urbanicity correlates with elevated behavioral and physiological risk factors, though these do not necessarily lead to increased biological risk factors. The biological risks probably stem from a complex interaction involving prolonged exposure.",2.6054570009253947e-07,0.13584688921207055,0.0507015306122449,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
120,0.3,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: In Thailand, does the timing of urban living influence non-communicable disease risk? Answer: Urban living is associated with rises in behavioral and physiological risk factors; however, these may not directly increase biological risk factors, which likely arise from a complex combination of long-term factors.",3.552895910352811e-07,0.2543649562271524,0.027986549541395792,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
120,0.3,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the duration of urban residence affect non-communicable disease risk in Thailand? Answer: Urbanicity is linked to increased behavioral and physiological risks, but these associations might not directly elevate biological risk factors, which probably result from a complex interaction of long-term accumulation.",4.026615365066519e-07,0.26937828183659374,0.0507015306122449,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
120,0.3,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: What is the relationship between urban living timing and non-communicable disease risk in Thailand? Answer: Urban living correlates with higher behavioral and physiological risk factors, yet these do not necessarily translate into increased biological risks, which are likely due to complex long-term interactions.",3.789755637709665e-07,0.2780871881733735,0.027458900226757378,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
120,0.3,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does the timing of living in urban areas influence non-communicable disease risk in Thailand? Answer: Urbanicity is associated with increased behavioral and physiological risk factors, but these associations may not directly cause biological risk factors, which likely result from a complex long-term interaction.",3.789755637709665e-07,0.2780871881733735,0.027458900226757378,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
120,0.3,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How does the timing of urban exposure relate to non-communicable disease risk in Thailand? Answer: Urban living is linked to rises in behavioral and physiological risk factors; however, these may not directly cause biological risk factors, which probably arise from complex long-term interactions.",3.789755637709665e-07,0.24584778442639932,0.0507015306122449,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
120,0.3,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Is the timing of urban residency important for non-communicable disease risk in Thailand? Answer: Urbanicity associates with increased behavioral and physiological risk factors, but these may not directly increase biological risk factors, which likely result from complex long-term processes.",4.73719454713708e-07,0.3790322632498011,0.025078261914183952,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
120,0.3,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: Does living in an urban environment at certain times affect non-communicable disease risk in Thailand? Answer: Urban living is related to higher behavioral and physiological risk factors, though these may not directly lead to biological risk factors, which probably come from complex long-term interactions.",3.552895910352811e-07,0.2543649562271524,0.027986549541395796,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
120,0.3,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of","Question: How important is the timing of urban living for non-communicable disease risk in Thailand? Answer: Urbanicity is linked to elevated behavioral and physiological risk factors, but these do not necessarily cause biological risk factors, which likely result from complex long-term accumulation.",4.263475092423373e-07,0.3272878910039436,0.0263265306122449,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
121,0.3,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect the response to intravenous thrombolysis in ischemic stroke? Yes, sex can impact the response to intravenous thrombolysis in ischemic stroke. Research shows women might face a greater risk of symptomatic intracranial hemorrhage after treatment. Nonetheless, males and females typically experience comparable functional outcomes following thrombolysis. More studies are required for a thorough understanding.",7.105791820705622e-08,0.03703054902509706,0.010960766859765131,0.005440279394345618,0.036502088039712444,0.012177740243756535,0.0054324046228586,0.035909484458663155,0.01345876485848442,7.105791820705622e-08,0.03524657940343623,0.01480384070394862
121,0.3,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Indeed, sex can influence the response to intravenous thrombolysis in ischemic stroke. Evidence suggests that women may have an increased risk of symptomatic intracranial hemorrhage after treatment. However, both men and women usually have similar functional outcomes post-thrombolysis. Additional research is necessary for a complete understanding.",2.3685972735685406e-08,0.003993923476006245,0.014609765474817377,0.0018134264647818726,0.004449862880897992,0.01537870049980776,0.0018108015409528666,0.004936368658722046,0.01614763552479817,2.3685972735685406e-08,0.0054559160177012345,0.016916570549788526
121,0.3,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? Yes, sex can affect the response to intravenous thrombolysis in ischemic stroke. Studies suggest women may be at higher risk for symptomatic intracranial hemorrhage following treatment. Still, functional outcomes after thrombolysis are generally alike in both sexes. Further investigation is needed for full comprehension.",2.3685972735685406e-08,0.003993923476006245,0.014609765474817377,0.0018134264647818726,0.004449862880897992,0.01537870049980776,0.0018108015409528666,0.004936368658722046,0.01614763552479817,2.3685972735685406e-08,0.00545591601770079,0.016916570549788526
121,0.3,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can sex influence the effectiveness of intravenous thrombolysis in ischemic stroke? Yes, sex can influence how patients respond to intravenous thrombolysis in ischemic stroke. Research indicates women might have a higher likelihood of symptomatic intracranial hemorrhage post-treatment. Despite this, functional outcomes are generally similar between males and females after thrombolysis. More research is essential for a detailed understanding.",2.3685972735685406e-08,0.07695678458757893,0.06594685804605069,0.0018134264647818726,0.07871563222660605,0.06814093344914825,0.0018108015409528666,0.08055242471980728,0.07025194488349686,2.3685972735685406e-08,0.08247226941325136,0.07227989234909649
121,0.3,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is the response to intravenous thrombolysis in ischemic stroke dependent on sex? Yes, sex can impact the response to intravenous thrombolysis in ischemic stroke. Studies reveal that women may have an elevated risk of symptomatic intracranial hemorrhage after treatment. However, functional outcomes post-thrombolysis tend to be comparable between men and women. Further studies are needed for comprehensive insight.",2.3685972735685406e-08,0.003993923476006245,0.014609765474817377,0.0018134264647818726,0.004449862880897992,0.01537870049980776,0.0018108015409528666,0.004936368658722046,0.01614763552479817,2.3685972735685406e-08,0.0054559160177012345,0.016916570549788526
121,0.3,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does sex affect outcomes after intravenous thrombolysis in ischemic stroke? Yes, sex can affect the outcomes of intravenous thrombolysis in ischemic stroke. Research shows women may have a higher risk of symptomatic intracranial hemorrhage following treatment. Nonetheless, both males and females generally achieve similar functional recovery after thrombolysis. Additional research is required for a complete understanding.",7.105791820705622e-08,0.038585507035988176,0.06405208852307599,0.005440279394345618,0.040514265355837686,0.06682397985299236,0.0054324046228586,0.042560007680198186,0.06956658112833253,7.105791820705622e-08,0.04473194143040393,0.07227989234909649
121,0.3,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is there a sex difference in response to intravenous thrombolysis for ischemic stroke? Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate women might have a greater risk of symptomatic intracranial hemorrhage post-treatment. However, functional outcomes after thrombolysis are usually similar for both sexes. More research is needed for thorough understanding.",7.105791820705622e-08,0.038585507035988176,0.06405208852307598,0.005440279394345618,0.040514265355837686,0.06682397985299236,0.0054324046228586,0.042560007680198186,0.06956658112833253,7.105791820705622e-08,0.04473194143040393,0.07227989234909649
121,0.3,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Does gender impact the response to intravenous thrombolysis in ischemic stroke? Yes, gender can impact the response to intravenous thrombolysis in ischemic stroke. Evidence suggests women may be at increased risk of symptomatic intracranial hemorrhage after treatment. Despite this, functional outcomes are generally alike in men and women following thrombolysis. Further research is necessary for a full understanding.",2.3685972735685406e-08,0.020327030227851317,0.0019840061514801582,0.0018134264647818726,0.02030539356767136,0.0017937716262976244,0.0018108015409528666,0.020268983361639403,0.001572472126105326,2.3685972735685406e-08,0.020216201780815624,0.0013201076509034987
121,0.3,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Can the patient's sex influence the response to intravenous thrombolysis in ischemic stroke? Yes, the patient's sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies suggest women may face a higher risk of symptomatic intracranial hemorrhage after treatment. However, functional outcomes post-thrombolysis are typically similar between sexes. More research is needed to fully understand this.",2.3685972735685406e-08,0.06896893763556733,0.03392775615148021,0.0018134264647818726,0.045060650016241155,0.018642751218134343,0.0018108015409528666,0.020268983361639403,0.001572472126105326,2.3685972735685406e-08,0.020216201780815624,0.0013201076509034987
121,0.3,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes, sex can influence the response to intravenous thrombolysis in ischemic stroke. Studies indicate that women may have a higher risk of symptomatic intracranial hemorrhage post-treatment. However, both males and females generally have similar functional outcomes after thrombolysis. Further research is needed for a comprehensive understanding.","Is sex a factor in the response to intravenous thrombolysis in ischemic stroke? Yes, sex is a factor that can influence the response to intravenous thrombolysis in ischemic stroke. Research indicates women might have an increased risk of symptomatic intracranial hemorrhage following treatment. Nonetheless, functional outcomes after thrombolysis are generally comparable between males and females. Further studies are required for comprehensive understanding.",7.105791820705622e-08,0.05865928256513797,0.005590205096805051,0.005440279394345618,0.08169448651737232,0.021161600274528902,0.0054324046228586,0.08197597703240866,0.020989511344969028,7.105791820705622e-08,0.08222635264781353,0.02070964441521219
122,0.3,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal-induced anxiety in alcoholism linked to a deficiency in beta-endorphin? Yes, anxiety caused by withdrawal in alcoholism is connected to a lack of beta-endorphin. This peptide plays a role in regulating stress and pain. When alcohol",7.10579182070559e-08,0.13602178369588858,0.034636678200692064,0.005440279394345639,0.17625555625968126,0.06222222222222223,0.005432404622858621,0.1370924930703663,0.0322222222222222,7.105791820705622e-08,0.09531017980432521,0.0
122,0.3,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does withdrawal-induced anxiety in alcoholism stem from beta-endorphin deficiency? Indeed, anxiety during withdrawal in alcoholism is related to beta-endorphin shortage. Beta-endorphin is a peptide that helps control stress and pain. When alcohol",4.73719454713706e-08,0.018787230181123604,0.05777777777777784,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
122,0.3,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during alcohol withdrawal due to a beta-endorphin deficiency? Yes, withdrawal anxiety in alcoholism is associated with reduced beta-endorphin levels. Beta-endorphin is a peptide that modulates stress and pain. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
122,0.3,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency the cause of withdrawal-induced anxiety in alcoholism? Yes, anxiety induced by withdrawal in alcoholism is linked to a deficiency in beta-endorphin, a peptide involved in stress and pain regulation. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
122,0.3,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is withdrawal anxiety in alcoholism caused by a lack of beta-endorphin? Yes, the anxiety seen during withdrawal in alcoholism is connected to beta-endorphin deficiency. Beta-endorphin is a peptide that manages stress and pain. When alcohol",2.36859727356853e-08,0.11510635968914018,0.0606152433425161,0.0018134264647818796,0.11741505623674797,0.06222222222222223,0.0018108015409528735,0.07646787125393084,0.0322222222222222,2.3685972735685406e-08,0.0327898228229917,0.0
122,0.3,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety from alcohol withdrawal due to beta-endorphin deficiency? Yes, withdrawal-related anxiety in alcoholism is indeed associated with a deficiency of beta-endorphin, a peptide that helps regulate stress and pain. When alcohol",2.36859727356853e-08,0.09525510143505445,0.09000000000000004,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
122,0.3,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Yes, the anxiety linked to withdrawal in alcoholism is related to a shortage of beta-endorphin, a peptide that modulates stress and pain. When alcohol",4.73719454713706e-08,0.06350640312047462,0.09000000000000004,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
122,0.3,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety caused by alcohol withdrawal related to beta-endorphin deficiency? Yes, withdrawal anxiety in alcoholism is connected to a lack of beta-endorphin, a peptide involved in controlling stress and pain. When alcohol",2.36859727356853e-08,0.09525510143505445,0.09000000000000004,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
122,0.3,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is beta-endorphin deficiency responsible for withdrawal-induced anxiety in alcoholism? Yes, anxiety during withdrawal in alcoholism is associated with a deficiency in beta-endorphin, a peptide that regulates stress and pain. When alcohol",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
122,0.3,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Yes, withdrawal-induced anxiety in alcoholism is indeed associated with beta-endorphin deficiency. Beta-endorphin is a peptide involved in managing stress and pain. When alcohol","Is the anxiety experienced during withdrawal from alcoholism due to beta-endorphin deficiency? Yes, withdrawal-induced anxiety in alcoholism is linked to a deficiency in beta-endorphin, a peptide that helps manage stress and pain. When alcohol",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
123,0.3,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are we adhering to guidelines when preparing high-fall-risk patients for discharge home after rehabilitation? Compliance with these guidelines varies, emphasizing the importance of thorough assessments, tailored care plans, patient education, and home safety precautions. Nonetheless, research indicates inconsistent application, underscoring the necessity for enhancement.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.3,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we follow the recommended guidelines for discharging patients at high risk of falls after rehabilitation? Guideline adherence is variable, with a focus on comprehensive evaluations, individualized care strategies, patient education, and ensuring home safety. However, studies reveal inconsistent implementation, pointing to a need for better practices.",4.026615365066519e-07,0.3144933299024406,0.0,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
123,0.3,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of high-fall-risk patients for home discharge after rehabilitation aligned with established guidelines? Compliance fluctuates, stressing the need for detailed assessments, customized care plans, educational efforts, and home safety measures. Yet, evidence shows inconsistent adherence, indicating room for improvement.",5.447773729207643e-07,0.454255272277599,0.0,0.04170880868998307,0.46357273891544715,0.0,0.04164843544191593,0.4732877044469239,0.0,5.447773729207643e-07,0.48342664957787385,0.0
123,0.3,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","When discharging patients at high risk of falls post-rehabilitation, do we meet the guidelines? Adherence to these guidelines is inconsistent, though it is vital to conduct thorough assessments, create personalized care plans, provide education, and implement home safety protocols. Research highlights gaps in application, suggesting improvements are necessary.",3.789755637709665e-07,0.29298712468147725,0.0,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
123,0.3,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are guidelines being met in preparing high-risk fall patients for discharge home following rehabilitation? Compliance is variable, with critical components including comprehensive assessments, individualized care plans, patient education, and home safety measures. Studies suggest inconsistent practice, highlighting the need for improvement.",5.447773729207643e-07,0.454255272277599,0.0,0.04170880868998307,0.46357273891544715,0.0,0.04164843544191593,0.4732877044469239,0.0,5.447773729207643e-07,0.48342664957787385,0.0
123,0.3,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we comply with guidelines for preparing patients at high risk of falls for home discharge after rehabilitation? Compliance varies, emphasizing the importance of thorough assessments, personalized care, education, and home safety. However, research points to inconsistent implementation, indicating a need for improvement.",4.974054274493935e-07,0.40546510810816727,0.0,0.038081955760419325,0.4135623183407837,0.0,0.0380268323600102,0.4219944100593742,0.0,4.974054274493935e-07,0.430782916092455,0.0
123,0.3,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is there adherence to guidelines when preparing high-risk fall patients for home discharge post-rehabilitation? Compliance is inconsistent, though comprehensive assessments, tailored care plans, patient education, and home safety are essential. Studies show gaps in guideline application, underscoring the need for enhancement.",5.447773729207643e-07,0.454255272277599,0.0,0.04170880868998307,0.46357273891544715,0.0,0.04164843544191593,0.4732877044469239,0.0,5.447773729207643e-07,0.48342664957787385,0.0
123,0.3,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Are the guidelines followed when preparing patients at high risk of falls for discharge home after rehabilitation? Compliance varies, with a focus on thorough assessments, personalized care plans, education, and home safety measures. Research indicates inconsistent implementation, highlighting the necessity for improvement.",5.210914001850789e-07,0.4295626596872273,0.0,0.0398953822252012,0.4382549309311554,0.0,0.039837633900963065,0.44731221804366594,0.0,5.210914001850789e-07,0.456758402495713,0.0
123,0.3,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Do we meet the recommended guidelines for preparing high-risk fall patients for discharge home after rehabilitation? Compliance is inconsistent, stressing the importance of comprehensive assessments, individualized care plans, patient education, and home safety. Studies reveal gaps in adherence, suggesting the need for better implementation.",4.737194547137081e-07,0.38193461069797285,0.0,0.03626852929563745,0.3894647667617237,0.0,0.03621603081905733,0.3973017974690025,0.0,4.737194547137081e-07,0.4054651081081633,0.0
123,0.3,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: Compliance with guidelines for preparing high-risk fall patients for home discharge post-rehabilitation varies. It's critical to ensure comprehensive assessments, personalized care plans, education, and home safety measures are in place. However, studies suggest that implementation of these guidelines is inconsistent, highlighting the need for improvement.","Is the preparation of patients at high risk of falls for home discharge after rehabilitation compliant with guidelines? Compliance varies, emphasizing comprehensive assessments, personalized care plans, education, and home safety measures. Research points to inconsistent adherence, indicating room for improvement.",5.684633456564496e-07,0.4795730802618907,0.0,0.04352223515476494,0.4895482253187051,0.0,0.0434592369828688,0.4999559515290848,0.0,5.684633456564497e-07,0.5108256237659892,0.0
124,0.3,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both effective and safe for preventing CSF fistulas in cases involving large dural tears and in debilitated or irradiated patients, as well as for treating existing CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.3,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? Evidence suggests lumbar drainage is a safe and effective approach for preventing CSF fistulas in patients with significant dural tears or compromised health due to irradiation, and it also aids in healing CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.3,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage successfully manage cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered both a safe and effective method to prevent CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, and it also helps treat CSF leaks.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.3,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a reliable treatment for postoperative CSF fistula following spine surgery? It seems that lumbar drainage is effective and safe for both preventing CSF fistulas in cases of large dural tears or in debilitated/irradiated patients and for treating CSF leaks.,2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.3,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,How effective is lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to be a safe and effective strategy to prevent CSF fistulas in patients with large dural tears or compromised conditions and to treat CSF leaks.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.3,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective prevention and treatment for postoperative CSF fistulas after spine surgery? Lumbar drainage is regarded as both safe and effective in preventing CSF fistulas in cases of extensive dural tears and in debilitated or irradiated patients, as well as in treating CSF leaks.",1.4211583641411244e-07,0.11414563352837703,0.018404866306964203,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.3,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula management after spine surgery? The procedure seems effective and safe for preventing CSF fistulas in patients with large dural tears or debilitated/irradiated conditions and for treating CSF leaks.,9.47438909427412e-08,0.07070315662982951,0.02498356344510192,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
124,0.3,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively prevent and treat cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered a safe and effective method for preventing CSF fistulas in cases of large dural tears and debilitated or irradiated patients, and for treating CSF leaks.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.3,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a safe and effective approach for postoperative CSF fistula after spine surgery? It appears that lumbar drainage effectively prevents CSF fistulas in patients with large dural tears or debilitated/irradiated status and also treats CSF leaks.,7.10579182070559e-08,0.08077159760711661,0.0020226093944042435,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
124,0.3,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How safe and effective is lumbar drainage in managing postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage seems to be both a safe and effective option for preventing CSF fistulas in cases of large dural tears and debilitated or irradiated patients, as well as for treating CSF leaks.",1.8948778188548325e-07,0.13033551825195833,0.0372386587771203,0.014507411718254981,0.15709033087573498,0.0212665406427221,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
125,0.3,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? The concurrent use of a neuroendoscope does not have a direct impact on the incidence of ventriculoperitoneal shunt infections. However, it enables",4.73719454713706e-08,0.21121684305236954,0.14999999999999997,0.003626852929563759,0.22224058789736478,0.18180026968948756,0.003621603081905747,0.18953316322228275,0.1728395061728395,4.737194547137081e-08,0.10874827400241571,0.12244897959183673
125,0.3,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infection affected by the simultaneous use of a neuroendoscope? The simultaneous application of a neuroendoscope does not directly alter the rate of ventriculoperitoneal shunt infections. Nonetheless, it permits",4.73719454713706e-08,0.16920792301843335,0.12109393579072529,0.003626852929563759,0.22224058789736478,0.18180026968948756,0.003621603081905747,0.18953316322228275,0.1728395061728395,4.737194547137081e-08,0.10874827400241571,0.12244897959183673
125,0.3,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the use of a neuroendoscope at the same time influence ventriculoperitoneal shunt infection rates? Using a neuroendoscope simultaneously does not directly affect the frequency of ventriculoperitoneal shunt infections. However, it facilitates",9.47438909427412e-08,0.18528490029414169,0.1757907253269917,0.007253705859127518,0.20102376554479084,0.21301775147928986,0.007243206163811494,0.12284178872360929,0.1728395061728395,9.474389094274162e-08,0.039755402515464944,0.12244897959183673
125,0.3,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does employing a neuroendoscope concurrently impact the occurrence of ventriculoperitoneal shunt infections? Concurrent use of a neuroendoscope does not directly change the incidence of ventriculoperitoneal shunt infections. Still, it allows for",1.184298636784265e-07,0.10330398723786338,0.14123456790123454,0.009067132323909398,0.11931896003738895,0.17857897596908578,0.009054007704764368,0.08775046891234028,0.1728395061728395,1.1842986367842703e-07,0.0033877583445902637,0.12244897959183673
125,0.3,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is there an effect on ventriculoperitoneal shunt infection rates from the simultaneous use of a neuroendoscope? The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infections. However, it enables",2.36859727356853e-08,0.16322974849211125,0.09731272294887042,0.0018134264647818796,0.17030718524730792,0.12301775147928982,0.0018108015409528735,0.1346384639668683,0.11061728395061726,2.3685972735685406e-08,0.0968189238860564,0.09022675736961452
125,0.3,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does simultaneous neuroendoscope use influence the frequency of ventriculoperitoneal shunt infections? The use of a neuroendoscope at the same time does not directly impact the incidence of ventriculoperitoneal shunt infections. Nevertheless, it allows for",4.73719454713706e-08,0.2532257630863053,0.17964620187304892,0.003626852929563759,0.22224058789736478,0.18180026968948756,0.003621603081905747,0.18953316322228275,0.1728395061728395,4.737194547137081e-08,0.10874827400241571,0.12244897959183673
125,0.3,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the simultaneous application of a neuroendoscope affect ventriculoperitoneal shunt infection incidence? Applying a neuroendoscope simultaneously does not directly affect the rate of ventriculoperitoneal shunt infections. However, it facilitates",1.658018091497971e-07,0.07391952606862295,0.16899408284023665,0.012693985253473157,0.0956632498869654,0.21301775147928986,0.012675610786670115,0.013642496758618616,0.1728395061728395,1.6580180914979784e-07,0.07357328279153919,0.12244897959183673
125,0.3,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Is the incidence of ventriculoperitoneal shunt infections influenced by concurrent neuroendoscope use? Concurrent neuroendoscope use does not directly impact ventriculoperitoneal shunt infection rates. However, it allows for",2.131737546211677e-07,0.007805448069273524,0.1636111111111111,0.016320838183036916,0.018702208750835947,0.21301775147928986,0.016297213868575862,0.06640021091491866,0.1728395061728395,2.1317375462116866e-07,0.15695489173058963,0.12244897959183673
125,0.3,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does the combined use of a neuroendoscope alter the incidence of ventriculoperitoneal shunt infections? The combined use of a neuroendoscope does not directly affect the frequency of ventriculoperitoneal shunt infections. However, it enables",7.10579182070559e-08,0.003220052992447542,0.03839999999999996,0.005440279394345639,0.010217723671026135,0.057692307692307626,0.005432404622858621,0.018113904287301974,0.07407407407407404,7.105791820705622e-08,0.020759785336706305,0.05386187396769407
125,0.3,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not directly influence the incidence of ventriculoperitoneal shunt infection. However, it allows for","Does using a neuroendoscope at the same time affect ventriculoperitoneal shunt infection incidence? Using a neuroendoscope simultaneously does not directly influence the incidence of ventriculoperitoneal shunt infections. However, it permits",1.421158364141118e-07,0.06462211017901032,0.13792899408284023,0.010880558788691277,0.08252038116070093,0.1773524565547357,0.010864809245717241,0.051382824741465605,0.1728395061728395,1.4211583641411244e-07,0.034352569638256725,0.12244897959183673
126,0.3,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
126,0.3,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can automatic transmission enhance driving habits in elderly drivers? Answer: It is suggested that older drivers switch to automatic transmission to help preserve safe driving and improve their transportation quality.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.3,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is automatic transmission beneficial for the driving performance of senior drivers? Answer: Older drivers might be advised to use automatic transmission to sustain safe driving and ensure better transport mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.3,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does using automatic transmission positively affect the driving behavior of older adults? Answer: Recommending automatic transmission for older drivers can help them maintain safety and the quality of their travel.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.3,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Can automatic transmission aid in improving driving skills among elderly drivers? Answer: For older drivers, switching to automatic transmission is often recommended to uphold safe driving and enhance transport mobility.",1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.3,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is it advantageous for older drivers to use automatic transmission for better driving behavior? Answer: Older drivers may benefit from automatic transmission as it supports safer driving and maintains the quality of their transportation.,2.36859727356853e-08,0.07092585368024018,0.03004703719723184,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
126,0.3,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission contribute to safer driving in senior drivers? Answer: Advising older drivers to switch to automatic transmission can help maintain their driving safety and transport quality.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.3,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can the adoption of automatic transmission improve driving safety in older individuals? Answer: Older drivers are often encouraged to use automatic transmission to preserve safe driving and improve their mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.3,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is automatic transmission recommended to enhance driving behavior in elderly drivers? Answer: Switching to automatic transmission is a suggested strategy for older drivers to keep their driving safe and maintain transport quality.,7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.3,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does the use of automatic transmission help older drivers maintain safe driving habits? Answer: It is recommended that older drivers adopt automatic transmission to sustain safe driving and the quality of their transport mobility.,2.36859727356853e-08,0.11169921724258858,0.058862236208678254,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
127,0.3,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact the results of colon and rectal surgeries? Answer: Analysis of this extensive multicenter database indicates that severe, moderate, and even mild preoperative anemia independently increases the risk of complications and prolongs hospital stays following colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.3,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on outcomes in colon and rectal surgery? Answer: This large-scale multicenter database study shows that severe, moderate, and mild preoperative anemia serve as independent risk factors for postoperative complications and extended hospitalization after colon surgery.",2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
127,0.3,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery worsen outcomes in colon and rectal operations? Answer: Findings from this comprehensive multicenter database analysis reveal that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.3,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia affect the outcomes of colon and rectal surgery? Answer: Data from a large multicenter database suggest that severe, moderate, and even mild anemia before surgery independently increase the risk of complications and lengthen hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.3,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Answer: This extensive multicenter database analysis indicates that severe, moderate, and mild anemia prior to surgery are independent risk factors for complications and prolonged hospitalization following colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.3,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia before surgery adversely influence colon and rectal surgery results? Answer: According to this large multicenter database study, severe, moderate, and mild preoperative anemia independently raise the likelihood of complications and extend hospital stays after colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.3,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: What is the impact of preoperative anemia on colon and rectal surgery outcomes? Answer: Analysis from a large multicenter database suggests that severe, moderate, and mild anemia before surgery independently increase the risk of complications and longer hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.3,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia affect complications and hospital stay length after colon and rectal surgery? Answer: This large multicenter database analysis demonstrates that severe, moderate, and mild preoperative anemia are independent risk factors for complications and extended hospitalization following colon surgery.",9.474389094274162e-08,0.13311820783486716,0.027146514774026225,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.3,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Are colon and rectal surgery outcomes worse with preoperative anemia? Answer: The analysis of a large multicenter database shows that severe, moderate, and mild anemia before surgery independently contribute to higher complication rates and longer hospital stays after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.3,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of preoperative anemia impact colon and rectal surgery outcomes? Answer: Findings from this large multicenter database analysis suggest that severe, moderate, and mild preoperative anemia independently increase the risk of complications and prolong hospital stays after colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
128,0.3,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? Research suggests that the first urinary ACR in these women could be a prognostic indicator for negative maternal and neonatal results.,2.1317375462116866e-07,0.2087037060909509,0.19916194165512466,0.016320838183036854,0.1900316138122351,0.22231061559945972,0.0162972138685758,0.1708816791771488,0.23615916955017302,2.1317375462116866e-07,0.11378168946640876,0.21551020408163268
128,0.3,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict maternal and neonatal adverse outcomes? Studies show that the initial urinary ACR may act as a prognostic factor for such outcomes.,3.7897556377096576e-07,0.08564653149948898,0.2490234375,0.029014823436509983,0.027751879741801044,0.24793388429752067,0.028972824655245893,0.03271727606409103,0.23615916955017302,3.789755637709665e-07,0.0959388415156619,0.21551020408163268
128,0.3,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic marker for adverse maternal and neonatal outcomes? Evidence suggests it might be predictive of these outcomes.,4.2634750924233636e-07,0.023126174518155462,0.2490234375,0.03264167636607374,0.03678664139577048,0.24793388429752067,0.03259442773715164,0.09940865056276449,0.23615916955017302,4.263475092423373e-07,0.16493171300261267,0.21551020408163268
128,0.3,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic factor for maternal and neonatal adverse events? Research indicates it may be.,5.447773729207629e-07,0.15276449194550867,0.2490234375,0.04170880868998314,0.21910819818972538,0.24793388429752067,0.04164843544191601,0.28865065020129244,0.23615916955017302,5.447773729207643e-07,0.36164200724866724,0.21551020408163268
128,0.3,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia have prognostic value for maternal and neonatal adverse outcomes? Findings suggest it could be a significant predictor.,4.974054274493923e-07,0.078656519791787,0.2490234375,0.03808195576041938,0.14214715705359593,0.24793388429752067,0.03802683236001026,0.20860794252775516,0.23615916955017302,4.974054274493935e-07,0.2782603983096168,0.21551020408163268
128,0.3,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia associated with predicting maternal and neonatal adverse outcomes? Research points to its potential as a prognostic factor.,4.974054274493923e-07,0.078656519791787,0.2490234375,0.03808195576041938,0.14214715705359593,0.24793388429752067,0.03802683236001026,0.20860794252775516,0.23615916955017302,4.974054274493935e-07,0.2782603983096168,0.21551020408163268
128,0.3,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia forecast maternal and neonatal adverse outcomes? Studies indicate it may serve this prognostic role.,5.684633456564482e-07,0.19198520509879113,0.2490234375,0.04352223515476502,0.2599301927099802,0.24793388429752067,0.04345923698286888,0.33121026462008807,0.23615916955017302,5.684633456564497e-07,0.4060937698195013,0.21551020408163268
128,0.3,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Is the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a prognostic indicator for adverse maternal and neonatal outcomes? Research supports this possibility.,5.921493183921335e-07,0.23280719961904595,0.2490234375,0.0453356616195469,0.3024898071287758,0.24793388429752067,0.045270038523821755,0.3756620271909221,0.23615916955017302,5.921493183921352e-07,0.45261378545439523,0.21551020408163268
128,0.3,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Does the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia predict negative maternal and neonatal outcomes? Evidence suggests it may be a useful prognostic factor.,5.447773729207629e-07,0.15276449194550867,0.2490234375,0.04170880868998314,0.21910819818972538,0.24793388429752067,0.04164843544191601,0.28865065020129244,0.23615916955017302,5.447773729207643e-07,0.36164200724866724,0.21551020408163268
128,0.3,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Research indicates that the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia may serve as a prognostic factor for maternal and neonatal adverse outcomes. It,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia be used as a prognostic factor for adverse maternal and neonatal outcomes? Research indicates it might be effective for this purpose.,4.0266153650665106e-07,0.05487487283273529,0.2490234375,0.030828249901291863,0.003996818572778782,0.24793388429752067,0.030783626196198767,0.06550709888708273,0.23615916955017302,4.026615365066519e-07,0.12984039319134366,0.21551020408163268
129,0.3,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT offer additional benefits over multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Yes, PET/CT significantly enhances multidetector CT by providing detailed metabolic data, improving tumor extent assessment, lesion detection, and treatment planning.",6.868932093348762e-07,0.4265349382629875,0.12234491957034577,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.3,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In preoperative staging of liver metastases from colorectal cancer, does PET/CT contribute beyond multidetector CT? Indeed, PET/CT adds crucial metabolic insights that help better define tumor spread, identify extra lesions, and optimize treatment strategies.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.3,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is there added value of PET/CT compared to multidetector CT for preoperative staging in colorectal carcinoma liver metastases? Yes, PET/CT delivers important metabolic information that refines tumor evaluation, uncovers additional lesions, and supports more precise treatment planning.",6.63207236599191e-07,0.3587556509785794,0.15089163237311393,0.050775941013892434,0.41174928571229463,0.124297520661157,0.05070244314668027,0.44425675514119867,0.11107438016528923,6.632072365991914e-07,0.4780094803015946,0.09719008264462808
129,0.3,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of colorectal carcinoma liver metastases, does PET/CT improve upon multidetector CT? Absolutely, PET/CT provides enhanced metabolic imaging that aids in accurately determining tumor extent, detecting further lesions, and guiding treatment decisions.",7.342651548062468e-07,0.44576702796820955,0.15089163237311393,0.05621622040823807,0.5013614444019816,0.124297520661157,0.05613484776953889,0.536630075272214,0.11107438016528923,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
129,0.3,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT enhance preoperative staging of liver metastases in colorectal cancer patients beyond what multidetector CT offers? Yes, it contributes significant metabolic detail that improves tumor assessment, lesion identification, and treatment planning.",7.816371002776174e-07,0.5082873849495431,0.15089163237311393,0.05984307333780183,0.5658999655395531,0.124297520661157,0.05975645085144464,0.6033214497708874,0.11107438016528923,7.816371002776184e-07,0.6423125315928706,0.09719008264462808
129,0.3,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In patients with colorectal carcinoma liver metastases, does PET/CT add value to multidetector CT during preoperative staging? Yes, PET/CT offers critical metabolic information that assists in more precise tumor extent evaluation, additional lesion detection, and effective treatment guidance.",6.395212638635056e-07,0.3313566767904641,0.15089163237311393,0.04896251454911056,0.3835784087455978,0.124297520661157,0.0488916416057274,0.41526921826794716,0.11107438016528923,6.39521263863506e-07,0.44815651715191285,0.09719008264462808
129,0.3,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Is PET/CT beneficial over multidetector CT for preoperative staging of liver metastases from colorectal cancer? Yes, it provides valuable metabolic data that enhances tumor delineation, uncovers extra lesions, and informs better treatment planning.",7.579511275419321e-07,0.47653868663496324,0.15089163237311393,0.05802964687301995,0.5331101427165614,0.124297520661157,0.057945649310491766,0.5694198980952057,0.11107438016528923,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
129,0.3,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","Does PET/CT provide added benefit to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Indeed, PET/CT supplies detailed metabolic insights that improve tumor extent determination, lesion detection, and treatment planning.",7.816371002776174e-07,0.5082873849495431,0.15089163237311393,0.05984307333780183,0.5658999655395531,0.124297520661157,0.05975645085144464,0.6033214497708874,0.11107438016528923,7.816371002776184e-07,0.6423125315928706,0.09719008264462808
129,0.3,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","In the context of preoperative staging for colorectal carcinoma liver metastases, does PET/CT add to multidetector CT? Yes, it offers significant metabolic information that aids in accurate tumor assessment, detection of additional lesions, and treatment planning.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
129,0.3,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, PET/CT adds significant value to multidetector CT in preoperative staging of patients with liver metastases of colorectal carcinoma. It provides more detailed metabolic information about the tumor, aiding in more accurate determination of tumor extent, detection of additional lesions, and guiding effective treatment planning.","For preoperative staging of liver metastases in colorectal cancer, does PET/CT add value beyond multidetector CT? Yes, PET/CT enhances multidetector CT by providing detailed metabolic data that improves tumor extent evaluation, lesion detection, and treatment guidance.",6.868932093348762e-07,0.38692652794527627,0.15089163237311393,0.05258936747867431,0.44073682258554614,0.124297520661157,0.052513244687633145,0.47410971829088044,0.11107438016528923,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
130,0.3,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE might increase the risk of developing IPE, but multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.3,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long term? Are they indicative of interictal psychotic episodes? While a history of PIPE could be a risk factor for IPE, multivariate analysis suggests it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.3,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term relevance of postictal psychotic episodes II? Can they forecast interictal psychotic episodes? A history of PIPE may raise the risk of IPE, but multivariate analysis reveals it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.3,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the enduring significance of postictal psychotic episodes II? Do they serve as predictors for interictal psychotic episodes? Although PIPE history may pose a risk for IPE, multivariate analysis indicates it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.3,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What long-term implications do postictal psychotic episodes II have? Are they predictive of interictal psychotic episodes? A history of PIPE might be a risk factor for IPE, yet multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.3,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How important are postictal psychotic episodes II over the long term? Are they predictive of interictal psychotic episodes? A history of PIPE may increase the risk of IPE, but multivariate analysis suggests it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term impact of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? While a history of PIPE could be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What long-term significance do postictal psychotic episodes II hold? Can they predict interictal psychotic episodes? A history of PIPE may be linked to a higher risk of IPE, but multivariate analysis shows it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting significance of postictal psychotic episodes II? Are they indicators of interictal psychotic episodes? Although a history of PIPE might be a risk factor for IPE, multivariate analysis reveals it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term predictive value of postictal psychotic episodes II regarding interictal psychotic episodes? A history of PIPE may pose a risk for IPE, but multivariate analysis demonstrates it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
131,0.3,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a previous benign prostate biopsy forecast results for patients undergoing radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy might independently correlate with better surgical and biochemical outcomes following prostatectomy. Further research is necessary to validate these results.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.3,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a history of benign prostate biopsy influence outcomes in patients treated with radical perineal prostatectomy? Answer: A history of benign prostate biopsy may be independently linked to improved surgical and biochemical outcomes after prostatectomy. More studies are required to confirm these observations.,4.737194547137081e-08,0.012132796980746097,0.04155124653739603,0.0036268529295637453,0.013923152166945396,0.04432132963988918,0.003621603081905733,0.015879742930722696,0.04709141274238227,4.737194547137081e-08,0.018021423668444392,0.049861495844875335
131,0.3,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is prior benign prostate biopsy predictive of outcomes in patients receiving radical perineal prostatectomy? Answer: Prior benign prostate biopsy could be independently associated with more favorable surgical and biochemical results post-prostatectomy. Additional research is needed to substantiate these findings.,4.7371945471370706e-08,0.055212275588245596,0.0036742074484456683,0.0036268529295637453,0.05494143744312874,0.0026076399575938047,0.003621603081905733,0.054565139391337336,0.0013829041414452105,4.737194547137081e-08,0.05406722127027619,0.0
131,0.3,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does undergoing a benign prostate biopsy before radical perineal prostatectomy affect patient outcomes? Answer: A previous benign prostate biopsy may independently predict better surgical and biochemical outcomes after prostatectomy. Further studies are needed to confirm these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.3,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can prior benign prostate biopsy serve as a predictor for outcomes in radical perineal prostatectomy patients? Answer: Prior benign prostate biopsy might be independently linked to more favorable surgical and biochemical outcomes following prostatectomy. Additional studies are necessary to verify these findings.,2.3685972735685406e-08,0.026512698549651326,0.0017087642806799253,0.0018134264647818726,0.02638321546978606,0.0012092933465189942,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.3,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a prior benign prostate biopsy impact the prognosis of patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may independently correlate with improved surgical and biochemical outcomes after prostatectomy. Further investigation is required to confirm these results.,0.0,0.033812057588289424,0.023706063628950516,0.0,0.034657359027996826,0.0246454435269289,0.0,0.03554600925948437,0.025508944596314496,0.0,0.03648143055578634,0.026296566837107373
131,0.3,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is there a predictive value of prior benign prostate biopsy on outcomes after radical perineal prostatectomy? Answer: Prior benign prostate biopsy may be independently associated with better surgical and biochemical outcomes post-prostatectomy. More research is needed to confirm these findings.,2.3685972735685406e-08,0.027228516909492573,0.0017922579313610076,0.0018134264647818726,0.027095108447265925,0.0012707174495001153,0.0018108015409528666,0.026910907699560394,0.0006732981390464195,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.3,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a previous benign prostate biopsy predict surgical and biochemical outcomes for patients undergoing radical perineal prostatectomy? Answer: A previous benign prostate biopsy might independently relate to more favorable outcomes after prostatectomy. Additional studies are needed to validate these results.,2.3685972735685406e-08,0.06188587593748984,0.026050750658322228,0.0018134264647818726,0.06264111770674985,0.02652739304401356,0.0018108015409528666,0.06339233825534718,0.026845867104408186,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
131,0.3,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a benign prostate biopsy performed before radical perineal prostatectomy predict patient outcomes? Answer: A benign prostate biopsy done prior may be independently associated with improved surgical and biochemical outcomes following prostatectomy. Further studies are necessary to confirm these findings.,2.3685972735685406e-08,0.027228516909492573,0.0017922579313610076,0.0018134264647818726,0.027095108447265925,0.0012707174495001153,0.0018108015409528666,0.026910907699560394,0.0006732981390464195,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.3,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does having a prior benign prostate biopsy influence the outcomes of radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy may independently predict better surgical and biochemical outcomes after prostatectomy. Additional research is required to confirm these observations.,4.7371945471370706e-08,0.1263042941072139,0.05271784451111382,0.0036268529295637453,0.12790429855470276,0.053944732528827095,0.003621603081905733,0.1294999697221435,0.05482655829155839,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
132,0.3,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? Yes, it might. Neoadjuvant chemotherapy can potentially shrink the tumor and reduce lymph node involvement, which may limit the extent of lymphadenectomy needed. Further studies are necessary to confirm this.",3.316036182995957e-07,0.31037343956974395,0.007136943968819601,0.025387970506946217,0.29935279380258306,0.005267786705624562,0.025351221573340132,0.3234794824662144,0.007073191212347663,3.316036182995957e-07,0.3209077200800996,0.0
132,0.3,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it possible for neoadjuvant chemotherapy to change the extent of lymphadenectomy in cervical cancer? Yes, it could. This treatment may decrease tumor size and the number of affected lymph nodes, potentially reducing the surgical area. Additional research is still needed.",3.316036182995957e-07,0.17174400345775576,0.09162848812994587,0.025387970506946217,0.22826077528361477,0.05640000000000001,0.025351221573340132,0.28699805191042804,0.01922337562475971,3.316036182995957e-07,0.3209077200800996,0.0
132,0.3,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy influence how extensive lymphadenectomy is in cervical cancer cases? Yes, it can. By shrinking the tumor and lowering lymph node involvement, neoadjuvant chemotherapy might lessen the extent of lymphadenectomy required. More investigation is warranted.",4.263475092423369e-07,0.3156126958133565,0.06387338608912954,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.3,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? Yes, it does. It may reduce tumor burden and lymph node involvement, thereby possibly limiting the surgical extent. However, further research is essential.",4.500334819780222e-07,0.3052753960822785,0.09162848812994587,0.03445510283085559,0.3654618967970973,0.05640000000000001,0.03440522927810448,0.42807665017033436,0.01922337562475971,4.500334819780227e-07,0.46608972992459874,0.0
132,0.3,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Might neoadjuvant chemotherapy affect the scope of lymphadenectomy in cervical cancer? Yes, it may. This therapy can reduce tumor size and lymph node involvement, potentially decreasing the extent of lymphadenectomy. More studies are needed to validate this.",4.263475092423369e-07,0.27710451911558165,0.09162848812994587,0.03264167636607371,0.3364743599238458,0.05640000000000001,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.3,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Could the use of neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer treatment? Yes, it could. It may shrink tumors and reduce lymph node involvement, thus possibly reducing the surgical scope. Further research is required to establish this.",3.55289591035281e-07,0.19706181144204749,0.09162848812994587,0.02720139697172809,0.25423626168687274,0.05640000000000001,0.027162023114293,0.3136662989925889,0.01922337562475971,3.552895910352811e-07,0.3483066942682149,0.0
132,0.3,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? Yes, it is possible. Neoadjuvant chemotherapy might reduce tumor size and lymph node involvement, which could decrease the extent of lymphadenectomy. Additional research is necessary.",4.263475092423369e-07,0.35412087251113133,0.036265166330637894,0.03264167636607371,0.376082770241557,0.027853287197231853,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
132,0.3,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Can neoadjuvant chemotherapy modify the extent of lymphadenectomy in cervical cancer? Yes, it can potentially do so by reducing tumor size and the number of involved lymph nodes, thereby lessening the surgical extent. More research is needed to confirm these effects.",3.316036182995957e-07,0.17174400345775576,0.09162848812994587,0.025387970506946217,0.22826077528361477,0.05640000000000001,0.025351221573340132,0.28699805191042804,0.01922337562475971,3.316036182995957e-07,0.3209077200800996,0.0
132,0.3,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Does neoadjuvant chemotherapy potentially alter the extent of lymphadenectomy in cervical cancer? Yes, it may. This treatment can reduce tumor size and lymph node involvement, possibly decreasing the extent of lymphadenectomy required. Further studies are needed.",4.500334819780222e-07,0.4241006270354122,0.0066675506299458676,0.03445510283085559,0.4470086239217972,0.0021937499999999874,0.03440522927810448,0.4700855702042701,0.01105006187524029,4.500334819780227e-07,0.46608972992459874,0.0
132,0.3,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: Yes, neoadjuvant chemotherapy in cervical cancer could potentially modify the extent of lymphadenectomy. It may reduce the tumor size and the number of lymph nodes involved, thus decreasing the scope of the surgical procedure. However, more research is required to","Is it feasible for neoadjuvant chemotherapy to modify the extent of lymphadenectomy in cervical cancer? Yes, it is feasible. By reducing tumor size and lymph node involvement, it might reduce the extent of lymphadenectomy. However, more research is necessary to confirm this.",3.079176455639103e-07,0.2146755060439638,0.04297628563158953,0.023574544042164344,0.23760032632731942,0.03141643655489809,0.023540420032387266,0.26102256550717007,0.01922337562475971,3.079176455639103e-07,0.29423947299793873,0.0
133,0.3,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a role in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been found. The findings also confirm earlier reported connections with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.3,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences significant in primary systemic vasculitis? Answer: A notable association between farming and PSV has been discovered for the first time. The results also back previously reported links with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an importance of environmental factors in primary systemic vasculitis? Answer: A significant correlation between farming and PSV has been identified for the first time. The data also supports earlier reported associations with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.3,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors matter in primary systemic vasculitis? Answer: A strong association between farming and PSV has been established for the first time. The findings further support previously reported connections with silica, solvents, and allergy.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.3,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental elements relevant in primary systemic vasculitis? Answer: For the first time, a significant link between farming and PSV has been recognized. The results also reinforce earlier reported associations with silica, solvents, and allergic conditions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a role of environmental factors in primary systemic vasculitis? Answer: A significant relationship between farming and PSV has been identified for the first time. The findings also uphold previously reported links with silica, solvents, and allergy.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.3,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors influence primary systemic vasculitis? Answer: A notable association between farming and PSV has been found for the first time. The results also confirm earlier reported connections with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.3,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors crucial in primary systemic vasculitis? Answer: A significant association between farming and PSV has been discovered for the first time. The data also supports previously reported links with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is the impact of environmental factors significant in primary systemic vasculitis? Answer: For the first time, a strong correlation between farming and PSV has been identified. The findings also back earlier reported associations with silica, solvents, and allergy.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.3,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors linked to primary systemic vasculitis? Answer: A significant association between farming and PSV has been established for the first time. The results also reinforce previously reported connections with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
134,0.3,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.3,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: While the Supplemental Security Income program does not directly decrease disability among the elderly, it offers financial support to disabled elderly individuals, which can indirectly improve their health by helping them access essential medical care, medications, and therapies.",9.474389094274162e-08,0.007459204792188867,0.04606009070294789,0.0072537058591274906,0.031027519531036774,0.03140624999999998,0.007243206163811466,0.05539646218537486,0.015432766243752394,9.474389094274162e-08,0.08060683971738136,0.0015383588099934231
134,0.3,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program itself does not directly lessen disability in elderly people. Nevertheless, it provides monetary aid to elderly disabled individuals, which may indirectly benefit their health by allowing them to obtain necessary medical treatments, drugs, and therapies.",4.737194547137081e-08,0.008558561976528267,0.030820491461890892,0.0036268529295637453,0.010515996282596696,0.033599999999999956,0.003621603081905733,0.014042988476523632,0.01696332179930795,4.737194547137081e-08,0.03949202582307443,0.0007390532544378596
134,0.3,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Although the Supplemental Security Income program does not directly reduce disability in older adults, it supplies financial assistance to elderly individuals with disabilities, which can indirectly enhance their health and well-being by enabling access to required medical treatments, medications, and therapies.",2.3685972735685406e-08,0.004036177515137407,0.014993752603082111,0.0018134264647818726,0.004989150239545825,0.016399999999999998,0.0018108015409528666,0.006011225624154903,0.017685505574778944,2.3685972735685406e-08,0.019551204535685596,0.0003624288791975773
134,0.3,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly impact disability rates in the elderly. However, it provides financial support to elderly disabled persons, which can indirectly improve their health outcomes by facilitating access to necessary medical care, medications, and therapies.",4.737194547137081e-08,0.008558561976528267,0.030820491461890892,0.0036268529295637453,0.010515996282596696,0.033599999999999956,0.003621603081905733,0.014042988476523632,0.01696332179930795,4.737194547137081e-08,0.03949202582307443,0.0007390532544378596
134,0.3,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Direct reduction of disability in the elderly is not achieved by the Supplemental Security Income program, but it offers financial aid to disabled elderly individuals, indirectly supporting their health by enabling them to afford essential medical treatments, medications, and therapies.",4.737194547137081e-08,0.008558561976528711,0.030820491461890864,0.0036268529295637453,0.010515996282596696,0.033599999999999956,0.003621603081905733,0.012616518468089755,0.03613994617454825,4.737194547137081e-08,0.012309783448174905,0.018860946745562133
134,0.3,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability among the elderly; however, it provides financial assistance to elderly people with disabilities, which can indirectly affect their health positively by helping them access necessary medical treatments, medications, and therapies.",4.737194547137081e-08,0.008558561976528267,0.030820491461890892,0.0036268529295637453,0.010515996282596696,0.033599999999999956,0.003621603081905733,0.014042988476523632,0.01696332179930795,4.737194547137081e-08,0.03949202582307443,0.0007390532544378596
134,0.3,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Although the Supplemental Security Income program does not directly reduce disability in elderly individuals, it grants financial support to disabled elderly persons, indirectly influencing their health and well-being by making medical treatments, medications, and therapies more affordable.",1.1842986367842703e-07,0.08333271712023738,0.0068934240362811955,0.009067132323909363,0.08018696859210817,0.010604914933837417,0.009054007704764333,0.07673083836911365,0.014620904415876525,1.1842986367842703e-07,0.10181553778793972,0.0019629554726361513
134,0.3,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program itself does not directly reduce disability in the elderly, but it provides financial assistance to elderly individuals with disabilities, indirectly benefiting their health by enabling access to essential medical care, medications, and therapies.",9.474389094274162e-08,0.08743772562602814,0.008909045099521215,0.0072537058591274906,0.08539200428083671,0.006880907372400782,0.007243206163811466,0.08312234940777241,0.004392223696391473,9.474389094274162e-08,0.08060683971738136,0.0015383588099934231
134,0.3,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly reduce disability in the elderly. However, it provides financial assistance to elderly individuals with disabilities, which can indirectly influence their health and well-being by enabling them to afford necessary medical treatments, medications, and therapies.","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: The Supplemental Security Income program does not directly lower disability rates in elderly individuals. However, it offers financial aid to elderly disabled persons, which can indirectly improve their health by facilitating access to necessary medical treatments, medications, and therapies.",7.105791820705622e-08,0.013601028438475549,0.04748021657642652,0.005440279394345618,0.01004122738307478,0.03252394835485212,0.0054324046228586,0.034506545194199045,0.016212967780149266,7.105791820705622e-08,0.05983829796675266,0.001130723391880601
135,0.3,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a valid alternative to thrombolysis? Yes, primary angioplasty is widely regarded as an acceptable and frequently better option than thrombolysis, typically linked to lower death rates, fewer reinfarctions, and a decreased risk of brain hemorrhage.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,0.3,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty be used instead of thrombolysis? Indeed, primary angioplasty is considered a suitable and often preferable alternative to thrombolysis, with benefits including reduced mortality, lower chances of reinfarction, and less intracranial bleeding.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
135,0.3,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is it acceptable to use primary angioplasty as an alternative to thrombolysis? Yes, primary angioplasty is accepted and often seen as superior to thrombolysis, generally resulting in lower mortality, fewer reinfarctions, and reduced intracranial hemorrhage risk.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.3,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Yes, it is regarded as an acceptable and often better alternative, associated with decreased mortality rates, less reinfarction, and a lower risk of intracranial hemorrhage.",2.1317375462116802e-07,0.25190751070815187,0.012192798185603794,0.016320838183036868,0.2831709768508235,0.0302734375,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.3,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty an appropriate substitute for thrombolysis? Yes, primary angioplasty is considered an acceptable and frequently superior alternative, typically linked to reduced death rates, fewer reinfarctions, and less risk of brain bleeding.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,0.3,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Can primary angioplasty replace thrombolysis? Yes, it is an acceptable and often preferred alternative, generally associated with lower mortality, decreased reinfarction risk, and less intracranial hemorrhage.",4.263475092423357e-07,0.47784548333141386,0.046400951814396206,0.032641676366073784,0.5596157879354227,0.0,0.03259442773715168,0.5780778507751583,0.0,4.263475092423373e-07,0.5978370007556206,0.0
135,0.3,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a feasible alternative to thrombolysis? Yes, it is accepted as an alternative and often superior, with benefits including lower mortality, reduced reinfarction, and less chance of intracranial bleeding.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,0.3,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty recognized as an alternative to thrombolysis? Yes, it is considered an acceptable and often better option, usually resulting in lower death rates, fewer reinfarctions, and decreased risk of intracranial hemorrhage.",2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,0.3,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a recommended alternative to thrombolysis? Yes, it is widely accepted and often superior, commonly associated with reduced mortality, less reinfarction, and lower intracranial hemorrhage risk.",3.789755637709651e-07,0.4008844421952844,0.046400951814396206,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
135,0.3,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Yes, primary angioplasty is considered an acceptable, and often superior, alternative to thrombolysis. It is generally associated with lower mortality rates, reduced risk of reinfarction, and less chance of intracranial hemorrhage. The choice between","Is primary angioplasty a valid treatment option instead of thrombolysis? Yes, it is considered acceptable and often preferable, generally linked to lower mortality, fewer reinfarctions, and less risk of brain hemorrhage.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
136,0.3,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Indeed, recovery outcome measures ought to take into account culture, attitudes, and faith, as these elements greatly affect an individual's view of recovery and their method.",7.10579182070559e-08,0.08892920998840648,0.006255739210284647,0.005440279394345618,0.08536507799889792,0.002250145965660786,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
136,0.3,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, it is important for recovery outcome measures to include culture, attitudes, and faith because these aspects can profoundly shape how a person perceives recovery and approaches it.",1.1842986367842661e-07,0.14414148557665252,0.009929946658730315,0.009067132323909363,0.13848244391423759,0.0035631493576662385,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
136,0.3,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Absolutely, culture, attitudes, and faith should be integrated into recovery outcome measures since they play a crucial role in influencing a person's recovery perspective and strategy.",7.10579182070559e-08,0.08892920998840648,0.006255739210284647,0.005440279394345618,0.08536507799889792,0.002250145965660786,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
136,0.3,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, considering culture, attitudes, and faith in recovery outcome measures is essential as these factors impact how individuals understand and engage with recovery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
136,0.3,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures must reflect culture, attitudes, and faith because these components significantly shape a person's perception and approach to recovery.",4.73719454713706e-08,0.06395397443367212,0.004764320912272885,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
136,0.3,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Indeed, incorporating culture, attitudes, and faith into recovery outcome measures is vital since they influence how recovery is perceived and pursued by individuals.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
136,0.3,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should acknowledge culture, attitudes, and faith as these factors heavily affect a person's view and handling of recovery.",2.36859727356853e-08,0.031471577826506,0.002316309400826458,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.3,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: It is important that recovery outcome measures include culture, attitudes, and faith because these elements can deeply impact a person's perception and approach to recovery.",4.73719454713706e-08,0.06014745969624036,0.004277281160398022,0.0036268529295637453,0.05771084630712098,0.001540539963261995,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
136,0.3,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, culture, attitudes, and faith have a significant place in recovery outcome measures as they influence how individuals perceive and approach recovery.",2.36859727356853e-08,0.031471577826506,0.002316309400826458,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.3,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider culture, attitudes, and faith. These factors can significantly influence a person's perception of recovery and their approach","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Certainly, recovery outcome measures should encompass culture, attitudes, and faith since these factors play a key role in shaping a person's recovery perception and methods.",4.73719454713706e-08,0.06014745969624036,0.004277281160398022,0.0036268529295637453,0.05771084630712098,0.001540539963261995,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
137,0.3,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy truly a reason to perform splenectomy simultaneously in mild hereditary spherocytosis? No, cholecystectomy alone does not automatically indicate the need for a concurrent splenectomy in mild hereditary spherocytosis. Both surgeries can treat hereditary spherocytosis, but their application depends on the patient's specific condition. Splenectomy is usually reserved for more severe cases. Decisions should be individualized.",7.105791820705622e-08,0.188644745943233,0.09335171830795999,0.005440279394345618,0.19084115629836074,0.0952459671041202,0.0054324046228586,0.19306962571444952,0.09688090737240077,7.105791820705622e-08,0.16917245701356665,0.07939508506616257
137,0.3,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy warrant a simultaneous splenectomy in mild hereditary spherocytosis? No, undergoing cholecystectomy does not necessarily mean a splenectomy must be done at the same time in mild hereditary spherocytosis. Both procedures can be treatments for hereditary spherocytosis, but their use depends on the severity of the patient's condition. Splenectomy is generally reserved for severe cases. Treatment decisions should be personalized.",1.6580180914979784e-07,0.26093831828999337,0.09572331525391725,0.012693985253473108,0.2627542523967179,0.09647743594469636,0.012675610786670066,0.2645285896965932,0.09688090737240077,1.6580180914979784e-07,0.24193181129599584,0.07939508506616257
137,0.3,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is performing a cholecystectomy an indication to also do a splenectomy in mild hereditary spherocytosis? No, cholecystectomy is not inherently an indication for a concomitant splenectomy in mild hereditary spherocytosis. Both surgeries are options for managing hereditary spherocytosis, but the choice depends on the individual patient's condition. Splenectomy is typically reserved for severe disease. Decisions should be made on a case-by-case basis.",1.8948778188548325e-07,0.23277288400837692,0.06376616681823286,0.014507411718254981,0.2568480732710219,0.08012785211592108,0.014486412327622933,0.25812650846064056,0.07993679322257913,1.8948778188548325e-07,0.25932355400786467,0.07939508506616257
137,0.3,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Should a cholecystectomy lead to a simultaneous splenectomy in mild hereditary spherocytosis? No, cholecystectomy does not necessarily require a concomitant splenectomy in patients with mild hereditary spherocytosis. Both procedures can be used to treat hereditary spherocytosis, but their use depends on the patient's clinical status. Splenectomy is usually reserved for severe forms. Treatment choices should be individualized.",7.105791820705622e-08,0.188644745943233,0.09335171830795999,0.005440279394345618,0.21604650831872263,0.113421550094518,0.0054324046228586,0.19306962571444952,0.09688090737240077,7.105791820705622e-08,0.16917245701356665,0.07939508506616257
137,0.3,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is cholecystectomy an automatic indication for splenectomy in mild hereditary spherocytosis? No, cholecystectomy is not automatically an indication for a concomitant splenectomy in mild hereditary spherocytosis. Both procedures may be considered treatments for hereditary spherocytosis, but their application depends on the patient's condition severity. Splenectomy is generally reserved for severe cases. Decisions should be tailored to the patient.",9.474389094274162e-08,0.15857102112434163,0.05924129233539775,0.0072537058591274906,0.1845545009242615,0.07775625516996383,0.007243206163811466,0.1862134123622834,0.07870532438200296,9.474389094274162e-08,0.18786459002572098,0.07939508506616257
137,0.3,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does mild hereditary spherocytosis require splenectomy when cholecystectomy is performed? No, cholecystectomy does not automatically indicate the need for splenectomy in mild hereditary spherocytosis. Both surgeries can be treatment options, but splenectomy is typically reserved for severe cases. The decision depends on the individual patient's condition and should be made accordingly.",7.105791820705622e-08,0.09710068631097046,0.10902534309507142,0.005440279394345618,0.10053362119687836,0.113421550094518,0.0054324046228586,0.07528659005806526,0.09688090737240077,7.105791820705622e-08,0.04902814517150356,0.07939508506616257
137,0.3,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is splenectomy indicated alongside cholecystectomy in mild hereditary spherocytosis? No, splenectomy is not necessarily indicated along with cholecystectomy in mild hereditary spherocytosis. Both procedures are treatment options, but splenectomy is usually reserved for severe disease cases. Treatment decisions should be individualized based on the patient's condition.",1.8948778188548325e-07,0.10376010755733622,0.04097418158468551,0.014507411718254981,0.07011042304639137,0.0680700761716155,0.014486412327622933,0.06695370890323771,0.07363827698691325,1.8948778188548325e-07,0.06344983825518646,0.07939508506616257
137,0.3,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","In mild hereditary spherocytosis, does cholecystectomy require concurrent splenectomy? No, cholecystectomy does not require a concurrent splenectomy in mild hereditary spherocytosis. Both procedures can be used to treat the condition, but splenectomy is typically reserved for severe cases. Decisions should be based on the patient's specific clinical scenario.",1.4211583641411244e-07,0.003959920405923967,0.08654787743004502,0.010880558788691236,0.007217885637957444,0.0916931550327896,0.0108648092457172,0.010748068920493736,0.09688090737240077,1.4211583641411244e-07,0.016929822620292523,0.07939508506616257
137,0.3,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Is it necessary to perform splenectomy with cholecystectomy in mild hereditary spherocytosis? No, it is not necessary to perform splenectomy alongside cholecystectomy in mild hereditary spherocytosis. Both surgeries can be options for treatment, but splenectomy is generally reserved for severe cases. Treatment should be individualized.",2.1317375462116866e-07,0.19204693812922713,0.0039469756871534645,0.016320838183036854,0.15904417620808253,0.02137684266519517,0.0162972138685758,0.12425881976264197,0.04938090737240075,2.1317375462116866e-07,0.08754738983424648,0.07939508506616257
137,0.3,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: No, cholecystectomy isn't necessarily an indication for concomitant splenectomy in mild hereditary spherocytosis. While both procedures are treatment options for hereditary spherocytosis, their use depends on the patient's individual condition. Splenectomy is typically reserved for severe cases. Decisions should be","Does cholecystectomy in mild hereditary spherocytosis mandate splenectomy? No, cholecystectomy does not mandate splenectomy in mild hereditary spherocytosis. Both are treatment options, but splenectomy is typically reserved for severe cases. Decisions should be made based on the patient's individual condition.",3.316036182995956e-07,0.19472680428410083,0.07788479993813871,0.025387970506946217,0.19018194774314834,0.08712498325741062,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.3,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? Physicians generally consider aneurysm repair justified for patients 80 years or older after aneurysmal subarachnoid hemorrhage. The decision mainly depends on the patient's overall health and surgical fitness rather than age alone. Nevertheless, the risks and benefits must be evaluated.",0.0,0.13078248689810312,0.08977283950617279,0.0,0.15995704166767943,0.113421550094518,0.0,0.1359112118744994,0.09688090737240077,0.0,0.11090354888959109,0.07939508506616257
138,0.3,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 or older who have experienced aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Typically, doctors justify aneurysm repair in patients aged 80 or above after such hemorrhage, basing the decision on the patient's general health and ability to undergo surgery, rather than age by itself. However, the risks and benefits are carefully considered.",4.737194547137081e-08,0.14547184263586788,0.07389294715707634,0.0036268529295637453,0.14635313405349315,0.07643930157380795,0.003621603081905733,0.1482209953226743,0.07801996062683864,4.737194547137081e-08,0.15012426204287355,0.07939508506616257
138,0.3,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is it appropriate to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Physicians usually justify aneurysm repair for those aged 80+ after this condition, with the primary factor being the patient's overall health and surgical readiness, not just their age. Still, the risks and benefits must be weighed.",2.3685972735685406e-08,0.16354427712165842,0.12694946388141312,0.0018134264647818726,0.14053895581057674,0.113421550094518,0.0018108015409528666,0.11610858457831963,0.09688090737240077,2.3685972735685406e-08,0.09070084157207248,0.07939508506616257
138,0.3,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should aneurysm repair be performed on patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Generally, aneurysm repair is justified by physicians for patients 80 years and older after such hemorrhage, with the main consideration being the patient's health and fitness for surgery rather than age alone. Risks and benefits are also assessed.",2.3685972735685406e-08,0.16354427712165842,0.12694946388141312,0.0018134264647818726,0.14053895581057674,0.113421550094518,0.0018108015409528666,0.11610858457831963,0.09688090737240077,2.3685972735685406e-08,0.09070084157207248,0.07939508506616257
138,0.3,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair advisable for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Physicians typically find aneurysm repair justified in patients aged 80+ after this event, focusing on the patient's overall health and surgical suitability instead of age alone. Nonetheless, the risks and benefits are evaluated.",1.6580180914979784e-07,0.007327794099160734,0.1027844097541067,0.012693985253473108,0.01537581285657108,0.113421550094518,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
138,0.3,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Can aneurysm repair be justified for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? It is generally justified by doctors for patients aged 80 or more after aneurysmal subarachnoid hemorrhage, with the decision mainly guided by the patient's general health and fitness for surgery rather than age alone. However, risks and benefits must be considered.",4.737194547137081e-08,0.09506113859514453,0.03871761251741816,0.0036268529295637453,0.09500889845645988,0.039821550094518016,0.003621603081905733,0.12206449794305385,0.05920309114787175,4.737194547137081e-08,0.12346475509826016,0.060171709441402856
138,0.3,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair considered justified for patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Physicians commonly justify aneurysm repair in patients 80 years or older after this condition, basing the decision on the patient's overall health and ability to tolerate surgery, not just their age. The risks and benefits are also taken into account.",2.3685972735685406e-08,0.17659987645208597,0.10919059098546276,0.0018134264647818726,0.17900523663837253,0.113421550094518,0.0018108015409528666,0.1553292977316021,0.09688090737240077,2.3685972735685406e-08,0.13070617618577085,0.07939508506616257
138,0.3,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? Typically, aneurysm repair is justified by physicians for patients aged 80+ after such hemorrhage, with the key factor being the patient's general health and surgical fitness rather than age alone. Risks and benefits are carefully weighed.",9.474389094274162e-08,0.04590519862894693,0.08520875633036945,0.0072537058591274906,0.05103320147081192,0.09259764787631972,0.007243206163811466,0.0542331808602321,0.09688090737240077,9.474389094274162e-08,0.027521939950540197,0.07939508506616257
138,0.3,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Is aneurysm repair appropriate for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Physicians usually justify aneurysm repair for patients 80 years or older following this hemorrhage, primarily considering the patient's overall health and readiness for surgery instead of age alone. The risks and benefits are also evaluated.",1.1842986367842703e-07,0.023517678822742027,0.0839506172839506,0.009067132323909363,0.058860924796309444,0.113421550094518,0.009054007704764333,0.03272697563926874,0.09688090737240077,1.1842986367842703e-07,0.005543033231765193,0.07939508506616257
138,0.3,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Aneurysm repair for patients aged 80 or older after aneurysmal subarachnoid hemorrhage is typically justified by physicians. It is primarily determined by the patient's general health and fitness for surgery, not just age. However, risks and benefits","Should aneurysm repair be considered for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Generally, doctors justify aneurysm repair for patients aged 80 or more after this event, focusing on the patient's health and fitness for surgery rather than age alone. Risks and benefits must also be assessed.",1.1842986367842703e-07,0.03424458622392024,0.043414591804712604,0.009067132323909363,0.029625949317725997,0.04988849224327835,0.009054007704764333,0.027546692235508985,0.05349247762033464,1.1842986367842703e-07,0.025263508126454504,0.05718434126450968
139,0.3,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? The systolic blood pressure recorded by the nurse is significantly lower than that measured by the physician and closely matches ambulatory blood pressure monitoring. Measuring blood pressure by the nurse is recommended for both diagnosis and assessing control levels.,2.8423167282822487e-07,0.22648957095866384,0.13366525127653858,0.02176111757738247,0.1825064819945732,0.008358373714499087,0.0217296184914344,0.20187382556512645,0.0032536362502692488,2.8423167282822487e-07,0.20067069546214888,0.0
139,0.3,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Nurse-measured systolic blood pressure is notably lower than physician measurements and nearly identical to ambulatory monitoring results. Nurse measurements are preferred for diagnosis and evaluating blood pressure control.",6.158352911278206e-07,0.3812406704497655,0.05155330910418729,0.04714908808432869,0.4206780415492153,0.044023668639053264,0.04708084006477453,0.4704295920729278,0.014921946740128552,6.158352911278206e-07,0.500775287912488,0.0
139,0.3,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Is there a difference in blood pressure readings in treated hypertensive patients depending on whether a physician or nurse measures it? Systolic BP taken by nurses is significantly lower than that taken by physicians and aligns closely with ambulatory BP monitoring. Nurse measurement is beneficial for diagnosis and control assessment.,4.737194547137081e-07,0.20226484071136408,0.12633544316790596,0.03626852929563745,0.2871466489246921,0.044023668639053264,0.03621603081905733,0.33385405706717775,0.014921946740128552,4.737194547137081e-07,0.36101334553732967,0.0
139,0.3,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For treated hypertensive patients, does blood pressure change based on whether a physician or nurse measures it? Nurses record significantly lower systolic BP than physicians, with values almost matching ambulatory BP monitoring. Nurse-based BP measurement is advisable for diagnosis and control evaluation.",6.632072365991914e-07,0.35222135046217495,0.1467347487234615,0.050775941013892434,0.469468205718647,0.044023668639053264,0.050702443146680265,0.5204400126475912,0.014921946740128552,6.632072365991914e-07,0.5520685823000377,0.0
139,0.3,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does the blood pressure of treated hypertensive patients vary when measured by a physician compared to a nurse? Nurses measure systolic BP significantly lower than physicians, with readings nearly identical to ambulatory monitoring. Blood pressure measurement by nurses is recommended for diagnosis and control assessment.",5.921493183921352e-07,0.3131104732736736,0.1240197676526124,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.3,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","In treated hypertensive patients, is there a difference in blood pressure readings depending on whether a nurse or physician measures it? Systolic BP measured by nurses is significantly lower than that by physicians and closely matches ambulatory BP monitoring. Nurse measurement is desirable for diagnosis and evaluating control.",5.210914001850789e-07,0.21564581545642492,0.1467347487234615,0.0398953822252012,0.3297062633434886,0.044023668639053264,0.039837633900963065,0.3773391690069161,0.014921946740128552,5.210914001850789e-07,0.4054651081081624,0.0
139,0.3,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control",Does blood pressure in treated hypertensive patients differ when measured by a nurse versus a physician? The systolic BP recorded by nurses is significantly lower than physician measurements and almost identical to ambulatory BP monitoring. Nurse measurement is preferred for both diagnosis and control evaluation.,5.921493183921352e-07,0.281603783248221,0.1467347487234615,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.3,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Is blood pressure in treated hypertensive patients affected by whether a physician or nurse takes the measurement? Nurses measure systolic BP significantly lower than physicians, with results nearly matching ambulatory BP monitoring. Measuring BP by nurses is recommended for diagnosis and assessing control.",6.39521263863506e-07,0.32812379888311494,0.1467347487234615,0.04896251454911056,0.4447755931282753,0.044023668639053264,0.0488916416057274,0.4951222046632995,0.014921946740128552,6.39521263863506e-07,0.5260930958967798,0.0
139,0.3,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","For patients with treated hypertension, does blood pressure vary depending on whether a nurse or physician measures it? Systolic BP readings by nurses are significantly lower than those by physicians and closely resemble ambulatory BP monitoring. Nurse measurement is beneficial for diagnosis and control assessment.",5.921493183921352e-07,0.281603783248221,0.1467347487234615,0.045335661619546816,0.39714754413902087,0.044023668639053264,0.045270038523821665,0.44633204049386777,0.014921946740128552,5.921493183921352e-07,0.47608267532211634,0.0
139,0.3,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control","Does blood pressure measurement in treated hypertensive patients differ between physicians and nurses? Nurses record significantly lower systolic BP than physicians, with readings almost identical to ambulatory BP monitoring. Blood pressure measurement by nurses is desirable for diagnosis and evaluating control.",6.868932093348768e-07,0.44622868110854075,0.09687325287858617,0.052589367478674306,0.5303320229624227,0.01840039994099231,0.05251324468763313,0.5464154990508492,0.014921946740128552,6.868932093348768e-07,0.5787368293821986,0.0
140,0.3,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The use of audits to detect maternal mortality across various settings: is it merely a disparity between wealthier and poorer populations? Differences in maternal mortality extend beyond just economic status. Recognizing the scale of maternal deaths and mobilizing strong political commitment are crucial. Nonetheless, there is no universal solution to lowering maternal mortality, and pinpointing the problems is essential.",3.079176455639103e-07,0.12114243778591227,0.08308532313820656,0.023574544042164372,0.16583556389709742,0.02854671280276816,0.023540420032387266,0.1886635912371819,0.014489619377162637,3.079176455639103e-07,0.21217451994363756,0.0
140,0.3,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to identify maternal mortality in different environments: is it simply a matter of wealth disparity? Maternal mortality differences involve more than just rich versus poor distinctions. Understanding the extent of maternal mortality and fostering political will are key factors. However, no single solution exists to reduce maternal mortality, and identifying the underlying issues is necessary.",3.552895910352811e-07,0.19118636043139992,0.02761906381435003,0.027201396971728117,0.2015536464991765,0.02854671280276816,0.027162023114293,0.22503123540805614,0.014489619377162637,3.552895910352811e-07,0.24921579162398766,0.0
140,0.3,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the use of audits to find maternal mortality in various contexts just a reflection of the gap between rich and poor? Maternal mortality differences are more complex than economic divides alone. Recognizing the severity of maternal mortality and securing strong political determination are important. Yet, there is no one-size-fits-all solution to reduce maternal mortality, and problem identification is critical.",2.8423167282822487e-07,0.136008019307436,0.031377105225002505,0.0217611175773825,0.14844382118522859,0.02854671280276816,0.0217296184914344,0.17096401413778128,0.014489619377162637,2.8423167282822487e-07,0.1941560144409591,0.0
140,0.3,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Auditing maternal mortality in diverse settings: is it only about the divide between affluent and impoverished groups? The disparities in maternal mortality go beyond wealth differences. Acknowledging the magnitude of the issue and leveraging political will are vital. Still, no single, universal approach exists to decrease maternal mortality, and identifying the challenges is necessary.",4.263475092423373e-07,0.21354840524397112,0.08146044903037912,0.032641676366073735,0.2576431131502197,0.02854671280276816,0.0325944277371516,0.28218964924800627,0.014489619377162637,4.263475092423373e-07,0.3074846997479632,0.0
140,0.3,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Does auditing maternal mortality in different contexts simply reflect the difference between the rich and the poor? The variation in maternal mortality is more than just economic disparity. Recognizing the scale of maternal deaths and applying strong political will are important. However, no single general solution can reduce maternal mortality, and identifying problems is crucial.",4.026615365066519e-07,0.19437189265071275,0.08180946982364506,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
140,0.3,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The role of audits in identifying maternal mortality across settings: is it just a rich-poor divide? Maternal mortality differences surpass mere economic status. Understanding the extent of maternal mortality and harnessing political will are key. Nonetheless, no single solution exists to reduce maternal mortality, and problem identification is essential.",5.447773729207643e-07,0.35514607855033686,0.015255233205052829,0.0417088086899831,0.3587392300215897,0.02854671280276816,0.04164843544191593,0.3853738854832369,0.014489619377162637,5.447773729207643e-07,0.4128452154057891,0.0
140,0.3,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is auditing maternal mortality in various settings merely a matter of rich versus poor? Differences in maternal mortality involve more than economic factors. Recognizing the magnitude of maternal mortality and mobilizing political will are important. However, there is no single, general solution to reduce maternal mortality, and identifying the problems is necessary.",4.737194547137081e-07,0.2904824409667408,0.020354715226170314,0.03626852929563748,0.29686382630350217,0.02854671280276816,0.03621603081905733,0.32219498386170464,0.014489619377162637,4.737194547137081e-07,0.3483066942682176,0.0
140,0.3,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Using audits to uncover maternal mortality in different contexts: is it just about wealth differences? Maternal mortality disparities are more than just rich and poor distinctions. Acknowledging the scale of maternal mortality and fostering political will are vital. Yet, no single solution exists to reduce maternal mortality, and problem identification is crucial.",4.737194547137081e-07,0.2904824409667408,0.020354715226170314,0.03626852929563748,0.29686382630350217,0.02854671280276816,0.03621603081905733,0.32219498386170464,0.014489619377162637,4.737194547137081e-07,0.3483066942682176,0.0
140,0.3,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","The application of audits to identify maternal mortality in diverse settings: is it simply a difference between rich and poor? Maternal mortality differences are more complex than economic status alone. Recognizing the magnitude of maternal mortality and leveraging political will are important. However, there is no universal solution to reduce maternal mortality, and identifying the issues is essential.",3.316036182995957e-07,0.17245425298550598,0.028916437098255296,0.025387970506946245,0.18353514099649804,0.02854671280276816,0.025351221573340132,0.20668209673986038,0.014489619377162637,3.316036182995957e-07,0.23052365861183333,0.0
140,0.3,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems","Is the use of audit to detect maternal mortality across different settings just a matter of rich versus poor? Differences in maternal mortality go beyond economic divides. Acknowledging the scale of maternal mortality and harnessing strong political will are key. Nonetheless, no single solution exists to reduce maternal mortality, and identifying the problems is necessary.",4.026615365066519e-07,0.22973379088931356,0.024877608793692718,0.030828249901291863,0.2385949181795266,0.02854671280276816,0.030783626196198732,0.2627715633909036,0.014489619377162637,4.026615365066519e-07,0.28768207245178345,0.0
141,0.3,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is measuring visceral adipose tissue area at a single level a reliable indicator of visceral adipose tissue volume? VAT area measurement taken 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area at a CT slice 3 cm above the lower margin of L3 vertebra can represent VAT volume.,9.474389094274162e-08,0.044378191010316925,0.02248520710059168,0.0072537058591274906,0.02904714867097491,0.025355795610425308,0.007243206163811466,0.025056282451688894,0.02977049916280422,9.474389094274162e-08,0.0239651388400004,0.03151048618020334
141,0.3,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level measurement of visceral adipose tissue area represent the total visceral adipose tissue volume? Measuring VAT area at a level 3 cm above the lower edge of the L3 vertebra is feasible and reflects variations in VAT volume and body weight. Knowledge advancement: VAT area on a CT slice 3 cm above L3's lower margin correlates with VAT volume.,0.0,0.12424533248940017,0.1173553719008265,0.0,0.07048954378575578,0.05016263313688156,0.0,0.04780325383172013,0.03443877551020409,0.0,0.024320953703857562,0.017538265306122455
141,0.3,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does measuring visceral adipose tissue area at one level accurately reflect visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is practical and can mirror changes in VAT volume and body weight. Progress in understanding: VAT area at a CT slice 3 cm above L3's lower margin is indicative of VAT volume.,2.3685972735685406e-08,0.05848714209957606,0.08350591715976334,0.0018134264647818726,0.052584885785240676,0.0495804288793706,0.0018108015409528666,0.030411511119851298,0.03443877551020409,2.3685972735685406e-08,0.006621376604456941,0.017538265306122455
141,0.3,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is the visceral adipose tissue area measured at a single level representative of the visceral adipose tissue volume? VAT area measured 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances: VAT area on a CT slice 3 cm above L3's lower margin can represent VAT volume.,2.3685972735685406e-08,0.011494112909071319,0.0524,0.0018134264647818726,0.02868325886937928,0.032448956455690396,0.0018108015409528666,0.006090557415993736,0.016900510204081638,2.3685972735685406e-08,0.006621376604456941,0.017538265306122455
141,0.3,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can visceral adipose tissue area at a single level serve as a proxy for visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge progress: VAT area at a CT slice 3 cm above L3's lower margin correlates with VAT volume.,2.3685972735685406e-08,0.03499062750432369,0.0677431757016532,0.0018134264647818726,0.028683258869379724,0.03244895645569038,0.0018108015409528666,0.030411511119851298,0.03443877551020409,2.3685972735685406e-08,0.006621376604456941,0.017538265306122455
141,0.3,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is it possible for visceral adipose tissue area measured at one level to represent visceral adipose tissue volume? VAT area measurement at 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances in knowledge: VAT area on a CT slice 3 cm above L3's lower margin can indicate VAT volume.,2.3685972735685406e-08,0.1199423421286987,0.10280991735537193,0.0018134264647818726,0.08807987925531213,0.050725506410977776,0.0018108015409528666,0.06489768719101985,0.03443877551020409,2.3685972735685406e-08,0.04171269641572639,0.017538265306122455
141,0.3,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can a single-level visceral adipose tissue area measurement reflect visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above L3's lower margin is representative of VAT volume.,9.474389094274162e-08,0.02224545240435649,0.09439999999999998,0.0072537058591274906,0.0031323897377104615,0.047707349636993704,0.007243206163811466,0.02365571015042356,0.03443877551020409,9.474389094274162e-08,0.04843840057857163,0.017538265306122455
141,0.3,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Does a single-level measurement of visceral adipose tissue area correspond to visceral adipose tissue volume? VAT area measured 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances: VAT area on a CT slice 3 cm above L3's lower margin can represent VAT volume.,1.1842986367842703e-07,0.001526373470924547,0.09254477301124535,0.009067132323909363,0.0224150599622166,0.04703695586886464,0.009054007704764333,0.04234784316257789,0.03443877551020409,1.1842986367842703e-07,0.06748659554926473,0.017538265306122455
141,0.3,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Is visceral adipose tissue area measurement at a single level an accurate reflection of visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is feasible and can mirror changes in VAT volume and body weight. Progress in knowledge: VAT area at a CT slice 3 cm above L3's lower margin correlates with VAT volume.,2.3685972735685406e-08,0.07449006799362046,0.07184051263794947,0.0018134264647818726,0.08807987925531213,0.050725506410977776,0.0018108015409528666,0.06489768719101985,0.03443877551020409,2.3685972735685406e-08,0.04171269641572639,0.017538265306122455
141,0.3,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower,Can measuring visceral adipose tissue area at one level effectively represent visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is practical and reflects changes in VAT volume and body weight. Advances in understanding: VAT area on a CT slice 3 cm above L3's lower margin indicates VAT volume.,9.474389094274162e-08,0.02224545240435649,0.09439999999999997,0.0072537058591274906,0.0031323897377104615,0.047707349636993704,0.007243206163811466,0.02365571015042356,0.03443877551020409,9.474389094274162e-08,0.04843840057857163,0.017538265306122455
142,0.3,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition impact quality of life? Yes, it does. This phase is commonly linked to physical symptoms including hot flashes and sleep problems, as well as psychological challenges like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.3,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life influenced by the menopausal transition? Indeed, it is. Menopausal transition often brings physical symptoms such as hot flashes and sleep disturbances, along with psychological issues like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.3,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does going through menopause affect one's quality of life? Yes, it does. The menopausal transition is frequently accompanied by physical symptoms like hot flashes and disrupted sleep, and psychological problems such as mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.3,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Can the menopausal transition alter quality of life? Yes, it can. This period is typically associated with physical symptoms including hot flashes and sleep difficulties, as well as psychological concerns like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.3,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is the quality of life affected during the menopausal transition? Yes, it is affected. Menopausal transition often involves physical symptoms such as hot flashes and sleep disturbances, alongside psychological issues like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.3,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the transition through menopause impact quality of life? Yes, it does. It is commonly linked with physical symptoms like hot flashes and sleep problems, as well as psychological challenges such as mood swings and depression.",1.421158364141119e-07,0.022975774861734966,0.09642074506939374,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,0.3,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life changed by the menopausal transition? Yes, it is. Menopausal transition is often accompanied by physical symptoms including hot flashes and sleep disturbances, and psychological issues like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.3,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does the menopausal transition influence quality of life? Yes, it does. This stage is frequently associated with physical symptoms such as hot flashes and sleep problems, along with psychological difficulties like mood swings and depression.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,0.3,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Does experiencing menopausal transition affect quality of life? Yes, it does. It is often connected to physical symptoms like hot flashes and sleep disturbances, as well as psychological issues including mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
142,0.3,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition does affect the quality of life. It is often associated with physical symptoms such as hot flashes, sleep disturbances, and psychological issues like mood swings and depression. These factors","Is quality of life impacted by the menopausal transition? Yes, it is. Menopausal transition commonly brings physical symptoms such as hot flashes and sleep problems, together with psychological challenges like mood swings and depression.",1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
143,0.3,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafnessdoes it always lead to Meniere's disease? We found that not every patient with low-tone sudden deafness (SD) experienced endolymphatic hydrops, even if vertigo occurred initially, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",9.474389094274162e-08,0.06370511892904052,0.01959306984724757,0.0072537058591274906,0.06228388170779198,0.02221074380165289,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
143,0.3,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably develop into Meniere's disease? Our conclusion is that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is a helpful prognostic tool.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.3,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression from low-tone sudden deafness to Meniere's disease unavoidable? We determined that some low-tone sudden deafness (SD) patients do not have endolymphatic hydrops even when vertigo is present initially, and electrocochleography (ECochG) provides useful prognostic information.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.3,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? Our study indicates that not all patients with low-tone sudden deafness (SD) suffer from endolymphatic hydrops, even if vertigo attacks occur at onset, and that electrocochleography (ECochG) is an effective prognostic tool.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
143,0.3,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an inevitable outcome of low-tone sudden deafness? We conclude that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients despite vertigo at onset, and electrocochleography (ECochG) is useful for prognosis.",2.6054570009253894e-07,0.2526280774426146,0.014841716949297964,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.3,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily lead to Meniere's disease? Our findings show that endolymphatic hydrops is absent in some low-tone sudden deafness (SD) patients even with initial vertigo, and electrocochleography (ECochG) is a valuable prognostic method.",2.6054570009253894e-07,0.2922364877603254,0.013544536271808981,0.019947691112600606,0.29026878735828765,0.007174012855831045,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
143,0.3,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Will low-tone sudden deafness always develop into Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is a useful tool for prognosis.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.3,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the progression from low-tone sudden deafness to Meniere's disease certain? Our conclusion is that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even with vertigo initially, and electrocochleography (ECochG) is a helpful prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.3,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably evolve into Meniere's disease? We found that some patients with low-tone sudden deafness (SD) do not have endolymphatic hydrops even if they experienced vertigo at onset, and electrocochleography (ECochG) is a useful prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.3,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is it certain that low-tone sudden deafness progresses to Meniere's disease? Our study concludes that endolymphatic hydrops is not present in all patients with low-tone sudden deafness (SD) despite vertigo at onset, and electrocochleography (ECochG) is a beneficial prognostic tool.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
144,0.3,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: Yes, a resident's leadership abilities can be linked to their technical skill ratings. Strong leaders often possess excellent technical skills because they must comprehend and manage the tasks. Their technical expertise can impact their credibility, decision-making, and leadership effectiveness.",2.3685972735685406e-08,0.030839513777210392,0.043586439677911995,0.0018134264647818726,0.00552684604305087,0.01719999999999996,0.0018108015409528666,0.006605292843934851,0.018454440599769306,2.3685972735685406e-08,0.007241421087510691,0.01922337562475971
144,0.3,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are a resident's leadership skills associated with their technical skill evaluations? Answer: Yes, leadership skills in residents can correlate with technical skill ratings. Effective leaders usually have strong technical skills as they need to understand and supervise the work. Their technical knowledge can affect their credibility, decisions, and guidance abilities.",1.1842986367842703e-07,0.02725572934934828,0.04769968149305523,0.009067132323909363,0.005524722740418486,0.07359999999999998,0.009054007704764333,0.04677790788498859,0.037677816224529016,1.1842986367842703e-07,0.0744366099267566,0.01922337562475971
144,0.3,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does a resident's leadership capability influence their technical skill ratings? Answer: Yes, leadership capability in residents can influence technical skill ratings. Leaders who are effective tend to have solid technical skills since they need to grasp and oversee tasks. Their technical competence can shape their credibility, decision-making, and leadership.",1.4211583641411244e-07,0.049155939966197604,0.04649114381295129,0.010880558788691236,0.015094564462317273,0.07359999999999998,0.0108648092457172,0.06783131708282175,0.037677816224529016,1.4211583641411244e-07,0.09594281514771996,0.01922337562475971
144,0.3,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a relationship between residents' leadership skills and their technical skill ratings? Answer: Yes, residents' leadership skills can relate to how their technical skills are rated. Good leaders often demonstrate strong technical skills because they must understand and manage their work. Their technical ability can impact their credibility, decision-making, and ability to lead.",2.3685972735685406e-08,0.00516739597869309,0.02498958767180344,0.0018134264647818726,0.057839840802291764,0.054739053254437856,0.0018108015409528666,0.03326479978854824,0.037677816224529016,2.3685972735685406e-08,0.007241421087510691,0.01922337562475971
144,0.3,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do leadership skills in residents impact their technical skill ratings? Answer: Yes, leadership skills can impact technical skill ratings in residents. Effective leaders generally excel in technical skills as they need to comprehend and oversee tasks. Their technical proficiency influences their credibility, decision-making, and leadership capacity.",2.1317375462116866e-07,0.11787017843337289,0.042555281072042914,0.016320838183036854,0.0796330855998888,0.07359999999999998,0.0162972138685758,0.13378928487461783,0.037677816224529016,2.1317375462116866e-07,0.1633840959432522,0.01922337562475971
144,0.3,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Can a resident's leadership skills affect their technical skill ratings? Answer: Yes, a resident's leadership skills can affect their technical skill ratings. Effective leaders often have strong technical skills since they need to understand and supervise the work. Their technical expertise can influence their credibility, decisions, and guidance.",1.6580180914979784e-07,0.19796899286082192,0.08290765224979386,0.012693985253473108,0.15413047247886436,0.010769929691725272,0.012675610786670066,0.14961119017856284,0.0057106135275371075,1.6580180914979784e-07,0.11792172186649497,0.01922337562475971
144,0.3,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Are technical skill ratings related to a resident's leadership abilities? Answer: Yes, technical skill ratings can be related to a resident's leadership abilities. Effective leaders usually possess good technical skills because they must understand and oversee tasks. Their technical proficiency can impact their credibility, decision-making, and leadership.",1.8948778188548325e-07,0.1829272196283136,0.0174704125115428,0.014507411718254981,0.17820151463066924,0.012567800453514771,0.014486412327622933,0.1729295117389995,0.006670480151890666,1.8948778188548325e-07,0.17190126774400527,0.0034916054460894
144,0.3,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Is there a link between a resident's leadership skills and their technical skill ratings? Answer: Yes, there is a link between leadership skills and technical skill ratings in residents. Effective leaders tend to have strong technical skills as they need to understand and manage their work. Their technical competence can affect their credibility, decisions, and ability to lead.",7.105791820705622e-08,0.06093217594095712,0.005384221071594933,0.005440279394345618,0.10811378505662583,0.03855867768595038,0.0054324046228586,0.1073727719422699,0.037677816224529016,7.105791820705622e-08,0.08274897359565658,0.01922337562475971
144,0.3,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Do residents' leadership skills correspond with their technical skill ratings? Answer: Yes, residents' leadership skills can correspond with their technical skill ratings. Effective leaders often excel in technical skills because they need to understand and oversee tasks. Their technical proficiency can influence their credibility, decision-making, and leadership.",1.8948778188548325e-07,0.2235557835620252,0.08691977301124536,0.014507411718254981,0.17820151463066924,0.012567800453514771,0.014486412327622933,0.1729295117389995,0.006670480151890666,1.8948778188548325e-07,0.17190126774400527,0.0034916054460894
144,0.3,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: Yes, resident's leadership skills can relate to ratings of technical skill. Effective leaders often excel in technical skills as they need to understand and oversee the work. Their technical proficiency can influence their credibility, decision-making capability, and their ability to guide, which can be","Question: Does leadership ability in residents relate to their technical skill ratings? Answer: Yes, leadership ability in residents relates to their technical skill ratings. Effective leaders typically have strong technical skills as they must comprehend and supervise their work. Their technical expertise can impact their credibility, decisions, and leadership effectiveness.",1.4211583641411244e-07,0.17300136013444511,0.07905270951918182,0.010880558788691236,0.13061909455564136,0.009044628099173571,0.0108648092457172,0.1268225664921787,0.004791319577940115,1.4211583641411244e-07,0.09594281514771996,0.01922337562475971
145,0.3,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Student examiners can be viewed as suitable replacements for faculty in this context, offering valuable peer review and assessment. However, they may",1.8948778188548293e-07,0.06169449175654407,0.08901693707173934,0.014507411718254981,0.050138732007214415,0.1052088868788513,0.014486412327622933,0.04465503546927829,0.11426592797783926,1.8948778188548325e-07,0.07928105927483475,0.09418282548476452
145,0.3,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Are student examiners acceptable substitutes for faculty in an undergraduate OSCE focused on medical emergencies? Student examiners can reasonably replace faculty members, providing important peer evaluation and assessment, though they may",3.5528959103528003e-07,0.2052225892797357,0.13617306608276178,0.02720139697172813,0.22785366377907668,0.13296398891966763,0.027162023114293048,0.26779858678348756,0.11426592797783926,3.552895910352811e-07,0.3098047178866672,0.09418282548476452
145,0.3,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Is it reasonable for student examiners to substitute faculty in an undergraduate OSCE on medical emergencies? Student examiners can act as effective substitutes for faculty, contributing valuable peer review and assessment, but they may",2.8423167282822413e-07,0.10571151747201668,0.1391933265613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1660158924735451,0.11426592797783926,2.8423167282822487e-07,0.20444420222884174,0.09418282548476452
145,0.3,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","May student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? They can be considered appropriate replacements, offering useful peer review and assessment, although they may",4.0266153650665063e-07,0.2280056487293569,0.1694667640613587,0.03082824990129189,0.29931262776122036,0.13296398891966763,0.030783626196198795,0.3419065589372092,0.11426592797783926,4.026615365066519e-07,0.38676575902279664,0.09418282548476452
145,0.3,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Can student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Yes, they can provide meaningful peer review and assessment, but they may",4.2634750924233593e-07,0.2643732929002316,0.1694667640613587,0.03264167636607377,0.33705295574406735,0.13296398891966763,0.03259442773715167,0.3811272720904917,0.11426592797783926,4.263475092423373e-07,0.42758775354305145,0.09418282548476452
145,0.3,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Are student examiners reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? They can serve as acceptable substitutes, providing valuable peer review and assessment, yet they may",4.0266153650665063e-07,0.2280056487293569,0.1694667640613587,0.03082824990129189,0.29931262776122036,0.13296398891966763,0.030783626196198795,0.3419065589372092,0.11426592797783926,4.026615365066519e-07,0.38676575902279664,0.09418282548476452
145,0.3,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Is it appropriate for student examiners to act as substitutes for faculty in an undergraduate OSCE on medical emergencies? Student examiners may be reasonable substitutes, offering beneficial peer review and assessment, though they may",2.8423167282822413e-07,0.10571151747201668,0.1391933265613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1660158924735451,0.11426592797783926,2.8423167282822487e-07,0.20444420222884174,0.09418282548476452
145,0.3,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Could student examiners reasonably replace faculty in an undergraduate OSCE on medical emergencies? They can be considered reasonable substitutes, contributing valuable peer review and assessment, but they may",4.2634750924233593e-07,0.2643732929002316,0.1694667640613587,0.03264167636607377,0.33705295574406735,0.13296398891966763,0.03259442773715167,0.3811272720904917,0.11426592797783926,4.263475092423373e-07,0.42758775354305145,0.09418282548476452
145,0.3,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Do student examiners make reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? They can be effective substitutes, providing important peer review and assessment, although they may",4.0266153650665063e-07,0.2280056487293569,0.1694667640613587,0.03082824990129189,0.29931262776122036,0.13296398891966763,0.030783626196198795,0.3419065589372092,0.11426592797783926,4.026615365066519e-07,0.38676575902279664,0.09418282548476452
145,0.3,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners can be considered as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies. They can provide valuable peer review and assessment. However, they may","Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? They can reasonably fill the role, offering valuable peer review and assessment, but they may",4.0266153650665063e-07,0.2280056487293569,0.1694667640613587,0.03082824990129189,0.29931262776122036,0.13296398891966763,0.030783626196198795,0.3419065589372092,0.11426592797783926,4.026615365066519e-07,0.38676575902279664,0.09418282548476452
146,0.3,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could be a crucial new tool for enhancing population health, particularly among lower-income groups. Although the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various types of income support.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.3,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income support might serve as an important mechanism to improve health outcomes in the population, especially for those with lower incomes. Despite robust findings, more research is required to confirm these results. Subsequent studies should assess different forms of income support.",2.3685972735685406e-08,0.018133879844112855,0.00031297436329903727,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
146,0.3,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies may represent a powerful approach to boosting population health, particularly for lower-income individuals. Although the evidence is strong, further analysis is needed to ensure its validity. Future research should investigate a range of income support programs.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.3,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support could be a key strategy for enhancing health across populations, especially among economically disadvantaged groups. While the findings are compelling, additional research is necessary to confirm their reliability. Future studies should examine multiple income support options.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.3,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies may act as an effective lever for improving health outcomes in the population, particularly for low-income individuals. Despite strong findings, further research is needed to validate these conclusions. Future investigations should explore various income support mechanisms.",7.105791820705622e-08,0.08261751549370011,0.019826576555107524,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
146,0.3,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Supporting income through policy could be a significant factor in advancing population health, especially among lower-income people. Although the results are robust, more analysis is required to confirm their dependability. Future research should look into different types of income support.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
146,0.3,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may provide an important means to enhance health outcomes, particularly for those with lower incomes. While the findings are strong, additional studies are necessary to verify their accuracy. Future research should consider a variety of income support programs.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
146,0.3,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies aimed at income support might be a vital tool for improving population health, especially among low-income groups. Despite robust findings, further research is needed to confirm their validity. Future studies should examine different income support strategies.",1.1842986367842703e-07,0.09595304393715409,0.001748760330578504,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
146,0.3,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could serve as a major lever to improve health outcomes in the population, particularly for economically disadvantaged individuals. Although the evidence is strong, more research is necessary to confirm these findings. Future investigations should explore various income support approaches.",0.0,0.024755256448569796,0.017814055255132678,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
146,0.3,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support through policy may be a key method to enhance population health, especially for lower-income persons. While the findings are compelling, additional analysis is required to ensure their reliability. Future research should investigate a range of income support options.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
147,0.3,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correspond to the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone seen on contrast enema and the length of aganglionosis is weak. Therefore, systematic preoperative biopsy via coelioscopy or umbilical incision is essential.",2.3685972735685406e-08,0.025920373110786876,0.002044707429322834,0.0018134264647818726,0.05730511085940426,0.02425736961451249,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
147,0.3,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease? The relationship between the transition zone on contrast enema and the aganglionosis length is minimal. Hence, a systematic preoperative biopsy using coelioscopy or umbilical incision is mandatory.",2.3685972735685406e-08,0.00631903063618644,0.020625000000000004,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
147,0.3,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the radiographic transition zone on imaging match the level of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and aganglionosis length is low. Systematic preoperative biopsy through coelioscopy or umbilical incision is required.,9.474389094274162e-08,0.10791285581450483,0.008765432098765472,0.0072537058591274906,0.17203709359539587,0.05314625850340137,0.007243206163811466,0.17304631966855455,0.05246913580246914,9.474389094274162e-08,0.1401215692254847,0.027006172839506164
147,0.3,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Is the radiographic transition zone indicative of the extent of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and the length of aganglionosis remains limited. Therefore, systematic preoperative biopsy by coelioscopy or umbilical incision is necessary.",9.474389094274162e-08,0.03859813775851073,0.04013850415512466,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
147,0.3,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Does the level of the radiographic transition zone correlate with the aganglionosis length in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and aganglionosis length is low. Systematic preoperative biopsy via coelioscopy or umbilical incision is mandatory.,7.105791820705622e-08,0.07983903746530441,0.006420745069393746,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
147,0.3,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is there a strong correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and the length of aganglionosis is weak. Systematic preoperative biopsy by coelioscopy or umbilical incision is essential.,2.3685972735685406e-08,0.05815977685776108,0.02426592797783926,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
147,0.3,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone on contrast enema accurately reflect the level of aganglionosis in Hirschsprung's disease? The correlation between the radiographic transition zone and aganglionosis length is low. Therefore, systematic preoperative biopsy using coelioscopy or umbilical incision is required.",1.1842986367842692e-07,0.10123925546526058,0.013611111111111102,0.009067132323909363,0.16433741333177476,0.029226505416981616,0.009054007704764333,0.1642191208045447,0.027006172839506164,1.1842986367842703e-07,0.1300531282481976,0.0
147,0.3,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone a reliable indicator of the extent of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and the length of aganglionosis remains poor. Systematic preoperative biopsy by coelioscopy or umbilical incision is mandatory.,7.105791820705622e-08,0.012214922288724672,0.04134779750164366,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
147,0.3,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,"Does the radiographic transition zone correlate well with the level of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and the length of aganglionosis is low. Hence, systematic preoperative biopsy via coelioscopy or umbilical incision is necessary.",2.3685972735685406e-08,0.025920373110786876,0.002044707429322834,0.0018134264647818726,0.05730511085940426,0.02425736961451249,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
147,0.3,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.,Is the radiographic transition zone on contrast enema correlated with the level of aganglionosis in Hirschsprung's disease? The correlation between the radiographic transition zone and aganglionosis length remains low. Systematic preoperative biopsy by coelioscopy or umbilical incision is mandatory.,1.4211583641411222e-07,0.1300210057574267,0.01163265306122449,0.010880558788691236,0.19297762963316822,0.030634920634920654,0.0108648092457172,0.19265885652503245,0.02775510204081633,1.4211583641411244e-07,0.15822400521489444,0.0
148,0.3,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Isolated sternal fractures in children usually result from common age-specific trauma. Ultrasonography serves as an effective diagnostic method for detecting fractures, while radiography is preferred for assessing the degree of dislocation.",1.4211583641411244e-07,0.10010748428748562,0.01999167013744273,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
148,0.3,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children uncommon and often unnoticed? Answer: In childhood, isolated sternal fractures typically arise from usual age-related traumatic events. Ultrasonography is valuable for fracture detection, and radiography is the preferred technique to visualize dislocation extent.",2.6054570009253936e-07,0.2562814813355869,0.0056315985606182235,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
148,0.3,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is a sternal fracture in children a rare and frequently overlooked injury? Answer: Isolated sternal fractures in children commonly occur due to typical trauma associated with their age. Ultrasonography is a helpful diagnostic tool for identifying fractures, and radiography is the best method to evaluate the dislocation's severity.",4.737194547137081e-08,0.0708583723445182,0.02159623156388053,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
148,0.3,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children rare and often missed? Answer: Childhood isolated sternal fractures are generally caused by common age-related trauma. Ultrasonography is useful for detecting fractures, while radiography is the standard for visualizing the extent of dislocation.",2.6054570009253936e-07,0.2562814813355869,0.0056315985606182235,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
148,0.3,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is the sternal fracture in children a rare and often unrecognized injury? Answer: Isolated sternal fractures in childhood usually stem from typical traumatic incidents related to age. Ultrasonography is an effective diagnostic tool for fracture detection, and radiography is the preferred method to assess dislocation extent.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856674,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
148,0.3,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children uncommon and frequently overlooked? Answer: In children, isolated sternal fractures often result from typical age-related trauma. Ultrasonography aids in fracture detection, and radiography is the method of choice to visualize dislocation extent.",3.0791764556390996e-07,0.31084662072692426,0.007014502702063434,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,0.3,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children a rare and often missed diagnosis? Answer: Isolated sternal fractures in childhood are typically caused by common age-related trauma. Ultrasonography is a useful tool for detecting fractures, and radiography is preferred for assessing the degree of dislocation.",1.6580180914979784e-07,0.12309700251218514,0.01999167013744273,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
148,0.3,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children rare and frequently unnoticed? Answer: Isolated sternal fractures in childhood commonly arise from typical traumatic events related to age. Ultrasonography is valuable for fracture detection, and radiography is the best method to visualize dislocation extent.",2.3685972735685406e-07,0.26473238214780537,0.029869825707432605,0.018134264647818726,0.2638046612404663,0.025623268698060954,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
148,0.3,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in children a rare and often overlooked injury? Answer: Isolated sternal fractures in childhood usually occur due to typical age-related trauma. Ultrasonography is a helpful diagnostic tool for fracture detection, while radiography is the preferred technique to assess dislocation extent.",1.6580180914979784e-07,0.12309700251218514,0.01999167013744273,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
148,0.3,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children uncommon and often missed? Answer: Childhood isolated sternal fractures generally result from typical trauma related to age. Ultrasonography is useful for detecting fractures, and radiography is the standard method for visualizing the extent of dislocation.",2.1317375462116866e-07,0.20453710908972944,0.0043833298625572704,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
149,0.3,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might explain the emergence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated alongside other documented case reports. The dopamine partial agonist mechanism of aripiprazole may account for the development of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.3,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: does it represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed in relation to existing case reports. The dopamine partial agonist property of aripiprazole could clarify the occurrence of pathological gambling.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
149,0.3,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole associated with a new risk for pathological gambling? Answer: Adverse drug reactions were reviewed with reference to other published case reports. The dopamine partial agonist effect of aripiprazole might explain pathological gambling cases.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.3,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were compared to previously reported cases. The dopamine partial agonist mechanism of aripiprazole could explain pathological gambling onset.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Does aripiprazole pose a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other published case reports. The dopamine partial agonist activity of aripiprazole may elucidate the occurrence of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.3,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is there a new risk factor for pathological gambling in aripiprazole? Answer: Adverse drug reactions were assessed alongside other case reports. The dopamine partial agonist mechanism of aripiprazole could explain pathological gambling.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
149,0.3,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with existing case reports. The dopamine partial agonist function of aripiprazole might explain pathological gambling.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,0.3,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Might aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated with other published case reports. The dopamine partial agonist mechanism of aripiprazole could clarify pathological gambling occurrence.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside other case reports. The dopamine partial agonist effect of aripiprazole may explain the emergence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
150,0.3,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Yes, studies show that taking statins before surgery decreases postoperative atrial fibrillation rates.",0.0,0.053319013889226774,0.03798888888888887,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,0.3,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation",Can preoperative statins help prevent atrial fibrillation after coronary artery bypass grafting? Research confirms that preoperative statin use reduces the occurrence of postoperative atrial fibrillation.,4.73719454713706e-08,0.026595320104916276,0.07638888888888888,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.3,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Is there a reduction in atrial fibrillation after coronary artery bypass grafting when patients use preoperative statins? Yes, evidence suggests preoperative statins lessen postoperative atrial fibrillation.",2.36859727356853e-08,0.06741731462517109,0.07638888888888888,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.3,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do statins administered before coronary artery bypass grafting reduce atrial fibrillation afterward? Yes, research supports that preoperative statins lower the frequency of postoperative atrial fibrillation.",4.73719454713706e-08,0.026595320104916276,0.07638888888888888,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.3,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Does taking statins before coronary artery bypass grafting decrease the chance of atrial fibrillation post-surgery? Yes, studies indicate preoperative statins reduce postoperative atrial fibrillation.",7.10579182070559e-08,0.015964294313879357,0.07638888888888888,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
150,0.3,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass grafting? Yes, research demonstrates that preoperative statins can diminish postoperative atrial fibrillation rates.",4.73719454713706e-08,0.08892920998840648,0.006255739210284661,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.3,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Will preoperative statin therapy reduce atrial fibrillation following coronary artery bypass grafting? Yes, evidence shows that preoperative statins help reduce postoperative atrial fibrillation.",9.47438909427412e-08,0.06041605688471341,0.07638888888888888,0.007253705859127518,0.17435338714477844,0.0,0.007243206163811494,0.1823215567939549,0.0,9.474389094274152e-08,0.1910552367627094,0.0
150,0.3,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Do preoperative statins contribute to a lower risk of atrial fibrillation after coronary artery bypass grafting? Yes, research indicates that preoperative statins reduce the incidence of postoperative atrial fibrillation.",4.73719454713706e-08,0.13123548703503607,0.040723593964334705,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
150,0.3,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Is the use of statins before coronary artery bypass grafting associated with reduced atrial fibrillation postoperatively? Yes, studies confirm that preoperative statins decrease postoperative atrial fibrillation.",2.36859727356853e-08,0.06741731462517109,0.07638888888888888,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.3,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Yes, research indicates that preoperative statins can reduce the rate of postoperative atrial fibrillation","Can administering statins before coronary artery bypass grafting reduce the rate of atrial fibrillation afterward? Yes, research suggests preoperative statins effectively reduce postoperative atrial fibrillation.",4.73719454713706e-08,0.026595320104916276,0.07638888888888888,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
151,0.3,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the best method to guarantee that RBC morphology changes are understood as intended by the clinical pathologist. Reporting methods should be carefully reviewed.,4.737194547137081e-08,0.03428893658603549,0.048261993679977015,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.3,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a mismatch between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ notably in how they view the clinical importance of specific RBC morphology terminology. Including explanatory notes on CBC reports is the most effective way to ensure RBC morphology changes are interpreted correctly by clinical pathologists. Reporting procedures need critical evaluation.,9.474389094274162e-08,0.021216822352577047,0.03121748178980229,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
151,0.3,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians disagree on reporting and interpreting red blood cell morphology? There are important differences between clinicians and clinical pathologists about the clinical relevance of certain RBC morphology terms. The clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically assessed.,0.0,0.07803552045206974,0.084949215143121,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.3,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there discordance between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Significant differences exist between clinicians and clinical pathologists concerning the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the most straightforward way to ensure RBC morphology changes are understood as intended by clinical pathologists. Reporting practices warrant critical examination.,9.474389094274162e-08,0.021216822352577047,0.03121748178980229,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
151,0.3,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are clinical pathologists and clinicians aligned in how they report and interpret red blood cell morphology? Important clinical differences exist between clinicians and clinical pathologists regarding certain RBC morphology terms. Adding interpretive comments to CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting approaches should be scrutinized carefully.,9.474389094274162e-08,0.1526023576855975,0.09113563545745816,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
151,0.3,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a difference between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists hold differing views on the clinical significance of some RBC morphology terms. The best way to ensure RBC morphology changes are interpreted correctly by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically reviewed.,0.0,0.07803552045206796,0.08494921514312095,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.3,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Do clinical pathologists and clinicians have differing perspectives on reporting and interpreting red blood cell morphology? There are notable differences between clinicians and clinical pathologists about the clinical importance of certain RBC morphology terms. Including interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are understood as clinical pathologists intend. Reporting methods should be critically evaluated.,0.0,0.07803552045206974,0.084949215143121,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.3,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a gap between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Important differences exist between clinicians and clinical pathologists regarding the clinical relevance of specific RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically examined.,1.1842986367842703e-07,0.037387496562156564,0.03073822121441168,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
151,0.3,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Are there inconsistencies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists about the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the clearest way to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be carefully reviewed.,2.3685972735685406e-08,0.0961652747083166,0.08641581632653059,0.0018134264647818726,0.01709443335929972,0.0,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
151,0.3,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically,Is there a divergence between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Important differences exist between clinicians and clinical pathologists concerning the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest way to guarantee RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically assessed.,1.1842986367842703e-07,0.037387496562156564,0.03073822121441168,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
152,0.3,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections contribute to benign paroxysmal positional vertigo? Yes, viral infections can influence benign paroxysmal positional vertigo (BPPV). Viruses might induce inflammation or harm the inner ear, causing calcium crystals to dislodge and result in BPPV. However, this is only one factor.",2.1317375462116866e-07,0.10290134361093717,0.0627750745757739,0.016320838183036854,0.12135944742253635,0.055020085066162565,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
152,0.3,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can viral infections be involved in benign paroxysmal positional vertigo? Indeed, viral infections may play a role in benign paroxysmal positional vertigo (BPPV). They can cause inflammation or damage within the inner ear, leading to the displacement of calcium crystals that trigger BPPV. Nonetheless, this is just one aspect.",7.105791820705622e-08,0.014126544714540668,0.051136363636363646,0.005440279394345618,0.009963104237853404,0.036925949263693435,0.0054324046228586,0.008440570592397112,0.039235688114074976,7.105791820705622e-08,0.006776256090909705,0.04158790170132326
152,0.3,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections linked to benign paroxysmal positional vertigo? Yes, viral infections can be a factor in benign paroxysmal positional vertigo (BPPV). Such infections might cause inner ear inflammation or injury, resulting in the movement of calcium crystals that cause BPPV. Still, it is only one contributing cause.",9.474389094274162e-08,0.02011079149599615,0.07024793388429755,0.0072537058591274906,0.0026148939868484433,0.05766669000443417,0.007243206163811466,0.0002826433737834755,0.060964083175803374,9.474389094274162e-08,0.02924911194296742,0.04158790170132326
152,0.3,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections have any connection to benign paroxysmal positional vertigo? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). They may cause inflammation or damage in the inner ear, which leads to the dislodgement of calcium crystals responsible for BPPV. However, this is only one possible cause.",4.737194547137081e-08,0.03710347538856862,0.05279333741454954,0.0036268529295637453,0.012319289322674898,0.037807183364839306,0.003621603081905733,0.013706843861276408,0.039697542533081276,4.737194547137081e-08,0.0152026506278653,0.04158790170132326
152,0.3,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is there a role for viral infections in benign paroxysmal positional vertigo? Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses might cause inflammation or damage to the inner ear, resulting in calcium crystals becoming dislodged and causing BPPV. Yet, this is just one factor among others.",0.0,0.05436448474979949,0.03690008436313644,0.0,0.05545177444479554,0.039464529510607,0.0,0.056583443311015724,0.04056477762024782,0.0,0.05776226504666182,0.04158790170132326
152,0.3,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Can benign paroxysmal positional vertigo be caused by viral infections? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). They may lead to inflammation or damage in the inner ear, causing calcium crystals to dislodge and trigger BPPV. However, it is only one of several causes.",9.474389094274162e-08,0.02011079149599615,0.07024793388429755,0.0072537058591274906,0.03275172792423753,0.03600665531409644,0.007243206163811466,0.031089184732003172,0.038753339374150486,9.474389094274162e-08,0.02924911194296742,0.04158790170132326
152,0.3,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Do viral infections influence benign paroxysmal positional vertigo? Yes, viral infections can affect benign paroxysmal positional vertigo (BPPV). They can cause inflammation or injury to the inner ear, which may dislodge calcium crystals and cause BPPV. Still, this is only one contributing factor.",2.1317375462116866e-07,0.10290134361093717,0.0627750745757739,0.016320838183036854,0.12135944742253635,0.055020085066162565,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
152,0.3,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Are viral infections a factor in benign paroxysmal positional vertigo? Yes, viral infections can be involved in benign paroxysmal positional vertigo (BPPV). They might cause inner ear inflammation or damage, leading to the displacement of calcium crystals that cause BPPV. However, this is just one of the causes.",9.474389094274162e-08,0.00938483320868233,0.049411062043811946,0.0072537058591274906,0.03275172792423753,0.03600665531409644,0.007243206163811466,0.031089184732003172,0.038753339374150486,9.474389094274162e-08,0.02924911194296742,0.04158790170132326
152,0.3,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Could viral infections cause benign paroxysmal positional vertigo? Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). They may cause inflammation or damage to the inner ear, resulting in the dislodgement of calcium crystals that trigger BPPV. Nonetheless, this is only one contributing cause.",9.474389094274162e-08,0.02011079149599615,0.07024793388429755,0.0072537058591274906,0.0026148939868484433,0.05766669000443417,0.007243206163811466,0.0002826433737834755,0.060964083175803374,9.474389094274162e-08,0.02924911194296742,0.04158790170132326
152,0.3,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: Yes, viral infections can play a role in benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or damage to the inner ear, leading to the dislodgement of calcium crystals which can cause BPPV. However, it's just one of","Is benign paroxysmal positional vertigo related to viral infections? Yes, viral infections can contribute to benign paroxysmal positional vertigo (BPPV). Viruses may cause inflammation or injury in the inner ear, leading to calcium crystals becoming dislodged and causing BPPV. Yet, it is only one factor among others.",1.1842986367842703e-07,0.0033190414230981347,0.06888104581882545,0.009067132323909363,0.0560700494846742,0.03504678868974288,0.009054007704764333,0.05426218925129378,0.03824910210495426,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
153,0.3,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes be involved in transient tachypnea of the newborn (TTN)? Answer: Studies indicate a possible involvement of ADRB gene polymorphisms in TTN.,1.894877818854824e-07,0.12071623032995538,0.20964406472648223,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.3,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is there a connection between beta-adrenergic receptor (ADRB) gene polymorphisms and transient tachypnea of the newborn (TTN)? Answer: Research points to a potential role of ADRB polymorphisms in TTN.,1.894877818854824e-07,0.1685194841616755,0.24408284023668633,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.3,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Do polymorphisms in the beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: Evidence suggests ADRB gene polymorphisms may play a role in TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.3,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: What role do beta-adrenergic receptor (ADRB) gene polymorphisms have in transient tachypnea of the newborn (TTN)? Answer: Research suggests these polymorphisms could be involved in TTN.,2.605457000925383e-07,0.05932019219668483,0.24408284023668633,0.01994769111260067,0.01806952330793754,0.22222222222222218,0.01991881695048161,0.10003535891749049,0.1875,2.6054570009253947e-07,0.18699949087526413,0.14268727705112957
153,0.3,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Could transient tachypnea of the newborn (TTN) be influenced by polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: Studies suggest a potential link between ADRB polymorphisms and TTN.,2.131737546211677e-07,0.1334281643504065,0.24408284023668633,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.3,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research indicates a possible association of ADRB gene polymorphisms with TTN.,1.894877818854824e-07,0.1685194841616755,0.24408284023668633,0.01450741171825503,0.09525916199906659,0.22222222222222218,0.014486412327622988,0.01774767673889377,0.1875,1.8948778188548325e-07,0.06439716878293122,0.14268727705112957
153,0.3,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) genes implicated in transient tachypnea of the newborn (TTN)? Answer: Evidence points to a potential role of ADRB polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.3,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests these polymorphisms may contribute to TTN.,2.842316728282236e-07,0.02009947904340237,0.24408284023668633,0.021761117577382548,0.05889151782819235,0.22222222222222218,0.021729618491434483,0.14259497333628612,0.1875,2.8423167282822487e-07,0.23145125344609818,0.14268727705112957
153,0.3,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: What is the role of beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: Studies indicate a potential involvement of ADRB polymorphisms in TTN.,2.131737546211677e-07,0.08391765145326735,0.20841754531213216,0.01632083818303691,0.05889151782819191,0.22222222222222218,0.016297213868575862,0.01999265124395322,0.1875,2.1317375462116866e-07,0.10361788193621368,0.14268727705112957
153,0.3,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Research suggests a potential role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the,Question: Are beta-adrenergic receptor (ADRB) gene polymorphisms a factor in transient tachypnea of the newborn (TTN)? Answer: Research suggests a possible role for these polymorphisms in TTN.,2.605457000925383e-07,0.05932019219668483,0.24408284023668633,0.01994769111260067,0.01806952330793754,0.22222222222222218,0.01991881695048161,0.10003535891749049,0.1875,2.6054570009253947e-07,0.18699949087526413,0.14268727705112957
154,0.3,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.3,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, parents, children, and their doctors often have varying perceptions of body image. Parents might be shaped by cultural or personal values, children by their self-esteem and peer pressure, and physicians by clinical criteria and health concerns. Therefore, each group",0.0,0.025205352020361893,0.018052050572862813,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.3,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, the way parents, children, and their children's doctors view body image can vary. Parents' perspectives may stem from cultural or individual beliefs, children from their self-confidence and social influences, and physicians from medical guidelines and health risks. Thus, each group",2.3685972735685406e-08,0.005386464230514587,0.016642011834319514,0.0018134264647818726,0.00638944757401072,0.017799928800284807,0.0018108015409528666,0.006979984786362525,0.01851192595229618,2.3685972735685406e-08,0.0190481949706931,0.0
154,0.3,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Absolutely, perceptions of body image can differ between parents, their children, and the children's physicians. Parents' opinions might be shaped by cultural or personal convictions, children by their self-esteem and peer groups, and physicians by health standards and medical considerations. Consequently, each group",7.105791820705622e-08,0.033119373711592015,0.014223200298698849,0.005440279394345618,0.031097431661075703,0.016529396361753424,0.0054324046228586,0.030304520734458773,0.017851239669421492,7.105791820705622e-08,0.056089466651043196,0.0
154,0.3,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, body image perceptions vary among parents, children, and their doctors. Parents may be influenced by cultural or personal beliefs, children by their self-esteem and peer dynamics, and physicians by clinical standards and health implications. As a result, each group",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.3,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Indeed, parents, children, and physicians often have different views on body image. Parents' perceptions are often influenced by cultural or personal beliefs, children's by self-esteem and peer influence, and physicians' by medical standards and health concerns. Hence, each group",2.3685972735685406e-08,0.03159479959437261,0.035851979373147616,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
154,0.3,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, the perceptions of body image held by parents, their children, and the children's physicians can differ. Parents' views may be shaped by cultural or personal beliefs, children by their self-esteem and peer influences, and physicians by health standards and medical considerations. Therefore, each group",1.1842986367842703e-07,0.04710290295739039,0.028280722773729713,0.009067132323909363,0.06723248594945552,0.015344645300396944,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
154,0.3,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Certainly, parents, children, and physicians may perceive body image differently. Parents' perspectives might be influenced by cultural or personal beliefs, children by their self-esteem and peer pressure, and physicians by medical norms and health factors. Thus, each group",4.737194547137081e-08,0.0660512051377471,0.02060485768996645,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
154,0.3,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, there are differences in how parents, children, and their physicians perceive body image. Parents' views can be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical criteria and health implications. Hence, each group",2.3685972735685406e-08,0.005386464230514587,0.016642011834319514,0.0018134264647818726,0.00638944757401072,0.017799928800284807,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
154,0.3,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, perceptions of body image may differ among parents, children, and their physicians. Parents' views could be influenced by cultural or personal beliefs, children by self-esteem and peer influence, and physicians by medical standards and health implications. Hence, each group","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, parents, children, and physicians often have distinct perceptions of body image. Parents' opinions may be shaped by cultural or personal beliefs, children by their self-esteem and peer influences, and physicians by medical standards and health considerations. Therefore, each group",0.0,0.025205352020361893,0.018052050572862813,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
155,0.3,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain linked to a decline in health-related quality of life after six months? Yes, studies indicate that neck pain correlates with poorer health-related quality of life six months later. Ongoing neck pain may lead to emotional distress, reduced physical function, and impaired daily activity performance, affecting overall health and wellbeing.",9.474389094274162e-08,0.010522113130646549,0.043434403509958086,0.0072537058591274906,0.029724344386858448,0.03366944444444442,0.007243206163811466,0.02829384495814047,0.03600069444444447,9.474389094274162e-08,0.026723693784310054,0.03840000000000001
155,0.3,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain result in a lower health-related quality of life six months afterward? Research shows that neck pain is connected to a diminished health-related quality of life six months later. Chronic neck pain can cause emotional strain, limit physical abilities, and hinder daily tasks, negatively influencing overall health and wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.3,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there an association between neck pain and reduced health-related quality of life six months later? Evidence suggests that neck pain is linked to worse health-related quality of life after six months. Persistent neck pain can induce emotional distress, restrict physical functionality, and decrease the capacity to perform daily activities, impacting overall wellbeing.",7.105791820705622e-08,0.011706953099520412,0.04617473970122235,0.005440279394345618,0.008834427395682631,0.03444964598084129,0.0054324046228586,0.007525303207511769,0.03640832986255729,7.105791820705622e-08,0.006104406581574295,0.03840000000000001
155,0.3,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can neck pain affect health-related quality of life six months down the line? Yes, research demonstrates that neck pain is associated with a decline in health-related quality of life six months later. Long-lasting neck pain may contribute to emotional difficulties, limited physical function, and reduced ability to carry out daily routines, affecting overall health.",4.737194547137081e-08,0.01885294104702373,0.011298297649844719,0.0036268529295637453,0.04168988456723399,0.0027888888888888963,0.003621603081905733,0.04154351581363347,0.0021937499999999735,4.737194547137081e-08,0.04135347370885123,0.0015305555555555558
155,0.3,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does experiencing neck pain lead to poorer health-related quality of life six months later? Studies suggest that neck pain correlates with a worsened health-related quality of life after six months. Ongoing neck pain can cause emotional distress, impair physical function, and reduce daily activity performance, impacting overall wellbeing.",1.8948778188548325e-07,0.10464022749804469,0.03129924068616441,0.014507411718254981,0.11792784675589152,0.03021157024793386,0.014486412327622933,0.11596647300115936,0.03418925619834713,1.8948778188548325e-07,0.1137350707739393,0.03840000000000001
155,0.3,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain related to a decrease in health-related quality of life six months later? Research indicates that neck pain is associated with a decline in health-related quality of life six months afterward. Persistent neck pain may lead to emotional challenges, limited physical capabilities, and diminished ability to perform daily tasks, affecting overall health.",4.737194547137081e-08,0.04500943842664462,0.006823712198693127,0.0036268529295637453,0.06834939151184649,0.02146564056134001,0.003621603081905733,0.06872575818853388,0.021463286555002258,4.737194547137081e-08,0.06907936093124878,0.021355545495699423
155,0.3,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is there a connection between neck pain and worsened health-related quality of life six months later? Yes, evidence shows that neck pain is linked to poorer health-related quality of life six months later. Chronic neck pain can result in emotional distress, restricted physical function, and decreased daily activity performance, impacting overall wellbeing.",9.474389094274162e-08,0.06488659788044604,0.004558034561841368,0.0072537058591274906,0.08517611883165399,0.005795085066162581,0.007243206163811466,0.08487728826915619,0.004564083175803348,9.474389094274162e-08,0.08448595883097187,0.0031879017013232494
155,0.3,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Does neck pain contribute to a decline in health-related quality of life six months later? Research suggests that neck pain is associated with reduced health-related quality of life six months afterward. Persistent neck pain may cause emotional strain, limit physical functionality, and reduce the ability to carry out daily activities, affecting overall health and wellbeing.",2.3685972735685406e-08,0.0034126750788998628,0.014486192847442458,0.0018134264647818726,0.020629651336569577,0.0013687630154102653,0.0018108015409528666,0.020557223665671476,0.0010760516451478394,2.3685972735685406e-08,0.020463556717675413,0.0007503540191586833
155,0.3,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Is neck pain associated with a negative impact on health-related quality of life six months later? Yes, studies indicate that neck pain correlates with worsened health-related quality of life six months later. Ongoing neck pain can lead to emotional distress, decreased physical function, and impaired daily activity performance, influencing overall wellbeing.",1.1842986367842703e-07,0.08869993445960711,0.0009920574198526433,0.009067132323909363,0.1076421638816134,0.007387654320987674,0.009054007704764333,0.1072648080753611,0.005822222222222194,1.1842986367842703e-07,0.10676835239150018,0.00406913580246912
155,0.3,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, research suggests that neck pain is associated with a worsened health-related quality of life 6 months later. Persistent neck pain can contribute to emotional distress, limited physical functionality, and decreased ability to conduct daily activities, impacting overall health and wellbeing.","Can neck pain lead to poorer health-related quality of life six months later? Research demonstrates that neck pain is linked to a decline in health-related quality of life six months afterward. Chronic neck pain may contribute to emotional difficulties, limit physical abilities, and reduce the capacity to perform daily tasks, impacting overall health.",7.105791820705622e-08,0.04161206078970636,0.007991102616121654,0.005440279394345618,0.06319891214548301,0.004263286555002299,0.0054324046228586,0.06297707765230687,0.0033555454956994066,7.105791820705622e-08,0.06268784989259002,0.002342417383431425
156,0.3,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer for assessing tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it primarily measures glucose metabolism in tissues. Specialized tracers like (18)F-fluoromisonidazole are used instead.",1.658018091497972e-07,0.09389713739753835,0.11177472445794134,0.012693985253473122,0.13776029660334022,0.038411633971814386,0.012675610786670087,0.13450941433646335,0.04517140709908659,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.3,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? No, (18)F-FDG is not suitable for measuring tumor hypoxia. It is mainly utilized to assess glucose metabolism, while other tracers such as (18)F-fluoromisonidazole target hypoxia.",1.1842986367842661e-07,0.0855813671294583,0.19918367346938776,0.009067132323909363,0.0050980434874654534,0.09876543209876547,0.00905400770476434,0.0305630937350303,0.0763888888888889,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
156,0.3,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not effective for this purpose; it is primarily used to gauge glucose metabolism rates. Tumor hypoxia is measured with specialized tracers like (18)F-fluoromisonidazole.",1.1842986367842661e-07,0.047073190431683454,0.17142857142857143,0.009067132323909363,0.0050980434874654534,0.09876543209876547,0.00905400770476434,0.0305630937350303,0.0763888888888889,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
156,0.3,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG act as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia. Its main role is to measure tissue glucose metabolism, whereas tracers such as (18)F-fluoromisonidazole are designed for hypoxia detection.",7.1057918207056e-08,0.006277133823412662,0.09537744509568533,0.005440279394345618,0.051734350853930966,0.01831560510914612,0.0054324046228586,0.050421033290631634,0.02102556708958092,7.105791820705622e-08,0.04888364744311113,0.02392242299970098
156,0.3,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a surrogate tracer for detecting tumor hypoxia? No, (18)F-FDG is not used as a surrogate tracer for tumor hypoxia; it measures glucose metabolism instead. Specialized tracers like (18)F-fluoromisonidazole are employed for hypoxia imaging.",1.658018091497972e-07,0.09389713739753835,0.11177472445794134,0.012693985253473122,0.13776029660334022,0.038411633971814386,0.012675610786670087,0.13450941433646335,0.04517140709908659,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.3,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG serve as a surrogate tracer to detect tumor hypoxia? No, (18)F-FDG does not serve this function. It is primarily used to measure glucose metabolism, while other tracers such as (18)F-fluoromisonidazole are used for hypoxia assessment.",1.1842986367842661e-07,0.0855813671294583,0.19918367346938776,0.009067132323909363,0.0050980434874654534,0.09876543209876547,0.00905400770476434,0.0305630937350303,0.0763888888888889,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
156,0.3,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG utilized as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not utilized for measuring tumor hypoxia. It mainly measures glucose metabolic activity, with other tracers like (18)F-fluoromisonidazole specialized for hypoxia.",2.131737546211678e-07,0.03220166852692552,0.19918367346938776,0.01632083818303688,0.11626281351680134,0.09876543209876547,0.016297213868575834,0.1557262366890373,0.0763888888888889,2.1317375462116866e-07,0.19732746862834016,0.05246913580246914
156,0.3,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? No, (18)F-FDG does not function as a surrogate tracer for tumor hypoxia; it is used to measure glucose metabolism. Tumor hypoxia is assessed using tracers such as (18)F-fluoromisonidazole.",9.474389094274131e-08,0.11182414967484089,0.043096264520376265,0.0072537058591274906,0.15927196303471103,0.036510322323711084,0.007243206163811466,0.16000919813262326,0.03599404555439932,9.474389094274162e-08,0.1605828646856997,0.03493981320897727
156,0.3,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Is (18)F-FDG a valid surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG is not valid for measuring tumor hypoxia. Its primary use is to evaluate glucose metabolism, whereas hypoxia is measured with tracers like (18)F-fluoromisonidazole.",1.658018091497972e-07,0.028422953289509945,0.19918367346938776,0.012693985253473122,0.05374245653546783,0.09876543209876547,0.012675610786670087,0.09118771555146576,0.0763888888888889,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
156,0.3,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is mainly used to measure the glucose metabolism rate in tissues. Other specialized tracers, such as (18)F-fluoromisonidazole, are used","Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? No, (18)F-FDG cannot be considered a surrogate tracer for tumor hypoxia; it mainly measures glucose metabolism. Other tracers, including (18)F-fluoromisonidazole, are used for hypoxia detection.",1.658018091497972e-07,0.216217228084588,0.03081632653061217,0.012693985253473122,0.26378705670514835,0.04791824137062224,0.012675610786670087,0.264474510691453,0.04606009070294784,1.6580180914979784e-07,0.26479361294772064,0.04319412950365333
157,0.3,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain considered a clinically important issue in general adult psychiatry? Our findings indicate that pain is a notable clinical concern among psychiatric patients, often underestimated in psychiatric practice. Patients in general adult psychiatry exhibit particular risk factors.",1.8948778188548293e-07,0.17825978338224058,0.01244897959183671,0.014507411718254981,0.2076721821344738,0.00504012096996722,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
157,0.3,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Does pain represent a clinically relevant problem in general adult psychiatry? Evidence suggests that pain is a significant clinical issue in psychiatric patients, which appears to be underrecognized in psychiatry. Those treated in general adult psychiatry show distinct risk factors.",1.4211583641411233e-07,0.1217732380849843,0.015194317317869438,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.3,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically significant problem within general adult psychiatry? Research shows that pain can be a major clinical concern in psychiatric patients and is often undervalued in psychiatric care. Patients in this field have specific risk factors.,1.8948778188548293e-07,0.14079236821683727,0.03932035777273872,0.014507411718254981,0.16916400543669896,0.02271498107084911,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
157,0.3,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain an important clinical problem in general adult psychiatry? We discovered that pain is a considerable clinical issue among psychiatric patients and tends to be underestimated in psychiatric settings. The patients studied in general adult psychiatry have unique risk factors.,1.1842986367842703e-07,0.09467812963771838,0.016465034767369553,0.009067132323909363,0.12466730702264872,0.002908287627211844,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
157,0.3,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a relevant clinical problem in general adult psychiatry? Our study found that pain is a significant clinical challenge for psychiatric patients, often overlooked in psychiatry. Patients in general adult psychiatry possess particular risk factors.",2.3685972735685353e-07,0.23811162484166903,0.009393564588369784,0.018134264647818733,0.26709578283899704,0.006669775586634827,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
157,0.3,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically pertinent issue in general adult psychiatry? Evidence indicates that pain is a major clinical problem for psychiatric patients and is frequently underestimated in psychiatric practice. The patients examined in general adult psychiatry have specific risk factors.,1.4211583641411233e-07,0.1217732380849843,0.015194317317869438,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.3,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically meaningful problem in general adult psychiatry? Findings reveal that pain can be a significant clinical concern in psychiatric patients, often underappreciated in psychiatry. Patients in this specialty are characterized by particular risk factors.",2.1317375462116823e-07,0.13072392723955018,0.06632653061224489,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
157,0.3,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,"Is pain a clinically relevant concern in general adult psychiatry? We found that pain is a substantial clinical problem in psychiatric patients, which seems to be underestimated in psychiatric care. The patients in general adult psychiatry show specific risk factors.",1.4211583641411233e-07,0.15731924734446823,0.010062358276644007,0.010880558788691236,0.15157821472220911,0.0035815857662582634,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
157,0.3,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically important issue in general adult psychiatry? Our research indicates that pain is a significant clinical problem for psychiatric patients and is often underestimated in psychiatry. Patients in general adult psychiatry have distinct risk factors.,1.8948778188548293e-07,0.17825978338224058,0.01244897959183671,0.014507411718254981,0.2076721821344738,0.00504012096996722,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
157,0.3,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors,Is pain a clinically significant concern in general adult psychiatry? The evidence suggests that pain is a notable clinical problem among psychiatric patients and is often underestimated in psychiatric practice. The patients studied in general adult psychiatry are marked by specific risk factors.,7.105791820705622e-08,0.042587264608476616,0.018826530612244874,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
158,0.3,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient for detecting cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not fully identify cervical spine fractures in geriatric blunt trauma cases.,4.73719454713706e-08,0.08972715631972861,0.0795083676268861,0.003626852929563759,0.14210373737751691,0.13253628745716917,0.003621603081905747,0.14918185953507868,0.14422109492081137,4.737194547137081e-08,0.1569044901980834,0.15532544378698224
158,0.3,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors reliably detect cervical spine fractures in geriatric blunt trauma patients with low-energy injuries? Answer: Clinical predictors may be insufficient for identifying cervical spine fractures in elderly blunt trauma patients.,4.73719454713706e-08,0.08972715631972861,0.0795083676268861,0.003626852929563759,0.14210373737751691,0.13253628745716917,0.003621603081905747,0.14918185953507868,0.14422109492081137,4.737194547137081e-08,0.1569044901980834,0.15532544378698224
158,0.3,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors effective in diagnosing cervical spine fractures in older adults with blunt trauma from low-energy mechanisms? Answer: Clinical predictors might not be completely reliable for detecting cervical spine fractures in geriatric blunt trauma patients.,4.73719454713706e-08,0.2315778024122226,0.09512424557752344,0.003626852929563759,0.2736861196250642,0.1398125961063024,0.003621603081905747,0.2797814509640655,0.14813003624192433,4.737194547137081e-08,0.28611622167809037,0.15532544378698224
158,0.3,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Do clinical predictors adequately identify cervical spine fractures in elderly patients experiencing blunt trauma from low-energy events? Answer: Clinical predictors may not be entirely adequate for recognizing cervical spine fractures in geriatric blunt trauma cases.,2.36859727356853e-08,0.19790575734584337,0.09151111111111113,0.0018134264647818796,0.24236867626253478,0.1381518121301775,0.0018108015409528735,0.24869293134279769,0.14724135539940827,2.3685972735685406e-08,0.2553445630113367,0.15532544378698224
158,0.3,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: How adequate are clinical predictors in diagnosing cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may fall short in identifying cervical spine fractures in elderly blunt trauma patients.,0.0,0.16309345424939936,0.08771272294887042,0.0,0.21004460016968052,0.13639176400322642,0.0,0.21660849392498216,0.14629731110960598,0.0,0.22359586469675685,0.15532544378698224
158,0.3,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors sufficient to detect cervical spine fractures in older blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not be fully adequate for identifying cervical spine fractures in geriatric blunt trauma patients.,2.36859727356853e-08,0.19790575734584337,0.09151111111111113,0.0018134264647818796,0.24236867626253478,0.1381518121301775,0.0018108015409528735,0.24869293134279769,0.14724135539940827,2.3685972735685406e-08,0.2553445630113367,0.15532544378698224
158,0.3,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Can clinical predictors alone identify cervical spine fractures in elderly blunt trauma patients with low-energy injuries? Answer: Clinical predictors may not be completely sufficient for detecting cervical spine fractures in geriatric blunt trauma cases.,0.0,0.16309345424939936,0.08771272294887042,0.0,0.21004460016968052,0.13639176400322642,0.0,0.21660849392498216,0.14629731110960598,0.0,0.22359586469675685,0.15532544378698224
158,0.3,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Are clinical predictors reliable for identifying cervical spine fractures in geriatric patients with blunt trauma from low-energy mechanisms? Answer: Clinical predictors may not be entirely reliable for detecting cervical spine fractures in elderly blunt trauma patients.,4.73719454713706e-08,0.19306962571444775,0.07039999999999996,0.003626852929563759,0.2736861196250642,0.1398125961063024,0.003621603081905747,0.2797814509640655,0.14813003624192433,4.737194547137081e-08,0.28611622167809037,0.15532544378698224
158,0.3,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Is the use of clinical predictors adequate for diagnosing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors might not fully suffice in identifying cervical spine fractures in geriatric blunt trauma patients.,7.10579182070559e-08,0.2641805842621978,0.0985640625,0.005440279394345632,0.30405746383163335,0.14138224033086952,0.005432404622858621,0.3099339410819555,0.14896808009664012,7.105791820705622e-08,0.31596918482777214,0.15532544378698224
158,0.3,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors may not be entirely adequate for identifying cervical spine fractures in geriatric blunt trauma patients with,Question: Do clinical predictors provide adequate identification of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors may not be entirely adequate for detecting cervical spine fractures in elderly blunt trauma patients.,4.73719454713706e-08,0.2315778024122226,0.09512424557752344,0.003626852929563759,0.2736861196250642,0.1398125961063024,0.003621603081905747,0.2797814509640655,0.14813003624192433,4.737194547137081e-08,0.28611622167809037,0.15532544378698224
159,0.3,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target, assessed using RTOG consensus definitions and daily CT on rails, vary between the superior and inferior parts of the clinical target volume? Answer: No statistically significant motion differences exist between the superior CTV (SUP-CTV) and inferior CTV (INF-CTV). The current uniform planning target volume (PTV) margins sufficiently cover both CTV regions.",7.105791820705622e-08,0.007515577720608846,0.03128520829819529,0.005440279394345618,0.053444495023886596,0.0009071255195998509,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
159,0.3,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior sections of the prostate bed clinical target volume? Answer: There are no statistically significant differences in motion between the superior and inferior portions of the CTV. The uniform PTV margins currently used are adequate for both areas.",2.3685972735685406e-08,0.07737611137557643,0.06702968360311015,0.0018134264647818726,0.05482898126746116,0.0519244812276949,0.0018108015409528666,0.05624726384303047,0.0533997864008544,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099
159,0.3,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion differ between the superior and inferior clinical target volume regions of the prostate bed when evaluated with RTOG consensus definitions and daily CT on rails? Answer: No statistically significant motion difference is observed between the SUP-CTV and INF-CTV. Existing uniform PTV margins effectively cover both parts of the CTV.,1.1842986367842703e-07,0.09648465573463305,0.003358677685950412,0.009067132323909363,0.06877080156225457,0.017851239669421492,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
159,0.3,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When using RTOG consensus definitions and daily CT on rails, is there a difference in prostate bed target motion between the superior and inferior clinical target volume areas? Answer: No significant motion differences are found between the superior and inferior CTV. The current uniform PTV margins adequately encompass both portions.",1.6580180914979784e-07,0.19328990388827982,0.04435376275211298,0.012693985253473108,0.19365130114247675,0.04311284350638188,0.012675610786670066,0.19389443937124184,0.04158790170132326,1.6580180914979784e-07,0.1683320695588959,0.021266540642722105
159,0.3,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the prostate bed target show different interfractional motion in the superior versus inferior clinical target volume parts according to RTOG consensus and daily CT on rails? Answer: There is no statistically significant difference in motion between SUP-CTV and INF-CTV. Uniform PTV margins presently in use are sufficient to cover both CTV portions.,9.474389094274162e-08,0.024117446874713178,0.0350413223140496,0.0072537058591274906,0.04935271570515187,0.017851239669421492,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
159,0.3,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a difference in interfractional motion between the superior and inferior parts of the clinical target volume of the prostate bed using RTOG consensus definitions and daily CT on rails? Answer: No statistically significant motion differences exist between the superior and inferior CTV. The uniform PTV margins currently applied adequately cover both regions.,7.105791820705622e-08,0.1337859028551427,0.05658716581589628,0.005440279394345618,0.10877401287332056,0.03854876033057854,0.0054324046228586,0.10940848054026997,0.03840000000000001,7.105791820705622e-08,0.08434065621484965,0.019599999999999992
159,0.3,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, does the prostate bed clinical target volume exhibit different interfractional motion between its superior and inferior portions? Answer: No statistically significant differences in motion are observed between SUP-CTV and INF-CTV. The current uniform PTV margins sufficiently cover both areas.",2.1317375462116866e-07,0.1232083495189431,0.0350413223140496,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.3,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion vary between the superior and inferior clinical target volume sections of the prostate bed based on RTOG consensus definitions and daily CT on rails? Answer: There are no statistically significant motion differences between the superior and inferior CTV. Current uniform PTV margins are adequate for both parts.,1.6580180914979784e-07,0.19328990388827982,0.04435376275211297,0.012693985253473108,0.19365130114247675,0.04311284350638188,0.012675610786670066,0.19389443937124184,0.04158790170132326,1.6580180914979784e-07,0.1683320695588959,0.0212665406427221
159,0.3,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior clinical target volume of the prostate bed? Answer: No statistically significant motion difference is found between SUP-CTV and INF-CTV. The uniform PTV margins currently used cover both portions effectively.",1.4211583641411244e-07,0.06258372770250897,0.0350413223140496,0.010880558788691236,0.08857342885843433,0.017851239669421492,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
159,0.3,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed target differ between the superior and inferior clinical target volume areas when assessed using RTOG consensus definitions and daily CT on rails? Answer: There are no statistically significant differences in motion between the superior and inferior CTV. The current uniform PTV margins adequately cover both regions.,7.105791820705622e-08,0.10811378505662583,0.038558677685950386,0.005440279394345618,0.10877401287332056,0.03854876033057854,0.0054324046228586,0.10940848054026997,0.03840000000000001,7.105791820705622e-08,0.08434065621484965,0.019599999999999992
160,0.3,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories accurately reporting serum quantitative hCG results? The precision of serum quantitative hCG reporting by laboratories depends greatly on the individual lab and their compliance with testing standards. Although numerous labs deliver dependable and precise results, inconsistencies may arise from factors such as equipment calibration, reagent quality, and staff expertise. Routine audits and quality control measures are crucial to maintain accuracy.",7.105791820705622e-08,0.014842753641051587,0.0448147084171215,0.005440279394345618,0.01612361940681417,0.04653835104854929,0.0054324046228586,0.01748181826965478,0.048261993679977015,7.105791820705622e-08,0.004978579491813129,0.03274920999712727
160,0.3,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories report serum quantitative hCG results correctly? The reliability of serum quantitative hCG results from laboratories is largely influenced by the lab's adherence to established testing protocols. Many laboratories produce accurate and trustworthy results, but errors can occur due to issues like equipment calibration, reagent quality, and technician training. Regular quality control and audits are necessary to ensure result accuracy.",9.474389094274162e-08,0.025548992231074763,0.027702422569373435,0.0072537058591274906,0.02457162208140673,0.02934365856632442,0.007243206163811466,0.023514242005505004,0.03102592104224233,9.474389094274162e-08,0.022370322203681958,0.03274920999712727
160,0.3,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results reported correctly by laboratories? The correctness of serum quantitative hCG results reported by labs depends on the lab's compliance with testing procedures. While many labs provide accurate and reliable outcomes, discrepancies may happen because of factors such as equipment calibration, reagent quality, and the training level of technicians. Continuous audits and quality control are vital to guarantee accuracy.",4.737194547137081e-08,0.012882797230792775,0.013354643741240457,0.0036268529295637453,0.0124205838259277,0.014151478332691751,0.003621603081905733,0.011920875451293611,0.0149682957013801,4.737194547137081e-08,0.011380660727765779,0.01580509584730563
160,0.3,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG results by laboratories accurate? The accuracy of serum quantitative hCG reporting in laboratories is contingent upon the specific lab and its adherence to testing protocols. Although many labs offer reliable results, discrepancies can occur due to equipment calibration, reagent quality, and technician expertise. Ongoing audits and quality control checks are essential to ensure correctness.",9.474389094274162e-08,0.025548992231074763,0.027702422569373435,0.0072537058591274906,0.02457162208140673,0.02934365856632442,0.007243206163811466,0.023514242005505004,0.03102592104224233,9.474389094274162e-08,0.022370322203681958,0.03274920999712727
160,0.3,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories provide correct serum quantitative hCG results? The accuracy of serum quantitative hCG results reported by laboratories depends on the lab's strict adherence to testing protocols. Many labs yield reliable and precise results, but discrepancies may arise from factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control are critical for maintaining accuracy.",1.6580180914979784e-07,0.05616947597034638,0.042522596100199164,0.012693985253473108,0.054519602510040954,0.04534899014959605,0.012675610786670066,0.05272244040359286,0.048261993679977015,1.6580180914979784e-07,0.07643754347395681,0.03274920999712727
160,0.3,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are serum quantitative hCG results from laboratories reported accurately? The accuracy of serum quantitative hCG results depends largely on the laboratory's compliance with testing standards. While many labs produce dependable results, discrepancies can occur due to equipment calibration, reagent quality, and technician training. Consistent audits and quality control procedures are necessary to ensure accuracy.",2.6054570009253947e-07,0.15875641498392135,0.021163918414248743,0.0199476911126006,0.1571913321044196,0.024800229819017534,0.019918816950481533,0.15541223528663828,0.028661993679977023,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.3,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","How accurately do laboratories report serum quantitative hCG results? The precision of serum quantitative hCG reporting by labs depends on their adherence to testing protocols. Many laboratories provide accurate results, but discrepancies can arise from equipment calibration, reagent quality, and technician expertise. Regular quality control and audits are essential to maintain correctness.",3.079176455639103e-07,0.17311768842265485,0.038413564395090076,0.023574544042164344,0.17081891859087328,0.04320855968157481,0.023540420032387266,0.16823532752543713,0.048261993679977015,3.079176455639103e-07,0.19422057913034108,0.03274920999712727
160,0.3,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Are laboratories consistent in reporting serum quantitative hCG results accurately? The reliability of serum quantitative hCG results depends on the lab's compliance with testing protocols. Although many labs deliver accurate results, discrepancies may occur due to equipment calibration, reagent quality, and technician training. Routine audits and quality control checks are vital to ensure accuracy.",2.6054570009253947e-07,0.15875641498392135,0.021163918414248743,0.0199476911126006,0.1571913321044196,0.024800229819017534,0.019918816950481533,0.15541223528663828,0.028661993679977023,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
160,0.3,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Is the reporting of serum quantitative hCG results by labs dependable? The dependability of serum quantitative hCG results from laboratories largely hinges on their adherence to testing protocols. Many labs provide accurate results, but discrepancies can happen due to factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control are important to guarantee correctness.",1.6580180914979784e-07,0.10481138337806195,0.007788197517132361,0.012693985253473108,0.1040301154071801,0.009800443418163142,0.012675610786670066,0.1031331444443162,0.011950138927396027,1.6580180914979784e-07,0.10210966127247367,0.01423728404483109
160,0.3,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: The accuracy of laboratories reporting serum quantitative hCG results largely depends on the specific lab and their adherence to testing protocols. While many labs provide reliable and accurate results, discrepancies can occur due to various factors like equipment calibration, reagent quality, and technician training. Regular audits and quality control checks are essential to ensure correctness.","Do laboratories accurately report serum quantitative hCG results? The accuracy of serum quantitative hCG results reported by labs depends on their adherence to testing protocols. While many labs produce reliable results, discrepancies can occur due to equipment calibration, reagent quality, and technician training. Continuous audits and quality control checks are essential to ensure accuracy.",2.6054570009253947e-07,0.1325999176043009,0.03988610218971975,0.0199476911126006,0.13053182515980621,0.043976854194257835,0.019918816950481533,0.12822999291173875,0.048261993679977015,2.6054570009253947e-07,0.1533985846100867,0.03274920999712727
161,0.3,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are we overlooking certain prognostic indicators? Answer: The prognosis of Hepatorenal syndrome (HRS) mainly depends on the severity of liver disease and kidney function. Nevertheless, research indicates that additional factors like systemic inflammation, infections, circulatory issues, and genetic predispositions might be overlooked. More studies are required to comprehensively understand and incorporate these elements.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
161,0.3,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: could there be missing prognostic factors? Answer: Prognosis for Hepatorenal syndrome (HRS) is largely determined by liver disease severity and renal function. Yet, evidence suggests other factors such as systemic inflammation, infection, circulatory dysfunction, and genetic predispositions may be underrecognized. Further investigation is necessary to fully grasp and integrate these factors.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
161,0.3,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are some prognostic factors being missed? Answer: The prognosis of Hepatorenal syndrome (HRS) is chiefly based on liver disease severity and kidney function. However, studies imply that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be additional factors not yet fully considered. Further research is needed to better understand and include these.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
161,0.3,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: might we be missing prognostic factors? Answer: Prognostic evaluation of Hepatorenal syndrome (HRS) primarily relies on liver disease severity and renal function. Nonetheless, research suggests that systemic inflammation, infection, circulatory dysfunction, and genetic predispositions could be overlooked factors. More research is essential to fully comprehend and incorporate these.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
161,0.3,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are additional prognostic factors overlooked? Answer: The prognosis of Hepatorenal syndrome (HRS) is mainly based on the severity of liver disease and kidney function. However, studies indicate that systemic inflammation, infections, circulatory dysfunction, and individual genetic predispositions may be missing factors. Further studies are required to understand and include these fully.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
161,0.3,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: could we be missing key prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily determined by liver disease severity and renal function. Yet, research suggests other factors like systemic inflammation, infection, circulatory dysfunction, and genetic predispositions might be overlooked. More research is needed to fully understand and integrate these factors.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
161,0.3,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are we neglecting some prognostic factors? Answer: Prognosis in Hepatorenal syndrome (HRS) is largely based on liver disease severity and kidney function. However, studies suggest that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions may be additional factors not fully accounted for. Further research is necessary to clarify and include these.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
161,0.3,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: is there a gap in prognostic factors? Answer: The prognosis of Hepatorenal syndrome (HRS) depends mainly on liver disease severity and renal function. Nonetheless, evidence points to missing factors such as systemic inflammation, infection, circulatory dysfunction, and genetic predispositions. Further investigation is needed to fully understand and incorporate these.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
161,0.3,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: are we missing important prognostic factors? Answer: Prognosis for Hepatorenal syndrome (HRS) is primarily based on liver disease severity and kidney function. However, studies suggest that systemic inflammation, infections, circulatory dysfunction, and genetic predispositions might be overlooked. More research is required to fully comprehend and include these factors.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
161,0.3,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Hepatorenal syndrome (HRS) prognosis is primarily based on liver disease severity and renal function. However, studies suggest we might be missing other factors such as systemic inflammation and infection, circulatory dysfunction, and individual genetic predispositions. Further research is needed to fully understand and include these","Question: Hepatorenal syndrome: might some prognostic factors be overlooked? Answer: The prognosis of Hepatorenal syndrome (HRS) is mainly determined by liver disease severity and renal function. Yet, research indicates that systemic inflammation, infection, circulatory dysfunction, and genetic predispositions could be missing factors. Further studies are essential to fully understand and incorporate these.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
162,0.3,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? The majority of acetabular components in this group remained stable despite the limited contact area between the component and pelvic bone. However, three out of ten showed migration beyond the thresholds that indicate potential future loosening in primary cases.",7.105791820705622e-08,0.05505977718302857,0.0,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
162,0.3,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Most acetabular components in this study were stable even though the contact surface between the component and pelvic bone was minimal. Yet, three of ten migrated beyond the limits that suggest later loosening in primary procedures.",4.737194547137081e-08,0.038466280827795796,0.0,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
162,0.3,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does using oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? In this cohort, most acetabular components were stable despite a small contact surface with the pelvic bone. Still, three out of ten migrated past the thresholds predictive of future loosening in primary surgeries.",7.105791820705622e-08,0.05826890812397556,0.0,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
162,0.3,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can cup-cage reconstruction with oversized cups ensure initial stability in THA for osteoporotic acetabular fractures? The majority of acetabular components in this cohort remained stable despite limited contact between the component and pelvic bone. However, three of ten migrated beyond the limits associated with later loosening in primary cases.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.3,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction involving oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components were stable despite the small contact surface with the pelvic bone, though three out of ten migrated beyond the limits that predict future loosening in primary THA.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
162,0.3,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Is initial stability in THA for osteoporotic acetabular fractures achieved through cup-cage reconstruction with oversized cups? The majority of acetabular components remained stable despite minimal contact with the pelvic bone, but three of ten migrated beyond the thresholds that indicate potential loosening later on.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
162,0.3,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does the use of oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Most acetabular components in this cohort were stable despite limited contact with the pelvic bone, although three of ten migrated beyond the limits predictive of future loosening in primary cases.",1.4211583641411244e-07,0.12014431184206309,0.0,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
162,0.3,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups deliver initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The majority of acetabular components were stable despite a small contact surface with the pelvic bone, but three out of ten migrated beyond the limits that forecast later loosening in primary surgeries.",1.1842986367842703e-07,0.09909090264422993,0.0,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
162,0.3,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Can initial stability be achieved in THA for osteoporotic acetabular fractures using cup-cage reconstruction with oversized cups? Most acetabular components remained stable despite limited contact with the pelvic bone, though three of ten migrated beyond the limits that predict future loosening in primary procedures.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
162,0.3,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary,"Does cup-cage reconstruction with oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Most acetabular components in this cohort were stable despite a small contact area with the pelvic bone, but three out of ten migrated beyond the thresholds that suggest later loosening in primary cases.",9.474389094274162e-08,0.07847161544149417,0.0,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
163,0.3,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
163,0.3,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study indicates a potential link between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.3,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Are cervical cord plaques related to discopathy in patients with multiple sclerosis? Answer: The data from the study points to a possible association between cervical discopathy and cervical MS plaques.,0.0,0.046209812037329545,0.033293697978596916,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
163,0.3,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Does cervical cord plaque have any association with discopathy in multiple sclerosis patients? Answer: Study findings suggest a possible correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.059150703620495904,0.033293697978596916,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.3,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there an association between cervical cord plaques and discopathy in multiple sclerosis? Answer: The research data implies a potential relationship between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.3,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Can cervical cord plaques be linked to discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible connection between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.3,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there any correlation between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study results indicate a possible association between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,0.3,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Are cervical cord plaques connected to discopathy in multiple sclerosis patients? Answer: The study data suggests a potential correlation between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.09689103160334289,0.033293697978596916,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.3,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study suggests a possible link between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.3,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Question: Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? Answer: The study data indicates a potential association between cervical discopathy and cervical MS plaques.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
164,0.3,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80 or older following aneurysmal subarachnoid hemorrhage? The study shows that elderly patients who underwent repair of ruptured aneurysms had better outcomes compared to those treated conservatively. Therefore, definitive surgery should be offered without hesitation to elderly patients with aSAH.",9.474389094274162e-08,0.054450342337760915,0.017278510668973467,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
164,0.3,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be considered for patients aged 80 and above after an aneurysmal subarachnoid hemorrhage? The findings indicate that elderly patients receiving repair of ruptured aneurysms had improved prognoses compared to conservative treatment, suggesting that definitive surgery is warranted for elderly aSAH patients.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.3,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Results demonstrate that repairing ruptured aneurysms in elderly patients leads to better outcomes than conservative management, supporting the recommendation to offer definitive surgery to elderly aSAH patients.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.3,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? The study reveals that elderly patients who had their ruptured aneurysms repaired experienced better prognoses than those treated conservatively, indicating that definitive surgery should be offered to this group.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.3,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Evidence shows that elderly patients undergoing repair of ruptured aneurysms have better outcomes than those managed conservatively, so definitive surgery should be considered for elderly aSAH patients.",3.316036182995956e-07,0.2544172726632352,0.03767781622452902,0.025387970506946217,0.31365755885504143,0.0,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
164,0.3,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it beneficial to perform aneurysm repair on patients aged 80 or older following aneurysmal subarachnoid hemorrhage? The studys results suggest that elderly patients who received surgical repair of ruptured aneurysms had better prognoses than those treated conservatively, thus definitive surgery should be offered to these patients.",1.6580180914979784e-07,0.08933752230378511,0.03767781622452902,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
164,0.3,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should patients aged 80 or older with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? Findings indicate that repairing ruptured aneurysms in elderly patients yields better outcomes than conservative treatment, supporting the use of definitive surgery for elderly aSAH patients.",3.789755637709662e-07,0.30706100614865406,0.03767781622452902,0.029014823436509962,0.3677247801253176,0.0,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
164,0.3,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study found that elderly patients who had their ruptured aneurysms repaired had better prognoses than those treated conservatively, so definitive surgery should be offered to elderly patients with aSAH.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.3,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair advisable for patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Results show that elderly patients who underwent repair of ruptured aneurysms had better outcomes compared to conservative treatment, indicating that definitive surgery should not be withheld from elderly aSAH patients.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.3,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair appropriate? The study demonstrates that elderly patients who received surgical repair of ruptured aneurysms had better prognoses than those managed conservatively, thus definitive surgery should be offered without hesitation.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
165,0.3,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals with episodic migraines specifically focus on headache-related visual cues? Answer: Considering the substantial sample size and earlier pilot tests of the images shown, the findings indicate that episodic migraine sufferers do not show selective attention to headache-related facial images. Although there is limited evidence of attentional biases in chronic headache groups, these results suggest otherwise.",1.8948778188548325e-07,0.23610613469044717,0.060964083175803374,0.014507411718254981,0.18303181235058918,0.020823902218198284,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
165,0.3,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are people with episodic migraines more likely to notice headache-related visual stimuli? Answer: Based on the large number of participants and prior pilot testing of the images, the data imply that episodic migraine patients do not preferentially attend to facial stimuli linked to headaches. While some modest evidence exists for attentional biases in chronic headache cases, these findings do not support that for episodic migraineurs.",3.789755637709665e-07,0.34611453119584246,0.045583223800803374,0.029014823436509962,0.31656320497511103,0.020823902218198284,0.028972824655245866,0.29298712468147725,0.0,3.789755637709665e-07,0.29849298855599704,0.0
165,0.3,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraine sufferers pay more attention to headache-related visual information? Answer: Given the extensive sample size and previous pilot testing of the images used, the results suggest that those with episodic migraines do not exhibit selective attention to headache-related facial stimuli. Although there is some limited evidence of attentional bias in chronic headache populations, these findings do not confirm that for episodic migraineurs.",3.552895910352811e-07,0.2869554020380751,0.014202459956238742,0.02720139697172809,0.27881017560824706,0.004955015641715445,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
165,0.3,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is there selective attention to headache-related visual stimuli among episodic migraineurs? Answer: Taking into account the large sample and prior pilot testing of the images, the findings indicate that episodic migraine sufferers do not differentially focus on headache-related facial stimuli. Despite modest evidence of attentional biases in chronic headache sufferers, these results do not show the same for episodic migraineurs.",2.6054570009253947e-07,0.2642945230593319,0.04430220440533512,0.0199476911126006,0.23521756552115836,0.020823902218198284,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
165,0.3,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do individuals experiencing episodic migraines selectively focus on headache-related facial images? Answer: With a large sample size and earlier pilot testing of the images, results suggest that episodic migraineurs do not demonstrate selective attention to headache-related facial stimuli. Although there is some modest evidence of attentional bias in chronic headache samples, these findings do not extend to episodic migraineurs.",2.3685972735685406e-07,0.22359928157111097,0.027107511923110242,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
165,0.3,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related visual stimuli selectively attended to by episodic migraine patients? Answer: Considering the large sample and prior pilot testing of the images, the evidence suggests that episodic migraineurs do not show selective attention to headache-related facial stimuli. While modest attentional biases have been observed in chronic headache groups, these findings do not support such biases in episodic migraineurs.",2.3685972735685406e-07,0.24709579616636335,0.04401996902598174,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
165,0.3,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do people with episodic migraines show selective attention to headache-related facial stimuli? Answer: Based on the large sample size and previous pilot testing of the images, the results indicate that episodic migraine sufferers do not selectively attend to headache-related facial stimuli. Despite some modest evidence of attentional biases in chronic headache populations, these findings do not confirm this for episodic migraineurs.",2.8423167282822487e-07,0.23575031982659,0.011915331689477573,0.02176111757738247,0.22891977781887451,0.0041620234477300275,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
165,0.3,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Is selective attention to headache-related visual cues present in episodic migraineurs? Answer: Given the large sample and prior pilot testing of the images, the results suggest that episodic migraine patients do not differentially attend to headache-related facial stimuli. Although modest evidence exists for attentional biases in chronic headache sufferers, these findings do not support such biases in episodic migraineurs.",2.3685972735685406e-07,0.17660625238060712,0.006473933353122255,0.018134264647818726,0.21812313216185863,0.020823902218198284,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
165,0.3,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Do episodic migraineurs exhibit selective attention to headache-related facial stimuli? Answer: Taking into account the large sample size and earlier pilot testing of the images, the findings suggest that episodic migraine sufferers do not show differential attention to headache-related facial stimuli. Despite modest evidence of attentional biases in chronic headache samples, these results do not indicate the same for episodic migraineurs.",2.8423167282822487e-07,0.21302418275905088,0.004286763238477931,0.02176111757738247,0.20581487180020996,0.012469795760398632,0.0217296184914344,0.20389332760040846,0.01694411414982164,2.8423167282822487e-07,0.23180161405732447,0.0
165,0.3,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings","Question: Are headache-related facial stimuli selectively noticed by individuals with episodic migraines? Answer: Considering the large sample and prior pilot testing of the images, the evidence indicates that episodic migraineurs do not selectively attend to headache-related facial stimuli. While there is modest evidence of attentional biases in chronic headache groups, these findings do not extend to episodic migraine sufferers.",2.1317375462116866e-07,0.20569462357059587,0.02652530766559929,0.016320838183036854,0.2007313894499898,0.020823902218198284,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
166,0.3,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of health care benefits align with the principles of universal coverage? Although Kenya is working towards universal health coverage, there are still major challenges in how healthcare benefits are distributed, such as regional disparities, resource limitations, and service delivery gaps. As a result, it does not yet fully comply with universal coverage principles.",4.737194547137081e-08,0.11020763962106717,0.10380622837370242,0.0036268529295637453,0.06265338162340406,0.07100591715976332,0.003621603081905733,0.013369432360373246,0.03631185475258099,4.737194547137081e-08,0.012068210184330574,0.01851192595229618
166,0.3,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Kenya aims for universal health coverage, but significant obstacles remain, including unequal regional access, scarce resources, and service delivery shortcomings, meaning it does not completely fulfill universal coverage standards at present.",3.079176455639103e-07,0.1444426017185947,0.0810912473028533,0.023574544042164344,0.16513054924730897,0.07100591715976332,0.023540420032387266,0.21925286290837986,0.03631185475258099,3.079176455639103e-07,0.2497398620614506,0.01851192595229618
166,0.3,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's health care benefits distribution fulfill the universal coverage principles? Despite efforts towards universal health coverage, Kenya faces considerable challenges like uneven regional access, limited resources, and service delivery gaps, so it currently falls short of fully meeting universal coverage criteria.",3.789755637709665e-07,0.21736553649538592,0.07943122837370242,0.029014823436509962,0.2374512108269351,0.07100591715976332,0.028972824655245866,0.2933608350621033,0.03631185475258099,3.789755637709665e-07,0.325725769039372,0.01851192595229618
166,0.3,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the allocation of health care benefits in Kenya in line with universal coverage principles? Kenya is progressing towards universal health coverage, but issues such as unequal access by region, resource constraints, and service delivery gaps persist, preventing full adherence to universal coverage principles.",3.316036182995957e-07,0.16816483366481583,0.08056359798821489,0.025387970506946217,0.18866104665750338,0.07100591715976332,0.025351221573340132,0.24335041448743988,0.03631185475258099,3.316036182995957e-07,0.2744324746518223,0.01851192595229618
166,0.3,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the way health care benefits are distributed in Kenya satisfy the principles of universal coverage? Kenya is striving for universal health coverage, yet significant challenges like regional disparities, limited resources, and gaps in service delivery remain, so it does not fully meet universal coverage principles at this time.",2.1317375462116866e-07,0.025924534703512858,0.10380622837370242,0.016320838183036854,0.07618306323081336,0.07100591715976332,0.0162972138685758,0.1282810847026532,0.03631185475258099,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
166,0.3,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of healthcare benefits in Kenya aligned with universal coverage principles? While Kenya is committed to universal health coverage, challenges including unequal regional access, resource scarcity, and service delivery gaps mean it does not currently fully meet these principles.",4.026615365066519e-07,0.20824609149746776,0.10380622837370242,0.030828249901291835,0.26276901881122683,0.07100591715976332,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
166,0.3,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does Kenya's distribution of health care benefits meet the standards of universal coverage? Kenya is working towards universal health coverage, but faces major challenges such as uneven access across regions, limited resources, and service delivery gaps, so it does not yet fully satisfy universal coverage principles.",2.8423167282822487e-07,0.09046305584108438,0.10380622837370242,0.02176111757738247,0.14214103102260944,0.07100591715976332,0.0217296184914344,0.19572236549818545,0.03631185475258099,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
166,0.3,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is the distribution of health care benefits in Kenya consistent with the ideals of universal coverage? Kenya aims for universal health coverage, but significant challenges like regional inequalities, resource limitations, and service delivery gaps mean it does not fully meet these ideals currently.",3.552895910352811e-07,0.15945592732803604,0.10380622837370242,0.02720139697172809,0.2127585982365634,0.07100591715976332,0.027162023114293,0.2680430270778116,0.03631185475258099,3.552895910352811e-07,0.29975028263611403,0.01851192595229618
166,0.3,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Does the distribution of health care benefits in Kenya conform to universal coverage principles? Kenya is progressing towards universal health coverage, but issues such as unequal access by region, scarce resources, and service delivery gaps prevent it from fully meeting these principles at present.",3.316036182995957e-07,0.13592542991784162,0.10380622837370242,0.025387970506946217,0.18866104665750338,0.07100591715976332,0.025351221573340132,0.24335041448743988,0.03631185475258099,3.316036182995957e-07,0.2744324746518223,0.01851192595229618
166,0.3,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: While Kenya strives towards universal health coverage, the distribution of healthcare benefits still faces significant challenges. These include unequal access across regions, limited resources, and gaps in service delivery. Therefore, it currently does not fully meet the principles of universal coverage.","Is Kenya's distribution of health care benefits in accordance with universal coverage principles? Although Kenya strives for universal health coverage, challenges including regional disparities, limited resources, and gaps in service delivery mean it does not fully meet the principles of universal coverage yet.",3.552895910352811e-07,0.19246293592612762,0.08001086846888386,0.02720139697172809,0.2127585982365634,0.07100591715976332,0.027162023114293,0.2680430270778116,0.03631185475258099,3.552895910352811e-07,0.29975028263611403,0.01851192595229618
167,0.3,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can a new surgical method for the temporomandibular joint enhance access and lower complication rates?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.3,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is it possible for an innovative surgical technique targeting the temporomandibular joint to improve accessibility and minimize complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,0.3,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could a novel approach in surgery for the temporomandibular joint provide better access and reduce the risk of complications?,7.105791820705601e-07,0.6920179277784153,0.19390581717451527,0.054402793943456304,0.780969260016414,0.16305062458908606,0.05432404622858612,0.8752316706249803,0.1275,7.105791820705619e-07,0.9753861232352303,0.08804283164782867
167,0.3,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does a new surgical strategy for the temporomandibular joint have the potential to improve access and decrease complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,0.3,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Might a fresh surgical method for the temporomandibular joint enhance access while reducing complications?,8.290090457489868e-07,1.017440328213043,0.19390581717451527,0.06346992626736568,1.1292759542846293,0.16305062458908606,0.0633780539333505,1.2499251200663908,0.1275,8.290090457489886e-07,1.3808512313433954,0.08804283164782867
167,0.3,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can innovative surgical techniques for the temporomandibular joint improve access and lessen complications?,8.526950184846721e-07,1.0974830358865795,0.19390581717451527,0.06528335273214755,1.2162873312742595,0.16305062458908606,0.06518885547430336,1.345235299870716,0.1275,8.52695018484674e-07,1.4862117470012213,0.08804283164782867
167,0.3,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Is a novel surgical approach to the temporomandibular joint capable of improving access and reducing complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.3,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Could advanced surgical methods for the temporomandibular joint lead to better access and fewer complications?,8.053230730133015e-07,0.9433323560593219,0.19390581717451527,0.06165649980258381,1.049233246611093,0.16305062458908606,0.06156725239239762,1.1629137430767607,0.1275,8.053230730133033e-07,1.2855410515390702,0.08804283164782867
167,0.3,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Does employing a new surgical approach to the temporomandibular joint improve access and lower complication risks?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,0.3,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: A novel surgical approach to the temporomandibular joint can potentially improve access and reduce complications. This could be achieved through minimally invasive techniques, advanced imaging technology, and innovative surgical instruments, which may lead",Can the use of a novel surgical technique on the temporomandibular joint enhance access and reduce complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
168,0.3,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the position of the head affect the anterior chamber depth in pseudoexfoliation syndrome? Yes, head positioning can impact the anterior chamber depth in pseudoexfoliation syndrome. Certain positions, like lying flat, may increase the anterior chamber depth, which can complicate managing the condition. Thus, head position should be taken into account during assessment and treatment.",1.1842986367842703e-07,0.1231621806444596,0.09536648755360666,0.009067132323909363,0.13519968271508276,0.06639553326474627,0.009054007704764333,0.09882320897538888,0.005006915842678754,1.1842986367842703e-07,0.09838002986348426,0.0034850590946045243
168,0.3,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome influenced by head positioning? Indeed, head position can alter anterior chamber depth in pseudoexfoliation syndrome. For example, lying flat can deepen the anterior chamber, potentially making management more challenging. Therefore, considering the patient's head position is important in evaluation and treatment.",2.8423167282822487e-07,0.21039236355228663,0.011618799393524656,0.02176111757738247,0.2266056082060497,0.003687159707430901,0.0217296184914344,0.22503899966909646,0.00812083942604943,2.8423167282822487e-07,0.22315823394520073,0.01295031385370506
168,0.3,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Yes, the depth of the anterior chamber in pseudoexfoliation syndrome can be influenced by how the head is positioned. Positions such as lying flat may increase the depth, which could complicate condition management. Hence, head position should be factored into assessment and therapy.",1.6580180914979784e-07,0.015137137046751015,0.07809408284023667,0.012693985253473108,0.03301087015865267,0.06858710562414265,0.012675610786670066,0.058065401294831176,0.05246913580246911,1.6580180914979784e-07,0.08402087972738315,0.03566529492455417
168,0.3,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the anterior chamber depth change with head positioning in pseudoexfoliation syndrome? Yes, head positioning does affect anterior chamber depth in pseudoexfoliation syndrome. Specific positions like lying flat can increase the depth, potentially complicating treatment. Therefore, the patient's head position needs consideration during diagnosis and management.",3.316036182995957e-07,0.22962551740151138,0.02845125119240803,0.025387970506946217,0.21215355899016863,0.045872124553293536,0.025351221573340132,0.2088882910294143,0.05246913580246911,3.316036182995957e-07,0.2381715595546421,0.03566529492455417
168,0.3,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is the anterior chamber depth in pseudoexfoliation syndrome affected by head position? Yes, head positioning can influence the anterior chamber depth in this syndrome. Lying flat, for instance, can increase the depth and complicate management. Thus, head position should be accounted for in patient assessment and treatment.",3.079176455639103e-07,0.20496778099941304,0.03032628238672193,0.023574544042164344,0.2505936371873174,0.0022605750118977613,0.023540420032387266,0.24891215285561952,0.007117661879566618,3.079176455639103e-07,0.24688046589142187,0.012422664539066645
168,0.3,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does head position have an effect on anterior chamber depth in pseudoexfoliation syndrome? Yes, the anterior chamber depth can be affected by head positioning in pseudoexfoliation syndrome. Certain positions, such as lying flat, may deepen the anterior chamber and complicate management. Therefore, head position is an important factor in evaluation and treatment.",1.8948778188548325e-07,0.15458943078882115,0.043505917159763347,0.014507411718254981,0.10826527189962798,0.028656550068587083,0.014486412327622933,0.07826810861234978,0.05246913580246911,1.8948778188548325e-07,0.1046401669301189,0.03566529492455417
168,0.3,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Can the anterior chamber depth in pseudoexfoliation syndrome be influenced by head positioning? Yes, head position can influence anterior chamber depth in pseudoexfoliation syndrome. Lying flat can increase the depth, which might complicate managing the condition. Hence, head positioning should be considered in patient care.",3.552895910352811e-07,0.25489896792249933,0.026494082840236688,0.02720139697172809,0.3003545984303386,0.0007878943758573426,0.027162023114293,0.2984328056357928,0.004969135802469098,3.552895910352811e-07,0.29608116872199197,0.011290294924554169
168,0.3,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does positioning of the head impact anterior chamber depth in pseudoexfoliation syndrome? Yes, anterior chamber depth in pseudoexfoliation syndrome can be influenced by head positioning. Positions like lying flat can increase the depth and complicate management. Therefore, head position should be taken into account during assessment and treatment.",2.8423167282822487e-07,0.18089673884760815,0.03212415314851143,0.02176111757738247,0.22660560820605014,0.003687159707430901,0.0217296184914344,0.22503899966909646,0.00812083942604943,2.8423167282822487e-07,0.22315823394520073,0.01295031385370506
168,0.3,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Is anterior chamber depth in pseudoexfoliation syndrome dependent on head position? Yes, head positioning can affect anterior chamber depth in pseudoexfoliation syndrome. Specific positions such as lying flat may increase the depth, potentially complicating management. Thus, the patient's head position should be considered in clinical evaluation and treatment.",2.8423167282822487e-07,0.18089673884760815,0.03212415314851143,0.02176111757738247,0.2266056082060497,0.003687159707430901,0.0217296184914344,0.22503899966909646,0.00812083942604943,2.8423167282822487e-07,0.22315823394520073,0.01295031385370506
168,0.3,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Yes, head positioning can influence anterior chamber depth in pseudoexfoliation syndrome. Specific positions, such as lying flat, can increase the depth of the anterior chamber, potentially complicating the management of the condition. Therefore, the patient's head position should be considered in the assessment and treatment of this syndrome.","Does the depth of the anterior chamber in pseudoexfoliation syndrome vary with head positioning? Yes, head position can influence anterior chamber depth in pseudoexfoliation syndrome. Lying flat can increase the depth, which may complicate management. Therefore, head positioning should be considered in the assessment and treatment of this condition.",2.6054570009253947e-07,0.09962309587772289,0.07490618113891342,0.0199476911126006,0.11468890117291997,0.06858710562414265,0.019918816950481533,0.14144701023388206,0.05246913580246911,2.6054570009253947e-07,0.16917868806769043,0.03566529492455417
169,0.3,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? It is suggested that CYP2D6*4 poor metabolizers may have reduced activation of procarcinogens, potentially offering protection against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.3,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with the CYP2D6*4 variant might exhibit decreased conversion of procarcinogens, which could provide a protective effect against carcinogens.",4.73719454713706e-08,0.12280319957917696,0.03698224852071005,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,0.3,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the association between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolizer status may lead to lower transformation of procarcinogens, possibly resulting in protection from carcinogens.",0.0,0.04780325383172013,0.03443877551020409,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.3,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Reduced procarcinogen metabolism in CYP2D6*4 poor metabolizers might confer a protective effect against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.3,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does carrying the CYP2D6*4 allele affect breast cancer risk? CYP2D6*4 poor metabolizers may have diminished procarcinogen activation, which could protect against carcinogenic effects.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.3,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is the CYP2D6*4 allele associated with breast cancer risk? The decreased transformation of procarcinogens by CYP2D6*4 poor metabolizers might lead to a protective effect against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.3,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Can the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with this allele may have reduced procarcinogen conversion, potentially offering protection from carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.3,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the relationship between CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers could experience decreased activation of procarcinogens, resulting in a protective effect against carcinogens.",7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
169,0.3,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolizer phenotype might reduce procarcinogen transformation, thereby providing protection against carcinogens.",9.47438909427412e-08,0.20387177956306823,0.03993055555555556,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.3,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the presence of the CYP2D6*4 allele relate to breast cancer risk? A possible reduction in procarcinogen metabolism by CYP2D6*4 poor metabolizers could confer a protective effect against carcinogens.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
170,0.3,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott call by Catholic bishops impact polio vaccination rates in Kenya in 2015? The boycott did not significantly affect the campaign, but a future repeat could harm polio eradication efforts, so precautions are necessary.",4.97405427449393e-07,0.30829409386464546,0.21635124638090528,0.03808195576041933,0.3611240473070607,0.1507112648981161,0.03802683236001021,0.4314424690606775,0.07544378698224853,4.974054274493935e-07,0.5045560107523945,0.0
170,0.3,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call influence Kenya's 2015 polio vaccination coverage? The campaign was not significantly affected, though a future boycott could negatively impact polio eradication, making preventive measures important.",6.158352911278195e-07,0.4228363633741927,0.24489795918367344,0.04714908808432873,0.5201887419367495,0.1507112648981161,0.04708084006477458,0.5957455203519535,0.07544378698224853,6.158352911278206e-07,0.6744550475477915,0.0
170,0.3,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Was polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? The campaign remained largely unaffected, but a repeated boycott could seriously hinder polio eradication, so vigilance is essential.",5.684633456564489e-07,0.3582978422366212,0.24489795918367344,0.04352223515476497,0.453497367438076,0.1507112648981161,0.04345923698286883,0.5267526488650027,0.07544378698224853,5.684633456564497e-07,0.6029960835656478,0.0
170,0.3,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call affect Kenya's 2015 polio vaccination campaign? It did not have a significant effect, but if repeated, it could negatively impact polio eradication, so it is important to take precautions.",5.210914001850783e-07,0.29767322042018574,0.24489795918367344,0.03989538222520121,0.3909770104567425,0.1507112648981161,0.039837633900963086,0.4622141277274312,0.07544378698224853,5.210914001850789e-07,0.5363047090669744,0.0
170,0.3,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott urged by Catholic bishops influence polio vaccination coverage in Kenya in 2015? The campaign was not significantly impacted, but future repetition could have serious negative consequences for polio eradication, thus caution is needed.",4.97405427449393e-07,0.26868568354693423,0.24489795918367344,0.03808195576041933,0.3611240473070607,0.1507112648981161,0.03802683236001021,0.4314424690606775,0.07544378698224853,4.974054274493935e-07,0.5045560107523945,0.0
170,0.3,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' call for boycott affect the 2015 polio vaccination coverage in Kenya? The campaign was not significantly affected, but a future boycott could have adverse effects on polio eradication, so preventive steps are crucial.",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
170,0.3,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the boycott call from Catholic bishops impact Kenya's polio vaccination coverage in 2015? The campaign was largely unaffected, but if repeated, it could negatively affect polio eradication, making it important to ensure safeguards.",5.447773729207636e-07,0.3275261835698675,0.24489795918367344,0.04170880868998309,0.4217486691234962,0.1507112648981161,0.04164843544191596,0.493962826042011,0.07544378698224853,5.447773729207643e-07,0.5690945318899661,0.0
170,0.3,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call influence the 2015 polio vaccination coverage in Kenya? The campaign was not significantly affected, but a repeat could have serious negative implications for polio eradication, so it is important to be vigilant.",4.500334819780224e-07,0.21311583239212206,0.24489795918367344,0.03445510283085558,0.30396563346711236,0.1507112648981161,0.034405229278104466,0.37260196903774423,0.07544378698224853,4.500334819780227e-07,0.44393138893595907,0.0
170,0.3,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the call for boycott by Catholic bishops affect polio vaccination coverage in Kenya in 2015? The campaign was not significantly impacted, but if repeated, it could have significant negative effects on polio eradication, so precautions are necessary.",4.500334819780224e-07,0.21311583239212206,0.24489795918367344,0.03445510283085558,0.30396563346711236,0.1507112648981161,0.034405229278104466,0.37260196903774423,0.07544378698224853,4.500334819780227e-07,0.44393138893595907,0.0
170,0.3,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that","Did the Catholic bishops' boycott call affect polio vaccination coverage in Kenya in 2015? The campaign was not significantly influenced, but a future repeat could harm polio eradication efforts, so it is important to ensure preventive measures.",4.737194547137077e-07,0.24051480658023738,0.24489795918367344,0.03626852929563745,0.3321365104338092,0.1507112648981161,0.03621603081905734,0.40158950591099574,0.07544378698224853,4.737194547137081e-07,0.47378435208564085,0.0
171,0.3,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation connect genetic and environmental factors in atrial fibrillation development? Yes, this mutation links genetic and environmental influences in atrial fibrillation by altering the heart's stress response, such as to hypertension, which can cause abnormal rhythms, bridging genetic predisposition and environmental triggers.",4.737194547137081e-07,0.17604359166840444,0.14216602457309463,0.03626852929563745,0.19943748617483426,0.11911986819172908,0.03621603081905733,0.18389255910941715,0.13888888888888887,4.737194547137081e-07,0.21058807500431742,0.1262002743484225
171,0.3,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a connection between genetic and environmental contributors to atrial fibrillation? Indeed, the mutation ties genetic and environmental factors by impacting how the heart reacts to stressors like high blood pressure, potentially leading to irregular heartbeats, thus linking inherited risk and external triggers.",4.500334819780227e-07,0.04867790950520767,0.2581525948210285,0.03445510283085558,0.1447577916300915,0.1422605983129787,0.034405229278104466,0.16090304088471763,0.13888888888888887,4.500334819780227e-07,0.187057577594123,0.1262002743484225
171,0.3,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation be seen as a bridge between genetic and environmental causes of atrial fibrillation? Yes, it connects these factors by modifying the heart's response to stress conditions such as hypertension, which may induce abnormal heart rhythms, thereby uniting genetic susceptibility with environmental influences.",4.500334819780227e-07,0.011595758369570053,0.3015410245730946,0.03445510283085558,0.1139512502718718,0.16447134211463157,0.034405229278104466,0.16090304088471763,0.13888888888888887,4.500334819780227e-07,0.187057577594123,0.1262002743484225
171,0.3,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation serve as a link between genetic and environmental elements in atrial fibrillation pathogenesis? Yes, this mutation affects the heart's reaction to stress like hypertension, possibly triggering arrhythmias, and thus connects genetic predisposition with environmental triggers.",6.158352911278205e-07,0.15348399198988005,0.3015410245730946,0.04714908808432869,0.2830275803158049,0.16447134211463157,0.04708084006477453,0.33417476215875386,0.13888888888888887,6.158352911278206e-07,0.36473875483157503,0.1262002743484225
171,0.3,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is there a connection between genetic and environmental factors in atrial fibrillation through the stretch-sensitive KCNQ1 mutation? Yes, this mutation represents that connection by influencing the heart's stress response, such as to hypertension, which can provoke abnormal rhythms, linking genetic and environmental causes.",5.447773729207643e-07,0.14539003703234066,0.25404102457309463,0.04170880868998307,0.24085373092617335,0.14009634211463157,0.04164843544191593,0.2562132206890433,0.13888888888888887,5.447773729207643e-07,0.28469604715804087,0.1262002743484225
171,0.3,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation illustrate a relationship between genetic and environmental factors in atrial fibrillation? Yes, it does by altering the heart's response to stressors like hypertension, potentially causing irregular heartbeats, thereby bridging genetic and environmental contributions.",6.632072365991911e-07,0.2810625558061046,0.24766347355268645,0.050775941013892434,0.3756029782838559,0.13671624007381525,0.050702443146680265,0.389744613313566,0.13888888888888887,6.632072365991914e-07,0.4218971686715234,0.1262002743484225
171,0.3,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a factor linking genetics and environment in atrial fibrillation? Yes, it connects these by affecting how the heart responds to stress such as hypertension, which may trigger abnormal rhythms, linking inherited and environmental factors.",6.395212638635058e-07,0.17945947839313803,0.3015410245730946,0.04896251454911056,0.30969582739796575,0.16447134211463157,0.0488916416057274,0.3615737363468692,0.13888888888888887,6.39521263863506e-07,0.3929096317982719,0.1262002743484225
171,0.3,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Can the stretch-sensitive KCNQ1 mutation be considered a link between genetic and environmental factors in atrial fibrillation? Yes, it influences the heart's stress response, including hypertension, which can lead to arrhythmias, thus bridging genetic predisposition and environmental triggers.",6.632072365991911e-07,0.2435951406407013,0.27453485173358844,0.050775941013892434,0.33709480158608107,0.16447134211463157,0.050702443146680265,0.389744613313566,0.13888888888888887,6.632072365991914e-07,0.4218971686715234,0.1262002743484225
171,0.3,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Does the stretch-sensitive KCNQ1 mutation connect genetic predisposition with environmental triggers in atrial fibrillation? Yes, it does by affecting the heart's response to stress like hypertension, potentially causing abnormal rhythms, linking genetic and environmental factors.",7.34265154806247e-07,0.29068511350336257,0.3015410245730946,0.056216220408238066,0.4241061785757112,0.16447134211463157,0.056134847769538886,0.479356772003253,0.13888888888888887,7.342651548062476e-07,0.5142704888025387,0.1262002743484225
171,0.3,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Yes, the stretch-sensitive KCNQ1 mutation represents a link between genetic and environmental factors in the pathogenesis of atrial fibrillation. This mutation affects the heart's response to stress, like hypertension, potentially triggering abnormal heart rhythms. Thus, it bridges the gap between genetic predisposition and environmental triggers in atrial fibrillation.","Is the stretch-sensitive KCNQ1 mutation a bridge between genetic and environmental causes of atrial fibrillation? Yes, this mutation impacts how the heart reacts to stressors such as hypertension, possibly inducing arrhythmias, thereby connecting genetic susceptibility and environmental influences.",6.632072365991911e-07,0.2435951406407013,0.27453485173358844,0.050775941013892434,0.33709480158608107,0.16447134211463157,0.050702443146680265,0.389744613313566,0.13888888888888887,6.632072365991914e-07,0.4218971686715234,0.1262002743484225
172,0.3,1,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery may effectively treat spinal cord sarcoidosis when it is accompanied by compressive cervical myelopathy, as studies indicate it can relieve neurological symptoms by removing compression.",2.3685972735685406e-08,0.07336235441567007,0.06472937758981585,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
172,0.3,2,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Can decompressive surgery successfully treat spinal cord sarcoidosis with compressive cervical myelopathy? Evidence suggests that decompressive surgery is beneficial for spinal cord sarcoidosis cases involving compressive cervical myelopathy, helping to improve neurological function by alleviating pressure.",1.421158364141119e-07,0.07997324336770895,0.051111875245293106,0.010880558788691243,0.13397757500412988,0.0204767391873914,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
172,0.3,3,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Does decompressive surgery work for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery has been shown to be effective in managing spinal cord sarcoidosis when compressive cervical myelopathy is present, as it helps reduce neurological deficits by decompressing the spinal cord.",0.0,0.10143617276487049,0.06707406461918759,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
172,0.3,4,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery a viable option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Surgical decompression can effectively treat spinal cord sarcoidosis with compressive cervical myelopathy by relieving neurological symptoms through removal of the compressive lesion.,1.1842986367842661e-07,0.008893255223492158,0.08085018158940778,0.009067132323909363,0.10382508488623987,0.021314783042107176,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.3,5,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery help patients with spinal cord sarcoidosis and compressive cervical myelopathy? Studies demonstrate that decompressive surgery can improve neurological symptoms in spinal cord sarcoidosis cases complicated by compressive cervical myelopathy by removing the source of compression.,9.474389094274131e-08,0.01583941160366331,0.05697506680520209,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
172,0.3,6,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Is decompressive surgery effective in cases of spinal cord sarcoidosis with compressive cervical myelopathy? The procedure can be effective, as it alleviates neurological symptoms by decompressing the spinal cord affected by sarcoidosis and compression.",1.894877818854825e-07,0.022389022153733507,0.13322137218858132,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
172,0.3,7,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,"Does decompressive surgery provide benefit for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Yes, it can be effective in treating neurological symptoms by removing compressive forces on the spinal cord in such cases.",1.894877818854825e-07,0.022389022153733507,0.13322137218858132,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
172,0.3,8,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is surgical decompression an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery has been found to relieve neurological symptoms by addressing the compressive pathology in spinal cord sarcoidosis with cervical myelopathy.,1.658018091497972e-07,0.07284722965716428,0.07608586067713491,0.012693985253473122,0.2070750146593343,0.010492302282075747,0.012675610786670087,0.20560143285543164,0.005594213091741351,1.6580180914979784e-07,0.20359895524123983,0.0
172,0.3,9,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Can decompressive surgery effectively treat spinal cord sarcoidosis when compressive cervical myelopathy is present? The surgery can alleviate neurological impairments by removing the compressive element associated with cervical myelopathy in spinal cord sarcoidosis.,2.131737546211678e-07,0.09779515835654573,0.10127258746635909,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
172,0.3,10,ai,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery can be effective for treating spinal cord sarcoidosis accompanied by compressive cervical myelopathy. Studies have shown that the surgery can alleviate neurological symptoms by removing,Is decompressive surgery a successful intervention for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Research indicates that it can effectively reduce neurological symptoms by decompressing the spinal cord affected by sarcoidosis and cervical myelopathy.,1.658018091497972e-07,0.00869949746753429,0.13411005303109738,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
173,0.3,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Do Indigenous Australians experience premature aging? Answer: This study, which examines a range of specific conditions, does not strongly support the notion that Indigenous people age prematurely. The existing emphasis and nature of services offered by the aged care sector might not be the",2.3685972735685406e-08,0.022989518224699523,0.0,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
173,0.3,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Is premature aging common among Indigenous Australians? Answer: According to this study analyzing various distinct conditions, there is little evidence to back the claim that Indigenous Australians age prematurely. The current priorities and types of services in aged care may not be the",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
173,0.3,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Are Indigenous Australians prone to premature aging? Answer: The research focusing on several discrete health conditions does not provide strong support for the idea that Indigenous Australians age earlier than others. The aged care sectors current focus and service types may not be the,2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
173,0.3,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Do Indigenous Australians show signs of aging earlier than others? Answer: This study of multiple specific conditions does not strongly confirm that Indigenous Australians age prematurely. The present focus and types of services in aged care might not be the,7.105791820705622e-08,0.10697802060762251,0.02498356344510192,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.3,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Is there evidence that Indigenous Australians age prematurely? Answer: The study examining a series of distinct conditions does not strongly support the belief that Indigenous Australians age prematurely. The aged care sectors current focus and service provision may not be the,4.737194547137081e-08,0.14906422175412404,0.07271468144044323,0.0036268529295637453,0.11810488222542581,0.049861495844875335,0.003621603081905733,0.08555642983414735,0.025623268698060954,4.737194547137081e-08,0.051293294387549704,0.0
173,0.3,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Are Indigenous Australians believed to age faster? Answer: This study, which looks at various discrete conditions, does not provide strong evidence that Indigenous Australians experience premature aging. The current focus and types of services in aged care may not be the",4.737194547137081e-08,0.0814401065775443,0.024375,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
173,0.3,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,"Question: Do Indigenous Australians age at an accelerated rate? Answer: Based on this study of several specific conditions, the idea that Indigenous Australians age prematurely is not well supported. The current priorities and service models in aged care may not be the",4.737194547137081e-08,0.11525216416583417,0.04865220249835634,0.0036268529295637453,0.0834475231974281,0.02498356344510192,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
173,0.3,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Is premature aging a characteristic of Indigenous Australians? Answer: The research into a range of discrete conditions does not strongly back the idea that Indigenous Australians age prematurely. The aged care sectors current focus and service types might not be the,4.737194547137081e-08,0.047628048989254435,0.0,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
173,0.3,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Are Indigenous Australians subject to early aging? Answer: This study analyzing a series of distinct conditions does not strongly support the concept that Indigenous Australians age prematurely. The current focus and nature of aged care services may not be the,7.105791820705622e-08,0.10697802060762251,0.02498356344510192,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
173,0.3,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the,Question: Do Indigenous Australians experience early onset of aging? Answer: The study of various specific conditions does not provide strong evidence for the idea that Indigenous Australians age prematurely. The aged care sectors current focus and types of services may not be the,2.3685972735685406e-08,0.056537506008286,0.023795359904818555,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
174,0.3,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable over time? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation contribute to major decreases in CLABSIs. Thoughtful organization can enhance comprehension of a unit's capacity to manage peak workloads and maintain exceptional performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.3,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Rigorous training, strict adherence to evidence-based guidelines, and detailed documentation are linked to substantial reductions in CLABSIs. Careful organizational strategies may improve understanding of how a unit manages peak demands and sustains outstanding long-term performance.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.3,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? Effective training, compliance with evidence-based practices, and thorough record-keeping are associated with significant CLABSI reductions. Mindful management may help better grasp what enables a unit to handle high demand and maintain exceptional performance over time.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.3,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable? High-quality education, strict guideline adherence, and comprehensive documentation correlate with notable decreases in CLABSIs. Thoughtful organizational efforts can lead to improved insight into a units ability to meet peak demands and sustain superior long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.3,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be maintained consistently? Intensive training, strict compliance with evidence-based standards, and detailed documentation are linked to significant CLABSI declines. Mindful coordination may foster a deeper understanding of how a unit sustains peak demand handling and exceptional performance over the long haul.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.3,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate feasible? Quality training, rigorous adherence to evidence-based protocols, and thorough documentation contribute to marked reductions in CLABSIs. Mindful organizational approaches may enhance understanding of a units capacity to manage peak demands and maintain outstanding long-term results.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.3,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? High-level training, strict compliance with evidence-based guidelines, and detailed documentation are associated with major CLABSI reductions. Thoughtful organization might improve insight into how a unit handles peak demands and sustains exceptional performance over time.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.3,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be upheld? Comprehensive training, strict adherence to evidence-based guidelines, and meticulous documentation are linked to significant decreases in CLABSIs. Mindful organizational practices may help better understand a units ability to manage peak demand and maintain extraordinary long-term performance.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.3,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to maintain zero central line-associated bloodstream infections? High-quality training, strict compliance with evidence-based protocols, and thorough documentation are associated with substantial CLABSI reductions. Mindful organization may provide better insight into how a unit handles peak demands and sustains exceptional long-term performance.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
174,0.3,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate achievable and sustainable? Effective training, strict adherence to evidence-based guidelines, and detailed documentation correlate with significant CLABSI reductions. Mindful organizational efforts can lead to a better understanding of a units capacity to manage peak demands and maintain exceptional performance over time.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
175,0.3,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonists before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? Research shows no significant improvement, though slight benefits may occur in some cases; more studies are needed.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.3,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide improve outcomes versus oral contraceptive pills? Evidence suggests no major advantage, with potential minor benefits in select situations; further research is warranted.",6.868932093348761e-07,0.2867041157944441,0.21484375,0.05258936747867432,0.3623117859425027,0.18240000000000006,0.05251324468763315,0.44060272776573095,0.14312130177514798,6.868932093348768e-07,0.5217279216249646,0.09876543209876548
175,0.3,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is IVF success in poor responders better with estradiol and antagonist pretreatment prior to microdose leuprolide than with oral contraceptive pills? Studies indicate no significant improvement, but slight benefits might exist for certain patients; additional investigation is required.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.3,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does using estradiol and antagonist pretreatment before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Research finds no substantial benefit, although marginal gains may be seen in some cases; more studies are necessary.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.3,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders in IVF, does pretreatment with estradiol and antagonists before microdose leuprolide outperform oral contraceptive pills? Current research shows no significant improvement, but minor benefits could be possible in specific instances; further studies are needed.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.3,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does pretreatment with estradiol and antagonists ahead of microdose leuprolide enhance IVF outcomes in poor responders relative to oral contraceptive pills? Evidence suggests no significant advantage, though slight improvements may occur in select cases; more research is required.",6.158352911278202e-07,0.20214672776638043,0.21484375,0.04714908808432869,0.27530040895287256,0.18240000000000006,0.04708084006477453,0.350990569076044,0.14312130177514798,6.158352911278206e-07,0.42935460149394933,0.09876543209876548
175,0.3,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","In IVF treatment for poor responders, does estradiol and antagonist pretreatment prior to microdose leuprolide lead to better outcomes than oral contraceptive pills? Studies show no significant improvement, but marginal benefits might be present in some cases; further research is necessary.",5.447773729207643e-07,0.12418518629666986,0.21484375,0.04170880868998307,0.1952577012793384,0.18240000000000006,0.04164843544191593,0.26875247083907094,0.14312130177514798,5.447773729207643e-07,0.34479721346588565,0.09876543209876548
175,0.3,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Is there an improvement in IVF outcomes for poor responders with estradiol and antagonist pretreatment before microdose leuprolide compared to oral contraceptive pills? Research indicates no major benefit, though minor advantages might exist in certain situations; additional studies are needed.",5.684633456564496e-07,0.1495029942809616,0.21484375,0.04352223515476494,0.22123318768259637,0.18240000000000006,0.0434592369828688,0.2954207179212318,0.14312130177514798,5.684633456564497e-07,0.372196187654001,0.09876543209876548
175,0.3,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","Does estradiol and antagonist pretreatment before microdose leuprolide improve IVF success in poor responders compared to oral contraceptive pills? Findings suggest no significant improvement, but slight benefits may be observed in specific cases; further investigation is warranted.",6.395212638635055e-07,0.22954570195449575,0.21484375,0.04896251454911056,0.3034712859195694,0.18240000000000006,0.048891641605727405,0.3799781059492955,0.14312130177514798,6.39521263863506e-07,0.4592075646436311,0.09876543209876548
175,0.3,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: Research indicates that estradiol and antagonist pretreatment prior to microdose leuprolide do not significantly improve IVF outcomes in poor responders compared to oral contraceptive pills. However, it might provide marginal benefits in specific cases. Further studies","For poor responders, does pretreatment with estradiol and antagonists prior to microdose leuprolide enhance IVF outcomes more than oral contraceptive pills? Research shows no substantial benefit, although marginal improvements might be possible in some cases; more studies are required.",5.921493183921349e-07,0.17547848068421956,0.21484375,0.045335661619546816,0.24790143476475723,0.18240000000000006,0.045270038523821665,0.32281969210934713,0.14312130177514798,5.921493183921352e-07,0.4003670646206978,0.09876543209876548
176,0.3,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in patients with positive lymph nodes. A cutoff of 205 (10(9)/L) platelet count may best predict survival in ESCC cases.",2.3685972735685406e-07,0.22575979203303165,0.0111111111111111,0.018134264647818726,0.20722121792945059,0.015119148685370482,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.3,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? It is a predictive marker for long-term survival in ESCC, especially among nodal-positive patients. The optimal platelet count cutoff for survival prediction is 205 (10(9)/L).",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.3,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Yes, it is a prognostic factor for long-term survival in ESCC, notably in patients with lymph node involvement. A platelet count of 205 (10(9)/L) is suggested as the ideal cutoff for survival prediction.",1.6580180914979784e-07,0.03396789449427784,0.11996724615772239,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,0.3,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? It predicts long-term survival in ESCC, particularly in those with nodal positivity. The platelet count cutoff of 205 (10(9)/L) may be optimal for forecasting survival.",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.3,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC patients, especially those with positive lymph nodes. A cutoff value of 205 (10(9)/L) platelet count is proposed for survival prediction.",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.3,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? It serves as a predictive factor for long-term survival in ESCC, mainly in nodal-positive patients. The optimal cutoff for platelet count is 205 (10(9)/L) for predicting survival.",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.3,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can the preoperative platelet count act as a prognostic marker in esophageal squamous cell carcinoma? It is predictive of long-term survival in ESCC, especially in patients with nodal involvement. A cutoff point of 205 (10(9)/L) platelet count may best predict survival.",2.3685972735685406e-07,0.10870651135492615,0.118226313098108,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.3,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is there prognostic value in preoperative platelet count for esophageal squamous cell carcinoma? Yes, it predicts long-term survival in ESCC, particularly in nodal-positive cases. The suggested cutoff for platelet count is 205 (10(9)/L) for survival prediction.",3.5528959103528056e-07,0.24718895526916373,0.11466316374044175,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
176,0.3,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count have prognostic significance in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC, especially in patients with positive lymph nodes. The platelet count cutoff of 205 (10(9)/L) may be optimal for predicting survival.",2.1317375462116866e-07,0.08316859732484794,0.1188348765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.3,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a reliable prognostic factor in esophageal squamous cell carcinoma? It predicts long-term survival in ESCC, notably in nodal-positive patients. The optimal cutoff for platelet count is 205 (10(9)/L) for survival prediction.",3.7897556377096586e-07,0.27734144538705374,0.11382511988572597,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
177,0.3,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a concurrent splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones requires reconsideration. With the advent of minimally invasive surgery, the decision to remove the spleen in these children should be evaluated independently.",4.737194547137081e-08,0.10017801828497319,0.07822441700960218,0.0036268529295637453,0.06439983492746082,0.01922337562475971,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
177,0.3,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a concomitant splenectomy in mild hereditary spherocytosis? The suggestion to do a splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones should be reexamined. Given the advances in minimal access surgery, splenectomy indications should be assessed separately.",2.8423167282822487e-07,0.202189805811118,0.07202499999999998,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.3,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The practice of recommending simultaneous splenectomy in children with mild HS undergoing cholecystectomy for gallstones needs to be reviewed. In the current era of minimally invasive techniques, the necessity for splenectomy should be considered on its own.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.3,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be an indication for concurrent splenectomy in mild hereditary spherocytosis? The advice to perform splenectomy with cholecystectomy in children with mild HS and symptomatic gallstones merits reevaluation. With minimal access surgery now available, splenectomy decisions should be made independently.",3.079176455639103e-07,0.19307036081319984,0.09639999999999999,0.023574544042164344,0.26102256550717007,0.01922337562475971,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
177,0.3,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The recommendation to do splenectomy alongside cholecystectomy in children with mild HS and symptomatic gallstones needs to be revisited. The need for splenectomy should be judged on its own merits in the era of minimal access surgery.,1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.3,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify a splenectomy during cholecystectomy? The guidance to perform a simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reconsidered. With minimally invasive surgery, splenectomy necessity should be independently evaluated.",3.552895910352809e-07,0.2808450857565359,0.07010343316289261,0.02720139697172809,0.3136662989925889,0.01922337562475971,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
177,0.3,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a concomitant splenectomy necessary when performing cholecystectomy in mild hereditary spherocytosis? The recommendation to remove the spleen during cholecystectomy in children with mild HS and symptomatic gallstones requires reassessment. In the age of minimal access surgery, splenectomy should be considered on its own.",2.3685972735685406e-07,0.1529891029805479,0.07315736961451247,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.3,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should children with mild hereditary spherocytosis undergoing cholecystectomy also have a splenectomy? The advice to perform splenectomy simultaneously in these cases needs to be reconsidered. The decision for splenectomy should stand alone, especially with the availability of minimal access surgery.",3.316036182995956e-07,0.21838816879749157,0.09639999999999999,0.025387970506946217,0.28699805191042804,0.01922337562475971,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
177,0.3,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is it appropriate to perform a splenectomy along with cholecystectomy in mild hereditary spherocytosis? The current recommendation for concomitant splenectomy in children with mild HS and symptomatic gallstones should be reviewed. The necessity of splenectomy should be judged independently in the era of minimally invasive surgery.,1.8948778188548325e-07,0.10609386651503616,0.0741892561983471,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.3,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is splenectomy truly indicated during cholecystectomy for children with mild hereditary spherocytosis? The advice to perform both procedures together in mild HS cases with symptomatic gallstones needs to be reconsidered. With minimal access surgical options, splenectomy should be evaluated on its own merits.",2.6054570009253947e-07,0.14428019664376812,0.09639999999999999,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
178,0.3,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can measuring visceral adipose tissue area at a single level accurately represent the total visceral adipose tissue volume? Answer: Measuring visceral adipose tissue area at one level might offer an estimate, but it does not fully reflect the total visceral adipose tissue volume, as fat distribution differs across the body and a single measurement may miss this variation.",4.737194547137081e-08,0.0515751721585036,0.21298046628859474,0.0036268529295637453,0.005086901141887701,0.025822573927530235,0.003621603081905733,0.015457840558955827,0.013643478043265087,4.737194547137081e-08,0.014050323847732749,0.0154118155716726
178,0.3,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is a single-level measurement of visceral adipose tissue area sufficient to represent the entire visceral adipose tissue volume? Answer: A single-level measurement of visceral adipose tissue area can approximate but cannot completely represent the total visceral adipose tissue volume due to the heterogeneous distribution of adipose tissue throughout the body.,2.3685972735685406e-07,0.20042471960511365,0.04772339907475032,0.018134264647818726,0.18188098014688725,0.018509539327877744,0.018108015409528666,0.1902379007600219,0.0006872417843004769,2.3685972735685406e-07,0.21360235012777462,0.014594208794608848
178,0.3,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Does measuring visceral adipose tissue area at one level accurately indicate visceral adipose tissue volume? Answer: While a single-level measurement of visceral adipose tissue area may provide an estimate, it cannot fully capture the total volume because adipose tissue distribution varies in different body regions.",3.552895910352811e-07,0.0948560978311912,0.33136094674556227,0.02720139697172809,0.14129822278341386,0.16828403592494795,0.027162023114293,0.18807253710466965,0.07882837553167221,3.552895910352811e-07,0.20809783473575072,0.06977572089711641
178,0.3,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Can the visceral adipose tissue area measured at a single level serve as a proxy for visceral adipose tissue volume? Answer: The area measurement at a single level may approximate visceral adipose tissue volume but cannot fully represent it, given the variable distribution of adipose tissue across the body.",2.6054570009253947e-07,0.04772879190103119,0.31449534007535196,0.0199476911126006,0.07430030553847056,0.1567821259048399,0.019918816950481533,0.09638127204587832,0.08080446527443765,2.6054570009253947e-07,0.11712605653002406,0.06977572089711641
178,0.3,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Is it possible to represent visceral adipose tissue volume by measuring its area at a single level? Answer: Measuring the visceral adipose tissue area at one level might give an approximate value but does not fully represent the volume due to the uneven distribution of adipose tissue throughout the body.,2.3685972735685406e-07,0.11640943209739252,0.5437933207309389,0.018134264647818726,0.04445279309717609,0.2644819939030033,0.018108015409528666,0.04583223814336668,0.10207100591715974,2.3685972735685406e-07,0.0956198513090607,0.06977572089711641
178,0.3,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Question: Does a single-level measurement of visceral adipose tissue area accurately reflect the total visceral adipose tissue volume? Answer: Although it may provide an approximation, a single-level measurement cannot completely represent visceral adipose tissue volume because adipose tissue distribution varies across different body regions.",3.789755637709665e-07,0.15400095111860113,0.2970538105673242,0.029014823436509962,0.16676244038819954,0.16550629945855885,0.028972824655245866,0.17936363076788986,0.10207100591715974,3.789755637709665e-07,0.23219538631481074,0.06977572089711641
178,0.3,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can a single-level visceral adipose tissue area measurement stand in for the total visceral adipose tissue volume? Answer: A single-level area measurement may serve as an estimate but cannot fully represent the total volume since adipose tissue distribution is not uniform throughout the body.,3.789755637709665e-07,0.0909875710676964,0.4810710987996306,0.029014823436509962,0.09011507141135455,0.2616386690730714,0.028972824655245866,0.17936363076788986,0.10207100591715974,3.789755637709665e-07,0.23219538631481074,0.06977572089711641
178,0.3,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Question: Is measuring visceral adipose tissue area at one level an accurate method to estimate visceral adipose tissue volume? Answer: Measuring at a single level may approximate the volume, but it cannot fully represent it because adipose tissue distribution varies throughout the body.",4.026615365066519e-07,0.021931718596128302,0.5472916666666666,0.030828249901291835,0.11441317367266635,0.2610859395537403,0.030783626196198732,0.20346118234694988,0.10207100591715974,4.026615365066519e-07,0.25688799890518244,0.06977572089711641
178,0.3,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.",Question: Can the measurement of visceral adipose tissue area at a single level accurately represent the visceral adipose tissue volume? Answer: The measurement at a single level might provide an estimate but does not fully capture the volume due to the variable distribution of adipose tissue in the body.,2.8423167282822487e-07,0.016112981316391828,0.47630378742811813,0.02176111757738247,0.057415055761920186,0.22134824160731925,0.0217296184914344,0.11852868649955184,0.08034261085543135,2.8423167282822487e-07,0.13910496324879906,0.06977572089711641
178,0.3,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an approximation but it cannot fully represent visceral adipose tissue volume. This is because adipose tissue distribution varies throughout the body, and a single level measurement might not capture this variability accurately.","Question: Question: Does a single-level measurement of visceral adipose tissue area provide a true representation of visceral adipose tissue volume? Answer: It may offer an approximation, but cannot fully represent the volume since adipose tissue distribution varies across the body and a single measurement might not reflect this variability accurately.",2.6054570009253947e-07,0.09372981637650879,0.5412345679012345,0.0199476911126006,0.005637037496713404,0.24329339775723563,0.019918816950481533,0.09638127204587832,0.08080446527443765,2.6054570009253947e-07,0.11712605653002406,0.06977572089711641
179,0.3,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can locoregional opening of the rodent blood-brain barrier for paclitaxel be achieved using Nd:YAG laser-induced thermo therapy as a novel approach for adjuvant glioma treatment? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, which may benefit brain tumor therapy.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
179,0.3,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is Nd:YAG laser-induced thermo therapy effective for locoregional opening of the rodent blood-brain barrier to deliver paclitaxel, proposing a new adjuvant glioma treatment? Answer: LITT promotes targeted passage of chemotherapeutic agents into brain tissue, offering potential for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.3,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy enable locoregional opening of the rodent blood-brain barrier for paclitaxel, suggesting a new concept in adjuvant glioma therapy? Answer: LITT causes localized permeability allowing chemotherapy drugs to enter brain tissue, which could be useful in treating brain tumors.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
179,0.3,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can the rodent blood-brain barrier be locally opened for paclitaxel delivery using Nd:YAG laser-induced thermo therapy as a novel adjuvant glioma therapy? Answer: LITT induces localized passage of chemotherapeutic agents into brain tissue, presenting potential for brain tumor treatment.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.3,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional opening of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy a new approach for adjuvant glioma therapy with paclitaxel? Answer: LITT enables localized entry of chemotherapy drugs into brain tissue, which holds promise for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.3,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy provide locoregional opening of the rodent blood-brain barrier to facilitate paclitaxel delivery as a new adjuvant glioma therapy? Answer: LITT allows targeted passage of chemotherapeutic agents into brain tissue, potentially benefiting brain tumor treatment.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.3,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Could Nd:YAG laser-induced thermo therapy open the rodent blood-brain barrier locally for paclitaxel, introducing a novel adjuvant glioma therapy? Answer: LITT induces localized permeability for chemotherapeutic agents to enter brain tissue, which may aid brain tumor treatment.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
179,0.3,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the locoregional opening of the rodent blood-brain barrier for paclitaxel by Nd:YAG laser-induced thermo therapy a novel concept in adjuvant glioma therapy? Answer: LITT promotes localized passage of chemotherapy drugs into brain tissue, offering potential advantages for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.3,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy achieve locoregional opening of the rodent blood-brain barrier to deliver paclitaxel as a new adjuvant glioma therapy? Answer: LITT facilitates localized entry of chemotherapeutic agents into brain tissue, which could be beneficial for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.3,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does the use of Nd:YAG laser-induced thermo therapy for locoregional opening of the rodent blood-brain barrier represent a new adjuvant glioma therapy concept with paclitaxel? Answer: LITT induces localized passage of chemotherapy drugs into brain tissue, showing potential for brain tumor treatment.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
180,0.3,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, it can. This specialized consultation evaluates an older patient's overall health, functional abilities, and possible vulnerabilities, aiding doctors in customizing treatment plans accordingly.",3.3160361829959526e-07,0.07897108197045499,0.17132659131469363,0.025387970506946217,0.1384301850326577,0.13888888888888887,0.02535122157334014,0.20043482367507393,0.10275824770146022,3.316036182995957e-07,0.2651531661295423,0.06353305785123965
180,0.3,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation alter the cancer treatment plan for elderly patients? Yes, it can. This consultation reviews the patient's general health, functional status, and risks to help physicians adjust treatment plans.",4.2634750924233646e-07,0.1967541176268388,0.17132659131469363,0.032641676366073735,0.2597910420369245,0.13888888888888887,0.032594427737151634,0.3255979666290809,0.10275824770146022,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
180,0.3,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, such a consultation assesses the patient's health, functional capacity, and vulnerabilities to guide treatment adjustments.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.3,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does consulting a geriatric oncologist influence the cancer treatment plan for older patients? Yes, it does. This evaluation considers the patient's overall health and potential weaknesses to tailor the treatment.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.3,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation impact the cancer treatment plan for elderly individuals? Yes, it can. It involves assessing the patient's health, functional status, and vulnerabilities to personalize treatment.",5.210914001850777e-07,0.3302855102513611,0.17132659131469363,0.039895382225201254,0.39794138051774164,0.13888888888888887,0.03983763390096313,0.46869881026975335,0.10275824770146022,5.210914001850789e-07,0.5427849027278224,0.06353305785123965
180,0.3,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation lead to changes in the cancer treatment plan for elderly patients? Yes, it does. This consultation examines the patient's health and functional abilities to help customize treatment.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.3,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients affected by a geriatric oncology consultation? Yes, it is. The consultation evaluates overall health and vulnerabilities to inform treatment decisions.",5.44777372920763e-07,0.3666531544222358,0.17132659131469363,0.04170880868998313,0.4356817085005886,0.13888888888888887,0.041648435441916,0.5079195234230358,0.10275824770146022,5.447773729207643e-07,0.5836068972480772,0.06353305785123965
180,0.3,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Can a geriatric oncology consultation modify cancer treatment plans for older patients? Yes, it can. It assesses health, functional status, and risks to help tailor treatments.",5.921493183921336e-07,0.44361419555836523,0.17132659131469363,0.04533566161954689,0.5157244161741259,0.13888888888888887,0.04527003852382175,0.5913011323620863,0.10275824770146022,5.921493183921352e-07,0.6706182742377069,0.06353305785123965
180,0.3,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Does a geriatric oncology consultation adjust the cancer treatment plan for elderly patients? Yes, it does. This specialized assessment looks at the patient's health and vulnerabilities to guide treatment.",5.210914001850777e-07,0.3302855102513611,0.17132659131469363,0.039895382225201254,0.39794138051774164,0.13888888888888887,0.03983763390096313,0.46869881026975335,0.10275824770146022,5.210914001850789e-07,0.5427849027278224,0.06353305785123965
180,0.3,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation assesses an older patient's overall health, functional status, and potential vulnerabilities, helping physicians tailor treatment plans to the patient's","Is the cancer treatment plan for elderly patients changed by a geriatric oncology consultation? Yes, it can be. The consultation reviews the patient's overall health and functional status to personalize treatment.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
181,0.3,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it possible to implement an advance care planning model in community palliative care? An advance care planning model can be successfully applied within community palliative care services. Incorporating quality audit processes is crucial, with documentation of advance care planning discussions serving as a key outcome metric.",2.3685972735685406e-08,0.026478710685982954,0.005460634451018881,0.0018134264647818726,0.024910513283144198,0.003036471380144401,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.3,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be effectively used in community palliative care? Yes, an advance care planning model is practical for community palliative care services. Quality audits play a vital role in the model, with recording advance care planning conversations recognized as an important outcome measure.",2.3685972735685406e-08,0.02647871068598251,0.005460634451018881,0.0018134264647818726,0.024910513283144198,0.003036471380144401,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
181,0.3,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the use of an advance care planning model viable in community palliative care? An advance care planning model is indeed feasible for community palliative care services. Essential to the model are quality audit procedures, with documentation of advance care planning discussions identified as a significant outcome indicator.",0.0,0.0,0.0,0.0,4.440892098500626e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0
181,0.3,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Does an advance care planning model work in community palliative care? The advance care planning model is feasible within community palliative care services. Quality audit processes form a critical part of the model, and documenting advance care planning discussions is an important outcome measure.",9.474389094274162e-08,0.07798578007331924,0.00040129656683718373,0.0072537058591274906,0.07052879774064591,0.011498879630747721,0.007243206163811466,0.06528939793786215,0.01997329637641968,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
181,0.3,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is implementing an advance care planning model achievable in community palliative care? Yes, it is feasible to implement an advance care planning model in community palliative care services. Quality audits are a key element of the model, with documentation of advance care planning discussions as a vital outcome measure.",2.3685972735685406e-08,0.0030624055881909307,0.015625,0.0018134264647818726,0.005182562134851576,0.0187074829931973,0.0018108015409528666,0.023318321560436672,0.0009598666243535586,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,0.3,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can community palliative care adopt an advance care planning model? An advance care planning model is feasible for use in community palliative care services. Quality audit processes are essential, and documenting advance care planning discussions is a crucial outcome measure.",1.8948778188548314e-07,0.2335060071477595,0.051523437499999936,0.014507411718254981,0.21882835158304825,0.02884290971290479,0.014486412327622933,0.17159890957505697,0.017342123536913518,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
181,0.3,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is an advance care planning model practical for community palliative care? The model is feasible for community palliative care services. Quality audit processes are a fundamental component, with documentation of advance care planning discussions serving as an important outcome measure.",1.8948778188548314e-07,0.1000347412275353,0.14315051020408165,0.014507411718254981,0.1320958024776706,0.08131771227009321,0.014486412327622933,0.13413149440965455,0.04434829637641968,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
181,0.3,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it feasible to apply an advance care planning model in community palliative care? Yes, the advance care planning model is feasible for community palliative care services. Quality audit procedures are essential, with documentation of advance care planning discussions as a key outcome measure.",9.474389094274162e-08,0.07798578007331924,0.000401296566837156,0.0072537058591274906,0.07052879774064591,0.011498879630747721,0.007243206163811466,0.06528939793786215,0.01997329637641968,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
181,0.3,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be integrated into community palliative care? The advance care planning model is feasible for community palliative care services. Quality audits are a necessary part of the model, with documentation of advance care planning discussions considered an important outcome measure.",7.105791820705622e-08,0.05004686308844519,0.006147853185595603,0.005440279394345618,0.04440575812274128,0.014411848072562322,0.0054324046228586,0.040386797368603844,0.020552936471601127,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
181,0.3,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the advance care planning model suitable for community palliative care? It is feasible to use an advance care planning model in community palliative care services. Quality audit processes are a vital component, with documentation of advance care planning discussions recognized as an important outcome measure.",4.737194547137081e-08,0.022844581754445148,0.01163338264299818,0.0036268529295637453,0.018941540517955158,0.01718958453895142,0.003621603081905733,0.01608869510729205,0.02110566599093216,4.737194547137081e-08,0.015013325609441353,0.02271498107084911
182,0.3,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure indicate fluid responsiveness? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness depends mainly on the heart and circulatory system interaction.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.3,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure predict fluid responsiveness? Central venous pressure (CVP) does not consistently predict fluid responsiveness. The key factor is the heart's interaction with the circulatory system.,1.894877818854824e-07,0.2947186713230505,0.0244140625,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
182,0.3,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure a good predictor of fluid responsiveness? Central venous pressure (CVP) fails to reliably forecast fluid responsiveness. Fluid responsiveness is mainly influenced by heart and circulatory dynamics.,1.421158364141118e-07,0.16483350821324727,0.016373831875857336,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.3,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does measuring central venous pressure help predict fluid responsiveness? Central venous pressure (CVP) is not a dependable measure for predicting fluid responsiveness. The primary determinant is the relationship between the heart and circulation.,7.10579182070559e-08,0.057430325306548013,0.022738715277777773,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
182,0.3,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can fluid responsiveness be predicted by central venous pressure? Central venous pressure (CVP) does not reliably indicate fluid responsiveness. The main factor is how the heart interacts with the circulatory system.,1.184298636784265e-07,0.0815352609114548,0.051667239521403084,0.009067132323909398,0.11829133106733902,0.029384756657483937,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.3,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is fluid responsiveness predicted by central venous pressure? Central venous pressure (CVP) is not a reliable predictor of fluid responsiveness. Fluid responsiveness is chiefly governed by heart and circulatory system interplay.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.11829133106733902,0.029384756657483937,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.3,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure predict fluid responsiveness accurately? Central venous pressure (CVP) does not reliably predict fluid responsiveness. The interaction between the heart and circulatory system is the primary determinant.,1.421158364141118e-07,0.2126367620449674,0.01711006841715977,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
182,0.3,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Is central venous pressure an effective predictor of fluid responsiveness? Central venous pressure (CVP) does not consistently predict fluid responsiveness. Fluid responsiveness depends mainly on heart and circulation interaction.,1.658018091497971e-07,0.20333934615535476,0.01395502034023667,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
182,0.3,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Can central venous pressure reliably predict fluid responsiveness? Central venous pressure (CVP) is not a reliable indicator of fluid responsiveness. The main factor is the heart's interaction with the circulatory system.,1.184298636784265e-07,0.12774507294878434,0.018634406887755126,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
182,0.3,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the interaction between the heart and the circulatory system, not",Does central venous pressure serve as a reliable predictor of fluid responsiveness? Central venous pressure (CVP) does not reliably predict fluid responsiveness. Fluid responsiveness is primarily determined by the heart and circulatory system interaction.,4.73719454713706e-08,0.024033109137672426,0.024607139373048918,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
183,0.3,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine insertion of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not necessary to routinely place a nasobiliary drainage tube after endoscopic clearance in these patients. The decision should be individualized.",1.8948778188548325e-07,0.10196457632338696,0.13514500693987883,0.014507411718254981,0.08602542260201229,0.15569425207756232,0.014486412327622933,0.09762436370350702,0.17870299643969173,1.8948778188548325e-07,0.07637726349325291,0.174375
183,0.3,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be",Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? Routine insertion is not required. The choice should be based on clinical judgment.,4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.3,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it mandatory to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? No, routine insertion is not necessary. The decision depends on the specific case.",3.552895910352808e-07,0.08622630517661012,0.24691358024691368,0.02720139697172809,0.005062456605483323,0.22506925207756232,0.027162023114293,0.05169018449235585,0.20249835634451027,3.552895910352811e-07,0.11083427859489303,0.174375
183,0.3,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Do patients with choledocholithiasis-induced cholangitis need a nasobiliary drainage tube inserted routinely after endoscopic common bile duct clearance? No, routine insertion is not needed. The decision should be made on a case-by-case basis.",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
183,0.3,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine nasobiliary drainage tube placement required after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis? No, it is not routinely necessary. The decision should be individualized.",5.684633456564485e-07,0.1924870972924113,0.24691358024691368,0.043522235154765,0.28261961584629747,0.22506925207756232,0.04345923698286886,0.3489417079602868,0.20249835634451027,5.684633456564497e-07,0.4183189783428549,0.174375
183,0.3,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is it necessary to routinely insert a nasobiliary drainage tube? No, routine insertion is not necessary. The decision should be tailored to the patient.",3.789755637709661e-07,0.0588273309884948,0.24691358024691368,0.029014823436509962,0.023108420361213522,0.22506925207756232,0.028972824655245873,0.08067772136560736,0.20249835634451027,3.789755637709665e-07,0.1406872417445748,0.174375
183,0.3,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it essential to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, routine insertion is not essential. The decision should be individualized.",4.50033481978022e-07,0.028184046001135332,0.24691358024691368,0.0344551028308556,0.1127205790509005,0.22506925207756232,0.03440522927810449,0.17305104149662265,0.20249835634451027,4.500334819780227e-07,0.23599742154890002,0.174375
183,0.3,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Should a nasobiliary drainage tube be routinely placed after endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? No, routine placement is not required. The decision should be based on clinical factors.",4.50033481978022e-07,0.028184046001135332,0.24691358024691368,0.0344551028308556,0.1127205790509005,0.22506925207756232,0.03440522927810449,0.17305104149662265,0.20249835634451027,4.500334819780227e-07,0.23599742154890002,0.174375
183,0.3,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is routine placement of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No, it is not routinely necessary. The decision should be made according to individual patient needs.",3.552895910352808e-07,0.08622630517661012,0.24691358024691368,0.02720139697172809,0.005062456605483323,0.22506925207756232,0.027162023114293,0.05169018449235585,0.20249835634451027,3.552895910352811e-07,0.11083427859489303,0.174375
183,0.3,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: No, it's not necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision should be","Is it required to routinely insert a nasobiliary drainage tube following endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis patients? No, routine insertion is not required. The decision should be individualized.",4.737194547137073e-07,0.05895570466788902,0.24691358024691368,0.03626852929563748,0.14446927736548032,0.22506925207756232,0.03621603081905737,0.20584086431961435,0.20249835634451027,4.737194547137081e-07,0.2698989732245818,0.174375
184,0.3,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological treatment for depression influence the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. Nevertheless, due to the study's design, no causal conclusions can be made. Additional research, ideally through a randomized controlled trial, is necessary to confirm this.",7.105791820705622e-08,0.07804634346179373,0.019175437823872196,0.005440279394345618,0.0286892385753168,0.01694411414982164,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
184,0.3,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there a connection between the duration of depression treatment and the probability of re-entering treatment? Answer: The data imply that longer treatment periods could help prevent relapse into mental health care in some populations. However, the study's methodology does not allow for causal claims. More studies, preferably randomized controlled trials, are required to establish causality.",2.3685972735685406e-08,0.05526328401217295,0.05246913580246911,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
184,0.3,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of psychological therapy for depression affect the risk of returning to treatment? Answer: Results suggest that prolonged therapy may reduce the likelihood of returning to mental health care in certain groups. However, the study design limits causal interpretation. Further investigation, ideally via randomized controlled trials, is needed to verify this.",9.474389094274162e-08,0.052109487930096954,0.014791319577940096,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
184,0.3,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the duration of psychological treatment for depression associated with the chance of returning to treatment? Answer: The findings suggest that longer treatment duration might prevent return to mental health services in some groups. Yet, due to the study design, causal inferences cannot be made. Additional research, preferably randomized controlled trials, is needed to clarify this.",2.3685972735685406e-08,0.05526328401217295,0.05246913580246911,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
184,0.3,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the length of treatment for depression relate to the likelihood of re-entering mental health care? Answer: The results indicate that extended treatment duration may help prevent return to care in some groups. However, the study's design precludes causal conclusions. Further research, ideally randomized controlled trials, is necessary to determine causality.",1.4211583641411244e-07,0.03826277399865141,0.05246913580246911,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
184,0.3,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is there a relationship between how long psychological treatment lasts for depression and the chance of returning to treatment? Answer: Findings suggest that longer treatment may reduce the risk of returning to mental health care for some groups. Nonetheless, the study design does not support causal claims. More research, preferably randomized controlled trials, is needed to confirm this.",2.3685972735685406e-08,0.042551349991722276,0.018030360292265027,0.0018134264647818726,0.006621376604456941,0.01753826530612245,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
184,0.3,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of depression treatment impact the likelihood of returning to mental health services? Answer: The data suggest that longer treatment duration might prevent return to care in certain groups. However, no causal inference can be drawn due to the study design. Further studies, ideally randomized controlled trials, are required to establish causality.",7.105791820705622e-08,0.018895639841298717,0.05246913580246911,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
184,0.3,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of psychological treatment for depression linked to the probability of returning to treatment? Answer: Results indicate that prolonged treatment may reduce return to mental health care in some groups. Yet, the study design limits causal conclusions. Additional research, preferably randomized controlled trials, is needed to verify this.",1.6580180914979784e-07,0.058065401294831176,0.05246913580246911,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
184,0.3,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Does the duration of psychological treatment influence the chance of relapse into treatment for depression? Answer: The findings suggest that longer treatment duration could prevent return to mental health services in some groups. However, causal inferences cannot be made due to the study design. Further research, ideally randomized controlled trials, is necessary.",1.1842986367842703e-07,0.018844688141548716,0.05246913580246911,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
184,0.3,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether","Question: Is the length of treatment for depression associated with the likelihood of returning to mental health care? Answer: The results imply that extended treatment might reduce the risk of returning to care in some groups. Nonetheless, the study's design does not allow for causal conclusions. More research, preferably randomized controlled trials, is needed to confirm this.",2.3685972735685406e-08,0.005752771115033362,0.016803840877914943,0.0018134264647818726,0.043223857523040365,0.0181755829903978,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
185,0.3,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to predict discordance between TEOAE and AABR results in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be predicted. Factors such as ear canal debris or ambient noise can cause variations, making predictions unreliable.",1.1842986367842703e-07,0.0772727276868217,0.01713345935727791,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
185,0.3,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes be anticipated in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is unpredictable. Various factors like ear canal debris or background noise contribute to this variability, preventing reliable predictions.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.3,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is discordance between TEOAE and AABR test results foreseeable in newborns? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns is not predictable. Influences such as debris in the ear canal or ambient noise levels cause variations, making it unreliable to predict.",7.105791820705622e-08,0.006104406581574295,0.03840000000000001,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
185,0.3,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we predict discordance in TEOAE and AABR outcomes in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not predictable. This is due to factors like ear canal debris or environmental noise, which lead to inconsistent outcomes.",9.474389094274162e-08,0.026723693784310054,0.03840000000000001,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
185,0.3,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it feasible to predict discordance in TEOAE and AABR results in newborns? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns cannot be reliably predicted. Variations arise from factors such as debris in the ear canal or ambient noise, making predictions uncertain.",4.737194547137081e-08,0.01362758648645368,0.018408329862557277,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
185,0.3,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Are discordant TEOAE and AABR outcomes predictable in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is unpredictable. Factors like ear canal debris or noise levels contribute to this unpredictability.",3.079176455639102e-07,0.23436305856255668,0.03840000000000001,0.023574544042164344,0.29423947299793873,0.0,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
185,0.3,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is predicting discordance in TEOAE and AABR outcomes possible in newborns? No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is not predictable. Various factors including debris in the ear canal and ambient noise cause this variability.",1.8948778188548325e-07,0.1137350707739393,0.03840000000000001,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
185,0.3,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can discordance in TEOAE and AABR outcomes be forecasted in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not forecastable. This is due to influences like ear canal debris and environmental noise, which affect reliability.",1.4211583641411244e-07,0.06928330820310658,0.03840000000000001,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
185,0.3,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Is it possible to foresee discordance in TEOAE and AABR results in newborns? No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns cannot be foreseen. Factors such as debris in the ear canal and ambient noise levels cause unpredictable variations.",1.1842986367842703e-07,0.0772727276868217,0.01713345935727791,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
185,0.3,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: No, the discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes is not predictable in newborns. Variations can occur due to numerous factors like debris in the ear canal or ambient noise levels, making predictions unreliable.","Can we anticipate discordance in TEOAE and AABR test outcomes in newborns? No, the discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns is not anticipatable. Variations due to ear canal debris or ambient noise make predictions unreliable.",2.1317375462116866e-07,0.13672458899863882,0.03840000000000001,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
186,0.3,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Current research does not show direct evidence that laparoscopic cholecystectomy impacts peri-sinusoidal cell activity. Since this procedure targets the gallbladder, it is typically not linked to changes in peri-sinusoidal cells found in the liver.",2.3685972735685406e-07,0.19881564482771896,0.05244724114018582,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.3,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Existing scientific studies do not provide direct proof that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The surgery primarily involves the gallbladder, so its effects are usually unrelated to peri-sinusoidal cells in the liver.",2.3685972735685406e-07,0.16415828579972125,0.07732517353995924,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.3,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does the laparoscopic removal of the gallbladder alter peri-sinusoidal cell activity? There is no direct evidence in current scientific literature indicating that laparoscopic cholecystectomy changes peri-sinusoidal cell activity. Since the procedure focuses on the gallbladder, it generally does not impact peri-sinusoidal cells located in the liver.",1.1842986367842703e-07,0.04252443247356119,0.08009799318340827,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
186,0.3,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Can laparoscopic cholecystectomy modify peri-sinusoidal cell activity? Scientific literature to date lacks direct evidence that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. The operation is centered on the gallbladder, so it is not commonly associated with effects on peri-sinusoidal cells in the liver.",2.1317375462116866e-07,0.1724324293579329,0.053656534486704814,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.3,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? Current studies do not directly link laparoscopic cholecystectomy to changes in peri-sinusoidal cell activity. Because the procedure targets the gallbladder, it is generally not connected to peri-sinusoidal cells in the liver.",2.3685972735685406e-07,0.19881564482771896,0.05244724114018582,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
186,0.3,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there an impact of laparoscopic cholecystectomy on peri-sinusoidal cell activity? The available scientific data does not directly support that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. This surgery mainly concerns the gallbladder, so it typically does not influence peri-sinusoidal cells in the liver.",1.8948778188548325e-07,0.1797317883965719,0.03130281982529785,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
186,0.3,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does undergoing laparoscopic cholecystectomy influence peri-sinusoidal cell activity? There is no direct scientific evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. Since the procedure is focused on the gallbladder, it is usually not related to peri-sinusoidal cells in the liver.",2.6054570009253936e-07,0.2259107532749849,0.051176523690685705,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
186,0.3,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Current scientific literature does not provide direct evidence that laparoscopic cholecystectomy changes peri-sinusoidal cell activity. The procedure mainly targets the gallbladder, so its effects are generally not associated with peri-sinusoidal cells in the liver.",2.1317375462116866e-07,0.13862037176964304,0.07793373698506115,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
186,0.3,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? There is no direct evidence in scientific literature that laparoscopic cholecystectomy influences peri-sinusoidal cell activity. Since the surgery is primarily on the gallbladder, it is not usually linked to peri-sinusoidal cells in the liver.",1.8948778188548325e-07,0.11371777120038473,0.0785133770802426,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
186,0.3,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Current scientific literature does not provide direct evidence on laparoscopic cholecystectomy influencing peri-sinusoidal cell activity. As laparoscopic cholecystectomy is a procedure mainly focused on the gallbladder, its effects are generally not associated with peri-sinusoidal cells which are primarily located in the liver.","Is there a connection between laparoscopic cholecystectomy and peri-sinusoidal cell activity? Current research does not show direct evidence that laparoscopic cholecystectomy affects peri-sinusoidal cell activity. The procedure mainly involves the gallbladder, so it generally does not affect peri-sinusoidal cells in the liver.",2.1317375462116866e-07,0.20624448694622322,0.029594055544617914,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
187,0.3,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Yes, it can promote the development of such care by motivating healthcare providers to organize their services efficiently, fostering a process-focused approach that enhances patient outcomes and optimizes resource use.",3.789755637709665e-07,0.16318544148122704,0.12244897959183677,0.029014823436509962,0.21774477900101807,0.08999999999999998,0.028972824655245866,0.27438153344233873,0.05536332179930796,3.789755637709665e-07,0.30706100614865406,0.037677816224529016
187,0.3,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement drive the growth of process-oriented care delivery? Indeed, it incentivizes providers to deliver care in a structured and efficient manner, supporting a process-oriented model that improves patient results and resource management.",5.210914001850783e-07,0.3257043709790013,0.12244897959183677,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.3,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Yes, because it encourages healthcare providers to streamline their services, leading to a more process-driven approach that benefits patient outcomes and resource allocation.",5.210914001850783e-07,0.3257043709790013,0.12244897959183677,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.3,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does reimbursement based on case-mix promote process-oriented care delivery? Yes, it motivates healthcare providers to design their services efficiently, fostering a process-oriented care model that enhances patient outcomes and optimizes health system resources.",5.684633456564489e-07,0.42965069158043434,0.09123149780203446,0.04352223515476497,0.4473192206455159,0.08999999999999998,0.04345923698286883,0.5107703115065703,0.05536332179930796,5.684633456564497e-07,0.5506830888064065,0.037677816224529016
187,0.3,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix based reimbursement foster the development of process-oriented care delivery? Yes, it incentivizes providers to organize care processes effectively, which supports better patient outcomes and more efficient use of resources.",6.158352911278195e-07,0.4508675139330083,0.12244897959183677,0.04714908808432873,0.5140105951441893,0.08999999999999998,0.04708084006477458,0.579763182993521,0.05536332179930796,6.158352911278206e-07,0.6221420527885502,0.037677816224529016
187,0.3,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix reimbursement encourage the adoption of process-oriented care delivery? Yes, by incentivizing efficient structuring of services, it promotes a process-focused approach that improves patient outcomes and resource distribution.",6.632072365991901e-07,0.519860385419959,0.12244897959183677,0.05077594101389249,0.585469559126333,0.08999999999999998,0.05070244314668033,0.6538711551472427,0.05536332179930796,6.632072365991914e-07,0.6991030939246796,0.037677816224529016
187,0.3,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Is process-oriented care delivery development encouraged by case-mix based reimbursement? Yes, as it motivates healthcare providers to deliver care in a more organized and efficient way, leading to improved patient outcomes and better resource allocation.",5.210914001850783e-07,0.3257043709790013,0.12244897959183677,0.03989538222520121,0.38479886366418237,0.08999999999999998,0.039837633900963086,0.44623179036899874,0.05536332179930796,5.210914001850789e-07,0.483991714307733,0.037677816224529016
187,0.3,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement stimulate process-oriented care delivery development? Yes, it encourages providers to structure their services efficiently, promoting a process-oriented approach that benefits patient outcomes and resource use.",6.632072365991901e-07,0.519860385419959,0.12244897959183677,0.05077594101389249,0.585469559126333,0.08999999999999998,0.05070244314668033,0.6538711551472427,0.05536332179930796,6.632072365991914e-07,0.6991030939246796,0.037677816224529016
187,0.3,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Can case-mix reimbursement stimulate the growth of process-oriented care delivery? Yes, it incentivizes healthcare providers to adopt efficient service structures, fostering a process-oriented approach that improves patient outcomes and resource management.",6.158352911278195e-07,0.4508675139330083,0.12244897959183677,0.04714908808432873,0.5140105951441893,0.08999999999999998,0.04708084006477458,0.579763182993521,0.05536332179930796,6.158352911278206e-07,0.6221420527885502,0.037677816224529016
187,0.3,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Yes, case-mix based reimbursement can stimulate the development of process-oriented care delivery. It incentivizes healthcare providers to structure their services efficiently and effectively, thereby promoting a more process-oriented approach. This can lead to improved patient outcomes and better resource allocation within the health system.","Does case-mix based reimbursement lead to the development of process-oriented care delivery? Yes, it motivates providers to organize care efficiently, supporting a process-driven model that enhances patient outcomes and optimizes resource allocation.",5.921493183921342e-07,0.4180776911100166,0.12244897959183677,0.04533566161954685,0.4801090434685076,0.08999999999999998,0.04527003852382171,0.544671863182252,0.05536332179930796,5.921493183921352e-07,0.5857744086176755,0.037677816224529016
188,0.3,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside evaluation a dependable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity to serve as screening tools in acute stroke cases, and there are doubts regarding videofluoroscopy as the definitive standard. The significance of aspiration and bedside evaluation in forecasting complications remains a concern.",4.737194547137081e-08,0.10017801828497319,0.07822441700960218,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
188,0.3,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably excluded through bedside assessment following an acute stroke? Answer: Bedside swallowing assessments lack the sensitivity required for screening in acute stroke, and the reliability of videofluoroscopy as the gold standard is questioned. The role of aspiration and bedside assessment in predicting complications is still debated.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
188,0.3,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment effectively rule out aspiration after acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and videofluoroscopy's status as the gold standard is under scrutiny. The importance of aspiration and bedside assessment in predicting complications is uncertain.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
188,0.3,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside swallowing assessment a reliable method to exclude aspiration post-acute stroke? Answer: Bedside assessments do not have adequate sensitivity for screening acute stroke patients, and concerns exist about videofluoroscopy being the gold standard. The predictive value of aspiration and bedside assessment for complications is questioned.",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.3,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be excluded reliably by bedside assessment after an acute stroke? Answer: Bedside swallowing assessments lack the necessary sensitivity to function as screening instruments in acute stroke, and videofluoroscopy as the gold standard is controversial. The relevance of aspiration and bedside assessment in predicting complications is debated.",1.1842986367842703e-07,0.03962993654257563,0.0755760977818017,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
188,0.3,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside assessment a dependable screening tool to rule out aspiration following acute stroke? Answer: Bedside swallowing assessments are insufficiently sensitive for acute stroke screening, and videofluoroscopy's role as the gold standard is challenged. The significance of aspiration and bedside assessment in forecasting complications is uncertain.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.3,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can bedside assessment accurately exclude aspiration after an acute stroke? Answer: Bedside swallowing assessments do not possess the sensitivity needed for screening in acute stroke, and videofluoroscopy's status as the gold standard is questioned. The importance of aspiration and bedside assessment in predicting complications remains unclear.",1.6580180914979784e-07,0.0834452523754301,0.07467160493827159,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.3,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Is bedside swallowing assessment effective in ruling out aspiration post-acute stroke? Answer: Bedside assessments lack the sensitivity required for acute stroke screening, and there are concerns about videofluoroscopy as the definitive standard. The predictive role of aspiration and bedside assessment in complications is still under discussion.",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
188,0.3,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Can aspiration be reliably ruled out by bedside assessment following acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and videofluoroscopy's designation as the gold standard is debated. The relative importance of aspiration and bedside assessment in predicting complications is uncertain.",4.737194547137081e-08,0.02269357542228967,0.0768,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
188,0.3,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and","Question: Does bedside assessment provide a reliable exclusion of aspiration after acute stroke? Answer: Bedside swallowing assessments lack sufficient sensitivity for screening in acute stroke, and videofluoroscopy as the gold standard is questioned. The role of aspiration and bedside assessment in predicting complications remains a concern.",1.8948778188548325e-07,0.13690040787325586,0.0520517036235803,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
189,0.3,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Are musculoskeletal symptoms related to aromatase inhibitors best prevented by focusing on osteoporosis? Patients using AIs who develop osteoporosis face a higher risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates lowers the risk of osteoporosis and these symptoms. Those previously treated with tamoxifen before starting AIs show fewer AI-related musculoskeletal issues. We advise that patients on AIs...,4.737194547137081e-08,0.01215103825547903,0.015192180233632675,0.0036268529295637453,0.01079664565701588,0.016661878770468257,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
189,0.3,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is preventing osteoporosis the key to stopping musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis have an increased chance of musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates together reduces this risk. Patients who took tamoxifen before AIs are less prone to these symptoms. Our recommendation for patients on AIs is...,1.4211583641411244e-07,0.11097832379930717,0.005315153839118,0.010880558788691236,0.10792772743767642,0.0018500471818279247,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
189,0.3,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could stopping osteoporosis be crucial in eliminating musculoskeletal symptoms linked to aromatase inhibitors? Osteoporosis in AI patients raises the risk of musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates decreases the likelihood of these issues. Prior tamoxifen use before AIs lowers the chance of developing such symptoms. We suggest that patients on AIs...,1.8948778188548325e-07,0.09856003679819292,0.030187804740763668,0.014507411718254981,0.119995937622007,0.016661878770468257,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
189,0.3,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the prevention of osteoporosis essential for avoiding musculoskeletal symptoms related to aromatase inhibitors? Patients on AIs with osteoporosis have a higher risk of musculoskeletal symptoms and fractures. Combining calcium and bisphosphonates reduces this risk. Those who had tamoxifen before AIs are less likely to experience these symptoms. We recommend that patients on AIs...,1.8948778188548325e-07,0.12471653417781337,0.011370935261796784,0.014507411718254981,0.119995937622007,0.016661878770468257,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
189,0.3,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Does preventing osteoporosis hold the key to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms and bone fractures. Co-treatment with calcium and bisphosphonates lowers this risk. Patients previously treated with tamoxifen before AIs show fewer AI-related musculoskeletal symptoms. We advise patients on AIs to...,1.6580180914979784e-07,0.13072775980196827,0.0063145703129821595,0.012693985253473108,0.1271042400309348,0.002199067975093876,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.3,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the key to preventing aromatase inhibitor-related musculoskeletal symptoms the management of osteoporosis? Patients undergoing AI therapy who develop osteoporosis face increased risks of musculoskeletal symptoms and fractures. Calcium and bisphosphonate co-medication reduces these risks. Those treated with tamoxifen prior to AIs are less likely to develop such symptoms. We recommend that patients on AIs...,1.6580180914979784e-07,0.07938352420493455,0.03053682553402962,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.3,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Are musculoskeletal symptoms from aromatase inhibitors best controlled by preventing osteoporosis? Patients on AIs who develop osteoporosis have an elevated risk of musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates reduces this risk. Patients who received tamoxifen before AIs are less prone to these symptoms. We suggest that patients on AIs...,2.3685972735685406e-07,0.1652343049961673,0.009898397467167107,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
189,0.3,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is osteoporosis prevention the key to mitigating musculoskeletal symptoms associated with aromatase inhibitors? Patients on AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and fractures. Using calcium and bisphosphonates together reduces this risk. Patients previously treated with tamoxifen before AIs are less likely to develop these symptoms. We recommend patients on AIs...,1.6580180914979784e-07,0.10505564200345141,0.012066502965615747,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
189,0.3,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Could managing osteoporosis be the solution to aromatase inhibitor-related musculoskeletal symptoms? Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates lowers this likelihood. Patients who had tamoxifen before AIs show reduced incidence of these symptoms. We advise patients on AIs...,2.6054570009253947e-07,0.15839833476494558,0.029057081348883067,0.0199476911126006,0.17941935809280807,0.016661878770468257,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
189,0.3,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs,Is the prevention of osteoporosis the key factor in eliminating musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis face increased risks of musculoskeletal symptoms and bone fractures. Co-medication with calcium and bisphosphonates reduces these risks. Patients previously treated with tamoxifen before AIs are less likely to develop AI-related musculoskeletal symptoms. We recommend patients on AIs...,7.105791820705622e-08,0.030055696255994135,0.014609975976121709,0.005440279394345618,0.02818838836888471,0.016661878770468257,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
190,0.3,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do higher depression rates in women result from differences in symptom reporting? Answer: In this community sample, men and women reported similar depressive symptom patterns. There was no evidence that depressive symptom presentation varies by gender.",9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,0.3,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are increased depression rates among women explained by different symptom reporting? Answer: Men and women in this community sample showed comparable depressive symptom patterns. No indication was found that symptom presentation differs between genders.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.3,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the higher incidence of depression in women due to differences in how symptoms are reported? Answer: Both men and women in this community sample reported similar depressive symptom patterns. No proof was found that symptom presentation differs by gender.,0.0,0.03465735902799638,0.024983563445101917,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
190,0.3,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates explained by differential symptom reporting? Answer: In this community sample, men and women reported similar patterns of depressive symptoms. No evidence supports that symptom presentation varies by gender.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.3,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does differential symptom reporting account for higher depression rates in women? Answer: Men and women in this community sample reported similar depressive symptom patterns. No evidence suggests that symptom presentation differs by gender.,1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.3,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are higher depression rates in women due to differences in symptom reporting? Answer: Men and women in this community sample reported similar depressive symptom patterns. No evidence was found that symptom presentation differs by gender.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the greater prevalence of depression in women explained by varying symptom reports? Answer: Men and women in this community sample showed similar depressive symptom patterns. No evidence indicates that symptom presentation differs by gender.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does the difference in symptom reporting explain higher depression rates in women? Answer: Men and women in this community sample reported similar depressive symptom patterns. No evidence was found that symptom presentation differs by gender.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are elevated depression rates in women accounted for by differences in symptom reporting? Answer: Men and women in this community sample reported similar depressive symptom patterns. No evidence suggests symptom presentation differs by gender.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.3,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the higher rate of depression among women due to differential symptom reporting? Answer: Men and women in this community sample reported similar depressive symptom patterns. No evidence was found that the presentation of depressive symptoms differs by gender.,2.36859727356853e-08,0.009339551043704652,0.024983563445101917,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
191,0.3,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is implementing an advance care planning model practical in community palliative care? Yes, it is feasible and supports proactive conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to deliver patient-centered care. Additionally, it improves the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.3,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be effectively used in community palliative care? Yes, it is viable and promotes early discussions regarding care preferences, medical choices, and end-of-life desires, helping healthcare professionals offer patient-focused care. Furthermore, it strengthens the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.3,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it possible to apply an advance care planning model within community palliative care? Yes, it is achievable and encourages proactive dialogue about care preferences, medical decisions, and end-of-life wishes, enabling healthcare workers to provide care centered on the patient. It also enhances the",9.474389094274162e-08,0.11752188691625376,0.144375,0.0072537058591274906,0.05971239148121743,0.10707911957168353,0.007243206163811466,0.0006707989913525836,0.06632653061224489,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
191,0.3,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model workable in community palliative care? Yes, it is feasible and supports early conversations about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to focus on patient-centered care. Moreover, it improves the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.3,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be implemented in community palliative care? Yes, it is practical and facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to deliver patient-centered care. Additionally, it enhances the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.3,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is the use of an advance care planning model feasible in community palliative care? Yes, it is possible and encourages proactive talks about care preferences, medical decisions, and end-of-life wishes, helping healthcare providers offer patient-centered care. Furthermore, it strengthens the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
191,0.3,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is adopting an advance care planning model feasible in community palliative care? Yes, it is workable and promotes early discussions about care preferences, medical decisions, and end-of-life wishes, allowing healthcare professionals to provide patient-focused care. Moreover, it improves the",2.1317375462116844e-07,0.006092069050922078,0.144375,0.016320838183036854,0.06703931415792486,0.10707911957168353,0.0162972138685758,0.13072392723955018,0.06632653061224489,2.1317375462116866e-07,0.1973348824033958,0.02271498107084911
191,0.3,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is an advance care planning model applicable in community palliative care? Yes, it is feasible and supports proactive conversations about care preferences, medical decisions, and end-of-life wishes, enabling healthcare providers to deliver patient-centered care. Additionally, it enhances the",2.3685972735685374e-07,0.032760316133082945,0.144375,0.018134264647818726,0.09443828834604018,0.10707911957168353,0.018108015409528666,0.15889480420624702,0.06632653061224489,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
191,0.3,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Is it feasible to use an advance care planning model in community palliative care? Yes, it is practical and facilitates early discussions about care preferences, medical decisions, and end-of-life wishes, helping healthcare professionals provide patient-centered care. Furthermore, it strengthens the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
191,0.3,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It facilitates proactive discussions about care preferences, medical decisions, and end-of-life wishes, enabling healthcare professionals to provide patient-centered care. Moreover, it enhances the","Can an advance care planning model be adopted in community palliative care? Yes, it is achievable and encourages proactive talks about care preferences, medical decisions, and end-of-life wishes, allowing healthcare providers to focus on patient-centered care. Moreover, it improves the",1.8948778188548314e-07,0.019883417352335897,0.144375,0.014507411718254981,0.04037106707576399,0.10707911957168353,0.014486412327622933,0.10332495305143485,0.06632653061224489,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
192,0.3,1,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is it still advisable to perform second-look laparotomy? Answer: The use of second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains controversial. Although it offers important insights into the disease status,",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.028872408910239677,0.002459057697152933,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,0.3,2,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy still be recommended? Answer: The role of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is debated. It can yield critical information regarding the condition,",7.1057918207056e-08,0.05285134125961921,0.015792537058396394,0.005440279394345618,0.014266935688528104,0.04488788107835729,0.0054324046228586,0.011912856592856791,0.04863378684807257,7.105791820705622e-08,0.009275237125399904,0.05246913580246914
192,0.3,3,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy continue to be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: There is ongoing debate about second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women. It can provide essential information about the disease's status,",2.3685972735685406e-08,0.09823383784490325,0.047527038057341056,0.0018134264647818726,0.06441841816972405,0.026667093852791604,0.0018108015409528666,0.0652631808479529,0.027417339484813535,2.3685972735685406e-08,0.06610763146679632,0.027980691187150207
192,0.3,4,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still warranted? Answer: The application of second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma is controversial. It may supply valuable data on the current status of the disease,",2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.04221960960872817,0.04763321880439002,0.0018108015409528666,0.0441811108194079,0.05009232205178152,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
192,0.3,5,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: In cases of advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy be maintained? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a debated topic. It can offer important information about the disease's progression,",4.7371945471370706e-08,0.09422618819011896,0.02916156514641359,0.0036268529295637453,0.05858958049870866,0.005040796274936962,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.3,6,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should we persist in offering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: The practice of second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women is contentious. It provides useful insights into the status of the carcinoma,",0.0,0.03381205758828987,0.023178020362705068,0.0,0.0693147180559941,0.04890393625389013,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914
192,0.3,7,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy advisable? Answer: There is debate surrounding second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women. It can deliver valuable information about the disease status,",1.1842986367842661e-07,0.19204190049339642,0.04040123456790122,0.009067132323909363,0.15333559778337902,0.013617502344522747,0.00905400770476434,0.1528831844220786,0.011020060122557518,1.1842986367842703e-07,0.15213357721620557,0.007884662324481942
192,0.3,8,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still recommended? Answer: The use of second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women is controversial. It can give important information about the condition,",9.474389094274131e-08,0.08346352678024394,0.01307902254871958,0.0072537058591274906,0.0052392562436125445,0.07101033005794914,0.007243206163811466,0.001575556861778793,0.0763888888888889,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
192,0.3,9,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Should second-look laparotomy be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: The role of second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women is a matter of debate. It can provide critical information about the disease status,",0.0,0.03381205758829031,0.02244205089443184,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
192,0.3,10,ai,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women is a subject of debate. While it can provide valuable information about the status of the,"Question: Is it appropriate to continue second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women remains a debated issue. It can supply valuable information regarding the status of the disease,",0.0,0.10143617276487049,0.06405596367717571,0.0,0.1039720770839927,0.0683603713906744,0.0,0.10663802777845222,0.07237144168962348,0.0,0.10944429166736036,0.07608917457402303
193,0.3,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it can impair aerobic fitness by lowering maximum aerobic capacity because of frequent sleep disruptions, causing daytime tiredness and reduced endurance for aerobic exercises. Ongoing sleep deprivation also harms heart health, which further decreases aerobic fitness.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917357,0.009067132323909363,0.08298235872201154,0.0212665406427221,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
193,0.3,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea influence aerobic fitness? Indeed, obstructive sleep apnea negatively affects aerobic fitness by decreasing the maximum aerobic capacity due to repeated sleep interruptions, resulting in daytime fatigue and diminished stamina for aerobic workouts. Chronic lack of sleep also impacts cardiovascular health, further reducing aerobic fitness.",2.3685972735685406e-08,0.03547987148613396,0.04017549229670444,0.0018134264647818726,0.02214741445367352,0.00046185441900629606,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.3,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can reduce aerobic fitness by limiting maximum aerobic capacity through frequent sleep disturbances, leading to tiredness during the day and lower endurance for aerobic activities. Long-term sleep deprivation also compromises heart health, which further lowers aerobic fitness.",0.0,0.057762265046662264,0.04105672639785031,0.0,0.02949562470467848,0.0212665406427221,0.0,0.0,0.0,0.0,0.0,0.0
193,0.3,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, it can decrease aerobic fitness by reducing maximum aerobic capacity because of frequent disruptions in sleep, causing fatigue during the day and less stamina for aerobic exercise. Persistent sleep deprivation also negatively affects heart health, further impairing aerobic fitness.",2.3685972735685406e-08,0.13614381729605984,0.08264462809917357,0.0018134264647818726,0.05054903390251164,0.0212665406427221,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
193,0.3,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can aerobic fitness be affected by obstructive sleep apnea? Yes, obstructive sleep apnea can diminish aerobic fitness by lowering the maximum aerobic capacity due to repeated sleep interruptions, resulting in daytime exhaustion and reduced endurance for aerobic activities. Chronic sleep loss also impacts cardiovascular health, further decreasing aerobic fitness.",0.0,0.057762265046662264,0.04105672639785031,0.0,0.02949562470467848,0.0212665406427221,0.0,0.0,0.0,0.0,0.0,0.0
193,0.3,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is there an impact of obstructive sleep apnea on aerobic fitness? Yes, obstructive sleep apnea can impair aerobic fitness by reducing maximum aerobic capacity from frequent sleep disruptions, leading to daytime fatigue and less stamina for aerobic exercise. Long-term sleep deprivation also affects heart health, further diminishing aerobic fitness.",0.0,0.057762265046662264,0.04105672639785031,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
193,0.3,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it can lower aerobic fitness by decreasing maximum aerobic capacity because of frequent sleep interruptions, causing daytime tiredness and reduced endurance for aerobic activities. Chronic sleep deprivation also harms cardiovascular health, further reducing aerobic fitness.",1.4211583641411244e-07,0.018006862531199097,0.08264462809917357,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
193,0.3,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Can obstructive sleep apnea lower aerobic fitness? Yes, obstructive sleep apnea reduces aerobic fitness by limiting maximum aerobic capacity due to frequent sleep disturbances, leading to fatigue during the day and decreased stamina for aerobic workouts. Ongoing sleep deprivation also negatively impacts heart health, further decreasing aerobic fitness.",2.3685972735685406e-08,0.03547987148613396,0.04017549229670444,0.0018134264647818726,0.02214741445367352,0.00046185441900629606,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
193,0.3,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea can compromise aerobic fitness by reducing maximum aerobic capacity through frequent sleep interruptions, resulting in daytime fatigue and less endurance for aerobic activities. Chronic sleep deprivation also affects heart health, further impairing aerobic fitness.",7.105791820705622e-08,0.010627073760686834,0.03829633172275389,0.005440279394345618,0.0364623430871176,0.0212665406427221,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
193,0.3,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It reduces the maximum aerobic capacity due to frequent sleep interruptions, leading to daytime fatigue and less stamina for aerobic activities. Chronic sleep deprivation also affects heart health, further diminishing aerobic fitness.","Does obstructive sleep apnea influence aerobic fitness levels? Yes, it can influence aerobic fitness by lowering maximum aerobic capacity due to repeated sleep disruptions, causing daytime fatigue and reduced stamina for aerobic exercise. Persistent sleep deprivation also impacts cardiovascular health, further diminishing aerobic fitness.",1.1842986367842703e-07,0.05895517261495309,0.036243676284777364,0.009067132323909363,0.11598936732010312,0.0025288192620964538,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
194,0.3,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for laparoscopic surgery for GERD? No, advanced age itself is not a contraindication for GERD laparoscopic surgery. However, the patient's general health, existing comorbidities, and surgical tolerance are crucial considerations.",1.8948778188548261e-07,0.16859414136379058,0.029464681375697466,0.014507411718254995,0.15763725250689387,0.04244124394044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,0.3,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age contraindicate laparoscopic surgery for GERD? No, being elderly is not a contraindication for GERD laparoscopic surgery. Nonetheless, the patient's overall health status, other medical conditions, and capacity to withstand surgery are important factors.",1.6580180914979731e-07,0.017286513803490777,0.11687363038714388,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.3,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is elderly age a reason to avoid laparoscopic surgery for GERD? No, advanced age alone does not contraindicate GERD laparoscopic surgery. Still, the patient's health condition, coexisting diseases, and ability to tolerate surgery must be evaluated.",1.6580180914979731e-07,0.017286513803490777,0.11687363038714388,0.012693985253473115,0.08577536932327634,0.07271468144044323,0.01267561078667008,0.12305717459146193,0.049861495844875335,1.6580180914979784e-07,0.16227973407043406,0.025623268698060954
194,0.3,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a barrier to performing laparoscopic surgery for GERD? No, advanced age is not a barrier to GERD laparoscopic surgery. The patient's overall health, presence of other illnesses, and surgical endurance are key factors to consider.",1.1842986367842671e-07,0.0741189081448872,0.03642380339752453,0.009067132323909363,0.06712513218110283,0.0449595793996269,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.3,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does being of advanced age prevent laparoscopic surgery for GERD? No, advanced age does not prevent GERD laparoscopic surgery. However, the patient's general health, other diseases, and ability to handle surgery are important considerations.",2.1317375462116791e-07,0.11813593386035981,0.08660019288714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,0.3,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is laparoscopic surgery for GERD contraindicated in elderly patients? No, elderly age is not a contraindication for GERD laparoscopic surgery. The patient's overall health, comorbidities, and surgical tolerance remain important factors.",2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,0.3,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a reason to avoid GERD laparoscopic surgery? No, advanced age itself is not a reason to avoid GERD laparoscopic surgery. The patient's health condition, other medical issues, and ability to endure surgery are significant factors.",1.1842986367842671e-07,0.18652115364109312,0.03921377856186761,0.009067132323909363,0.18264966227442736,0.03666031855955677,0.009054007704764333,0.18304190552166189,0.035099441655124665,1.1842986367842703e-07,0.1832018393786985,0.032970481301939046
194,0.3,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Does advanced age exclude patients from GERD laparoscopic surgery? No, advanced age does not exclude patients from GERD laparoscopic surgery. However, the patient's overall health, presence of other diseases, and surgical endurance are important.",2.1317375462116791e-07,0.2861716139961046,0.02981004308224383,0.016320838183036875,0.2763650874947028,0.020032048642791025,0.016297213868575827,0.2750158774514979,0.014347778828132977,2.1317375462116866e-07,0.2730280672453351,0.007670429280535962
194,0.3,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a contraindication for GERD laparoscopic surgery? No, advanced age is not a contraindication. Still, the patient's general health, other illnesses, and ability to tolerate surgery are important considerations.",2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,0.3,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: No, advanced age is not a contraindication to GERD laparoscopic surgery. However, the patient's overall health condition, presence of other diseases, and ability to endure surgery are important factors that can","Is advanced age a limiting factor for GERD laparoscopic surgery? No, advanced age is not a limiting factor for GERD laparoscopic surgery. The patient's overall health, comorbid conditions, and surgical tolerance are important factors to assess.",1.6580180914979731e-07,0.2549369757097577,0.04721673822165515,0.012693985253473115,0.2488688235726748,0.042840874115112365,0.01267561078667008,0.24908393469327006,0.0401385041551247,1.6580180914979784e-07,0.24892313164042834,0.03659895352416127
195,0.3,1,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT showed strong correlations with traditional cardiovascular risk factors, yet no independent relationship was found between hsCRP levels and carotid IMT in healthy Korean adults.",0.0,0.07664736897684499,0.09787494194978598,0.0,0.06601401719618716,0.04721055725494473,0.0,0.06762411517657974,0.048652202498356334,0.0,0.03465735902799638,0.02498356344510192
195,0.3,2,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Korean individuals? While hsCRP levels and carotid IMT were closely associated with conventional cardiovascular risk factors, no independent association existed between hsCRP levels and carotid IMT in healthy Korean adults.",9.474389094274152e-08,0.18195691013292592,0.056715623149189556,0.0072537058591274906,0.213002172182037,0.08001086846888386,0.007243206163811466,0.177588984390888,0.05387755102040818,9.474389094274162e-08,0.14386869235560074,0.02775510204081633
195,0.3,3,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis among healthy Koreans? Both hsCRP and carotid IMT correlated significantly with standard cardiovascular risk factors, but hsCRP levels were not independently linked to carotid IMT in healthy Korean adults.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001487,0.012693985253473108,0.14931454819586287,0.023795359904818555,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
195,0.3,4,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Though hsCRP levels and carotid IMT were strongly related to traditional cardiovascular risk factors, no independent association was observed between hsCRP and carotid IMT in healthy Korean adults.",4.737194547137081e-08,0.06668081420243333,0.058430091694124844,0.0036268529295637453,0.05044051459933652,0.001188203540283362,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
195,0.3,5,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT correlated well with conventional cardiovascular risk factors, but no independent link was found between hsCRP levels and carotid IMT in this population.",4.737194547137081e-08,0.05391866435451753,0.0043760376400708845,0.0036268529295637453,0.11975523265533106,0.05071157946698568,0.003621603081905733,0.12110243909363172,0.05113221329437545,4.737194547137081e-08,0.08777472494333605,0.026296566837107373
195,0.3,6,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? While hsCRP and carotid IMT were strongly associated with conventional cardiovascular risk factors, there was no independent connection between hsCRP levels and carotid IMT in healthy Korean adults.",1.1842986367842682e-07,0.10410063264663982,0.013677360490547338,0.009067132323909363,0.13121211220645312,0.003210812934687609,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
195,0.3,7,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT were strongly correlated with traditional cardiovascular risk factors, yet no independent association was detected between hsCRP and carotid IMT in healthy Koreans.",2.3685972735685406e-08,0.03905920595192036,0.05476969700281008,0.0018134264647818726,0.024902600569258304,0.0005796400951814454,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
195,0.3,8,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Does high-sensitivity C-reactive protein associate with carotid atherosclerosis in healthy Koreans? Although hsCRP levels and carotid IMT showed strong correlations with conventional cardiovascular risk factors, no independent association was found between hsCRP and carotid IMT in healthy Korean adults.",1.1842986367842682e-07,0.10410063264663982,0.013677360490547338,0.009067132323909363,0.13121211220645312,0.003210812934687609,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
195,0.3,9,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Korean adults? Both hsCRP levels and carotid IMT were strongly linked to conventional cardiovascular risk factors, but no independent association existed between hsCRP levels and carotid IMT in this group.",9.474389094274152e-08,0.11086489161395763,0.009179782366595557,0.0072537058591274906,0.1765207416262502,0.05457198703395695,0.007243206163811466,0.177588984390888,0.05387755102040818,9.474389094274162e-08,0.14386869235560074,0.02775510204081633
195,0.3,10,human,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.","Is there an independent association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? While hsCRP levels and carotid IMT correlated strongly with conventional cardiovascular risk factors, no independent link was found between hsCRP and carotid IMT in healthy Korean adults.",4.737194547137081e-08,0.06668081420243333,0.05843009169412487,0.0036268529295637453,0.05044051459933652,0.001188203540283362,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
196,0.3,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux used in perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging and is commonly chosen as an alternative to heparin for high-risk patients.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.3,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a role in perioperative bridging? Indeed, fondaparinux is utilized in perioperative bridging, frequently serving as a substitute for heparin in patients at high risk.",2.36859727356853e-07,0.18620053083498123,0.09687575442247653,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.3,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux involved in perioperative bridging? Yes, fondaparinux is employed in perioperative bridging and is often preferred over heparin for patients with elevated risk.",3.079176455639089e-07,0.3157575069128655,0.09188732467041041,0.023574544042164434,0.3058719668602534,0.11238293444328822,0.023540420032387356,0.359517996205692,0.08740894901144641,3.0791764556391023e-07,0.41675744784461743,0.06035379812695108
196,0.3,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Can fondaparinux be used for perioperative bridging? Yes, fondaparinux has a role in perioperative bridging and is commonly used instead of heparin for high-risk individuals.",2.842316728282236e-07,0.21292422461929172,0.13527575442247655,0.021761117577382555,0.26142020428941937,0.11238293444328822,0.021729618491434483,0.3129979805707981,0.08740894901144641,2.8423167282822487e-07,0.36796728367518616,0.06035379812695108
196,0.3,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is there a place for fondaparinux in perioperative bridging? Yes, fondaparinux is used in perioperative bridging, often as an alternative to heparin in patients at high risk.",2.36859727356853e-07,0.18620053083498123,0.09687575442247653,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
196,0.3,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux serve a purpose in perioperative bridging? Yes, fondaparinux is part of perioperative bridging strategies and is frequently an alternative to heparin for patients with significant risk.",2.131737546211677e-07,0.09514118896290746,0.13527575442247655,0.016320838183036916,0.13881788219708646,0.11238293444328822,0.016297213868575862,0.1851646090609136,0.08740894901144641,2.1317375462116866e-07,0.23443589105066254,0.06035379812695108
196,0.3,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux applicable in perioperative bridging? Yes, fondaparinux is utilized in perioperative bridging and is often chosen as a heparin alternative for patients at high risk.",2.605457000925383e-07,0.227554004543832,0.095345198866921,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.3,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux recommended for perioperative bridging? Yes, fondaparinux plays a role in perioperative bridging and is commonly used as a substitute for heparin in high-risk patients.",2.605457000925383e-07,0.1721022300990369,0.13527575442247655,0.019947691112600675,0.21886058987062373,0.11238293444328822,0.01991881695048161,0.26854621799996403,0.08740894901144641,2.6054570009253947e-07,0.3214472680402922,0.06035379812695108
196,0.3,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Is fondaparinux indicated for perioperative bridging? Yes, fondaparinux is involved in perioperative bridging and often replaces heparin for patients with increased risk.",3.552895910352795e-07,0.34645561724381535,0.13527575442247655,0.027201396971728194,0.40118214666457863,0.11238293444328822,0.027162023114293103,0.45960145476267344,0.08740894901144641,3.5528959103528093e-07,0.5221179635024429,0.06035379812695108
196,0.3,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, there is a role for Fondaparinux in perioperative bridging. It is often used as an alternative to heparin for patients with a high risk of","Does fondaparinux have a function in perioperative bridging? Yes, fondaparinux is used in perioperative bridging and is frequently an alternative to heparin for patients at high risk.",2.36859727356853e-07,0.18620053083498123,0.09687575442247653,0.018134264647818796,0.17803859535036892,0.11238293444328822,0.018108015409528735,0.2259866035811684,0.08740894901144641,2.3685972735685406e-07,0.27699550546945817,0.06035379812695108
197,0.3,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors significant in primary systemic vasculitis? Yes, they are crucial as exposure to specific infections, drugs, or harmful substances can provoke an abnormal immune reaction.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.3,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors matter in primary systemic vasculitis? Indeed, they have an important role since contact with certain infections, medications, or toxic materials may trigger an abnormal immune response.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.3,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the role of environmental factors important in primary systemic vasculitis? Yes, environmental influences are key, as exposure to particular infections, drugs, or hazardous agents can induce an abnormal immune reaction.",9.47438909427412e-08,0.00284305226695869,0.08740894901144641,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
197,0.3,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental influences important in primary systemic vasculitis? Yes, they significantly contribute because exposure to certain infections, medications, or harmful substances can cause an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.3,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Do environmental factors influence primary systemic vasculitis? Yes, they are important, as exposure to specific infections, medications, or dangerous materials can lead to an abnormal immune reaction.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.3,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is exposure to environmental factors relevant in primary systemic vasculitis? Yes, it plays a vital role since certain infections, drugs, or hazardous substances can trigger an abnormal immune response.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.3,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental factors a key aspect of primary systemic vasculitis? Yes, they are, because contact with certain infections, medications, or toxic materials can provoke an abnormal immune reaction.",1.658018091497971e-07,0.10820356792478414,0.08740894901144641,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,0.3,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Does primary systemic vasculitis involve environmental factors? Yes, environmental factors are significant, as exposure to specific infections, drugs, or harmful agents can cause an abnormal immune response.",1.894877818854824e-07,0.14594389590763113,0.08740894901144641,0.014507411718255037,0.23562281656434436,0.0302734375,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.3,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Are environmental elements important in primary systemic vasculitis? Yes, they play a major role since exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune reaction.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
197,0.3,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors play a significant role in primary systemic vasculitis. Exposure to certain infections, medications, or hazardous materials can trigger an abnormal immune response","Is the impact of environmental factors notable in primary systemic vasculitis? Yes, it is, because exposure to particular infections, drugs, or dangerous substances can induce an abnormal immune response.",1.421158364141118e-07,0.07183592375390946,0.08740894901144641,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
198,0.3,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition impact quality of life? This longitudinal study showed no significant impact on quality of life among Taiwanese women during menopausal transition. The decrease in role limitations caused by emotional problems was linked to vasomotor symptoms.,7.1057918207056e-08,0.04484322235712801,0.022355635661248967,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.3,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life affected by the menopausal transition? According to this longitudinal study, menopausal transition did not significantly influence the quality of life in Taiwanese women. The reduction in role limitations due to emotional issues was associated with vasomotor symptoms.",2.3685972735685406e-08,0.02638321546978606,0.0012092933465189942,0.0018134264647818726,0.06086381724377565,0.025623268698060954,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.3,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does going through menopause affect quality of life? This longitudinal research found no notable effect of menopausal transition on the quality of life of Taiwanese women. The decline in role limitations related to emotional problems was connected to vasomotor symptoms.,4.7371945471370706e-08,0.017932314657567616,0.023028933800295387,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.3,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition influence quality of life? The longitudinal study revealed no significant effect on quality of life among Taiwanese women during menopausal transition. The decrease in role limitations caused by emotional problems was related to vasomotor symptoms.,7.1057918207056e-08,0.04484322235712801,0.022355635661248967,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.3,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is there an effect of menopausal transition on quality of life? This longitudinal study indicated no significant impact on quality of life for Taiwanese women undergoing menopausal transition. The decline in role limitations due to emotional problems was linked to vasomotor symptoms.,0.0,0.0,0.0,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0,0.0,0.0,0.0
198,0.3,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition alter quality of life? Findings from this longitudinal study showed no significant effect on quality of life among Taiwanese women in menopausal transition. The reduction in role limitations caused by emotional problems was associated with vasomotor symptoms.,4.7371945471370706e-08,0.017932314657567616,0.023028933800295387,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.3,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the transition through menopause affect quality of life? This longitudinal study found no significant influence on quality of life among Taiwanese women during menopausal transition. The decline in role limitations due to emotional problems was related to vasomotor symptoms.,4.7371945471370706e-08,0.017932314657567616,0.023028933800295387,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.3,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is quality of life impacted by menopausal transition? This longitudinal study found no significant effect on quality of life among Taiwanese women experiencing menopausal transition. The decrease in role limitations due to emotional problems was linked to vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.3,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition have an effect on quality of life? According to this longitudinal study, there was no significant effect on quality of life among Taiwanese women during menopausal transition. The decline in role limitations caused by emotional problems was associated with vasomotor symptoms.",4.737194547137081e-08,0.018533952924911112,0.02072279750164365,0.0036268529295637453,0.017223853026752334,0.047500000000000014,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
198,0.3,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition affect quality of life? This longitudinal study found no significant impact on quality of life among Taiwanese women undergoing menopausal transition. The reduction in role limitations due to emotional problems was related to vasomotor symptoms.,7.1057918207056e-08,0.04484322235712801,0.022355635661248967,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
199,0.3,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Yes, grandmultiparity is recognized as an independent risk factor for negative perinatal results, potentially causing complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",1.421158364141119e-07,0.11378530095599926,0.029657881883242435,0.010880558788691243,0.11155222504483708,0.03504003058039032,0.010864809245717214,0.10888788769310054,0.04087069166896732,1.4211583641411244e-07,0.10572766404429723,0.0471498651489732
199,0.3,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Indeed, grandmultiparity is an independent risk factor for adverse perinatal outcomes and may lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and a higher likelihood of cesarean delivery.",4.7371945471370706e-08,0.1173159156955923,0.1164175476284697,0.0036268529295637453,0.12199350075243576,0.12244897959183673,0.003621603081905733,0.0895403035525173,0.1012244897959184,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
199,0.3,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity a standalone risk factor for negative perinatal outcomes? Yes, it is considered an independent risk factor that can result in complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",1.894877818854825e-07,0.05620107974202382,0.11176737882653065,0.014507411718255002,0.04985675617422425,0.12244897959183673,0.01448641232762296,0.08739040460656167,0.1012244897959184,1.8948778188548325e-07,0.12694448639687117,0.0783673469387755
199,0.3,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Can grandmultiparity independently contribute to adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor associated with complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean deliveries.",3.316036182995943e-07,0.21486285517023873,0.14204081632653065,0.02538797050694628,0.2574961209524682,0.12244897959183673,0.025351221573340202,0.30250178422350826,0.1012244897959184,3.316036182995957e-07,0.3500880377110809,0.0783673469387755
199,0.3,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity linked independently to adverse perinatal outcomes? Yes, it is regarded as an independent risk factor that may cause complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean rates.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.3,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity pose an independent risk for adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor that can lead to complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and more frequent cesarean sections.",2.131737546211678e-07,0.13160721594483604,0.07981859410430842,0.01632083818303688,0.1263246274281551,0.09022675736961452,0.016297213868575834,0.12018022742955337,0.1012244897959184,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
199,0.3,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent contributor to adverse perinatal outcomes? Yes, it is considered an independent risk factor potentially causing postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean rates.",3.316036182995943e-07,0.266207090767272,0.1050585678058206,0.02538797050694628,0.2574961209524682,0.12244897959183673,0.025351221573340202,0.30250178422350826,0.1012244897959184,3.316036182995957e-07,0.3500880377110809,0.0783673469387755
199,0.3,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity independently associated with adverse perinatal outcomes? Yes, grandmultiparity is an independent risk factor that may result in complications like postpartum hemorrhage, gestational diabetes, preeclampsia, and higher cesarean delivery rates.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,0.3,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Does grandmultiparity independently increase the likelihood of adverse perinatal outcomes? Yes, it is an independent risk factor linked to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and elevated cesarean section rates.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.3,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity is considered an independent risk factor for adverse perinatal outcomes. It can potentially lead to complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and higher rates of cesarean","Is grandmultiparity an independent risk factor for poor perinatal outcomes? Yes, it is considered an independent risk factor that can lead to complications including postpartum hemorrhage, gestational diabetes, preeclampsia, and increased cesarean deliveries.",2.131737546211678e-07,0.17492891472983274,0.0492940862432964,0.01632083818303688,0.17104380036750655,0.05823970491882842,0.016297213868575834,0.1663900394668829,0.06793079181732148,2.1317375462116866e-07,0.16084603807255293,0.0783673469387755
200,0.3,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese populations accurate using current prediction equations? Answer: Currently, the newly developed Singapore equation provides the most precise BMR prediction for Chinese individuals and is suitable for a wide BMI range, including overweight and obese groups.",2.3685972735685406e-08,0.022472855852057716,0.0,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
200,0.3,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are existing prediction equations valid for estimating basal metabolic rate in Chinese people? Answer: The Singapore equation, recently developed, is the most accurate BMR prediction model for Chinese and works well across a broad BMI spectrum, including those who are overweight or obese.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
200,0.3,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Can current prediction equations reliably estimate basal metabolic rate in Chinese individuals? Answer: The newly formulated Singapore equation is the most accurate for predicting BMR in Chinese populations and is applicable for a large BMI range, encompassing overweight and obese categories.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.3,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How accurate are current basal metabolic rate prediction equations for Chinese populations? Answer: The Singapore equation, newly developed, stands as the most precise BMR predictor for Chinese and is effective across a wide BMI range, including overweight and obese individuals.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.3,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are the current BMR prediction equations suitable for Chinese people? Answer: To date, the Singapore equation is the most accurate for estimating BMR in Chinese and applies to a broad BMI range, covering overweight and obese subjects.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
200,0.3,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the basal metabolic rate estimation in Chinese populations accurate with existing equations? Answer: The newly developed Singapore equation is currently the most accurate BMR prediction tool for Chinese and is valid for a large BMI range, including overweight and obese persons.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
200,0.3,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Do current prediction equations accurately estimate basal metabolic rate in Chinese individuals? Answer: The Singapore equation, recently created, is the most precise BMR predictor for Chinese and is applicable across a wide BMI range, including those who are overweight or obese.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
200,0.3,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Are current BMR prediction formulas applicable to Chinese populations? Answer: The Singapore equation is the most accurate newly developed method for predicting BMR in Chinese and is suitable for a broad BMI range, including overweight and obese individuals.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
200,0.3,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: How well do current prediction equations estimate basal metabolic rate in Chinese people? Answer: The newly developed Singapore equation is the most accurate for BMR prediction in Chinese and works across a large BMI range, including overweight and obese groups.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
200,0.3,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.","Question: Is the estimation of basal metabolic rate in Chinese using current equations effective? Answer: The Singapore equation, recently developed, is the most accurate BMR prediction equation for Chinese and applies to a wide BMI range, including overweight and obese individuals.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
201,0.3,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? A routinely inserted ENBD tube did not enhance the clinical outcome, although it increased procedure time and patient discomfort, making the insertion unnecessary.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.3,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube placement did not improve clinical progression and caused longer procedures and more discomfort, thus it is not needed.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.3,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube required after endoscopic removal of common bile duct stones in patients with cholangitis due to choledocholithiasis? Routine ENBD insertion did not benefit the clinical course, while increasing procedure duration and patient discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.3,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-related cholangitis? Routine ENBD tube insertion did not improve clinical outcomes and resulted in longer procedures and more discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.3,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in patients with cholangitis caused by choledocholithiasis? Routine ENBD placement did not enhance clinical course but increased procedure time and discomfort, so it is unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.3,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve the clinical course and caused longer procedures and discomfort, thus it is not necessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.3,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should nasobiliary drainage tubes be routinely inserted after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine insertion did not improve clinical outcomes but increased procedure time and patient discomfort, so it is unnecessary.",3.552895910352808e-07,0.3403258059372023,0.0,0.02720139697172809,0.3483066942682149,0.0,0.027162023114293,0.356674943938732,0.0,3.552895910352811e-07,0.3654597734944649,0.0
201,0.3,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion after endoscopic clearance of the common bile duct necessary in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not improve clinical course and led to longer procedures and more discomfort, making it unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.3,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it advisable to routinely insert a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD insertion did not improve clinical outcomes and increased procedure time and discomfort, so it is unnecessary.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
201,0.3,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine placement of a nasobiliary drainage tube after endoscopic clearance of the common bile duct necessary in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube insertion did not improve the clinical course but increased procedure duration and patient discomfort, thus it is unnecessary.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
202,0.3,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears with glandular cell abnormalities identified through rapid prescreening? Yes, rapid prescreening frequently flags Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected this way.",1.6580180914979784e-07,0.21657244391739328,0.038079049900111475,0.012693985253473108,0.21685328558521988,0.03632454387920665,0.012675610786670066,0.21690753899485404,0.034019050562355824,1.6580180914979784e-07,0.21669986157938936,0.031162569949559068
202,0.3,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly detected as abnormal by rapid prescreening, showing a sensitivity of 36.4% at the AGC threshold. Crucially, certain AGC cases are identified through this process.",1.1842986367842703e-07,0.06050950180416015,0.03686992969172524,0.009067132323909363,0.05847088556091018,0.04052494591671175,0.009054007704764333,0.05616995293994398,0.04434829637641968,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
202,0.3,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Rapid prescreening often identifies Pap smears with glandular cell abnormalities as abnormal, with a sensitivity rate of 36.4% at the AGC threshold. Importantly, some AGC cases are detected using this method.",1.6580180914979784e-07,0.14725772586139874,0.009862990319921022,0.012693985253473108,0.11021525780676766,0.039276677218650795,0.012675610786670066,0.10746324732749368,0.04434829637641968,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
202,0.3,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears exhibiting glandular cell abnormalities are frequently marked abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are detected through this screening.",9.474389094274162e-08,0.03544379469173009,0.03796897787732905,0.0072537058591274906,0.033568284991651876,0.04110458601189319,0.007243206163811466,0.03147734034957228,0.04434829637641968,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
202,0.3,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Yes, rapid prescreening often flags Pap smears with glandular cell abnormalities as abnormal, yielding a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are identified this way.",1.6580180914979784e-07,0.14725772586139874,0.009862990319921022,0.012693985253473108,0.11021525780676766,0.039276677218650795,0.012675610786670066,0.10746324732749368,0.04434829637641968,1.6580180914979784e-07,0.14176503124858364,0.02271498107084911
202,0.3,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Does rapid prescreening detect Pap smears with glandular cell abnormalities? Pap smears with glandular cell abnormalities are often detected as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are found through this method.",1.4211583641411244e-07,0.1538412665401956,0.012050815377668486,0.010880558788691236,0.15332351764698293,0.009606993455092486,0.0108648092457172,0.152579779443204,0.006783916917955768,1.4211583641411244e-07,0.15157821472220911,0.0035815857662582634
202,0.3,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Are Pap smears showing glandular cell abnormalities caught by rapid prescreening? Rapid prescreening frequently flags these Pap smears as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected by this approach.",2.3685972735685374e-07,0.1587146054125208,0.05736375685221909,0.018134264647818726,0.1547119562208179,0.06489994591671175,0.018108015409528666,0.18970134556446672,0.04434829637641968,2.3685972735685406e-07,0.2263224192766473,0.02271498107084911
202,0.3,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Can Pap smears with glandular cell abnormalities be detected by rapid prescreening? Yes, they are often identified as abnormal by rapid prescreening, with a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected through this technique.",1.8948778188548314e-07,0.10414946602118347,0.0587466609936643,0.014507411718254981,0.10064473495054171,0.06489994591671175,0.014486412327622933,0.13413149440965455,0.04434829637641968,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
202,0.3,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Is rapid prescreening able to detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly flagged abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are detected this way.",1.1842986367842703e-07,0.06050950180416015,0.03686992969172524,0.009067132323909363,0.05847088556091018,0.04052494591671175,0.009054007704764333,0.05616995293994398,0.04434829637641968,1.1842986367842703e-07,0.0891212977631648,0.02271498107084911
202,0.3,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? Often, rapid prescreening marks these Pap smears as abnormal, with a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are detected through this process.",1.8948778188548314e-07,0.10414946602118347,0.0587466609936643,0.014507411718254981,0.10064473495054171,0.06489994591671175,0.014486412327622933,0.13413149440965455,0.04434829637641968,1.8948778188548325e-07,0.16916400543669896,0.02271498107084911
203,0.3,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines early reduce the time to headache peak and lessen its intensity? Yes, early migraine treatment can shorten the time to headache peak and decrease its severity because early intervention helps the medication control symptoms more effectively before they worsen.",2.8423167282822487e-07,0.242684653131918,0.00941824780041535,0.02176111757738247,0.26769616585641387,0.003699791537425473,0.0217296184914344,0.29335528724843396,0.017795138888888895,2.8423167282822487e-07,0.29194793236853656,0.012538580246913573
203,0.3,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment shorten the time until the headache peaks and reduce how severe it is? Yes, treating migraines early can both shorten the time to peak headache and diminish its severity by allowing medication to act sooner and control symptoms better.",2.6054570009253947e-07,0.1155408308075927,0.08151701323251415,0.0199476911126006,0.13818617474234385,0.07069064056134,0.019918816950481533,0.16139945148569002,0.05859375,2.6054570009253947e-07,0.19300958485370545,0.039930555555555566
203,0.3,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is the time to headache peak shortened and severity reduced by early migraine treatment? Yes, early treatment of migraines can shorten the time to headache peak and reduce severity since early medication use controls symptoms before they escalate.",3.789755637709662e-07,0.32614817991216194,0.02249727034913493,0.029014823436509962,0.3499517754955761,0.012421012462166453,0.028972824655245866,0.37414766474563477,0.0016607839761248952,3.789755637709665e-07,0.3709840699295377,0.01054579889807163
203,0.3,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does initiating migraine treatment early shorten the headache peak time and lessen its severity? Yes, early migraine treatment can reduce both the time to headache peak and the severity because prompt intervention allows medications to work more effectively.",3.789755637709662e-07,0.25121334958135666,0.07513946221210599,0.029014823436509962,0.23442724540225157,0.09506564056134,0.028972824655245866,0.29493084411021275,0.05859375,3.789755637709665e-07,0.33021070636718797,0.039930555555555566
203,0.3,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early treatment of migraines shorten the time to headache peak and decrease its severity? Yes, early migraine treatment helps shorten the time to peak headache and reduce severity by enabling medication to manage symptoms before they become severe.",3.552895910352809e-07,0.25905456383575043,0.050649666293738654,0.02720139697172809,0.281963101544942,0.04118808954093182,0.027162023114293,0.30526814384129075,0.03083864795918367,3.552895910352811e-07,0.30122316949393646,0.039930555555555566
203,0.3,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does early intervention in migraine treatment shorten the time to headache peak and reduce its severity? Yes, early treatment can both shorten the headache peak time and lessen severity due to more effective symptom control from timely medication.",3.789755637709662e-07,0.25121334958135666,0.07513946221210599,0.029014823436509962,0.23442724540225157,0.09506564056134,0.028972824655245866,0.29493084411021275,0.05859375,3.789755637709665e-07,0.33021070636718797,0.039930555555555566
203,0.3,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is early migraine treatment effective in shortening the time to headache peak and reducing severity? Yes, treating migraines early can shorten the peak time and reduce severity because medications work better when given promptly.",4.737194547137074e-07,0.2906888704282964,0.12901701323251416,0.036268529295637474,0.3522102810586354,0.09506564056134,0.03621603081905736,0.41629170111447955,0.05859375,4.737194547137081e-07,0.45537384932119496,0.039930555555555566
203,0.3,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Does treating migraines at an early stage shorten the time to headache peak and reduce its severity? Yes, early treatment can shorten the headache peak time and decrease severity by allowing medications to control symptoms before they worsen.",3.789755637709662e-07,0.25121334958135666,0.07513946221210599,0.029014823436509962,0.23442724540225157,0.09506564056134,0.028972824655245866,0.29493084411021275,0.05859375,3.789755637709665e-07,0.33021070636718797,0.039930555555555566
203,0.3,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Can early migraine treatment reduce the time to headache peak and the severity of the headache? Yes, early intervention can shorten the time to peak headache and reduce severity by enabling more effective symptom control.",4.500334819780221e-07,0.3423826344033145,0.07042326323251416,0.034455102830855594,0.36344754242581745,0.06479220306134,0.034405229278104486,0.3845430027998997,0.05859375,4.500334819780227e-07,0.42258402649820326,0.039930555555555566
203,0.3,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Yes, early migraine treatment can both shorten the time to headache peak and reduce the severity. This is because early intervention allows for the medication to work more effectively in controlling the symptoms before they become severe. Therefore, it's","Is the severity of migraines and the time to headache peak reduced by early treatment? Yes, early migraine treatment can shorten the time to headache peak and reduce severity as medications work more effectively when administered early.",4.026615365066515e-07,0.35771020022976563,0.01964201323251416,0.030828249901291835,0.38142335332208166,0.010104703061339995,0.03078362619619874,0.40546510810816416,0.0,4.026615365066519e-07,0.4020725895508055,0.009657118055555566
204,0.3,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction using oversized cups offer initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures? Yes, it does provide initial stability in such cases.",6.395212638635045e-07,0.5834249268925067,0.08631772268135902,0.04896251454911063,0.6278626264903435,0.07349099453896243,0.048891641605727475,0.672225075251681,0.05859375,6.39521263863506e-07,0.7488029022765978,0.019991670137442734
204,0.3,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Yes, this technique ensures initial stability.",7.57951127541931e-07,0.690360999412114,0.1627066115702479,0.05802964687302003,0.7955544033597581,0.113421550094518,0.05794564931049184,0.905839926433186,0.05859375,7.579511275419328e-07,0.9939253603095826,0.019991670137442734
204,0.3,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can cup-cage reconstruction with oversized cups ensure initial stability in THA for osteoporotic acetabular fractures? Yes, it can provide that stability.",7.816371002776163e-07,0.7391511635815453,0.1627066115702479,0.05984307333780191,0.8468476977473083,0.113421550094518,0.059756450851444716,0.9599071477034613,0.05859375,7.816371002776182e-07,1.0510837741495314,0.019991670137442734
204,0.3,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does the use of oversized cups in cup-cage reconstruction contribute to initial stability in THA for osteoporotic acetabular fractures? Yes, it contributes effectively.",7.342651548062457e-07,0.6438409837772201,0.1627066115702479,0.05621622040823815,0.7467642391903269,0.113421550094518,0.05613484776953897,0.8545466320456359,0.05859375,7.342651548062475e-07,0.9398581390393073,0.019991670137442734
204,0.3,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures attainable with cup-cage reconstruction using oversized cups? Yes, it is attainable.",7.57951127541931e-07,0.690360999412114,0.1627066115702479,0.05802964687302003,0.7955544033597581,0.113421550094518,0.05794564931049184,0.905839926433186,0.05859375,7.579511275419328e-07,0.9939253603095826,0.019991670137442734
204,0.3,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction with oversized cups help achieve initial stability in THA for osteoporotic acetabular fractures? Yes, it helps achieve initial stability.",7.57951127541931e-07,0.756375016608299,0.11520661157024789,0.05802964687302003,0.7955544033597581,0.113421550094518,0.05794564931049184,0.905839926433186,0.05859375,7.579511275419328e-07,0.9939253603095826,0.019991670137442734
204,0.3,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Can initial stability be provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Yes, it can provide initial stability.",7.342651548062457e-07,0.6438409837772201,0.1627066115702479,0.05621622040823815,0.7467642391903269,0.113421550094518,0.05613484776953897,0.8545466320456359,0.05859375,7.342651548062475e-07,0.9398581390393073,0.019991670137442734
204,0.3,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does employing oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Yes, it provides initial stability.",7.816371002776163e-07,0.7391511635815453,0.1627066115702479,0.05984307333780191,0.8468476977473083,0.113421550094518,0.059756450851444716,0.9599071477034613,0.05859375,7.816371002776182e-07,1.0510837741495314,0.019991670137442734
204,0.3,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Is initial stability in THA for osteoporotic acetabular fractures possible with cup-cage reconstruction using oversized cups? Yes, it is possible.",8.053230730133017e-07,0.7904444579690955,0.1627066115702479,0.06165649980258379,0.9009149190175836,0.113421550094518,0.06156725239239759,1.01706556154341,0.05859375,8.053230730133036e-07,1.1117083959659664,0.019991670137442734
204,0.3,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Yes, cup-cage reconstruction with oversized cups can provide initial stability in Total Hip Arthroplasty (THA) for osteoporotic acetabular fractures. This method assists in reducing the risk of implant migration and helps promote bone ingrowth for long-term fixation.","Does cup-cage reconstruction with oversized cups offer initial stability in Total Hip Arthroplasty for osteoporotic acetabular fractures? Yes, it offers initial stability.",7.57951127541931e-07,0.690360999412114,0.1627066115702479,0.05802964687302003,0.7955544033597581,0.113421550094518,0.05794564931049184,0.905839926433186,0.05859375,7.579511275419328e-07,0.9939253603095826,0.019991670137442734
205,0.3,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging required to diagnose appendicitis in children? Yes, imaging is frequently needed to confirm appendicitis in pediatric patients. This typically involves an ultrasound or CT scan, which can reveal inflammation of the appendix, indicating appendicitis.",2.3685972735685353e-07,0.19850321452395825,0.03777981780947673,0.018134264647818733,0.19481572925119517,0.045351473922902494,0.01810801540952868,0.23245315048010795,0.023242630385487524,2.3685972735685406e-07,0.2719337154836414,0.0
205,0.3,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do we need to use imaging to diagnose appendicitis in kids? Indeed, imaging is commonly essential for diagnosing appendicitis in children. Ultrasound or CT scans are often employed to detect appendix inflammation, a key indicator.",2.6054570009253883e-07,0.22865570464184826,0.03694177395476095,0.019947691112600613,0.22466869240087695,0.045351473922902494,0.019918816950481553,0.26322480914686164,0.023242630385487524,2.6054570009253947e-07,0.30368241379822125,0.0
205,0.3,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it necessary to perform imaging to diagnose appendicitis in children? Yes, imaging such as ultrasound or CT scans is often required to identify inflammation of the appendix, which signals appendicitis.",3.5528959103528003e-07,0.3130454840335055,0.06632653061224489,0.02720139697172813,0.3538804238808839,0.045351473922902494,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
205,0.3,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Should imaging be used to diagnose appendicitis in children? Yes, imaging tests like ultrasound or CT scans are usually necessary to detect an inflamed appendix, confirming appendicitis.",4.5003348197802123e-07,0.45614632767417795,0.06632653061224489,0.03445510283085565,0.5023004289991571,0.045351473922902494,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
205,0.3,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging important for diagnosing appendicitis in children? Yes, it is often needed, with ultrasound or CT scans helping to identify signs of appendix inflammation.",4.974054274493918e-07,0.5361890353477152,0.06632653061224489,0.03808195576041941,0.5856820379382075,0.045351473922902494,0.03802683236001029,0.6379182585882726,0.023242630385487524,4.974054274493935e-07,0.6931471805599463,0.0
205,0.3,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Do children suspected of appendicitis require imaging for diagnosis? Yes, imaging methods such as ultrasound or CT scans are often used to confirm if the appendix is inflamed.",4.2634750924233593e-07,0.41840599969133097,0.06632653061224489,0.03264167636607377,0.4630797158458746,0.045351473922902494,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
205,0.3,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is imaging a necessary step to diagnose appendicitis in pediatric cases? Yes, imaging tests including ultrasound or CT scans are frequently utilized to detect appendix inflammation.",4.7371945471370653e-07,0.4953670408274604,0.06632653061224489,0.03626852929563753,0.5431224235194119,0.045351473922902494,0.036216030819057415,0.5934664960174385,0.023242630385487524,4.737194547137081e-07,0.6466271649250523,0.0
205,0.3,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","To diagnose appendicitis in children, is imaging required? Yes, imaging like ultrasound or CT scans is commonly necessary to determine if the appendix is inflamed.",4.974054274493918e-07,0.5361890353477152,0.06632653061224489,0.03808195576041941,0.5856820379382075,0.045351473922902494,0.03802683236001029,0.6379182585882726,0.023242630385487524,4.974054274493935e-07,0.6931471805599463,0.0
205,0.3,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Does diagnosing appendicitis in children involve imaging? Yes, it often does, with ultrasound or CT scans helping to reveal inflammation of the appendix.",5.447773729207624e-07,0.6232004123373449,0.06632653061224489,0.04170880868998317,0.6766538161439355,0.045351473922902494,0.041648435441916036,0.7332284383925978,0.023242630385487524,5.447773729207642e-07,0.7932306391169277,0.0
205,0.3,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is often necessary to diagnose appendicitis in children. This may include an ultrasound or a CT scan. These imaging tests can help determine if the appendix is inflamed, which is a sign of","Is it common to use imaging to diagnose appendicitis in children? Yes, imaging techniques such as ultrasound or CT scans are often essential to identify appendix inflammation, a sign of appendicitis.",3.5528959103528003e-07,0.3130454840335055,0.06632653061224489,0.02720139697172813,0.3538804238808839,0.045351473922902494,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
206,0.3,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does cognitive function forecast frequency compressed speech recognition in individuals with normal hearing and cognition?,9.474389094274139e-07,1.0418613033668183,0.20408163265306123,0.07253705859127504,1.143777582294378,0.17847485127095727,0.07243206163811482,1.2264015062919076,0.16549486208761494,9.474389094274157e-07,1.3164724209267562,0.15143320713899402
206,0.3,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is frequency compressed speech recognition in listeners with normal hearing and cognition influenced by cognitive function?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.3,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Can cognitive abilities predict how well listeners with normal hearing and cognition recognize frequency compressed speech?,9.237529366917285e-07,0.9728684318798662,0.20408163265306123,0.07072363212649316,1.0696696101406569,0.17847485127095727,0.07062126009716195,1.1463587986183712,0.16549486208761494,9.237529366917304e-07,1.229461043937126,0.15143320713899402
206,0.3,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Does the recognition of frequency compressed speech depend on cognitive function in those with normal hearing and cognition?,8.763809912203578e-07,0.8477052889258605,0.20408163265306123,0.06709677919692941,0.9361382175161341,0.17847485127095727,0.0669996570152562,1.0032579549776979,0.16549486208761494,8.763809912203596e-07,1.0753103641098685,0.15143320713899402
206,0.3,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition?,8.290090457489871e-07,0.7364796538156364,0.20408163265306123,0.06346992626736567,0.8183551818597503,0.17847485127095727,0.06337805393335046,0.8780948120236922,0.16549486208761494,8.29009045748989e-07,0.9417789714853457,0.15143320713899402
206,0.3,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Do cognitive skills, especially working memory, determine frequency compressed speech recognition in normal hearing and cognitively typical listeners?",8.763809912203578e-07,0.8477052889258605,0.20408163265306123,0.06709677919692941,0.9361382175161341,0.17847485127095727,0.0669996570152562,1.0032579549776979,0.16549486208761494,8.763809912203596e-07,1.0753103641098685,0.15143320713899402
206,0.3,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Is cognitive function a predictor of frequency compressed speech recognition performance in listeners with normal hearing and normal cognition?,8.526950184846725e-07,0.7905468750859117,0.20408163265306123,0.06528335273214754,0.8755135956996991,0.17847485127095727,0.06518885547430332,0.9387194338401272,0.16549486208761494,8.526950184846743e-07,1.0063174926229164,0.15143320713899402
206,0.3,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",How does cognitive function relate to frequency compressed speech recognition in individuals with normal hearing and cognition?,9.000669639560431e-07,0.9083299107422955,0.20408163265306123,0.06891020566171129,1.0006767386537048,0.17847485127095727,0.06881045855620907,1.07225082646465,0.16549486208761494,9.00066963956045e-07,1.1494183362635897,0.15143320713899402
206,0.3,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding",Are cognitive abilities linked to the ability to recognize frequency compressed speech in listeners with normal hearing and cognition?,8.526950184846725e-07,0.7905468750859117,0.20408163265306123,0.06528335273214754,0.8755135956996991,0.17847485127095727,0.06518885547430332,0.9387194338401272,0.16549486208761494,8.526950184846743e-07,1.0063174926229164,0.15143320713899402
206,0.3,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Cognitive abilities, particularly working memory, play a significant role in the successful use of frequency-compressed speech, contributing to better understanding","Does cognitive function, particularly working memory, influence frequency compressed speech recognition in those with normal hearing and normal cognition?",8.526950184846725e-07,0.7905468750859117,0.20408163265306123,0.06528335273214754,0.8755135956996991,0.17847485127095727,0.06518885547430332,0.9387194338401272,0.16549486208761494,8.526950184846743e-07,1.0063174926229164,0.15143320713899402
207,0.3,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters in iliac cancellous bone, suggesting the iliac crest may not fully represent overall bone turnover.",7.105791820705622e-08,0.07840381648300676,0.008748996854200664,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.3,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? While bone turnover markers were significantly associated with turnover parameters in iliac cancellous bone, the iliac crest might not perfectly represent total bone turnover.",1.6580180914979753e-07,0.10432706309570561,0.08959109069410477,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
207,0.3,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers correlated significantly but modestly with bone turnover in iliac cancellous bone, indicating the iliac crest may not fully capture whole bone turnover.",1.4211583641411222e-07,0.1634053805093063,0.0189129405480217,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.3,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? There was a significant yet modest association between bone turnover markers and parameters in iliac cancellous bone, implying the iliac crest may not represent entire bone turnover.",7.105791820705622e-08,0.031829609046800655,0.0679450610352546,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.3,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Can biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly but modestly linked to turnover parameters in iliac cancellous bone, suggesting the iliac crest does not perfectly reflect overall bone turnover.",1.4211583641411222e-07,0.07667283140392867,0.09030069669650356,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.3,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Significant but modest associations were found between bone turnover markers and iliac cancellous bone parameters, indicating the iliac crest might not fully represent bone turnover.",1.4211583641411222e-07,0.07667283140392867,0.09030069669650356,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.3,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? The markers showed a significant yet modest relationship with bone turnover in iliac cancellous bone, meaning the iliac crest may not perfectly represent total bone turnover.",1.1842986367842692e-07,0.08530793296385264,0.06546505023923549,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
207,0.3,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Is there a representative relationship between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly but modestly associated with parameters in iliac cancellous bone, suggesting the iliac crest may not fully represent bone turnover.",7.105791820705622e-08,0.0019824485414892123,0.09222226353361093,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
207,0.3,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? There was a significant but modest association between these markers and bone turnover parameters in iliac cancellous bone, indicating the iliac crest may not perfectly reflect whole bone turnover.",4.737194547137081e-08,0.026885049110747516,0.09280190362879238,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
207,0.3,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.,"Are biochemical markers of bone turnover indicative of bone histomorphometry findings in 370 postmenopausal women? Bone turnover markers were significantly yet modestly correlated with turnover parameters in iliac cancellous bone, implying the iliac crest might not represent the entire bone turnover.",9.474389094274162e-08,0.058212824516586714,0.0667357676887356,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
208,0.3,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can severe hypotensive episodes trigger myocardial ischemic events in patients with coronary disease? In individuals with ischemic heart disease and low blood pressure, both symptomatic and silent ischemia have been observed to occur in a time-related manner with hypotension, especially related to diastolic pressure, indicating that coronary patients might be vulnerable to ischemic events caused by hypotension.",2.3685972735685406e-08,0.10359825974945647,0.0936443389541848,0.0018134264647818726,0.06969337426522948,0.036982248520710054,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
208,0.3,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Do profound hypotensive events lead to myocardial ischemic episodes in patients suffering from coronary disease? Among patients with ischemic heart disease and hypotension, symptomatic and silent ischemia appear temporally linked to hypotensive episodes, particularly concerning diastolic blood pressure, suggesting susceptibility to ischemic events due to hypotension.",2.3685972735685406e-07,0.09033568476680376,0.11149557862360629,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.3,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is there a causal relationship between severe hypotension and myocardial ischemic events in coronary disease patients? Patients with ischemic heart disease experiencing hypotension show both symptomatic and silent ischemia closely timed with hypotensive episodes, especially with low diastolic pressures, implying that coronary disease patients may be prone to ischemic events triggered by hypotension.",7.105791820705622e-08,0.0009265301550778204,0.07309557862360627,0.005440279394345618,0.005814178242916412,0.036982248520710054,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
208,0.3,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can profound drops in blood pressure cause myocardial ischemic events in those with coronary disease? In patients with ischemic heart disease and hypotension, symptomatic and silent ischemic events have been temporally associated with hypotension, notably diastolic hypotension, suggesting a risk of ischemia induced by low blood pressure in coronary patients.",1.4211583641411244e-07,0.0617613197375122,0.07075316124017486,0.010880558788691236,0.06643880005935054,0.036982248520710054,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
208,0.3,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Are myocardial ischemic events caused by significant hypotensive episodes in patients with coronary disease? Symptomatic and silent ischemia occur in a time-related manner with hypotension in ischemic heart disease patients, especially linked to diastolic pressure, indicating that these patients may be vulnerable to ischemic events resulting from hypotension.",1.8948778188548325e-07,0.07634619753174388,0.09022903798088419,0.014507411718254981,0.10899841447814707,0.036982248520710054,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
208,0.3,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Does profound hypotension provoke myocardial ischemic events in coronary disease patients? In individuals with ischemic heart disease, both symptomatic and silent ischemia have been temporally correlated with hypotensive episodes, particularly with diastolic hypotension, suggesting that coronary disease patients might be susceptible to ischemic events caused by hypotension.",2.1317375462116866e-07,0.12863044592280648,0.06810714887154017,0.016320838183036854,0.13097732119692207,0.036982248520710054,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
208,0.3,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Can severe hypotensive events induce myocardial ischemic episodes in patients with coronary artery disease? Symptomatic and silent ischemia have been observed in a temporal association with hypotension in ischemic heart disease patients, especially related to diastolic pressures, indicating a susceptibility to ischemic events from hypotension.",2.6054570009253947e-07,0.11280854061886147,0.11149557862360629,0.0199476911126006,0.1764396952736793,0.036982248520710054,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
208,0.3,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Is myocardial ischemia triggered by profound hypotension in patients with coronary disease? In patients with ischemic heart disease and hypotension, symptomatic and silent ischemia occur in a temporally causal relationship with hypotension, particularly diastolic hypotension, suggesting vulnerability to ischemic events in this population.",3.079176455639103e-07,0.22534257344993947,0.06399557862360628,0.023574544042164344,0.2578798018512236,0.012607248520710053,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
208,0.3,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Do profound hypotensive events cause myocardial ischemic events in coronary disease patients? Symptomatic and silent ischemia in ischemic heart disease patients have a temporal causal link with hypotension, especially diastolic pressure drops, indicating that these patients may be at risk for ischemic events due to hypotension.",2.3685972735685406e-07,0.12114222612502346,0.0892848348219534,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
208,0.3,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result","Are myocardial ischemic events temporally related to profound hypotension in patients with coronary disease? In ischemic heart disease patients, both symptomatic and silent ischemia have been shown to occur in close temporal relation to hypotensive episodes, particularly involving diastolic pressures, suggesting susceptibility to ischemic events caused by hypotension.",1.8948778188548325e-07,0.07634619753174388,0.09022903798088419,0.014507411718254981,0.10899841447814707,0.036982248520710054,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
209,0.3,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability forecast how well listeners with normal hearing and cognition recognize frequency compressed speech? The link between cognitive function and recognizing frequency compressed speech in noisy environments was not statistically significant. Results might have differed if participants had received training or time to adapt to frequency-compressed conditions.,1.4211583641411244e-07,0.12099205038119809,0.0023119762659021027,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
209,0.3,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is there a predictive relationship between cognitive function and recognition of frequency compressed speech in individuals with normal hearing and cognition? The study found no significant statistical correlation between cognitive function and frequency compressed speech recognition in noise. Outcomes could have varied if participants had undergone training or acclimatization to frequency-compressed speech.,7.105791820705622e-08,0.16739750791593266,0.07836898142010458,0.005440279394345618,0.14144656979116865,0.05975554549569943,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
209,0.3,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive performance predict how often listeners with normal hearing and cognition recognize frequency compressed speech? No statistically significant relationship was found between cognitive function and recognition of frequency compressed speech in noise. The results might have changed if participants were given training or time to acclimate to frequency compression.,1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
209,0.3,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive functioning serve as a predictor for frequency compressed speech recognition in listeners with normal hearing and cognition? The association between cognitive function and recognizing frequency compressed speech in noisy settings was not statistically significant. The findings might have differed if participants had training or time to adjust to frequency compressed speech.,4.737194547137081e-08,0.10210919532133511,0.07978045222346393,0.0036268529295637453,0.06564852320269532,0.019599999999999992,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
209,0.3,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive function a predictor of frequency compressed speech recognition in individuals with normal hearing and cognition? The study showed no significant statistical link between cognitive function and recognition of frequency compressed speech in noise. Different results might have emerged if participants were provided training or time to acclimatize to frequency compression.,7.105791820705622e-08,0.14021526554103314,0.0593513606027061,0.005440279394345618,0.1137206825687711,0.039930555555555566,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
209,0.3,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive ability influence the recognition of frequency compressed speech in listeners with normal hearing and cognition? There was no statistically significant relationship between cognitive function and frequency compressed speech recognition in noise. The findings might have been different if participants had been given training or time to adapt to frequency compressed conditions.,4.737194547137081e-08,0.10210919532133511,0.07978045222346393,0.0036268529295637453,0.06564852320269532,0.019599999999999992,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
209,0.3,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Can cognitive function predict recognition of frequency compressed speech in listeners with normal hearing and normal cognition? The relationship between cognitive functioning and recognition of frequency compressed speech in noise was not statistically significant. The results might have varied if participants had training or time to acclimate to frequency compressed speech.,9.474389094274162e-08,0.22810920954729053,0.14471121454357155,0.0072537058591274906,0.19163850206352606,0.08098765432098766,0.007243206163811466,0.16668610524352978,0.06222222222222222,9.474389094274162e-08,0.14066928042362425,0.04246913580246913
209,0.3,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is there a significant link between cognitive function and frequency compressed speech recognition in individuals with normal hearing and cognition? The study found no statistically significant relationship between cognitive function and recognition of frequency compressed speech in noise. The findings could have been different if participants had training or time to adjust to frequency compressed speech.,2.3685972735685406e-08,0.11672445826935851,0.12975962756707077,0.0018134264647818726,0.05832422038339624,0.05536332179930796,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
209,0.3,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Does cognitive function predict the ability to recognize frequency compressed speech in listeners with normal hearing and cognition? No statistically significant relationship was found between cognitive function and recognition of frequency compressed speech in noisy environments. The results might have changed if participants had been provided with training or time to acclimatize to frequency compressed conditions.,2.3685972735685406e-08,0.09151910624899706,0.11148807404770382,0.0018134264647818726,0.03265210258487938,0.036982248520710054,0.0018108015409528666,0.007108302408927791,0.018860946745562133,2.3685972735685406e-08,0.019418085857102696,0.0
209,0.3,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.,Is cognitive functioning predictive of frequency compressed speech recognition in individuals with normal hearing and cognition? The association between cognitive function and recognition of frequency compressed speech in noise was not statistically significant. The findings might have differed if participants had training or time to adapt to frequency compressed speech.,1.1842986367842703e-07,0.1953370508233787,0.10692017281313594,0.009067132323909363,0.15685316769089175,0.04158790170132326,0.009054007704764333,0.13059174157604847,0.0212665406427221,1.1842986367842703e-07,0.10318423623523065,0.0
210,0.3,1,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does increased neutrophil migration following major trauma contribute to the development of acute respiratory distress syndrome? The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils, evident within 2 hours of admission, possibly due to changes in interleukin-8 receptor expression, affinity, or signaling. Patients who eventually develop ARDS show initially elevated levels.",1.6580180914979784e-07,0.1198011998126205,0.0,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
210,0.3,2,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is heightened neutrophil migratory activity after significant trauma a factor in causing acute respiratory distress syndrome? Data show that major blunt trauma enhances circulating neutrophil migration within 2 hours of admission, potentially linked to modifications in interleukin-8 receptor expression, affinity, or downstream signaling. Those who develop ARDS later have initially increased levels.",2.6054570009253947e-07,0.1953087523207664,0.0,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
210,0.3,3,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Could increased neutrophil migration post-major trauma play a role in acute respiratory distress syndrome? Evidence indicates that major blunt trauma increases the migratory capacity of circulating neutrophils within 2 hours of admission, possibly due to changes in interleukin-8 receptor expression, affinity, or signaling pathways. Patients who develop ARDS later exhibit initially elevated levels.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
210,0.3,4,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is the rise in neutrophil migratory activity after major trauma a contributing factor to acute respiratory distress syndrome? The data reveal that major blunt trauma enhances the migration of circulating neutrophils within 2 hours of admission, likely due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling. Initially elevated levels are seen in patients who develop ARDS.",1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
210,0.3,5,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does major blunt trauma increase neutrophil migration and thus influence the onset of acute respiratory distress syndrome? Findings indicate that trauma significantly boosts neutrophil migratory capacity within 2 hours of admission, possibly through changes in interleukin-8 receptor expression, affinity, or signaling, with initially elevated levels in patients who later develop ARDS.",2.8423167282822487e-07,0.21511137961694615,0.0,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
210,0.3,6,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is enhanced neutrophil migration after major trauma implicated in the etiology of acute respiratory distress syndrome? The data suggest that major blunt trauma augments circulating neutrophil migration within 2 hours of admission, potentially due to altered interleukin-8 receptor expression, affinity, or downstream signaling, with initially high levels in patients who develop ARDS.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
210,0.3,7,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Could the increased migratory activity of neutrophils following major trauma contribute to acute respiratory distress syndrome? Evidence shows that major blunt trauma raises the migratory capacity of circulating neutrophils within 2 hours of admission, possibly linked to changes in interleukin-8 receptor expression, affinity, or signaling, with initially elevated levels in patients who develop ARDS.",2.1317375462116866e-07,0.1568424714929706,0.0,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
210,0.3,8,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is the increased neutrophil migration seen after major trauma a factor in the development of acute respiratory distress syndrome? Data indicate that major blunt trauma enhances neutrophil migratory capacity within 2 hours of admission, likely due to modifications in interleukin-8 receptor expression, affinity, or downstream signaling, with initially elevated levels in those who develop ARDS.",1.8948778188548325e-07,0.13815033848081626,0.0,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
210,0.3,9,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Does major trauma-induced neutrophil migration increase contribute to acute respiratory distress syndrome? Findings demonstrate that major blunt trauma enhances circulating neutrophil migration within 2 hours of admission, possibly through changes in interleukin-8 receptor expression, affinity, or signaling, with initially high levels in patients who later develop ARDS.",3.789755637709665e-07,0.3286298224933857,0.021728395061728398,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
210,0.3,10,human,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated","Is the elevated neutrophil migratory activity after major trauma a factor in acute respiratory distress syndrome? The data reveal that major blunt trauma increases the migratory capacity of circulating neutrophils within 2 hours of admission, potentially due to alterations in interleukin-8 receptor expression, affinity, or downstream signaling, with initially elevated levels in patients who develop ARDS.",1.6580180914979784e-07,0.1198011998126205,0.0,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
211,0.3,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs impact health system strengthening in low- and middle-income countries? MPH programs play a crucial role in strengthening health systems in these regions by building capacity among local health workers with vital public health skills. They also support policy formulation, healthcare administration, and disease prevention efforts, leading to better health outcomes and lessening health inequities.",3.316036182995957e-07,0.08774738137598881,0.09332089317208371,0.025387970506946245,0.10431832036107647,0.0849609375,0.025351221573340132,0.12631720624015852,0.072021484375,3.316036182995957e-07,0.14897693148713298,0.05859375
211,0.3,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What is the effect of MPH programs on health system strengthening in low- and middle-income countries? MPH programs greatly aid in fortifying health systems by training local health professionals in key public health competencies. Additionally, they contribute to policy making, health management, and prevention strategies, which improve overall health and reduce disparities.",4.737194547137081e-07,0.20183430515725576,0.09125915847820618,0.03626852929563748,0.2176470056680806,0.0849609375,0.03621603081905733,0.24183009336200278,0.072021484375,4.737194547137081e-07,0.26675996714351724,0.05859375
211,0.3,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","In what ways do MPH programs contribute to health system strengthening in low- and middle-income countries? MPH programs enhance health system capacity by providing essential public health training to local practitioners. They also assist in developing policies, managing healthcare, and preventing diseases, thereby improving health results and minimizing health inequalities.",5.210914001850789e-07,0.27124084070707033,0.07011674109477473,0.039895382225201226,0.25846900018833496,0.0849609375,0.039837633900963065,0.2835027897625717,0.072021484375,5.210914001850789e-07,0.30931958156231376,0.05859375
211,0.3,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do Master of Public Health programs influence health system strengthening in low- and middle-income countries? MPH programs significantly bolster health systems by equipping local health workers with necessary public health skills. They further support policy development, healthcare leadership, and disease prevention, resulting in improved health outcomes and reduced disparities.",5.210914001850789e-07,0.2429491190515627,0.09045985292265062,0.039895382225201226,0.25846900018833496,0.0849609375,0.039837633900963065,0.2835027897625717,0.072021484375,5.210914001850789e-07,0.30931958156231376,0.05859375
211,0.3,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What role do MPH programs play in strengthening health systems in low- and middle-income countries? MPH programs contribute substantially by building local capacity through public health education. They also facilitate policy creation, healthcare oversight, and disease prevention, enhancing health outcomes and addressing health inequities.",6.632072365991914e-07,0.37751698356009333,0.08761652809271864,0.05077594101389246,0.39200039281285814,0.0849609375,0.050702443146680265,0.42007832476832174,0.072021484375,6.632072365991914e-07,0.44908152393747214,0.05859375
211,0.3,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How significant is the contribution of MPH programs to health system strengthening in low- and middle-income countries? These programs strengthen health systems by training local health professionals in public health practices. They promote policy development, healthcare management, and disease prevention, which improves health and reduces disparities.",6.158352911278206e-07,0.2998152057363619,0.11085915847820617,0.047149088084328716,0.3454803771779642,0.0849609375,0.04708084006477453,0.3724502757790673,0.072021484375,6.158352911278206e-07,0.4002913597680404,0.05859375
211,0.3,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs aid in health system strengthening in low- and middle-income countries? MPH programs enhance the skills of local health workers in public health, supporting capacity building. They also help in policy formulation, healthcare administration, and disease prevention, leading to better health outcomes and fewer disparities.",5.684633456564497e-07,0.285825718501302,0.08959261783548407,0.04352223515476497,0.3010286146071315,0.0849609375,0.0434592369828688,0.32698790170231007,0.072021484375,5.684633456564497e-07,0.3537713441331465,0.05859375
211,0.3,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What impact do MPH programs have on health system strengthening in low- and middle-income countries? MPH programs contribute by equipping local health professionals with essential public health skills, aiding in policy development, healthcare management, and disease prevention, which improves health outcomes and reduces disparities.",6.632072365991914e-07,0.37751698356009333,0.08761652809271864,0.05077594101389246,0.39200039281285814,0.0849609375,0.050702443146680265,0.42007832476832174,0.072021484375,6.632072365991914e-07,0.44908152393747214,0.05859375
211,0.3,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","How do MPH programs contribute to strengthening health systems in low- and middle-income countries? By building capacity through public health training, MPH programs support policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing disparities.",8.053230730133035e-07,0.5330271980278583,0.0838529856387,0.0616564998025837,0.5461510726401158,0.0849609375,0.061567252392397465,0.5783023299832162,0.072021484375,8.053230730133038e-07,0.6116004534352464,0.05859375
211,0.3,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: Master of Public Health (MPH) programs significantly contribute to health system strengthening in low- and middle-income countries. They enhance capacity building by equipping local health professionals with essential skills in public health practice. Furthermore, MPH programs aid in policy development, healthcare management, and disease prevention, ultimately improving health outcomes and reducing health disparities in these countries.","What is the contribution of MPH programs to health system strengthening in low- and middle-income countries? MPH programs play a vital role by training local health professionals in public health, aiding policy development, healthcare management, and disease prevention, which enhances health outcomes and decreases disparities.",6.39521263863506e-07,0.3537947516138722,0.08814417740735705,0.04896251454911059,0.3684698954026637,0.0849609375,0.0488916416057274,0.3959807731892617,0.072021484375,6.39521263863506e-07,0.42438891134710044,0.05859375
212,0.3,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): could polymorphisms in the beta-adrenergic receptor (ADRB) genes be involved? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may increase susceptibility to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both representing loss-of-function variants, might predispose individuals to TTN.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
212,0.3,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: We found that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, could contribute to TTN risk.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): are polymorphisms in beta-adrenergic receptor (ADRB) genes implicated? Answer: Our conclusion is that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function changes, may predispose to TTN.",2.36859727356853e-08,0.06590715088589016,0.02775510204081633,0.0018134264647818726,0.028170876966696845,0.0,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
212,0.3,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role in transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase the risk of TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.3,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there an association between transient tachypnea of the newborn (TTN) and polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variations, could predispose to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.3,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): does it involve polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Our study suggests that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may predispose to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could the beta-adrenergic receptor (ADRB) gene polymorphisms contribute to transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, might increase susceptibility to TTN.",0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.3,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) genes linked to transient tachypnea of the newborn (TTN)? Answer: We found that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may predispose to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) have a genetic basis involving polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, could increase the risk of TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
213,0.3,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: The generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects failed to meet the RCT criteria. However, because the RCT participants were more severely ill, it remains uncertain if the treatment outcomes from the RCT will apply to children with milder mania.",2.3685972735685406e-08,0.016837161883194618,0.002302299768924043,0.0018134264647818726,0.015748356968136257,0.0,0.0018108015409528666,0.01600034134644357,0.0,2.3685972735685406e-08,0.016260520871781203,0.0
213,0.3,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample is supported as only 7.8% of Phenomenology subjects did not meet the RCT criteria. Still, since the RCT subjects were more severely affected, it is unclear whether the treatment results from the RCT will be relevant for children with less severe mania.",7.105791820705622e-08,0.028998130532637667,0.009576637646409092,0.005440279394345618,0.046520015634889056,0.0,0.0054324046228586,0.04725288485054513,0.0,7.105791820705622e-08,0.04800921918636103,0.0
213,0.3,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize regarding diagnostic traits of child bipolar I disorder? Answer: The RCT sample generalization was supported because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nonetheless, due to the greater severity of illness in RCT subjects, it is uncertain if RCT treatment findings apply to children with milder mania.",7.105791820705622e-08,0.01590804131609147,0.1287333900683805,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
213,0.3,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic criteria of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was confirmed as only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, since RCT participants were more severely ill, applicability of RCT treatment findings to children with less severe mania is unclear.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.3,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can the 'Treatment of Early Age Mania (TEAM)' sample be generalized for diagnostic characteristics of child bipolar I disorder? Answer: The RCT sample generalization is supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. Yet, due to the more severe illness in RCT subjects, it is uncertain if treatment findings from the RCT will apply to children with milder mania.",2.3685972735685406e-08,0.04889036820312764,0.12925339238078656,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
213,0.3,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are diagnostic features of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was supported as only 7.8% of Phenomenology subjects did not fit RCT criteria. Nevertheless, since RCT subjects were more severely ill, it is unclear if treatment outcomes from the RCT will be relevant for children with less severe mania.",2.3685972735685406e-08,0.026885695804398146,0.11341037355549569,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
213,0.3,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize to diagnostic characteristics of child bipolar I disorder? Answer: The RCT sample generalization was supported because only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, given the greater severity of illness in RCT subjects, it remains uncertain if RCT treatment findings will apply to children with milder mania.",9.474389094274162e-08,0.02210487643241965,0.1451222789572694,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
213,0.3,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic characteristics of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects did not meet RCT criteria. Still, because RCT subjects were more severely ill, it is unclear if treatment results from the RCT will be applicable to children with less severe mania.",4.737194547137081e-08,0.03253511278573562,0.12899758129535055,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
213,0.3,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can the 'Treatment of Early Age Mania (TEAM)' sample generalize regarding diagnostic features of child bipolar I disorder? Answer: The RCT sample generalization was supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. Nonetheless, since RCT subjects were more severely ill, it is uncertain if RCT treatment findings will apply to children with milder mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.3,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic traits of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was supported because only 7.8% of Phenomenology subjects did not fit RCT criteria. However, due to the more severe illness in RCT subjects, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.",4.737194547137081e-08,0.07540613620280912,0.1148488414572694,0.0036268529295637453,0.03125254350410156,0.0,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
214,0.3,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy effective for gallbladder carcinoma? It can help alleviate symptoms like pain and obstruction, though it has limited impact on survival due to the disease's advanced stage.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.3,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy work for gallbladder carcinoma? It is useful for symptom relief, including pain and obstruction, but offers minimal survival benefit because the disease is usually advanced.",3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.3,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy manage gallbladder carcinoma effectively? It helps control symptoms such as pain and obstruction, but its effect on extending survival is limited given the advanced disease.",3.7897556377096523e-07,0.29445167361579827,0.11176857330703485,0.029014823436510018,0.33640563470133644,0.09204470742932283,0.028972824655245928,0.38055205446760665,0.0710059171597633,3.789755637709665e-07,0.4270721266595281,0.04865220249835634
214,0.3,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy beneficial for gallbladder carcinoma? It can reduce symptoms like pain and obstruction, though it does not significantly improve survival rates due to the late stage of the cancer.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.3,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How effective is external palliative radiotherapy for gallbladder carcinoma? It provides symptom relief, particularly for pain and obstruction, but has a limited role in increasing survival because of the disease's progression.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
214,0.3,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Does external palliative radiotherapy help patients with gallbladder carcinoma? It is effective in symptom management, including pain and obstruction, but has restricted impact on survival outcomes due to advanced disease.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.3,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is palliative external radiotherapy effective for gallbladder carcinoma? It can ease symptoms such as pain and obstruction, but its ability to improve survival is limited by the advanced stage of the illness.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.3,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Can external palliative radiotherapy be effective in gallbladder carcinoma? It aids in controlling symptoms like pain and obstruction, though it has a limited effect on survival because the disease is often advanced.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
214,0.3,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","Is external palliative radiotherapy a useful treatment for gallbladder carcinoma? It helps manage symptoms including pain and obstruction, but does not significantly enhance survival due to the advanced disease stage.",3.5528959103527993e-07,0.25936035380452926,0.11176857330703485,0.027201396971728138,0.30003799053046176,0.09204470742932283,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
214,0.3,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External palliative radiotherapy for gallbladder carcinoma can be effective in managing symptoms such as pain and obstruction. However, its role in improving survival rates is limited due to the advanced nature of the disease at","How useful is external palliative radiotherapy for gallbladder carcinoma? It is effective for symptom relief such as pain and obstruction, but offers limited survival benefits because the cancer is typically advanced.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
215,0.3,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH levels? Answer: The success of in vitro fertilization is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment proved to be a more accurate predictor of IVF results than age or follicle-stimulating hormone. This assessment might serve as a unique indicator of ovarian age separate from other markers.",4.737194547137081e-08,0.1398025784015502,0.1608547465117977,0.003626852929563773,0.0909262753015625,0.06990171083565046,0.003621603081905733,0.046019006101889914,0.013695987654320991,4.737194547137081e-08,0.027398974188114877,0.0
215,0.3,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle assessment better predict IVF outcomes than age and FSH? Answer: IVF success correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Notably, antral follicle assessment outperforms age and FSH as a predictor of IVF outcomes. It may represent a distinct marker of ovarian aging.",4.500334819780227e-07,0.1902013505672664,0.14378698224852057,0.03445510283085566,0.2211978012168725,0.07802269468236003,0.03440522927810448,0.2824850608701439,0.013695987654320991,4.500334819780227e-07,0.30637420546393335,0.0
215,0.3,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle count a more reliable predictor of IVF success than age and FSH? Answer: The outcome of in vitro fertilization is significantly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle count was found to be a better predictor of IVF success than either age or follicle-stimulating hormone, potentially serving as a unique marker of ovarian aging.",1.4211583641411244e-07,0.021303658863791597,0.12084028594474436,0.010880558788691319,0.06536465637757338,0.037604527672757834,0.010864809245717214,0.10815840927091358,0.016126497552779596,1.4211583641411244e-07,0.10801583700659734,0.01514792899408284
215,0.3,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does antral follicle assessment predict IVF outcomes better than age and FSH? Answer: IVF results are strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment. Among these factors, antral follicle assessment is a superior predictor compared to age or follicle-stimulating hormone, offering a distinct measure of ovarian age.",4.500334819780227e-07,0.16544609411869704,0.1621188024123642,0.03445510283085566,0.2211978012168725,0.07802269468236003,0.03440522927810448,0.2824850608701439,0.013695987654320991,4.500334819780227e-07,0.30637420546393335,0.0
215,0.3,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? Answer: The success of in vitro fertilization is closely related to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle assessment has been shown to be a better predictor of IVF outcomes than age or follicle-stimulating hormone, potentially indicating ovarian age uniquely.",2.6054570009253947e-07,0.021463515719342574,0.1737059294043561,0.019947691112600682,0.08219558043617425,0.08032939109627499,0.019918816950481547,0.14433472238932765,0.013695987654320991,2.6054570009253947e-07,0.16579225484274396,0.0
215,0.3,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle assessment a better predictor of IVF success than age and FSH? Answer: IVF outcomes are strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle assessment outperforms age and follicle-stimulating hormone as a predictor, possibly serving as a distinct marker of ovarian aging.",4.500334819780227e-07,0.21495660701583574,0.1256112237214179,0.03445510283085566,0.2211978012168725,0.07802269468236003,0.03440522927810448,0.2824850608701439,0.013695987654320991,4.500334819780227e-07,0.30637420546393335,0.0
215,0.3,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Can antral follicle assessment outperform age and FSH in predicting IVF outcomes? Answer: The outcome of in vitro fertilization is linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle assessment was found to be a better predictor than age or follicle-stimulating hormone, suggesting it may uniquely mark ovarian age.",3.789755637709665e-07,0.10900901114141615,0.1668386215432918,0.029014823436510045,0.16678425079842274,0.07896220503502314,0.02897282465524588,0.22841783959986905,0.013695987654320991,3.789755637709665e-07,0.2513144282809048,0.0
215,0.3,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Is antral follicle assessment more effective than age and FSH at predicting IVF outcomes? Answer: IVF success correlates with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. This assessment is a better predictor of IVF results than age or follicle-stimulating hormone, potentially reflecting ovarian age distinctly.",5.210914001850789e-07,0.18920937986231934,0.21557662164529337,0.03989538222520128,0.2520819158475538,0.09619827767275783,0.03983763390096308,0.33964347471009404,0.013695987654320991,5.210914001850789e-07,0.3646431135879089,0.0
215,0.3,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: Does antral follicle assessment provide a better prediction of IVF outcomes than age and FSH? Answer: The success of in vitro fertilization is strongly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle assessment is a superior predictor compared to age or follicle-stimulating hormone and may serve as a unique marker of ovarian aging.",2.6054570009253947e-07,0.021463515719342574,0.17370592940435609,0.019947691112600682,0.08219558043617425,0.08032939109627499,0.019918816950481547,0.14433472238932765,0.013695987654320991,2.6054570009253947e-07,0.16579225484274396,0.0
215,0.3,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from","Question: How effective is antral follicle assessment compared to age and FSH in predicting IVF outcomes? Answer: IVF outcomes are closely correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle assessment was shown to be a better predictor than age or follicle-stimulating hormone, potentially indicating ovarian age in a distinct way.",3.552895910352811e-07,0.09087925688516751,0.1683052227267014,0.027201396971728173,0.14928470511851533,0.0792541635229362,0.027162023114293013,0.21102609688800023,0.013695987654320991,3.552895910352811e-07,0.23361485118150416,0.0
216,0.3,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are reports of home blood pressure readings from stroke patients dependable? This group of elderly stroke patients reliably recorded their blood pressures at home. Any bias was minimal and unlikely to impact treatment. Given that BP readings at GP surgeries often poorly reflect true blood pressure, GPs might consider using hypertensive patients' home readings.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.3,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients' self-reported home blood pressure measurements be trusted? Elderly stroke patients in this study were able to accurately measure their blood pressure at home. The bias observed was small and unlikely to influence clinical decisions. Since blood pressure readings taken at GP offices often do not represent true BP, GPs may want to rely on hypertensive patients' home readings.",4.737194547137081e-08,0.02102906275772387,0.06777645659928656,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
216,0.3,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings reported by stroke patients accurate? This elderly stroke patient group successfully recorded their blood pressures reliably at home. Any bias present was minor and unlikely to affect management. Because BP readings in GP clinics often poorly indicate true blood pressure, GPs might consider using home readings from hypertensive patients.",1.1842986367842703e-07,0.09015109699429802,0.0,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.3,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Do stroke patients provide reliable home blood pressure readings? The elderly stroke patients in this group were capable of accurately recording their blood pressures at home. The small bias found would probably not impact treatment decisions. Since blood pressure measurements at GP surgeries often fail to reflect true BP, GPs might consider using hypertensive patients' home readings.",4.737194547137081e-08,0.08460183270840904,0.03566529492455417,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
216,0.3,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is the home blood pressure data reported by stroke patients trustworthy? This cohort of elderly stroke patients reliably measured their blood pressure at home. The bias was minimal and unlikely to affect clinical management. Given that BP readings taken at GP surgeries often do not accurately represent true BP, GPs might consider relying on hypertensive patients' home readings.",2.3685972735685406e-08,0.06603365011958484,0.035041322314049606,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,0.3,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are home blood pressure readings from stroke patients dependable? Elderly stroke patients in this group were able to reliably record their blood pressures at home. The bias was small and unlikely to influence treatment. Since BP readings in GP surgeries often poorly indicate true blood pressure, GPs might consider using hypertensive patients' home readings.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
216,0.3,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Can stroke patients accurately report their home blood pressure readings? This group of elderly stroke patients reliably recorded their blood pressures at home. Any bias was minor and unlikely to affect clinical management. Because BP readings in GP clinics often do not reflect true BP, GPs might consider using hypertensive patients' home measurements.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
216,0.3,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are self-reported home blood pressure readings by stroke patients reliable? The elderly stroke patients in this study were able to accurately record their blood pressures at home. The small bias observed would likely not impact treatment decisions. Since blood pressure readings at GP surgeries often poorly reflect true BP, GPs might consider using hypertensive patients' home readings.",4.737194547137081e-08,0.1093570891569784,0.0533997864008544,0.0036268529295637453,0.060923434622440986,0.0181755829903978,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
216,0.3,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Is it reliable for stroke patients to report their home blood pressure readings? This group of elderly stroke patients successfully recorded their blood pressures at home with minimal bias, unlikely to affect management. Given that BP readings taken in GP surgeries often do not represent true BP, GPs might consider using hypertensive patients' home readings.",9.474389094274162e-08,0.09713108178066054,0.01851192595229618,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
216,0.3,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients'","Are the home blood pressure readings reported by stroke patients accurate? Elderly stroke patients in this group reliably measured their blood pressures at home. The small bias present would probably not influence clinical management. Since BP readings in GP clinics often poorly indicate true BP, GPs might consider using hypertensive patients' home readings.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
217,0.3,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering required before scoliosis correction in a patient with myelomeningocele? Typically, untethering is necessary prior to scoliosis correction to prevent worsening neurological issues, though the decision varies based on the patient's specific condition.",4.0266153650665116e-07,0.34662081510600995,0.04912164756616258,0.030828249901291856,0.36950095199988464,0.040742417383431435,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
217,0.3,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For a patient with myelomeningocele, is untethering essential before scoliosis surgery? Usually, untethering is performed first to avoid further neurological decline that scoliosis correction might cause, but the choice depends on individual circumstances.",4.2634750924233646e-07,0.3353835537388279,0.07939508506616258,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
217,0.3,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does a patient with myelomeningocele need untethering before undergoing scoliosis correction? Generally, untethering is needed beforehand to reduce the risk of neurological damage, although the decision should be tailored to the patient's unique condition.",4.0266153650665116e-07,0.3046118950720742,0.07939508506616258,0.030828249901291856,0.36950095199988464,0.040742417383431435,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
217,0.3,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","In patients with myelomeningocele, is it necessary to untether before scoliosis correction? Untethering is commonly required prior to scoliosis surgery to prevent neurological deterioration, but the approach depends on each patient's situation.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,0.3,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Should untethering be done before scoliosis correction in myelomeningocele patients? Typically, yes; untethering helps avoid neurological worsening caused by scoliosis correction, though the decision is individualized.",5.921493183921336e-07,0.5822436316703543,0.07939508506616258,0.04533566161954689,0.6571830244516659,0.040742417383431435,0.04527003852382175,0.7357067949787415,0.0,5.921493183921352e-07,0.7591051483517424,0.0
217,0.3,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is untethering a prerequisite for scoliosis correction in patients with myelomeningocele? Usually, untethering is performed first to prevent neurological decline, but the final decision depends on the patient's specific condition.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.3,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","For scoliosis correction in myelomeningocele patients, is untethering necessary beforehand? It is generally necessary to untether prior to surgery to avoid further neurological issues, but this depends on individual patient factors.",4.7371945471370706e-07,0.3999220748763994,0.07939508506616258,0.036268529295637494,0.46794102481313793,0.040742417383431435,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
217,0.3,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","When treating scoliosis in myelomeningocele patients, is untethering required before correction? Untethering is typically done first to prevent neurological deterioration, though the decision varies with patient condition.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.3,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Does scoliosis correction in a patient with myelomeningocele require prior untethering? Usually, untethering is necessary to prevent neurological worsening, but the decision should be based on the patient's unique clinical picture.",4.7371945471370706e-07,0.3999220748763994,0.07939508506616258,0.036268529295637494,0.46794102481313793,0.040742417383431435,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
217,0.3,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Untethering prior to scoliosis correction in a patient with myelomeningocele is typically necessary. This procedure helps prevent further neurological deterioration, which can be aggravated by scoliosis correction. However, the decision depends on individual patient conditions and should be","Is it necessary to perform untethering before scoliosis correction in patients with myelomeningocele? Generally, untethering is advised before scoliosis surgery to prevent neurological decline, but the decision depends on individual patient factors.",4.5003348197802176e-07,0.41185142499275873,0.04717286284394038,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
218,0.3,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair pointless? No, it is essential to prevent spinal cord ischemia and reduce paralysis risk, making it a vital part of the surgery.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
218,0.3,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is crucial, not futile, as it helps avoid spinal cord ischemia and lowers the chance of paralysis, playing a key role in the procedure.",6.868932093348761e-07,0.40719064286020856,0.1758667226324568,0.05258936747867432,0.4964693047605566,0.09566326530612247,0.05251324468763315,0.5769595501709666,0.049048751486325794,6.868932093348768e-07,0.6372524517182883,0.016661878770468257
218,0.3,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","During thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is important and not a waste, as it prevents ischemia of the spinal cord and decreases paralysis risk, integral to the surgery.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.3,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The process of reimplanting spinal cord arteries in thoracic and thoracoabdominal aneurysm repair is necessary, not time-wasting, because it protects against spinal cord ischemia and reduces paralysis likelihood, making it a critical surgical step.",7.105791820705614e-07,0.43827916248147636,0.17497804178994075,0.0544027939434562,0.5272409634273103,0.09566326530612247,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.67004227454128,0.016661878770468257
218,0.3,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a valuable procedure that prevents spinal cord ischemia and minimizes paralysis risk, thus it is not a waste of time.",7.57951127541932e-07,0.5035097723682251,0.17302925706771854,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7390351460282307,0.016661878770468257
218,0.3,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","In thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is an important measure to prevent spinal cord ischemia and lower paralysis risk, and therefore it is not considered a waste of time.",7.342651548062467e-07,0.4703635998992919,0.17403399750013845,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.7039438262169617,0.016661878770468257
218,0.3,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","The reimplantation of spinal cord arteries is a vital component of thoracic and thoracoabdominal aneurysm repair, as it helps prevent spinal cord ischemia and reduces the risk of paralysis, making it a necessary procedure.",7.105791820705614e-07,0.43827916248147636,0.17497804178994075,0.0544027939434562,0.5272409634273103,0.09566326530612247,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.67004227454128,0.016661878770468257
218,0.3,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.","Reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is essential, not a waste, because it helps avoid spinal cord ischemia and decreases the risk of paralysis, forming a key part of the surgical approach.",6.632072365991908e-07,0.37703815274231856,0.1767047664871726,0.05077594101389244,0.46661634161087484,0.09566326530612247,0.05070244314668028,0.5461878915042129,0.049048751486325794,6.632072365991914e-07,0.6055037534037084,0.016661878770468257
218,0.3,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.",It is not a waste of time to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair; this procedure is critical for preventing spinal cord ischemia and minimizing paralysis risk.,7.816371002776173e-07,0.5377902342891954,0.17195778131134384,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7754027901991054,0.016661878770468257
218,0.3,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not a waste of time. It's a critical procedure that helps to prevent spinal cord ischemia, minimizing the risk of paralysis. Hence, it's a significant part of the overall surgical strategy for aneurysm repair.",Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a significant and necessary procedure that prevents spinal cord ischemia and reduces the chance of paralysis.,8.526950184846732e-07,0.6482851735067245,0.1682692307692307,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8931858258554897,0.016661878770468257
219,0.3,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program enhance bariatric surgery results? MSWM seems to offer no extra advantage over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes following LAGB in our patients.,1.8948778188548293e-07,0.20906632474046027,0.009529254643988495,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.3,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? MSWM does not seem to provide additional benefits compared to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patient group.,2.3685972735685406e-08,0.023873153186523055,0.0010031775464828044,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
219,0.3,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a medically supervised weight loss program before surgery improve outcomes of bariatric surgery? MSWM does not appear to yield more benefits than the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes post-LAGB in our patients.,9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.3,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a preoperative medically supervised weight loss program improve the results of bariatric surgery? MSWM does not seem to offer added benefits over the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patient population.,9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.3,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery improve bariatric surgery outcomes? MSWM does not appear to provide additional benefits compared to the standard preoperative bariatric surgery protocol in weight loss and most behavioral outcomes following LAGB in our patients.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.3,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a preoperative medically supervised weight loss program beneficial for bariatric surgery outcomes? MSWM does not seem to confer extra benefits beyond the standard preoperative bariatric surgery protocol concerning weight loss and most behavioral outcomes after LAGB in our patient population.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.3,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participation in a preoperative medically supervised weight loss program improve bariatric surgery outcomes? MSWM does not appear to offer more benefits than the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB in our patient group.,9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.3,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program lead to better bariatric surgery outcomes? MSWM does not seem to provide additional benefits compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes post-LAGB in our patients.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.3,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Will a preoperative medically supervised weight loss program improve bariatric surgery outcomes? MSWM does not appear to deliver extra benefits over the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patient population.,1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.3,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does engaging in a medically supervised weight loss program before surgery improve bariatric surgery results? MSWM does not seem to confer added benefits compared to the standard preoperative bariatric surgery protocol in weight loss and most behavioral outcomes following LAGB in our patient group.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
220,0.3,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does receiving birth center care in a woman's first pregnancy influence her future reproductive outcomes? The type of care, like birth center care, during the initial pregnancy does not appear to significantly impact later reproduction in Sweden.",2.3685972735685364e-07,0.1932201329185923,0.03714484387589542,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
220,0.3,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is there an effect of birth center care during a woman's first pregnancy on her future childbearing? In Sweden, the model of care during the first pregnancy, including birth center care, does not seem to play a major role in subsequent reproduction.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.3,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Can birth center care during a woman's first pregnancy affect her future reproductive behavior? Evidence from Sweden suggests that the care model, such as birth center care, during the first pregnancy is not a crucial factor influencing later reproduction.",1.8948778188548304e-07,0.1736075960621144,0.012430810114242609,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.3,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does the care provided at birth centers during a woman's first pregnancy influence her future fertility? In Sweden, the type of care during the initial pregnancy, like birth center care, does not appear to significantly affect future reproduction.",2.1317375462116834e-07,0.12731298203270214,0.06489994591671175,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
220,0.3,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is birth center care during a woman's first pregnancy linked to changes in her future reproduction? The model of care, including birth center care, during the first pregnancy in Sweden does not seem to be an important determinant of subsequent reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.3,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does the experience of birth center care in a woman's first pregnancy impact her later reproductive decisions? In Sweden, the care model during the first pregnancy, such as birth center care, does not seem to substantially influence future reproduction.",1.8948778188548304e-07,0.1371261655063276,0.03860337907960437,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.3,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Does receiving birth center care during the first pregnancy have an effect on a woman's future reproduction? The evidence from Sweden indicates that birth center care during the initial pregnancy is not a significant factor in later reproduction.,2.1317375462116834e-07,0.27718264269431314,0.04161979696666748,0.016320838183036854,0.3386680814075338,0.08264462809917354,0.0162972138685758,0.3080583930642704,0.056932966023875105,2.1317375462116866e-07,0.2756129546397501,0.029384756657483937
220,0.3,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is there a relationship between birth center care in a woman's first pregnancy and her future reproductive outcomes? In Sweden, the model of care during the first pregnancy, including birth center care, does not appear to affect subsequent reproduction.",1.8948778188548304e-07,0.1371261655063276,0.03860337907960437,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.3,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does birth center care during a woman's first pregnancy have any bearing on her future fertility? The care model during the first pregnancy, such as birth center care, does not seem to be a key factor influencing later reproduction in Sweden.",1.4211583641411244e-07,0.08400879959098795,0.03991638247160983,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.3,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Can the type of care, like birth center care, during a woman's first pregnancy impact her future reproduction? In Sweden, birth center care during the initial pregnancy does not appear to be a significant factor affecting subsequent reproduction.",2.1317375462116834e-07,0.16478039719810456,0.03789377307720558,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
221,0.3,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia negatively impact the results of colon and rectal surgery? Yes, preoperative anemia can worsen the outcomes of colon and rectal surgery. Studies indicate it raises the risk of postoperative complications such as infections, extended hospital stays, and increased mortality rates.",4.737194547137081e-08,0.05252128992545613,0.004182825484764535,0.0036268529295637453,0.08301276041885997,0.025409572112868817,0.003621603081905733,0.0834475231974281,0.02498356344510192,4.737194547137081e-08,0.05001042057466343,0.0
221,0.3,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia detrimental to colon and rectal surgery outcomes? Indeed, preoperative anemia can harm the results of colon and rectal surgery. Research demonstrates it is associated with a higher chance of postoperative complications, including infections, prolonged hospitalization, and greater mortality.",9.474389094274162e-08,0.07325549678650756,0.015493060628195762,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
221,0.3,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia adversely influence the outcomes of colon and rectal surgery? Yes, having anemia before surgery can negatively affect colon and rectal surgery outcomes. Evidence shows it increases the likelihood of postoperative issues like infections, longer hospital admissions, and elevated death rates.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
221,0.3,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does anemia before surgery negatively affect colon and rectal surgery results? Yes, preoperative anemia can lead to poorer outcomes in colon and rectal surgery. Studies reveal it contributes to a higher risk of postoperative complications, such as infections, extended hospital stays, and increased mortality.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
221,0.3,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is there a negative effect of preoperative anemia on colon and rectal surgery outcomes? Yes, anemia prior to surgery can adversely impact colon and rectal surgery results. Research highlights an increased risk of postoperative complications including infections, longer hospitalization, and higher mortality rates.",4.737194547137081e-08,0.01951428132736366,0.018994082840236695,0.0036268529295637453,0.08301276041885997,0.025409572112868817,0.003621603081905733,0.0834475231974281,0.02498356344510192,4.737194547137081e-08,0.05001042057466343,0.0
221,0.3,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does preoperative anemia have a harmful effect on the outcomes of colon and rectal surgery? Yes, anemia before surgery can negatively influence the outcomes of colon and rectal surgery. Studies show it is linked to more postoperative complications, such as infections, prolonged hospital stays, and greater mortality.",4.737194547137081e-08,0.01979435298569765,0.017079119571683538,0.0036268529295637453,0.04552438760914734,0.06480020126234115,0.003621603081905733,0.048000054441462936,0.06781677572873293,4.737194547137081e-08,0.016850758504693975,0.046400951814396206
221,0.3,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Can preoperative anemia worsen the outcomes of colon and rectal surgery? Yes, anemia before surgery can adversely affect colon and rectal surgery outcomes. Research indicates it leads to a higher risk of postoperative complications including infection, longer hospital stays, and increased mortality.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
221,0.3,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia associated with worse outcomes in colon and rectal surgery? Yes, anemia prior to surgery can negatively impact the results of colon and rectal surgery. Evidence suggests it raises the risk of postoperative complications like infections, extended hospital stays, and higher death rates.",0.0,0.06301338005090429,0.0446485260770975,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
221,0.3,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Does having anemia before surgery negatively impact colon and rectal surgery outcomes? Yes, preoperative anemia can adversely affect the outcomes of colon and rectal surgery. Studies confirm it increases the risk of postoperative complications such as infections, longer hospital stays, and elevated mortality.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
221,0.3,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia can adversely affect outcomes of colon and rectal surgery. Research shows it leads to increased risk of postoperative complications, including infection, longer hospital stay, and even higher mortality rate. It","Is preoperative anemia a factor that worsens colon and rectal surgery outcomes? Yes, anemia before surgery can lead to poorer outcomes in colon and rectal surgery. Research shows it is associated with increased postoperative complications including infection, prolonged hospitalization, and higher mortality rates.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
222,0.3,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early indicator of bronchiectasis? Yes, this dysfunction can precede bronchiectasis by hindering bacterial clearance in the lungs, causing ongoing infections and inflammation.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.3,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis lead to bronchiectasis? Indeed, this impairment can act as a precursor by reducing the lungs' ability to eliminate bacteria, resulting in chronic infections and inflammation that may progress to bronchiectasis.",3.316036182995957e-07,0.06691295034490796,0.15737240075614362,0.025387970506946217,0.09472765006220696,0.14366729678638948,0.025351221573340132,0.12363478576513254,0.12901701323251416,3.316036182995957e-07,0.153700517187362,0.113421550094518
222,0.3,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does alveolar macrophage phagocytic dysfunction in children with prolonged bacterial bronchitis signal the onset of bronchiectasis? Yes, because this dysfunction compromises bacterial clearance in the lungs, fostering persistent infections and inflammation that can develop into bronchiectasis.",4.737194547137076e-07,0.2251369555598024,0.15737240075614362,0.03626852929563746,0.2572465795599812,0.14366729678638948,0.036216030819057346,0.29068887042829683,0.12901701323251416,4.737194547137081e-07,0.325550774114022,0.113421550094518
222,0.3,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis a potential forerunner to bronchiectasis? Yes, as this dysfunction diminishes the lungs' capacity to clear bacteria, leading to sustained infections and inflammation that can eventually cause bronchiectasis.",4.500334819780223e-07,0.19696607859310555,0.15737240075614362,0.03445510283085558,0.2282590426867297,0.14366729678638948,0.03440522927810447,0.26083590727861505,0.12901701323251416,4.500334819780227e-07,0.2947791154472683,0.113421550094518
222,0.3,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Could alveolar macrophage phagocytic dysfunction in children with chronic bacterial bronchitis be an early stage of bronchiectasis? Yes, since this dysfunction impairs bacterial clearance in the lungs, it promotes ongoing infections and inflammation that may result in bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.3,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis a precursor to bronchiectasis? Yes, because it weakens the lungs' bacterial clearance, causing persistent infections and inflammation that can lead to bronchiectasis.",4.974054274493929e-07,0.2541244924330539,0.15737240075614362,0.03808195576041934,0.287099542709663,0.14366729678638948,0.03802683236001022,0.3214605290950505,0.12901701323251416,4.974054274493935e-07,0.3572994724286018,0.113421550094518
222,0.3,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Does dysfunction in alveolar macrophage phagocytosis in children with extended bacterial bronchitis precede bronchiectasis? Yes, this dysfunction hampers bacterial removal from the lungs, resulting in chronic infections and inflammation that can culminate in bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
222,0.3,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with long-term bacterial bronchitis an early sign of bronchiectasis? Yes, as it impairs the ability to clear bacteria from the lungs, causing persistent infections and inflammation that may progress to bronchiectasis.",4.26347509242337e-07,0.16956710440499023,0.15737240075614362,0.03264167636607371,0.20008816572003285,0.14366729678638948,0.0325944277371516,0.23184837040536355,0.12901701323251416,4.263475092423373e-07,0.26492615229758654,0.113421550094518
222,0.3,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Can alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis serve as a forerunner to bronchiectasis? Yes, this dysfunction reduces bacterial clearance in the lungs, leading to ongoing infections and inflammation that can eventually cause bronchiectasis.",4.500334819780223e-07,0.19696607859310555,0.15737240075614362,0.03445510283085558,0.2282590426867297,0.14366729678638948,0.03440522927810447,0.26083590727861505,0.12901701323251416,4.500334819780227e-07,0.2947791154472683,0.113421550094518
222,0.3,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Yes, alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis can be a precursor to bronchiectasis. This dysfunction impairs the child's ability to clear bacteria from the lungs, leading to persistent infections and inflammation that can ultimately result","Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis indicative of future bronchiectasis? Yes, because this dysfunction compromises bacterial clearance, resulting in persistent lung infections and inflammation that can develop into bronchiectasis.",5.210914001850782e-07,0.2839774555827357,0.15737240075614362,0.03989538222520122,0.31787120137641667,0.14366729678638948,0.03983763390096309,0.35320922740963034,0.12901701323251416,5.210914001850789e-07,0.3900892952515935,0.113421550094518
223,0.3,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection required for metastatic carcinoma to the cervical nodes when the primary head and neck site is unknown? Yes, neck dissection is frequently needed in such cases to manage regional disease, reduce the risk of further metastasis, and enhance survival rates, though individual assessment is essential to weigh benefits against risks.",4.026615365066519e-07,0.06842762146133374,0.1469816105248248,0.030828249901291835,0.06342857285885861,0.15574022776238844,0.030783626196198732,0.08576000782552295,0.14465989535241613,4.026615365066519e-07,0.10879430376308541,0.13296398891966757
223,0.3,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma in cervical nodes with an unknown primary head and neck origin, is neck dissection necessary? Yes, it is commonly performed to control local disease, prevent additional metastases, and improve patient survival, but decisions should be personalized based on each case.",6.39521263863506e-07,0.25534221481478037,0.1662049861495845,0.04896251454911056,0.28168213887887594,0.15574022776238844,0.0488916416057274,0.3089035591397322,0.14465989535241613,6.39521263863506e-07,0.3370529557440678,0.13296398891966757
223,0.3,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical nodes from an unknown head and neck primary site require neck dissection? Yes, neck dissection is often indicated to manage regional disease, limit metastasis, and increase survival chances, with careful consideration of individual patient factors.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.3,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection needed for metastatic carcinoma in cervical lymph nodes when the primary tumor in the head and neck is unknown? Yes, it is typically necessary to control disease spread, prevent further metastasis, and improve survival outcomes, though each patient should be evaluated on a case-by-case basis.",5.210914001850789e-07,0.14286423138809035,0.1662049861495845,0.0398953822252012,0.16661280909408926,0.15574022776238844,0.039837633900963065,0.19112052348334885,0.14465989535241613,5.210914001850789e-07,0.2164249679554504,0.13296398891966757
223,0.3,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","When metastatic carcinoma affects cervical nodes from an unknown head and neck primary, is neck dissection warranted? Yes, it is generally required to control regional disease, avoid future metastases, and enhance overall survival, but individual risk-benefit analysis is important.",7.342651548062474e-07,0.3554256733717618,0.1662049861495845,0.05621622040823805,0.3843362929389582,0.15574022776238844,0.056134847769538865,0.4142640747975581,0.14465989535241613,7.342651548062476e-07,0.4452665403842988,0.13296398891966757
223,0.3,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Should neck dissection be performed for metastatic carcinoma to cervical nodes with an unknown primary site in the head and neck? Yes, it is often essential for regional disease control, metastasis prevention, and survival improvement, although each case needs individual evaluation.",6.868932093348768e-07,0.3041323789842121,0.1662049861495845,0.052589367478674306,0.33169255945353937,0.15574022776238844,0.05251324468763313,0.3601968535272819,0.14465989535241613,6.868932093348768e-07,0.38969668922948664,0.13296398891966757
223,0.3,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection necessary for metastatic carcinoma involving cervical nodes from an unknown primary head and neck tumor? Yes, it usually plays a key role in managing regional disease, preventing metastasis, and improving survival, with personalized assessment for each patient.",7.105791820705621e-07,0.3294501869685038,0.1662049861495845,0.05440279394345618,0.35766804585679735,0.15574022776238844,0.054324046228586,0.3868651006094428,0.14465989535241613,7.105791820705622e-07,0.41709566341760196,0.13296398891966757
223,0.3,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","For metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary, is neck dissection indicated? Yes, it is commonly needed to control disease locally, reduce metastasis risk, and improve survival, but decisions should be tailored to the individual case.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
223,0.3,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Does metastatic carcinoma to cervical nodes from an unknown head and neck primary site require neck dissection? Yes, neck dissection is often performed to control regional disease, prevent future metastases, and enhance survival, with individualized case evaluation.",7.81637100277618e-07,0.409492894642038,0.1662049861495845,0.0598430733378018,0.4399061440937704,0.15574022776238844,0.059756450851444605,0.47142248863750646,0.14465989535241613,7.816371002776184e-07,0.5041070404072321,0.13296398891966757
223,0.3,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: Yes, neck dissection is often necessary for metastatic carcinoma to the cervical nodes from an unknown head and neck primary site. It aids in controlling regional disease, preventing future metastasis, and improving overall survival. However, each case should be evaluated individually to balance benefits and potential risks.","Is neck dissection recommended for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Yes, it is frequently necessary to manage regional disease, prevent further metastasis, and improve overall survival, though each case should be assessed individually.",6.632072365991914e-07,0.2794397663938404,0.1662049861495845,0.050775941013892434,0.30637475146924764,0.15574022776238844,0.050702443146680265,0.33422136712402395,0.14465989535241613,6.632072365991914e-07,0.36302844214732577,0.13296398891966757
224,0.3,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Emergency laparotomy is associated with a high mortality rate, particularly among patients older than 70, highlighting the need for enhanced outcomes, especially for this demographic. This may require boosting acute surgical staffing and early identification of patients in need.",5.447773729207641e-07,0.4732877044469239,0.0,0.04170880868998307,0.48342664957787385,0.0,0.04164843544191593,0.49401850544960846,0.0,5.447773729207643e-07,0.5050949490570056,0.0
224,0.3,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","The mortality rate following emergency laparotomy is notably high, especially in individuals over 70 years old, indicating a pressing need for improvement in care, potentially through increased acute surgical personnel and prompt patient recognition.",6.632072365991906e-07,0.6143663027068302,0.0,0.050775941013892455,0.628608659422373,0.0,0.05070244314668029,0.6435502394205721,0.0,6.632072365991914e-07,0.6592456288842641,0.0
224,0.3,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","High mortality rates after emergency laparotomy, especially in those above 70, call for urgent improvements, including expanding acute surgical workforce and early detection of patients who need intervention.",8.053230730133024e-07,0.8150369981689809,0.0,0.06165649980258373,0.836248024200617,0.0,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
224,0.3,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Emergency general surgery laparotomies have a significant mortality risk, particularly for patients aged over 70, necessitating efforts to improve outcomes by augmenting surgical staff and early patient identification.",8.053230730133024e-07,0.8150369981689809,0.0,0.06165649980258373,0.836248024200617,0.0,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
224,0.3,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","There is a concerningly high 30-day and 1-year mortality following emergency laparotomies, especially in patients older than 70, underscoring the need for better outcomes through increased acute surgical manpower and timely patient recognition.",6.868932093348759e-07,0.6451379613735839,0.0,0.052589367478674334,0.6603573577369528,0.0,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
224,0.3,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Mortality rates remain high after emergency laparotomy, particularly in the elderly over 70, suggesting a need for enhanced care strategies such as more acute surgical staff and early detection of critical patients.",7.105791820705612e-07,0.6768866596881637,0.0,0.054402793943456214,0.6931471805599445,0.0,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
224,0.3,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Patients undergoing emergency laparotomy face a high risk of death, notably those over 70, indicating a need for improved outcomes via increased acute surgical resources and early patient assessment.",7.816371002776171e-07,0.7786693539981062,0.0,0.05984307333780185,0.79850769621777,0.0,0.05975645085144466,0.8194409058842362,0.0,7.816371002776184e-07,0.841567185678219,0.0
224,0.3,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","The high mortality associated with emergency laparotomy, especially in patients older than 70, points to the necessity of improving care by expanding acute surgical teams and recognizing patients requiring urgent intervention sooner.",7.105791820705612e-07,0.6768866596881637,0.0,0.054402793943456214,0.6931471805599445,0.0,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
224,0.3,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","Emergency laparotomy mortality is alarmingly high in patients over 70, emphasizing the need for better outcomes through increased acute surgical manpower and early identification of at-risk patients.",8.290090457489877e-07,0.8527773261518279,0.0,0.06346992626736561,0.8754687373538994,0.0,0.06337805393335041,0.8994836135577735,0.0,8.290090457489892e-07,0.9249487946172694,0.0
224,0.3,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring","There is a significant concern about mortality rates in emergency laparotomy patients, particularly those over 70, highlighting the importance of improving outcomes by boosting acute surgical care staffing and early patient recognition.",7.105791820705612e-07,0.6768866596881637,0.0,0.054402793943456214,0.6931471805599445,0.0,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
225,0.3,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss caused by amblyopia permanent? Answer: Amblyopia, commonly called lazy eye, usually begins in childhood. Without treatment, it may result in lasting vision impairment. Nevertheless, early diagnosis and interventions such as vision therapy or corrective lenses can frequently reverse the condition, allowing for normal or nearly normal vision restoration.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
225,0.3,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia cause permanent vision loss? Answer: Amblyopia, or lazy eye, typically develops in childhood. If not treated, it can cause permanent vision damage. However, with prompt detection and treatment like vision therapy or glasses, the condition is often reversible, enabling normal or near-normal sight.",9.474389094274162e-08,0.14677089105674668,0.04434829637641968,0.0072537058591274906,0.11851806701508183,0.02271498107084911,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
225,0.3,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss from amblyopia irreversible? Answer: Amblyopia, known as lazy eye, usually begins in childhood. If untreated, it can lead to permanent vision loss. Early detection and treatment, including vision therapy or corrective eyewear, often make it possible to restore normal or nearly normal vision.",7.105791820705622e-08,0.06317890162153228,0.0,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
225,0.3,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can amblyopia cause permanent visual impairment? Answer: Amblyopia, or lazy eye, often starts during childhood. If left untreated, it may result in permanent vision loss. However, early diagnosis and treatment such as vision therapy or corrective glasses can often reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.3,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision loss in amblyopia permanent? Answer: Amblyopia, also called lazy eye, commonly begins in childhood. Without treatment, it can cause lasting vision loss. Yet, with early detection and appropriate treatment like vision therapy or corrective eyewear, the condition can often be reversed to restore normal or near-normal vision.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
225,0.3,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does lazy eye lead to permanent vision loss? Answer: Amblyopia, known as lazy eye, usually develops in childhood. If untreated, it can cause permanent vision impairment. But early detection and treatment, including vision therapy or corrective lenses, can often reverse the condition and restore normal or near-normal vision.",2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
225,0.3,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is vision loss from lazy eye permanent? Answer: Amblyopia, or lazy eye, typically begins in childhood. If left untreated, it can result in permanent vision loss. However, early diagnosis and treatment such as vision therapy or corrective eyewear often allow for reversal of the condition and restoration of normal or near-normal vision.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
225,0.3,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Can vision loss caused by amblyopia be permanent? Answer: Amblyopia, also called lazy eye, generally starts in childhood. If untreated, it can lead to permanent vision loss. However, with early detection and treatment including vision therapy or corrective glasses, the condition can often be reversed to restore normal or near-normal vision.",4.737194547137081e-08,0.04000533461369837,0.0,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
225,0.3,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Is the vision impairment from amblyopia permanent? Answer: Amblyopia, commonly referred to as lazy eye, usually begins in childhood. If left untreated, it can cause permanent vision loss. Nevertheless, early detection and treatment such as vision therapy or corrective eyewear can often reverse the condition and restore normal or near-normal vision.",4.737194547137081e-08,0.04000533461369837,0.0,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
225,0.3,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Amblyopia, also known as lazy eye, often starts during childhood. If left untreated, it can lead to permanent vision loss. However, with early detection and treatment, including vision therapy or corrective eyewear, the condition can often be reversed, restoring normal or near-normal vision.","Question: Does amblyopia result in permanent vision loss? Answer: Amblyopia, or lazy eye, often starts during childhood. Without treatment, it can cause lasting vision impairment. However, early diagnosis and treatment including vision therapy or corrective lenses can often reverse the condition and restore normal or near-normal vision.",7.105791820705622e-08,0.06317890162153228,0.0,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
226,0.3,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it acceptable for student examiners to act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears reasonable and justified to allow medical students to serve as examiners in formative OSCE assessments in emergency medicine, though this may not apply to summative evaluations.",4.737194547137081e-08,0.04348511193973836,0.0,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
226,0.3,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to officiate as examiners during formative emergency medicine OSCEs seems permissible and justified, but this does not necessarily extend to summative assessments.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.3,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems quite acceptable and justified to have medical students act as examiners in formative OSCE testing for emergency medicine, but not necessarily in summative evaluations.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.3,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students serve as reasonable substitute examiners for faculty during an undergraduate OSCE on medical emergencies? It appears justified and appropriate to encourage medical students to officiate in formative emergency medicine OSCEs, although this may not be suitable for summative assessments.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.3,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justified to allow student examiners to replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to act as examiners in formative OSCEs for emergency medicine seems reasonable, but this is not necessarily appropriate for summative evaluations.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
226,0.3,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners be considered reasonable substitutes for faculty in an undergraduate emergency medicine OSCE? It seems both admissible and justified to have medical students officiate in formative OSCE testing, but not necessarily in summative assessments.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
226,0.3,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears justified and acceptable to encourage medical students to serve as examiners in formative emergency medicine OSCEs, though this may not apply to summative evaluations.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.3,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to act as substitutes for faculty in an undergraduate OSCE on medical emergencies? Allowing medical students to officiate in formative OSCE assessments in emergency medicine seems justified, but this may not extend to summative assessments.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
226,0.3,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners be used as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems justified and acceptable to encourage medical students to serve as examiners in formative emergency medicine OSCEs, but not necessarily in summative evaluations.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
226,0.3,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable to have student examiners replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate in formative OSCE testing in emergency medicine appears justified, though this may not be appropriate for summative assessments.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
227,0.3,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.3,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae higher than that of bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.3033591666562172,0.07359999999999998,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.3,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.3,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do preterm infants experience more noise from high flow nasal cannulae than from bubble CPAP? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.3,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is there more noise from high flow nasal cannulae than bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.3,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP when used with preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.3,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Does the use of high flow nasal cannulae generate more noise than bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.2725875079894635,0.07359999999999998,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,0.3,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae associated with higher noise levels than bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.3,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise from high flow nasal cannulae greater than that from bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.2725875079894635,0.07359999999999998,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,0.3,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: For preterm infants, do high flow nasal cannulae create more noise than bubble CPAP? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
228,0.3,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Yes, the coexistence of these disorders in adolescents typically worsens depression outcomes, intensifying symptoms and complicating treatment, which may cause more severe and enduring effects.",5.921493183921352e-07,0.2935593657804856,0.13488520408163265,0.045335661619546816,0.3436954914825394,0.1077254539858418,0.045270038523821665,0.39552520467150565,0.07877526753864447,5.921493183921352e-07,0.44913771299183836,0.048261993679977015
228,0.3,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is comorbidity of major depression and alcohol use disorder in adolescence associated with poorer depression outcomes? Indeed, adolescents with both conditions tend to experience more severe depression symptoms, making treatment more difficult and leading to more persistent and serious consequences.",6.158352911278205e-07,0.3188771737647773,0.13488520408163265,0.04714908808432869,0.3696709778857974,0.1077254539858418,0.04708084006477453,0.4221934517536665,0.07877526753864447,6.158352911278206e-07,0.4765366871799537,0.048261993679977015
228,0.3,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the combination of major depression and alcohol use disorder in adolescence lead to worse depression prognosis? Yes, when both disorders occur together in adolescents, they often aggravate depression symptoms and severity, complicating effective treatment and resulting in more significant and lasting impacts.",5.447773729207643e-07,0.24476920161105387,0.13488520408163265,0.04170880868998307,0.293685070907876,0.1077254539858418,0.04164843544191593,0.34423191028395594,0.07877526753864447,5.447773729207643e-07,0.3964939795064195,0.048261993679977015
228,0.3,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Are depression outcomes poorer in adolescents with both major depression and alcohol use disorder? Yes, the simultaneous presence of these disorders during adolescence generally leads to more severe depression symptoms and challenges in treatment, which can cause deeper and longer-lasting effects.",5.921493183921352e-07,0.2935593657804856,0.13488520408163265,0.045335661619546816,0.3436954914825394,0.1077254539858418,0.045270038523821665,0.39552520467150565,0.07877526753864447,5.921493183921352e-07,0.44913771299183836,0.048261993679977015
228,0.3,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder during adolescence cause more adverse depression outcomes? Yes, having both disorders concurrently in adolescence frequently intensifies depression severity, making treatment more challenging and potentially causing more profound and enduring effects.",6.395212638635058e-07,0.3448526601680353,0.13488520408163265,0.04896251454911056,0.39633922496795826,0.1077254539858418,0.0488916416057274,0.44959242594178184,0.07877526753864447,6.39521263863506e-07,0.5047075641466505,0.048261993679977015
228,0.3,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Is the prognosis for depression worse in adolescents with both major depression and alcohol use disorder? Yes, the coexistence of these conditions often exacerbates depression symptoms and complicates treatment, leading to more severe and lasting outcomes.",7.105791820705617e-07,0.4270907584050083,0.13488520408163265,0.054402793943456186,0.48089661299602193,0.1077254539858418,0.05432404622858601,0.536603802931412,0.07877526753864447,7.105791820705622e-07,0.5943197228363375,0.048261993679977015
228,0.3,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does the presence of both major depression and alcohol use disorder in adolescence result in poorer depression outcomes? Yes, adolescents experiencing both disorders simultaneously usually face more severe depression symptoms and treatment difficulties, which may lead to more significant and persistent effects.",5.684633456564497e-07,0.2688667531901139,0.13488520408163265,0.04352223515476494,0.3183776834982477,0.1077254539858418,0.0434592369828688,0.3695497182682477,0.07877526753864447,5.684633456564497e-07,0.4224694659096775,0.048261993679977015
228,0.3,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does comorbidity of major depression and alcohol use disorder in adolescence contribute to worse depression outcomes? Yes, the concurrent occurrence of these disorders often worsens depression severity and complicates treatment, resulting in more profound and lasting impacts.",6.868932093348764e-07,0.3989198814383115,0.13488520408163265,0.052589367478674306,0.4519090761227704,0.1077254539858418,0.05251324468763314,0.5067508397817302,0.07877526753864447,6.868932093348768e-07,0.5635480641695838,0.048261993679977015
228,0.3,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Are depression outcomes negatively affected by the coexistence of major depression and alcohol use disorder in adolescence? Yes, having both disorders at the same time during adolescence typically leads to more severe symptoms and treatment challenges, causing more enduring and serious effects.",5.684633456564497e-07,0.2688667531901139,0.13488520408163265,0.04352223515476494,0.3183776834982477,0.1077254539858418,0.0434592369828688,0.3695497182682477,0.07877526753864447,5.684633456564497e-07,0.4224694659096775,0.048261993679977015
228,0.3,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Yes, comorbidity of major depression and alcohol use disorder in adolescence often leads to poorer outcomes of depression. The concurrent presence of both disorders may exacerbate the symptoms and severity of depression, making it more challenging to treat effectively and potentially leading to more profound and lasting effects.","Does having both major depression and alcohol use disorder during adolescence lead to poorer outcomes for depression? Yes, the simultaneous presence of these disorders in adolescents often intensifies depression symptoms and severity, making effective treatment more difficult and potentially causing more lasting and severe effects.",4.974054274493935e-07,0.19824918597615993,0.13488520408163265,0.038081955760419325,0.24605702191862155,0.1077254539858418,0.0380268323600102,0.29544174611452423,0.07877526753864447,4.974054274493935e-07,0.3464835589317561,0.048261993679977015
229,0.3,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can severe hypotensive episodes trigger myocardial ischemic events in patients with coronary disease? Yes, significant drops in blood pressure can reduce coronary blood flow, leading to myocardial ischemia due to insufficient oxygen and nutrients for the heart muscle.",4.26347509242337e-07,0.21997780844571313,0.12456597222222221,0.03264167636607371,0.30277663691409806,0.0736,0.0325944277371516,0.38878735468308667,0.018860946745562133,4.263475092423373e-07,0.42488319396526597,0.0
229,0.3,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Do profound hypotensive events in coronary disease patients cause myocardial ischemia? Indeed, severe hypotension can lower coronary perfusion, increasing the risk of ischemic damage to the heart muscle.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.3,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is there a link between profound hypotension and myocardial ischemic events in coronary disease? Yes, drastic decreases in blood pressure may impair coronary circulation, resulting in myocardial ischemia.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.3,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can myocardial ischemic events be caused by severe hypotension in patients with coronary artery disease? Yes, because hypotension reduces blood flow to the heart muscle, potentially causing ischemia.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.3,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Does profound hypotension lead to myocardial ischemia in individuals with coronary disease? Yes, low blood pressure can diminish coronary blood flow, risking insufficient oxygen supply to the heart muscle.",6.395212638635047e-07,0.49869121091473456,0.12456597222222221,0.04896251454911062,0.5904587093658789,0.0736,0.04889164160572746,0.6860388781510176,0.018860946745562133,6.39521263863506e-07,0.7323678937132279,0.0
229,0.3,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Are myocardial ischemic events possible due to profound hypotension in coronary disease patients? Yes, significant hypotensive episodes can compromise coronary blood flow, causing ischemia in the heart muscle.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.3,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can severe hypotensive events induce myocardial ischemia in patients suffering from coronary disease? Yes, because hypotension decreases coronary perfusion, which may lead to ischemic injury of the heart muscle.",6.395212638635047e-07,0.49869121091473456,0.12456597222222221,0.04896251454911062,0.5904587093658789,0.0736,0.04889164160572746,0.6860388781510176,0.018860946745562133,6.39521263863506e-07,0.7323678937132279,0.0
229,0.3,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Is myocardial ischemia a consequence of profound hypotension in patients with coronary disease? Yes, as hypotension can reduce the oxygen and nutrient supply by lowering coronary blood flow.",6.6320723659919e-07,0.5350588550856092,0.12456597222222221,0.050775941013892496,0.6281990373487258,0.0736,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
229,0.3,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Can profound hypotension cause myocardial ischemic events in coronary disease patients? Yes, because it can reduce coronary blood flow, leading to inadequate oxygenation of the heart muscle.",6.868932093348753e-07,0.5727991830684562,0.12456597222222221,0.052589367478674376,0.6674197505020083,0.0736,0.05251324468763321,0.7660815858245549,0.018860946745562133,6.868932093348768e-07,0.8157495026522783,0.0
229,0.3,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Yes, profound hypotensive events in patients with coronary disease can potentially cause myocardial ischaemic events. Hypotension can decrease coronary blood flow, increasing the risk of myocardial ischaemia, where the heart muscle doesn't receive enough oxygen and nutrients to function properly.","Does profound hypotension in coronary disease patients increase the risk of myocardial ischemia? Yes, as it can decrease coronary circulation, resulting in insufficient oxygen and nutrients to the heart muscle.",6.158352911278194e-07,0.46359989110346556,0.12456597222222221,0.04714908808432874,0.5540910651950042,0.0736,0.04708084006477459,0.6482985501681706,0.018860946745562133,6.158352911278206e-07,0.6931471805599454,0.0
230,0.3,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to yield positive results compared to the general population, suggesting that physicians might consider recommending more systematic screening for these patients.",1.6580180914979784e-07,0.0725101167401263,0.03121748178980229,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
230,0.3,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it advisable to screen HIV-infected males older than 52 with two or more cardiovascular risk factors for silent myocardial ischemia via gated myocardial perfusion SPECT? The likelihood of a positive SMI screening in this group was approximately four times higher than in the general population, which could encourage physicians to implement more routine screening.",2.3685972735685406e-07,0.12657733801040116,0.03121748178980229,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
230,0.3,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-infected patients above 52 years with at least two other cardiovascular risk factors, should silent myocardial ischemia screening using gated myocardial perfusion SPECT be performed? This population showed about a fourfold increase in positive screening results compared to the general population, potentially prompting physicians to recommend more systematic screening.",3.316036182995957e-07,0.20353837914653106,0.03121748178980229,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
230,0.3,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should silent myocardial ischemia screening with myocardial SPECT be conducted in male HIV-infected patients older than 52 who have at least two additional cardiovascular risk factors? Such screening was nearly four times more likely to be positive than in the general population, motivating physicians to advise more consistent screening.",3.789755637709665e-07,0.24436037366678542,0.03121748178980229,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
230,0.3,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","In male HIV-infected patients over 52 years old with two or more cardiovascular risk factors, is screening for silent myocardial ischemia using gated myocardial perfusion SPECT justified? The screening positivity rate was about four times higher than in the general population, which may lead physicians to suggest more systematic screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.3,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is screening for silent myocardial ischemia using gated myocardial perfusion SPECT warranted in male HIV-infected patients older than 52 with at least two other cardiovascular risk factors? This group had roughly four times the likelihood of positive results compared to the general population, encouraging physicians to recommend more thorough screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
230,0.3,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should physicians screen male HIV-infected patients aged over 52 with two or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Positive screening was about four times more common in this group than in the general population, possibly prompting more systematic screening recommendations.",4.263475092423373e-07,0.28691998808558195,0.03121748178980229,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
230,0.3,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","For male HIV-infected patients older than 52 years with at least two additional cardiovascular risk factors, is gated myocardial perfusion SPECT screening for silent myocardial ischemia advisable? The chance of positive screening was approximately four times greater than in the general population, which might motivate physicians to pursue more systematic screening.",3.316036182995957e-07,0.20353837914653106,0.03121748178980229,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
230,0.3,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Is it beneficial to screen male HIV-infected patients over 52 with two or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening positivity was about four times higher than in the general population, potentially encouraging physicians to recommend more systematic screening.",4.500334819780227e-07,0.30889889480435695,0.03121748178980229,0.03445510283085558,0.35894509247327333,0.0,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
230,0.3,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for","Should silent myocardial ischemia screening via gated myocardial perfusion SPECT be considered for male HIV-infected patients older than 52 with at least two cardiovascular risk factors? This population showed a fourfold increase in positive screening results compared to the general population, which may lead physicians to advise more systematic screening.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
231,0.3,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is generally regarded as less invasive than retropubic radical prostatectomy.",9.47438909427412e-08,0.1264088932565297,0.1573553719008265,0.007253705859127518,0.14772276350701796,0.20408163265306126,0.007243206163811494,0.04622197089373836,0.14876033057851235,9.474389094274162e-08,0.06344983825518646,0.0793950850661626
231,0.3,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? Yes, it is considered to be less invasive.",1.8948778188548245e-07,0.059611866555897564,0.24000000000000005,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.3,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Yes, it is viewed as less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.3,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic approach? Yes, it is typically seen as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.3,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is considered less invasive.",1.658018091497971e-07,0.10840203072532884,0.24000000000000005,0.012693985253473157,0.007960821131858697,0.20408163265306126,0.012675610786670115,0.100381503298137,0.14876033057851235,1.6580180914979768e-07,0.21760051808244318,0.0793950850661626
231,0.3,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy a minimally invasive alternative to retropubic radical prostatectomy? Yes, it is considered less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.3,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is generally accepted as less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.3,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is recognized as a less invasive method.",1.8948778188548245e-07,0.009702851500096976,0.1901385041551247,0.014507411718255037,0.04333247325569145,0.20408163265306126,0.014486412327622988,0.1544487245684123,0.14876033057851235,1.8948778188548304e-07,0.274758931922392,0.0793950850661626
231,0.3,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is thought to be less invasive.",2.131737546211678e-07,0.008318572168347416,0.24000000000000005,0.016320838183036916,0.09739969452596675,0.20408163265306126,0.01629721386857586,0.2116071384083611,0.14876033057851235,2.131737546211684e-07,0.335383553738827,0.0793950850661626
231,0.3,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is considered less invasive than retropubic radical prostatectomy. The","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is regarded as less invasive.",2.3685972735685316e-07,0.045748649101927885,0.24000000000000005,0.018134264647818792,0.15455810836591555,0.20408163265306126,0.018108015409528732,0.2722317602247961,0.14876033057851235,2.3685972735685374e-07,0.39992207487639764,0.0793950850661626
232,0.3,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","The Nd:YAG laser-induced thermo therapy represents an innovative method in glioma treatment, enabling local opening of the rodent blood-brain barrier.",6.158352911278184e-07,0.7081908038127809,0.109375,0.04714908808432881,0.7992978059457401,0.06781677572873293,0.04708084006477466,0.895747367890372,0.023242630385487524,6.158352911278203e-07,0.9650808960435868,0.0
232,0.3,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","In glioma therapy, Nd:YAG laser-induced thermo therapy is a new technique that locally disrupts the rodent blood-brain barrier.",6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.3,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy introduces a novel concept in glioma treatment by locally opening the rodent blood-brain barrier.,6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
232,0.3,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",A new glioma treatment approach involves Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.3,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","The use of Nd:YAG laser-induced thermo therapy in glioma therapy allows for local opening of the rodent blood-brain barrier, presenting a novel concept.",5.447773729207624e-07,0.5615873296209055,0.109375,0.04170880868998317,0.6451471261184833,0.06781677572873293,0.041648435441916036,0.7332284383925978,0.023242630385487524,5.447773729207642e-07,0.7932306391169277,0.0
232,0.3,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy is a pioneering glioma therapy method that locally opens the rodent blood-brain barrier.,6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.3,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Local opening of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy is a new strategy in glioma treatment.,6.395212638635038e-07,0.7622580250830562,0.109375,0.048962514549110686,0.8564562197856889,0.06781677572873293,0.04889164160572752,0.956371989706807,0.023242630385487524,6.395212638635056e-07,1.0296194171811575,0.0
232,0.3,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","Glioma therapy has been advanced by Nd:YAG laser-induced thermo therapy, which locally opens the rodent blood-brain barrier.",6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.3,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the","The novel glioma therapy technique, Nd:YAG laser-induced thermo therapy, facilitates local opening of the rodent blood-brain barrier.",6.868932093348744e-07,0.88004106073944,0.109375,0.05258936747867443,0.9816193627396945,0.06781677572873293,0.05251324468763327,1.0899033823313298,0.023242630385487524,6.868932093348764e-07,1.1727202608218308,0.0
232,0.3,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The Nd:YAG laser-induced thermo therapy is a novel approach in glioma therapy, where the rodent blood-brain barrier is locally opened to allow the",Nd:YAG laser-induced thermo therapy is a cutting-edge approach in glioma treatment that locally opens the rodent blood-brain barrier.,6.632072365991891e-07,0.819416438923005,0.109375,0.05077594101389256,0.9170808416021239,0.06781677572873293,0.050702443146680404,1.0209105108443777,0.023242630385487524,6.63207236599191e-07,1.0986122886681096,0.0
233,0.3,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a unique clinical condition? Answer: Yes, colorectal cancer in young patients is regarded as a unique clinical condition. It usually exhibits more aggressive behavior and is frequently detected at later stages. Genetic predisposition,",0.0,0.035546009259483924,0.0233278046269553,0.0,0.03648143055578679,0.025438881434926924,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
233,0.3,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Does colorectal cancer in young individuals represent a separate clinical entity? Answer: Yes, colorectal cancer in young individuals is recognized as a separate clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.004896299886270938,0.019896193771626353,0.0018134264647818726,0.006764258967317804,0.022857142857142895,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
233,0.3,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in younger patients considered a distinct clinical entity? Answer: Yes, colorectal cancer in younger patients is viewed as a distinct clinical entity. It often shows more aggressive characteristics and is commonly diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.004896299886270938,0.019896193771626353,0.0018134264647818726,0.006764258967317804,0.022857142857142895,0.0018108015409528666,0.008827198864009844,0.025462962962962975,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
233,0.3,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients classified as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is classified as a distinct clinical entity. It tends to be more aggressive and is usually diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
233,0.3,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young people a distinct clinical entity? Answer: Yes, colorectal cancer in young people is considered a distinct clinical entity. It generally behaves more aggressively and is often diagnosed at advanced stages. Genetic predisposition,",4.73719454713706e-08,0.09971817818041284,0.03065488299745442,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.3,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients identified as a unique clinical entity? Answer: Yes, colorectal cancer in young patients is identified as a unique clinical entity. It tends to be more aggressive and is frequently diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
233,0.3,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients regarded as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is regarded as a distinct clinical entity. It is typically more aggressive and is often diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.07421101794226592,0.06206747404844293,0.0018134264647818726,0.0778562774862861,0.07039298363973687,0.0018108015409528666,0.08179005997558386,0.07680005553419625,2.3685972735685406e-08,0.0475358561426904,0.05387755102040818
233,0.3,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients seen as a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is seen as a distinct clinical entity. It tends to be more aggressive and is commonly diagnosed at advanced stages. Genetic predisposition,",4.7371945471370706e-08,0.042755993834235895,0.05822220315771748,0.0036268529295637453,0.04720656811307311,0.06696137278440792,0.003621603081905733,0.05207288838711488,0.07421831695641223,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
233,0.3,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients considered a unique clinical entity? Answer: Yes, colorectal cancer in young patients is considered a unique clinical entity. It often presents more aggressively and is usually diagnosed at advanced stages. Genetic predisposition,",2.36859727356853e-08,0.10361545399634364,0.04938537207133578,0.0018134264647818726,0.10456103124181393,0.053468590561224494,0.0018108015409528666,0.10545608911603743,0.055638455259667374,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,0.3,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Yes, colorectal cancer in young patients is considered a distinct clinical entity. It tends to be more aggressive and is often diagnosed at advanced stages. Genetic predisposition,","Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Yes, colorectal cancer in young patients is a separate clinical entity. It tends to be more aggressive and is frequently diagnosed at advanced stages. Genetic predisposition,",4.73719454713706e-08,0.09971817818041284,0.03065488299745442,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
234,0.3,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can analyzing APC mutations aid in making therapeutic decisions for familial adenomatous polyposis? Yes, analyzing APC mutations can assist in therapeutic decision-making for familial adenomatous polyposis by identifying mutation types, guiding targeted therapy choices, and predicting disease progression to tailor treatments.",2.6054570009253947e-07,0.1641176757231788,0.052667775040228584,0.0199476911126006,0.15319805448308266,0.06663638174694683,0.019918816950481533,0.14106725176220847,0.08098765432098766,2.6054570009253947e-07,0.17363970069367252,0.06222222222222222
234,0.3,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis useful for therapeutic decision-making in familial adenomatous polyposis? Indeed, APC mutation analysis is valuable in therapeutic decisions for familial adenomatous polyposis as it helps pinpoint mutation types, directs targeted therapy selection, and forecasts disease progression for personalized care.",2.3685972735685406e-07,0.10223179978568853,0.0787185256985508,0.018134264647818726,0.09144558700781902,0.09278503159622034,0.018108015409528666,0.11509176535895049,0.08098765432098766,2.3685972735685406e-07,0.14697145361151165,0.06222222222222222
234,0.3,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis play a role in therapy decisions for familial adenomatous polyposis? Yes, it does. APC mutation analysis aids in determining mutation specifics, selecting appropriate targeted therapies, and anticipating disease progression, facilitating individualized treatment plans.",3.5528959103528067e-07,0.2078651086645662,0.09606988533968605,0.02720139697172809,0.2299280309220566,0.08922188223855411,0.027162023114293006,0.252292886872433,0.08098765432098766,3.552895910352811e-07,0.28805005187141797,0.06222222222222222
234,0.3,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can therapeutic decisions in familial adenomatous polyposis benefit from APC mutation analysis? Yes, APC mutation analysis contributes by identifying mutation types, guiding targeted treatment options, and predicting how the disease will progress, enabling customized therapies.",4.0266153650665127e-07,0.2287805326713146,0.12204845048151008,0.03082824990129185,0.24916012062727866,0.11776859504132227,0.030783626196198753,0.3129175086888685,0.08098765432098766,4.026615365066519e-07,0.3505704088527515,0.06222222222222222
234,0.3,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis beneficial for therapeutic strategies in familial adenomatous polyposis? Yes, it helps by revealing the mutation type, informing targeted therapy choices, and predicting disease course, thus supporting personalized treatment approaches.",4.5003348197802187e-07,0.24863179092540033,0.15143320713899402,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.3,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does analyzing APC mutations help in therapeutic decision-making for familial adenomatous polyposis? Yes, APC mutation analysis assists by identifying mutation variants, guiding therapy selection, and forecasting disease progression to enable tailored treatment plans.",4.5003348197802187e-07,0.24863179092540033,0.15143320713899402,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.3,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can APC mutation analysis influence treatment decisions in familial adenomatous polyposis? Yes, it can. This analysis helps identify mutation types, select targeted therapies, and predict disease progression, allowing for personalized treatment strategies.",4.7371945471370717e-07,0.28038048923998016,0.15143320713899402,0.03626852929563749,0.34447030043160387,0.11776859504132227,0.036216030819057374,0.41135758150212176,0.08098765432098766,4.737194547137081e-07,0.45235310316269395,0.06222222222222222
234,0.3,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Is APC mutation analysis a useful tool for therapeutic decisions in familial adenomatous polyposis? Yes, it is. It aids in mutation identification, guides targeted therapy selection, and predicts disease progression, facilitating individualized treatment plans.",4.2634750924233657e-07,0.21786013225864664,0.15143320713899402,0.03264167636607373,0.27993177929403235,0.11776859504132227,0.03259442773715163,0.3446662070034483,0.08098765432098766,4.263475092423373e-07,0.3833602316757432,0.06222222222222222
234,0.3,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Can therapeutic decision-making in familial adenomatous polyposis be improved by APC mutation analysis? Yes, APC mutation analysis improves decisions by identifying mutation types, guiding targeted therapies, and predicting disease progression for personalized care.",4.5003348197802187e-07,0.2919534897103979,0.12021572534919173,0.03445510283085561,0.31168047760861217,0.11776859504132227,0.0344052292781045,0.37745602982644,0.08098765432098766,4.500334819780227e-07,0.41726178335142494,0.06222222222222222
234,0.3,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis. It can help identify the specific type of mutation, guide the selection of targeted therapies, and predict the disease's progression, thus enabling personalized treatment plans.","Does APC mutation analysis contribute to treatment planning in familial adenomatous polyposis? Yes, it contributes by detecting mutation types, informing targeted therapy choices, and forecasting disease progression, enabling customized treatment plans.",4.974054274493925e-07,0.31317031206297186,0.15143320713899402,0.03808195576041937,0.37837185210728563,0.11776859504132227,0.03802683236001025,0.44644890131339077,0.08098765432098766,4.974054274493935e-07,0.48872074733356863,0.06222222222222222
235,0.3,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might trade quality of life for experimental therapy.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.3,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Older adults in PICT with a higher symptom burden may compromise their quality of life for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.3,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection in phase I clinical trials? Answer: Older adults enrolled in PICT experiencing more symptoms might give up quality of life for experimental treatment.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
235,0.3,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence relevant for patient inclusion in phase I clinical trials? Answer: Older adults with more symptoms in PICT may sacrifice quality of life to undergo experimental treatment.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.3,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor when evaluating patients for phase I clinical trials? Answer: Older adults in PICT who have more symptoms could trade off quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.3,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with increased symptoms may give up quality of life for experimental therapy.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.3,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom severity be assessed when selecting patients for phase I clinical trials? Answer: Older adults in PICT with more symptoms might sacrifice their quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.3,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is it important to consider symptoms when enrolling patients in phase I clinical trials? Answer: Older adults with more symptoms in PICT may compromise quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.3,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms matter in the selection of patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might sacrifice quality of life for experimental therapy.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.3,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms significant when deciding on patients for phase I clinical trials? Answer: Older adults enrolled in PICT with a greater number of symptoms may trade quality of life for experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
236,0.3,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely",Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times higher than less experienced surgeons. This suggests that experience may be crucial in minimizing the risk of secondary TURP caused by recurring or incompletely removed adenomas.,1.4211583641411244e-07,0.10724553035359774,0.0,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
236,0.3,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the proficiency in transurethral resection of the prostate dependent on the surgeon's previous experience? The senior urologist resected tissue four times faster than the less experienced surgeons, indicating that experience might be key to lowering the chance of secondary TURP due to recurring or partially removed adenomas.",2.8423167282822487e-07,0.22738984219566083,0.0,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
236,0.3,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does prior surgical experience impact the ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time compared to less experienced surgeons, implying that experience could be important in reducing the risk of secondary TURP from recurring or incompletely resected adenomas.",2.6054570009253947e-07,0.20633643299782767,0.0,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
236,0.3,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the skill in performing transurethral resection of the prostate influenced by the surgeon's experience? The senior urologist was able to resect tissue at a rate four times greater than that of less experienced surgeons, suggesting that experience may help decrease the risk of secondary TURP caused by recurring or incompletely removed adenomas.",1.6580180914979784e-07,0.12629372532429084,0.0,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
236,0.3,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does the surgeon's previous experience affect their ability to perform transurethral resection of the prostate? The senior urologist resected tissue four times faster than less experienced surgeons, indicating that experience might be important to reduce the risk of secondary TURP due to recurring or incompletely excised adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.3,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the capability to perform transurethral resection of the prostate influenced by the surgeon's prior experience? The senior urologist resected tissue at a rate four times higher than less experienced surgeons, suggesting that experience is likely important in lowering the risk of secondary TURP from recurring or incompletely removed adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.3,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does experience affect a surgeon's ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per time unit than less experienced surgeons, implying that experience may be crucial to reduce the risk of secondary TURP caused by recurring or incompletely resected adenomas.",2.8423167282822487e-07,0.22738984219566083,0.0,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
236,0.3,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the proficiency in transurethral resection of the prostate influenced by the surgeon's experience level? The senior urologist resected tissue four times faster than less experienced surgeons, suggesting that experience could be key to minimizing the risk of secondary TURP due to recurring or incompletely removed adenomas.",3.079176455639103e-07,0.2488960474166242,0.0,0.023574544042164344,0.25378052077609947,0.0,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
236,0.3,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Does a surgeon's experience impact their ability to perform transurethral resection of the prostate? The senior urologist was able to resect tissue four times more quickly than less experienced surgeons, indicating that experience may be important in reducing the risk of secondary TURP caused by recurring or incompletely excised adenomas.",2.3685972735685406e-07,0.1857171457950919,0.0,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
236,0.3,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely","Is the ability to perform transurethral resection of the prostate affected by the surgeon's previous experience? The senior urologist resected tissue at a rate four times greater than less experienced surgeons, suggesting that experience might be essential to lower the risk of secondary TURP due to recurring or incompletely removed adenomas.",2.1317375462116866e-07,0.1655144384775733,0.0,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
237,0.3,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and an antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not seem to enhance IVF outcomes in the microdose leuprolide protocol relative to standard oral contraceptive pills in poor responders. Well-powered randomized trials are warranted to determine the best steroid pretreatment approach.,7.105791820705622e-08,0.12360605032511085,0.05140224725425495,0.005440279394345618,0.0753673119857785,0.0184793083900227,0.0054324046228586,0.05160634347521231,0.0008471837488457888,7.105791820705622e-08,0.05129329438754926,0.0
237,0.3,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol plus antagonist pretreatment before microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Estradiol and antagonist pretreatment does not improve IVF results in poor responders undergoing the microdose leuprolide protocol when compared to oral contraceptive pill pretreatment. Adequately powered randomized studies are needed to identify the optimal steroid pretreatment method.,1.1842986367842703e-07,0.13997974226249443,0.03964072630987531,0.009067132323909363,0.11232680538276352,0.02024691358024691,0.009054007704764333,0.0875512928191915,0.0014623507805325946,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.3,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does estradiol and antagonist pretreatment prior to microdose leuprolide enhance IVF success in poor responders versus oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not appear to improve IVF outcomes in poor responders using the microdose leuprolide protocol compared to oral contraceptive pills. Randomized controlled trials with sufficient sample size are justified to explore the best steroid pretreatment strategy.,4.737194547137081e-08,0.05859432262981734,0.018414815105983598,0.0036268529295637453,0.034280461920969785,0.0010714757563747151,0.003621603081905733,0.010610283200052528,0.016388888888888897,4.737194547137081e-08,0.03390155167568043,0.0
237,0.3,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol and antagonist pretreatment before microdose leuprolide in IVF: does it improve outcomes in poor responders compared to oral contraceptive pills? Answer: The combination of estradiol and antagonist pretreatment does not seem to offer better IVF outcomes than oral contraceptive pills in poor responders following the microdose leuprolide protocol. Further large-scale randomized trials are needed to determine optimal steroid pretreatment.,7.105791820705622e-08,0.10050114430644586,0.03585627393518963,0.005440279394345618,0.0753673119857785,0.0184793083900227,0.0054324046228586,0.05160634347521231,0.0008471837488457888,7.105791820705622e-08,0.05129329438754926,0.0
237,0.3,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol plus antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pill use? Answer: Estradiol and antagonist pretreatment does not improve IVF outcomes in poor responders undergoing the microdose leuprolide protocol relative to standard oral contraceptive pill pretreatment. Randomized trials with adequate power are justified to find the best steroid pretreatment approach.,7.105791820705622e-08,0.1236060503251104,0.05140224725425495,0.005440279394345618,0.12236034117628147,0.05179698216735252,0.0054324046228586,0.09940959730693333,0.03518135904499541,7.105791820705622e-08,0.09993520179526527,0.035041322314049606
237,0.3,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is there an improvement in IVF outcomes for poor responders with estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptive pills? Answer: Estradiol and antagonist pretreatment does not appear to enhance IVF outcomes in poor responders using the microdose leuprolide protocol versus oral contraceptive pills. Well-powered randomized studies are warranted to identify the optimal steroid pretreatment method.,7.105791820705622e-08,0.10050114430644541,0.03585627393518963,0.005440279394345618,0.051870797390526135,0.0016343490304709246,0.0054324046228586,0.05160634347521231,0.0008471837488457888,7.105791820705622e-08,0.05129329438754926,0.0
237,0.3,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does estradiol and antagonist pretreatment before microdose leuprolide improve IVF results in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not improve IVF outcomes in poor responders under the microdose leuprolide protocol compared to oral contraceptive pills. Randomized controlled trials with sufficient power are justified to determine the best steroid pretreatment strategy.,1.1842986367842703e-07,0.18778299609421456,0.07116225849217604,0.009067132323909363,0.13664775908662152,0.03755349867489421,0.009054007704764333,0.0875512928191915,0.0014623507805325946,1.1842986367842703e-07,0.08701137698962835,0.0
237,0.3,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Estradiol plus antagonist pretreatment prior to microdose leuprolide: does it enhance IVF outcomes in poor responders compared to oral contraceptive pills? Answer: The use of estradiol and antagonist pretreatment does not seem to improve IVF outcomes in poor responders compared to oral contraceptive pills in the microdose leuprolide protocol. Further randomized trials with adequate sample size are needed to explore optimal steroid pretreatment.,0.0,0.08801868959491266,0.06011362135024438,0.0,0.11179793234837954,0.07885215794306702,0.0,0.11363068533769649,0.08080119375573919,0.0,0.1155245300933232,0.08264462809917351
237,0.3,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Estradiol and antagonist pretreatment does not appear to improve IVF success in poor responders undergoing the microdose leuprolide protocol relative to oral contraceptive pills. Randomized trials with sufficient power are justified to study the best steroid pretreatment method.,9.474389094274162e-08,0.14354603725419235,0.05348155675970233,0.0072537058591274906,0.09367708230690219,0.01934802571166211,0.007243206163811466,0.04509645927122108,0.016388888888888897,9.474389094274162e-08,0.06899287148694988,0.0
237,0.3,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.,Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide effective in improving IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with estradiol and antagonist does not improve IVF outcomes in poor responders using the microdose leuprolide protocol compared to oral contraceptive pills. Adequately powered randomized trials are warranted to determine the optimal steroid pretreatment approach.,9.474389094274162e-08,0.1905390664446971,0.08365705232807767,0.0072537058591274906,0.16538196305448238,0.06984878369493755,0.007243206163811466,0.11805932038279465,0.036080246913580215,9.474389094274162e-08,0.09374812793551968,0.017851239669421492
238,0.3,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Is pain reduced in newborns undergoing minimal access major surgery? Answer: Minimal access major surgery in newborns is typically thought to result in less pain compared to conventional open surgery because,2.36859727356853e-08,0.007380578007353478,0.02678571428571426,0.0018134264647818796,0.05515788395773269,0.062369567327525556,0.0018108015409528735,0.05851807239897733,0.06632653061224487,2.3685972735685406e-08,0.012711934020451121,0.03443877551020409
238,0.3,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Question: Does minimal access major surgery cause less pain in newborns? Answer: Generally, minimal access major surgery in newborns is believed to be less painful than traditional open surgery due to",4.73719454713706e-08,0.029881162109572923,0.023683547493071277,0.003626852929563759,0.028140363344059782,0.02707615968197981,0.003621603081905747,0.026083760309430826,0.030661235687690698,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,0.3,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Question: Is there less pain with minimal access major surgery in newborns? Answer: Minimal access major surgery in newborns usually leads to less pain than open surgery, as",1.184298636784265e-07,0.2533334196405743,0.05317085511890712,0.009067132323909398,0.20169018931328875,0.017758284788395473,0.009054007704764368,0.20080548160888778,0.013068554453917719,1.1842986367842703e-07,0.1992010108534683,0.007149126191119168
238,0.3,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Does minimal access major surgery hurt less for newborns? Answer: Newborns undergoing minimal access major surgery generally experience less pain than those having traditional open surgery because,1.184298636784265e-07,0.15064494844650955,0.013073979591836732,0.009067132323909398,0.14837117542406375,0.01927437641723359,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.3,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Is pain minimized in newborns by minimal access major surgery? Answer: Minimal access major surgery is generally considered to cause less pain in newborns than open surgery due to,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.3,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Does minimal access major surgery reduce pain in newborns? Answer: Pain is generally less with minimal access major surgery in newborns compared to traditional open surgery because,1.184298636784265e-07,0.15064494844650955,0.013073979591836732,0.009067132323909398,0.14837117542406375,0.01927437641723359,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.3,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Is there a pain difference in newborns with minimal access major surgery? Answer: Minimal access major surgery in newborns is usually associated with less pain than open surgery owing to,4.73719454713706e-08,0.029881162109572923,0.023683547493071277,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,0.3,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,"Question: Does minimal access major surgery lead to less pain in newborns? Answer: Typically, minimal access major surgery causes less pain in newborns than traditional open surgery because",1.184298636784265e-07,0.2533334196405743,0.05317085511890712,0.009067132323909398,0.2016901893132892,0.017758284788395473,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.3,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Is minimal access major surgery less painful for newborns? Answer: Minimal access major surgery in newborns is often considered less painful than conventional open surgery due to,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.14837117542406375,0.01927437641723359,0.009054007704764368,0.1453537071640909,0.026395975056689315,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.3,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is generally considered to cause less pain than traditional open surgery. This is due to,Question: Are newborns less hurt by minimal access major surgery? Answer: Minimal access major surgery generally results in less pain for newborns than open surgery because,1.658018091497971e-07,0.18447683168113116,0.04305389452567414,0.012693985253473157,0.17953812036580796,0.05407536360479921,0.012675610786670115,0.17328354165834625,0.06632653061224487,1.6580180914979784e-07,0.2284501227964375,0.03443877551020409
239,0.3,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in patients with hypertension? Research suggests a possible association between ACE-1 gene polymorphism and chronic kidney disease among hypertensive individuals, though the connection is not fully established.",4.73719454713706e-08,0.20086715966627589,0.10248225415512466,0.0036268529295637453,0.16696738488754592,0.08089647418531828,0.003621603081905733,0.13108357466582587,0.055363321799307974,4.737194547137081e-08,0.0951782614725234,0.02854671280276816
239,0.3,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there a connection between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients? Studies have shown a potential link, but the relationship remains inconclusive.",2.605457000925383e-07,0.1228607103873367,0.15234375,0.01994769111260066,0.2029517139611321,0.10651974288337923,0.019918816950481602,0.28762676019236055,0.055363321799307974,2.6054570009253947e-07,0.337685820823757,0.02854671280276816
239,0.3,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Evidence points to a possible association, yet the link is not definitively proven.",2.605457000925383e-07,0.1228607103873367,0.15234375,0.01994769111260066,0.2029517139611321,0.10651974288337923,0.019918816950481602,0.28762676019236055,0.055363321799307974,2.6054570009253947e-07,0.337685820823757,0.02854671280276816
239,0.3,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in individuals with hypertension? Research indicates a potential correlation, but the relationship is not completely clear.",2.131737546211677e-07,0.051401746405193016,0.15234375,0.016320838183036902,0.12884374180741043,0.10651974288337923,0.016297213868575855,0.2106657190562311,0.055363321799307974,2.1317375462116866e-07,0.2576431131502197,0.02854671280276816
239,0.3,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is chronic kidney disease among hypertensive patients influenced by polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene? Studies suggest a possible connection, although it is not entirely confirmed.",2.842316728282236e-07,0.1606010383701837,0.15234375,0.02176111757738254,0.24217242711441456,0.10651974288337923,0.021729618491434476,0.32844875471261537,0.055363321799307974,2.8423167282822487e-07,0.3802454352425526,0.02854671280276816
239,0.3,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism play a role in the development of chronic kidney disease in hypertensive patients? There is some evidence suggesting a link, but the association is not fully understood.",1.421158364141118e-07,0.04703832640806027,0.15234375,0.010880558788691264,0.02706104749746796,0.10651974288337923,0.010864809245717234,0.10530520339840566,0.055363321799307974,1.4211583641411244e-07,0.14844382118522903,0.02854671280276816
239,0.3,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is there an association between ACE-1 gene polymorphism and chronic kidney disease in patients with high blood pressure? Research points to a potential link, but the relationship is not fully established.",1.894877818854824e-07,0.017500194729511254,0.15234375,0.014507411718255023,0.09375242199614142,0.10651974288337923,0.014486412327622981,0.17429807488535642,0.055363321799307974,1.8948778188548325e-07,0.21990278516737272,0.02854671280276816
239,0.3,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Does the polymorphism of the ACE-1 gene contribute to chronic kidney disease in hypertensive individuals? Studies indicate a possible connection, though the evidence is not conclusive.",3.079176455639089e-07,0.19982175152346615,0.15234375,0.02357454404216442,0.28299442163466937,0.10651974288337923,0.02354042003238735,0.371008369131411,0.055363321799307974,3.079176455639103e-07,0.42469719781338666,0.02854671280276816
239,0.3,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Can polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene be linked to chronic kidney disease among those with hypertension? Research suggests a potential association, but it is not definitively proven.",2.36859727356853e-07,0.08649306621646202,0.15234375,0.018134264647818782,0.1652113859782851,0.10651974288337923,0.01810801540952873,0.2484060470390781,0.055363321799307974,2.3685972735685406e-07,0.29686382630350217,0.02854671280276816
239,0.3,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Studies indicate a potential link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients. However, the relationship isn't entirely","Is the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism related to chronic kidney disease in hypertensive patients? Studies indicate a possible link, but the relationship is not entirely clear.",2.842316728282236e-07,0.1606010383701837,0.15234375,0.02176111757738254,0.24217242711441456,0.10651974288337923,0.021729618491434476,0.32844875471261537,0.055363321799307974,2.8423167282822487e-07,0.3802454352425526,0.02854671280276816
240,0.3,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? Yes, care at a birth center during the first pregnancy can influence future reproduction by offering thorough prenatal care, encouraging healthy pregnancy behaviors, and lowering complication risks.",1.1842986367842703e-07,0.09221328412603524,0.14182998614958445,0.009067132323909363,0.0670562124929357,0.13017751479289946,0.009054007704764333,0.036905462338642,0.11176857330703485,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.3,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an effect of birth center care during a woman's first pregnancy on her later reproductive health? Indeed, birth center care in the first pregnancy impacts future reproduction by delivering comprehensive prenatal services, fostering healthy pregnancy practices, and minimizing complications.",1.4211583641411244e-07,0.002639347960037508,0.09169804677778022,0.010880558788691236,0.006192395249160043,0.10455424609483852,0.0108648092457172,0.010929975935384029,0.11176857330703485,1.4211583641411244e-07,0.02132458806144033,0.09204470742932283
240,0.3,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care in a woman's first pregnancy influence her future reproductive health? Yes, it can, as birth center care provides detailed prenatal support, promotes healthy habits during pregnancy, and reduces the likelihood of complications.",2.6054570009253894e-07,0.11141548413599134,0.10927202012570936,0.019947691112600606,0.13623608056718828,0.10079275813541552,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,0.3,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during a woman's first pregnancy have consequences for her future reproduction? Yes, it does; birth center care offers extensive prenatal care, supports healthy pregnancy routines, and decreases complication risks.",2.8423167282822424e-07,0.10195956393617056,0.13682022949210051,0.021761117577382486,0.12531568015452033,0.13017751479289946,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
240,0.3,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is there an impact of birth center care during a woman's initial pregnancy on her future reproductive outcomes? Yes, birth center care during the first pregnancy can affect future reproduction by providing comprehensive prenatal care, encouraging healthy pregnancy habits, and lowering the risk of complications.",4.737194547137081e-08,0.10212283885192219,0.09838821042085152,0.0036268529295637453,0.07489806657861342,0.08377656297850325,0.003621603081905733,0.07800642589427387,0.0879732134022163,4.737194547137081e-08,0.08132956599864194,0.09204470742932283
240,0.3,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does receiving birth center care during a woman's first pregnancy influence her subsequent reproductive health? Yes, it does, as such care includes thorough prenatal care, promotes healthy pregnancy behaviors, and reduces complication risks.",3.3160361829959484e-07,0.1218108221902563,0.16620498614958445,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.2254588021288475,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
240,0.3,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can birth center care during a woman's first pregnancy affect her future reproductive health? Yes, it can, since it offers comprehensive prenatal care, supports healthy pregnancy habits, and decreases the chance of complications.",3.3160361829959484e-07,0.1218108221902563,0.16620498614958445,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.2254588021288475,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
240,0.3,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Is birth center care during a woman's first pregnancy linked to her future reproductive health? Yes, it is, because birth center care provides detailed prenatal care, fosters healthy pregnancy practices, and lowers complication risks.",3.0791764556390954e-07,0.175057003591375,0.10585118802263338,0.023574544042164365,0.1994090376062716,0.09896003300309716,0.023540420032387294,0.1926689793058558,0.11176857330703485,3.079176455639103e-07,0.231045119043511,0.09204470742932283
240,0.3,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Does care at a birth center during a woman's first pregnancy impact her future reproduction? Yes, birth center care during the initial pregnancy can influence future reproductive outcomes by delivering comprehensive prenatal care, promoting healthy habits, and reducing complications.",1.8948778188548304e-07,0.013558004180617367,0.13990841931247708,0.014507411718254981,0.010905328976774875,0.13017751479289946,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
240,0.3,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Yes, birth center care during a woman's first pregnancy can impact her future reproduction. It provides comprehensive prenatal care, promotes healthy pregnancy habits, and reduces the risk of complications,","Can receiving birth center care during a woman's first pregnancy affect her future reproductive outcomes? Yes, it can, as birth center care provides thorough prenatal care, encourages healthy pregnancy behaviors, and decreases the risk of complications.",2.6054570009253894e-07,0.11141548413599134,0.10927202012570936,0.019947691112600606,0.13623608056718828,0.10079275813541552,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
241,0.3,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there a link between the CYP2D6*4 allele and breast cancer risk? Yes, multiple studies have shown an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.3,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele relate to breast cancer risk? Yes, research has found a connection between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.3,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the CYP2D6*4 allele associated with breast cancer risk? Yes, several studies suggest a relationship between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.3,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Yes, various studies have demonstrated an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.12425081286987005,0.06977315689981095,0.005440279394345639,0.1925455059424257,0.04861111111111113,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.3,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does carrying the CYP2D6*4 allele affect breast cancer risk? Yes, evidence from multiple studies indicates an association between the CYP2D6*4 allele and breast cancer risk.",1.184298636784265e-07,0.057666232348033475,0.1573241773079742,0.009067132323909398,0.058941910532276154,0.09550045913682273,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,0.3,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is breast cancer risk linked to the CYP2D6*4 allele? Yes, numerous studies have reported an association between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.047486387376399986,0.19360535644629617,0.010880558788691277,0.04312000522833204,0.13888888888888887,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.3,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is there an association between the CYP2D6*4 allele and breast cancer risk? Yes, several research studies have found a connection between the CYP2D6*4 allele and breast cancer risk.",4.73719454713706e-08,0.07466181513386205,0.07569152424674966,0.003626852929563759,0.14266099001129717,0.04251700680272108,0.003621603081905747,0.19607966772124596,0.08059501133786852,4.737194547137081e-08,0.20001048892429552,0.08404897959183669
241,0.3,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Are the CYP2D6*4 allele and breast cancer risk connected? Yes, research has identified an association between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.2864577144521987,0.07216070015240605,0.012693985253473157,0.35369608964796573,0.04104190695886201,0.012675610786670115,0.40536027542425535,0.07172871972318341,1.6580180914979774e-07,0.4062642671889618,0.06540622837370241
241,0.3,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Does the CYP2D6*4 allele influence breast cancer risk? Yes, multiple studies have indicated a link between the CYP2D6*4 allele and breast cancer risk.",1.658018091497971e-07,0.16043095435039012,0.14680916798014335,0.012693985253473157,0.15565403805941092,0.09138888888888885,0.012675610786670115,0.19741612125627261,0.07359999999999998,1.6580180914979774e-07,0.26033854496581554,0.03840000000000001
241,0.3,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Yes, several studies have indicated an association between the CYP2D6*4 allele and breast cancer risk. The CYP2D6*4 allele","Is the presence of the CYP2D6*4 allele related to breast cancer risk? Yes, several studies have shown an association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.03570622879781027,0.16635160680529298,0.005440279394345639,0.02926159183675736,0.09895833333333331,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
242,0.3,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Yes, studies indicate a strong association between hs-CRP levels and carotid atherosclerosis in this population, with elevated hs-CRP serving as a reliable marker.",1.6580180914979742e-07,0.13200868859590598,0.031621299878665715,0.012693985253473108,0.16251735163509773,0.014072951135888197,0.012675610786670073,0.1941728480622058,0.005009756657483936,1.6580180914979784e-07,0.19237189264745602,0.0
242,0.3,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis among healthy Koreans? Research shows a significant connection, where increased hs-CRP levels reliably indicate the presence of carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.3,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean individuals? Evidence suggests a notable association, with elevated hs-CRP levels being a dependable indicator of carotid atherosclerosis.",3.789755637709651e-07,0.30416623095436224,0.11426592797783926,0.029014823436510025,0.38055205446760665,0.0710059171597633,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
242,0.3,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Are high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Yes, findings reveal that higher hs-CRP concentrations significantly correlate with carotid atherosclerosis, making hs-CRP a reliable marker.",3.552895910352798e-07,0.3173090996806267,0.07860063305328507,0.027201396971728145,0.34281172648475966,0.0710059171597633,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
242,0.3,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does research support an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Yes, elevated hs-CRP is significantly linked to carotid atherosclerosis and serves as a trustworthy indicator.",3.316036182995945e-07,0.2805105208039387,0.07982715246763517,0.025387970506946266,0.306444082313885,0.0710059171597633,0.025351221573340188,0.3839231431116885,0.024375,3.316036182995957e-07,0.43078291609245367,0.0
242,0.3,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Studies confirm a significant relationship, with increased hs-CRP levels indicating carotid atherosclerosis.",4.026615365066504e-07,0.3419065589372092,0.11426592797783926,0.030828249901291904,0.4197727676208891,0.0710059171597633,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
242,0.3,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Can high-sensitivity C-reactive protein levels indicate carotid atherosclerosis in healthy Koreans? Research suggests a strong association, where elevated hs-CRP is a reliable marker for carotid atherosclerosis.",4.263475092423357e-07,0.3811272720904917,0.11426592797783926,0.032641676366073784,0.4605947621411439,0.0710059171597633,0.03259442773715168,0.5442657931868684,0.024375,4.263475092423373e-07,0.5978370007556206,0.0
242,0.3,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Is high-sensitivity C-reactive protein a marker for carotid atherosclerosis in healthy Koreans? Yes, research demonstrates a significant association, with higher hs-CRP levels reliably indicating carotid atherosclerosis.",4.263475092423357e-07,0.3811272720904917,0.11426592797783926,0.032641676366073784,0.4605947621411439,0.0710059171597633,0.03259442773715168,0.5442657931868684,0.024375,4.263475092423373e-07,0.5978370007556206,0.0
242,0.3,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Are elevated high-sensitivity C-reactive protein levels associated with carotid atherosclerosis in healthy Koreans? Evidence supports a significant link, making hs-CRP a dependable indicator of carotid atherosclerosis.",4.263475092423357e-07,0.3811272720904917,0.11426592797783926,0.032641676366073784,0.4605947621411439,0.0710059171597633,0.03259442773715168,0.5442657931868684,0.024375,4.263475092423373e-07,0.5978370007556206,0.0
242,0.3,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, research suggests that there is a significant association between high-sensitivity C-reactive protein (hs-CRP) and carotid atherosclerosis in healthy Koreans. Elevated levels of hs-CRP are considered a reliable indicator of carotid","Does elevated high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Yes, studies show a significant association, with hs-CRP serving as a reliable marker for carotid atherosclerosis.",3.789755637709651e-07,0.30416623095436224,0.11426592797783926,0.029014823436510025,0.38055205446760665,0.0710059171597633,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
243,0.3,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a delicate esophageal mucosa that easily tears from minimal trauma during routine diagnostic endoscopy. This 'crpe-paper' appearance can help endoscopists identify the disease even when other mucosal changes are absent. Dilation proves effective for,1.6580180914979784e-07,0.13517860874017318,0.004711578508954602,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
243,0.3,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Could fragile esophageal mucosa be a pathognomonic endoscopic sign of primary eosinophilic esophagitis? In primary eosinophilic esophagitis, the esophageal mucosa is fragile and tears easily with slight trauma during diagnostic endoscopy. The 'crpe-paper' sign may alert endoscopists to the disease when no other mucosal abnormalities are visible. Dilation is beneficial for",1.8948778188548325e-07,0.15606852573134944,0.005491780045351467,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.3,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragility of the esophageal mucosa a hallmark endoscopic sign of primary eosinophilic esophagitis? This condition is marked by a fragile esophageal lining that tears easily during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign can signal the disease's presence even if other mucosal changes are missing. Dilation is an effective treatment,1.4211583641411244e-07,0.06139603813327099,0.03443877551020409,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
243,0.3,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does the fragile nature of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Primary eosinophilic esophagitis causes the esophageal mucosa to be fragile and prone to tearing with minor trauma during diagnostic endoscopy. The 'crpe-paper' sign may help endoscopists detect the disease when other mucosal signs are not evident. Dilation works well for,2.3685972735685406e-08,0.042551349991722276,0.01803036029226502,0.0018134264647818726,0.042454833547970416,0.017851239669421492,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
243,0.3,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is esophageal mucosal fragility a specific endoscopic sign indicative of primary eosinophilic esophagitis? The disease is characterized by a delicate esophageal mucosa that tears easily during minor trauma in diagnostic endoscopy. This 'crpe-paper' sign can alert endoscopists to the disease even without other mucosal alterations. Dilation is effective for,2.3685972735685406e-07,0.1703198783301385,0.013614873292005808,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
243,0.3,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for","Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? In this disease, the esophageal mucosa is fragile and tears readily with minimal trauma during diagnostic endoscopy. The 'crpe-paper' sign may indicate the disease's presence when other mucosal changes are lacking. Dilation is beneficial for",1.8948778188548325e-07,0.156068525731349,0.005491780045351474,0.014507411718254981,0.17952269137943144,0.020399305555555556,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.3,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the fragile esophageal mucosa a definitive endoscopic marker of primary eosinophilic esophagitis? Primary eosinophilic esophagitis is marked by an esophageal mucosa that tears easily under minor trauma during diagnostic endoscopy. The 'crpe-paper' sign can alert endoscopists to the disease even if other mucosal abnormalities are absent. Dilation is effective for,1.8948778188548325e-07,0.156068525731349,0.005491780045351474,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.3,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Could the fragility of the esophageal mucosa be a pathognomonic endoscopic sign of primary eosinophilic esophagitis? This condition features a fragile esophageal mucosa that tears easily with slight trauma during diagnostic endoscopy. The 'crpe-paper' sign may help endoscopists recognize the disease when other mucosal changes are missing. Dilation is effective for,1.8948778188548325e-07,0.12834263850895145,0.014447105372761358,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
243,0.3,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Is the delicate nature of the esophageal mucosa a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis involves fragile esophageal mucosa that tears easily during minor trauma in diagnostic endoscopy. The 'crpe-paper' sign can alert endoscopists to the disease even when other mucosal alterations are absent. Dilation is beneficial for,1.6580180914979784e-07,0.13517860874017318,0.004711578508954602,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
243,0.3,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for",Does fragility of the esophageal mucosa represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? The disease is characterized by an esophageal mucosa that is fragile and tears readily with minimal trauma during diagnostic endoscopy. This 'crpe-paper' sign may help endoscopists identify the disease when other mucosal changes are not present. Dilation is effective for,9.474389094274162e-08,0.07499994574745728,0.0025434730105059616,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
244,0.3,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? It might, depending on the patient's health status and the availability of follow-up care. Insufficient home care or support after discharge could raise the chance of readmission, suggesting a decline in care quality.",2.8423167282822487e-07,0.11478400954494106,0.08690828402366867,0.02176111757738247,0.1668962874711788,0.0533997864008544,0.0217296184914344,0.19572236549818545,0.03631185475258099,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
244,0.3,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Could earlier discharge from Winnipeg hospitals compromise care quality? The effect varies based on patient condition and post-discharge support. Lack of proper home care may lead to higher readmission rates, reflecting poorer overall care.",5.68463345656449e-07,0.42493893784878045,0.08690828402366867,0.043522235154764964,0.48535001858971416,0.0533997864008544,0.043459236982868826,0.5229352767066011,0.03631185475258099,5.684633456564497e-07,0.5621145471036035,0.01851192595229618
244,0.3,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Is the quality of care affected when patients leave Winnipeg hospitals sooner? Potentially yes, as it depends on individual health and follow-up services. Without adequate support at home, readmission risks rise, indicating lower care standards.",5.447773729207637e-07,0.3950859746990987,0.08690828402366867,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.4911865783920213,0.03631185475258099,5.447773729207643e-07,0.5293247242806118,0.01851192595229618
244,0.3,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does sending patients home earlier from Winnipeg hospitals harm care quality? It depends on the patient's situation and the follow-up care given. Inadequate post-discharge support can increase readmissions, showing a drop in care quality.",5.68463345656449e-07,0.42493893784878045,0.08690828402366867,0.043522235154764964,0.48535001858971416,0.0533997864008544,0.043459236982868826,0.5229352767066011,0.03631185475258099,5.684633456564497e-07,0.5621145471036035,0.01851192595229618
244,0.3,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does earlier discharge from Winnipeg hospitals reduce care quality? It could, contingent on patient condition and aftercare. Without sufficient home care, the likelihood of readmission grows, implying diminished quality of care.",6.395212638635049e-07,0.5202491176531057,0.08690828402366867,0.0489625145491106,0.5837900914029674,0.0533997864008544,0.04889164160572745,0.6247179710165436,0.03631185475258099,6.39521263863506e-07,0.667475062761429,0.01851192595229618
244,0.3,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Can discharging patients earlier from Winnipeg hospitals affect care quality? Yes, depending on patient health and follow-up care. Poor post-discharge support may elevate readmission risk, signaling reduced care quality.",6.868932093348755e-07,0.5892419891400564,0.08690828402366867,0.05258936747867436,0.6552490553851111,0.0533997864008544,0.052513244687633194,0.6988259431702653,0.03631185475258099,6.868932093348768e-07,0.7444361038975584,0.01851192595229618
244,0.3,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does releasing patients sooner from Winnipeg hospitals impact the quality of care? It might, based on individual conditions and follow-up services. Lack of proper home care can increase readmission chances, indicating a decline in care quality.",5.210914001850784e-07,0.36609843782584717,0.08690828402366867,0.039895382225201205,0.4247253967732787,0.0533997864008544,0.03983763390096308,0.4604149197252676,0.03631185475258099,5.210914001850789e-07,0.497576025966032,0.01851192595229618
244,0.3,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Is quality of care compromised by earlier discharge from Winnipeg hospitals? Potentially, as it depends on patient health and aftercare. Insufficient support after discharge may raise readmission rates, reflecting lower care quality.",6.158352911278196e-07,0.48745929483011396,0.08690828402366867,0.04714908808432872,0.5498885397272857,0.0533997864008544,0.04708084006477457,0.5896266512052746,0.03631185475258099,6.158352911278206e-07,0.6311074185905543,0.01851192595229618
244,0.3,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Does earlier patient discharge from Winnipeg hospitals adversely affect care quality? It depends on the patient's condition and the follow-up care provided. Without adequate home support, readmission risk may increase, suggesting reduced quality of care.",5.447773729207637e-07,0.3950859746990987,0.08690828402366867,0.041708808689983085,0.4545783599229605,0.0533997864008544,0.04164843544191595,0.4911865783920213,0.03631185475258099,5.447773729207643e-07,0.5293247242806118,0.01851192595229618
244,0.3,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Discharging patients earlier from Winnipeg hospitals could potentially affect the quality of care, depending on the individual patient's condition and the follow-up care provided. Without adequate home care or post-discharge support, the risk of readmissions may increase, indicating a reduction in the overall","Could early discharge from Winnipeg hospitals negatively influence quality of care? Yes, depending on the patient's health and post-discharge support. Lack of sufficient home care can lead to higher readmission rates, indicating a decline in overall care quality.",4.737194547137078e-07,0.310528586671035,0.08690828402366867,0.03626852929563745,0.36756698293333034,0.0533997864008544,0.03621603081905733,0.4015744197023343,0.03631185475258099,4.737194547137081e-07,0.43695140414959655,0.01851192595229618
245,0.3,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione have a statistically significant correlation with sexual desire across the entire female cohort. ADT-G did not show a stronger correlation than circulating androgens and thus is not a better measure than mass spectrometry of circulating androgens.,4.737194547137081e-08,0.07016337577644771,0.10861775147928998,0.0036268529295637453,0.013369432360373246,0.036311854752580995,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
245,0.3,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a relationship exist between androgens and sexual desire in women? In this study, FT and androstenedione were significantly correlated with sexual desire among all women studied. ADT-G did not correlate more strongly than circulating androgens and is therefore not superior to measuring circulating androgens via mass spectrometry.",2.1317375462116866e-07,0.10581570759477144,0.08206694214876038,0.016320838183036854,0.1282810847026532,0.036311854752580995,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
245,0.3,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there an association between androgens and sexual desire in women? The present research demonstrated that FT and androstenedione were statistically significantly linked to sexual desire in the total female cohort. ADT-G did not show a stronger correlation than circulating androgens and is not better than measuring circulating androgens by mass spectrometry.,1.1842986367842703e-07,0.04437977196606857,0.06773671344499775,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.3,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens correlated with sexual desire in women? This study found that FT and androstenedione had a statistically significant correlation with sexual desire in the entire group of women. ADT-G did not correlate more strongly than circulating androgens, so it is not superior to measuring circulating androgens using mass spectrometry.",1.6580180914979784e-07,0.06053130204669088,0.08463591682419666,0.012693985253473108,0.1434837353305185,0.005276046948742265,0.012675610786670066,0.1683320695588959,0.0212665406427221,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.3,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a correlation between androgen levels and sexual desire in women? The study showed that FT and androstenedione were significantly correlated with sexual desire in the whole cohort of women. ADT-G did not correlate more strongly than circulating androgens and thus is not better than measuring circulating androgens by mass spectrometry.,1.1842986367842703e-07,0.017197529591167715,0.08700625000000003,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.3,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does sexual desire in women correlate with androgens? The current study revealed a statistically significant correlation between FT and androstenedione and sexual desire in the total female cohort. ADT-G did not have a stronger correlation than circulating androgens and is therefore not superior to measuring circulating androgens through mass spectrometry.,1.6580180914979784e-07,0.06053130204669088,0.08463591682419666,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.3,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is sexual desire in women linked to androgens? In this study, FT and androstenedione showed a statistically significant correlation with sexual desire among all women. ADT-G did not correlate more strongly than circulating androgens and is not a better measure than mass spectrometry of circulating androgens.",2.6054570009253947e-07,0.09162048677869405,0.12338925619834715,0.0199476911126006,0.17273284727348592,0.036311854752580995,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
245,0.3,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a significant correlation between androgens and sexual desire in women? The present study found that FT and androstenedione were statistically significantly correlated with sexual desire in the entire cohort of women. ADT-G did not correlate more strongly than circulating androgens and is not superior to measuring circulating androgens by mass spectrometry.,9.474389094274162e-08,0.022870744387819553,0.06921111111111115,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.3,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are circulating androgens associated with sexual desire in women? This study demonstrated that FT and androstenedione had a statistically significant correlation with sexual desire in the total female cohort. ADT-G did not correlate more strongly than circulating androgens and is therefore not better than measuring circulating androgens by mass spectrometry.,1.6580180914979784e-07,0.12779327890392222,0.000577685950413187,0.012693985253473108,0.1434837353305185,0.005276046948742265,0.012675610786670066,0.1683320695588959,0.0212665406427221,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.3,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a connection between androgens and sexual desire in women? The study showed that FT and androstenedione were statistically significantly correlated with sexual desire across the entire group of women. ADT-G did not correlate more strongly than circulating androgens and is not superior to measuring circulating androgens by mass spectrometry.,1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.06510218308112092,0.036311854752580995,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
246,0.3,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a preoperative medically supervised weight loss program enhance the results of bariatric surgery? Yes, such a program can greatly improve the outcomes of bariatric surgery by boosting patients' physical fitness and reducing surgical risks, resulting in safer operations, fewer complications, and better overall results.",2.3685972735685406e-08,0.19247278498824816,0.1467517829905096,0.0018134264647818726,0.16605062192801245,0.13296398891966763,0.0018108015409528666,0.10542711757770196,0.09204470742932283,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
246,0.3,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can a medically supervised weight loss program before surgery improve bariatric surgery outcomes? Indeed, undergoing a preoperative medically supervised weight loss program significantly benefits bariatric surgery outcomes by improving physical fitness and decreasing surgical risks, leading to safer procedures and fewer complications.",9.474389094274162e-08,0.01569838014170255,0.04986799862925988,0.0072537058591274906,0.0102421167356046,0.05845704954786339,0.007243206163811466,0.03977287309498978,0.04091249413494738,9.474389094274162e-08,0.037543863318489024,0.044709350322655925
246,0.3,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is the outcome of bariatric surgery improved by a preoperative medically supervised weight loss program? Yes, engaging in a medically supervised weight loss program before surgery can markedly enhance bariatric surgery results by increasing patient fitness and lowering surgical risk, which contributes to safer surgeries and reduced complications.",4.737194547137081e-08,0.1719549439867829,0.08509683436963343,0.0036268529295637453,0.17321823484876697,0.0895755591676015,0.003621603081905733,0.14361344770643392,0.06983396362766994,4.737194547137081e-08,0.14554104142917268,0.0710059171597633
246,0.3,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does participating in a medically supervised weight loss program prior to bariatric surgery improve surgical outcomes? Yes, such a program can substantially improve outcomes by enhancing physical condition and minimizing surgical risks, resulting in safer surgeries and fewer complications.",1.6580180914979763e-07,0.07737600082182539,0.1694667640613587,0.012693985253473108,0.01576841887867575,0.13296398891966763,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,0.3,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Will a preoperative medically supervised weight loss program improve the results of bariatric surgery? Yes, this program can significantly enhance bariatric surgery outcomes by improving patients' fitness and decreasing the risk of surgery, leading to safer procedures and fewer complications.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.3,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a medically supervised weight loss program before bariatric surgery lead to better surgical outcomes? Yes, it can greatly improve outcomes by boosting physical fitness and reducing the risks associated with surgery, which results in safer operations and fewer complications.",1.4211583641411233e-07,0.10335148722508336,0.1694667640613587,0.010880558788691236,0.04243666596083662,0.13296398891966763,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.3,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can bariatric surgery outcomes be improved by a preoperative medically supervised weight loss program? Yes, such a program improves patient fitness and lowers surgical risk, thereby enhancing safety and reducing complications during bariatric surgery.",2.8423167282822413e-07,0.06370259743808093,0.1694667640613587,0.021761117577382492,0.1294135909658234,0.13296398891966763,0.021729618491434427,0.1982552962205193,0.09204470742932283,2.8423167282822487e-07,0.2374512108269342,0.0710059171597633
246,0.3,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Yes, this program significantly benefits patients by improving their physical fitness and lowering surgical risks, which leads to safer surgeries and fewer complications.",1.6580180914979763e-07,0.07737600082182539,0.1694667640613587,0.012693985253473108,0.01576841887867575,0.13296398891966763,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,0.3,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Does a preoperative medically supervised weight loss program positively affect bariatric surgery outcomes? Yes, it can enhance outcomes by improving physical fitness and reducing surgical risks, resulting in safer procedures and fewer complications.",3.0791764556390943e-07,0.09447425610483462,0.1694667640613587,0.023574544042164372,0.16116228928040321,0.13296398891966763,0.0235404200323873,0.231045119043511,0.09204470742932283,3.079176455639103e-07,0.271352762502616,0.0710059171597633
246,0.3,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes, a preoperative medically supervised weight loss program can significantly improve bariatric surgery outcomes. The program enhances patients' physical fitness and lowers surgical risk, leading to safer procedures, fewer complications, and improved","Can the outcomes of bariatric surgery be improved by a medically supervised weight loss program before the operation? Yes, participating in such a program can significantly improve surgery results by enhancing physical fitness and minimizing surgical risk, leading to safer procedures and fewer complications.",4.737194547137081e-08,0.20098995678900122,0.1694667640613587,0.0036268529295637453,0.14252012451781804,0.13296398891966763,0.003621603081905733,0.08132956599864194,0.09204470742932283,4.737194547137081e-08,0.05023086162484702,0.0710059171597633
247,0.3,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize the diagnostic characteristics of child bipolar I disorder? Yes, it effectively generalizes these characteristics by offering a thorough analysis of manic and hypomanic episodes in children, highlighting a wide range of bipolar I symptoms and aiding early diagnosis and treatment planning.",3.316036182995957e-07,0.015180829194874068,0.209150967309693,0.025387970506946217,0.03126770429362358,0.1530793876824493,0.025351221573340132,0.07705668237979468,0.1262002743484225,3.316036182995957e-07,0.12436944005801687,0.09719008264462808
247,0.3,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample successfully generalizes the diagnostic features of child bipolar I disorder, providing an extensive overview of manic and hypomanic episodes in children, which supports early diagnosis and treatment strategies.",6.868932093348762e-07,0.31376822752145994,0.22914263744713573,0.05258936747867431,0.3967274777880885,0.1530793876824493,0.052513244687633145,0.4517501318212056,0.1262002743484225,6.868932093348768e-07,0.5087811389683483,0.09719008264462808
247,0.3,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Diagnostic traits of child bipolar I disorder are well represented in the ""Treatment of Early Age Mania (TEAM)"" sample, which captures a broad spectrum of manic and hypomanic episodes, facilitating early diagnosis and treatment planning.",7.105791820705615e-07,0.34275576439471145,0.22914263744713573,0.05440279394345619,0.42658044093777026,0.1530793876824493,0.05432404622858602,0.4825217904879593,0.1262002743484225,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
247,0.3,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The sample from the ""Treatment of Early Age Mania (TEAM)"" study generalizes the diagnostic characteristics of child bipolar I disorder by thoroughly analyzing manic and hypomanic episodes, thereby aiding in early diagnosis and treatment.",7.342651548062468e-07,0.3726087275443932,0.22914263744713573,0.05621622040823807,0.45735209960452394,0.1530793876824493,0.05613484776953889,0.5142704888025391,0.1262002743484225,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
247,0.3,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Yes, the ""Treatment of Early Age Mania (TEAM)"" sample generalizes child bipolar I disorder's diagnostic features by providing a comprehensive examination of manic and hypomanic episodes in children, supporting early diagnosis and treatment planning.",7.342651548062468e-07,0.3726087275443932,0.22914263744713573,0.05621622040823807,0.45735209960452394,0.1530793876824493,0.05613484776953889,0.5142704888025391,0.1262002743484225,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
247,0.3,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The diagnostic characteristics of child bipolar I disorder are generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which offers a detailed analysis of manic and hypomanic episodes, helping with early diagnosis and treatment.",7.105791820705615e-07,0.34275576439471145,0.22914263744713573,0.05440279394345619,0.42658044093777026,0.1530793876824493,0.05432404622858602,0.4825217904879593,0.1262002743484225,7.105791820705622e-07,0.5405298372829281,0.09719008264462808
247,0.3,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample effectively generalizes the diagnostic features of child bipolar I disorder by presenting a broad analysis of manic and hypomanic episodes, aiding early diagnosis and treatment planning.",7.342651548062468e-07,0.3726087275443932,0.22914263744713573,0.05621622040823807,0.45735209960452394,0.1530793876824493,0.05613484776953889,0.5142704888025391,0.1262002743484225,7.342651548062476e-07,0.5733196601059198,0.09719008264462808
247,0.3,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample provides a generalizable overview of child bipolar I disorder's diagnostic characteristics through its comprehensive study of manic and hypomanic episodes, facilitating early diagnosis and treatment.",7.579511275419321e-07,0.4033803862111469,0.22914263744713573,0.05802964687301995,0.48910079791910377,0.1530793876824493,0.057945649310491766,0.5470603116255308,0.1262002743484225,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
247,0.3,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","Child bipolar I disorder's diagnostic traits are generalized by the ""Treatment of Early Age Mania (TEAM)"" sample, which delivers an extensive analysis of manic and hypomanic episodes, supporting early diagnosis and treatment.",7.816371002776174e-07,0.43512908452572674,0.22914263744713573,0.05984307333780183,0.5218906207420955,0.1530793876824493,0.05975645085144464,0.5809618633012126,0.1262002743484225,7.816371002776184e-07,0.6423125315928706,0.09719008264462808
247,0.3,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample does generalize diagnostic characteristics of child bipolar I disorder. It provides a comprehensive analysis of manic and hypomanic episodes in children, thus showcasing a broad spectrum of bipolar I symptoms. This helps in early diagnosis and treatment planning.","The ""Treatment of Early Age Mania (TEAM)"" sample generalizes the diagnostic characteristics of child bipolar I disorder by thoroughly examining manic and hypomanic episodes in children, thus aiding early diagnosis and treatment planning.",7.579511275419321e-07,0.4033803862111469,0.22914263744713573,0.05802964687301995,0.48910079791910377,0.1530793876824493,0.057945649310491766,0.5470603116255308,0.1262002743484225,7.57951127541933e-07,0.6072212117816016,0.09719008264462808
248,0.3,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Yes, higher carotid artery pulsatility and resistance indexes may serve as early markers of vascular abnormalities in young obese males. These ultrasound-measured indexes reflect blood flow changes that could signal cardiovascular risk.",9.474389094274162e-08,0.03548182241978681,0.06222222222222218,0.0072537058591274906,0.06984851158623773,0.094499716553288,0.007243206163811466,0.07574087425036247,0.10642664539798194,9.474389094274162e-08,0.051271160531809024,0.09454059251246921
248,0.3,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes suggest early vascular abnormalities in young obese males? Indeed, increased carotid artery pulsatility and resistance indexes can be early signs of vascular problems in young obese males, as these ultrasound measurements reveal alterations in blood flow that might predict cardiovascular risk.",9.474389094274162e-08,0.03548182241978681,0.06222222222222218,0.0072537058591274906,0.040352886881560135,0.07444936049970256,0.007243206163811466,0.045604040312973826,0.08515879086117893,9.474389094274162e-08,0.020464619173589327,0.072562358276644
248,0.3,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can higher carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes detected via ultrasound can indicate early vascular abnormalities in young obese males by showing changes in blood flow that may forecast cardiovascular risk.",9.474389094274162e-08,0.00660068989645568,0.04470742932281399,0.0072537058591274906,0.010857262176880766,0.05500000000000002,0.007243206163811466,0.015467206375585185,0.06424747174301015,9.474389094274162e-08,0.020464619173589327,0.072562358276644
248,0.3,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are raised carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes are potential early indicators of vascular abnormalities in young obese males, as these ultrasound-based indexes highlight blood flow changes linked to cardiovascular risk.",1.1842986367842703e-07,0.04947877363818254,0.024997970943916897,0.009067132323909363,0.04527424161044458,0.03317001385041557,0.009054007704764333,0.040666778805564796,0.04114907652179425,1.1842986367842703e-07,0.03561537270561832,0.0488888888888889
248,0.3,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes can serve as early signs of vascular abnormalities in young obese males, with ultrasound measurements revealing blood flow changes that might predict cardiovascular risk.",2.3685972735685406e-08,0.05533308067387166,0.03780818295987837,0.0018134264647818726,0.057394941048535486,0.045179988662131576,0.0018108015409528666,0.059579947751013496,0.051261691368776965,2.3685972735685406e-08,0.06189823429249586,0.056244260789715325
248,0.3,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Do increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Yes, these increased indexes, measured by ultrasound, can be early indicators of vascular abnormalities in young obese males by reflecting changes in blood flow that may signal cardiovascular risk.",1.8948778188548325e-07,0.053492745514997164,0.1322222222222222,0.014507411718254981,0.03166093785221147,0.13000000000000003,0.014486412327622933,0.009165580660618566,0.12382659131469367,1.8948778188548325e-07,0.014018237406053125,0.11451388888888889
248,0.3,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are increased carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, higher carotid artery pulsatility and resistance indexes, assessed through ultrasound, can be early signs of vascular abnormalities in young obese males by showing changes in blood flow that could predict cardiovascular risk.",7.105791820705622e-08,0.032524674909599316,0.04784722222222218,0.005440279394345618,0.03621211664414581,0.05779260856632959,0.0054324046228586,0.040179457760100235,0.06645130786798165,7.105791820705622e-08,0.044452648154857055,0.07398894297217715
248,0.3,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes measured via ultrasound can indicate early vascular abnormalities in young obese males by detecting changes in blood flow that may forecast cardiovascular risk.",9.474389094274162e-08,0.022280442626875452,0.02831640504770694,0.0072537058591274906,0.018638362527797714,0.036324375410913934,0.007243206163811466,0.0146696275618039,0.043826591314693686,9.474389094274162e-08,0.01034192218463037,0.05084605724106024
248,0.3,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Are elevated carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Yes, these elevated indexes, obtained through ultrasound, can be early markers of vascular abnormalities in young obese males by indicating changes in blood flow that might predict cardiovascular risk.",1.6580180914979784e-07,0.04795965467776542,0.11284722222222221,0.012693985253473108,0.025341907216025028,0.10937500000000003,0.012675610786670066,0.0019918840260739756,0.1019515913146937,1.6580180914979784e-07,0.02212264543488729,0.09138888888888888
248,0.3,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males. These indexes, measured through ultrasound, can indicate changes in blood flow, potentially predicting cardiovascular risk.","Is an increase in carotid artery pulsatility and resistance indexes an early indicator of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes, as measured by ultrasound, can be early signs of vascular abnormalities in young obese males by revealing blood flow changes potentially linked to cardiovascular risk.",0.0,0.10663802777845266,0.056727360134607274,0.0,0.10872896949959898,0.06559400826446282,0.0,0.11090354888959109,0.07256115921592823,0.0,0.11316688662203189,0.07792480571308552
249,0.3,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Answer: Based on our experience, definitive radiotherapy targeting the neck and potential mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",2.6054570009253947e-07,0.20899633383950444,0.025198675872076533,0.0199476911126006,0.22509834474927448,0.035041322314049606,0.019918816950481533,0.204096185104385,0.017851239669421492,2.6054570009253947e-07,0.18232155679395312,0.0
249,0.3,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should neck dissection be performed for metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively provides good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.6054570009253947e-07,0.18509470692364438,0.008181818181818193,0.0199476911126006,0.20077739104541603,0.017538265306122455,0.019918816950481533,0.1793409286558152,0.0,2.6054570009253947e-07,0.18232155679395312,0.0
249,0.3,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma in cervical nodes from an unknown primary head and neck tumor, is neck dissection required? Answer: We have found that definitive radiotherapy to the neck and potential mucosal sites, regardless of prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The necessity of neck dissection, especially for",2.6054570009253947e-07,0.2328979607553645,0.04205122848930092,0.0199476911126006,0.24941929845313204,0.05246913580246911,0.019918816950481533,0.22885144155295478,0.03566529492455417,2.6054570009253947e-07,0.20752690881431501,0.0181755829903978
249,0.3,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes with unknown head and neck primary? Answer: In our experience, definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",3.316036182995957e-07,0.24211570755109646,0.010975475573377691,0.025387970506946217,0.2561957764103502,0.01851192595229618,0.025351221573340132,0.23440070583884376,0.0,3.316036182995957e-07,0.23841102344499632,0.0
249,0.3,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Does metastatic carcinoma to cervical nodes from an unknown head and neck primary require neck dissection? Answer: According to our experience, definitive radiotherapy to the neck and potential mucosal sites, with or without neck dissection beforehand, is effective in attaining good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",2.8423167282822487e-07,0.17942347629564814,0.008347107438016511,0.02176111757738247,0.2189112708895289,0.017851239669421492,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
249,0.3,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection necessary in cases of metastatic carcinoma to cervical nodes from an unknown primary in the head and neck? Answer: Our experience indicates that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",1.8948778188548325e-07,0.1311373837517893,0.005660321734259684,0.014507411718254981,0.1251631429540092,0.0,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
249,0.3,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: For metastatic carcinoma to cervical nodes from an unknown head and neck primary site, should neck dissection be performed? Answer: We have observed that definitive radiotherapy to the neck and potential mucosal sites, regardless of prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The necessity of neck dissection, especially for",2.3685972735685406e-07,0.1667849366025207,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
249,0.3,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is there a need for neck dissection in metastatic carcinoma to cervical nodes from an unknown head and neck primary? Answer: Based on our experience, definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, is effective in achieving good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",1.6580180914979784e-07,0.13613679755609454,0.020820844920942196,0.012693985253473108,0.1313599780703374,0.016388888888888894,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
249,0.3,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Should patients with metastatic carcinoma to cervical nodes from an unknown head and neck primary undergo neck dissection? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The role of neck dissection, especially for",2.3685972735685406e-07,0.1667849366025198,0.007313100860178785,0.018134264647818726,0.1829663215455497,0.017236072637734686,0.018108015409528666,0.16164135155641457,0.0,2.3685972735685406e-07,0.16430305129127465,0.0
249,0.3,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for","Question: Is neck dissection warranted for metastatic carcinoma to cervical nodes from an unknown primary head and neck cancer? Answer: In our experience, definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, particularly for",2.8423167282822487e-07,0.2523863374072217,0.04351985427160258,0.02176111757738247,0.26842178378666803,0.0533997864008544,0.0217296184914344,0.247770138199217,0.03631185475258099,2.8423167282822487e-07,0.22634281326066574,0.01851192595229618
250,0.3,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell function? Laparoscopic surgery results in measurable harm to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the injury to liver hepatocytes and peri-sinusoidal cells is clinically insignificant, with the laparoscopic procedure likely being the cause.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.3,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity impacted by laparoscopic cholecystectomy? Laparoscopic operations cause observable damage to Kupffer and endothelial cells, shown by elevated post-op HA serum levels. This damage to hepatocytes and peri-sinusoidal cells lacks clinical importance, and the laparoscopic technique itself is probably responsible.",1.8948778188548325e-07,0.17963450852047114,0.0038036897673758216,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
250,0.3,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy alter peri-sinusoidal cell activity? The laparoscopic approach induces detectable injury to Kupffer and endothelial cells, as evidenced by raised post-operative HA serum levels. The harm to liver hepatocytes and peri-sinusoidal cells is not clinically significant, with the laparoscopic procedure being the likely cause.",1.1842986367842703e-07,0.1084411697936476,0.0022190736642101576,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.3,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Laparoscopic surgery causes measurable damage to Kupffer and endothelial cells, reflected by increased post-operative HA serum levels. The damage to hepatocytes and peri-sinusoidal cells has no clinical relevance, and the laparoscopic procedure is probably the cause.",1.8948778188548325e-07,0.17963450852047114,0.0038036897673758216,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
250,0.3,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell activity? Laparoscopic procedures cause detectable injury to Kupffer and endothelial cells, indicated by elevated post-op HA serum levels. The injury to liver hepatocytes and peri-sinusoidal cells is clinically insignificant, with the laparoscopic procedure itself likely responsible.",2.1317375462116866e-07,0.20453710908972944,0.004383329862557267,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
250,0.3,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic surgery leads to measurable damage to Kupffer and endothelial cells, as shown by increased post-operative HA serum levels. The damage to hepatocytes and peri-sinusoidal cells is not clinically significant, and the laparoscopic procedure is probably the cause.",1.1842986367842703e-07,0.1084411697936476,0.0022190736642101576,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
250,0.3,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? Laparoscopic procedures cause detectable harm to Kupffer and endothelial cells, reflected by elevated post-operative HA serum levels. The damage to liver hepatocytes and peri-sinusoidal cells lacks clinical significance, with the laparoscopic procedure itself likely responsible.",1.4211583641411244e-07,0.10010748428748562,0.019991670137442734,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
250,0.3,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Can laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery causes measurable injury to Kupffer and endothelial cells, indicated by increased post-op HA serum levels. The damage to hepatocytes and peri-sinusoidal cells has no clinical importance, and the laparoscopic procedure is probably the cause.",1.8948778188548325e-07,0.14662749992237956,0.019991670137442734,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
250,0.3,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Does laparoscopic cholecystectomy influence peri-sinusoidal cell function? Laparoscopic procedures induce detectable damage to Kupffer and endothelial cells, as evidenced by elevated post-operative HA serum levels. The injury to liver hepatocytes and peri-sinusoidal cells is clinically insignificant, with the laparoscopic procedure itself likely responsible.",1.8948778188548325e-07,0.14662749992237956,0.019991670137442734,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
250,0.3,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic surgery causes measurable harm to Kupffer and endothelial cells, shown by increased post-operative HA serum levels. The damage to hepatocytes and peri-sinusoidal cells has no clinical significance, and the laparoscopic procedure is probably the cause.",1.6580180914979784e-07,0.12309700251218514,0.019991670137442734,0.012693985253473108,0.15415067982725894,0.0,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
251,0.3,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a predictor of neuropsychological decline following a concussion? Answer: Findings from this research question the significance of LOC in forecasting neuropsychological test outcomes during the early recovery period after mild traumatic brain injury. Neuropsychological assessments have proven effective in detecting cognitive aftereffects.,1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
251,0.3,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Can loss of consciousness forecast neuropsychological impairments after a concussion? Answer: This study's findings challenge the role of LOC as an indicator of neuropsychological test performance in the acute recovery phase from mild traumatic brain injury. Neuropsychological tests are sensitive tools for identifying cognitive consequences.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.3,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does experiencing loss of consciousness indicate neuropsychological deficits post-concussion? Answer: The study results suggest that LOC may not be a reliable predictor of neuropsychological test results during the initial recovery stage of mild traumatic brain injury. Neuropsychological testing methods are effective in measuring cognitive impairments.,2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
251,0.3,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is LOC predictive of neuropsychological decline after a concussion? Answer: The outcomes of this study raise doubts about the predictive value of LOC for neuropsychological performance in the acute phase following mild traumatic brain injury. Neuropsychological tests have demonstrated sensitivity in detecting cognitive sequelae.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.3,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness predict cognitive impairments after concussion? Answer: This research casts uncertainty on the importance of LOC as a predictor of neuropsychological test performance during early recovery from mild traumatic brain injury. Neuropsychological testing is sensitive in assessing cognitive effects.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.3,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness an indicator of neuropsychological deficits after concussion? Answer: The study findings question the relevance of LOC for predicting neuropsychological test outcomes in the acute recovery phase of mild traumatic brain injury. Neuropsychological assessments are sensitive to cognitive sequelae.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.3,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Can loss of consciousness serve as a predictor for neuropsychological impairments post-concussion? Answer: Results from this study doubt the significance of LOC in predicting neuropsychological performance during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing effectively measures cognitive sequelae.,2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
251,0.3,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does LOC forecast neuropsychological test performance after concussion? Answer: The findings challenge the importance of LOC as a predictor during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing procedures have been shown to sensitively measure cognitive aftereffects.,3.316036182995957e-07,0.30010459245033916,0.0,0.025387970506946217,0.30673026742247655,0.0,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
251,0.3,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Is loss of consciousness a reliable predictor of neuropsychological decrements following concussion? Answer: This study's results question the predictive value of LOC for neuropsychological test performance in the early recovery period after mild traumatic brain injury. Neuropsychological tests are sensitive in detecting cognitive sequelae.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
251,0.3,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of,Question: Does loss of consciousness correlate with neuropsychological impairments after concussion? Answer: The study casts doubt on the role of LOC as a predictor of neuropsychological test outcomes during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing is sensitive to cognitive sequelae.,2.3685972735685406e-07,0.2047944126460135,0.0,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
252,0.3,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What is the value of PET/CT compared to multidetector CT in preoperative staging of liver metastases from colorectal cancer? PET/CT plays a limited role in staging liver metastases of colorectal carcinoma. While PET/CT is more sensitive in detecting extrahepatic disease in certain areas, its low positive predictive value limits its usefulness. It added valuable information in only 8% of cases but also...",7.105791820705622e-08,0.04907450686140358,0.0007678256487780397,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
252,0.3,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT improve preoperative staging of colorectal cancer liver metastases beyond multidetector CT? PET/CT has a restricted role in hepatic staging of colorectal liver metastases. Despite higher sensitivity for extrahepatic disease detection in some locations, its low PPV reduces reliability. PET/CT contributed additional useful data in 8% of cases but also...",3.316036182995957e-07,0.28065100298382495,0.024309492315444707,0.025387970506946217,0.2796061499364164,0.020399305555555556,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
252,0.3,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In preoperative staging of liver metastases from colorectal carcinoma, does PET/CT offer benefits over multidetector CT? PET/CT is of limited utility in hepatic staging of colorectal liver metastases. Although it detects extrahepatic disease with greater sensitivity in some regions, its low positive predictive value is a drawback. PET/CT provided extra valuable information in 8% of cases but also...",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
252,0.3,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also",How does PET/CT compare to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT has a limited role in staging liver metastases from colorectal cancer. It shows higher sensitivity for extrahepatic disease in certain anatomical sites but is hindered by a low PPV. PET/CT added useful information in 8% of cases but also...,2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.3,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Is PET/CT beneficial in the preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT? PET/CTs role in hepatic staging of colorectal liver metastases is limited. Although it is more sensitive for detecting extrahepatic disease in some areas, its low positive predictive value limits its effectiveness. PET/CT provided additional useful findings in 8% of cases but also...",1.4211583641411244e-07,0.12458247725247595,0.018817712270093233,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
252,0.3,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What additional value does PET/CT provide over multidetector CT in preoperative staging of colorectal liver metastases? PET/CT has a limited function in hepatic staging of colorectal liver metastases. Despite its higher sensitivity for extrahepatic disease in certain locations, its low PPV affects its reliability. PET/CT contributed extra useful information in 8% of cases but also...",2.3685972735685406e-07,0.2252545407984501,0.0397422585591971,0.018134264647818726,0.2251558075986555,0.037677816224529016,0.018108015409528666,0.20255017340827708,0.01922337562475971,2.3685972735685406e-07,0.17904823144898518,0.0
252,0.3,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also",Does PET/CT add significant information beyond multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT plays a minor role in hepatic staging of colorectal liver metastases. It has higher sensitivity for detecting extrahepatic disease in some anatomical sites but is limited by low positive predictive value. PET/CT offered additional useful data in 8% of cases but also...,1.4211583641411244e-07,0.12458247725247595,0.018817712270093233,0.010880558788691236,0.12440441226084253,0.017538265306122455,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
252,0.3,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","In the context of preoperative staging of colorectal carcinoma liver metastases, how useful is PET/CT compared to multidetector CT? PET/CT has a restricted role in hepatic staging of colorectal liver metastases. Although it detects extrahepatic disease more sensitively in some areas, its low PPV reduces its diagnostic value. PET/CT provided additional useful information in 8% of cases but also...",1.4211583641411244e-07,0.12458247725247595,0.018817712270093233,0.010880558788691236,0.12440441226084253,0.017538265306122455,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
252,0.3,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","Does PET/CT improve detection of liver metastases from colorectal carcinoma beyond multidetector CT in preoperative staging? PET/CT has limited utility in hepatic staging of colorectal liver metastases. While it is more sensitive for extrahepatic disease in certain anatomical regions, its low positive predictive value limits its usefulness. PET/CT added useful information in 8% of cases but also...",1.8948778188548325e-07,0.11187054323202528,0.015621063240110858,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
252,0.3,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also","What is the contribution of PET/CT compared to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? PET/CT has a limited role in hepatic staging of colorectal liver metastases. Despite higher sensitivity for extrahepatic disease detection in some locations, its low PPV hampers its effectiveness. PET/CT provided additional useful information in 8% of cases but also...",1.8948778188548325e-07,0.16138105612916487,0.02004423168444331,0.014507411718254981,0.16100689317942596,0.0181755829903978,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
253,0.3,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among patients identified through screening was satisfactory. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, proactive screening in coeliac risk groups appears to be beneficial rather than detrimental.",2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.3,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in at-risk populations? Patients detected via screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac subjects and the general population. Hence, active screening in coeliac risk groups seems justified and not harmful.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.3,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease in groups at risk? Screen-detected patients showed good long-term compliance with dietary restrictions. Their quality of life and bone mineral density were comparable to those without coeliac disease and to the general population. Active screening in these risk groups appears reasonable and not harmful.,4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.3,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups make sense? Patients identified through screening adhered well to the diet over the long term. Their quality of life and bone mineral density were on par with non-coeliac individuals and the general population. Active screening in coeliac risk groups seems appropriate rather than harmful.,4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.3,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in populations at risk? Long-term dietary adherence was good among patients detected by screening. Their quality of life and bone mineral density were similar to those of non-coeliac subjects and the general population. Active screening in coeliac risk groups appears to be a reasonable approach rather than a harmful one.,1.1842986367842703e-07,0.1820389134201723,0.060964083175803374,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
253,0.3,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to screen for coeliac disease in risk groups? Patients found through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Active screening in coeliac disease risk groups seems more beneficial than harmful.,2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.3,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Should at-risk groups be screened for coeliac disease? Screen-detected patients demonstrated good long-term adherence to diet. Their quality of life and bone mineral density were similar to those without coeliac disease and to the general population. Active screening in these groups appears justified and not harmful.,9.474389094274162e-08,0.0002826433737834755,0.060964083175803374,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.3,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in risk groups appropriate? Patients detected by screening showed good long-term dietary compliance. Their quality of life and bone mineral density matched those of non-coeliac subjects and the general population. Active screening in coeliac risk groups seems reasonable and not harmful.,9.474389094274162e-08,0.031089184732003172,0.038753339374150486,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.3,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening in risk groups advisable? Long-term dietary compliance among screen-detected patients was good. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Active screening in coeliac disease risk groups appears to be a sensible and safe strategy.,4.737194547137081e-08,0.04528440554808055,0.002568974675436278,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.3,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to conduct coeliac disease screening in risk groups? Patients identified through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to those of non-coeliac subjects and the general population. Active screening in coeliac risk groups seems reasonable and not harmful.,0.0,0.056583443311015724,0.04056477762024782,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.3,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that the elevated cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolytic abnormalities. However, we observe heightened sensitivity in NIDDM patients carrying the ACE DD genotype.",0.0,0.02772588722239755,0.019938885418112832,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.3,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our findings indicate that the increased cardiovascular risk linked to the DD genotype does not result from insulin resistance or fibrinolysis issues. On the other hand, we note increased sensitivity in NIDDM individuals with the ACE DD genotype.",1.1842986367842703e-07,0.1255566022287593,0.021754972565157765,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
254,0.3,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: We determine that the greater cardiovascular risk in DD genotype carriers is not mediated by insulin resistance or fibrinolytic dysfunction. Conversely, NIDDM subjects with the ACE DD genotype show enhanced sensitivity.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.3,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Answer: We conclude that the higher cardiovascular risk associated with the DD genotype is not caused by insulin resistance or fibrinolysis abnormalities. Instead, we report increased sensitivity in NIDDM patients with the ACE DD genotype.",0.0,0.0,6.938893903907228e-18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.3,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the insertion allele of the ACE gene I/D polymorphism linked to insulin resistance? Answer: We find that the increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or fibrinolytic abnormalities. Conversely, NIDDM subjects with the ACE DD genotype exhibit increased sensitivity.",7.105791820705622e-08,0.09491050338732743,0.023602502295684086,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.3,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: Our conclusion is that the cardiovascular risk elevation in DD genotype individuals is not due to insulin resistance or fibrinolysis defects, but we observe increased sensitivity in NIDDM patients with the ACE DD genotype.",7.105791820705622e-08,0.08756418518915021,0.021069608809993434,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.3,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: The insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk seen with the DD genotype is not mediated by insulin resistance or fibrinolytic abnormalities, while NIDDM subjects with the ACE DD genotype show increased sensitivity.",0.0,0.02772588722239755,0.019824989940143867,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.3,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: We conclude that the DD genotype's increased cardiovascular risk is not caused by insulin resistance or fibrinolysis abnormalities, but NIDDM subjects with the ACE DD genotype demonstrate increased sensitivity.",1.1842986367842703e-07,0.08071528257125005,0.017719811753902675,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
254,0.3,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: The insertion allele of the ACE gene I/D polymorphism and its role as a candidate gene for insulin resistance? Answer: We conclude that the cardiovascular risk increase in DD genotype carriers is not mediated by insulin resistance or fibrinolytic dysfunction, but NIDDM subjects with the ACE DD genotype have heightened sensitivity.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.3,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: We conclude that the elevated cardiovascular risk associated with the DD genotype is not mediated through insulin resistance or fibrinolysis abnormalities, whereas NIDDM subjects with the ACE DD genotype show increased sensitivity.",0.0,0.02772588722239755,0.019824989940143867,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
255,0.3,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: This study found that employing an endoscope during VPS surgeries did not raise the risk of infection.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
255,0.3,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is the simultaneous use of a neuroendoscope linked to higher ventriculoperitoneal shunt infection rates? Answer: Our research indicates that using an endoscope in VPS operations does not increase surgical infection risk.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.3,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the concurrent use of a neuroendoscope impact the frequency of ventriculoperitoneal shunt infections? Answer: The current study shows no increased infection risk when an endoscope is used during VPS procedures.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.3,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection incidence? Answer: Findings reveal that endoscope use during VPS surgery does not elevate infection risk.,2.842316728282236e-07,0.3802454352425526,0.02854671280276816,0.021761117577382555,0.4353180712578464,0.0,0.021729618491434483,0.45198512374305855,0.0,2.842316728282248e-07,0.47000362924573613,0.0
255,0.3,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is there an effect of neuroendoscope use on ventriculoperitoneal shunt infection rates during surgery? Answer: The study demonstrates that using an endoscope during VPS does not increase the chance of infection.,9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
255,0.3,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the use of a neuroendoscope at the same time as VPS surgery affect infection rates? Answer: Results from this study indicate no heightened risk of surgical infection with endoscope use in VPS.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
255,0.3,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.","Question: Does simultaneous neuroendoscope application alter the incidence of ventriculoperitoneal shunt infections? Answer: According to the study, endoscope use in VPS procedures does not raise infection risk.",2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
255,0.3,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Is the incidence of ventriculoperitoneal shunt infection affected by the concurrent use of a neuroendoscope? Answer: The present study found no increase in surgical infection risk when an endoscope was used during VPS.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
255,0.3,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does the use of a neuroendoscope during VPS surgery increase infection rates? Answer: This study concluded that endoscope use does not elevate the risk of ventriculoperitoneal shunt infections.,1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
255,0.3,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.",Question: Does employing a neuroendoscope simultaneously with VPS surgery impact the likelihood of shunt infections? Answer: The study results show no increased infection risk from using an endoscope during VPS procedures.,1.184298636784265e-07,0.11454226950954727,0.02854671280276816,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
256,0.3,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis? Since the age of onset and disease progression can differ significantly even among individuals with the same germline mutations, treatment decisions should rely on colonoscopy results for each patient rather than the mutation location.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999992,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
256,0.3,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation testing useful for guiding therapy in familial adenomatous polyposis? Given the variability in disease onset and progression among carriers of identical germline mutations, therapeutic strategies should be determined by colonoscopic evaluations of each patient instead of mutation site.",2.6054570009253947e-07,0.2157639362354895,0.019599999999999992,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
256,0.3,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does APC mutation analysis help inform therapeutic decisions in familial adenomatous polyposis? Because age at disease manifestation and progression can vary widely even in patients with the same germline mutation, treatment should be guided by individual colonoscopy findings rather than mutation position.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999992,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
256,0.3,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can the analysis of APC mutations influence treatment decisions in familial adenomatous polyposis? Since the timing and course of the disease may vary greatly among carriers of the same germline mutation, therapy should be based on colonoscopic findings in each patient rather than on mutation location.",1.4211583641411244e-07,0.12878744193732583,0.002610743801652899,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
256,0.3,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is it possible for APC mutation analysis to impact therapeutic choices in familial adenomatous polyposis? Due to the variability in age of onset and disease progression among individuals with identical germline mutations, treatment decisions should be made according to colonoscopic findings in individual patients instead of mutation site.",9.474389094274162e-08,0.05449578863936777,0.019599999999999992,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
256,0.3,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis be used to guide treatment in familial adenomatous polyposis? Because disease manifestation age and progression can differ even among carriers of the same germline mutation, therapeutic decisions should rely on colonoscopy results for each patient rather than mutation location.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999992,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
256,0.3,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Does analyzing APC mutations contribute to therapy decisions in familial adenomatous polyposis? Given that age at manifestation and disease course may vary among carriers of identical germline mutations, treatment should be based on colonoscopic findings in individual patients rather than mutation site.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999992,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
256,0.3,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation testing assist in therapeutic decision-making for familial adenomatous polyposis? Since the disease's onset age and progression can be quite variable even in patients with the same germline mutation, treatment should be guided by colonoscopy findings per patient rather than mutation location.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999992,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
256,0.3,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Is APC mutation analysis relevant for guiding therapy in familial adenomatous polyposis? Because the age at which the disease appears and its progression may vary even among carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in each patient instead of mutation site.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999992,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
256,0.3,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation.","Can APC mutation analysis influence therapeutic strategies in familial adenomatous polyposis? Since the age of onset and disease progression can vary significantly among individuals with the same germline mutation, treatment decisions should be made according to colonoscopic findings in individual patients rather than the mutation location.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
257,0.3,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does the nature of general practice affect the adoption of IT innovations in primary care? The analysis indicates that structural features of a practice do not impact the adoption of new IT tools, but usage might be affected by post-graduate training in the related clinical area. Specifically for this diabetes system, practice nurses...",1.4211583641411244e-07,0.11471505202249777,0.003961224489795925,0.010880558788691236,0.1384078774851245,0.019599999999999992,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
257,0.3,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do characteristics of general practices influence the adoption of IT innovations in primary care? Findings reveal that practice structural traits are not linked to the uptake of new IT facilities, though usage may be shaped by post-graduate education in the pertinent clinical condition. Regarding this diabetes system, practice nurses...",2.3685972735685406e-07,0.14143874580680782,0.034438775510204085,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
257,0.3,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are general practice features related to the uptake of IT innovations in primary care? The study shows no association between practice structure and adoption of new IT systems, but usage could be influenced by post-graduate education in the relevant clinical field. For this diabetes system, practice nurses...",2.8423167282822487e-07,0.18399836022560434,0.034438775510204085,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
257,0.3,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do attributes of general practices affect the implementation of IT innovations in primary care? Results demonstrate that structural characteristics of practices do not correlate with IT uptake, but usage might depend on post-graduate education in the clinical condition involved. In the case of this diabetes system, practice nurses...",2.6054570009253947e-07,0.19198777970931946,0.013172234867481977,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
257,0.3,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Is the uptake of IT innovations in primary care influenced by general practice characteristics? Analysis suggests structural aspects of a practice are unrelated to IT adoption, yet usage may be influenced by post-graduate training in the relevant clinical area. For this diabetes system, practice nurses...",3.316036182995957e-07,0.25995681282188965,0.011723794439354975,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
257,0.3,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do general practice traits impact the adoption of IT innovations in primary care? The data show no link between practice structure and IT uptake, but post-graduate education in the clinical condition may affect usage. Specifically for this diabetes system, practice nurses...",4.263475092423373e-07,0.3237603026007627,0.034438775510204085,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
257,0.3,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Does the uptake of an IT innovation in primary care depend on general practice characteristics? Analysis finds no association with structural features of the practice, but post-graduate education in the relevant clinical condition may influence its use. For this diabetes system, practice nurses...",3.789755637709665e-07,0.274970138431331,0.034438775510204085,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
257,0.3,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Are general practice characteristics determinants of IT innovation uptake in primary care? The findings indicate structural characteristics do not affect adoption, but usage might be shaped by post-graduate education in the clinical condition concerned. Regarding this diabetes system, practice nurses...",4.500334819780226e-07,0.34907811058505445,0.034438775510204085,0.03445510283085558,0.4054651081081637,0.0,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
257,0.3,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Do features of general practice influence the adoption of IT innovations in primary care? The study reveals no link between structural characteristics and uptake, but use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system, practice nurses...",3.789755637709665e-07,0.274970138431331,0.034438775510204085,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
257,0.3,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse","Is the adoption of IT innovations in primary care affected by general practice characteristics? Analyses show that structural features are not associated with uptake, but post-graduate education in the relevant clinical condition may impact usage. For this diabetes system, practice nurses...",4.263475092423373e-07,0.3237603026007627,0.034438775510204085,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
258,0.3,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban environment affect the risk of non-communicable diseases in Thailand? Yes, it does. Factors such as pollution, stress, and lifestyle habits linked to urban living can heighten disease risk, especially when urbanization happens rapidly without proper planning and health services.",3.079176455639103e-07,0.15490998903561604,0.06743801652892563,0.023574544042164344,0.18207564002851795,0.051570247933884296,0.023540420032387266,0.21021972650857235,0.035041322314049606,3.079176455639103e-07,0.23939631859301747,0.017851239669421492
258,0.3,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing important when considering the risk of non-communicable diseases from living in urban areas in Thailand? Absolutely. Urban living increases exposure to pollution, stress, and unhealthy lifestyles, and rapid urban growth without sufficient health infrastructure worsens these risks.",4.974054274493933e-07,0.3459652257983241,0.06743801652892563,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.3,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of residing in urban areas influence non-communicable disease risk in Thailand? Indeed, timing is significant. Urban environments contribute to higher disease risk through pollution, stress, and lifestyle factors, particularly when urbanization occurs quickly without adequate health support.",4.73719454713708e-07,0.35553574865455007,0.041814747830864675,0.03626852929563745,0.351151970072451,0.051570247933884296,0.03621603081905733,0.3834914477826086,0.035041322314049606,4.737194547137081e-07,0.4170774958304695,0.017851239669421492
258,0.3,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of urban living a factor in non-communicable disease risk in Thailand? Yes, timing plays a key role. The risks from pollution, stress, and lifestyle habits rise with urban living, especially if urban growth is fast and health services are lacking.",4.026615365066519e-07,0.2458817672413427,0.06743801652892563,0.030828249901291835,0.2751660630945296,0.051570247933884296,0.030783626196198732,0.305529906312898,0.035041322314049606,4.026615365066519e-07,0.3370347881569353,0.017851239669421492
258,0.3,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does living in an urban environment at certain times affect non-communicable disease risk in Thailand? Yes, timing matters. Urban living can increase disease risk due to pollution, stress, and lifestyle choices, with rapid urbanization and poor health planning making timing critical.",4.500334819780227e-07,0.3293292904387708,0.04245445308382371,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
258,0.3,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is the timing of living in urban areas linked to non-communicable disease risk in Thailand? Yes, it is important. Exposure to pollution, stress, and lifestyle factors in urban settings raises disease risk, and rapid urbanization without adequate health services intensifies this effect.",4.263475092423373e-07,0.3037913764086926,0.04306301652892563,0.03264167636607371,0.2998586756849013,0.051570247933884296,0.0325944277371516,0.33084771429718973,0.035041322314049606,4.263475092423373e-07,0.3630102745601933,0.017851239669421492
258,0.3,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of urban residence impact non-communicable disease risk in Thailand? Yes, timing is crucial. Urban environments contribute to higher risks through pollution, stress, and lifestyle habits, especially when urbanization is rapid and health infrastructure is insufficient.",5.210914001850786e-07,0.372633472880485,0.06743801652892563,0.0398953822252012,0.4052191913427272,0.051570247933884296,0.039837633900963065,0.43906129893742074,0.035041322314049606,5.210914001850789e-07,0.47423590967041784,0.017851239669421492
258,0.3,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing a factor in the risk of non-communicable diseases from urban living in Thailand? Yes, it is. Urban living increases exposure to harmful factors like pollution and stress, and rapid urbanization without proper health services exacerbates these risks.",4.974054274493933e-07,0.38244665635411046,0.04114144969181825,0.038081955760419325,0.3778202171546119,0.051570247933884296,0.0380268323600102,0.4108904219707239,0.035041322314049606,4.974054274493935e-07,0.44524837279716634,0.017851239669421492
258,0.3,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Does the timing of living in an urban setting affect non-communicable disease risk in Thailand? Yes, timing is important. Urban environments raise disease risk due to pollution, stress, and lifestyle habits, with rapid urban growth and inadequate health services making timing a key factor.",3.789755637709665e-07,0.2545906735781225,0.044195386143438105,0.029014823436509962,0.2510685115154696,0.051570247933884296,0.028972824655245866,0.2808372937225263,0.035041322314049606,3.789755637709665e-07,0.3117169801726436,0.017851239669421492
258,0.3,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Yes, timing does matter. Living in an urban environment in Thailand can increase the risk of non-communicable diseases due to factors like pollution, stress, and lifestyle habits. Rapid urbanization without adequate planning and health services can exacerbate these risks, making timing a crucial element.","Is timing relevant to the risk of non-communicable diseases associated with urban living in Thailand? Yes, timing matters. The risk increases due to pollution, stress, and lifestyle factors in urban areas, especially when urbanization happens quickly without sufficient health care planning.",4.500334819780227e-07,0.3293292904387708,0.04245445308382371,0.03445510283085558,0.32517648366919305,0.051570247933884296,0.034405229278104466,0.3568232007004477,0.035041322314049606,4.500334819780227e-07,0.38967852164235417,0.017851239669421492
259,0.3,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism caused by a deficiency in beta-endorphin? Our findings provide initial evidence that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly experienced in this condition.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.3,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Our results offer the first indication that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently observed in this state.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.3,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety during alcohol withdrawal linked to a lack of beta-endorphin in alcoholism? Our study presents the first evidence suggesting that lowered beta-endorphin levels during withdrawal may be a factor in the anxiety commonly seen.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.3,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Could beta-endorphin deficiency be responsible for withdrawal-induced anxiety in alcoholism? Our data provide initial proof that reduced beta-endorphin during alcohol withdrawal may be involved in the anxiety that often occurs.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.3,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety experienced during alcohol withdrawal in alcoholism due to beta-endorphin deficiency? Our findings are the first to suggest that a decrease in beta-endorphin during withdrawal might contribute to this common anxiety.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
259,0.3,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does a reduction in beta-endorphin cause withdrawal-induced anxiety in alcoholism? Our research offers the first evidence that lower beta-endorphin levels during alcohol withdrawal may be linked to the anxiety commonly present.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.3,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal anxiety in alcoholism associated with beta-endorphin deficiency? Our results provide initial evidence that diminished beta-endorphin during alcohol withdrawal could be a factor in the anxiety frequently experienced.,1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
259,0.3,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety during alcohol withdrawal in alcoholism based on a deficiency of beta-endorphin? Our findings give the first proof that lowered beta-endorphin during withdrawal may contribute to this common anxiety.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.3,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is beta-endorphin deficiency the cause of withdrawal-induced anxiety in alcoholism? Our study provides the first evidence that decreased beta-endorphin during alcohol withdrawal might contribute to anxiety as a typical symptom.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.3,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Could anxiety during alcohol withdrawal in alcoholism be due to beta-endorphin deficiency? Our results offer the first evidence that reduced beta-endorphin levels during withdrawal may play a role in this common anxiety.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
260,0.3,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts a real entity? Answer: Based on our study findings and international literature, the concept of the globulomaxillary cyst is no longer supported.",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts truly exist? Answer: Our research and global literature indicate that the globulomaxillary cyst is an outdated concept.,1.8948778188548245e-07,0.33647223662121384,0.0,0.014507411718255037,0.3513978868378893,0.0,0.014486412327622988,0.3677247801253176,0.0,1.8948778188548304e-07,0.38566248081198395,0.0
260,0.3,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a valid diagnosis? Answer: Evidence from our study and worldwide sources shows that the globulomaxillary cyst is no longer a justified entity.,4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.13241281558092455,0.03993055555555556,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.3,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts genuine? Answer: According to our study and international data, the globulomaxillary cyst is no longer recognized as a valid entity.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.3,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts really exist? Answer: The results of our research and international literature suggest that the globulomaxillary cyst is no longer a justified diagnosis.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a real pathological entity? Answer: Our findings and international literature confirm that the globulomaxillary cyst is no longer justified.,1.184298636784265e-07,0.31725762999561047,0.08616780045351473,0.009067132323909398,0.26780779269691823,0.04535147392290251,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.3,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts valid clinical entities? Answer: Based on our study and data from international literature, the globulomaxillary cyst is no longer considered valid.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.3,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Does the globulomaxillary cyst truly exist? Answer: According to our research and international sources, the globulomaxillary cyst is no longer a justified entity.",1.184298636784265e-07,0.31725762999561047,0.08616780045351473,0.009067132323909398,0.26780779269691823,0.04535147392290251,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.3,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a legitimate diagnosis? Answer: The data from our study and international literature indicate that the globulomaxillary cyst is no longer justified.,7.10579182070559e-08,0.2242322341965961,0.0793950850661626,0.005440279394345639,0.17554530070304475,0.04158790170132326,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a recognized condition? Answer: Our study results and international literature show that the globulomaxillary cyst is no longer justified.,1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
261,0.3,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not predict reduced aerobic fitness based on cycle ergometry tests. Yet, individuals with an apnea-hypopnea index above 20 show a statistically significant decline in aerobic fitness.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.3,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force members, OSA typically does not lead to lower aerobic fitness as measured by cycle ergometry. Still, those with an apnea-hypopnea index exceeding 20 experience a notable decrease in aerobic fitness.",1.6580180914979784e-07,0.10479760422188011,0.037847222222222206,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.3,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea influence aerobic fitness levels? In a study of US Air Force personnel, OSA was not linked to diminished aerobic fitness via cycle ergometry. However, patients with an apnea-hypopnea index greater than 20 demonstrated a significant reduction in aerobic fitness.",1.4211583641411244e-07,0.07989500365262181,0.03842686231740365,0.010880558788691236,0.07758428559639308,0.04246913580246913,0.0108648092457172,0.10962510843776974,0.021728395061728398,1.4211583641411244e-07,0.1431008436406751,0.0
261,0.3,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Can obstructive sleep apnea reduce aerobic fitness? Research in a US Air Force population shows OSA does not generally predict decreased aerobic fitness measured by cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index over 20 have a statistically significant drop in aerobic fitness.",1.4211583641411244e-07,0.04688799505453023,0.06222222222222221,0.010880558788691236,0.07758428559639308,0.04246913580246913,0.0108648092457172,0.10962510843776974,0.021728395061728398,1.4211583641411244e-07,0.1431008436406751,0.0
261,0.3,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is there an effect of obstructive sleep apnea on aerobic fitness? Data from US Air Force subjects indicate OSA does not predict lower aerobic fitness through cycle ergometry. However, those with an apnea-hypopnea index higher than 20 exhibit a significant decrease in aerobic fitness.",1.1842986367842703e-07,0.023357497644335812,0.06222222222222221,0.009067132323909363,0.05348673401733306,0.04246913580246913,0.009054007704764333,0.08493249584739804,0.021728395061728398,1.1842986367842703e-07,0.11778303565638337,0.0
261,0.3,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea cause a decline in aerobic fitness? In US Air Force personnel, OSA overall does not forecast reduced aerobic fitness as assessed by cycle ergometry. Yet, patients with an apnea-hypopnea index above 20 show a statistically significant fitness decline.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.3,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","How does obstructive sleep apnea affect aerobic fitness? Among US Air Force individuals, OSA does not generally predict decreased aerobic fitness based on cycle ergometry results. Still, those with an apnea-hypopnea index greater than 20 have a significant reduction in aerobic fitness.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.3,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","What is the impact of obstructive sleep apnea on aerobic fitness? In a US Air Force group, OSA does not typically predict lower aerobic fitness measured by cycle ergometry. However, patients with an apnea-hypopnea index exceeding 20 experience a statistically significant decrease in aerobic fitness.",9.474389094274162e-08,0.00036797941963628844,0.06222222222222221,0.0072537058591274906,0.029956236607138642,0.04246913580246913,0.007243206163811466,0.06083494426833802,0.021728395061728398,9.474389094274162e-08,0.09309042306601167,0.0
261,0.3,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Does obstructive sleep apnea lead to reduced aerobic fitness? Research involving US Air Force members shows OSA does not usually predict decreased aerobic fitness via cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index over 20 have a significant decline in aerobic fitness.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
261,0.3,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared","Is aerobic fitness compromised by obstructive sleep apnea? In a US Air Force population, OSA generally does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index greater than 20 have a statistically significant reduction in aerobic fitness.",7.105791820705622e-08,0.039508206284017966,0.017873925845802524,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
262,0.3,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts truly a distinct entity? Answer: Globulomaxillary cysts were historically considered a unique cyst type originating from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.08771187976790795,0.03698224852071005,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,0.3,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts actually exist? Answer: These cysts were once believed to be a specific form arising at the junction of two embryonic structures. However,",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.3,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the existence of globulomaxillary cysts real? Answer: Globulomaxillary cysts were previously thought to be a particular cyst type developing along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.3,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts a genuine pathological entity? Answer: They were once regarded as cysts arising specifically from the fusion line between two embryonic processes. However,",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.3,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts genuinely exist? Answer: Historically, globulomaxillary cysts were considered a distinct cyst type formed at the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.16878045975179923,0.03993055555555556,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.3,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts truly present? Answer: These cysts were once identified as a specific type originating from the fusion line between two embryonic processes. However,",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.3,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is there real evidence for globulomaxillary cysts? Answer: Globulomaxillary cysts were once thought to be a unique cyst type arising from the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,0.3,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Do globulomaxillary cysts exist as a separate entity? Answer: They were historically believed to be cysts developing at the fusion line between two embryonic processes. However,",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.3,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Are globulomaxillary cysts an actual clinical entity? Answer: These cysts were once considered to arise specifically from the fusion line of two embryonic processes. However,",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
262,0.3,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Globulomaxillary cysts were once thought to be a specific type of cyst arising from a fusion line between two embryonic processes. However,","Question: Is the concept of globulomaxillary cysts valid? Answer: Globulomaxillary cysts were once thought to be a distinct cyst type formed along the fusion line of two embryonic processes. However,",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
263,0.3,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients undergoing MMT and receiving medical care at various locations, the majority have opioid dependence and MMT documented in their medical records, though a significant portion do not. Most of these patients are prescribed medications that may interact with",1.4211583641411244e-07,0.06691179819077675,0.03018710562414264,0.010880558788691236,0.0897659700774085,0.015441322314049606,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
263,0.3,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? For patients on MMT receiving care at different sites, opioid dependence and MMT are documented in most medical records, but a notable number lack this documentation. Many of these patients are prescribed drugs that could potentially interact with",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.3,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical records? Among patients treated with MMT and receiving care at multiple sites, most have opioid dependence and MMT recorded, but a considerable number do not. The majority of these patients are prescribed medications that might interact with",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.3,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? For patients receiving MMT and medical care at various sites, documentation of opioid dependence and MMT appears in most medical records, yet a substantial number are missing this information. Most of these patients are prescribed medications with potential interactions",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.3,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? Among patients on MMT and receiving medical care at different locations, documentation of opioid dependence and MMT is present for most, but absent in a significant number. Most of these patients are prescribed medications that may have potential interactions with",1.4211583641411244e-07,0.06691179819077675,0.03018710562414264,0.010880558788691236,0.0897659700774085,0.015441322314049606,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
263,0.3,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients receiving MMT and medical care across various sites, opioid dependence and MMT are documented for the majority, though a notable number lack this documentation. Most of these patients are prescribed medications that could potentially interact with",1.8948778188548325e-07,0.10826527189962798,0.028656550068587083,0.014507411718254981,0.13088078397171543,0.014642016758494043,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
263,0.3,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients receiving MMT and medical care at multiple sites, documentation of opioid dependence and MMT is found in most cases, but is missing in a significant number of patients. Most of these patients are prescribed medications that might interact with",1.1842986367842703e-07,0.046857584090098214,0.030909289399613633,0.009067132323909363,0.06982514879001966,0.01581794668928989,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
263,0.3,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Among patients undergoing MMT and receiving medical care at different locations, opioid dependence and MMT are documented in most medical records, but a substantial number lack this information. Most of these patients are prescribed medications that potentially interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.3,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? Among patients receiving MMT and medical care at various sites, the majority have opioid dependence and MMT recorded in their medical records, but a significant number do not. Most of these patients are prescribed medications that may interact with",1.6580180914979784e-07,0.08737535490845216,0.029436751604983956,0.012693985253473108,0.11011224222108673,0.015049652176606865,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
263,0.3,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with","Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients on MMT and receiving medical care at different sites, documentation of opioid dependence and MMT occurs for most, but is missing in a substantial number of patients. Most of these patients are prescribed medications that could potentially interact with",1.1842986367842703e-07,0.046857584090098214,0.030909289399613633,0.009067132323909363,0.06982514879001966,0.01581794668928989,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
264,0.3,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does the quantity of needles influence acupuncture treatment for neck pain? It appears that whether 5 or 11 needles are used, the therapeutic outcome is similar if the stimulation duration is equal in both groups.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.3,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture for neck pain, does the number of needles affect treatment? Using 5 or 11 needles does not seem to significantly impact the therapeutic effect when both groups receive the same stimulation time.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.3,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding neck pain acupuncture, is the needle count important? The therapeutic effect seems unaffected by using either 5 or 11 needles, provided the stimulation time is consistent across groups.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,0.3,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does the number of needles used in acupuncture for neck pain matter? The treatment effect appears similar whether 5 or 11 needles are applied, as long as the stimulation duration is the same in both groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.3,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When treating neck pain with acupuncture, does needle quantity influence results? The therapeutic outcome seems independent of using 5 or 11 needles if the stimulation time remains equal between groups.",4.0266153650665074e-07,0.40107189862784365,0.043388429752066124,0.030828249901291883,0.4436514382368957,0.02221074380165289,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
264,0.3,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Is the number of needles a key factor in acupuncture treatment for neck pain? It seems that 5 or 11 needles yield comparable therapeutic effects when the stimulation time is identical in both groups.,3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.3,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","For neck pain acupuncture therapy, does the needle count affect efficacy? The number, either 5 or 11, does not appear to be a critical factor if stimulation time is matched in both groups.",3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,0.3,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture treatment of neck pain, does the number of needles used matter? The therapeutic effect seems similar whether 5 or 11 needles are used, given equal stimulation time in both groups.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
264,0.3,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Does the amount of needles influence acupuncture outcomes for neck pain? Using 5 or 11 needles seems to have no significant difference in therapeutic effect when stimulation time is the same in both groups.,3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.3,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding acupuncture for neck pain, is the needle number significant? The therapeutic effect appears consistent whether 5 or 11 needles are used, provided the stimulation time is equal in both groups.",3.7897556377096544e-07,0.3671703469521619,0.043388429752066124,0.029014823436510004,0.4085601184256267,0.02221074380165289,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
265,0.3,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, the development of endometrial polyps is connected to elevated expression of vascular endothelial growth factor and transforming growth factor-beta1, which promote angiogenesis and fibrosis, key processes in polyp growth.",9.474389094274162e-08,0.0066006898964565686,0.044707429322813935,0.0072537058591274906,0.010857262176881655,0.05500000000000002,0.007243206163811466,0.015467206375585185,0.0642474717430101,9.474389094274162e-08,0.017949799470877714,0.06900654372397377
265,0.3,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does endometrial polyp formation correlate with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Indeed, endometrial polyps are associated with upregulated vascular endothelial growth factor and transforming growth factor-beta1, facilitating angiogenesis and fibrosis that contribute to polyp formation.",2.8423167282822487e-07,0.12373482835550265,0.07689350249903873,0.02176111757738247,0.14698936676820384,0.07394247404844298,0.0217296184914344,0.17082958292332595,0.06752036294099122,2.8423167282822487e-07,0.16697085771854603,0.0765995483821831
265,0.3,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is there an association between endometrial polyp formation and elevated vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, the formation of endometrial polyps involves increased expression of these growth factors, which drive angiogenesis and fibrosis essential for polyp development.",2.8423167282822487e-07,0.08420932581248053,0.22222222222222215,0.02176111757738247,0.030740679529216663,0.19937500000000002,0.0217296184914344,0.024903860700178804,0.17132659131469363,2.8423167282822487e-07,0.05456861222233744,0.15704937537180244
265,0.3,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Are increased levels of vascular endothelial growth factor and transforming growth factor-beta1 linked to the formation of endometrial polyps? Yes, endometrial polyp formation is related to heightened expression of these growth factors, which support angiogenesis and fibrosis, crucial in polyp growth.",2.8423167282822487e-07,0.08420932581248053,0.22222222222222215,0.02176111757738247,0.030740679529216663,0.19937500000000002,0.0217296184914344,0.024903860700178804,0.17132659131469363,2.8423167282822487e-07,0.05456861222233744,0.15704937537180244
265,0.3,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does the development of endometrial polyps involve increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, these growth factors are upregulated during polyp formation, promoting angiogenesis and fibrosis that contribute to the process.",4.026615365066514e-07,0.04932206681204221,0.22222222222222215,0.030828249901291842,0.10646044198426585,0.19937500000000002,0.030783626196198746,0.16598245896008512,0.17132659131469363,4.026615365066519e-07,0.19975062206683658,0.15704937537180244
265,0.3,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is endometrial polyp formation associated with the upregulation of vascular endothelial growth factor and transforming growth factor-beta1? Yes, increased expression of these factors is observed in polyp development, aiding angiogenesis and fibrosis.",4.974054274493926e-07,0.170682923816309,0.22222222222222215,0.03808195576041936,0.23162358493827284,0.19937500000000002,0.03802683236001024,0.2951941904400921,0.17132659131469363,4.974054274493935e-07,0.3332820146913589,0.15704937537180244
265,0.3,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is there a connection between endometrial polyp formation and increased vascular endothelial growth factor and transforming growth factor-beta1? Yes, the formation of polyps in the endometrium is linked to elevated levels of these growth factors, which play roles in angiogenesis and fibrosis.",2.6054570009253947e-07,0.10890193840285223,0.22222222222222215,0.0199476911126006,0.05605848751350839,0.19937500000000002,0.019918816950481533,0.001071625703079171,0.17132659131469363,2.6054570009253947e-07,0.027900365140176575,0.15704937537180244
265,0.3,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the presence of endometrial polyps related to higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, endometrial polyps show increased expression of these growth factors, which contribute to angiogenesis and fibrosis important in polyp development.",3.316036182995955e-07,0.040046829686642305,0.169753086419753,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.17132659131469363,3.316036182995957e-07,0.11013846337714961,0.15704937537180244
265,0.3,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Is the formation of endometrial polyps associated with increased levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, these growth factors are upregulated in polyp formation, promoting angiogenesis and fibrosis that are vital to the process.",3.552895910352808e-07,0.0062477843427699575,0.22222222222222215,0.02720139697172809,0.0493020281443175,0.19937500000000002,0.027162023114293,0.10714195893715184,0.17132659131469363,3.552895910352811e-07,0.13912600025040112,0.15704937537180244
265,0.3,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1. These growth factors contribute to angiogenesis and fibrosis, respectively, which play significant roles in polyp development.","Does increased expression of vascular endothelial growth factor and transforming growth factor-beta1 accompany endometrial polyp formation? Yes, the development of endometrial polyps is linked to higher expression of these growth factors, which facilitate angiogenesis and fibrosis involved in polyp growth.",3.079176455639102e-07,0.023345508568704876,0.1965989535241612,0.023574544042164344,0.004765193125958689,0.19937500000000002,0.023540420032387266,0.05157210778233967,0.17132659131469363,3.079176455639103e-07,0.08196758641045276,0.15704937537180244
266,0.3,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? No, it does not completely explain the disparity. Other factors like genetics, maternal health, socio-economic status, and healthcare access also play roles.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
266,0.3,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? No, gestational age misclassification alone does not fully account for the variation. Additional influences include genetic factors, maternal health, socio-economic conditions, and access to care.",1.1842986367842692e-07,0.0958795231555154,0.14721623747477855,0.009067132323909363,0.03758306276769474,0.11426592797783926,0.009054007704764333,0.06073768844295824,0.047500000000000014,1.1842986367842703e-07,0.09624107065990772,0.024375
266,0.3,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can gestational age misclassification explain why Australian Aborigines and whites have different birthweights? No, it does not entirely explain the difference. Other contributing factors include genetics, maternal health, socio-economic disparities, and healthcare availability.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.31246417912954483,0.024375
266,0.3,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does misclassifying gestational age explain the birthweight gap between Australian Aborigines and whites? No, it does not fully explain the difference. Other elements such as genetic variation, maternal health, socio-economic inequalities, and access to medical care are also involved.",1.4211583641411222e-07,0.068968615455955,0.14654293933573212,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.08813666263107356,0.047500000000000014,1.4211583641411244e-07,0.12441194762660457,0.024375
266,0.3,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification responsible for the birthweight differences seen between Australian Aborigines and whites? No, it does not completely explain the discrepancy. Factors like genetics, maternal health, socio-economic status, and healthcare access also contribute.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.24577280463087137,0.024375
266,0.3,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does the misclassification of gestational age account for the birthweight differences between Australian Aborigines and whites? No, it does not fully explain the disparity. Other factors include genetic differences, maternal health, socio-economic challenges, and access to healthcare.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
266,0.3,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is the variation in birthweights between Australian Aborigines and whites explained by gestational age misclassification? No, this misclassification does not fully account for the difference. Other influences include genetics, maternal health, socio-economic factors, and healthcare access.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.21402410631629154,0.024375
266,0.3,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Can the difference in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? No, it cannot fully explain the difference. Other factors such as genetic makeup, maternal health, socio-economic status, and access to healthcare also play a role.",9.474389094274162e-08,0.15674334039929105,0.1728395061728395,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03406944136079737,0.047500000000000014,9.474389094274162e-08,0.0688420964717924,0.024375
266,0.3,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Does gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? No, it does not completely explain the variation. Additional factors include genetics, maternal health, socio-economic disparities, and healthcare access.",3.0791764556390933e-07,0.1428680821688495,0.1406172839506173,0.02357454404216438,0.1988057152965368,0.11426592797783926,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.34755549894081383,0.024375
266,0.3,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: No, gestational age misclassification does not fully explain the difference in birthweights between Australian aborigines and whites. Other factors such as genetic differences, maternal health, socio-economic disparities, and access","Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? No, it does not fully explain the difference. Other contributing factors include genetic differences, maternal health, socio-economic status, and access to medical care.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.18325244764953785,0.024375
267,0.3,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya align with the principles of universal coverage? Answer: Universal coverage principles mandate that everyone receives health care based on need. However, Kenya's health sector is evidently inequitable, with benefits not allocated according to need. Focused efforts are necessary to restructure the system.",1.4211583641411244e-07,0.04112406266969293,0.050175720897116416,0.010880558788691236,0.06381817240986454,0.03566529492455417,0.0108648092457172,0.09030753510148237,0.0181755829903978,1.4211583641411244e-07,0.11778303565638426,0.0
267,0.3,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Answer: Universal coverage demands that health care benefits be provided according to need for all. The Kenyan health sector is clearly unequal, and benefits are not distributed based on need. Intentional restructuring efforts are required.",1.8948778188548325e-07,0.1388223198750156,0.008811637721313034,0.014507411718254981,0.1335212994534496,0.014841392706355885,0.014486412327622933,0.1319802315020513,0.0181755829903978,1.8948778188548325e-07,0.16034265007518078,0.0
267,0.3,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya's health care benefits distribution adhere to universal coverage principles? Answer: The core of universal coverage is that all individuals receive health care according to their needs. Kenya's health sector is evidently inequitable, with benefits not aligned to need. Targeted efforts should aim at restructuring the system.",2.1317375462116866e-07,0.1612098396812205,0.007553498674894188,0.016320838183036854,0.12569357612795207,0.03566529492455417,0.0162972138685758,0.15348643672301465,0.0181755829903978,2.1317375462116866e-07,0.18232155679395579,0.0
267,0.3,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are health care benefits in Kenya distributed in line with universal coverage principles? Answer: Universal coverage principles require health care benefits to be allocated according to need. The Kenyan health sector is clearly unfair, with benefits not distributed based on need. Deliberate restructuring is necessary.",2.8423167282822487e-07,0.23152458732345815,0.00344919028487152,0.02176111757738247,0.22315823394520073,0.01295031385370506,0.0217296184914344,0.2209277175185469,0.0181755829903978,2.8423167282822487e-07,0.25131442828090744,0.0
267,0.3,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the Kenyan health care benefits distribution fulfill universal coverage principles? Answer: Universal coverage means everyone should benefit from health care based on need. The Kenyan health sector is evidently inequitable, and benefits are not distributed by need. Focused restructuring efforts are essential.",3.316036182995957e-07,0.3135249523134527,0.022268986532206422,0.025387970506946217,0.27117856815273367,0.011869935019735614,0.025351221573340132,0.26855576650780133,0.0181755829903978,3.316036182995957e-07,0.30010459245033916,0.0
267,0.3,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the distribution of health care benefits in Kenya equitable according to universal coverage principles? Answer: Universal coverage requires that health care benefits be distributed according to need for all. Kenya's health sector is clearly inequitable, with benefits not aligned to need. Intentional restructuring should be pursued.",2.3685972735685406e-07,0.21360235012777462,0.014594208794608848,0.018134264647818726,0.17733661528630407,0.013936899862825772,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
267,0.3,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does Kenya's distribution of health care benefits meet universal coverage standards? Answer: Universal coverage principles state that all should receive health care based on need. The Kenyan health sector is evidently unequal, with benefits not distributed according to need. Targeted restructuring efforts are needed.",3.079176455639103e-07,0.2245911991517615,0.024424246974213915,0.023574544042164344,0.21464106214444767,0.03566529492455417,0.023540420032387266,0.2444582149287413,0.0181755829903978,3.079176455639103e-07,0.27541197985996746,0.0
267,0.3,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Are health care benefits in Kenya allocated according to the principles of universal coverage? Answer: Universal coverage requires that all individuals benefit from health care based on need. The Kenyan health sector is clearly inequitable, and benefits are not distributed on this basis. Deliberate restructuring is necessary.",2.3685972735685406e-07,0.12511547601373918,0.04850918025439431,0.018134264647818726,0.14719978134891543,0.03566529492455417,0.018108015409528666,0.17546534344178966,0.0181755829903978,2.3685972735685406e-07,0.2047944126460135,0.0
267,0.3,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Does the distribution of health care benefits in Kenya conform to universal coverage principles? Answer: The principles of universal coverage demand that all receive health care according to need. Kenya's health sector is evidently inequitable, with benefits not distributed by need. Focused efforts should be made to restructure the system.",1.6580180914979784e-07,0.08919622203576871,0.029845165341560842,0.012693985253473108,0.08402087972738315,0.03566529492455417,0.012675610786670066,0.11092682230421813,0.0181755829903978,1.6580180914979784e-07,0.13883644485421742,0.0
267,0.3,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the,"Question: Is the Kenyan health care benefits distribution aligned with universal coverage principles? Answer: Universal coverage requires that everyone benefits from health care based on need. The Kenyan health sector is clearly inequitable, and benefits are not allocated according to need. Intentional restructuring efforts are essential.",2.8423167282822487e-07,0.26233112868167785,0.01826711075071226,0.02176111757738247,0.22315823394520073,0.01295031385370506,0.0217296184914344,0.2209277175185469,0.0181755829903978,2.8423167282822487e-07,0.25131442828090744,0.0
268,0.3,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: Postictal psychotic episodes may signal an increased risk of interictal psychotic episodes. Frequent occurrences after seizures imply a potential for psychotic episodes between seizures.,9.474389094274162e-08,0.07544035994788745,0.008900200876552272,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
268,0.3,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How significant are postictal psychotic episodes in the long term II? Are they indicators of interictal psychotic episodes? Answer: The presence of postictal psychotic episodes can suggest a greater chance of interictal psychotic episodes. Repeated episodes following seizures indicate a likelihood of psychotic episodes occurring during interictal periods.,7.105791820705622e-08,0.07489229884502091,0.010105124391563025,0.005440279394345618,0.06998009843334385,0.002882338120433363,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
268,0.3,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term relevance of postictal psychotic episodes II? Can they predict interictal psychotic episodes? Answer: Postictal psychotic episodes often point to a higher probability of interictal psychotic episodes. Frequent post-seizure episodes suggest the patient might experience psychotic episodes in the interictal phase.,2.3685972735685406e-08,0.005268824097956593,0.019374999999999948,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
268,0.3,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: Long-term implications of postictal psychotic episodes II: Are they predictive of interictal psychotic episodes? Answer: Experiencing postictal psychotic episodes can be a sign of increased risk for interictal psychotic episodes. If these episodes happen regularly after seizures, it indicates potential psychotic episodes between seizures.",2.3685972735685406e-08,0.005268824097956593,0.019374999999999948,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
268,0.3,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: What is the long-term impact of postictal psychotic episodes II? Do they forecast interictal psychotic episodes? Answer: Postictal psychotic episodes can serve as indicators of a higher likelihood of interictal psychotic episodes. Frequent post-seizure episodes suggest the patient may have psychotic episodes during interictal periods.,0.0,0.030806541358219697,0.022551680547293257,0.0,0.031506690025452144,0.022636492852053384,0.0,0.0,0.0,0.0,0.0,0.0
268,0.3,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: Long-term significance of postictal psychotic episodes II: Are they predictive markers for interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed predict a greater chance of interictal psychotic episodes. Recurrent episodes after seizures imply the patient might experience psychotic episodes between seizures.,7.105791820705622e-08,0.047818751697374484,0.012560595567867067,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
268,0.3,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: How do postictal psychotic episodes relate to interictal psychotic episodes in the long term II? Answer: Postictal psychotic episodes may indicate a higher risk of interictal psychotic episodes. Frequent occurrences after seizures suggest the patient could have psychotic episodes during interictal times.,7.105791820705622e-08,0.10137447975630876,0.11966079254930623,0.005440279394345618,0.04141624475133909,0.020976473922902493,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
268,0.3,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the prognostic value of postictal psychotic episodes II regarding interictal psychotic episodes? Answer: Postictal psychotic episodes can be predictive of interictal psychotic episodes. If these episodes frequently follow seizures, it suggests the patient may experience psychotic episodes in the interictal phase.",4.737194547137081e-08,0.020928107228350257,0.01604824128862592,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
268,0.3,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even",Question: Long-term importance of postictal psychotic episodes II: Are they predictive of interictal psychotic episodes? Answer: The occurrence of postictal psychotic episodes can indicate a higher probability of interictal psychotic episodes. Frequent episodes after seizures suggest the patient might develop psychotic episodes between seizures.,4.737194547137081e-08,0.08540691472229955,0.030544649379108862,0.0036268529295637453,0.08252766137826795,0.025654443236860794,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
268,0.3,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes can indeed indicate a higher likelihood of interictal psychotic episodes. If these episodes occur frequently after seizures, it suggests that the patient may experience psychotic episodes even","Question: What is the long-term significance of postictal psychotic episodes II? Are they indicative of interictal psychotic episodes? Answer: Postictal psychotic episodes can point to an increased likelihood of interictal psychotic episodes. If these episodes are common after seizures, it implies the patient may experience psychotic episodes during interictal periods.",9.474389094274162e-08,0.09868110983575162,0.013197314049586767,0.0072537058591274906,0.09226249199387215,0.003763572221579234,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
269,0.3,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? Yes, aerobic fitness has a significant impact on microvascular function in these individuals. Engaging in regular aerobic exercise enhances insulin sensitivity and endothelial health, which helps lower the risk of microvascular issues linked to prediabetes or early stages of diabetes.",2.3685972735685406e-08,0.25573056301521024,0.19430167384792865,0.0018134264647818726,0.22419284683448293,0.14182441700960224,0.0018108015409528666,0.2279441120491188,0.14617283950617282,2.3685972735685406e-08,0.20566474358298592,0.131358024691358
269,0.3,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function influenced by aerobic fitness in healthy adults at risk of Type 2 diabetes? Indeed, aerobic fitness plays a crucial role in microvascular function among these adults. Consistent aerobic activity improves insulin sensitivity and endothelial function, thereby decreasing the likelihood of microvascular complications related to prediabetes or early diabetes.",1.1842986367842703e-07,0.16121587260911951,0.2077709046932275,0.009067132323909363,0.13388531173300056,0.16000000000000003,0.009054007704764333,0.11016107639273454,0.14617283950617282,1.1842986367842703e-07,0.08552043174092283,0.131358024691358
269,0.3,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness impact microvascular function in healthy adults predisposed to Type 2 diabetes? Yes, it does. Aerobic fitness markedly affects microvascular function by improving insulin sensitivity and endothelial function, which reduces the risk of microvascular problems associated with prediabetes or early-stage diabetes.",3.079176455639103e-07,0.02369975728704654,0.20020146024878305,0.023574544042164344,0.0443629196733184,0.16000000000000003,0.023540420032387266,0.07216048040122036,0.14617283950617282,3.079176455639103e-07,0.10106552383949063,0.131358024691358
269,0.3,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness influence microvascular function in healthy adults at risk for developing Type 2 diabetes? Yes, aerobic fitness significantly affects microvascular function in such adults. Regular aerobic exercise boosts insulin sensitivity and endothelial function, helping to prevent microvascular complications linked to prediabetes or early diabetes.",2.3685972735685406e-07,0.018887507321430075,0.18137492963653817,0.018134264647818726,0.005252042484817032,0.13728501892915093,0.018108015409528666,0.00016018117840577162,0.14617283950617282,2.3685972735685406e-07,0.02695755168576719,0.131358024691358
269,0.3,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? Yes, aerobic fitness significantly influences microvascular function. Regular aerobic exercise enhances insulin sensitivity and endothelial function, thereby lowering the risk of microvascular complications in prediabetic or early diabetic stages.",1.8948778188548325e-07,0.09580099392647057,0.20523232444631392,0.014507411718254981,0.07070641011146828,0.16000000000000003,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.3,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness have an effect on microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness substantially impacts microvascular function. Engaging in regular aerobic exercise improves insulin sensitivity and endothelial function, reducing the risk of microvascular complications associated with prediabetes or early diabetes.",1.8948778188548325e-07,0.12529661863114905,0.22643491960606096,0.014507411718254981,0.07070641011146828,0.16000000000000003,0.014486412327622933,0.04562255525516301,0.14617283950617282,1.8948778188548325e-07,0.01956246394912675,0.131358024691358
269,0.3,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","How does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? Aerobic fitness significantly influences microvascular function by improving insulin sensitivity and endothelial function, which decreases the risk of microvascular complications in prediabetic or early diabetic individuals.",3.316036182995957e-07,0.08321946443479256,0.17498677880833985,0.025387970506946217,0.0690555322636901,0.16000000000000003,0.025351221573340132,0.09747828838551209,0.14617283950617282,3.316036182995957e-07,0.1270410102427486,0.131358024691358
269,0.3,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Is microvascular function in healthy adults at risk of Type 2 diabetes influenced by aerobic fitness? Yes, aerobic fitness has a significant positive effect. Regular aerobic exercise enhances insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications linked to prediabetes or early-stage diabetes.",2.3685972735685406e-07,0.08050059003786947,0.22549071644713017,0.018134264647818726,0.026254647540635556,0.16000000000000003,0.018108015409528666,0.00016018117840577162,0.14617283950617282,2.3685972735685406e-07,0.02695755168576719,0.131358024691358
269,0.3,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Does aerobic fitness play a role in microvascular function among healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness plays an important role by significantly improving microvascular function. This is achieved through enhanced insulin sensitivity and endothelial function, which lowers the risk of microvascular complications in prediabetic or early diabetic stages.",7.105791820705622e-08,0.22922885326258413,0.22847808462402336,0.005440279394345618,0.17389064634669893,0.16000000000000003,0.0054324046228586,0.1509830709129889,0.14617283950617282,7.105791820705622e-08,0.12719312814149175,0.131358024691358
269,0.3,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness significantly influences microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise improves insulin sensitivity and endothelial function, thereby reducing the risk of microvascular complications associated with prediabetes or early-stage","Can aerobic fitness alter microvascular function in healthy adults at risk of developing Type 2 diabetes? Yes, it can. Aerobic fitness significantly improves microvascular function by boosting insulin sensitivity and endothelial health, thus reducing the risk of microvascular complications associated with prediabetes or early-stage diabetes.",2.6054570009253947e-07,0.005685794532325428,0.17988468452005013,0.0199476911126006,0.003265129315936033,0.16000000000000003,0.019918816950481533,0.023370316231788646,0.14617283950617282,2.6054570009253947e-07,0.051055103264827206,0.131358024691358
270,0.3,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does initiating migraine treatment early reduce the time to reach headache peak and lessen its severity? Early intervention and triptan use might shorten the interval from migraine onset to peak but do not diminish headache intensity at peak. This may lower the overall migraine burden by shortening total headache duration.,9.474389094274162e-08,0.05231511806187328,0.018860946745562133,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
270,0.3,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Can early migraine treatment speed up the time to headache peak and decrease its severity? Starting treatment early with triptans may reduce the time from migraine onset to peak but does not reduce the severity of the headache at peak. This could help lessen the migraine burden by cutting down total headache duration.,2.3685972735685406e-08,0.04621071148029898,0.019539053254437878,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
270,0.3,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does treating migraines early shorten the time to peak headache and reduce how severe it is? Early treatment and triptan administration may lead to a quicker progression from migraine onset to peak but do not lessen headache severity at peak. This might reduce the migraine burden by decreasing overall headache duration.,7.105791820705622e-08,0.05983829796675266,0.001130723391880601,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
270,0.3,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Is early treatment of migraines effective in reducing time to headache peak and its severity? Early use of triptans can shorten the duration from migraine onset to peak but does not alleviate peak headache severity. This may decrease migraine burden by reducing total headache duration.,2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.3,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does early intervention in migraine treatment reduce the time to headache peak and its intensity? Early treatment with triptans might shorten the time from migraine start to peak but does not reduce headache severity at peak. This could result in a lower migraine burden by shortening total headache duration.,1.1842986367842703e-07,0.10181553778793972,0.0019629554726361513,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
270,0.3,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Can early migraine treatment shorten the time to reach headache peak and lessen its severity? Early use of triptans may lead to a shorter duration from migraine onset to peak but does not reduce headache severity at peak. This may help decrease the overall migraine burden by reducing total headache duration.,7.105791820705622e-08,0.03211241074435467,0.018860946745562133,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
270,0.3,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does early migraine therapy reduce the time to headache peak and its severity? Early treatment and triptan use may shorten the time from migraine onset to peak but do not alleviate headache severity at peak. This could reduce migraine burden by decreasing total headache duration.,2.1317375462116866e-07,0.19145247227969087,0.003854034325286977,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
270,0.3,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Is early treatment of migraine effective in shortening time to headache peak and reducing its severity? Early intervention with triptans may shorten the duration from migraine onset to peak but does not lessen headache severity at peak. This might lower the migraine burden by reducing total headache duration.,1.4211583641411244e-07,0.0939878144624422,0.018860946745562133,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
270,0.3,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Does early administration of migraine treatment shorten the time to headache peak and reduce severity? Early treatment and triptan use may lead to a shorter time from migraine onset to peak but do not reduce headache severity at peak. This could decrease migraine burden by shortening overall headache duration.,1.1842986367842703e-07,0.07293440526460904,0.018860946745562133,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
270,0.3,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.,Can early treatment of migraines reduce the time to headache peak and its severity? Early use of triptans may shorten the duration from migraine onset to peak but does not alleviate headache severity at peak. This may help reduce the migraine burden by decreasing total headache duration.,1.6580180914979784e-07,0.1456308536207942,0.002867448316166265,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
271,0.3,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is necessary to assess if these changes benefit the outcomes for older patients.,1.8948778188548325e-07,0.06873095963088005,0.0749700721939469,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.3,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation alter the cancer treatment strategy for elderly patients? More than one third of cases saw treatment plan modifications following the consultation. Further studies are required to evaluate whether these adjustments improve outcomes for elderly patients.,2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.3,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? In over one third of cases, the consultation led to changes in the treatment plan. More research is needed to determine if these changes enhance patient outcomes.",2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.3,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist result in changes to cancer treatment plans for older patients? The consultation caused modifications in the treatment plan in more than a third of cases. Further investigation is needed to see if these modifications improve outcomes.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.3,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? Treatment plans were altered in over one third of cases after the consultation. Additional studies are needed to confirm if these changes improve patient outcomes.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.3,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation influence the cancer treatment plan for elderly patients? The consultation led to changes in the treatment plan in more than one third of cases. Further research is necessary to determine if these changes benefit older patients.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.3,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation lead to modifications in cancer treatment plans for elderly patients? More than one third of cases experienced treatment plan changes following the consultation. Further studies are required to assess if these modifications improve outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.3,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients affected by a geriatric oncology consultation? The consultation resulted in treatment plan modifications in over one third of cases. Additional research is needed to evaluate whether these changes improve patient outcomes.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.3,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation bring about changes in the cancer treatment plan for elderly patients? Treatment plans were modified in more than one third of cases after the consultation. Further studies are necessary to determine if these modifications enhance outcomes.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.3,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation modify the cancer treatment approach for elderly patients? The consultation led to changes in the treatment plan in over one third of cases. More research is needed to find out if these changes improve the outcomes for older patients.,1.6580180914979784e-07,0.012193453622594053,0.09876543209876545,0.012693985253473108,0.06927551486073513,0.060964083175803374,0.012675610786670066,0.1287478116802525,0.020823902218198284,1.6580180914979784e-07,0.16126814759612174,0.0
272,0.3,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can computerized tomography substitute bone scintigraphy for detecting bone metastases in breast cancer? Computerized tomography (CT) cannot entirely replace bone scintigraphy in detecting bone metastases from breast cancer. Although CT is useful in identifying,4.73719454713706e-08,0.12959951270072256,0.10742529673747085,0.003626852929563759,0.18146722433501505,0.16082641395779712,0.003621603081905747,0.1895331632222832,0.1728395061728395,4.737194547137081e-08,0.15206997278741197,0.1508916323731139
272,0.3,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases from breast cancer? Computerized tomography (CT) cannot completely replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,2.36859727356853e-08,0.15359750963944885,0.06633136094674552,0.0018134264647818796,0.19557585085656637,0.10708295824759942,0.0018108015409528735,0.20035975622859858,0.1142457561728395,2.3685972735685406e-08,0.20537123255780143,0.1206181948731139
272,0.3,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can CT scans replace bone scintigraphy in the detection of bone metastases from breast cancer? CT cannot fully substitute bone scintigraphy for detecting bone metastases from breast cancer. Although CT is capable of identifying,4.73719454713706e-08,0.12959951270072256,0.10742529673747085,0.003626852929563759,0.13814552555001836,0.12982167352537718,0.003621603081905747,0.14481399028293218,0.1406172839506173,4.737194547137081e-08,0.15206997278741197,0.1508916323731139
272,0.3,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Does computerized tomography serve as a replacement for bone scintigraphy in detecting bone metastases from breast cancer? Computerized tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,4.73719454713706e-08,0.11230622269099255,0.0265691730751641,0.003626852929563752,0.11152289858974829,0.03204389574759939,0.003621603081905747,0.11285196863799474,0.03395061728395063,4.737194547137081e-08,0.11413966149202048,0.03533607681755831
272,0.3,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Is it possible for computerized tomography to replace bone scintigraphy in the detection of bone metastases from breast cancer? Computerized tomography (CT) cannot entirely replace bone scintigraphy in detecting bone metastases from breast cancer. Although CT is effective in identifying,9.47438909427412e-08,0.21586721268324238,0.05543292344674555,0.0072537058591274975,0.2507134578235255,0.088237667373897,0.00724320616381148,0.29152904105055644,0.11896195515243133,9.474389094274162e-08,0.3343915295813673,0.1508916323731139
272,0.3,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can CT be used instead of bone scintigraphy to detect bone metastases from breast cancer? CT cannot completely replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,4.73719454713706e-08,0.12959951270072256,0.10742529673747085,0.003626852929563759,0.13814552555001836,0.12982167352537718,0.003621603081905747,0.14481399028293218,0.1406172839506173,4.737194547137081e-08,0.15206997278741197,0.1508916323731139
272,0.3,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Could computerized tomography replace bone scintigraphy for detecting bone metastases in breast cancer patients? Computerized tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. Although CT is effective in identifying,2.36859727356853e-08,0.12362133817440046,0.08364408389561598,0.0018134264647818796,0.17154274171889394,0.13169009762064834,0.0018108015409528735,0.22128186153686302,0.1728395061728395,2.3685972735685406e-08,0.18485979561040367,0.1508916323731139
272,0.3,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Is computerized tomography a suitable replacement for bone scintigraphy in detecting bone metastases from breast cancer? Computerized tomography (CT) cannot entirely replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,2.36859727356853e-08,0.07658115624389916,0.022249728293684295,0.0018134264647818796,0.07675061990343268,0.027953527138800394,0.0018108015409528735,0.07803966554155028,0.030152229121709923,2.3685972735685406e-08,0.07934447245599285,0.0319855681638392
272,0.3,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Can bone scintigraphy be replaced by computerized tomography in the detection of bone metastases from breast cancer? Computerized tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. Although CT is effective in identifying,4.73719454713706e-08,0.22470846818719892,0.09449542344674555,0.003626852929563752,0.26555560538084677,0.13668057394829145,0.003621603081905747,0.27128560990883877,0.14429279337007134,4.737194547137081e-08,0.27723311574141896,0.1508916323731139
272,0.3,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) cannot fully replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,Does CT have the capability to replace bone scintigraphy in detecting bone metastases from breast cancer? Computerized tomography (CT) cannot completely replace bone scintigraphy in detecting bone metastases from breast cancer. While CT is effective in identifying,2.36859727356853e-08,0.07658115624389916,0.022249728293684295,0.0018134264647818796,0.0371422095857219,0.004543895747599419,0.0018108015409528735,0.037266301979200556,0.0044721592340639105,2.3685972735685406e-08,0.03733555242205666,0.004207958903726189
273,0.3,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should patients infected with HIV undergo screening for silent myocardial ischemia using gated myocardial perfusion SPECT? Yes, it is recommended that HIV-infected individuals be screened for silent myocardial ischemia with gated myocardial perfusion SPECT because their risk of cardiovascular disease is elevated due to the chronic inflammation caused by HIV infection and antiretroviral therapy. Early identification allows for prompt treatment and improved prognosis.",4.737194547137081e-08,0.0730618632620228,0.07086700941220286,0.0036268529295637453,0.07559810576898496,0.0752487691748312,0.003621603081905733,0.1006223764460743,0.09441250139482096,4.737194547137081e-08,0.10302040213764396,0.09719008264462808
273,0.3,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it advisable to screen HIV-positive patients for silent myocardial ischemia using gated myocardial perfusion SPECT? Indeed, HIV-positive patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT since they face an increased risk of cardiovascular disease from the persistent inflammatory state triggered by HIV and its treatment. Detecting the condition early facilitates timely intervention and better health outcomes.",7.105791820705622e-08,0.013209821801693167,0.022732145011063354,0.005440279394345618,0.011382221091596811,0.025532088562391517,0.0054324046228586,0.010562408827902381,0.027055175775714535,7.105791820705622e-08,0.009680538885096901,0.028602977020485434
273,0.3,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischemia screening with gated myocardial perfusion SPECT be performed on patients with HIV infection? Yes, screening HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT is important because HIV infection and antiretroviral therapy induce chronic inflammation, raising cardiovascular disease risk. Early detection enables effective treatment and improved results.",2.8423167282822487e-07,0.12432840557632785,0.05582599181177393,0.02176111757738247,0.11681844160208188,0.065703770661157,0.0217296184914344,0.08632016155161315,0.09108271002784649,2.8423167282822487e-07,0.08269674365744795,0.09719008264462808
273,0.3,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischemia via gated myocardial perfusion SPECT recommended for HIV-infected patients? Yes, HIV-infected patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT due to their heightened cardiovascular risk from chronic inflammation caused by HIV and antiretroviral drugs. Early diagnosis supports timely management and better outcomes.",2.8423167282822487e-07,0.15098791252094124,0.037470082278595926,0.02176111757738247,0.14400068397698274,0.046434234106154715,0.0217296184914344,0.1140460487740107,0.07114382460973366,2.8423167282822487e-07,0.08269674365744795,0.09719008264462808
273,0.3,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV-infected individuals be evaluated for silent myocardial ischemia using gated myocardial perfusion SPECT? Yes, it is important to screen HIV-infected individuals for silent myocardial ischemia with gated myocardial perfusion SPECT because the chronic inflammatory state from HIV infection and antiretroviral treatment increases their cardiovascular disease risk. Early detection leads to prompt treatment and improved prognosis.",2.1317375462116866e-07,0.08617351632438908,0.043436405384359264,0.016320838183036854,0.05512965403298331,0.06893419886184904,0.0162972138685758,0.026481863584860488,0.0922134334197271,2.1317375462116866e-07,0.023273323186646877,0.09719008264462808
273,0.3,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is gated myocardial perfusion SPECT screening for silent myocardial ischemia necessary in HIV-infected patients? Yes, HIV-infected patients should undergo screening for silent myocardial ischemia using gated myocardial perfusion SPECT as they have an elevated risk of cardiovascular disease due to chronic inflammation from HIV infection and antiretroviral therapy. Early identification allows timely treatment and better outcomes.",2.1317375462116866e-07,0.11137886834475097,0.02632566015089173,0.016320838183036854,0.10647388963001614,0.03266903253121109,0.0162972138685758,0.07879485834410138,0.0546743801652892,2.1317375462116866e-07,0.049932830131260264,0.07796670701986838
273,0.3,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should HIV-positive patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Yes, screening for silent myocardial ischemia with gated myocardial perfusion SPECT is recommended for HIV-positive patients because the chronic inflammatory effects of HIV infection and antiretroviral treatment increase their cardiovascular risk. Early detection facilitates timely intervention and improved health outcomes.",2.6054570009253947e-07,0.12892166016029227,0.03952902485840144,0.0199476911126006,0.09583214945412033,0.06682146901600913,0.019918816950481533,0.06597388940793492,0.09147438016528923,2.6054570009253947e-07,0.06249403633992934,0.09719008264462808
273,0.3,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is it necessary to screen HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT? Yes, HIV-infected patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT due to their increased cardiovascular risk from the chronic inflammatory state caused by HIV and antiretroviral therapy. Early diagnosis allows for prompt treatment and better outcomes.",1.8948778188548325e-07,0.11496495028809628,0.012002743484225059,0.014507411718254981,0.11099627409140744,0.016842293672402336,0.014486412327622933,0.10999382218566911,0.019445892035343346,1.8948778188548325e-07,0.10885111773443601,0.022221319629217848
273,0.3,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Should silent myocardial ischemia be screened in HIV-infected patients using gated myocardial perfusion SPECT? Yes, HIV-infected patients should be screened for silent myocardial ischemia using gated myocardial perfusion SPECT because they are at higher risk of cardiovascular disease from chronic inflammation induced by HIV infection and antiretroviral treatment. Early detection enables timely treatment and improved prognosis.",2.1317375462116866e-07,0.11137886834475097,0.026325660150891717,0.016320838183036854,0.05512965403298287,0.06893419886184904,0.0162972138685758,0.026481863584860488,0.0922134334197271,2.1317375462116866e-07,0.023273323186646877,0.09719008264462808
273,0.3,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT. This is because they have a higher risk of cardiovascular disease due to the chronic inflammatory state induced by HIV infection and antiretroviral treatment. Early detection can lead to timely treatment and better outcomes.","Is screening for silent myocardial ischemia with gated myocardial perfusion SPECT indicated in HIV-infected patients? Yes, it is indicated to screen HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT since the chronic inflammatory state from HIV infection and antiretroviral therapy increases their cardiovascular disease risk. Early detection helps ensure timely treatment and better outcomes.",1.8948778188548325e-07,0.06545443739095713,0.045291632373113885,0.014507411718254981,0.0605855700506841,0.05201762831206051,0.014486412327622933,0.03297746879011898,0.07409213164457917,1.8948778188548325e-07,0.004225128215953777,0.09719008264462808
274,0.3,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a link between crime and over-the-counter pharmacy syringe sales? Although no direct connection exists, misuse of syringes can happen, including for illegal drug use.",1.894877818854824e-07,0.19361389653040773,0.06035379812695108,0.014507411718255037,0.24436037366678365,0.031217481789802305,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
274,0.3,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does crime relate to the sale of syringes over the counter at pharmacies? There is no direct association, but syringes may be misused, such as for illicit drug consumption.",1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.1265773380103994,0.031217481789802305,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
274,0.3,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are over-the-counter pharmacy syringe sales connected to crime? While no direct link is established, syringes can be misused, particularly for illegal drug use.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.3,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime linked to the sale of syringes at pharmacies without a prescription? No direct association exists, but misuse, including for illicit drugs, is possible.",2.131737546211677e-07,0.23443589105066254,0.06035379812695108,0.016320838183036916,0.2869199880855793,0.031217481789802305,0.016297213868575862,0.3429447511268311,0.0,2.1317375462116866e-07,0.35667494393873334,0.0
274,0.3,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Do over-the-counter pharmacy syringe sales contribute to crime? There is no direct connection, though syringes can be used improperly for illegal drug purposes.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.3,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a crime association with syringes sold over the counter in pharmacies? Direct links are absent, but misuse for illicit drug use can occur.",2.131737546211677e-07,0.23443589105066254,0.06035379812695108,0.016320838183036916,0.2869199880855793,0.031217481789802305,0.016297213868575862,0.3429447511268311,0.0,2.1317375462116866e-07,0.35667494393873334,0.0
274,0.3,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Are crime rates affected by over-the-counter sales of pharmacy syringes? No direct correlation is found, but syringes might be misused for illegal drug use.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.3,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is there a direct relationship between crime and pharmacy syringe sales without prescriptions? No, but misuse involving illicit drugs can happen.",3.0791764556390896e-07,0.41675744784461743,0.06035379812695108,0.023574544042164434,0.4779752248482887,0.031217481789802305,0.023540420032387356,0.5436154465889818,0.0,3.0791764556391007e-07,0.5679840376059389,0.0
274,0.3,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Does the sale of syringes over the counter at pharmacies have a crime association? No direct link exists, though misuse for illegal drug use is possible.",1.894877818854824e-07,0.19361389653040773,0.06035379812695108,0.014507411718255037,0.24436037366678365,0.031217481789802305,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
274,0.3,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: While there isn't a direct association between crime and over-the-counter pharmacy syringe sales, misuse can occur. Syringes can be used for illicit drug use,","Is crime connected to the availability of syringes over the counter in pharmacies? While no direct association is present, misuse for illicit drug use can occur.",1.894877818854824e-07,0.19361389653040773,0.06035379812695108,0.014507411718255037,0.24436037366678365,0.031217481789802305,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
275,0.3,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer be established as a novel diagnostic marker for acute appendicitis? Answer: Although investigations continue, existing research indicates that D-dimer levels might be used as a new",2.36859727356853e-08,0.038201366870768805,0.0013169535961558704,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.3,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Current studies, while ongoing, imply that D-dimer levels could act as a new",7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,0.3,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer serve as a new diagnostic indicator for acute appendicitis? Answer: Research is still underway, but current findings suggest D-dimer levels may function as a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer become a novel diagnostic parameter for acute appendicitis? Answer: Although research is in progress, present studies propose that D-dimer levels have potential as a new",0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is it possible for D-dimer to be a new diagnostic marker for acute appendicitis? Answer: While research continues, current evidence suggests D-dimer levels could be a new",0.0,0.05134423559703327,0.03661775147928994,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer be considered a new diagnostic criterion for acute appendicitis? Answer: Research is ongoing, yet current studies indicate that D-dimer levels might serve as a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Could D-dimer levels emerge as a new diagnostic parameter for acute appendicitis? Answer: Although studies are ongoing, current data suggest D-dimer levels may be utilized as a new",2.36859727356853e-08,0.06081965892350949,0.06861775147928997,0.0018134264647818796,0.013603907614186284,0.03698224852071005,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,0.3,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Is D-dimer likely to become a new diagnostic factor for acute appendicitis? Answer: While investigations proceed, existing research suggests D-dimer levels could potentially serve as a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Can D-dimer act as a new diagnostic marker for acute appendicitis? Answer: Research is still ongoing, but current studies indicate that D-dimer levels might be a new",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: While research is ongoing, current studies suggest that D-dimer levels can potentially serve as a new","Question: Might D-dimer be used as a novel diagnostic parameter for acute appendicitis? Answer: Although research continues, current findings suggest that D-dimer levels can potentially serve as a new",2.36859727356853e-08,0.038201366870768805,0.0013169535961558704,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
276,0.3,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current studies indicate that bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, may possess anti-cancer effects. However, definitive research confirming its role in colon cancer prevention is lacking.",4.737194547137081e-08,0.11567263112572368,0.04782276367722613,0.0036268529295637453,0.14854167857445288,0.07152215646424138,0.003621603081905733,0.1506368755954397,0.07317811468390623,4.737194547137081e-08,0.15276224125342264,0.07450693937180423
276,0.3,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in coronary artery disease patients? Answer: Research to date suggests that bezafibrate has potential anti-cancer properties, though specific evidence proving its effectiveness in colon cancer prevention is not yet established.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.3,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, prevent colon cancer in those with coronary artery disease? Answer: Current findings imply that bezafibrate may have anti-cancer benefits, but conclusive studies demonstrating its preventive effect on colon cancer are still needed.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
276,0.3,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can bezafibrate, a lipid-lowering agent targeting peroxisome proliferator-activated receptors, prevent colon cancer in patients with coronary artery disease? Answer: Existing research suggests bezafibrate has potential anti-cancer properties, although specific proof of its ability to prevent colon cancer remains unconfirmed.",9.474389094274152e-08,0.024705934398959073,0.08473338203067934,0.0072537058591274906,0.028470153877695914,0.0905770635500365,0.007243206163811466,0.0325940762930772,0.09642074506939374,9.474389094274162e-08,0.0013884385738349714,0.07450693937180423
276,0.3,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the lipid-lowering drug bezafibrate, a peroxisome proliferator-activated receptor ligand, help prevent colon cancer in coronary artery disease patients? Answer: Research indicates bezafibrate might have anti-cancer effects, but there is no definitive study confirming its efficacy in colon cancer prevention.",7.105791820705622e-08,0.08645840187422271,0.11088203187995288,0.005440279394345618,0.09092707083674023,0.11687363038714388,0.0054324046228586,0.05926232337523807,0.09642074506939374,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
276,0.3,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is the peroxisome proliferator-activated receptor ligand bezafibrate effective at preventing colon cancer in patients with coronary artery disease? Answer: Current research points to possible anti-cancer properties of bezafibrate, yet specific studies validating its preventive role against colon cancer are lacking.",7.105791820705622e-08,0.08645840187422271,0.11088203187995288,0.005440279394345618,0.09092707083674023,0.11687363038714388,0.0054324046228586,0.05926232337523807,0.09642074506939374,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
276,0.3,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, offer protection against colon cancer in coronary artery disease patients? Answer: Research suggests bezafibrate may have anti-cancer potential, but conclusive evidence for colon cancer prevention is still absent.",1.6580180914979742e-07,0.022752931453381642,0.10811049328423847,0.012693985253473108,0.017286513803490777,0.11687363038714388,0.012675610786670073,0.05196331173498647,0.09642074506939374,1.6580180914979784e-07,0.0883998155634651,0.07450693937180423
276,0.3,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in individuals with coronary artery disease? Answer: Studies show bezafibrate has potential anti-cancer properties, though specific proof of its effectiveness in colon cancer prevention is not established.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.3,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Is bezafibrate, which lowers lipids through peroxisome proliferator-activated receptor activation, capable of preventing colon cancer in coronary artery disease patients? Answer: Current research suggests potential anti-cancer benefits of bezafibrate, but definitive studies on colon cancer prevention are missing.",1.1842986367842682e-07,0.03334103595888305,0.10956902848794742,0.009067132323909363,0.03828333735132139,0.11687363038714388,0.009054007704764333,0.0051951021049618795,0.09642074506939374,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
276,0.3,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Current research suggests that the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate does have potential anti-cancer properties. However, specific studies establishing its efficacy in preventing colon","Question: Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate have a role in preventing colon cancer among patients with coronary artery disease? Answer: Research indicates bezafibrate might possess anti-cancer properties; however, specific evidence confirming its preventive effect on colon cancer is not yet available.",0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374,0.0,0.10397207708399092,0.07450693937180423
277,0.3,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The R14C KCNQ1 mutation by itself does not appear to cause atrial fibrillation; instead, a 'second hit' like hypertension, which induces atrial stretch, reveals the inherited ion channel defect.",8.763809912203588e-07,0.8208551541647413,0.015380859375,0.06709677919692934,0.8630462173553419,0.0,0.06699965701525612,0.8850381883700527,0.0,8.7638099122036e-07,0.9082585601768915,0.0
277,0.3,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","These findings indicate that the R14C mutation in KCNQ1 alone is not enough to trigger AF, but when combined with an environmental factor such as hypertension causing atrial stretch, the inherited ion channel abnormality is exposed.",7.105791820705617e-07,0.597711602850532,0.015380859375,0.054402793943456186,0.6325225587435095,0.0,0.05432404622858601,0.646627164925055,0.0,7.105791820705622e-07,0.6613984822453651,0.0
277,0.3,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),",Our data imply that the R14C KCNQ1 mutation is insufficient on its own to cause atrial fibrillation; a secondary factor like hypertension that leads to atrial stretch is necessary to reveal the genetic ion channel defect.,7.105791820705617e-07,0.597711602850532,0.015380859375,0.054402793943456186,0.6325225587435095,0.0,0.05432404622858601,0.646627164925055,0.0,7.105791820705622e-07,0.6613984822453651,0.0
277,0.3,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The R14C mutation in KCNQ1 does not solely cause AF; rather, an environmental stressor like hypertension causing atrial stretch acts as a 'second hit' that unmasks the inherited ion channel dysfunction.",8.290090457489882e-07,0.7518622826777905,0.015380859375,0.06346992626736558,0.7915872533731982,0.0,0.06337805393335039,0.810930216216331,0.0,8.290090457489892e-07,0.8312975190407621,0.0
277,0.3,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","These results suggest that AF does not develop from the R14C KCNQ1 mutation alone, but requires an additional factor such as hypertension-induced atrial stretch to expose the underlying genetic defect.",8.526950184846735e-07,0.7857638343534723,0.015380859375,0.06528335273214747,0.8266785731844672,0.0,0.06518885547430325,0.8472978603872057,0.0,8.526950184846746e-07,0.8690378470236091,0.0
277,0.3,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The data propose that the R14C KCNQ1 mutation is not sufficient by itself to cause atrial fibrillation, but a 'second hit' like hypertension, which promotes atrial stretch, reveals the inherited ion channel defect.",7.816371002776176e-07,0.687323761540219,0.015380859375,0.059843073337801825,0.7248958788745248,0.0,0.05975645085144463,0.7419373447293802,0.0,7.816371002776184e-07,0.7598385550586184,0.0
277,0.3,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","According to the data, the R14C mutation in KCNQ1 alone cannot cause AF; an environmental trigger like hypertension that causes atrial stretch is needed to unmask the inherited ion channel abnormality.",8.290090457489882e-07,0.7518622826777905,0.015380859375,0.06346992626736558,0.7915872533731982,0.0,0.06337805393335039,0.810930216216331,0.0,8.290090457489892e-07,0.8312975190407621,0.0
277,0.3,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),",The findings suggest that the R14C KCNQ1 mutation requires a secondary environmental factor such as hypertension-induced atrial stretch to reveal the inherited ion channel defect and cause AF.,9.000669639560441e-07,0.857222798335616,0.015380859375,0.06891020566171122,0.9007865453381889,0.0,0.068810458556209,0.9242589015233351,0.0,9.000669639560454e-07,0.9490805546971464,0.0
277,0.3,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),",These data indicate that the R14C mutation in KCNQ1 is not enough to cause atrial fibrillation by itself; a 'second hit' like hypertension leading to atrial stretch is necessary to expose the inherited ion channel defect.,7.105791820705617e-07,0.597711602850532,0.015380859375,0.054402793943456186,0.6325225587435095,0.0,0.05432404622858601,0.646627164925055,0.0,7.105791820705622e-07,0.6613984822453651,0.0
277,0.3,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the ""first hit""),","The R14C KCNQ1 mutation alone does not cause AF; rather, an environmental factor such as hypertension that causes atrial stretch acts as a second hit to unmask the inherited ion channel defect.",8.053230730133029e-07,0.7190724598547988,0.015380859375,0.061656499802583704,0.7576857016975165,0.0,0.061567252392397506,0.775838896405062,0.0,8.053230730133038e-07,0.7949298748698874,0.0
278,0.3,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.3,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably identify cervical spine fractures in geriatric blunt trauma cases with low-energy mechanisms? Answer: Clinical predictors are inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.054050463202671484,0.07562061685554133,0.003626852929563759,0.02149748308653887,0.06035379812695108,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
278,0.3,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in diagnosing cervical spine fractures in older patients with blunt trauma from low-energy impacts? Answer: Clinical predictors do not adequately assess the cervical spine in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.1548024872942162,0.08340640943877556,0.0018134264647818796,0.11387080321755416,0.06035379812695108,0.0018108015409528735,0.07409335745175127,0.031217481789802305,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.3,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide accurate evaluation of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear to be insufficient for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.10925771172517296,0.03309159251629901,0.003626852929563759,0.06364151945538365,0.003420832103075977,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
278,0.3,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors adequate for detecting cervical spine fractures in elderly blunt trauma patients with low-energy injury mechanisms? Answer: Clinical predictors seem inadequate for evaluating the cervical spine in geriatric trauma patients with low-energy mechanisms.,9.47438909427412e-08,0.17345866370538898,0.03980903656228338,0.007253705859127504,0.12349336091481211,0.006476247106542911,0.007243206163811487,0.12259655774360656,0.0034623797489859755,9.474389094274162e-08,0.1213608570042668,0.0
278,0.3,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for cervical spine fracture evaluation in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for assessing the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.3,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately evaluate cervical spine fractures in elderly patients experiencing blunt trauma with low-energy mechanisms? Answer: Clinical predictors are insufficient for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.08876045812260802,0.07836734693877552,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.3,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient to assess cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.004742618054735637,0.02168367346938782,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.3,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors adequately identify cervical spine fractures in elderly blunt trauma patients with low-energy injury mechanisms? Answer: Clinical predictors seem inadequate for evaluating the cervical spine in geriatric trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.3,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is clinical prediction effective for evaluating cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.04675153808867183,0.04946128272950086,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
279,0.3,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the interfractional motion of the prostate bed target, defined by RTOG consensus and monitored via daily CT on rails, differ between the superior and inferior parts of the clinical target volume? Research indicates that there is some variation in motion, particularly in the superior portion.",2.8423167282822487e-07,0.042491491073337606,0.17522985397512175,0.02176111757738247,0.0559010205659467,0.19834710743801648,0.0217296184914344,0.03112580268506937,0.1875,2.8423167282822487e-07,0.005406749704258029,0.17561983471074377
279,0.3,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using RTOG consensus definitions and daily CT on rails, does the prostate bed target's interfractional motion vary between the superior and inferior sections of the clinical target volume? Studies suggest that the superior portion exhibits some differences in motion.",4.500334819780225e-07,0.10145318680994242,0.19328158351443406,0.03445510283085558,0.11737070070808953,0.19834710743801648,0.034405229278104466,0.14655537455238266,0.1875,4.500334819780227e-07,0.17691480708969642,0.17561983471074377
279,0.3,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is there a difference in interfractional motion of the prostate bed target between the superior and inferior regions of the clinical target volume when assessed by RTOG consensus and daily CT on rails? Research shows some variation, especially in the superior part.",3.789755637709665e-07,0.05660996445281441,0.1709259478531851,0.029014823436509962,0.039409159238378955,0.19834710743801648,0.028972824655245866,0.06651266687884849,0.1875,3.789755637709665e-07,0.09467670885272339,0.17561983471074377
279,0.3,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to RTOG consensus and daily CT on rails, does the prostate bed target's interfractional motion differ between the upper and lower parts of the clinical target volume? Evidence suggests variation exists, notably in the superior portion.",4.974054274493931e-07,0.11903897752443227,0.21957815035154143,0.038081955760419325,0.1729405518629017,0.19834710743801648,0.038026832360010206,0.203713788392331,0.1875,4.974054274493935e-07,0.2357553071126297,0.17561983471074377
279,0.3,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Does the prostate bed target exhibit different interfractional motion in the superior versus inferior parts of the clinical target volume based on RTOG consensus definitions and daily CT on rails? Research findings indicate some motion variation, particularly in the superior section.",4.026615365066519e-07,0.08299317992260047,0.1697166545066661,0.030828249901291835,0.10027297648215461,0.17272383873995553,0.030783626196198732,0.09248815328210647,0.1875,4.026615365066519e-07,0.12134495593488426,0.17561983471074377
279,0.3,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Using daily CT on rails and RTOG consensus definitions, is there a difference in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume? Studies suggest the superior portion shows some variation.",4.974054274493931e-07,0.1575471542222071,0.1918230483107251,0.038081955760419325,0.1729405518629017,0.19834710743801648,0.038026832360010206,0.203713788392331,0.1875,4.974054274493935e-07,0.2357553071126297,0.17561983471074377
279,0.3,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is interfractional motion of the prostate bed target, as defined by RTOG consensus and monitored with daily CT on rails, different between the superior and inferior areas of the clinical target volume? Research indicates some variation in the superior part.",4.263475092423372e-07,0.1100882883698664,0.16844593705716598,0.03264167636607371,0.09070245362592866,0.19834710743801648,0.0325944277371516,0.11915640036426733,0.1875,4.263475092423373e-07,0.14874393012299958,0.17561983471074377
279,0.3,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,Does interfractional motion vary between the superior and inferior parts of the prostate bed clinical target volume when using RTOG consensus definitions and daily CT on rails? Research suggests the superior portion experiences some motion variation.,5.210914001850784e-07,0.18681826480884034,0.19103143754877328,0.039895382225201205,0.2019280887361532,0.19834710743801648,0.03983763390096308,0.23356675154201278,0.1875,5.210914001850789e-07,0.2665269657793834,0.17561983471074377
279,0.3,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"According to research using RTOG consensus definitions and daily CT on rails, does the prostate bed target's interfractional motion differ between the superior and inferior clinical target volume regions? Findings show some variation in the superior portion.",4.974054274493931e-07,0.1575471542222071,0.1918230483107251,0.038081955760419325,0.1729405518629017,0.19834710743801648,0.038026832360010206,0.203713788392331,0.1875,4.974054274493935e-07,0.2357553071126297,0.17561983471074377
279,0.3,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Research suggests that the prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails does show some variation. The superior portion of the,"Is there a difference in prostate bed target interfractional motion between the superior and inferior parts of the clinical target volume based on RTOG consensus and daily CT on rails? Research suggests some variation occurs, especially in the superior portion.",4.263475092423372e-07,0.07454227911038203,0.1939548816534805,0.03264167636607371,0.09070245362592866,0.19834710743801648,0.0325944277371516,0.11915640036426733,0.1875,4.263475092423373e-07,0.14874393012299958,0.17561983471074377
280,0.3,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? Yes, mental imagery fMRI can potentially predict recovery by evaluating cognitive function and neural responses, assisting in prognosis formulation, though further research is needed for definitive conclusions.",4.026615365066519e-07,0.12129868200617544,0.15696350649818733,0.030828249901291835,0.13899273656837918,0.1548211860570394,0.030783626196198732,0.1933095613635527,0.12456597222222221,4.026615365066519e-07,0.24970554492746588,0.09162848812994587
280,0.3,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it possible for mental imagery functional MRI to predict recovery in patients with disorders of consciousness? Yes, mental imagery fMRI shows promise in predicting recovery by assessing brain activity and cognitive function, helping to guide prognoses, but more research is necessary for certainty.",3.316036182995957e-07,0.04656006514552713,0.15870443955780172,0.025387970506946217,0.06488476441465574,0.1548211860570394,0.025351221573340132,0.1173236543856313,0.12456597222222221,3.316036182995957e-07,0.1717440034577553,0.09162848812994587
280,0.3,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery functional magnetic resonance imaging be used to predict recovery in patients suffering from disorders of consciousness? Yes, it can evaluate neural responses and cognitive functions to aid in prognosis, although more comprehensive studies are required to confirm this.",4.026615365066519e-07,0.08664132297817906,0.18194706994328924,0.030828249901291835,0.13899273656837918,0.1548211860570394,0.030783626196198732,0.1933095613635527,0.12456597222222221,4.026615365066519e-07,0.24970554492746588,0.09162848812994587
280,0.3,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional MRI have the capability to predict recovery in patients with consciousness disorders? Yes, it can assess cognitive and neural activity to help predict outcomes, but conclusive evidence awaits further research.",5.68463345656449e-07,0.2790132156256351,0.18194706994328924,0.043522235154764964,0.33681847989829716,0.1548211860570394,0.043459236982868826,0.39690851660479254,0.12456597222222221,5.684633456564497e-07,0.45942607590953655,0.09162848812994587
280,0.3,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional magnetic resonance imaging effective in predicting recovery for patients with disorders of consciousness? Yes, it helps in assessing brain function and neural responses to support prognosis, but definitive proof needs more extensive investigation.",4.974054274493931e-07,0.19200183863600495,0.18194706994328924,0.038081955760419325,0.2472063212086102,0.1548211860570394,0.038026832360010206,0.30453519647377725,0.12456597222222221,4.974054274493935e-07,0.36411589610521133,0.09162848812994587
280,0.3,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can recovery in patients with disorders of consciousness be predicted using mental imagery functional MRI? Yes, this imaging technique can evaluate cognitive and neural function to assist prognosis, though additional research is essential for confirmation.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.3,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Does mental imagery functional magnetic resonance imaging predict recovery in patients with consciousness disorders? Yes, it has potential by assessing cognitive function and neural responses, aiding prognosis, but more research is required for conclusive results.",5.447773729207637e-07,0.2491602524759533,0.18194706994328924,0.041708808689983085,0.3060468212315435,0.1548211860570394,0.04164843544191595,0.3651598182902127,0.12456597222222221,5.447773729207643e-07,0.42663625308654485,0.09162848812994587
280,0.3,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is mental imagery functional MRI a reliable predictor of recovery in patients with disorders of consciousness? Yes, it can help assess brain and cognitive functions to guide prognosis, but further studies are needed for definitive conclusions.",5.210914001850784e-07,0.2201727156027018,0.18194706994328924,0.039895382225201205,0.2761938580818617,0.1548211860570394,0.03983763390096308,0.334388159623459,0.12456597222222221,5.210914001850789e-07,0.394887554771965,0.09162848812994587
280,0.3,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Can mental imagery fMRI predict recovery in patients with consciousness disorders? Yes, it evaluates neural and cognitive responses to aid prognosis, though more extensive research is necessary for certainty.",6.868932093348755e-07,0.44331626691691106,0.18194706994328924,0.05258936747867436,0.5067175166936941,0.1548211860570394,0.052513244687633194,0.5727991830684567,0.12456597222222221,6.868932093348768e-07,0.6417476327034914,0.09162848812994587
280,0.3,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, Mental Imagery Functional Magnetic Resonance Imaging (fMRI) has the potential to predict recovery in patients with disorders of consciousness. It can help assess cognitive function and neural response, thus aiding in formulating prognoses. However, definitive conclusions require more extensive research.","Is it feasible to use mental imagery functional magnetic resonance imaging to predict recovery in patients with disorders of consciousness? Yes, it can assess cognitive and neural activity to help formulate prognoses, but conclusive evidence requires further research.",4.737194547137078e-07,0.16460286444788963,0.18194706994328924,0.03626852929563745,0.21903544424191335,0.1548211860570394,0.03621603081905733,0.27554765960052574,0.12456597222222221,4.737194547137081e-07,0.33426293295552956,0.09162848812994587
281,0.3,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This research shows that hospital management can promote the creation of care programs by integrating case-mix reimbursement into hospital budgeting. Further studies are suggested to validate this result and to assess if care programs will eventually be established.,1.8948778188548325e-07,0.059255530107741095,0.06760362565569637,0.014507411718254981,0.08156952746132795,0.05436390532544379,0.014486412327622933,0.13467053227666392,0.01851192595229618,1.8948778188548325e-07,0.16362942378180145,0.0
281,0.3,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does reimbursement based on case-mix foster the development of process-oriented healthcare delivery? The study indicates that hospital administrators can drive care program development by adopting case-mix reimbursement in budgeting. Additional research is needed to confirm these findings and to explore whether care programs will ultimately be implemented.,2.3685972735685406e-07,0.07293401200320693,0.08842752787389466,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.3,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery stimulated by case-mix based reimbursement? Findings reveal that hospital management can encourage care program development through the use of case-mix reimbursement in budgeting. Future investigations should verify this and determine if care programs will be established over time.,3.552895910352811e-07,0.1880033417879936,0.08842752787389466,0.02720139697172809,0.2428376750574497,0.05436390532544379,0.027162023114293,0.29975028263611403,0.01851192595229618,3.552895910352811e-07,0.33270575382573453,0.0
281,0.3,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the use of case-mix reimbursement promote the growth of process-oriented care delivery? This study suggests hospital management can facilitate care program development by incorporating case-mix reimbursement in budgeting processes. Further research is recommended to confirm these findings and to see if care programs will be developed eventually.,2.1317375462116866e-07,0.08092343148692205,0.06716098723117256,0.016320838183036854,0.10307573268229131,0.05436390532544379,0.0162972138685758,0.15664943899543893,0.01851192595229618,2.1317375462116866e-07,0.18610227963385917,0.0
281,0.3,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Can case-mix based reimbursement drive the development of process-oriented care delivery? The study demonstrates that hospital management can stimulate care program creation by adopting case-mix reimbursement within budgeting. Additional research is advised to validate this and to determine if care programs will be established in the future.,2.3685972735685406e-07,0.07293401200320693,0.08842752787389466,0.018134264647818726,0.12505463940106631,0.05436390532544379,0.018108015409528666,0.17912229484749664,0.01851192595229618,2.3685972735685406e-07,0.2090917978585587,0.0
281,0.3,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix reimbursement encourage the development of process-oriented care delivery? This research shows that hospital management can promote care programs by integrating case-mix reimbursement into hospital budgets. Future studies are needed to confirm this and to assess whether care programs will be implemented over time.,2.8423167282822487e-07,0.18039915462494438,0.04307605395099216,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.3,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? The study finds that hospital management can foster care program development by adopting case-mix reimbursement in budgeting. Further research is necessary to confirm this and to evaluate if care programs will be established eventually.,2.6054570009253947e-07,0.09491291872198193,0.08842752787389466,0.0199476911126006,0.14752749525312403,0.05436390532544379,0.019918816950481533,0.20211181307219617,0.01851192595229618,2.6054570009253947e-07,0.2326222952687531,0.0
281,0.3,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does case-mix based reimbursement lead to the development of process-oriented care delivery? This study demonstrates that hospital management can encourage care program development by using case-mix reimbursement in budgeting processes. Future research should confirm this and determine if care programs will be established over time.,2.8423167282822487e-07,0.11738577457403965,0.08842752787389466,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.3,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Does the adoption of case-mix reimbursement stimulate process-oriented care delivery development? The study indicates hospital management can promote care programs by incorporating case-mix reimbursement in budgeting. Further research is recommended to validate this and to see if care programs will be created in the future.,2.8423167282822487e-07,0.18039915462494438,0.04307605395099216,0.02176111757738247,0.17051701347782355,0.05436390532544379,0.0217296184914344,0.22564231048239058,0.01851192595229618,2.8423167282822487e-07,0.2567198468478131,0.0
281,0.3,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed,Is process-oriented care delivery development driven by case-mix based reimbursement? Findings suggest hospital management can stimulate care program development by adopting case-mix reimbursement within budgeting processes. Additional studies are needed to confirm this and to determine if care programs will be established eventually.,3.316036182995957e-07,0.1639057902089336,0.08842752787389466,0.025387970506946217,0.218145062467078,0.05436390532544379,0.025351221573340132,0.2744324746518223,0.01851192595229618,3.316036182995957e-07,0.30673026742247655,0.0
282,0.3,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy harm the kidneys in women who have had multiple pregnancies? Glomerular hyperfiltration is a typical physiological change in pregnancy and does not inherently damage kidneys in women with multiple parities. However, in women with existing kidney disease, the elevated filtration rate could worsen their condition. Therefore, regular monitoring is advised.",7.105791820705622e-08,0.0006547715319822345,0.0738510646605581,0.005440279394345618,0.061407687809529765,0.00225273933102655,0.0054324046228586,0.08771514212630915,0.020399305555555556,7.105791820705622e-08,0.06062462181643413,0.0
282,0.3,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage caused by glomerular hyperfiltration in pregnant women with higher parity? Glomerular hyperfiltration is a normal adaptation in pregnancy and generally does not lead to kidney damage in women with several pregnancies. Yet, if there are underlying kidney issues, the increased filtration might aggravate the problem. Hence, routine check-ups are recommended.",2.3685972735685406e-08,0.020986292147961993,0.001117698354852148,0.0018134264647818726,0.07525440174097531,0.039930555555555566,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
282,0.3,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does increased glomerular filtration during pregnancy affect kidney health in women with many pregnancies? The physiological increase in glomerular filtration during pregnancy usually does not harm the kidneys in women with multiple parities. But for those with pre-existing kidney disease, this rise could worsen their condition. Thus, regular assessments are important.",2.3685972735685406e-08,0.07688533628346939,0.040171682098765454,0.0018134264647818726,0.049626097839246874,0.021033527620247808,0.0018108015409528666,0.021208698070558363,0.0004245966626427282,2.3685972735685406e-08,0.02105340919783316,0.0
282,0.3,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Can glomerular hyperfiltration in pregnancy cause kidney damage in women with multiple births? This common pregnancy adaptation typically does not damage kidneys in women with more parities. Nevertheless, if kidney disease is present beforehand, the heightened filtration rate may intensify the damage. Therefore, ongoing monitoring is necessary.",1.1842986367842703e-07,0.08191117698530892,0.015205320247933876,0.009067132323909363,0.08071528257125005,0.017719811753902675,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
282,0.3,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is there kidney damage from glomerular hyperfiltration in pregnant women with numerous parities? Glomerular hyperfiltration is a normal pregnancy change and does not usually cause kidney harm in women with many pregnancies. However, existing kidney conditions might be aggravated by the increased filtration. Routine evaluation is therefore essential.",9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
282,0.3,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does pregnancy-related glomerular hyperfiltration harm kidneys in women with higher parity? This physiological change during pregnancy generally does not damage kidneys in women with multiple pregnancies. But if kidney disease exists, the increased filtration can worsen it. Regular monitoring is thus advised.",2.3685972735685406e-07,0.23814301166018748,0.014120931440443227,0.018134264647818726,0.23700649492540782,0.009930940289319769,0.018108015409528666,0.23551293958495823,0.005223963142505398,2.3685972735685406e-07,0.2336148511815046,0.0
282,0.3,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration during pregnancy lead to kidney damage in women with several parities? It is a typical adaptation and does not inherently cause kidney injury in women with more pregnancies. However, pre-existing kidney problems may be exacerbated by the increased filtration rate. Hence, routine monitoring is important.",9.474389094274162e-08,0.059122553298924796,0.01612461419753087,0.0072537058591274906,0.058066668431643986,0.01820216049382717,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
282,0.3,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage a result of glomerular hyperfiltration in pregnant women with many parities? Glomerular hyperfiltration is a normal adaptation in pregnancy and usually does not damage kidneys in women with multiple births. Still, if kidney disease is present, the increased filtration may worsen it. Therefore, regular check-ups are recommended.",4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
282,0.3,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Does glomerular hyperfiltration in pregnancy cause kidney damage in women with multiple pregnancies? This physiological adaptation typically does not harm kidneys in women with more parities. However, if pre-existing kidney disease exists, the higher filtration rate might aggravate the condition. Thus, routine monitoring is advised.",1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
282,0.3,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Glomerular hyperfiltration, a common physiological adaptation during pregnancy, does not necessarily cause kidney damage in women with more parities. However, if a woman has pre-existing kidney conditions, the increased filtration rate may exacerbate the condition. Thus, routine","Is kidney damage caused by pregnancy-induced glomerular hyperfiltration in women with higher parity? Glomerular hyperfiltration is a common physiological change during pregnancy and does not necessarily damage kidneys in women with multiple pregnancies. But if kidney disease is already present, the increased filtration rate may worsen it. Therefore, ongoing evaluation is important.",0.0,4.440892098500626e-16,0.0,0.0,0.02772588722239755,0.019938885418112832,0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0
283,0.3,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum, does not directly affect the size of compensatory hypertrophy in the middle turbinate.",9.47438909427412e-08,0.12244491871651686,0.0012975246361896509,0.007253705859127518,0.12196881423277617,0.003928926969497065,0.007243206163811494,0.1211537644002374,0.007382467757631295,9.474389094274162e-08,0.1199314161721925,0.011658147000592867
283,0.3,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can septoplasty modify the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, a surgery to fix a deviated septum, does not directly change the hypertrophy size of the middle turbinate.",9.47438909427412e-08,0.1548139535074613,0.17972405350069298,0.007253705859127518,0.16485070875754593,0.1967455621301775,0.007243206163811494,0.12639880008545745,0.17751479289940827,9.474389094274162e-08,0.08544552621593926,0.15532544378698224
283,0.3,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is the size of compensatory hypertrophy of the middle turbinate affected by septoplasty? Septoplasty, performed to correct a deviated septum, does not directly alter the dimensions of this hypertrophy.",1.421158364141118e-07,0.13203089405784008,0.2130177514792899,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079809811,0.15532544378698224
283,0.3,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does undergoing septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty, aimed at correcting a deviated septum, does not directly modify the hypertrophy dimensions.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
283,0.3,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Will septoplasty change the size of compensatory hypertrophy in the middle turbinate? Septoplasty, a procedure to fix a deviated septum, does not directly influence the hypertrophy size.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
283,0.3,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty influence the dimensions of compensatory hypertrophy of the middle turbinate? Septoplasty, a corrective surgery for a deviated septum, does not directly affect the hypertrophy dimensions.",1.894877818854824e-07,0.05792292190411841,0.2130177514792899,0.014507411718255037,0.016430703639272792,0.1967455621301775,0.014486412327622988,0.02775187974180149,0.17751479289940827,1.8948778188548325e-07,0.07489712385924063,0.15532544378698224
283,0.3,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Can the dimensions of compensatory hypertrophy in the middle turbinate be changed by septoplasty? Septoplasty, which corrects a deviated septum, does not directly alter these dimensions.",2.131737546211677e-07,0.018702208750835947,0.2130177514792899,0.016320838183036916,0.02439129088098202,0.1967455621301775,0.016297213868575862,0.07031149416059712,0.17751479289940827,2.1317375462116866e-07,0.11934888643007469,0.15532544378698224
283,0.3,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Is compensatory hypertrophy of the middle turbinate dimensionally changed by septoplasty? Septoplasty, a surgical correction of a deviated septum, does not directly change the hypertrophy size.",2.131737546211677e-07,0.018702208750835947,0.2130177514792899,0.016320838183036916,0.02439129088098202,0.1967455621301775,0.016297213868575862,0.07031149416059712,0.17751479289940827,2.1317375462116866e-07,0.11934888643007469,0.15532544378698224
283,0.3,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does the surgical procedure septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty, used to correct a deviated septum, does not directly impact the hypertrophy dimensions.",1.421158364141118e-07,0.13203089405784008,0.2130177514792899,0.010880558788691277,0.09339174477540224,0.1967455621301775,0.010864809245717241,0.052290827931735784,0.17751479289940827,1.4211583641411244e-07,0.008484485079809811,0.15532544378698224
283,0.3,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty, a surgical procedure to correct a deviated septum, does not directly change the dimensions of compensatory hypertrophy of the middle","Does septoplasty have an effect on the size of compensatory hypertrophy in the middle turbinate? Septoplasty, which corrects a deviated septum, does not directly change the hypertrophy size.",1.658018091497971e-07,0.0956632498869654,0.2130177514792899,0.012693985253473157,0.05565141679255525,0.1967455621301775,0.012675610786670115,0.013070114778453323,0.17751479289940827,1.6580180914979784e-07,0.032337509440445,0.15532544378698224
284,0.3,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research suggests Indigenous Australians might face some age-related health problems sooner than non-Indigenous Australians because of socio-economic conditions, lifestyle, and healthcare access. However, this does not definitively imply premature aging.",3.316036182995945e-07,0.3616648819601149,0.023242630385487524,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
284,0.3,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Studies show that Indigenous Australians could experience certain health issues linked to aging earlier than their non-Indigenous counterparts, influenced by socio-economic status, lifestyle choices, and healthcare availability. Still, this doesn't confirm premature aging.",2.605457000925386e-07,0.26322480914686164,0.023242630385487524,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
284,0.3,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may encounter age-associated health challenges earlier than non-Indigenous Australians, primarily due to socio-economic factors, lifestyle, and healthcare access, but this is not conclusive evidence of premature aging.",3.552895910352798e-07,0.39675620177138393,0.023242630385487524,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
284,0.3,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Evidence points to Indigenous Australians potentially developing some age-related health problems earlier than non-Indigenous Australians, driven by socio-economic and lifestyle factors as well as healthcare access, though this doesn't necessarily mean they age prematurely.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
284,0.3,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research indicates that due to socio-economic conditions, lifestyle, and healthcare access, Indigenous Australians might experience certain aging health issues earlier than non-Indigenous Australians, but this does not equate to premature aging.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.3,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians may be prone to earlier onset of some age-related health issues compared to non-Indigenous Australians, influenced by socio-economic and lifestyle factors and healthcare access; however, this is not a definitive sign of premature aging.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
284,0.3,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Certain age-related health problems may appear earlier in Indigenous Australians than in non-Indigenous Australians, largely due to socio-economic, lifestyle, and healthcare disparities, but this does not imply they age prematurely.",3.316036182995945e-07,0.3616648819601149,0.023242630385487524,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
284,0.3,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Due to factors like socio-economic status, lifestyle, and healthcare availability, Indigenous Australians might face some aging-related health issues sooner than non-Indigenous Australians, though this doesn't necessarily indicate premature aging.",3.552895910352798e-07,0.39675620177138393,0.023242630385487524,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
284,0.3,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Indigenous Australians could experience some health issues related to aging earlier than non-Indigenous Australians because of socio-economic and lifestyle factors and healthcare access, but this does not mean they age prematurely.",3.079176455639092e-07,0.32776333028443316,0.023242630385487524,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
284,0.3,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: Research indicates that Indigenous Australians may experience certain age-related health issues earlier than non-Indigenous Australians due to socio-economic factors, lifestyle and access to healthcare. However, it's essential to note that this doesn't necessarily mean they age prematurely.","Research shows that Indigenous Australians may develop certain age-related health conditions earlier than non-Indigenous Australians, influenced by socio-economic factors, lifestyle, and healthcare access, yet this does not confirm premature aging.",3.316036182995945e-07,0.3616648819601149,0.023242630385487524,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
285,0.3,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a discrepancy between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, discrepancies frequently occur due to variations in training, interpretative abilities, and communication, with clinicians sometimes missing subtle changes that experienced pathologists detect.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.3,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are clinical pathologists and clinicians often at odds when reporting and interpreting red blood cell morphology? Yes, differences in education, skill levels, and communication can lead to discordance, where clinicians may fail to recognize subtle alterations noticed by pathologists.",5.210914001850787e-07,0.2488142483277307,0.14532871972318342,0.0398953822252012,0.30214392909472654,0.11649408284023667,0.039837633900963065,0.3574159375110071,0.08543965824136704,5.210914001850789e-07,0.4147403452335632,0.05246913580246911
285,0.3,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Does discordance exist between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? Yes, such discordance is common, arising from differences in training, interpretation expertise, and communication, with clinicians potentially overlooking nuances seen by pathologists.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.3,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there often disagreement between clinical pathologists and clinicians about red blood cell morphology interpretation and reporting? Yes, this disagreement can result from differing training backgrounds, interpretive skills, and communication issues, causing clinicians to miss subtle findings identified by pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.3,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Do clinical pathologists and clinicians frequently differ in their reporting and interpretation of red blood cell morphology? Yes, differences in training, interpretive proficiency, and communication gaps can cause clinicians to misinterpret or miss subtle changes that pathologists detect.",5.44777372920764e-07,0.27548249540989156,0.14532871972318342,0.04170880868998307,0.32954290328284186,0.11649408284023667,0.04164843544191593,0.38558681447770393,0.08543965824136704,5.447773729207643e-07,0.4437278821068147,0.05246913580246911
285,0.3,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is discordance common between clinical pathologists and clinicians when interpreting and reporting red blood cell morphology? Yes, due to variations in training, skill, and communication, clinicians may overlook subtle morphological changes that experienced pathologists recognize.",6.158352911278199e-07,0.36003988343795523,0.14532871972318342,0.0471490880843287,0.416554280272472,0.11649408284023667,0.04708084006477455,0.4751989731673909,0.08543965824136704,6.158352911278206e-07,0.53610120223783,0.05246913580246911
285,0.3,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Are there often inconsistencies between clinical pathologists and clinicians in red blood cell morphology reporting and interpretation? Yes, these inconsistencies arise from differences in training, interpretation skills, and communication, with clinicians sometimes failing to notice subtle changes seen by pathologists.",4.974054274493934e-07,0.22283876192447272,0.14532871972318342,0.038081955760419325,0.27547568201256567,0.11649408284023667,0.0380268323600102,0.33001696332289177,0.08543965824136704,4.974054274493935e-07,0.38656946826686633,0.05246913580246911
285,0.3,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there a frequent mismatch between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Yes, this mismatch can be attributed to differences in training, interpretive ability, and communication, leading clinicians to miss subtle changes that pathologists identify.",4.263475092423373e-07,0.14873078977074927,0.14532871972318342,0.03264167636607371,0.19948977503464427,0.11649408284023667,0.0325944277371516,0.2520554218531812,0.08543965824136704,4.263475092423373e-07,0.30652676059333217,0.05246913580246911
285,0.3,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Can clinical pathologists and clinicians disagree when reporting and interpreting red blood cell morphology? Yes, disagreements often occur due to disparities in training, interpretation skills, and communication, with clinicians potentially overlooking subtle changes detected by pathologists.",5.921493183921346e-07,0.3310523465647037,0.14532871972318342,0.04533566161954682,0.3867013171227902,0.11649408284023667,0.04527003852382168,0.4444273145006372,0.08543965824136704,5.921493183921352e-07,0.5043525039232502,0.05246913580246911
285,0.3,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Yes, there can often be discordance between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology. This may stem from differences in training, interpretation skills, and communication gaps. Clinicians might misinterpret or overlook subtle changes that a seasoned pathologist would notice.","Is there often a lack of concordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Yes, this lack of concordance stems from differences in training, interpretive expertise, and communication gaps, causing clinicians to miss subtle morphological details noted by pathologists.",3.789755637709665e-07,0.16522415418676006,0.09997724580028093,0.029014823436509962,0.18410112979236404,0.09325145245474914,0.028972824655245866,0.20326525768374948,0.08543965824136704,3.789755637709665e-07,0.25651634001866874,0.05246913580246911
286,0.3,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Individuals diagnosed with type 2 diabetes exhibiting lower initial blood sugar levels, possibly indicating an earlier disease stage, experienced fewer negative clinical events despite comparable glycemic progression. Given that most of these individuals show no symptoms at diagnosis, proactive case identification is important.",1.1842986367842703e-07,0.08958041220022217,0.0029160849274268985,0.009067132323909363,0.0891118229913257,0.0015137042199295445,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
286,0.3,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and improved patient outcomes? Patients with type 2 diabetes who have lower initial blood glucose, suggesting an earlier phase of the disease, tend to have fewer adverse clinical outcomes even though their glycemic progression is similar. Since many are asymptomatic at diagnosis, active case detection is necessary.",9.474389094274162e-08,0.07229357234676037,0.0023715969459572536,0.0072537058591274906,0.07191309609835717,0.0012314688405761602,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
286,0.3,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correlate with better outcomes? People diagnosed with type 2 diabetes who present with lower initial glycemia, possibly indicating an earlier stage of the disease, experience fewer adverse clinical outcomes despite similar progression of blood sugar levels. Because most are asymptomatic when diagnosed, active case finding is crucial.",7.105791820705622e-08,0.05470323687720402,0.0018087236718610442,0.005440279394345618,0.05441355041844975,0.000939510352663115,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
286,0.3,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are decreased fasting plasma glucose levels at type 2 diabetes diagnosis associated with improved clinical outcomes? Individuals with type 2 diabetes who show lower initial glycemia, potentially reflecting an earlier disease course, have fewer negative clinical outcomes despite comparable glycemic progression. Since most are asymptomatic at diagnosis, active case identification is important.",1.1842986367842703e-07,0.09838002986348426,0.0034850590946045243,0.009067132323909363,0.09783071500636176,0.0018160871470449327,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
286,0.3,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and better health outcomes? Patients presenting with type 2 diabetes with lower initial blood sugar, possibly earlier in their disease progression, have fewer adverse clinical outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active case detection is essential.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.3,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to improved clinical outcomes? People with type 2 diabetes who have lower initial glycemia, suggesting an earlier stage of the disease, experience fewer adverse outcomes even though their glycemic progression is similar. Since most are asymptomatic at diagnosis, active case finding is important.",2.3685972735685406e-08,0.0185681825888242,0.000623972610504564,0.0018134264647818726,0.01846860107447057,0.0003243433209763093,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
286,0.3,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Do reduced fasting plasma glucose levels at diagnosis of type 2 diabetes relate to better outcomes? Individuals presenting with type 2 diabetes with lower initial blood sugar, possibly indicating an earlier disease stage, had fewer adverse clinical outcomes despite similar glycemic progression. Given that most are asymptomatic at diagnosis, active case detection is necessary.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
286,0.3,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are lower fasting plasma glucose levels at the diagnosis of type 2 diabetes associated with better clinical outcomes? Patients with type 2 diabetes who present with lower initial glycemia, potentially earlier in their disease course, have fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case finding is important.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.3,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Is there a link between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved outcomes? People diagnosed with type 2 diabetes with lower initial blood sugar, possibly earlier in their disease progression, experience fewer adverse clinical outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active case detection is crucial.",4.737194547137081e-08,0.03820136687076836,0.0013169535961558843,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
286,0.3,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case","Are decreased fasting plasma glucose levels at diagnosis of type 2 diabetes connected to better outcomes? Individuals presenting with type 2 diabetes with lower initial glycemia, potentially reflecting an earlier stage of the disease, had fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case finding is essential.",7.105791820705622e-08,0.057862259045130315,0.002012521299974847,0.005440279394345618,0.05754362157529469,0.001047792634361909,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
287,0.3,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.3,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children did not accurately assess their level of overweight. This misunderstanding was also common among their parents and their doctors. The findings highlight the importance of improving physician education on identifying obesity and overweight to better support children and their families.",4.737194547137081e-08,0.0031017352188560388,0.05322937568728815,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
287,0.3,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A significant number of children underestimated how overweight they were. This misjudgment was also found among their parents and physicians. The study underscores the necessity to enhance physician training to detect obesity and overweight for effective counseling of children and families.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.3,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children failed to recognize their overweight status accurately. Their parents and even their healthcare providers shared this incorrect perception. The research points to the need for better physician education on obesity recognition to aid in counseling children and their families.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.3,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children often underestimated their overweight condition. This misperception was also common among their parents and doctors. The study highlights the need to educate physicians more thoroughly to identify obesity and overweight and provide proper guidance to children and families.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.3,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not accurately perceive their overweight status, a misunderstanding also present among their parents and attending physicians. This research emphasizes the importance of educating physicians to better recognize obesity and overweight to counsel children and their families effectively.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.3,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A large number of children underestimated their overweight level, a misperception shared by their parents and doctors. The study reveals the need for enhanced physician education to identify obesity and overweight and support counseling for children and families.",4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
287,0.3,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated how overweight they were, a misconception also held by their parents and physicians. This study highlights the necessity of improving physician training to recognize obesity and overweight in order to counsel children and their families.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
287,0.3,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children frequently underestimated their overweight status, and this misperception was shared by their parents and doctors. The findings suggest a need for better physician education to identify obesity and overweight and provide appropriate counseling to children and families.",4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
287,0.3,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their overweight condition, with their parents and attending physicians sharing this misperception. The study demonstrates the importance of further educating physicians to recognize obesity and overweight to better counsel children and their families.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
288,0.3,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it justified to screen risk groups for coeliac disease? Yes, screening is justified as it helps in early diagnosis and treatment, preventing complications such as malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are particularly considered.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.3,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should coeliac disease screening be done in risk groups? Yes, it is justified because it enables early detection and management, reducing the risk of complications like malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or autoimmune diseases are especially targeted.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.3,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in high-risk groups warranted? Yes, screening is warranted as it facilitates early identification and treatment, avoiding complications like malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially included.",1.6580180914979784e-07,0.012692071549718964,0.10072314049586772,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.0727812734820863,0.06353305785123965,1.6580180914979784e-07,0.10480608248467238,0.043388429752066124
288,0.3,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Does screening for coeliac disease in risk groups make sense? Yes, it makes sense because it promotes early diagnosis and intervention, preventing issues such as malnutrition, osteoporosis, and lymphoma. Individuals with a family history, type 1 diabetes, Down syndrome, or autoimmune diseases are particularly considered.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.3,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it appropriate to screen risk groups for coeliac disease? Yes, it is appropriate since it allows early detection and treatment, helping to prevent complications like malnutrition, osteoporosis, and lymphoma. People with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are especially considered.",7.105791820705622e-08,0.0782797066560077,0.10072314049586772,0.005440279394345618,0.05098600895575256,0.08264462809917357,0.0054324046228586,0.02252890632223936,0.06353305785123965,7.105791820705622e-08,0.007167612920754518,0.043388429752066124
288,0.3,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening justified in populations at risk? Yes, it is justified as it supports early diagnosis and management, preventing complications including malnutrition, osteoporosis, and lymphoma. Those with family history, type 1 diabetes, Down syndrome, or autoimmune conditions are especially targeted.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,0.3,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified because it aids in early detection and treatment, reducing the risk of complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune diseases are especially considered.",0.0,0.14145860827753998,0.10072314049586772,0.0,0.11552453009332408,0.08264462809917357,0.0,0.08848687411403544,0.06353305785123965,0.0,0.060273667874777725,0.043388429752066124
288,0.3,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is it reasonable to conduct coeliac disease screening in risk groups? Yes, it is reasonable as it helps in early identification and treatment, preventing complications like malnutrition, osteoporosis, and lymphoma. Individuals with family history, type 1 diabetes, Down syndrome, or autoimmune conditions are particularly included.",1.1842986367842703e-07,0.03382794408517498,0.10072314049586772,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.02399110931265458,0.06353305785123965,1.1842986367842703e-07,0.05479566191000895,0.043388429752066124
288,0.3,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is coeliac disease screening in high-risk groups justified? Yes, it is justified because it facilitates early detection and treatment, avoiding complications such as malnutrition, osteoporosis, and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune disorders are especially considered.",1.4211583641411244e-07,0.010838425860475454,0.10072314049586772,0.010880558788691236,0.018006862531199097,0.08264462809917357,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
288,0.3,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. It aids in early detection and treatment, preventing complications like malnutrition, osteoporosis and lymphoma. Those with a family history, type 1 diabetes, Down syndrome, or other autoimmune conditions are especially considered","Is screening for coeliac disease in risk groups necessary? Yes, it is necessary as it promotes early diagnosis and intervention, preventing complications like malnutrition, osteoporosis, and lymphoma. People with family history, type 1 diabetes, Down syndrome, or autoimmune diseases are particularly targeted.",1.8948778188548325e-07,0.03678962312877898,0.10072314049586772,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
289,0.3,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites representative of community practice? Patient care opportunities at the Northeastern Ohio Universities College of Medicine residency sites align with those identified in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,0.3,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do family practices at residency teaching sites reflect the nature of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care similar to that found in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.3,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice during residency at teaching sites correspond to community practice? The residency training sites at Northeastern Ohio Universities College of Medicine deliver patient care experiences akin to those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching sites consistent with community practice? The residency sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities that resemble those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.3,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites represent community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,0.3,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites reflective of community practice? The residency training locations of Northeastern Ohio Universities College of Medicine offer patient care experiences similar to those found in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice mirror community practice? The Northeastern Ohio Universities College of Medicine residency training sites provide patient care opportunities like those reported in a national survey of family and general practitioners.,1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,0.3,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites parallel community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those documented in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.3,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites analogous to community practice? The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities similar to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
290,0.3,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week of life? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 can assist in tracking or screening abnormal PaCO2 levels in ELBW infants during the first week of life.,2.3685972735685406e-08,0.03240743131034085,0.06192804591113557,0.0018134264647818726,0.026484536901801192,0.03005636932548933,0.0018108015409528666,0.005912492424360316,0.015621063240110858,2.3685972735685406e-08,0.01600034134644357,0.0
290,0.3,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants in their first week? End-tidal CO2 shows good correlation and agreement with arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring is useful for trending or screening abnormal PaCO2 values in these infants during their first week.,1.1842986367842703e-07,0.05000885327523141,0.1190029567315874,0.009067132323909363,0.005267714549224145,0.06127385111529162,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.3,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does measuring end-tidal CO2 correlate with arterial CO2 in extremely low birth weight infants within the first week of life? There is a strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants at EtCO2 levels between 30 and 50 mmHg. End-tidal CO2 monitoring can be beneficial for tracking or screening abnormal PaCO2 in these infants during their first week.,1.1842986367842703e-07,0.05000885327523141,0.1190029567315874,0.009067132323909363,0.017837191469440405,0.044611972344823364,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
290,0.3,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants during the initial week of life? A good correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is helpful for trending or detecting abnormal PaCO2 values in the first week of life.,7.105791820705622e-08,0.040424764702430505,0.08927644067926871,0.005440279394345618,0.03805753737221629,0.06127385111529162,0.0054324046228586,0.026348369793864457,0.015621063240110858,7.105791820705622e-08,0.04879016416943571,0.0
290,0.3,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correlate with arterial CO2 in extremely low birth weight infants in their first week? There is a strong agreement and correlation between end-tidal and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. Monitoring end-tidal CO2 can aid in trending or screening for abnormal PaCO2 values during the first week.,2.1317375462116866e-07,0.022598192972485,0.11558257241544406,0.016320838183036854,0.08848041338629553,0.04342261144587013,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
290,0.3,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal CO2 and arterial CO2 in extremely low birth weight infants during their first week of life? End-tidal CO2 correlates well and agrees with arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be useful for tracking or screening abnormal PaCO2 values in these infants.,2.3685972735685406e-07,0.075699651607529,0.0585842525966114,0.018134264647818726,0.1069490144607661,0.04309826812489382,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
290,0.3,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal carbon dioxide measurement align with arterial carbon dioxide levels in extremely low birth weight infants in the first week? There is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants in the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can assist in trending or screening abnormal PaCO2 values during the first week of life.,1.4211583641411244e-07,0.013866567566685362,0.08540708011873967,0.010880558788691236,0.035035918362408935,0.044329736965469976,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
290,0.3,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a correlation between end-tidal CO2 and arterial CO2 in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring helps in trending or screening abnormal PaCO2 values in these infants.,2.3685972735685406e-07,0.09111119120315969,0.07962418034401852,0.018134264647818726,0.13215436648112755,0.024961996362710633,0.018108015409528666,0.17391030520141637,0.002890862712185324,2.3685972735685406e-07,0.17284281283941416,0.0
290,0.3,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Does end-tidal CO2 measurement correspond with arterial CO2 in extremely low birth weight infants in the first week of life? There is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 can be helpful for trending or screening abnormal PaCO2 values during the first week.,1.8948778188548325e-07,0.0607732434484225,0.04487620091994238,0.014507411718254981,0.07034653354218268,0.04373558580916917,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
290,0.3,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.,Is there a relationship between end-tidal CO2 and arterial CO2 in extremely low birth weight infants in their first week? End-tidal CO2 shows good correlation and agreement with arterial CO2 in ELBW infants at EtCO2 levels between 30 and 50 mmHg. End-tidal CO2 monitoring can aid in trending or screening abnormal PaCO2 values in these infants during the first week.,1.6580180914979784e-07,0.018003826776930243,0.06425005532535116,0.012693985253473108,0.05253546404231635,0.04403777847755694,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
291,0.3,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Antral follicle count is a valuable predictor for IVF success. Although age and FSH are important markers, the antral follicle count may better reflect ovarian reserve and response, thus providing a more accurate prediction. Using all these indicators together might yield the best overall prognosis.",3.789755637709665e-07,0.20644122499639472,0.01795440247075973,0.029014823436510045,0.2300562944082083,0.009770100201771478,0.02897282465524588,0.2474081733138398,0.0,3.789755637709665e-07,0.2513144282809048,0.0
291,0.3,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle assessment better predict IVF results than age and FSH? Antral follicle evaluation is an effective tool for forecasting IVF outcomes. While age and FSH remain important, the antral follicle count offers a potentially more precise measure of ovarian reserve and responsiveness, enhancing prediction accuracy. Combining these factors could provide the most thorough prediction.",4.737194547137081e-07,0.2589204713574409,0.028930611576339485,0.036268529295637536,0.2776136314744919,0.027006172839506164,0.036216030819057346,0.320167527596269,0.0,4.737194547137081e-07,0.32542240043462645,0.0
291,0.3,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? Antral follicle count serves as a useful predictor in IVF. Although age and FSH are significant, the antral follicle number may more accurately represent ovarian reserve and response, leading to better predictions. Integrating all these parameters might offer the most comprehensive outlook.",5.210914001850789e-07,0.325330680367411,0.005970965817299237,0.03989538222520128,0.34201346640195274,0.007782797214746454,0.03983763390096308,0.3586338084240648,0.0,5.210914001850789e-07,0.3646431135879089,0.0
291,0.3,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is the antral follicle count a better predictor of IVF success than age and FSH levels? Antral follicle assessment is a helpful method for anticipating IVF outcomes. Age and FSH are key indicators, but the antral follicle count may provide a more precise evaluation of ovarian reserve and responsiveness, improving prediction accuracy. Using all three factors together may yield the best forecast.",3.316036182995957e-07,0.2151847945692209,0.01179766364494271,0.0253879705069463,0.24156783387266145,0.02285532300536917,0.025351221573340146,0.23641851183792362,0.01694411414982164,3.316036182995957e-07,0.21622310846963533,0.0
291,0.3,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? Antral follicle count is a valuable predictor tool for IVF. While age and FSH are important, the antral follicle count might more accurately reflect ovarian reserve and responsiveness, offering a more reliable prediction. Combining these measures could provide the most complete prediction.",4.737194547137081e-07,0.3093311753981647,0.008243944636678255,0.036268529295637536,0.32895786707152563,0.00997607568120389,0.036216030819057346,0.320167527596269,0.0,4.737194547137081e-07,0.32542240043462645,0.0
291,0.3,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment more effective than age and FSH for predicting IVF results? Antral follicle count is a useful predictor for IVF outcomes. Although age and FSH are important, the antral follicle count may better indicate ovarian reserve and responsiveness, leading to more accurate predictions. A combined approach using all factors may provide the most comprehensive forecast.",4.263475092423373e-07,0.26885729059553487,0.0036137671218853945,0.03264167636607379,0.2907565002007573,0.008659122085048005,0.03259442773715161,0.2831262559159189,0.0,4.263475092423373e-07,0.287682072451779,0.0
291,0.3,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Can antral follicle count better predict IVF success compared to age and FSH? Antral follicle assessment is a valuable tool for predicting IVF outcomes. Age and FSH are also significant, but the antral follicle count potentially offers a more precise measure of ovarian reserve and response, resulting in improved prediction. Using all these factors together might give the best overall prediction.",3.552895910352811e-07,0.18791986216356094,0.019715239036791135,0.027201396971728173,0.21255674872830088,0.010062058689684523,0.027162023114293013,0.23001643060197097,0.0,3.552895910352811e-07,0.23361485118150416,0.0
291,0.3,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment a more reliable predictor of IVF outcomes than age and FSH? Antral follicle count is an effective predictor for IVF. While age and FSH are key markers, the antral follicle count may provide a more accurate reflection of ovarian reserve and responsiveness, enhancing prediction accuracy. Combining these factors could yield the most comprehensive forecast.",4.263475092423373e-07,0.2688572905955344,0.0036137671218853668,0.03264167636607379,0.2660012437521875,0.009154933170084673,0.03259442773715161,0.2831262559159189,0.0,4.263475092423373e-07,0.287682072451779,0.0
291,0.3,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Does antral follicle count provide better IVF outcome predictions than age and FSH? Antral follicle assessment is a useful tool for forecasting IVF success. Although age and FSH are important, the antral follicle count may more precisely indicate ovarian reserve and responsiveness, offering improved prediction. Using all factors together might provide the most thorough prognosis.",4.974054274493935e-07,0.3045182029848017,0.008156055363321743,0.03808195576041941,0.32246226186626714,0.008145226093944032,0.03802683236001021,0.3392157225669621,0.0,4.974054274493935e-07,0.34484048629172914,0.0
291,0.3,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment is a useful tool for predicting outcomes in IVF. While age and FSH levels are also key indicators, antral follicle count potentially provides a more accurate representation of ovarian reserve and responsiveness, thereby offering a more precise prediction of IVF success. However, combining all these factors may give the most comprehensive forecast.","Is antral follicle assessment superior to age and FSH in predicting IVF outcomes? Antral follicle count is a valuable predictor for IVF success. While age and FSH are significant, the antral follicle count may better represent ovarian reserve and responsiveness, leading to more accurate predictions. A combined evaluation of all factors may provide the most comprehensive forecast.",4.500334819780227e-07,0.28889230627556284,0.005887158785082738,0.03445510283085566,0.3096751968470195,0.009305681913074824,0.03440522927810448,0.30147539458411465,0.0,4.500334819780227e-07,0.30637420546393335,0.0
292,0.3,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and their carers found the reorganization of care to provide a primary angioplasty service acceptable. Satisfaction was generally high across all care types, except for discharge and aftercare.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,0.3,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable substitute for thrombolysis? The restructuring of care to include primary angioplasty was well-received by patients and their carers. Overall satisfaction was high regardless of care type, except in areas of discharge and aftercare.",9.474389094274152e-08,0.10425168058893775,0.004731261479979244,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
292,0.3,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is offering primary angioplasty instead of thrombolysis acceptable? Patients and carers accepted the care reorganization to provide primary angioplasty. Satisfaction levels remained high for all care types except discharge and aftercare.,3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
292,0.3,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable alternative treatment to thrombolysis? Patients and their carers accepted the changes in care to offer primary angioplasty. Satisfaction was high across care types, with the exception of discharge and aftercare.",2.1317375462116802e-07,0.17036078358345197,0.046400951814396206,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.3,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Does primary angioplasty serve as an acceptable alternative to thrombolysis? The care reorganization to provide primary angioplasty was accepted by patients and carers. Satisfaction was high in all care types except discharge and aftercare.,2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.3,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is it acceptable to reorganize care to provide primary angioplasty instead of thrombolysis? Patients and carers found this acceptable, with high satisfaction levels regardless of care type, except for discharge and aftercare.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.3,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty, with high satisfaction except in discharge and aftercare.",4.026615365066504e-07,0.4386247701781314,0.046400951814396206,0.030828249901291904,0.5187937934151678,0.0,0.03078362619619881,0.5355182363563626,0.0,4.026615365066519e-07,0.5533852381847866,0.0
292,0.3,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option compared to thrombolysis? Patients and carers accepted the reorganization of care to provide primary angioplasty, with high satisfaction except for discharge and aftercare.",3.552895910352798e-07,0.3645167980244097,0.046400951814396206,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
292,0.3,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis acceptably? Patients and carers accepted the care changes to offer primary angioplasty, with high satisfaction except in discharge and aftercare.",4.50033481978021e-07,0.5186674778516687,0.046400951814396206,0.03445510283085566,0.6021754023542183,0.0,0.034405229278104556,0.6225296133459923,0.0,4.500334819780227e-07,0.6443570163905146,0.0
292,0.3,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a preferred alternative to thrombolysis? The reorganization of care to provide primary angioplasty was acceptable to patients and carers, with high satisfaction except for discharge and aftercare.",3.316036182995945e-07,0.37722873204486085,0.011962176304192114,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
293,0.3,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better outcomes? Yes, lower fasting plasma glucose at diagnosis typically reflects superior glycemic control and correlates with enhanced outcomes, such as fewer diabetes complications and improved overall health, resulting in a more favorable prognosis.",1.6580180914979784e-07,0.10694824144729598,0.15760469005458505,0.012693985253473108,0.087040213355706,0.1520156039546412,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.3,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose levels when type 2 diabetes is diagnosed correlate with improved patient outcomes? Indeed, lower fasting glucose at diagnosis usually signifies better blood sugar management and is associated with positive outcomes, including reduced diabetes-related complications and better health status, leading to improved prognosis.",2.3685972735685406e-07,0.07021594919939078,0.17661871237628807,0.018134264647818726,0.05138282474146516,0.1728395061728395,0.018108015409528666,0.0005825297421186981,0.14366729678638948,2.3685972735685406e-07,0.025996316201214675,0.12901701323251416
293,0.3,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and better health outcomes? Yes, having lower fasting glucose levels at diagnosis generally indicates improved glycemic control and is linked to better outcomes, such as fewer complications and enhanced overall health, which contribute to a better prognosis.",1.1842986367842703e-07,0.12199029224731106,0.13975335743801648,0.009067132323909363,0.12901745317689306,0.15284783603539676,0.009054007704764333,0.1082131939344837,0.14366729678638948,1.1842986367842703e-07,0.08400457901311409,0.12901701323251416
293,0.3,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are decreased fasting plasma glucose levels at the time of type 2 diabetes diagnosis connected to improved clinical outcomes? Yes, lower fasting glucose at diagnosis often means better glycemic regulation and is associated with favorable outcomes, including fewer diabetes complications and improved overall patient health, resulting in a better prognosis.",1.6580180914979784e-07,0.1635316847583117,0.19834710743801648,0.012693985253473108,0.11592134587903669,0.1728395061728395,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.3,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Does a lower fasting plasma glucose level at the diagnosis of type 2 diabetes predict better outcomes? Yes, lower fasting glucose levels at diagnosis are typically indicative of improved glycemic control and correlate with better outcomes like reduced complications and enhanced overall health, leading to a more positive prognosis.",1.8948778188548325e-07,0.11403126503224525,0.17752320521981818,0.014507411718254981,0.09486793668120352,0.1728395061728395,0.014486412327622933,0.04503429231295142,0.14366729678638948,1.8948778188548325e-07,0.019466057875542564,0.12901701323251416
293,0.3,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at the point of type 2 diabetes diagnosis linked to improved health outcomes? Yes, generally, lower fasting glucose at diagnosis suggests better glycemic management and is associated with improved outcomes, including fewer diabetes-related complications and better overall health, which leads to a better prognosis.",1.6580180914979784e-07,0.13523996310280362,0.17794780188246093,0.012693985253473108,0.11592134587903669,0.1728395061728395,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.3,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is there a relationship between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved outcomes? Yes, lower fasting glucose levels at diagnosis usually reflect better glycemic control and are connected to improved outcomes such as fewer complications and enhanced overall health status, resulting in a better prognosis.",1.6580180914979784e-07,0.0786565197917879,0.1373830242622131,0.012693985253473108,0.087040213355706,0.1520156039546412,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
293,0.3,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Do lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis indicate improved patient outcomes? Yes, lower fasting glucose at diagnosis generally signifies superior glycemic control and is linked to better outcomes, including fewer diabetes complications and improved overall health, leading to a better prognosis.",2.1317375462116866e-07,0.0923633636530643,0.17708056679529438,0.016320838183036854,0.07336173146024016,0.1728395061728395,0.0162972138685758,0.023055385594176414,0.14366729678638948,2.1317375462116866e-07,0.003006797976515152,0.12901701323251416
293,0.3,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with better clinical outcomes? Yes, lower fasting glucose levels at diagnosis typically indicate improved glycemic control and are correlated with positive outcomes, such as fewer diabetes-related complications and enhanced overall health, resulting in a better prognosis.",1.8948778188548325e-07,0.027387867462251858,0.11570247933884292,0.014507411718254981,0.035876687271846563,0.13037037037037036,0.014486412327622933,0.014897458375562778,0.12193890172466108,1.8948778188548325e-07,0.019466057875542564,0.12901701323251416
293,0.3,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Yes, lower fasting plasma glucose levels at diagnosis of type 2 diabetes generally indicate better glycemic control and are associated with improved outcomes. These outcomes include fewer diabetes-related complications and improved overall health status, leading to better patient prognosis.","Is a lower fasting plasma glucose level at the diagnosis of type 2 diabetes associated with improved health outcomes? Yes, lower fasting glucose at diagnosis generally means better glycemic control and is linked to improved outcomes, including fewer complications and better overall health status, which leads to a better prognosis.",1.6580180914979784e-07,0.13523996310280362,0.17794780188246093,0.012693985253473108,0.11592134587903669,0.1728395061728395,0.012675610786670066,0.06654049753391478,0.14366729678638948,1.6580180914979784e-07,0.04144496459431757,0.12901701323251416
294,0.3,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the position of the head affect the anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically evident unilateral pseudoexfoliation, the lens appears to be more mobile in the affected eye, causing a shallower anterior chamber when the head is in a prone position. This mobility might potentially cause transient pupillary block during certain activities.",9.474389094274162e-08,0.07362193352346624,0.002455283499887856,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
294,0.3,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation show increased lens mobility in the affected eye, leading to a shallower anterior chamber when the head is prone. This may result in transient pupillary block during some activities.",3.789755637709665e-07,0.3015837027686259,0.010613940867205608,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
294,0.3,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head position impact anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation cases, the affected eyes lens is more mobile, causing the anterior chamber to become shallower when the head is prone, which could potentially cause transient pupillary block during activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
294,0.3,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head positioning alter anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, resulting in a shallower anterior chamber when the head is prone, possibly leading to transient pupillary block during certain actions.",3.789755637709665e-07,0.3015837027686259,0.010613940867205608,0.029014823436509962,0.32277339226305113,0.0,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
294,0.3,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Can head position influence anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation, the lens mobility in the affected eye increases, causing a shallower anterior chamber when the head is prone, which might cause transient pupillary block during activities.",4.974054274493933e-07,0.42943968554461387,0.007560004415585759,0.038081955760419325,0.4495250979021934,0.0,0.0380268323600102,0.4595323293784399,0.0,4.974054274493935e-07,0.47000362924573613,0.0
294,0.3,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation have a more mobile lens in the affected eye, leading to a shallower anterior chamber in the prone position, potentially causing transient pupillary block during some activities.",3.552895910352811e-07,0.3093681608478569,0.011494902670209362,0.02720139697172809,0.2992428948528567,0.0,0.027162023114293,0.3053816495511823,0.0,3.552895910352811e-07,0.3117796240308417,0.0
294,0.3,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does the anterior chamber depth change with head position in pseudoexfoliation syndrome? The lens in the affected eye of unilateral pseudoexfoliation patients is more mobile, resulting in a shallower anterior chamber when prone, which may lead to transient pupillary block during activities.",4.263475092423373e-07,0.350784405599196,0.009481571252693131,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
294,0.3,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","How does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation, the affected eyes lens is more mobile, causing a shallower anterior chamber when the head is prone, possibly resulting in transient pupillary block during certain activities.",4.73719454713708e-07,0.4025287778450535,0.008233302554632178,0.03626852929563745,0.42285685082003255,0.0,0.03621603081905733,0.4321333551903246,0.0,4.737194547137081e-07,0.4418327522790393,0.0
294,0.3,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Is anterior chamber depth affected by head position in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, making the anterior chamber shallower in the prone position, which might cause transient pupillary block during activities.",4.263475092423373e-07,0.38459646318748586,0.014795631245663209,0.03264167636607371,0.37156355643248284,0.0,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
294,0.3,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities","Does head posture influence anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the lens is more mobile in the affected eye, leading to a shallower anterior chamber when the head is prone, potentially causing transient pupillary block during some activities.",4.026615365066519e-07,0.3258818050299377,0.010061211347874577,0.030828249901291835,0.34687094384211115,0.0,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
295,0.3,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission enhance driving performance in elderly drivers? Yes, automatic transmission can greatly enhance driving performance in elderly drivers by simplifying the process and removing the need to manually shift gears.",9.47438909427412e-08,0.1469146701124684,0.01643655489809337,0.007253705859127518,0.14147248837894733,0.011356483087319041,0.007243206163811494,0.14080039907557484,0.008233307497191582,9.474389094274162e-08,0.13972020673666385,0.004447813134751871
295,0.3,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission improve the driving habits of older adults? Indeed, automatic transmission can notably improve the driving habits of older adults by making driving easier and eliminating manual gear changes.",1.184298636784265e-07,0.2333675004626814,0.04861111111111113,0.009067132323909398,0.22795761926952096,0.04699105098855355,0.009054007704764368,0.22881674991482104,0.045246201873048945,1.1842986367842703e-07,0.22926580920446593,0.04238251821019768
295,0.3,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is driving behavior better in older drivers with automatic transmission? Yes, automatic transmission can substantially improve driving behavior in older drivers by simplifying gear shifting.",2.605457000925383e-07,0.35253897469289797,0.016439909297052163,0.019947691112600675,0.3288198858747422,0.04402051925938028,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.3,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does using automatic transmission benefit older drivers' driving skills? Yes, automatic transmission benefits older drivers' driving skills by reducing the complexity of changing gears manually.",2.605457000925383e-07,0.35253897469289797,0.016439909297052163,0.019947691112600675,0.3288198858747422,0.04402051925938028,0.01991881695048161,0.3214472680402922,0.06035379812695108,2.6054570009253947e-07,0.3778917662913073,0.031217481789802305
295,0.3,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission lead to safer driving in elderly drivers? Yes, automatic transmission can lead to safer driving in elderly drivers by removing the need for manual gear shifts and simplifying vehicle control.",7.10579182070559e-08,0.15150029981111146,0.03862590401051941,0.005440279394345639,0.14892992120137238,0.038791325336976074,0.005432404622858621,0.14992177584844146,0.03841163397181437,7.105791820705622e-08,0.15072488169169596,0.03736962383434036
295,0.3,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission positively affect older drivers' driving? Yes, automatic transmission positively affects older drivers' driving by making it easier to operate the vehicle without manual gear changes.",1.894877818854824e-07,0.2155018506876285,0.029513888888888867,0.014507411718255037,0.1992629097968579,0.0490089490114464,0.014486412327622988,0.19361389653040773,0.06035379812695108,1.8948778188548325e-07,0.24436037366678365,0.031217481789802305
295,0.3,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Is there an improvement in driving behavior among older drivers using automatic transmission? Yes, automatic transmission improves driving behavior among older drivers by simplifying the driving task and eliminating manual gear shifting.",9.47438909427412e-08,0.10219549717311693,0.01268861454046638,0.007253705859127518,0.14147248837894777,0.011356483087319041,0.007243206163811494,0.14080039907557484,0.008233307497191582,9.474389094274162e-08,0.13972020673666385,0.004447813134751871
295,0.3,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission help older drivers drive better? Yes, automatic transmission helps older drivers drive better by simplifying the driving process and removing the need to manually change gears.",1.658018091497971e-07,0.17363303841707145,0.03328888888888884,0.012693985253473157,0.1595478035218174,0.050426700490736366,0.012675610786670115,0.15439318337712526,0.06035379812695108,1.6580180914979784e-07,0.20353837914652884,0.031217481789802305
295,0.3,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Can automatic transmission improve the driving experience for elderly drivers? Yes, automatic transmission improves the driving experience for elderly drivers by making gear changes automatic and easier to manage.",1.658018091497971e-07,0.27265406421134886,0.031243436252888113,0.012693985253473157,0.26223627471588395,0.021966050988553587,0.012675610786670115,0.2610312111555788,0.0160350907619378,1.6580180914979784e-07,0.25899015359132393,0.008713073765753254
295,0.3,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes, automatic transmission can significantly improve driving behavior in older drivers. It simplifies the driving process by eliminating the need to manually change gears. This","Does automatic transmission make driving easier for older drivers? Yes, automatic transmission makes driving easier for older drivers by eliminating the need to manually shift gears, thus improving overall driving behavior.",1.184298636784265e-07,0.14094787638802186,0.008711374095989433,0.009067132323909398,0.1323511116060807,0.01882184338730375,0.009054007704764368,0.12979572412054274,0.024688503202396905,1.1842986367842703e-07,0.1265773380103994,0.031217481789802305
296,0.3,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does participation in provider service networks lead to reduced spending compared to HMOs or primary care case management within Florida's Medicaid program? The Florida Medicaid Demonstration seems to lower per member per month (PMPM) costs. Provider service networks (PSNs) under the demonstration showed slightly larger expenditure decreases than demonstration HMOs. PSNs seem to be an effective approach for providing care to Medicaid beneficiaries.,9.474389094274162e-08,0.09367708230690219,0.01934802571166211,0.0072537058591274906,0.06941741297507864,0.0011493764172335573,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
296,0.3,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with decreased expenditures relative to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to reduce PMPM costs. Demonstration PSNs achieved marginally greater expenditure reductions than demonstration HMOs. PSNs seem to represent a promising care delivery model for Medicaid enrollees.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.3,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks reduce costs more than HMOs or primary care case management in Florida's Medicaid program? Evidence from Florida's Medicaid Demonstration indicates lower PMPM expenditures. PSNs in the demonstration showed slightly better cost reductions compared to demonstration HMOs. PSNs appear to be a viable model for Medicaid care delivery.,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.3,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a cost advantage to provider service networks over HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM spending. Demonstration PSNs produced somewhat greater expenditure decreases than demonstration HMOs. PSNs appear to be a promising method for delivering Medicaid care.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.3,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in lower Medicaid expenditures compared with HMOs or primary care case management in Florida? Florida's Medicaid Demonstration shows reduced PMPM costs. Demonstration PSNs yielded slightly more expenditure reductions than demonstration HMOs. PSNs seem to be an effective model for Medicaid enrollee care.,2.8423167282822487e-07,0.1600967333097434,0.05157024793388431,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,0.3,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to reduce PMPM expenditures. Demonstration PSNs generated marginally greater cost reductions than demonstration HMOs. PSNs seem to be a promising care delivery model for Medicaid enrollees.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.3,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to decreased expenditures compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows lower PMPM expenditures. Demonstration PSNs achieved slightly greater reductions in spending than demonstration HMOs. PSNs appear to be a promising approach for Medicaid care delivery.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.3,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does Florida's Medicaid program see lower expenditures with provider service networks versus HMOs or primary care case management? The Medicaid Demonstration indicates reduced PMPM costs. Demonstration PSNs produced slightly larger expenditure reductions than demonstration HMOs. PSNs appear to be a promising model for Medicaid enrollee care.,3.079176455639103e-07,0.1820756400285184,0.05157024793388431,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
296,0.3,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM expenditures. Demonstration PSNs resulted in slightly greater expenditure reductions than demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.3,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks in Florida's Medicaid program reduce expenditures compared to HMOs or primary care case management? The Medicaid Demonstration suggests lower PMPM spending. Demonstration PSNs showed slightly better expenditure reductions than demonstration HMOs. PSNs appear to be a promising care delivery model for Medicaid enrollees.,2.8423167282822487e-07,0.1600967333097434,0.05157024793388431,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
297,0.3,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers secrete GABA? We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this GABAergic signal in mossy fibers remains unclear, though it might play a role in development. Additional data imply that this GABAergic signal is",4.737194547137081e-08,0.037595839324870095,0.04283872595087333,0.0036268529295637453,0.07732830868434881,0.023623078861174096,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
297,0.3,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are GABA molecules released by mossy fibers? Our findings strongly support the existence of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this signal is not fully understood but could be significant during development. Further evidence indicates that this GABAergic signal is,0.0,0.061613082716439393,0.043694535271409,0.0,0.06301338005090473,0.045351473922902494,0.0,0.0,0.0,0.0,0.0,0.0
297,0.3,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Is GABA released by mossy fibers? We have demonstrated convincing evidence for a GABAergic signal associated with mossy fibers. The physiological significance of this mossy fiber GABAergic signal is uncertain, yet it may be important in developmental processes. Other studies suggest that this GABAergic signal is",0.0,0.01917880483011869,0.025902746583463837,0.0,0.031506690025452144,0.022636492852053387,0.0,0.0,0.0,0.0,0.0,0.0
297,0.3,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers emit GABA? We have provided strong evidence for a GABAergic signal from mossy fibers. The role of this GABAergic signal in physiology is unclear but may be crucial during development. Additional evidence points to this GABAergic signal being,1.1842986367842703e-07,0.1116101509016092,0.040518161778029596,0.009067132323909363,0.09316061699719658,0.019728205224841543,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.3,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers discharge GABA? We have shown compelling evidence supporting a GABAergic signal from mossy fibers. The physiological role of this signal is not well defined but might be important for development. Other findings suggest that this GABAergic signal is,1.1842986367842703e-07,0.06387158827949868,0.038181335802953346,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.3,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Are mossy fibers responsible for releasing GABA? Our research offers convincing proof of a GABAergic signal in mossy fibers. The physiological function of this signal is uncertain but could have developmental relevance. Further evidence supports the presence of this GABAergic signal,1.1842986367842703e-07,0.06387158827949868,0.038181335802953346,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.3,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is","Do mossy fibers produce GABA? We have gathered strong evidence indicating a GABAergic signal from mossy fibers. The physiological importance of this signal is unclear, though it may be significant in developmental stages. Additional data suggest that this GABAergic signal is",1.1842986367842703e-07,0.06387158827949868,0.038181335802953346,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.3,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Is there a GABA release from mossy fibers? We have presented compelling proof of a GABAergic signal associated with mossy fibers. The physiological role of this signal remains uncertain but might be important for development. Other evidence points to this GABAergic signal being,7.105791820705622e-08,0.02122628534783555,0.06424747174301013,0.005440279394345618,0.007604187163049225,0.045351473922902494,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.3,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers generate GABA? We have provided convincing evidence for a GABAergic signal from mossy fibers. The physiological role of this signal is not fully understood but may be relevant during development. Further findings suggest that this GABAergic signal is,1.1842986367842703e-07,0.06387158827949868,0.038181335802953346,0.009067132323909363,0.05761460773771265,0.045351473922902494,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
297,0.3,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is",Do mossy fibers liberate GABA? We have demonstrated strong evidence indicating a GABAergic signal from mossy fibers. The physiological function of this signal is uncertain but could play a role in development. Other evidence suggests that this GABAergic signal is,1.4211583641411233e-07,0.0909666967267646,0.03691061835345323,0.010880558788691236,0.08359009414097063,0.045351473922902494,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
298,0.3,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always lead to Meniere's disease? Answer: No, low-tone sudden deafness does not necessarily develop into Meniere's disease. Although it can be a symptom of Meniere's disease, it may also result from other causes such as viral infections.",1.1842986367842703e-07,0.032009275274421434,0.05842691707332719,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.3,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is progression to Meniere's disease inevitable in cases of low-tone sudden deafness? Answer: No, low-tone sudden deafness does not inevitably progress to Meniere's disease. It is one possible symptom, but other factors like viral infections can also cause it.",1.6580180914979774e-07,0.08548759919147342,0.055946906277308084,0.012693985253473108,0.07665670596927399,0.06632653061224489,0.012675610786670066,0.14176503124858364,0.02271498107084911,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.3,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always indicate Meniere's disease? Answer: No, low-tone sudden deafness does not always indicate Meniere's disease. While it can be a symptom, it may also arise from other causes including viral infections.",2.6054570009253894e-07,0.2810428065835806,0.005303814871604681,0.019947691112600606,0.26942906820419843,0.007732780612244888,0.019918816950481547,0.2561753824263291,0.02271498107084911,2.6054570009253947e-07,0.29546421289383584,0.0
298,0.3,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Will low-tone sudden deafness definitely develop into Meniere's disease? Answer: No, low-tone sudden deafness does not definitely develop into Meniere's disease. It can be a symptom of Meniere's, but other causes such as viral infections are also possible.",1.8948778188548304e-07,0.2227782198546966,0.021479190804808646,0.014507411718254981,0.21572719854764344,0.014123296377374459,0.014486412327622933,0.2076721821344738,0.00504012096996722,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.3,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is low-tone sudden deafness a guaranteed precursor to Meniere's disease? Answer: No, low-tone sudden deafness is not a guaranteed precursor to Meniere's disease. It might be a symptom, but other factors like viral infections can cause it as well.",1.6580180914979774e-07,0.22767163622940956,0.04168121100682884,0.012693985253473108,0.22258242819242113,0.03747969776145753,0.012675610786670066,0.21669986157938936,0.031162569949559068,1.6580180914979784e-07,0.21618935393522687,0.02775510204081633
298,0.3,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness always progress to Meniere's disease? Answer: No, low-tone sudden deafness does not always progress to Meniere's disease. Although it is a symptom, other causes such as viral infections can also lead to it.",2.1317375462116834e-07,0.2543763899849374,0.024756817928316466,0.016320838183036854,0.2462484573328747,0.016318097486928654,0.0162972138685758,0.23694329272110703,0.005831731731919049,2.1317375462116866e-07,0.23483959107740038,0.0
298,0.3,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is Meniere's disease an inevitable outcome of low-tone sudden deafness? Answer: No, Meniere's disease is not an inevitable outcome of low-tone sudden deafness. It can be one symptom, but other causes like viral infections exist.",2.6054570009253894e-07,0.36025962721900306,0.05701124903711549,0.019947691112600606,0.350975795328897,0.049229024943310704,0.019918816950481547,0.3822021425281372,0.06728501892915092,2.6054570009253947e-07,0.3821076104638301,0.06222222222222223
298,0.3,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Does low-tone sudden deafness necessarily mean Meniere's disease will develop? Answer: No, low-tone sudden deafness does not necessarily mean Meniere's disease will develop. It can be caused by other factors including viral infections.",3.0791764556390954e-07,0.43350318553928613,0.06576038660115596,0.023574544042164365,0.42179375803592123,0.056122448979591844,0.023540420032387294,0.4081340852863651,0.0414942936021592,3.079176455639103e-07,0.4062125460687369,0.033293697978596916
298,0.3,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Is the prognosis of low-tone sudden deafness always linked to Meniere's disease? Answer: No, the prognosis of low-tone sudden deafness is not always linked to Meniere's disease. It may be a symptom, but other causes such as viral infections are possible.",1.1842986367842703e-07,0.23488162080416153,0.07657560953759102,0.009067132323909363,0.23330756574970746,0.07900218911093854,0.009054007704764333,0.23130533480110094,0.07850950872506929,1.1842986367842703e-07,0.19657681707874897,0.05246913580246914
298,0.3,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: No, low-tone sudden deafness doesn't inevitably progress to Meniere's disease. While it is one of the symptoms of Meniere's disease, it can also be caused by other various factors, like viral infections,","Question: Can low-tone sudden deafness occur without progressing to Meniere's disease? Answer: Yes, low-tone sudden deafness can occur without progressing to Meniere's disease. It is one symptom but can also be caused by other factors like viral infections.",2.1317375462116834e-07,0.2918438051503385,0.04900828937732796,0.016320838183036854,0.28475663403064955,0.04304846938775511,0.0162972138685758,0.2765517030388178,0.034217984953026,2.1317375462116866e-07,0.2756129546397501,0.029384756657483937
299,0.3,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is it possible to use mental imagery functional magnetic resonance imaging to forecast recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm shows strong agreement with the subsequent clinical progression of patients in a vegetative state (VS). All five VS patients exhibiting significant activation in regions of interest (ROIs) experienced a favorable clinical outcome by the end of the study.,1.4211583641411244e-07,0.15104164726983083,0.03660024922598627,0.010880558788691236,0.1265379507585127,0.01785123966942149,0.0108648092457172,0.10354067894083929,0.0,1.4211583641411244e-07,0.10536051565782412,0.0
299,0.3,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI predict recovery outcomes in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm correlates highly with the clinical progression of patients in a vegetative state. All five VS patients who demonstrated significant ROI activation had positive clinical courses through the study's conclusion.,2.1317375462116866e-07,0.15664966086174736,0.010881234101145852,0.016320838183036854,0.17994445728119945,0.0034153009733006133,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
299,0.3,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does mental imagery functional MRI have predictive value for recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm aligns closely with the clinical trajectory of patients in a vegetative state. Each of the five VS patients showing notable activation in ROIs had a favorable outcome by the study's end.,1.1842986367842703e-07,0.0455041950861621,0.0332457601777094,0.009067132323909363,0.06877080156225368,0.01785123966942149,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.3,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can recovery in patients with disorders of consciousness be predicted using mental imagery fMRI? Answer: The mental imagery fMRI paradigm exhibits strong concordance with the clinical course of vegetative state patients. All five VS patients with significant ROI activation experienced positive clinical progression until the study's conclusion.,2.3685972735685406e-07,0.17893205442227567,0.009999999999999967,0.018134264647818726,0.17195503779748433,0.01785123966942149,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
299,0.3,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is mental imagery functional MRI effective in predicting recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm shows high agreement with the clinical development of patients in a vegetative state. All five VS patients who had significant activation in ROIs showed favorable outcomes by the end of the follow-up.,1.1842986367842703e-07,0.0455041950861621,0.0332457601777094,0.009067132323909363,0.06877080156225368,0.01785123966942149,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.3,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI serve as a predictor for recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates strong consistency with the clinical course of patients in a vegetative state. All five VS patients with significant ROI activation had a positive clinical progression through the study period.,1.1842986367842703e-07,0.09882320897538888,0.005006915842678754,0.009067132323909363,0.0959530439371532,0.001748760330578504,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
299,0.3,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Does mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows high concordance with the clinical progression of VS patients. All five VS patients showing significant activation in ROIs had favorable clinical outcomes by the end of the study.,1.6580180914979784e-07,0.08579128851722917,0.03247746566502638,0.012693985253473108,0.10877613617595205,0.01785123966942149,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
299,0.3,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery fMRI be used to predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm correlates well with the clinical course of patients in a vegetative state. All five VS patients with significant ROI activation experienced favorable clinical outcomes until the study's conclusion.,1.8948778188548325e-07,0.1631432735788736,0.008494947373334269,0.014507411718254981,0.1582765559020185,0.0029726625487767958,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
299,0.3,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Is the mental imagery fMRI paradigm predictive of recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm exhibits high concordance with the clinical progression of vegetative state patients. All five VS patients who showed significant activation in ROIs had positive clinical courses by the end of the study.,1.1842986367842703e-07,0.12548271592000226,0.02391975308641977,0.009067132323909363,0.1503175286869527,0.04074251033057851,0.009054007704764333,0.1507619542491212,0.039930555555555566,1.1842986367842703e-07,0.12545547010915659,0.020399305555555556
299,0.3,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the,Question: Can mental imagery functional MRI predict the recovery trajectory in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm aligns strongly with the clinical course of patients in a vegetative state. All five VS patients demonstrating significant ROI activation had favorable outcomes through the study's duration.,2.1317375462116866e-07,0.12776852833841623,0.03164523358427083,0.016320838183036854,0.15044883257652097,0.01785123966942149,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
